doc	unit1_toks	unit2_toks	unit1_txt	unit2_txt	u1_raw	u2_raw	s1_toks	s2_toks	unit1_sent	unit2_sent	dir	rel_type	orig_label	label
00c862a6402381a8541bcffe843696e059095300	1-18	19-22	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds ,	aged 15 days .	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds ,	aged 15 days .	1-22	1-22	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds , aged 15 days .	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds , aged 15 days .	1<2	none	elaboration	elaboration
00c862a6402381a8541bcffe843696e059095300	1-18	23-32	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds ,	RT - PCR for TReoV detected 3.3 % positive samples	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds ,	RT - PCR for TReoV detected 3.3 % positive samples	1-22	23-41	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds , aged 15 days .	RT - PCR for TReoV detected 3.3 % positive samples and TReoV was successfully isolated in Vero cells .	1<2	none	findings	findings
00c862a6402381a8541bcffe843696e059095300	23-32	33-41	RT - PCR for TReoV detected 3.3 % positive samples	and TReoV was successfully isolated in Vero cells .	RT - PCR for TReoV detected 3.3 % positive samples	and TReoV was successfully isolated in Vero cells .	23-41	23-41	RT - PCR for TReoV detected 3.3 % positive samples and TReoV was successfully isolated in Vero cells .	RT - PCR for TReoV detected 3.3 % positive samples and TReoV was successfully isolated in Vero cells .	1<2	none	joint	joint
00c862a6402381a8541bcffe843696e059095300	23-32	42-58	RT - PCR for TReoV detected 3.3 % positive samples	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	RT - PCR for TReoV detected 3.3 % positive samples	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	23-41	42-58	RT - PCR for TReoV detected 3.3 % positive samples and TReoV was successfully isolated in Vero cells .	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	1<2	none	elaboration	elaboration
00c862a6402381a8541bcffe843696e059095300	42-58	59-76	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	The number of CD8 ? , CD4 ? and IgM ? cells was lower in infected BF .	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	The number of CD8 ? , CD4 ? and IgM ? cells was lower in infected BF .	42-58	59-76	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	The number of CD8 ? , CD4 ? and IgM ? cells was lower in infected BF .	1<2	none	elaboration	elaboration
00c862a6402381a8541bcffe843696e059095300	77-78,83	84-102	Phylogenetic analysis <*> showed	that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains	Phylogenetic analysis <*> showed	that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains	77-108	77-108	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	1>2	none	attribution	attribution
00c862a6402381a8541bcffe843696e059095300	77-78,83	79-82	Phylogenetic analysis <*> showed	based on S3 gene	Phylogenetic analysis <*> showed	based on S3 gene	77-108	77-108	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	1<2	none	manner-means	manner-means
00c862a6402381a8541bcffe843696e059095300	42-58	84-102	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains	42-58	77-108	Histological analysis of positive bursa of Fabricius ( BF ) revealed atrophied follicles and lymphocyte depletion .	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	1<2	none	joint	joint
00c862a6402381a8541bcffe843696e059095300	84-102	103-108	that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains	circulating in the United States .	that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains	circulating in the United States .	77-108	77-108	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	Phylogenetic analysis based on S3 gene showed that the Brazilian TReoV isolates clustered in a single group with 98 - 100 % similarity to TReoV strains circulating in the United States .	1<2	none	elaboration	elaboration
00c862a6402381a8541bcffe843696e059095300	1-18	109-113	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds ,	This is the first indication	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds ,	This is the first indication	1-22	109-127	In this study , we investigated turkey reovirus ( TReoV ) in tissue samples from young birds , aged 15 days .	This is the first indication that TReoV infection may be a contributing factor to immunosuppression in young birds .	1<2	none	findings	findings
00c862a6402381a8541bcffe843696e059095300	109-113	114-127	This is the first indication	that TReoV infection may be a contributing factor to immunosuppression in young birds .	This is the first indication	that TReoV infection may be a contributing factor to immunosuppression in young birds .	109-127	109-127	This is the first indication that TReoV infection may be a contributing factor to immunosuppression in young birds .	This is the first indication that TReoV infection may be a contributing factor to immunosuppression in young birds .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	1-8	9-16	This is an extensive review on epiphytic plants	that have been used traditionally as medicines .	This is an extensive review on epiphytic plants	that have been used traditionally as medicines .	1-16	1-16	This is an extensive review on epiphytic plants that have been used traditionally as medicines .	This is an extensive review on epiphytic plants that have been used traditionally as medicines .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	1-8	17-29,37-40	This is an extensive review on epiphytic plants	It provides information on 185 epiphytes and their traditional medicinal uses , regions <*> parts of the plants	This is an extensive review on epiphytic plants	It provides information on 185 epiphytes and their traditional medicinal uses , regions <*> parts of the plants	1-16	17-61	This is an extensive review on epiphytic plants that have been used traditionally as medicines .	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	17-29,37-40	30-36	It provides information on 185 epiphytes and their traditional medicinal uses , regions <*> parts of the plants	where Indigenous people use the plants ,	It provides information on 185 epiphytes and their traditional medicinal uses , regions <*> parts of the plants	where Indigenous people use the plants ,	17-61	17-61	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	37-40,44-55	41-43	parts of the plants <*> and their preparation , and their reported phytochemical properties and pharmacological properties	used as medicines	parts of the plants <*> and their preparation , and their reported phytochemical properties and pharmacological properties	used as medicines	17-61	17-61	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	44-55	56-61	and their preparation , and their reported phytochemical properties and pharmacological properties	aligned with their traditional uses .	and their preparation , and their reported phytochemical properties and pharmacological properties	aligned with their traditional uses .	17-61	17-61	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	It provides information on 185 epiphytes and their traditional medicinal uses , regions where Indigenous people use the plants , parts of the plants used as medicines and their preparation , and their reported phytochemical properties and pharmacological properties aligned with their traditional uses .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	1-8	62-75	This is an extensive review on epiphytic plants	These epiphytic medicinal plants are able to produce a range of secondary metabolites ,	This is an extensive review on epiphytic plants	These epiphytic medicinal plants are able to produce a range of secondary metabolites ,	1-16	62-90	This is an extensive review on epiphytic plants that have been used traditionally as medicines .	These epiphytic medicinal plants are able to produce a range of secondary metabolites , including alkaloids , and a total of 842 phytochemicals have been identified to date .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	62-75	76-78	These epiphytic medicinal plants are able to produce a range of secondary metabolites ,	including alkaloids ,	These epiphytic medicinal plants are able to produce a range of secondary metabolites ,	including alkaloids ,	62-90	62-90	These epiphytic medicinal plants are able to produce a range of secondary metabolites , including alkaloids , and a total of 842 phytochemicals have been identified to date .	These epiphytic medicinal plants are able to produce a range of secondary metabolites , including alkaloids , and a total of 842 phytochemicals have been identified to date .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	62-75	79-90	These epiphytic medicinal plants are able to produce a range of secondary metabolites ,	and a total of 842 phytochemicals have been identified to date .	These epiphytic medicinal plants are able to produce a range of secondary metabolites ,	and a total of 842 phytochemicals have been identified to date .	62-90	62-90	These epiphytic medicinal plants are able to produce a range of secondary metabolites , including alkaloids , and a total of 842 phytochemicals have been identified to date .	These epiphytic medicinal plants are able to produce a range of secondary metabolites , including alkaloids , and a total of 842 phytochemicals have been identified to date .	1<2	none	joint	joint
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	1-8	91-104	This is an extensive review on epiphytic plants	As many as 71 epiphytic medicinal plants were studied for their biological activities ,	This is an extensive review on epiphytic plants	As many as 71 epiphytic medicinal plants were studied for their biological activities ,	1-16	91-121	This is an extensive review on epiphytic plants that have been used traditionally as medicines .	As many as 71 epiphytic medicinal plants were studied for their biological activities , showing promising pharmacological activities , including as anti - inflammatory , antimicrobial , and anticancer agents .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	91-104	105-109	As many as 71 epiphytic medicinal plants were studied for their biological activities ,	showing promising pharmacological activities ,	As many as 71 epiphytic medicinal plants were studied for their biological activities ,	showing promising pharmacological activities ,	91-121	91-121	As many as 71 epiphytic medicinal plants were studied for their biological activities , showing promising pharmacological activities , including as anti - inflammatory , antimicrobial , and anticancer agents .	As many as 71 epiphytic medicinal plants were studied for their biological activities , showing promising pharmacological activities , including as anti - inflammatory , antimicrobial , and anticancer agents .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	105-109	110-121	showing promising pharmacological activities ,	including as anti - inflammatory , antimicrobial , and anticancer agents .	showing promising pharmacological activities ,	including as anti - inflammatory , antimicrobial , and anticancer agents .	91-121	91-121	As many as 71 epiphytic medicinal plants were studied for their biological activities , showing promising pharmacological activities , including as anti - inflammatory , antimicrobial , and anticancer agents .	As many as 71 epiphytic medicinal plants were studied for their biological activities , showing promising pharmacological activities , including as anti - inflammatory , antimicrobial , and anticancer agents .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	91-104	122-125	As many as 71 epiphytic medicinal plants were studied for their biological activities ,	There are several species	As many as 71 epiphytic medicinal plants were studied for their biological activities ,	There are several species	91-121	122-138	As many as 71 epiphytic medicinal plants were studied for their biological activities , showing promising pharmacological activities , including as anti - inflammatory , antimicrobial , and anticancer agents .	There are several species that were not investigated for their activities and are worthy of exploration .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	122-125	126-132	There are several species	that were not investigated for their activities	There are several species	that were not investigated for their activities	122-138	122-138	There are several species that were not investigated for their activities and are worthy of exploration .	There are several species that were not investigated for their activities and are worthy of exploration .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	126-132	133-138	that were not investigated for their activities	and are worthy of exploration .	that were not investigated for their activities	and are worthy of exploration .	122-138	122-138	There are several species that were not investigated for their activities and are worthy of exploration .	There are several species that were not investigated for their activities and are worthy of exploration .	1<2	none	joint	joint
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	122-125	139-143	There are several species	These epipythes have the potential	There are several species	These epipythes have the potential	122-138	139-160	There are several species that were not investigated for their activities and are worthy of exploration .	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	139-143	144-149	These epipythes have the potential	to furnish drug lead compounds ,	These epipythes have the potential	to furnish drug lead compounds ,	139-160	139-160	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	1<2	none	enablement	enablement
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	144-149	150-154	to furnish drug lead compounds ,	especially for treating cancers ,	to furnish drug lead compounds ,	especially for treating cancers ,	139-160	139-160	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	1<2	none	elaboration	elaboration
0146a0b36f80ebcb868c7e16fb60c1a9d2afbf83	139-143	155-160	These epipythes have the potential	and thus warrant indepth investigations .	These epipythes have the potential	and thus warrant indepth investigations .	139-160	139-160	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	These epipythes have the potential to furnish drug lead compounds , especially for treating cancers , and thus warrant indepth investigations .	1<2	none	cause-result	cause-result
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	1-16	143-152	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	In this work it is presented a virtual screening methodology	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	In this work it is presented a virtual screening methodology	1-30	143-225	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit - to - lead optimization stages .	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	1>2	none	background	background
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	1-16	17-30	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	to identify hits suitable for subsequent hit - to - lead optimization stages .	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	to identify hits suitable for subsequent hit - to - lead optimization stages .	1-30	1-30	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit - to - lead optimization stages .	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit - to - lead optimization stages .	1<2	none	enablement	enablement
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	1-16	31-42	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	A feature of the LASSBio Chemical Library worth highlighting is the fact	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	A feature of the LASSBio Chemical Library worth highlighting is the fact	1-30	31-60	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit - to - lead optimization stages .	A feature of the LASSBio Chemical Library worth highlighting is the fact that it is a smart library designed by medicinal chemists with pharmacological activity as the main priority .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	31-42	43-48	A feature of the LASSBio Chemical Library worth highlighting is the fact	that it is a smart library	A feature of the LASSBio Chemical Library worth highlighting is the fact	that it is a smart library	31-60	31-60	A feature of the LASSBio Chemical Library worth highlighting is the fact that it is a smart library designed by medicinal chemists with pharmacological activity as the main priority .	A feature of the LASSBio Chemical Library worth highlighting is the fact that it is a smart library designed by medicinal chemists with pharmacological activity as the main priority .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	43-48	49-60	that it is a smart library	designed by medicinal chemists with pharmacological activity as the main priority .	that it is a smart library	designed by medicinal chemists with pharmacological activity as the main priority .	31-60	31-60	A feature of the LASSBio Chemical Library worth highlighting is the fact that it is a smart library designed by medicinal chemists with pharmacological activity as the main priority .	A feature of the LASSBio Chemical Library worth highlighting is the fact that it is a smart library designed by medicinal chemists with pharmacological activity as the main priority .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	1-16	61-79	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	The great majority of the compounds part of this library have shown in vivo activity in animal models ,	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening	The great majority of the compounds part of this library have shown in vivo activity in animal models ,	1-30	61-98	Herein , the LASSBio Chemical Library is presented as a valuable source of compounds for screening to identify hits suitable for subsequent hit - to - lead optimization stages .	The great majority of the compounds part of this library have shown in vivo activity in animal models , which is an indication that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	61-79	80-83	The great majority of the compounds part of this library have shown in vivo activity in animal models ,	which is an indication	The great majority of the compounds part of this library have shown in vivo activity in animal models ,	which is an indication	61-98	61-98	The great majority of the compounds part of this library have shown in vivo activity in animal models , which is an indication that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	The great majority of the compounds part of this library have shown in vivo activity in animal models , which is an indication that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	80-83	84-98	which is an indication	that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	which is an indication	that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	61-98	61-98	The great majority of the compounds part of this library have shown in vivo activity in animal models , which is an indication that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	The great majority of the compounds part of this library have shown in vivo activity in animal models , which is an indication that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	61-79	99-108	The great majority of the compounds part of this library have shown in vivo activity in animal models ,	This , in turn , is supported by the fact	The great majority of the compounds part of this library have shown in vivo activity in animal models ,	This , in turn , is supported by the fact	61-98	99-126	The great majority of the compounds part of this library have shown in vivo activity in animal models , which is an indication that they possess overall favorable bioavailability properties and , hence , adequate pharmacokinetic profiles .	This , in turn , is supported by the fact that approximately 85 % of the compounds are compliant with Lipinski 's rule of five and ca .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	99-108	109-126	This , in turn , is supported by the fact	that approximately 85 % of the compounds are compliant with Lipinski 's rule of five and ca .	This , in turn , is supported by the fact	that approximately 85 % of the compounds are compliant with Lipinski's rule of five and ca .	99-126	99-126	This , in turn , is supported by the fact that approximately 85 % of the compounds are compliant with Lipinski 's rule of five and ca .	This , in turn , is supported by the fact that approximately 85 % of the compounds are compliant with Lipinski 's rule of five and ca .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	109-126	127-142	that approximately 85 % of the compounds are compliant with Lipinski 's rule of five and ca .	95 % are compliant with Veber 's rules , two important guidelines for oral bioavailability .	that approximately 85 % of the compounds are compliant with Lipinski's rule of five and ca .	95 % are compliant with Veber's rules , two important guidelines for oral bioavailability .	99-126	127-142	This , in turn , is supported by the fact that approximately 85 % of the compounds are compliant with Lipinski 's rule of five and ca .	95 % are compliant with Veber 's rules , two important guidelines for oral bioavailability .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	143-152	153-173	In this work it is presented a virtual screening methodology	combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction	In this work it is presented a virtual screening methodology	combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction	143-225	143-225	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	153-173	174-198	combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction	to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme ,	combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction	to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme ,	143-225	143-225	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	1<2	none	enablement	enablement
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	174-198	199-207,221-225	to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme ,	which is related to the development of viral infections <*> cancers and neurological diseases .	to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme ,	which is related to the development of viral infections <*> cancers and neurological diseases .	143-225	143-225	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	199-207,221-225	208-220	which is related to the development of viral infections <*> cancers and neurological diseases .	( including enteroviruses , SARS coronavirus , and hepatitis C virus ) ,	which is related to the development of viral infections <*> cancers and neurological diseases .	( including enteroviruses , SARS coronavirus , and hepatitis C virus ) ,	143-225	143-225	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	143-152	226-245	In this work it is presented a virtual screening methodology	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) ,	In this work it is presented a virtual screening methodology	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) ,	143-225	226-266	In this work it is presented a virtual screening methodology combining a pharmacophore - based model and an empirical Gibbs free energy - based model for the ligand - protein interaction to explore the LASSBio Chemical Library as a source of new hits for the inhibition of the phosphatidylinositol 4-kinase IIIβ ( PI4KIIIβ ) enzyme , which is related to the development of viral infections ( including enteroviruses , SARS coronavirus , and hepatitis C virus ) , cancers and neurological diseases .	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) , which inhibited the target enzyme with IC 50 values of 3.66 μM and IC 50 and 6.09 μM , respectively .	1<2	none	findings	findings
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	226-245	246-266	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) ,	which inhibited the target enzyme with IC 50 values of 3.66 μM and IC 50 and 6.09 μM , respectively .	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) ,	which inhibited the target enzyme with IC 50 values of 3.66 μM and IC 50 and 6.09 μM , respectively .	226-266	226-266	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) , which inhibited the target enzyme with IC 50 values of 3.66 μM and IC 50 and 6.09 μM , respectively .	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) , which inhibited the target enzyme with IC 50 values of 3.66 μM and IC 50 and 6.09 μM , respectively .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	226-245	267-285	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) ,	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ ,	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) ,	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ ,	226-266	267-307	The approach resulted in the identification of two hits , LASSBio-1799 ( 7 ) and LASSBio-1814 ( 10 ) , which inhibited the target enzyme with IC 50 values of 3.66 μM and IC 50 and 6.09 μM , respectively .	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ , demonstrating the importance of both acceptor and donor hydrogen bonding groups for forming interactions with binding site residues Val598 and Lys549 .	1<2	none	elaboration	elaboration
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	267-285	286-296	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ ,	demonstrating the importance of both acceptor and donor hydrogen bonding groups	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ ,	demonstrating the importance of both acceptor and donor hydrogen bonding groups	267-307	267-307	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ , demonstrating the importance of both acceptor and donor hydrogen bonding groups for forming interactions with binding site residues Val598 and Lys549 .	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ , demonstrating the importance of both acceptor and donor hydrogen bonding groups for forming interactions with binding site residues Val598 and Lys549 .	1<2	none	cause-result	cause-result
0232f18e7bbf3192e9e34da1c0abe2a20b2ba1e4	286-296	297-307	demonstrating the importance of both acceptor and donor hydrogen bonding groups	for forming interactions with binding site residues Val598 and Lys549 .	demonstrating the importance of both acceptor and donor hydrogen bonding groups	for forming interactions with binding site residues Val598 and Lys549 .	267-307	267-307	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ , demonstrating the importance of both acceptor and donor hydrogen bonding groups for forming interactions with binding site residues Val598 and Lys549 .	This study also enabled the determination of the structural requirements for interactions with the active site of PI4KIIIβ , demonstrating the importance of both acceptor and donor hydrogen bonding groups for forming interactions with binding site residues Val598 and Lys549 .	1<2	none	elaboration	elaboration
09bdbea1700a3826acc33484ed51e2fa8c23f047	1-10	16-38	Data - centric models of COVID-19 have been tried ,	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	Data - centric models of COVID-19 have been tried ,	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	1-15	16-38	Data - centric models of COVID-19 have been tried , but have certain limitations .	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	1>2	none	background	background
09bdbea1700a3826acc33484ed51e2fa8c23f047	1-10	11-15	Data - centric models of COVID-19 have been tried ,	but have certain limitations .	Data - centric models of COVID-19 have been tried ,	but have certain limitations .	1-15	1-15	Data - centric models of COVID-19 have been tried , but have certain limitations .	Data - centric models of COVID-19 have been tried , but have certain limitations .	1<2	none	comparison	comparison
09bdbea1700a3826acc33484ed51e2fa8c23f047	16-38	39-76	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	An extension to the SEIR model allows us to consider the difference between the appearance ( black - box view ) of the spread of disease , and the real situation ( glass - box view ) .	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	An extension to the SEIR model allows us to consider the difference between the appearance ( black - box view ) of the spread of disease , and the real situation ( glass - box view ) .	16-38	39-76	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	An extension to the SEIR model allows us to consider the difference between the appearance ( black - box view ) of the spread of disease , and the real situation ( glass - box view ) .	1<2	none	elaboration	elaboration
09bdbea1700a3826acc33484ed51e2fa8c23f047	39-76	77-101	An extension to the SEIR model allows us to consider the difference between the appearance ( black - box view ) of the spread of disease , and the real situation ( glass - box view ) .	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters	An extension to the SEIR model allows us to consider the difference between the appearance ( black - box view ) of the spread of disease , and the real situation ( glass - box view ) .	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters	39-76	77-117	An extension to the SEIR model allows us to consider the difference between the appearance ( black - box view ) of the spread of disease , and the real situation ( glass - box view ) .	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters such as the extent to which hygiene and social distancing are observed in a population .	1<2	none	enablement	enablement
09bdbea1700a3826acc33484ed51e2fa8c23f047	77-101	102-105	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters	such as the extent	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters	such as the extent	77-117	77-117	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters such as the extent to which hygiene and social distancing are observed in a population .	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters such as the extent to which hygiene and social distancing are observed in a population .	1<2	none	elaboration	elaboration
09bdbea1700a3826acc33484ed51e2fa8c23f047	102-105	106-117	such as the extent	to which hygiene and social distancing are observed in a population .	such as the extent	to which hygiene and social distancing are observed in a population .	77-117	77-117	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters such as the extent to which hygiene and social distancing are observed in a population .	Our model allows for simulations of lockdowns , social distancing , personal hygiene , quarantine , and hospitalization , with further considerations of different parameters such as the extent to which hygiene and social distancing are observed in a population .	1<2	none	elaboration	elaboration
09bdbea1700a3826acc33484ed51e2fa8c23f047	16-38	118-131	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	Our results give qualitative indications of the effects of various policies and parameters ;	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	Our results give qualitative indications of the effects of various policies and parameters ;	16-38	118-191	In this work , we propose an agent - based model of the epidemic in a confined space of agents representing humans .	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	1<2	none	findings	findings
09bdbea1700a3826acc33484ed51e2fa8c23f047	118-131	132-148	Our results give qualitative indications of the effects of various policies and parameters ;	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	Our results give qualitative indications of the effects of various policies and parameters ;	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	118-191	118-191	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	1<2	none	elaboration	elaboration
09bdbea1700a3826acc33484ed51e2fa8c23f047	132-148	149-155	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	and may indeed make things worse ,	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	and may indeed make things worse ,	118-191	118-191	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	1<2	none	joint	joint
09bdbea1700a3826acc33484ed51e2fa8c23f047	132-148	156-164	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	that social distancing matters more than personal hygiene ,	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	that social distancing matters more than personal hygiene ,	118-191	118-191	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	1<2	none	joint	joint
09bdbea1700a3826acc33484ed51e2fa8c23f047	132-148	165-191	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic	and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	118-191	118-191	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	Our results give qualitative indications of the effects of various policies and parameters ; for instance , that lockdowns by themselves are extremely unlikely to bring an end to an epidemic and may indeed make things worse , that social distancing matters more than personal hygiene , and that the growth of infection comes down significantly for moderately high levels of social distancing and hygiene , even in the absence of herd immunity .	1<2	none	joint	joint
0b362bc7e9278b56c2740ab7bc10e91c036f835a	1-22	23-29	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	We derive a mean - field description	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	We derive a mean - field description	1-22	23-50	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	We derive a mean - field description that accurately captures the salient features of the model , most notably a phase transition between annual and biennial outbreaks .	1<2	none	elaboration	elaboration
0b362bc7e9278b56c2740ab7bc10e91c036f835a	23-29	30-50	We derive a mean - field description	that accurately captures the salient features of the model , most notably a phase transition between annual and biennial outbreaks .	We derive a mean - field description	that accurately captures the salient features of the model , most notably a phase transition between annual and biennial outbreaks .	23-50	23-50	We derive a mean - field description that accurately captures the salient features of the model , most notably a phase transition between annual and biennial outbreaks .	We derive a mean - field description that accurately captures the salient features of the model , most notably a phase transition between annual and biennial outbreaks .	1<2	none	elaboration	elaboration
0b362bc7e9278b56c2740ab7bc10e91c036f835a	1-22	51-64	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit ,	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit ,	1-22	51-76	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit , which confirms the presence of a classical discrete time crystalline phase .	1<2	none	findings	findings
0b362bc7e9278b56c2740ab7bc10e91c036f835a	51-64	65-76	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit ,	which confirms the presence of a classical discrete time crystalline phase .	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit ,	which confirms the presence of a classical discrete time crystalline phase .	51-76	51-76	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit , which confirms the presence of a classical discrete time crystalline phase .	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit , which confirms the presence of a classical discrete time crystalline phase .	1<2	none	elaboration	elaboration
0b362bc7e9278b56c2740ab7bc10e91c036f835a	65-76	77-94	which confirms the presence of a classical discrete time crystalline phase .	We derive the phase diagram of the model both from mean - field theory and from numerics .	which confirms the presence of a classical discrete time crystalline phase .	We derive the phase diagram of the model both from mean - field theory and from numerics .	51-76	77-94	A numerical scaling analysis exhibits a diverging autocorrelation time in the thermodynamic limit , which confirms the presence of a classical discrete time crystalline phase .	We derive the phase diagram of the model both from mean - field theory and from numerics .	1<2	none	elaboration	elaboration
0b362bc7e9278b56c2740ab7bc10e91c036f835a	1-22	95-99	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	Our work offers new perspectives	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	Our work offers new perspectives	1-22	95-139	We study seasonal epidemic spreading in a susceptible - infected - removed - susceptible ( SIRS ) model on smallworld graphs .	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	1<2	none	findings	findings
0b362bc7e9278b56c2740ab7bc10e91c036f835a	100-101	102-117	by demonstrating	that small - worldness and non - Markovianity can stabilize a classical discrete time crystal ,	by demonstrating	that small - worldness and non - Markovianity can stabilize a classical discrete time crystal ,	95-139	95-139	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	1>2	none	attribution	attribution
0b362bc7e9278b56c2740ab7bc10e91c036f835a	95-99	102-117	Our work offers new perspectives	that small - worldness and non - Markovianity can stabilize a classical discrete time crystal ,	Our work offers new perspectives	that small - worldness and non - Markovianity can stabilize a classical discrete time crystal ,	95-139	95-139	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	1<2	none	manner-means	manner-means
0b362bc7e9278b56c2740ab7bc10e91c036f835a	102-117	118-122,130-139	that small - worldness and non - Markovianity can stabilize a classical discrete time crystal ,	and by linking recent efforts <*> to the century - old problem of biennial epidemics .	that small - worldness and non - Markovianity can stabilize a classical discrete time crystal ,	and by linking recent efforts <*> to the century - old problem of biennial epidemics .	95-139	95-139	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	1<2	none	joint	joint
0b362bc7e9278b56c2740ab7bc10e91c036f835a	118-122,130-139	123-129	and by linking recent efforts <*> to the century - old problem of biennial epidemics .	to understand such dynamical phases of matter	and by linking recent efforts <*> to the century - old problem of biennial epidemics .	to understand such dynamical phases of matter	95-139	95-139	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	Our work offers new perspectives by demonstrating that small - worldness and non - Markovianity can stabilize a classical discrete time crystal , and by linking recent efforts to understand such dynamical phases of matter to the century - old problem of biennial epidemics .	1<2	none	enablement	enablement
0b6936373351a029b06b8784ff8077d755e7ee96	1-35	83-101	Ebola virus ( EBOV ) , a non - segmented single - stranded RNA virus , is often - most transmitted through body fluids like sweat , tears , saliva , and nasal secretions .	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	Ebola virus ( EBOV ) , a non - segmented single - stranded RNA virus , is often - most transmitted through body fluids like sweat , tears , saliva , and nasal secretions .	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	1-35	83-120	Ebola virus ( EBOV ) , a non - segmented single - stranded RNA virus , is often - most transmitted through body fluids like sweat , tears , saliva , and nasal secretions .	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	1>2	none	background	background
0b6936373351a029b06b8784ff8077d755e7ee96	1-35	36-51	Ebola virus ( EBOV ) , a non - segmented single - stranded RNA virus , is often - most transmitted through body fluids like sweat , tears , saliva , and nasal secretions .	Till date , there is no licensed vaccine of EBOV is available in the market ;	Ebola virus ( EBOV ) , a non - segmented single - stranded RNA virus , is often - most transmitted through body fluids like sweat , tears , saliva , and nasal secretions .	Till date , there is no licensed vaccine of EBOV is available in the market ;	1-35	36-51	Ebola virus ( EBOV ) , a non - segmented single - stranded RNA virus , is often - most transmitted through body fluids like sweat , tears , saliva , and nasal secretions .	Till date , there is no licensed vaccine of EBOV is available in the market ;	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	36-51	52-63	Till date , there is no licensed vaccine of EBOV is available in the market ;	however , the world is increasingly vulnerable to this emerging threat .	Till date , there is no licensed vaccine of EBOV is available in the market ;	however , the world is increasingly vulnerable to this emerging threat .	36-51	52-63	Till date , there is no licensed vaccine of EBOV is available in the market ;	however , the world is increasingly vulnerable to this emerging threat .	1<2	none	comparison	comparison
0b6936373351a029b06b8784ff8077d755e7ee96	52-63	64-77	however , the world is increasingly vulnerable to this emerging threat .	Hence , it is the need of time to develop a vaccine for EBOV	however , the world is increasingly vulnerable to this emerging threat .	Hence , it is the need of time to develop a vaccine for EBOV	52-63	64-82	however , the world is increasingly vulnerable to this emerging threat .	Hence , it is the need of time to develop a vaccine for EBOV to hinder its dissemination .	1<2	none	cause-result	cause-result
0b6936373351a029b06b8784ff8077d755e7ee96	64-77	78-82	Hence , it is the need of time to develop a vaccine for EBOV	to hinder its dissemination .	Hence , it is the need of time to develop a vaccine for EBOV	to hinder its dissemination .	64-82	64-82	Hence , it is the need of time to develop a vaccine for EBOV to hinder its dissemination .	Hence , it is the need of time to develop a vaccine for EBOV to hinder its dissemination .	1<2	none	enablement	enablement
0b6936373351a029b06b8784ff8077d755e7ee96	83-101	102-108	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	using the Immuno - informatics tools ,	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	using the Immuno - informatics tools ,	83-120	83-120	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	1<2	none	manner-means	manner-means
0b6936373351a029b06b8784ff8077d755e7ee96	83-101	109-120	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	and it helped in finding the potent vaccine candidates against EBOV .	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	and it helped in finding the potent vaccine candidates against EBOV .	83-120	83-120	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	83-101	121-136	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	Prediction , antigenicity and allergenicity testing of predicted B and T cells' epitopes was done	83-120	121-154	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done as well to identify their potential as a vaccine candidate and to measure their safety level respectively .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	121-136	137-146	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done	as well to identify their potential as a vaccine candidate	Prediction , antigenicity and allergenicity testing of predicted B and T cells' epitopes was done	as well to identify their potential as a vaccine candidate	121-154	121-154	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done as well to identify their potential as a vaccine candidate and to measure their safety level respectively .	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done as well to identify their potential as a vaccine candidate and to measure their safety level respectively .	1<2	none	enablement	enablement
0b6936373351a029b06b8784ff8077d755e7ee96	137-146	147-154	as well to identify their potential as a vaccine candidate	and to measure their safety level respectively .	as well to identify their potential as a vaccine candidate	and to measure their safety level respectively .	121-154	121-154	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done as well to identify their potential as a vaccine candidate and to measure their safety level respectively .	Prediction , antigenicity and allergenicity testing of predicted B and T cells ' epitopes was done as well to identify their potential as a vaccine candidate and to measure their safety level respectively .	1<2	none	joint	joint
0b6936373351a029b06b8784ff8077d755e7ee96	83-101	155-167	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	The current study has been designed for identification and characterization of the potential B and T - cell epitopes	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	83-120	155-180	The current study has been designed for identification and characterization of the potential B and T - cell epitopes using the Immuno - informatics tools , and it helped in finding the potent vaccine candidates against EBOV .	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	1<2	none	findings	findings
0b6936373351a029b06b8784ff8077d755e7ee96	155-167	168-174	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	and it would play an important role	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	and it would play an important role	155-180	155-180	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	1<2	none	joint	joint
0b6936373351a029b06b8784ff8077d755e7ee96	168-174	175-180	and it would play an important role	in evoking the immune response .	and it would play an important role	in evoking the immune response .	155-180	155-180	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	155-167	181-199	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score ,	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score ,	155-180	181-214	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score , which binds to MHC class - I and MHC class - II alleles respectively .	1<2	none	joint	joint
0b6936373351a029b06b8784ff8077d755e7ee96	181-199	200-214	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score ,	which binds to MHC class - I and MHC class - II alleles respectively .	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score ,	which binds to MHC class - I and MHC class - II alleles respectively .	181-214	181-214	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score , which binds to MHC class - I and MHC class - II alleles respectively .	In T - cell epitopes , peptides " AIGLAWIPY " and " IRGFPRCRY " presented high antigenicity score , which binds to MHC class - I and MHC class - II alleles respectively .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	155-167	215-219	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	All predicted epitopes were analyzed	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score	All predicted epitopes were analyzed	155-180	215-227	Among B - cell epitopes " WIPAGIGVTGVIIA " showed a high antigenicity score and it would play an important role in evoking the immune response .	All predicted epitopes were analyzed and compared with already reported peptides carefully .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	215-219	220-227	All predicted epitopes were analyzed	and compared with already reported peptides carefully .	All predicted epitopes were analyzed	and compared with already reported peptides carefully .	215-227	215-227	All predicted epitopes were analyzed and compared with already reported peptides carefully .	All predicted epitopes were analyzed and compared with already reported peptides carefully .	1<2	none	joint	joint
0b6936373351a029b06b8784ff8077d755e7ee96	215-219	228-230,236-244	All predicted epitopes were analyzed	Comparatively , Peptides <*> showed more immunogenicity score than already reported peptides ,	All predicted epitopes were analyzed	Comparatively , Peptides <*> showed more immunogenicity score than already reported peptides ,	215-227	228-258	All predicted epitopes were analyzed and compared with already reported peptides carefully .	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	228-230,236-244	231-235	Comparatively , Peptides <*> showed more immunogenicity score than already reported peptides ,	predicted in the present study	Comparatively , Peptides <*> showed more immunogenicity score than already reported peptides ,	predicted in the present study	228-258	228-258	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	236-244	245-249	showed more immunogenicity score than already reported peptides ,	used as positive control ,	showed more immunogenicity score than already reported peptides ,	used as positive control ,	228-258	228-258	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	1<2	none	elaboration	elaboration
0b6936373351a029b06b8784ff8077d755e7ee96	236-244	250-253	showed more immunogenicity score than already reported peptides ,	and are more immunogenic	showed more immunogenicity score than already reported peptides ,	and are more immunogenic	228-258	228-258	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	1<2	none	joint	joint
0b6936373351a029b06b8784ff8077d755e7ee96	250-253	254-258	and are more immunogenic	as compared to them .	and are more immunogenic	as compared to them .	228-258	228-258	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	Comparatively , Peptides predicted in the present study showed more immunogenicity score than already reported peptides , used as positive control , and are more immunogenic as compared to them .	1<2	none	comparison	comparison
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	1-2	3-38	Background :	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	Background :	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	1-2	3-49	Background :	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis , all three associated with bovine respiratory disease ( BRD ) .	1>2	none	textual-organization	textual-organization
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	3-38	39-49	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	all three associated with bovine respiratory disease ( BRD ) .	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	all three associated with bovine respiratory disease ( BRD ) .	3-49	3-49	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis , all three associated with bovine respiratory disease ( BRD ) .	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis , all three associated with bovine respiratory disease ( BRD ) .	1<2	none	elaboration	elaboration
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	3-38	50-80	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	Primers and probes of the RespoCheck Mycoplasma triplex real - time PCR are based on the V3 / V4 region of the 16S rRNA gene of the three Mycoplasma species .	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	Primers and probes of the RespoCheck Mycoplasma triplex real - time PCR are based on the V3 / V4 region of the 16S rRNA gene of the three Mycoplasma species .	3-49	50-80	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis , all three associated with bovine respiratory disease ( BRD ) .	Primers and probes of the RespoCheck Mycoplasma triplex real - time PCR are based on the V3 / V4 region of the 16S rRNA gene of the three Mycoplasma species .	1<2	none	elaboration	elaboration
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	81-82	83-95,110-131	Results :	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	Results :	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	81-82	83-131	Results :	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	1>2	none	textual-organization	textual-organization
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	3-38	83-95,110-131	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	3-49	83-131	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis , all three associated with bovine respiratory disease ( BRD ) .	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	1<2	none	findings	findings
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	83-95,110-131	96-109	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline ,	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline ,	83-131	83-131	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	1<2	none	manner-means	manner-means
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	83-95,110-131	132-145,152-169	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	83-131	132-169	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined on purified DNA , 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	1<2	none	joint	joint
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	132-145,152-169	146-151	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	as determined on purified DNA ,	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	as determined on purified DNA ,	132-169	132-169	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined on purified DNA , 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	The analytical sensitivity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined on purified DNA , 10 fg DNA per assay for M. dispar and 100 fg fo rM. bovis and M. bovirhinis .	1<2	none	manner-means	manner-means
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	83-95,110-131	170-183,205-221	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	83-131	170-221	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	1<2	none	joint	joint
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	170-183,205-221	184-189,195-198	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	as determined by testing Mycoplasmas strains <*> and other bacterial strains	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , <*> 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	as determined by testing Mycoplasmas strains <*> and other bacterial strains	170-221	170-221	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	1<2	none	manner-means	manner-means
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	184-189,195-198	190-194	as determined by testing Mycoplasmas strains <*> and other bacterial strains	( n = 17 )	as determined by testing Mycoplasmas strains <*> and other bacterial strains	( n = 17 )	170-221	170-221	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	1<2	none	elaboration	elaboration
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	195-198	199-204	and other bacterial strains	( n = 107 ) ,	and other bacterial strains	( n = 107 ) ,	170-221	170-221	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	The analytical specificity of the RespoCheck Mycoplasma triplex real - time PCR was , as determined by testing Mycoplasmas strains ( n = 17 ) and other bacterial strains ( n = 107 ) , 100 , 98.2 and 99.1 % for M. bovis , M. dispar and M. bovirhinis respectively .	1<2	none	elaboration	elaboration
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	83-95,110-131	222-247	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively	The analytical sensitivity of the RespoCheck triplex real - time PCR was , <*> 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively	83-131	222-255	The analytical sensitivity of the RespoCheck triplex real - time PCR was , as determined by spiking experiments of the Mycoplasma strains in Phosphate Buffered Saline , 300 colony forming units ( cfu)/mL for M. dispar , and 30 cfu / mL for M. bovis or M. bovirhinis .	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively by testing 44 BALF samples from calves .	1<2	none	elaboration	elaboration
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	222-247	248-255	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively	by testing 44 BALF samples from calves .	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively	by testing 44 BALF samples from calves .	222-255	222-255	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively by testing 44 BALF samples from calves .	The RespoCheck Mycoplasma triplex real - time PCR was compared with the PCR / DGGE analysis for M. bovis , M. dispar and M. bovirhinis respectively by testing 44 BALF samples from calves .	1<2	none	manner-means	manner-means
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	256-257	258-278	Conclusion :	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species	Conclusion :	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species	256-257	258-285	Conclusion :	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species associated with in bovine respiratory disease .	1>2	none	textual-organization	textual-organization
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	3-38	258-278	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis ,	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species	3-49	258-285	In this study we evaluated the RespoCheck Mycoplasma triplex real - time PCR for the detection in bronchoalveolar lavage fluid ( BALF ) of Mycoplasma ( M. ) dispar , M. bovis and M. bovirhinis , all three associated with bovine respiratory disease ( BRD ) .	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species associated with in bovine respiratory disease .	1<2	none	findings	findings
0b7581ab8ae5da78a11692b4c7d9399ec6dea283	258-278	279-285	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species	associated with in bovine respiratory disease .	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species	associated with in bovine respiratory disease .	258-285	258-285	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species associated with in bovine respiratory disease .	In conclusion , the RespoCheck PCR assay can be a valuable tool for timely and accurate detection of three Mycoplasma species associated with in bovine respiratory disease .	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	1-21	117-120,134-139	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	that emerging diseases , <*> have occurred throughout recorded history .	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	that emerging diseases , <*> have occurred throughout recorded history .	1-21	106-139	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	1>2	none	background	background
0c44f901baca3850ff6e79e5f26ee898faa9b68d	1-21	22-43	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal	1-21	22-48	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal or caused international alarm .	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	22-43	44-48	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal	or caused international alarm .	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal	or caused international alarm .	22-48	22-48	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal or caused international alarm .	HIV / AIDS , severe acute respiratory syndrome , H5N1 avian influenza , and many other emerging diseases have either proved fatal or caused international alarm .	1<2	none	joint	joint
0c44f901baca3850ff6e79e5f26ee898faa9b68d	1-21	49-58,69-72	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	Common and interactive co - determinants of disease emergence , <*> have been increasingly documented	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	Common and interactive co - determinants of disease emergence , <*> have been increasingly documented	1-21	49-75	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	Common and interactive co - determinants of disease emergence , including population growth , travel , and environmental disruption , have been increasingly documented and studied .	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	49-58,69-72	59-68	Common and interactive co - determinants of disease emergence , <*> have been increasingly documented	including population growth , travel , and environmental disruption ,	Common and interactive co - determinants of disease emergence , <*> have been increasingly documented	including population growth , travel , and environmental disruption ,	49-75	49-75	Common and interactive co - determinants of disease emergence , including population growth , travel , and environmental disruption , have been increasingly documented and studied .	Common and interactive co - determinants of disease emergence , including population growth , travel , and environmental disruption , have been increasingly documented and studied .	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	69-72	73-75	have been increasingly documented	and studied .	have been increasingly documented	and studied .	49-75	49-75	Common and interactive co - determinants of disease emergence , including population growth , travel , and environmental disruption , have been increasingly documented and studied .	Common and interactive co - determinants of disease emergence , including population growth , travel , and environmental disruption , have been increasingly documented and studied .	1<2	none	joint	joint
0c44f901baca3850ff6e79e5f26ee898faa9b68d	1-21	76-81	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	Are emerging infections a new phenomenon	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	Are emerging infections a new phenomenon	1-21	76-105	Emerging and re - emerging infectious diseases , and their determinants , have recently attracted substantial scientific and popular attention .	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	76-81	82-86	Are emerging infections a new phenomenon	related to modern life ,	Are emerging infections a new phenomenon	related to modern life ,	76-105	76-105	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	76-81	87-92,102-105	Are emerging infections a new phenomenon	or do more basic determinants , <*> govern disease generation ?	Are emerging infections a new phenomenon	or do more basic determinants , <*> govern disease generation ?	76-105	76-105	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	1<2	none	joint	joint
0c44f901baca3850ff6e79e5f26ee898faa9b68d	87-92,102-105	93-101	or do more basic determinants , <*> govern disease generation ?	transcending time , place , and human progress ,	or do more basic determinants , <*> govern disease generation ?	transcending time , place , and human progress ,	76-105	76-105	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	Are emerging infections a new phenomenon related to modern life , or do more basic determinants , transcending time , place , and human progress , govern disease generation ?	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	106-114	117-120,134-139	By examining a number of historically notable epidemics ,	that emerging diseases , <*> have occurred throughout recorded history .	By examining a number of historically notable epidemics ,	that emerging diseases , <*> have occurred throughout recorded history .	106-139	106-139	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	1>2	none	manner-means	manner-means
0c44f901baca3850ff6e79e5f26ee898faa9b68d	115-116	117-120,134-139	we suggest	that emerging diseases , <*> have occurred throughout recorded history .	we suggest	that emerging diseases , <*> have occurred throughout recorded history .	106-139	106-139	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	1>2	none	attribution	attribution
0c44f901baca3850ff6e79e5f26ee898faa9b68d	117-120,134-139	121-133	that emerging diseases , <*> have occurred throughout recorded history .	similar in their novelty , impact , and elicitation of control responses ,	that emerging diseases , <*> have occurred throughout recorded history .	similar in their novelty , impact , and elicitation of control responses ,	106-139	106-139	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	1<2	none	comparison	comparison
0c44f901baca3850ff6e79e5f26ee898faa9b68d	117-120,134-139	140-142,148-153	that emerging diseases , <*> have occurred throughout recorded history .	Fundamental determinants , <*> seem to underlie their emergence ,	that emerging diseases , <*> have occurred throughout recorded history .	Fundamental determinants , <*> seem to underlie their emergence ,	106-139	140-169	By examining a number of historically notable epidemics , we suggest that emerging diseases , similar in their novelty , impact , and elicitation of control responses , have occurred throughout recorded history .	Fundamental determinants , typically acting in concert , seem to underlie their emergence , and infections such as these are likely to continue to remain challenges to human survival .	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	140-142,148-153	143-147	Fundamental determinants , <*> seem to underlie their emergence ,	typically acting in concert ,	Fundamental determinants , <*> seem to underlie their emergence ,	typically acting in concert ,	140-169	140-169	Fundamental determinants , typically acting in concert , seem to underlie their emergence , and infections such as these are likely to continue to remain challenges to human survival .	Fundamental determinants , typically acting in concert , seem to underlie their emergence , and infections such as these are likely to continue to remain challenges to human survival .	1<2	none	elaboration	elaboration
0c44f901baca3850ff6e79e5f26ee898faa9b68d	148-153	154-169	seem to underlie their emergence ,	and infections such as these are likely to continue to remain challenges to human survival .	seem to underlie their emergence ,	and infections such as these are likely to continue to remain challenges to human survival .	140-169	140-169	Fundamental determinants , typically acting in concert , seem to underlie their emergence , and infections such as these are likely to continue to remain challenges to human survival .	Fundamental determinants , typically acting in concert , seem to underlie their emergence , and infections such as these are likely to continue to remain challenges to human survival .	1<2	none	elaboration	elaboration
1399e34d62b515e482ccde6c4cae500b19546909	1-15	16-38,50-57	Influenza viruses are among the major infectious disease threats of animal and human health .	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range <*> and implications to animal and human health .	Influenza viruses are among the major infectious disease threats of animal and human health .	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range <*> and implications to animal and human health .	1-15	16-57	Influenza viruses are among the major infectious disease threats of animal and human health .	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range including the ability to cross species barriers and geographic boundaries , and implications to animal and human health .	1>2	none	background	background
1399e34d62b515e482ccde6c4cae500b19546909	16-38,50-57	39-41	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range <*> and implications to animal and human health .	including the ability	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range <*> and implications to animal and human health .	including the ability	16-57	16-57	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range including the ability to cross species barriers and geographic boundaries , and implications to animal and human health .	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range including the ability to cross species barriers and geographic boundaries , and implications to animal and human health .	1<2	none	elaboration	elaboration
1399e34d62b515e482ccde6c4cae500b19546909	39-41	42-49	including the ability	to cross species barriers and geographic boundaries ,	including the ability	to cross species barriers and geographic boundaries ,	16-57	16-57	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range including the ability to cross species barriers and geographic boundaries , and implications to animal and human health .	This review examines the recent discovery of novel influenza viruses in bats and cattle , the evolving complexity of influenza virus host range including the ability to cross species barriers and geographic boundaries , and implications to animal and human health .	1<2	none	enablement	enablement
13e4291652008b528006f89f67d55955c2aac729	1-10	128-132,147-149	Hepatitis B virus ( HBV ) is a DNA virus	Therefore , a detailed study <*> was performed .	Hepatitis B virus ( HBV ) is a DNA virus	Therefore , a detailed study <*> was performed .	1-18	128-149	Hepatitis B virus ( HBV ) is a DNA virus that infects the liver as primary target .	Therefore , a detailed study to investigate the binding of HBV to DC - SIGN and L - SIGN was performed .	1>2	none	background	background
13e4291652008b528006f89f67d55955c2aac729	1-10	11-18	Hepatitis B virus ( HBV ) is a DNA virus	that infects the liver as primary target .	Hepatitis B virus ( HBV ) is a DNA virus	that infects the liver as primary target .	1-18	1-18	Hepatitis B virus ( HBV ) is a DNA virus that infects the liver as primary target .	Hepatitis B virus ( HBV ) is a DNA virus that infects the liver as primary target .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	1-10	19-30	Hepatitis B virus ( HBV ) is a DNA virus	Currently , a high affinity receptor for HBV is still unknown .	Hepatitis B virus ( HBV ) is a DNA virus	Currently , a high affinity receptor for HBV is still unknown .	1-18	19-30	Hepatitis B virus ( HBV ) is a DNA virus that infects the liver as primary target .	Currently , a high affinity receptor for HBV is still unknown .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	19-30	31-50	Currently , a high affinity receptor for HBV is still unknown .	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose	Currently , a high affinity receptor for HBV is still unknown .	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose	19-30	31-64	Currently , a high affinity receptor for HBV is still unknown .	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose containing carbohydrates leading to the induction of an anti - viral immune response .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	31-50	51-52	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose	containing carbohydrates	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose	containing carbohydrates	31-64	31-64	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose containing carbohydrates leading to the induction of an anti - viral immune response .	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose containing carbohydrates leading to the induction of an anti - viral immune response .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	51-52	53-64	containing carbohydrates	leading to the induction of an anti - viral immune response .	containing carbohydrates	leading to the induction of an anti - viral immune response .	31-64	31-64	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose containing carbohydrates leading to the induction of an anti - viral immune response .	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose containing carbohydrates leading to the induction of an anti - viral immune response .	1<2	none	cause-result	cause-result
13e4291652008b528006f89f67d55955c2aac729	31-50	65-72	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose	Many glycosylated viruses subvert this immune surveillance function	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose	Many glycosylated viruses subvert this immune surveillance function	31-64	65-91	The dendritic cell specific C - type lectin DC - SIGN is involved in pathogen recognition through mannose and fucose containing carbohydrates leading to the induction of an anti - viral immune response .	Many glycosylated viruses subvert this immune surveillance function and exploit DC - SIGN as a port of entry and for trans - infection of target cells .	1<2	none	comparison	comparison
13e4291652008b528006f89f67d55955c2aac729	65-72	73-91	Many glycosylated viruses subvert this immune surveillance function	and exploit DC - SIGN as a port of entry and for trans - infection of target cells .	Many glycosylated viruses subvert this immune surveillance function	and exploit DC - SIGN as a port of entry and for trans - infection of target cells .	65-91	65-91	Many glycosylated viruses subvert this immune surveillance function and exploit DC - SIGN as a port of entry and for trans - infection of target cells .	Many glycosylated viruses subvert this immune surveillance function and exploit DC - SIGN as a port of entry and for trans - infection of target cells .	1<2	none	joint	joint
13e4291652008b528006f89f67d55955c2aac729	65-72	92-127	Many glycosylated viruses subvert this immune surveillance function	The glycosylation pattern on HBV surface antigens ( HBsAg ) together with the tissue distribution of HBV would allow interaction between HBV and DC - SIGN and its liver - expressed homologue L - SIGN .	Many glycosylated viruses subvert this immune surveillance function	The glycosylation pattern on HBV surface antigens ( HBsAg ) together with the tissue distribution of HBV would allow interaction between HBV and DC - SIGN and its liver - expressed homologue L - SIGN .	65-91	92-127	Many glycosylated viruses subvert this immune surveillance function and exploit DC - SIGN as a port of entry and for trans - infection of target cells .	The glycosylation pattern on HBV surface antigens ( HBsAg ) together with the tissue distribution of HBV would allow interaction between HBV and DC - SIGN and its liver - expressed homologue L - SIGN .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	128-132,147-149	133-146	Therefore , a detailed study <*> was performed .	to investigate the binding of HBV to DC - SIGN and L - SIGN	Therefore , a detailed study <*> was performed .	to investigate the binding of HBV to DC - SIGN and L - SIGN	128-149	128-149	Therefore , a detailed study to investigate the binding of HBV to DC - SIGN and L - SIGN was performed .	Therefore , a detailed study to investigate the binding of HBV to DC - SIGN and L - SIGN was performed .	1<2	none	enablement	enablement
13e4291652008b528006f89f67d55955c2aac729	128-132,147-149	150-170	Therefore , a detailed study <*> was performed .	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	Therefore , a detailed study <*> was performed .	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	128-149	150-170	Therefore , a detailed study to investigate the binding of HBV to DC - SIGN and L - SIGN was performed .	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	1<2	none	findings	findings
13e4291652008b528006f89f67d55955c2aac729	150-170	171-186	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	Soluble DC - SIGN and L - SIGN specifically bound HCV virus - like particles ,	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	Soluble DC - SIGN and L - SIGN specifically bound HCV virus - like particles ,	150-170	171-198	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	Soluble DC - SIGN and L - SIGN specifically bound HCV virus - like particles , but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	150-170	187-198	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	150-170	171-198	For HCV , both DC - SIGN and L - SIGN are known to bind envelope glycoproteins E1 and E2 .	Soluble DC - SIGN and L - SIGN specifically bound HCV virus - like particles , but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	1<2	none	comparison	comparison
13e4291652008b528006f89f67d55955c2aac729	187-198	199-214	but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	Also , neither DC - SIGN nor L - SIGN transfected Raji cells bound HBsAg .	but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	Also , neither DC - SIGN nor L - SIGN transfected Raji cells bound HBsAg .	171-198	199-214	Soluble DC - SIGN and L - SIGN specifically bound HCV virus - like particles , but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	Also , neither DC - SIGN nor L - SIGN transfected Raji cells bound HBsAg .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	187-198	215-221,238-244	but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	In contrast , highly mannosylated HBV , <*> is recognized by DC - SIGN .	but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	In contrast , highly mannosylated HBV , <*> is recognized by DC - SIGN .	171-198	215-244	Soluble DC - SIGN and L - SIGN specifically bound HCV virus - like particles , but no interaction with either HBsAg or HepG2.2.15-derived HBV was detected .	In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .	1<2	none	comparison	comparison
13e4291652008b528006f89f67d55955c2aac729	215-221,238-244	222	In contrast , highly mannosylated HBV , <*> is recognized by DC - SIGN .	obtained	In contrast , highly mannosylated HBV , <*> is recognized by DC - SIGN .	obtained	215-244	215-244	In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .	In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .	1<2	none	elaboration	elaboration
13e4291652008b528006f89f67d55955c2aac729	222	223-237	obtained	by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine ,	obtained	by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine ,	215-244	215-244	In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .	In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .	1<2	none	manner-means	manner-means
13e4291652008b528006f89f67d55955c2aac729	215-221,238-244	245-264	In contrast , highly mannosylated HBV , <*> is recognized by DC - SIGN .	The a - mannosidase I trimming of N - linked oligosaccharide structures thus prevents recognition by DC - SIGN .	In contrast , highly mannosylated HBV , <*> is recognized by DC - SIGN .	The a - mannosidase I trimming of N - linked oligosaccharide structures thus prevents recognition by DC - SIGN .	215-244	245-264	In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .	The a - mannosidase I trimming of N - linked oligosaccharide structures thus prevents recognition by DC - SIGN .	1<2	none	cause-result	cause-result
13e4291652008b528006f89f67d55955c2aac729	128-132,147-149	265-284	Therefore , a detailed study <*> was performed .	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way	Therefore , a detailed study <*> was performed .	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way	128-149	265-300	Therefore , a detailed study to investigate the binding of HBV to DC - SIGN and L - SIGN was performed .	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way to escape recognition by DC - SIGN and thereby subvert a possible immune activation response .	1<2	none	findings	findings
13e4291652008b528006f89f67d55955c2aac729	265-284	285-291	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way	to escape recognition by DC - SIGN	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way	to escape recognition by DC - SIGN	265-300	265-300	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way to escape recognition by DC - SIGN and thereby subvert a possible immune activation response .	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way to escape recognition by DC - SIGN and thereby subvert a possible immune activation response .	1<2	none	enablement	enablement
13e4291652008b528006f89f67d55955c2aac729	285-291	292-300	to escape recognition by DC - SIGN	and thereby subvert a possible immune activation response .	to escape recognition by DC - SIGN	and thereby subvert a possible immune activation response .	265-300	265-300	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way to escape recognition by DC - SIGN and thereby subvert a possible immune activation response .	On the basis of these findings , it is tempting to speculate that HBV exploits mannose trimming as a way to escape recognition by DC - SIGN and thereby subvert a possible immune activation response .	1<2	none	cause-result	cause-result
1723e7c27aadbc83619fd69629fcc089e700418b	1-20	90-107	The COVID-19 pandemic has forced us to consider the physiologic role of obesity in the response to infectious disease .	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation )	The COVID-19 pandemic has forced us to consider the physiologic role of obesity in the response to infectious disease .	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation )	1-20	90-114	The COVID-19 pandemic has forced us to consider the physiologic role of obesity in the response to infectious disease .	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation ) that characterizes obesity on innate immunity .	1>2	none	background	background
1723e7c27aadbc83619fd69629fcc089e700418b	1-20	21-36	The COVID-19 pandemic has forced us to consider the physiologic role of obesity in the response to infectious disease .	There are significant disparities in morbidity and mortality by sex , weight and diabetes status .	The COVID-19 pandemic has forced us to consider the physiologic role of obesity in the response to infectious disease .	There are significant disparities in morbidity and mortality by sex , weight and diabetes status .	1-20	21-36	The COVID-19 pandemic has forced us to consider the physiologic role of obesity in the response to infectious disease .	There are significant disparities in morbidity and mortality by sex , weight and diabetes status .	1<2	none	elaboration	elaboration
1723e7c27aadbc83619fd69629fcc089e700418b	21-36	37-49	There are significant disparities in morbidity and mortality by sex , weight and diabetes status .	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection	There are significant disparities in morbidity and mortality by sex , weight and diabetes status .	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection	21-36	37-67	There are significant disparities in morbidity and mortality by sex , weight and diabetes status .	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection including hormone and immune mediators , hyperglycemia , leukocyte responses , cytokine secretion , and tissue dysfunction .	1<2	none	elaboration	elaboration
1723e7c27aadbc83619fd69629fcc089e700418b	37-49	50-67	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection	including hormone and immune mediators , hyperglycemia , leukocyte responses , cytokine secretion , and tissue dysfunction .	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection	including hormone and immune mediators , hyperglycemia , leukocyte responses , cytokine secretion , and tissue dysfunction .	37-67	37-67	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection including hormone and immune mediators , hyperglycemia , leukocyte responses , cytokine secretion , and tissue dysfunction .	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection including hormone and immune mediators , hyperglycemia , leukocyte responses , cytokine secretion , and tissue dysfunction .	1<2	none	elaboration	elaboration
1723e7c27aadbc83619fd69629fcc089e700418b	37-49	68-82	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses	37-67	68-89	Numerous endocrine changes might drive these varied responses to SARS - CoV-2 infection including hormone and immune mediators , hyperglycemia , leukocyte responses , cytokine secretion , and tissue dysfunction .	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses in driving immunopathology and tissue injury .	1<2	none	elaboration	elaboration
1723e7c27aadbc83619fd69629fcc089e700418b	68-82	83-89	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses	in driving immunopathology and tissue injury .	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses	in driving immunopathology and tissue injury .	68-89	68-89	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses in driving immunopathology and tissue injury .	Studies of patients with severe COVID-19 disease have revealed the importance of innate immune responses in driving immunopathology and tissue injury .	1<2	none	elaboration	elaboration
1723e7c27aadbc83619fd69629fcc089e700418b	90-107	108-114	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation )	that characterizes obesity on innate immunity .	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation )	that characterizes obesity on innate immunity .	90-114	90-114	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation ) that characterizes obesity on innate immunity .	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation ) that characterizes obesity on innate immunity .	1<2	none	elaboration	elaboration
1723e7c27aadbc83619fd69629fcc089e700418b	115-116	117-139	We consider	that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	We consider	that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	115-139	115-139	We consider that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	We consider that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	1>2	none	attribution	attribution
1723e7c27aadbc83619fd69629fcc089e700418b	90-107	117-139	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation )	that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation )	that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	90-114	115-139	In this review we will describe the impact of the metabolically induced inflammation ( meta - inflammation ) that characterizes obesity on innate immunity .	We consider that obesity - driven dysregulation of innate immune responses may drive organ injury in development of severe COVID-19 and impair viral clearance .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	1-12,20-22	13-19	We investigate the difference in the spread of COVID-19 between the states <*> and the states	won by Donald Trump ( Red )	We investigate the difference in the spread of COVID-19 between the states <*> and the states	won by Donald Trump ( Red )	1-49	1-49	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	20-22	23-35	and the states	won by Hillary Clinton ( Blue ) in the 2016 presidential election ,	and the states	won by Hillary Clinton ( Blue ) in the 2016 presidential election ,	1-49	1-49	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	1-12,20-22	36-49	We investigate the difference in the spread of COVID-19 between the states <*> and the states	by mining transportation patterns of US residents from March 2020 to July 2020 .	We investigate the difference in the spread of COVID-19 between the states <*> and the states	by mining transportation patterns of US residents from March 2020 to July 2020 .	1-49	1-49	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	1<2	none	manner-means	manner-means
17c5d5036721bc5935b23a9e23f69fde366ecc20	50-55	56-64	To ensure a fair comparison ,	we first use a K - means clustering method	To ensure a fair comparison ,	we first use a K - means clustering method	50-82	50-82	To ensure a fair comparison , we first use a K - means clustering method to group the 50 states into five clusters according to their population , area and population density .	To ensure a fair comparison , we first use a K - means clustering method to group the 50 states into five clusters according to their population , area and population density .	1>2	none	enablement	enablement
17c5d5036721bc5935b23a9e23f69fde366ecc20	1-12,20-22	56-64	We investigate the difference in the spread of COVID-19 between the states <*> and the states	we first use a K - means clustering method	We investigate the difference in the spread of COVID-19 between the states <*> and the states	we first use a K - means clustering method	1-49	50-82	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	To ensure a fair comparison , we first use a K - means clustering method to group the 50 states into five clusters according to their population , area and population density .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	56-64	65-82	we first use a K - means clustering method	to group the 50 states into five clusters according to their population , area and population density .	we first use a K - means clustering method	to group the 50 states into five clusters according to their population , area and population density .	50-82	50-82	To ensure a fair comparison , we first use a K - means clustering method to group the 50 states into five clusters according to their population , area and population density .	To ensure a fair comparison , we first use a K - means clustering method to group the 50 states into five clusters according to their population , area and population density .	1<2	none	enablement	enablement
17c5d5036721bc5935b23a9e23f69fde366ecc20	56-64	83-94	we first use a K - means clustering method	We then characterize daily transportation patterns of the residents of different states	we first use a K - means clustering method	We then characterize daily transportation patterns of the residents of different states	50-82	83-109	To ensure a fair comparison , we first use a K - means clustering method to group the 50 states into five clusters according to their population , area and population density .	We then characterize daily transportation patterns of the residents of different states using the mean percentage of residents traveling and the number of trips per person .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	83-94	95-100,102-109	We then characterize daily transportation patterns of the residents of different states	using the mean percentage of residents <*> and the number of trips per person .	We then characterize daily transportation patterns of the residents of different states	using the mean percentage of residents <*> and the number of trips per person .	83-109	83-109	We then characterize daily transportation patterns of the residents of different states using the mean percentage of residents traveling and the number of trips per person .	We then characterize daily transportation patterns of the residents of different states using the mean percentage of residents traveling and the number of trips per person .	1<2	none	manner-means	manner-means
17c5d5036721bc5935b23a9e23f69fde366ecc20	95-100,102-109	101	using the mean percentage of residents <*> and the number of trips per person .	traveling	using the mean percentage of residents <*> and the number of trips per person .	traveling	83-109	83-109	We then characterize daily transportation patterns of the residents of different states using the mean percentage of residents traveling and the number of trips per person .	We then characterize daily transportation patterns of the residents of different states using the mean percentage of residents traveling and the number of trips per person .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	83-94	110-136	We then characterize daily transportation patterns of the residents of different states	For each state , we study the correlations between travel patterns and infection rate for a 2-month period before and after the official states reopening dates .	We then characterize daily transportation patterns of the residents of different states	For each state , we study the correlations between travel patterns and infection rate for a 2-month period before and after the official states reopening dates .	83-109	110-136	We then characterize daily transportation patterns of the residents of different states using the mean percentage of residents traveling and the number of trips per person .	For each state , we study the correlations between travel patterns and infection rate for a 2-month period before and after the official states reopening dates .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	137-138	139-162	We observe	that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	We observe	that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	137-162	137-162	We observe that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	We observe that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	1>2	none	attribution	attribution
17c5d5036721bc5935b23a9e23f69fde366ecc20	1-12,20-22	139-162	We investigate the difference in the spread of COVID-19 between the states <*> and the states	that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	We investigate the difference in the spread of COVID-19 between the states <*> and the states	that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	1-49	137-162	We investigate the difference in the spread of COVID-19 between the states won by Donald Trump ( Red ) and the states won by Hillary Clinton ( Blue ) in the 2016 presidential election , by mining transportation patterns of US residents from March 2020 to July 2020 .	We observe that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	1<2	none	findings	findings
17c5d5036721bc5935b23a9e23f69fde366ecc20	139-162	163-164,170-187	that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	However , <*> that Red states had higher travel - infection correlations than Blue states in all five state clusters .	that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	However , <*> that Red states had higher travel - infection correlations than Blue states in all five state clusters .	137-162	163-187	We observe that during the lock - down , Red and Blue states both displayed strong positive correlations between their travel patterns and infection rates .	However , after states reopened we find that Red states had higher travel - infection correlations than Blue states in all five state clusters .	1<2	none	comparison	comparison
17c5d5036721bc5935b23a9e23f69fde366ecc20	165-167	170-187	after states reopened	that Red states had higher travel - infection correlations than Blue states in all five state clusters .	after states reopened	that Red states had higher travel - infection correlations than Blue states in all five state clusters .	163-187	163-187	However , after states reopened we find that Red states had higher travel - infection correlations than Blue states in all five state clusters .	However , after states reopened we find that Red states had higher travel - infection correlations than Blue states in all five state clusters .	1>2	none	temporal	temporal
17c5d5036721bc5935b23a9e23f69fde366ecc20	168-169	170-187	we find	that Red states had higher travel - infection correlations than Blue states in all five state clusters .	we find	that Red states had higher travel - infection correlations than Blue states in all five state clusters .	163-187	163-187	However , after states reopened we find that Red states had higher travel - infection correlations than Blue states in all five state clusters .	However , after states reopened we find that Red states had higher travel - infection correlations than Blue states in all five state clusters .	1>2	none	attribution	attribution
17c5d5036721bc5935b23a9e23f69fde366ecc20	188-189	190-211	We find	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	We find	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	188-237	188-237	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	1>2	none	attribution	attribution
17c5d5036721bc5935b23a9e23f69fde366ecc20	163-164,170-187	190-211	However , <*> that Red states had higher travel - infection correlations than Blue states in all five state clusters .	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	However , <*> that Red states had higher travel - infection correlations than Blue states in all five state clusters .	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	163-187	188-237	However , after states reopened we find that Red states had higher travel - infection correlations than Blue states in all five state clusters .	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	212-215	216-237	leading us to conclude	that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	leading us to conclude	that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	188-237	188-237	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	1>2	none	attribution	attribution
17c5d5036721bc5935b23a9e23f69fde366ecc20	190-211	216-237	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	188-237	188-237	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	1<2	none	cause-result	cause-result
17c5d5036721bc5935b23a9e23f69fde366ecc20	190-211	238-243	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	Furthermore , we use temperature data	that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states ,	Furthermore , we use temperature data	188-237	238-259	We find that the residents of both Red and Blue states displayed similar travel patterns during the period post the reopening of states , leading us to conclude that , on average , the residents in Red states might be mobilizing less safely than the residents in Blue states .	Furthermore , we use temperature data to attempt to explain the difference in the way residents travel and practice safety measures .	1<2	none	elaboration	elaboration
17c5d5036721bc5935b23a9e23f69fde366ecc20	238-243	244-252	Furthermore , we use temperature data	to attempt to explain the difference in the way	Furthermore , we use temperature data	to attempt to explain the difference in the way	238-259	238-259	Furthermore , we use temperature data to attempt to explain the difference in the way residents travel and practice safety measures .	Furthermore , we use temperature data to attempt to explain the difference in the way residents travel and practice safety measures .	1<2	none	enablement	enablement
17c5d5036721bc5935b23a9e23f69fde366ecc20	244-252	253-259	to attempt to explain the difference in the way	residents travel and practice safety measures .	to attempt to explain the difference in the way	residents travel and practice safety measures .	238-259	238-259	Furthermore , we use temperature data to attempt to explain the difference in the way residents travel and practice safety measures .	Furthermore , we use temperature data to attempt to explain the difference in the way residents travel and practice safety measures .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	1-2	3-26	Background :	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	Background :	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	1-2	3-26	Background :	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	1>2	none	textual-organization	textual-organization
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	3-26	68-76	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	3-26	68-76	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	1>2	none	background	background
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	3-26	27-45	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap , effective vaccines .	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap , effective vaccines .	3-26	27-45	Human immunodeficiency virus type 1 ( HIV-1 ) has infected more than 40 million people worldwide , mainly in sub - Saharan Africa .	The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap , effective vaccines .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	27-45	46-55	The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap , effective vaccines .	One means of production is the use of plants ,	The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap , effective vaccines .	One means of production is the use of plants ,	27-45	46-67	The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap , effective vaccines .	One means of production is the use of plants , for which a number of different techniques have been successfully developed .	1<2	none	manner-means	manner-means
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	46-55	56-67	One means of production is the use of plants ,	for which a number of different techniques have been successfully developed .	One means of production is the use of plants ,	for which a number of different techniques have been successfully developed .	46-67	46-67	One means of production is the use of plants , for which a number of different techniques have been successfully developed .	One means of production is the use of plants , for which a number of different techniques have been successfully developed .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	68-76	77-100	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	68-76	77-114	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp . using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	77-100	101-114	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	77-114	77-114	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp . using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp . using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	1<2	none	manner-means	manner-means
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	77-100	115-139	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	We also investigated the influence of subcellular localisation of recombinant protein to the chloroplast and the endoplasmic reticulum ( ER ) on protein yield .	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	We also investigated the influence of subcellular localisation of recombinant protein to the chloroplast and the endoplasmic reticulum ( ER ) on protein yield .	77-114	115-139	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp . using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	We also investigated the influence of subcellular localisation of recombinant protein to the chloroplast and the endoplasmic reticulum ( ER ) on protein yield .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	77-100	140-146	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	We partially purified a selected vaccine candidate	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp .	We partially purified a selected vaccine candidate	77-114	140-160	we compared the expression of this and a truncated Gag ( p17 / p24 ) and the p24 capsid subunit in Nicotiana spp . using transgenic plants and transient expression via Agrobacterium tumefaciens and recombinant tobamovirus vectors .	We partially purified a selected vaccine candidate and tested its stimulation of a humoral and cellular immune response in mice .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	140-146	147-160	We partially purified a selected vaccine candidate	and tested its stimulation of a humoral and cellular immune response in mice .	We partially purified a selected vaccine candidate	and tested its stimulation of a humoral and cellular immune response in mice .	140-160	140-160	We partially purified a selected vaccine candidate and tested its stimulation of a humoral and cellular immune response in mice .	We partially purified a selected vaccine candidate and tested its stimulation of a humoral and cellular immune response in mice .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	68-76	161-172	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Both transient and transgenic expression of the HIV antigens were successful ,	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Both transient and transgenic expression of the HIV antigens were successful ,	68-76	161-182	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Both transient and transgenic expression of the HIV antigens were successful , although expression of Pr55Gag was low in all systems ;	1<2	none	findings	findings
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	161-172	173-182	Both transient and transgenic expression of the HIV antigens were successful ,	although expression of Pr55Gag was low in all systems ;	Both transient and transgenic expression of the HIV antigens were successful ,	although expression of Pr55Gag was low in all systems ;	161-182	161-182	Both transient and transgenic expression of the HIV antigens were successful , although expression of Pr55Gag was low in all systems ;	Both transient and transgenic expression of the HIV antigens were successful , although expression of Pr55Gag was low in all systems ;	1<2	none	comparison	comparison
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	161-172	183-210	Both transient and transgenic expression of the HIV antigens were successful ,	however , the Agrobacterium - mediated transient expression of p24 and p17 / p24 yielded best , to more than 1 mg p24 / kg fresh weight .	Both transient and transgenic expression of the HIV antigens were successful ,	however , the Agrobacterium - mediated transient expression of p24 and p17 / p24 yielded best , to more than 1 mg p24 / kg fresh weight .	161-182	183-210	Both transient and transgenic expression of the HIV antigens were successful , although expression of Pr55Gag was low in all systems ;	however , the Agrobacterium - mediated transient expression of p24 and p17 / p24 yielded best , to more than 1 mg p24 / kg fresh weight .	1<2	none	comparison	comparison
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	183-210	211-228	however , the Agrobacterium - mediated transient expression of p24 and p17 / p24 yielded best , to more than 1 mg p24 / kg fresh weight .	Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17 / p24 .	however , the Agrobacterium - mediated transient expression of p24 and p17 / p24 yielded best , to more than 1 mg p24 / kg fresh weight .	Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17 / p24 .	183-210	211-228	however , the Agrobacterium - mediated transient expression of p24 and p17 / p24 yielded best , to more than 1 mg p24 / kg fresh weight .	Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17 / p24 .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	211-228	229-245	Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17 / p24 .	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine ,	Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17 / p24 .	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine ,	211-228	229-264	Chloroplast targeted protein levels were highest in transient and transgenic expression of p24 and p17 / p24 .	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine , but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine , pTHGagC.	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	229-245	246-256	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine ,	but it significantly boosted a humoral and T cell immune response	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine ,	but it significantly boosted a humoral and T cell immune response	229-264	229-264	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine , but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine , pTHGagC.	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine , but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine , pTHGagC.	1<2	none	comparison	comparison
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	246-256	257-264	but it significantly boosted a humoral and T cell immune response	primed by a gag DNA vaccine , pTHGagC.	but it significantly boosted a humoral and T cell immune response	primed by a gag DNA vaccine , pTHGagC.	229-264	229-264	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine , but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine , pTHGagC.	The transiently - expressed p17 / p24 was not immunogenic in mice as a homologous vaccine , but it significantly boosted a humoral and T cell immune response primed by a gag DNA vaccine , pTHGagC.	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	265-266	267-280	Conclusion :	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	Conclusion :	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	265-266	267-295	Conclusion :	Transient agroinfiltration was best for expression of all of the recombinant proteins tested , and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	1>2	none	textual-organization	textual-organization
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	68-76	267-280	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	68-76	267-295	HIV-1 Pr55Gag is a promising HIV-1 vaccine candidate :	Transient agroinfiltration was best for expression of all of the recombinant proteins tested , and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	1<2	none	findings	findings
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	267-280	281-295	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	267-295	267-295	Transient agroinfiltration was best for expression of all of the recombinant proteins tested , and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	Transient agroinfiltration was best for expression of all of the recombinant proteins tested , and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	1<2	none	joint	joint
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	267-280	296-304	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	Our results highlight the usefulness of plastid signal peptides	Transient agroinfiltration was best for expression of all of the recombinant proteins tested ,	Our results highlight the usefulness of plastid signal peptides	267-295	296-317	Transient agroinfiltration was best for expression of all of the recombinant proteins tested , and p24 and p17 / p24 were expressed at much higher levels than Pr55Gag .	Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	296-304	305-311	Our results highlight the usefulness of plastid signal peptides	in enhancing the production of recombinant proteins	Our results highlight the usefulness of plastid signal peptides	in enhancing the production of recombinant proteins	296-317	296-317	Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines .	Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	305-311	312-317	in enhancing the production of recombinant proteins	meant for use as vaccines .	in enhancing the production of recombinant proteins	meant for use as vaccines .	296-317	296-317	Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines .	Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines .	1<2	none	enablement	enablement
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	296-304	318-331	Our results highlight the usefulness of plastid signal peptides	The p17 / p24 protein effectively boosted T cell and humoral responses in mice	Our results highlight the usefulness of plastid signal peptides	The p17 / p24 protein effectively boosted T cell and humoral responses in mice	296-317	318-353	Our results highlight the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines .	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	318-331	332-338	The p17 / p24 protein effectively boosted T cell and humoral responses in mice	primed by the DNA vaccine pTHGagC ,	The p17 / p24 protein effectively boosted T cell and humoral responses in mice	primed by the DNA vaccine pTHGagC ,	318-353	318-353	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	1<2	none	elaboration	elaboration
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	339	340-353	showing	that this plant - produced protein has potential for use as a vaccine .	showing	that this plant - produced protein has potential for use as a vaccine .	318-353	318-353	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	1>2	none	attribution	attribution
1b7c700ee3a33c0a675a5f7e71a20ce62467b900	318-331	340-353	The p17 / p24 protein effectively boosted T cell and humoral responses in mice	that this plant - produced protein has potential for use as a vaccine .	The p17 / p24 protein effectively boosted T cell and humoral responses in mice	that this plant - produced protein has potential for use as a vaccine .	318-353	318-353	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	The p17 / p24 protein effectively boosted T cell and humoral responses in mice primed by the DNA vaccine pTHGagC , showing that this plant - produced protein has potential for use as a vaccine .	1<2	none	cause-result	cause-result
1ca87acde2d673e129b4360d84dce19f2555438b	1-52	181-196	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies	In this chapter , we review published studies for evidence of CLI risk - modulating factors	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies	In this chapter , we review published studies for evidence of CLI risk - modulating factors	1-64	181-303	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies to qualify as being ill based on personal and cultural definitions .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1>2	none	background	background
1ca87acde2d673e129b4360d84dce19f2555438b	1-52	53-57	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies	to qualify as being ill	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies	to qualify as being ill	1-64	1-64	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies to qualify as being ill based on personal and cultural definitions .	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies to qualify as being ill based on personal and cultural definitions .	1<2	none	enablement	enablement
1ca87acde2d673e129b4360d84dce19f2555438b	53-57	58-64	to qualify as being ill	based on personal and cultural definitions .	to qualify as being ill	based on personal and cultural definitions .	1-64	1-64	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies to qualify as being ill based on personal and cultural definitions .	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies to qualify as being ill based on personal and cultural definitions .	1<2	none	manner-means	manner-means
1ca87acde2d673e129b4360d84dce19f2555438b	1-52	65-94	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers	1-64	65-106	The development of a " cold - like illness " ( CLI ) usually requires infection with an upper respiratory virus such as rhinovirus , influenza virus , respiratory syncytial virus , parainfluenza virus , coronavirus or adenovirus , among others , and the development of sufficient signs , symptoms and pathophysiologies to qualify as being ill based on personal and cultural definitions .	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers and , therefore , will not be diagnosed as a CLI .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	65-94	95-106	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers	and , therefore , will not be diagnosed as a CLI .	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers	and , therefore , will not be diagnosed as a CLI .	65-106	65-106	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers and , therefore , will not be diagnosed as a CLI .	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers and , therefore , will not be diagnosed as a CLI .	1<2	none	cause-result	cause-result
1ca87acde2d673e129b4360d84dce19f2555438b	65-94	107-110,115-124	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers	The degree of illness <*> is directly related to the extent of provoked inflammation ,	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers	The degree of illness <*> is directly related to the extent of provoked inflammation ,	65-106	107-136	A viral upper respiratory tract infection ( vURTI ) in the absence of overt illness ( subclinical vURTI ) will not be made manifest to the individual or to observers and , therefore , will not be diagnosed as a CLI .	The degree of illness occurring during a vURTI is directly related to the extent of provoked inflammation , which in turn depends on the engagement of antiviral defense systems .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	107-110,115-124	111-114	The degree of illness <*> is directly related to the extent of provoked inflammation ,	occurring during a vURTI	The degree of illness <*> is directly related to the extent of provoked inflammation ,	occurring during a vURTI	107-136	107-136	The degree of illness occurring during a vURTI is directly related to the extent of provoked inflammation , which in turn depends on the engagement of antiviral defense systems .	The degree of illness occurring during a vURTI is directly related to the extent of provoked inflammation , which in turn depends on the engagement of antiviral defense systems .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	115-124	125-136	is directly related to the extent of provoked inflammation ,	which in turn depends on the engagement of antiviral defense systems .	is directly related to the extent of provoked inflammation ,	which in turn depends on the engagement of antiviral defense systems .	107-136	107-136	The degree of illness occurring during a vURTI is directly related to the extent of provoked inflammation , which in turn depends on the engagement of antiviral defense systems .	The degree of illness occurring during a vURTI is directly related to the extent of provoked inflammation , which in turn depends on the engagement of antiviral defense systems .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	107-110,115-124	137-148,158-164	The degree of illness <*> is directly related to the extent of provoked inflammation ,	Thus , risk factors for CLI can modulate either the vURTI risk <*> or the CLI risk given a vURTI	The degree of illness <*> is directly related to the extent of provoked inflammation ,	Thus , risk factors for CLI can modulate either the vURTI risk <*> or the CLI risk given a vURTI	107-136	137-180	The degree of illness occurring during a vURTI is directly related to the extent of provoked inflammation , which in turn depends on the engagement of antiviral defense systems .	Thus , risk factors for CLI can modulate either the vURTI risk by affecting virus exposure and/or susceptibility to infection , or the CLI risk given a vURTI by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	1<2	none	cause-result	cause-result
1ca87acde2d673e129b4360d84dce19f2555438b	137-148,158-164	149-157	Thus , risk factors for CLI can modulate either the vURTI risk <*> or the CLI risk given a vURTI	by affecting virus exposure and/or susceptibility to infection ,	Thus , risk factors for CLI can modulate either the vURTI risk <*> or the CLI risk given a vURTI	by affecting virus exposure and/or susceptibility to infection ,	137-180	137-180	Thus , risk factors for CLI can modulate either the vURTI risk by affecting virus exposure and/or susceptibility to infection , or the CLI risk given a vURTI by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	Thus , risk factors for CLI can modulate either the vURTI risk by affecting virus exposure and/or susceptibility to infection , or the CLI risk given a vURTI by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	1<2	none	manner-means	manner-means
1ca87acde2d673e129b4360d84dce19f2555438b	158-164	165-180	or the CLI risk given a vURTI	by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	or the CLI risk given a vURTI	by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	137-180	137-180	Thus , risk factors for CLI can modulate either the vURTI risk by affecting virus exposure and/or susceptibility to infection , or the CLI risk given a vURTI by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	Thus , risk factors for CLI can modulate either the vURTI risk by affecting virus exposure and/or susceptibility to infection , or the CLI risk given a vURTI by affecting immunocompetence , the provoked inflammation and/or the interpretation of illness as a CLI .	1<2	none	manner-means	manner-means
1ca87acde2d673e129b4360d84dce19f2555438b	197-198	199-216	and report	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	and report	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1>2	none	attribution	attribution
1ca87acde2d673e129b4360d84dce19f2555438b	181-196	199-216	In this chapter , we review published studies for evidence of CLI risk - modulating factors	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	In this chapter , we review published studies for evidence of CLI risk - modulating factors	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	findings	findings
1ca87acde2d673e129b4360d84dce19f2555438b	199-216	217-229	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	that extant immunological factors and age can affect the probability of virus infection	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	that extant immunological factors and age can affect the probability of virus infection	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	joint	joint
1ca87acde2d673e129b4360d84dce19f2555438b	217-229	230-232	that extant immunological factors and age can affect the probability of virus infection	given exposure ,	that extant immunological factors and age can affect the probability of virus infection	given exposure ,	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	condition	condition
1ca87acde2d673e129b4360d84dce19f2555438b	199-216	233-235,243-244	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	that stress levels <*> health practices	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	that stress levels <*> health practices	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	joint	joint
1ca87acde2d673e129b4360d84dce19f2555438b	233-235,243-244	236-242	that stress levels <*> health practices	( moderated by social environment ) ,	that stress levels <*> health practices	( moderated by social environment ) ,	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	243-244,256-261	245-255	health practices <*> and genetics contribute to CLI risk	( exercise , tobacco and alcohol consumption , sleep efficiency )	health practices <*> and genetics contribute to CLI risk	( exercise , tobacco and alcohol consumption , sleep efficiency )	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	256-261	262-273	and genetics contribute to CLI risk	most probably by modulating the immune - inflammatory response to infection ,	and genetics contribute to CLI risk	most probably by modulating the immune - inflammatory response to infection ,	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	manner-means	manner-means
1ca87acde2d673e129b4360d84dce19f2555438b	199-216	274-277,288-290	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	and that other factors <*> affect CLI risk	that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses ,	and that other factors <*> affect CLI risk	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	joint	joint
1ca87acde2d673e129b4360d84dce19f2555438b	274-277,288-290	278-287	and that other factors <*> affect CLI risk	such as pollution , home environment and certain personality traits	and that other factors <*> affect CLI risk	such as pollution , home environment and certain personality traits	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	elaboration	elaboration
1ca87acde2d673e129b4360d84dce19f2555438b	288-290	291-303	affect CLI risk	by biasing illness interpretation for a given set of symptoms and signs .	affect CLI risk	by biasing illness interpretation for a given set of symptoms and signs .	181-303	181-303	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	In this chapter , we review published studies for evidence of CLI risk - modulating factors and report that climate , crowding and perhaps female gender can affect the probability of exposure to vURTI viruses , that extant immunological factors and age can affect the probability of virus infection given exposure , that stress levels ( moderated by social environment ) , health practices ( exercise , tobacco and alcohol consumption , sleep efficiency ) and genetics contribute to CLI risk most probably by modulating the immune - inflammatory response to infection , and that other factors such as pollution , home environment and certain personality traits affect CLI risk by biasing illness interpretation for a given set of symptoms and signs .	1<2	none	manner-means	manner-means
1d5a95f805753e4ae9c605845a395adf47cabce8	1-10	70-83	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus	In this study 2000 aerial net - captured houseflies were examined for their ability	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus	In this study 2000 aerial net - captured houseflies were examined for their ability	1-18	70-92	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus shed in the faeces of infected birds .	In this study 2000 aerial net - captured houseflies were examined for their ability to harbour Newcastle disease virus ( NDV ) .	1>2	none	background	background
1d5a95f805753e4ae9c605845a395adf47cabce8	1-10	11-18	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus	shed in the faeces of infected birds .	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus	shed in the faeces of infected birds .	1-18	1-18	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus shed in the faeces of infected birds .	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus shed in the faeces of infected birds .	1<2	none	elaboration	elaboration
1d5a95f805753e4ae9c605845a395adf47cabce8	1-10	19-30	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus	Non - biting Muscid flies characteristically visit manure and decaying organic material	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus	Non - biting Muscid flies characteristically visit manure and decaying organic material	1-18	19-42	Newcastle disease ( Paramyxoviridae ) is a highly infectious virus shed in the faeces of infected birds .	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	1<2	none	elaboration	elaboration
1d5a95f805753e4ae9c605845a395adf47cabce8	19-30	31-32	Non - biting Muscid flies characteristically visit manure and decaying organic material	to feed	Non - biting Muscid flies characteristically visit manure and decaying organic material	to feed	19-42	19-42	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	1<2	none	enablement	enablement
1d5a95f805753e4ae9c605845a395adf47cabce8	31-32	33-35	to feed	and oviposit ,	to feed	and oviposit ,	19-42	19-42	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	1<2	none	joint	joint
1d5a95f805753e4ae9c605845a395adf47cabce8	19-30	36-42	Non - biting Muscid flies characteristically visit manure and decaying organic material	and may contribute to disease transmission .	Non - biting Muscid flies characteristically visit manure and decaying organic material	and may contribute to disease transmission .	19-42	19-42	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	1<2	none	cause-result	cause-result
1d5a95f805753e4ae9c605845a395adf47cabce8	19-30	43-69	Non - biting Muscid flies characteristically visit manure and decaying organic material	The housefly , Musca domestica ( Linnaeus , 1758 ) ( Diptera : Muscidae ) , has been implicated as a mechanical vector of numerous pathogens .	Non - biting Muscid flies characteristically visit manure and decaying organic material	The housefly , Musca domestica ( Linnaeus , 1758 ) ( Diptera : Muscidae ) , has been implicated as a mechanical vector of numerous pathogens .	19-42	43-69	Non - biting Muscid flies characteristically visit manure and decaying organic material to feed and oviposit , and may contribute to disease transmission .	The housefly , Musca domestica ( Linnaeus , 1758 ) ( Diptera : Muscidae ) , has been implicated as a mechanical vector of numerous pathogens .	1<2	none	elaboration	elaboration
1d5a95f805753e4ae9c605845a395adf47cabce8	70-83	84-92	In this study 2000 aerial net - captured houseflies were examined for their ability	to harbour Newcastle disease virus ( NDV ) .	In this study 2000 aerial net - captured houseflies were examined for their ability	to harbour Newcastle disease virus ( NDV ) .	70-92	70-92	In this study 2000 aerial net - captured houseflies were examined for their ability to harbour Newcastle disease virus ( NDV ) .	In this study 2000 aerial net - captured houseflies were examined for their ability to harbour Newcastle disease virus ( NDV ) .	1<2	none	enablement	enablement
1d5a95f805753e4ae9c605845a395adf47cabce8	70-83	93-110	In this study 2000 aerial net - captured houseflies were examined for their ability	In an adjacent study , laboratory - reared flies were experimentally exposed to NDV La Sota strain .	In this study 2000 aerial net - captured houseflies were examined for their ability	In an adjacent study , laboratory - reared flies were experimentally exposed to NDV La Sota strain .	70-92	93-110	In this study 2000 aerial net - captured houseflies were examined for their ability to harbour Newcastle disease virus ( NDV ) .	In an adjacent study , laboratory - reared flies were experimentally exposed to NDV La Sota strain .	1<2	none	elaboration	elaboration
1d5a95f805753e4ae9c605845a395adf47cabce8	93-110	111-133	In an adjacent study , laboratory - reared flies were experimentally exposed to NDV La Sota strain .	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure ,	In an adjacent study , laboratory - reared flies were experimentally exposed to NDV La Sota strain .	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure ,	93-110	111-141	In an adjacent study , laboratory - reared flies were experimentally exposed to NDV La Sota strain .	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure , whereas the untreated control flies were negative .	1<2	none	findings	findings
1d5a95f805753e4ae9c605845a395adf47cabce8	111-133	134-141	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure ,	whereas the untreated control flies were negative .	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure ,	whereas the untreated control flies were negative .	111-141	111-141	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure , whereas the untreated control flies were negative .	The virus was detected in the dissected gastrointestinal tract of laboratory - exposed flies for up to 72 h post - exposure , whereas the untreated control flies were negative .	1<2	none	comparison	comparison
1dc818a92b31dc871d7020ec659faaeb38e519c6	1-11	53-56	Respiratory viral infections in infants and young children frequently cause illness	This review discusses vaccines	Respiratory viral infections in infants and young children frequently cause illness	This review discusses vaccines	1-20	53-103	Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death .	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	1>2	none	background	background
1dc818a92b31dc871d7020ec659faaeb38e519c6	1-11	12-20	Respiratory viral infections in infants and young children frequently cause illness	that can easily progress to hospitalization and death .	Respiratory viral infections in infants and young children frequently cause illness	that can easily progress to hospitalization and death .	1-20	1-20	Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death .	Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death .	1<2	none	cause-result	cause-result
1dc818a92b31dc871d7020ec659faaeb38e519c6	1-11	21-26	Respiratory viral infections in infants and young children frequently cause illness	There are currently no licensed vaccines	Respiratory viral infections in infants and young children frequently cause illness	There are currently no licensed vaccines	1-20	21-52	Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death .	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	1<2	none	comparison	comparison
1dc818a92b31dc871d7020ec659faaeb38e519c6	21-26	27-38	There are currently no licensed vaccines	to prevent respiratory viral disease in children younger than 6 months ,	There are currently no licensed vaccines	to prevent respiratory viral disease in children younger than 6 months ,	21-52	21-52	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	1<2	none	enablement	enablement
1dc818a92b31dc871d7020ec659faaeb38e519c6	21-26	39-44	There are currently no licensed vaccines	reflecting safety concerns and the difficulty	There are currently no licensed vaccines	reflecting safety concerns and the difficulty	21-52	21-52	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	1<2	none	cause-result	cause-result
1dc818a92b31dc871d7020ec659faaeb38e519c6	39-44	45-52	reflecting safety concerns and the difficulty	in inducing effective immune responses in infants .	reflecting safety concerns and the difficulty	in inducing effective immune responses in infants .	21-52	21-52	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months , reflecting safety concerns and the difficulty in inducing effective immune responses in infants .	1<2	none	elaboration	elaboration
1dc818a92b31dc871d7020ec659faaeb38e519c6	53-56	57-79	This review discusses vaccines	that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies	This review discusses vaccines	that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies	53-103	53-103	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	1<2	none	elaboration	elaboration
1dc818a92b31dc871d7020ec659faaeb38e519c6	57-79	80	that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies	performed	that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies	performed	53-103	53-103	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	1<2	none	elaboration	elaboration
1dc818a92b31dc871d7020ec659faaeb38e519c6	80	81-103	performed	to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	performed	to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	53-103	53-103	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	This review discusses vaccines that have been developed , or are currently being developed , against influenza and respiratory syncytial virus , with a focus on studies performed to demonstrate their safety and efficacy , and the impact of immunologic immaturity and maternal antibodies on the infant response to vaccines .	1<2	none	enablement	enablement
1ea771012595cf18bfe22d4933e45b8a190881fc	1-8	44-56	The novel Coronavirus has caused a global crisis	In this paper , we utilize a discrete - time Markov chain approach	The novel Coronavirus has caused a global crisis	In this paper , we utilize a discrete - time Markov chain approach	1-25	44-88	The novel Coronavirus has caused a global crisis and many governments have taken social measures , such as home quarantine and maintaining social distance .	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	1>2	none	background	background
1ea771012595cf18bfe22d4933e45b8a190881fc	1-8	9-16	The novel Coronavirus has caused a global crisis	and many governments have taken social measures ,	The novel Coronavirus has caused a global crisis	and many governments have taken social measures ,	1-25	1-25	The novel Coronavirus has caused a global crisis and many governments have taken social measures , such as home quarantine and maintaining social distance .	The novel Coronavirus has caused a global crisis and many governments have taken social measures , such as home quarantine and maintaining social distance .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	9-16	17-25	and many governments have taken social measures ,	such as home quarantine and maintaining social distance .	and many governments have taken social measures ,	such as home quarantine and maintaining social distance .	1-25	1-25	The novel Coronavirus has caused a global crisis and many governments have taken social measures , such as home quarantine and maintaining social distance .	The novel Coronavirus has caused a global crisis and many governments have taken social measures , such as home quarantine and maintaining social distance .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	26-29	30-43	Many recent studies show	that network structure and human mobility greatly influence the dynamics of epidemic spreading .	Many recent studies show	that network structure and human mobility greatly influence the dynamics of epidemic spreading .	26-43	26-43	Many recent studies show that network structure and human mobility greatly influence the dynamics of epidemic spreading .	Many recent studies show that network structure and human mobility greatly influence the dynamics of epidemic spreading .	1>2	none	attribution	attribution
1ea771012595cf18bfe22d4933e45b8a190881fc	9-16	30-43	and many governments have taken social measures ,	that network structure and human mobility greatly influence the dynamics of epidemic spreading .	and many governments have taken social measures ,	that network structure and human mobility greatly influence the dynamics of epidemic spreading .	1-25	26-43	The novel Coronavirus has caused a global crisis and many governments have taken social measures , such as home quarantine and maintaining social distance .	Many recent studies show that network structure and human mobility greatly influence the dynamics of epidemic spreading .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	44-56	57-61	In this paper , we utilize a discrete - time Markov chain approach	and propose an epidemic model	In this paper , we utilize a discrete - time Markov chain approach	and propose an epidemic model	44-88	44-88	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	1<2	none	joint	joint
1ea771012595cf18bfe22d4933e45b8a190881fc	57-61	62-70	and propose an epidemic model	to describe virus propagation in the heterogeneous graph ,	and propose an epidemic model	to describe virus propagation in the heterogeneous graph ,	44-88	44-88	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	1<2	none	enablement	enablement
1ea771012595cf18bfe22d4933e45b8a190881fc	62-70	71-73	to describe virus propagation in the heterogeneous graph ,	which is used	to describe virus propagation in the heterogeneous graph ,	which is used	44-88	44-88	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	1<2	none	manner-means	manner-means
1ea771012595cf18bfe22d4933e45b8a190881fc	71-73	74-88	which is used	to represent individuals with intra social connections and mobility between individuals and common locations .	which is used	to represent individuals with intra social connections and mobility between individuals and common locations .	44-88	44-88	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	1<2	none	enablement	enablement
1ea771012595cf18bfe22d4933e45b8a190881fc	57-61	89-100	and propose an epidemic model	There are two types of nodes , individuals and public places ,	and propose an epidemic model	There are two types of nodes , individuals and public places ,	44-88	89-116	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	There are two types of nodes , individuals and public places , and disease can spread by social contacts among individuals and people gathering in common areas .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	89-100	101-111	There are two types of nodes , individuals and public places ,	and disease can spread by social contacts among individuals and people	There are two types of nodes , individuals and public places ,	and disease can spread by social contacts among individuals and people	89-116	89-116	There are two types of nodes , individuals and public places , and disease can spread by social contacts among individuals and people gathering in common areas .	There are two types of nodes , individuals and public places , and disease can spread by social contacts among individuals and people gathering in common areas .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	101-111	112-116	and disease can spread by social contacts among individuals and people	gathering in common areas .	and disease can spread by social contacts among individuals and people	gathering in common areas .	89-116	89-116	There are two types of nodes , individuals and public places , and disease can spread by social contacts among individuals and people gathering in common areas .	There are two types of nodes , individuals and public places , and disease can spread by social contacts among individuals and people gathering in common areas .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	44-56	117-129	In this paper , we utilize a discrete - time Markov chain approach	We give theoretical results about epidemic threshold and influence of isolation factor .	In this paper , we utilize a discrete - time Markov chain approach	We give theoretical results about epidemic threshold and influence of isolation factor .	44-88	117-129	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	We give theoretical results about epidemic threshold and influence of isolation factor .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	44-56	130-134	In this paper , we utilize a discrete - time Markov chain approach	Several numerical simulations are performed	In this paper , we utilize a discrete - time Markov chain approach	Several numerical simulations are performed	44-88	130-145	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	Several numerical simulations are performed and experimental results further demonstrate the correctness of proposed model .	1<2	none	findings	findings
1ea771012595cf18bfe22d4933e45b8a190881fc	130-134	135-145	Several numerical simulations are performed	and experimental results further demonstrate the correctness of proposed model .	Several numerical simulations are performed	and experimental results further demonstrate the correctness of proposed model .	130-145	130-145	Several numerical simulations are performed and experimental results further demonstrate the correctness of proposed model .	Several numerical simulations are performed and experimental results further demonstrate the correctness of proposed model .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	130-134	146-170	Several numerical simulations are performed	Non - monotonic relationship between mobility possibility and epidemic threshold and differences between Erdös - Rényi and power - law social connections are revealed .	Several numerical simulations are performed	Non - monotonic relationship between mobility possibility and epidemic threshold and differences between Erdös - Rényi and power - law social connections are revealed .	130-145	146-170	Several numerical simulations are performed and experimental results further demonstrate the correctness of proposed model .	Non - monotonic relationship between mobility possibility and epidemic threshold and differences between Erdös - Rényi and power - law social connections are revealed .	1<2	none	elaboration	elaboration
1ea771012595cf18bfe22d4933e45b8a190881fc	44-56	171-195	In this paper , we utilize a discrete - time Markov chain approach	In summary , our proposed approach and findings are helpful to analyse and prevent the epidemic spreading in networked population with recurrent mobility pattern .	In this paper , we utilize a discrete - time Markov chain approach	In summary , our proposed approach and findings are helpful to analyse and prevent the epidemic spreading in networked population with recurrent mobility pattern .	44-88	171-195	In this paper , we utilize a discrete - time Markov chain approach and propose an epidemic model to describe virus propagation in the heterogeneous graph , which is used to represent individuals with intra social connections and mobility between individuals and common locations .	In summary , our proposed approach and findings are helpful to analyse and prevent the epidemic spreading in networked population with recurrent mobility pattern .	1<2	none	findings	findings
2074781d7ca96edc1ef37f4cc7196856653a14e0	1-34	35-42	This paper presents the dataset of a survey on workplace health and safety training , employees ' risk perceptions , behavioral safety compliance , and perceived job insecurity in Vietnam during COVID-19 pandemic .	The data were collected through an online questionnaire	This paper presents the dataset of a survey on workplace health and safety training , employees' risk perceptions , behavioral safety compliance , and perceived job insecurity in Vietnam during COVID-19 pandemic .	The data were collected through an online questionnaire	1-34	35-55	This paper presents the dataset of a survey on workplace health and safety training , employees ' risk perceptions , behavioral safety compliance , and perceived job insecurity in Vietnam during COVID-19 pandemic .	The data were collected through an online questionnaire completed by Vietnamese full - time employees between April and June 2020 .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	35-42	43-55	The data were collected through an online questionnaire	completed by Vietnamese full - time employees between April and June 2020 .	The data were collected through an online questionnaire	completed by Vietnamese full - time employees between April and June 2020 .	35-55	35-55	The data were collected through an online questionnaire completed by Vietnamese full - time employees between April and June 2020 .	The data were collected through an online questionnaire completed by Vietnamese full - time employees between April and June 2020 .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	56-65	66-72	Using E - mail , LinkedIn , and Facebook ,	the online questionnaire was sent to respondents	Using E - mail , LinkedIn , and Facebook ,	the online questionnaire was sent to respondents	56-78	56-78	Using E - mail , LinkedIn , and Facebook , the online questionnaire was sent to respondents who filled it out voluntarily .	Using E - mail , LinkedIn , and Facebook , the online questionnaire was sent to respondents who filled it out voluntarily .	1>2	none	manner-means	manner-means
2074781d7ca96edc1ef37f4cc7196856653a14e0	35-42	66-72	The data were collected through an online questionnaire	the online questionnaire was sent to respondents	The data were collected through an online questionnaire	the online questionnaire was sent to respondents	35-55	56-78	The data were collected through an online questionnaire completed by Vietnamese full - time employees between April and June 2020 .	Using E - mail , LinkedIn , and Facebook , the online questionnaire was sent to respondents who filled it out voluntarily .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	66-72	73-78	the online questionnaire was sent to respondents	who filled it out voluntarily .	the online questionnaire was sent to respondents	who filled it out voluntarily .	56-78	56-78	Using E - mail , LinkedIn , and Facebook , the online questionnaire was sent to respondents who filled it out voluntarily .	Using E - mail , LinkedIn , and Facebook , the online questionnaire was sent to respondents who filled it out voluntarily .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	66-72	79-83	the online questionnaire was sent to respondents	A twowave survey was conducted	the online questionnaire was sent to respondents	A twowave survey was conducted	56-78	79-92	Using E - mail , LinkedIn , and Facebook , the online questionnaire was sent to respondents who filled it out voluntarily .	A twowave survey was conducted in order to lessen the common method bias .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	79-83	84-92	A twowave survey was conducted	in order to lessen the common method bias .	A twowave survey was conducted	in order to lessen the common method bias .	79-92	79-92	A twowave survey was conducted in order to lessen the common method bias .	A twowave survey was conducted in order to lessen the common method bias .	1<2	none	enablement	enablement
2074781d7ca96edc1ef37f4cc7196856653a14e0	35-42	93-106	The data were collected through an online questionnaire	Totally , we received complete matched data for 732 full - time employees .	The data were collected through an online questionnaire	Totally , we received complete matched data for 732 full - time employees .	35-55	93-106	The data were collected through an online questionnaire completed by Vietnamese full - time employees between April and June 2020 .	Totally , we received complete matched data for 732 full - time employees .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	93-106	107-121	Totally , we received complete matched data for 732 full - time employees .	All data were processed through SPSS 22.0 , AMOS 23.0 and Smart PLS 3.0 .	Totally , we received complete matched data for 732 full - time employees .	All data were processed through SPSS 22.0 , AMOS 23.0 and Smart PLS 3.0 .	93-106	107-121	Totally , we received complete matched data for 732 full - time employees .	All data were processed through SPSS 22.0 , AMOS 23.0 and Smart PLS 3.0 .	1<2	none	elaboration	elaboration
2074781d7ca96edc1ef37f4cc7196856653a14e0	1-34	122-143	This paper presents the dataset of a survey on workplace health and safety training , employees ' risk perceptions , behavioral safety compliance , and perceived job insecurity in Vietnam during COVID-19 pandemic .	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper ,	This paper presents the dataset of a survey on workplace health and safety training , employees' risk perceptions , behavioral safety compliance , and perceived job insecurity in Vietnam during COVID-19 pandemic .	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper ,	1-34	122-154	This paper presents the dataset of a survey on workplace health and safety training , employees ' risk perceptions , behavioral safety compliance , and perceived job insecurity in Vietnam during COVID-19 pandemic .	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper , which may serve as a good reference for future studies .	1<2	none	findings	findings
2074781d7ca96edc1ef37f4cc7196856653a14e0	122-143	144-154	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper ,	which may serve as a good reference for future studies .	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper ,	which may serve as a good reference for future studies .	122-154	122-154	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper , which may serve as a good reference for future studies .	Besides descriptive statistics , the results of the explanatory factor analysis and the confirmation factor analysis were included in this paper , which may serve as a good reference for future studies .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	1-6	214-228	Enteroviruses are common human pathogens ,	Here , we discuss the function of the enteroviral proteases in the virus replication cycle	Enteroviruses are common human pathogens ,	Here , we discuss the function of the enteroviral proteases in the virus replication cycle	1-14	214-258	Enteroviruses are common human pathogens , and infections are particularly frequent in children .	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	1>2	none	background	background
20ec367d459abe3e88b7db18a359f087c37bd90e	1-6	7-14	Enteroviruses are common human pathogens ,	and infections are particularly frequent in children .	Enteroviruses are common human pathogens ,	and infections are particularly frequent in children .	1-14	1-14	Enteroviruses are common human pathogens , and infections are particularly frequent in children .	Enteroviruses are common human pathogens , and infections are particularly frequent in children .	1<2	none	joint	joint
20ec367d459abe3e88b7db18a359f087c37bd90e	1-6	15-24	Enteroviruses are common human pathogens ,	Severe infections can lead to a variety of diseases ,	Enteroviruses are common human pathogens ,	Severe infections can lead to a variety of diseases ,	1-14	15-35	Enteroviruses are common human pathogens , and infections are particularly frequent in children .	Severe infections can lead to a variety of diseases , including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	15-24	25-35	Severe infections can lead to a variety of diseases ,	including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	Severe infections can lead to a variety of diseases ,	including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	15-35	15-35	Severe infections can lead to a variety of diseases , including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	Severe infections can lead to a variety of diseases , including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	15-24	36-49	Severe infections can lead to a variety of diseases ,	Enterovirus infections have also been implicated in asthmatic exacerbations and type 1 diabetes .	Severe infections can lead to a variety of diseases ,	Enterovirus infections have also been implicated in asthmatic exacerbations and type 1 diabetes .	15-35	36-49	Severe infections can lead to a variety of diseases , including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	Enterovirus infections have also been implicated in asthmatic exacerbations and type 1 diabetes .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	15-24	50-73	Severe infections can lead to a variety of diseases ,	The large disease spectrum of the closely related enteroviruses may be partially , but not fully , explained by differences in tissue tropism .	Severe infections can lead to a variety of diseases ,	The large disease spectrum of the closely related enteroviruses may be partially , but not fully , explained by differences in tissue tropism .	15-35	50-73	Severe infections can lead to a variety of diseases , including poliomyelitis , aseptic meningitis , myocarditis and neonatal sepsis .	The large disease spectrum of the closely related enteroviruses may be partially , but not fully , explained by differences in tissue tropism .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	50-73	74-76,82-85	The large disease spectrum of the closely related enteroviruses may be partially , but not fully , explained by differences in tissue tropism .	The molecular mechanisms <*> are poorly understood ,	The large disease spectrum of the closely related enteroviruses may be partially , but not fully , explained by differences in tissue tropism .	The molecular mechanisms <*> are poorly understood ,	50-73	74-108	The large disease spectrum of the closely related enteroviruses may be partially , but not fully , explained by differences in tissue tropism .	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	74-76,82-85	77-81	The molecular mechanisms <*> are poorly understood ,	by which enteroviruses cause disease	The molecular mechanisms <*> are poorly understood ,	by which enteroviruses cause disease	74-108	74-108	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	82-85	86-90	are poorly understood ,	but there is increasing evidence	are poorly understood ,	but there is increasing evidence	74-108	74-108	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	1<2	none	comparison	comparison
20ec367d459abe3e88b7db18a359f087c37bd90e	86-90	91-108	but there is increasing evidence	that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	but there is increasing evidence	that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	74-108	74-108	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	86-90	109-120	but there is increasing evidence	These proteases perform the posttranslational proteolytic processing of the viral polyprotein ,	but there is increasing evidence	These proteases perform the posttranslational proteolytic processing of the viral polyprotein ,	74-108	109-151	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	109-120	121-129	These proteases perform the posttranslational proteolytic processing of the viral polyprotein ,	but they also cleave several host - cell proteins	These proteases perform the posttranslational proteolytic processing of the viral polyprotein ,	but they also cleave several host - cell proteins	109-151	109-151	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	1<2	none	comparison	comparison
20ec367d459abe3e88b7db18a359f087c37bd90e	121-129	130-140	but they also cleave several host - cell proteins	in order to promote the production of new virus particles ,	but they also cleave several host - cell proteins	in order to promote the production of new virus particles ,	109-151	109-151	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	1<2	none	enablement	enablement
20ec367d459abe3e88b7db18a359f087c37bd90e	130-140	141-151	in order to promote the production of new virus particles ,	as well as to evade the cellular antiviral immune responses .	in order to promote the production of new virus particles ,	as well as to evade the cellular antiviral immune responses .	109-151	109-151	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	1<2	none	joint	joint
20ec367d459abe3e88b7db18a359f087c37bd90e	109-120	152-164	These proteases perform the posttranslational proteolytic processing of the viral polyprotein ,	Enterovirus - associated processing of cellular proteins may also contribute to pathology ,	These proteases perform the posttranslational proteolytic processing of the viral polyprotein ,	Enterovirus - associated processing of cellular proteins may also contribute to pathology ,	109-151	152-184	These proteases perform the posttranslational proteolytic processing of the viral polyprotein , but they also cleave several host - cell proteins in order to promote the production of new virus particles , as well as to evade the cellular antiviral immune responses .	Enterovirus - associated processing of cellular proteins may also contribute to pathology , as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes contributing to Coxsackievirus - induced cardiomyopathy .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	152-164	165-177	Enterovirus - associated processing of cellular proteins may also contribute to pathology ,	as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes	Enterovirus - associated processing of cellular proteins may also contribute to pathology ,	as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes	152-184	152-184	Enterovirus - associated processing of cellular proteins may also contribute to pathology , as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes contributing to Coxsackievirus - induced cardiomyopathy .	Enterovirus - associated processing of cellular proteins may also contribute to pathology , as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes contributing to Coxsackievirus - induced cardiomyopathy .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	165-177	178-184	as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes	contributing to Coxsackievirus - induced cardiomyopathy .	as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes	contributing to Coxsackievirus - induced cardiomyopathy .	152-184	152-184	Enterovirus - associated processing of cellular proteins may also contribute to pathology , as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes contributing to Coxsackievirus - induced cardiomyopathy .	Enterovirus - associated processing of cellular proteins may also contribute to pathology , as elegantly demonstrated by the 2A pro -mediated cleavage of dystrophin in cardiomyocytes contributing to Coxsackievirus - induced cardiomyopathy .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	86-90	185-190,197-202	but there is increasing evidence	It is likely that improved tools <*> will reveal additional host protein substrates	but there is increasing evidence	It is likely that improved tools <*> will reveal additional host protein substrates	74-108	185-213	The molecular mechanisms by which enteroviruses cause disease are poorly understood , but there is increasing evidence that the two enteroviral proteases , 2A pro and 3C pro , are important mediators of pathology .	It is likely that improved tools to identify targets for these proteases will reveal additional host protein substrates that can be linked to specific enterovirus - associated diseases .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	185-190,197-202	191-196	It is likely that improved tools <*> will reveal additional host protein substrates	to identify targets for these proteases	It is likely that improved tools <*> will reveal additional host protein substrates	to identify targets for these proteases	185-213	185-213	It is likely that improved tools to identify targets for these proteases will reveal additional host protein substrates that can be linked to specific enterovirus - associated diseases .	It is likely that improved tools to identify targets for these proteases will reveal additional host protein substrates that can be linked to specific enterovirus - associated diseases .	1<2	none	enablement	enablement
20ec367d459abe3e88b7db18a359f087c37bd90e	197-202	203-213	will reveal additional host protein substrates	that can be linked to specific enterovirus - associated diseases .	will reveal additional host protein substrates	that can be linked to specific enterovirus - associated diseases .	185-213	185-213	It is likely that improved tools to identify targets for these proteases will reveal additional host protein substrates that can be linked to specific enterovirus - associated diseases .	It is likely that improved tools to identify targets for these proteases will reveal additional host protein substrates that can be linked to specific enterovirus - associated diseases .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	214-228	229-233	Here , we discuss the function of the enteroviral proteases in the virus replication cycle	and review the current knowledge	Here , we discuss the function of the enteroviral proteases in the virus replication cycle	and review the current knowledge	214-258	214-258	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	229-233	234-241	and review the current knowledge	regarding how these proteases modulate the infected cell	and review the current knowledge	regarding how these proteases modulate the infected cell	214-258	214-258	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	234-241	242-248	regarding how these proteases modulate the infected cell	in order to favour virus replication ,	regarding how these proteases modulate the infected cell	in order to favour virus replication ,	214-258	214-258	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	1<2	none	enablement	enablement
20ec367d459abe3e88b7db18a359f087c37bd90e	234-241	249-250	regarding how these proteases modulate the infected cell	including ways	regarding how these proteases modulate the infected cell	including ways	214-258	214-258	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	249-250	251-258	including ways	to avoid detection by the immune system .	including ways	to avoid detection by the immune system .	214-258	214-258	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	214-228	259-276	Here , we discuss the function of the enteroviral proteases in the virus replication cycle	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way	Here , we discuss the function of the enteroviral proteases in the virus replication cycle	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way	214-258	259-284	Here , we discuss the function of the enteroviral proteases in the virus replication cycle and review the current knowledge regarding how these proteases modulate the infected cell in order to favour virus replication , including ways to avoid detection by the immune system .	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way to discover novel mechanisms contributing to disease .	1<2	none	elaboration	elaboration
20ec367d459abe3e88b7db18a359f087c37bd90e	259-276	277-280	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way	to discover novel mechanisms	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way	to discover novel mechanisms	259-284	259-284	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way to discover novel mechanisms contributing to disease .	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way to discover novel mechanisms contributing to disease .	1<2	none	enablement	enablement
20ec367d459abe3e88b7db18a359f087c37bd90e	277-280	281-284	to discover novel mechanisms	contributing to disease .	to discover novel mechanisms	contributing to disease .	259-284	259-284	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way to discover novel mechanisms contributing to disease .	We also highlight new possibilities for the identification of protease - specific cellular targets and thereby a way to discover novel mechanisms contributing to disease .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	1-8	62-70	The study of infectious disease outbreaks is required	In this paper , we present a teaching exercise	The study of infectious disease outbreaks is required	In this paper , we present a teaching exercise	1-14	62-88	The study of infectious disease outbreaks is required to train today 's epidemiologists .	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	1>2	none	background	background
2134f97f11e3c3aee6903f4971a2d1195f9620b0	1-8	9-14	The study of infectious disease outbreaks is required	to train today 's epidemiologists .	The study of infectious disease outbreaks is required	to train today's epidemiologists .	1-14	1-14	The study of infectious disease outbreaks is required to train today 's epidemiologists .	The study of infectious disease outbreaks is required to train today 's epidemiologists .	1<2	none	enablement	enablement
2134f97f11e3c3aee6903f4971a2d1195f9620b0	1-8	15-17,25-33	The study of infectious disease outbreaks is required	A typical way <*> is through the analysis of a historical outbreak .	The study of infectious disease outbreaks is required	A typical way <*> is through the analysis of a historical outbreak .	1-14	15-33	The study of infectious disease outbreaks is required to train today 's epidemiologists .	A typical way to introduce and explain key epidemiological concepts is through the analysis of a historical outbreak .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	15-17,25-33	18-24	A typical way <*> is through the analysis of a historical outbreak .	to introduce and explain key epidemiological concepts	A typical way <*> is through the analysis of a historical outbreak .	to introduce and explain key epidemiological concepts	15-33	15-33	A typical way to introduce and explain key epidemiological concepts is through the analysis of a historical outbreak .	A typical way to introduce and explain key epidemiological concepts is through the analysis of a historical outbreak .	1<2	none	enablement	enablement
2134f97f11e3c3aee6903f4971a2d1195f9620b0	15-17,25-33	34-41	A typical way <*> is through the analysis of a historical outbreak .	There are , however , few training options	A typical way <*> is through the analysis of a historical outbreak .	There are , however , few training options	15-33	34-61	A typical way to introduce and explain key epidemiological concepts is through the analysis of a historical outbreak .	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	1<2	none	comparison	comparison
2134f97f11e3c3aee6903f4971a2d1195f9620b0	34-41	42-50	There are , however , few training options	that explicitly utilise real - time simulated stochastic outbreaks	There are , however , few training options	that explicitly utilise real - time simulated stochastic outbreaks	34-61	34-61	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	42-50	51-57	that explicitly utilise real - time simulated stochastic outbreaks	where the participants themselves comprise the dataset	that explicitly utilise real - time simulated stochastic outbreaks	where the participants themselves comprise the dataset	34-61	34-61	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	51-57	58-61	where the participants themselves comprise the dataset	they subsequently analyse .	where the participants themselves comprise the dataset	they subsequently analyse .	34-61	34-61	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	There are , however , few training options that explicitly utilise real - time simulated stochastic outbreaks where the participants themselves comprise the dataset they subsequently analyse .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	62-70	71-84	In this paper , we present a teaching exercise	in which an infectious disease outbreak is simulated over a five - day period	In this paper , we present a teaching exercise	in which an infectious disease outbreak is simulated over a five - day period	62-88	62-88	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	71-84	85-88	in which an infectious disease outbreak is simulated over a five - day period	and subsequently analysed .	in which an infectious disease outbreak is simulated over a five - day period	and subsequently analysed .	62-88	62-88	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	62-70	89-94	In this paper , we present a teaching exercise	We iteratively developed the teaching exercise	In this paper , we present a teaching exercise	We iteratively developed the teaching exercise	62-88	89-103	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	We iteratively developed the teaching exercise to offer additional insight into analysing an outbreak .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	89-94	95-103	We iteratively developed the teaching exercise	to offer additional insight into analysing an outbreak .	We iteratively developed the teaching exercise	to offer additional insight into analysing an outbreak .	89-103	89-103	We iteratively developed the teaching exercise to offer additional insight into analysing an outbreak .	We iteratively developed the teaching exercise to offer additional insight into analysing an outbreak .	1<2	none	enablement	enablement
2134f97f11e3c3aee6903f4971a2d1195f9620b0	62-70	104-118	In this paper , we present a teaching exercise	An R package for visualisation , analysis and simulation of the outbreak data was developed	In this paper , we present a teaching exercise	An R package for visualisation , analysis and simulation of the outbreak data was developed	62-88	104-127	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	An R package for visualisation , analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	104-118	119-122	An R package for visualisation , analysis and simulation of the outbreak data was developed	to accompany the practical	An R package for visualisation , analysis and simulation of the outbreak data was developed	to accompany the practical	104-127	104-127	An R package for visualisation , analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes .	An R package for visualisation , analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes .	1<2	none	enablement	enablement
2134f97f11e3c3aee6903f4971a2d1195f9620b0	104-118	123-127	An R package for visualisation , analysis and simulation of the outbreak data was developed	to reinforce learning outcomes .	An R package for visualisation , analysis and simulation of the outbreak data was developed	to reinforce learning outcomes .	104-127	104-127	An R package for visualisation , analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes .	An R package for visualisation , analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes .	1<2	none	enablement	enablement
2134f97f11e3c3aee6903f4971a2d1195f9620b0	104-118	128-138	An R package for visualisation , analysis and simulation of the outbreak data was developed	Computer simulations of the outbreak revealed deviations from observed dynamics ,	An R package for visualisation , analysis and simulation of the outbreak data was developed	Computer simulations of the outbreak revealed deviations from observed dynamics ,	104-127	128-152	An R package for visualisation , analysis and simulation of the outbreak data was developed to accompany the practical to reinforce learning outcomes .	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	1<2	none	findings	findings
2134f97f11e3c3aee6903f4971a2d1195f9620b0	139	140-142,148-152	highlighting	how simplifying assumptions <*> often differ from reality .	highlighting	how simplifying assumptions <*> often differ from reality .	128-152	128-152	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	1>2	none	attribution	attribution
2134f97f11e3c3aee6903f4971a2d1195f9620b0	128-138	140-142,148-152	Computer simulations of the outbreak revealed deviations from observed dynamics ,	how simplifying assumptions <*> often differ from reality .	Computer simulations of the outbreak revealed deviations from observed dynamics ,	how simplifying assumptions <*> often differ from reality .	128-152	128-152	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	1<2	none	cause-result	cause-result
2134f97f11e3c3aee6903f4971a2d1195f9620b0	140-142,148-152	143-147	how simplifying assumptions <*> often differ from reality .	conventionally made in mathematical models	how simplifying assumptions <*> often differ from reality .	conventionally made in mathematical models	128-152	128-152	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	Computer simulations of the outbreak revealed deviations from observed dynamics , highlighting how simplifying assumptions conventionally made in mathematical models often differ from reality .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	62-70	153-160	In this paper , we present a teaching exercise	Here we provide a pedagogical tool for others	In this paper , we present a teaching exercise	Here we provide a pedagogical tool for others	62-88	153-169	In this paper , we present a teaching exercise in which an infectious disease outbreak is simulated over a five - day period and subsequently analysed .	Here we provide a pedagogical tool for others to use and adapt in their own settings .	1<2	none	elaboration	elaboration
2134f97f11e3c3aee6903f4971a2d1195f9620b0	153-160	161-169	Here we provide a pedagogical tool for others	to use and adapt in their own settings .	Here we provide a pedagogical tool for others	to use and adapt in their own settings .	153-169	153-169	Here we provide a pedagogical tool for others to use and adapt in their own settings .	Here we provide a pedagogical tool for others to use and adapt in their own settings .	1<2	none	enablement	enablement
21a551af356295ada6e657054646444bca9d202b	1-45	46-55	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation ,	and highlights the most promising aims for future development .	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation ,	and highlights the most promising aims for future development .	1-55	1-55	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation , and highlights the most promising aims for future development .	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation , and highlights the most promising aims for future development .	1<2	none	elaboration	elaboration
21a551af356295ada6e657054646444bca9d202b	1-45	56-70	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation ,	Scientists have clarified the physicochemical properties and functions of the different components of surfactant ,	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation ,	Scientists have clarified the physicochemical properties and functions of the different components of surfactant ,	1-55	56-90	This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant , the role of different types of animal - derived and synthetic surfactants for RDS therapy , different modes of administration , potential risks and strategies of ventilation , and highlights the most promising aims for future development .	Scientists have clarified the physicochemical properties and functions of the different components of surfactant , and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function .	1<2	none	background	background
21a551af356295ada6e657054646444bca9d202b	56-70	71-84	Scientists have clarified the physicochemical properties and functions of the different components of surfactant ,	and part of this successful research is derived from the characterization of genetic diseases	Scientists have clarified the physicochemical properties and functions of the different components of surfactant ,	and part of this successful research is derived from the characterization of genetic diseases	56-90	56-90	Scientists have clarified the physicochemical properties and functions of the different components of surfactant , and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function .	Scientists have clarified the physicochemical properties and functions of the different components of surfactant , and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function .	1<2	none	elaboration	elaboration
21a551af356295ada6e657054646444bca9d202b	71-84	85-90	and part of this successful research is derived from the characterization of genetic diseases	affecting surfactant composition or function .	and part of this successful research is derived from the characterization of genetic diseases	affecting surfactant composition or function .	56-90	56-90	Scientists have clarified the physicochemical properties and functions of the different components of surfactant , and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function .	Scientists have clarified the physicochemical properties and functions of the different components of surfactant , and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function .	1<2	none	elaboration	elaboration
21a551af356295ada6e657054646444bca9d202b	56-70	91-106	Scientists have clarified the physicochemical properties and functions of the different components of surfactant ,	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important	Scientists have clarified the physicochemical properties and functions of the different components of surfactant ,	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important	56-90	91-124	Scientists have clarified the physicochemical properties and functions of the different components of surfactant , and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function .	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important also for improving therapy with animal - derived surfactant preparations and for the development of modified surfactants .	1<2	none	elaboration	elaboration
21a551af356295ada6e657054646444bca9d202b	91-106	107-124	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important	also for improving therapy with animal - derived surfactant preparations and for the development of modified surfactants .	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important	also for improving therapy with animal - derived surfactant preparations and for the development of modified surfactants .	91-124	91-124	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important also for improving therapy with animal - derived surfactant preparations and for the development of modified surfactants .	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important also for improving therapy with animal - derived surfactant preparations and for the development of modified surfactants .	1<2	none	enablement	enablement
21a551af356295ada6e657054646444bca9d202b	91-106	125-138	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important	In the past decade newly designed artificial surfactants and additives have gained much attention	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important	In the past decade newly designed artificial surfactants and additives have gained much attention	91-124	125-154	Knowledge from functional tests of surfactant action , its immunochemistry , kinetics and homeostasis are important also for improving therapy with animal - derived surfactant preparations and for the development of modified surfactants .	In the past decade newly designed artificial surfactants and additives have gained much attention and have proven different advantages , but their particular role still has to be defined .	1<2	none	elaboration	elaboration
21a551af356295ada6e657054646444bca9d202b	125-138	139-144	In the past decade newly designed artificial surfactants and additives have gained much attention	and have proven different advantages ,	In the past decade newly designed artificial surfactants and additives have gained much attention	and have proven different advantages ,	125-154	125-154	In the past decade newly designed artificial surfactants and additives have gained much attention and have proven different advantages , but their particular role still has to be defined .	In the past decade newly designed artificial surfactants and additives have gained much attention and have proven different advantages , but their particular role still has to be defined .	1<2	none	joint	joint
21a551af356295ada6e657054646444bca9d202b	125-138	145-154	In the past decade newly designed artificial surfactants and additives have gained much attention	but their particular role still has to be defined .	In the past decade newly designed artificial surfactants and additives have gained much attention	but their particular role still has to be defined .	125-154	125-154	In the past decade newly designed artificial surfactants and additives have gained much attention and have proven different advantages , but their particular role still has to be defined .	In the past decade newly designed artificial surfactants and additives have gained much attention and have proven different advantages , but their particular role still has to be defined .	1<2	none	comparison	comparison
21a572a6c0f75baa745480e28b596d73d4492cc8	1-11	122-134	The COVID-19 pandemic has resulted in a proliferation of clinical trials	Here we have provided a foundation for cardiovascular and cardio - oncology physicians	The COVID-19 pandemic has resulted in a proliferation of clinical trials	Here we have provided a foundation for cardiovascular and cardio - oncology physicians	1-29	122-178	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	1>2	none	background	background
21a572a6c0f75baa745480e28b596d73d4492cc8	1-11	12-14	The COVID-19 pandemic has resulted in a proliferation of clinical trials	that are designed	The COVID-19 pandemic has resulted in a proliferation of clinical trials	that are designed	1-29	1-29	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	12-14	15-25	that are designed	to slow the spread of SARS - CoV-2 , the virus	that are designed	to slow the spread of SARS - CoV-2 , the virus	1-29	1-29	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	1<2	none	enablement	enablement
21a572a6c0f75baa745480e28b596d73d4492cc8	15-25	26-29	to slow the spread of SARS - CoV-2 , the virus	that causes COVID-19 .	to slow the spread of SARS - CoV-2 , the virus	that causes COVID-19 .	1-29	1-29	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	1<2	none	cause-result	cause-result
21a572a6c0f75baa745480e28b596d73d4492cc8	1-11	30-47	The COVID-19 pandemic has resulted in a proliferation of clinical trials	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ;	The COVID-19 pandemic has resulted in a proliferation of clinical trials	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ;	1-29	30-67	The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	30-47	48-61	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ;	accordingly , the cardiovascular and cardio - oncology communities are playing a major role	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ;	accordingly , the cardiovascular and cardio - oncology communities are playing a major role	30-67	30-67	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .	1<2	none	cause-result	cause-result
21a572a6c0f75baa745480e28b596d73d4492cc8	48-61	62-67	accordingly , the cardiovascular and cardio - oncology communities are playing a major role	in caring for COVID-19 patients .	accordingly , the cardiovascular and cardio - oncology communities are playing a major role	in caring for COVID-19 patients .	30-67	30-67	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	48-61	68-72,82-88	accordingly , the cardiovascular and cardio - oncology communities are playing a major role	Many of the therapeutic agents <*> are repurposed treatments for influenza , drugs	accordingly , the cardiovascular and cardio - oncology communities are playing a major role	Many of the therapeutic agents <*> are repurposed treatments for influenza , drugs	30-67	68-121	The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	68-72,82-88	73-76	Many of the therapeutic agents <*> are repurposed treatments for influenza , drugs	that are being used	Many of the therapeutic agents <*> are repurposed treatments for influenza , drugs	that are being used	68-121	68-121	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	73-76	77-81	that are being used	to treat patients with COVID-19	that are being used	to treat patients with COVID-19	68-121	68-121	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	1<2	none	enablement	enablement
21a572a6c0f75baa745480e28b596d73d4492cc8	82-88,97-100	89-96	are repurposed treatments for influenza , drugs <*> or treatments for malaria	that were not effective in Ebola patients ,	are repurposed treatments for influenza , drugs <*> or treatments for malaria	that were not effective in Ebola patients ,	68-121	68-121	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	97-100	101-106	or treatments for malaria	that were developed decades ago ,	or treatments for malaria	that were developed decades ago ,	68-121	68-121	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	82-88,97-100	107-121	are repurposed treatments for influenza , drugs <*> or treatments for malaria	and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	are repurposed treatments for influenza , drugs <*> or treatments for malaria	and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	68-121	68-121	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	Many of the therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for influenza , drugs that were not effective in Ebola patients , or treatments for malaria that were developed decades ago , and are unlikely to be familiar to the cardiovascular and cardio - oncology communities .	1<2	none	joint	joint
21a572a6c0f75baa745480e28b596d73d4492cc8	122-134	135-139	Here we have provided a foundation for cardiovascular and cardio - oncology physicians	who are on the frontline	Here we have provided a foundation for cardiovascular and cardio - oncology physicians	who are on the frontline	122-178	122-178	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	135-139	140-145	who are on the frontline	providing care to COVID-19 patients ,	who are on the frontline	providing care to COVID-19 patients ,	122-178	122-178	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	1<2	none	elaboration	elaboration
21a572a6c0f75baa745480e28b596d73d4492cc8	122-134	146-168	Here we have provided a foundation for cardiovascular and cardio - oncology physicians	so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials	Here we have provided a foundation for cardiovascular and cardio - oncology physicians	so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials	122-178	122-178	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	1<2	none	enablement	enablement
21a572a6c0f75baa745480e28b596d73d4492cc8	146-168	169-178	so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials	that are ongoing for the treatment of COVID-19 patients .	so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials	that are ongoing for the treatment of COVID-19 patients .	122-178	122-178	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	Here we have provided a foundation for cardiovascular and cardio - oncology physicians who are on the frontline providing care to COVID-19 patients , so that they can better understand the emerging cardiovascular epidemiology of COVID-19 , as well as the biological rationale for the clinical trials that are ongoing for the treatment of COVID-19 patients .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	1-29	131-140	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	we developed guidelines for SARS screening of organ donors .	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	we developed guidelines for SARS screening of organ donors .	1-29	98-140	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	1>2	none	background	background
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	1-29	30-39	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	The etiology of SARS is likely a novel coronavirus .	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	The etiology of SARS is likely a novel coronavirus .	1-29	30-39	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	The etiology of SARS is likely a novel coronavirus .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	1-29	40-49,53-58	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	During the winter of 2003 , an outbreak of SARS <*> occurred in Toronto , Canada .	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	During the winter of 2003 , an outbreak of SARS <*> occurred in Toronto , Canada .	1-29	40-58	Severe acute respiratory syndrome ( SARS ) is a recently described infectious entity with salient features of fever , headache and malaise , with rapid progression to pneumonitis .	During the winter of 2003 , an outbreak of SARS involving several hospitals occurred in Toronto , Canada .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	40-49,53-58	50-52	During the winter of 2003 , an outbreak of SARS <*> occurred in Toronto , Canada .	involving several hospitals	During the winter of 2003 , an outbreak of SARS <*> occurred in Toronto , Canada .	involving several hospitals	40-58	40-58	During the winter of 2003 , an outbreak of SARS involving several hospitals occurred in Toronto , Canada .	During the winter of 2003 , an outbreak of SARS involving several hospitals occurred in Toronto , Canada .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	40-49,53-58	59-65	During the winter of 2003 , an outbreak of SARS <*> occurred in Toronto , Canada .	We describe a patient post liver transplant	During the winter of 2003 , an outbreak of SARS <*> occurred in Toronto , Canada .	We describe a patient post liver transplant	40-58	59-86	During the winter of 2003 , an outbreak of SARS involving several hospitals occurred in Toronto , Canada .	We describe a patient post liver transplant who contracted SARS and died during the outbreak , with subsequent infection of family and several health - care workers .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	59-65	66-68	We describe a patient post liver transplant	who contracted SARS	We describe a patient post liver transplant	who contracted SARS	59-86	59-86	We describe a patient post liver transplant who contracted SARS and died during the outbreak , with subsequent infection of family and several health - care workers .	We describe a patient post liver transplant who contracted SARS and died during the outbreak , with subsequent infection of family and several health - care workers .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	66-68	69-86	who contracted SARS	and died during the outbreak , with subsequent infection of family and several health - care workers .	who contracted SARS	and died during the outbreak , with subsequent infection of family and several health - care workers .	59-86	59-86	We describe a patient post liver transplant who contracted SARS and died during the outbreak , with subsequent infection of family and several health - care workers .	We describe a patient post liver transplant who contracted SARS and died during the outbreak , with subsequent infection of family and several health - care workers .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	59-65	87-97	We describe a patient post liver transplant	A novel coronavirus was detected in respiratory specimens by PCR .	We describe a patient post liver transplant	A novel coronavirus was detected in respiratory specimens by PCR .	59-86	87-97	We describe a patient post liver transplant who contracted SARS and died during the outbreak , with subsequent infection of family and several health - care workers .	A novel coronavirus was detected in respiratory specimens by PCR .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	98-119	131-140	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community ,	we developed guidelines for SARS screening of organ donors .	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community ,	we developed guidelines for SARS screening of organ donors .	98-140	98-140	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	1>2	none	cause-result	cause-result
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	120-130	131-140	in order to avoid transmission of SARS from a donor ,	we developed guidelines for SARS screening of organ donors .	in order to avoid transmission of SARS from a donor ,	we developed guidelines for SARS screening of organ donors .	98-140	98-140	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	1>2	none	enablement	enablement
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	131-140	141-143,157-158	we developed guidelines for SARS screening of organ donors .	A screening tool <*> was used	we developed guidelines for SARS screening of organ donors .	A screening tool <*> was used	98-140	141-171	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	A screening tool based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure was used to stratify donors as high , intermediate or low risk for SARS .	1<2	none	elaboration	elaboration
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	141-143,157-158	144-156	A screening tool <*> was used	based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure	A screening tool <*> was used	based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure	141-171	141-171	A screening tool based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure was used to stratify donors as high , intermediate or low risk for SARS .	A screening tool based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure was used to stratify donors as high , intermediate or low risk for SARS .	1<2	none	manner-means	manner-means
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	157-158	159-171	was used	to stratify donors as high , intermediate or low risk for SARS .	was used	to stratify donors as high , intermediate or low risk for SARS .	141-171	141-171	A screening tool based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure was used to stratify donors as high , intermediate or low risk for SARS .	A screening tool based on potential hospital SARS exposure , clinical symptoms , and epidemiological exposure was used to stratify donors as high , intermediate or low risk for SARS .	1<2	none	enablement	enablement
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	172-178	179-191	As SARS spreads throughout the world ,	it may become an increasingly significant problem for transplant patients and programs .	As SARS spreads throughout the world ,	it may become an increasingly significant problem for transplant patients and programs .	172-191	172-191	As SARS spreads throughout the world , it may become an increasingly significant problem for transplant patients and programs .	As SARS spreads throughout the world , it may become an increasingly significant problem for transplant patients and programs .	1>2	none	temporal	temporal
23d06bd7a12e6e729f5b2b06bbe825eb9a91270e	131-140	179-191	we developed guidelines for SARS screening of organ donors .	it may become an increasingly significant problem for transplant patients and programs .	we developed guidelines for SARS screening of organ donors .	it may become an increasingly significant problem for transplant patients and programs .	98-140	172-191	Due to the potential severity of SARS in transplant recipients and the large number of cases of SARS in the community , in order to avoid transmission of SARS from a donor , we developed guidelines for SARS screening of organ donors .	As SARS spreads throughout the world , it may become an increasingly significant problem for transplant patients and programs .	1<2	none	findings	findings
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	1-2	3-21	Background .	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention	Background .	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention	1-2	3-30	Background .	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention focused on the negative binomial dispersion parameter , k.	1>2	none	textual-organization	textual-organization
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	3-21	77-82	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention	This article presents a simulation study	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention	This article presents a simulation study	3-30	77-104	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention focused on the negative binomial dispersion parameter , k.	This article presents a simulation study exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	1>2	none	background	background
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	3-21	22-30	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention	focused on the negative binomial dispersion parameter , k.	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention	focused on the negative binomial dispersion parameter , k.	3-30	3-30	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention focused on the negative binomial dispersion parameter , k.	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention focused on the negative binomial dispersion parameter , k.	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	22-30	31-40	focused on the negative binomial dispersion parameter , k.	A substantial literature exists on the estimation of k ,	focused on the negative binomial dispersion parameter , k.	A substantial literature exists on the estimation of k ,	3-30	31-74	The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data , with attention focused on the negative binomial dispersion parameter , k.	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	31-40	41-47	A substantial literature exists on the estimation of k ,	but most attention has focused on datasets	A substantial literature exists on the estimation of k ,	but most attention has focused on datasets	31-74	31-74	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	1<2	none	comparison	comparison
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	41-47	48-52	but most attention has focused on datasets	that are not highly overdispersed	but most attention has focused on datasets	that are not highly overdispersed	31-74	31-74	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	48-52	53-60	that are not highly overdispersed	( i.e. , those with k$1 ) ,	that are not highly overdispersed	( i.e. , those with k$1 ) ,	31-74	31-74	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	41-47	61-66,70-74	but most attention has focused on datasets	and the accuracy of confidence intervals <*> is typically not explored .	but most attention has focused on datasets	and the accuracy of confidence intervals <*> is typically not explored .	31-74	31-74	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	1<2	none	joint	joint
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	61-66,70-74	67-69	and the accuracy of confidence intervals <*> is typically not explored .	estimated for k	and the accuracy of confidence intervals <*> is typically not explored .	estimated for k	31-74	31-74	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	A substantial literature exists on the estimation of k , but most attention has focused on datasets that are not highly overdispersed ( i.e. , those with k$1 ) , and the accuracy of confidence intervals estimated for k is typically not explored .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	75-76	77-82	Methodology .	This article presents a simulation study	Methodology .	This article presents a simulation study	75-76	77-104	Methodology .	This article presents a simulation study exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	1>2	none	textual-organization	textual-organization
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	77-82	83-104	This article presents a simulation study	exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	This article presents a simulation study	exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	77-104	77-104	This article presents a simulation study exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	This article presents a simulation study exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	77-82	105-123,134-146	This article presents a simulation study	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets <*> and from disease transmission data subject to selection bias for successful outbreaks .	This article presents a simulation study	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets <*> and from disease transmission data subject to selection bias for successful outbreaks .	77-104	105-146	This article presents a simulation study exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets influenced by two types of event under - counting , and from disease transmission data subject to selection bias for successful outbreaks .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	105-123,134-146	124-133	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets <*> and from disease transmission data subject to selection bias for successful outbreaks .	influenced by two types of event under - counting ,	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets <*> and from disease transmission data subject to selection bias for successful outbreaks .	influenced by two types of event under - counting ,	105-146	105-146	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets influenced by two types of event under - counting , and from disease transmission data subject to selection bias for successful outbreaks .	In addition to exploring small - sample bias on negative binomial estimates , the study addresses estimation from datasets influenced by two types of event under - counting , and from disease transmission data subject to selection bias for successful outbreaks .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	147-148	151-174	Conclusions .	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	Conclusions .	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	147-148	149-186	Conclusions .	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	1>2	none	textual-organization	textual-organization
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	149-150	151-174	Results show	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	Results show	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	149-186	149-186	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	1>2	none	attribution	attribution
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	77-82	151-174	This article presents a simulation study	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	This article presents a simulation study	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	77-104	149-186	This article presents a simulation study exploring the bias , precision , and confidence interval coverage of maximum - likelihood estimates of k from highly overdispersed distributions .	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	1<2	none	findings	findings
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	151-174	175-186	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	but are not biased downward by any of the factors considered .	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	but are not biased downward by any of the factors considered .	149-186	149-186	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	1<2	none	comparison	comparison
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	151-174	187-188,195-207	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	Confidence intervals <*> tend to exhibit coverage below the nominal level , with overestimates of k	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	Confidence intervals <*> tend to exhibit coverage below the nominal level , with overestimates of k	149-186	187-215	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	Confidence intervals estimated from the asymptotic sampling variance tend to exhibit coverage below the nominal level , with overestimates of k comprising the great majority of coverage errors .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	187-188,195-207	189-194	Confidence intervals <*> tend to exhibit coverage below the nominal level , with overestimates of k	estimated from the asymptotic sampling variance	Confidence intervals <*> tend to exhibit coverage below the nominal level , with overestimates of k	estimated from the asymptotic sampling variance	187-215	187-215	Confidence intervals estimated from the asymptotic sampling variance tend to exhibit coverage below the nominal level , with overestimates of k comprising the great majority of coverage errors .	Confidence intervals estimated from the asymptotic sampling variance tend to exhibit coverage below the nominal level , with overestimates of k comprising the great majority of coverage errors .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	195-207	208-215	tend to exhibit coverage below the nominal level , with overestimates of k	comprising the great majority of coverage errors .	tend to exhibit coverage below the nominal level , with overestimates of k	comprising the great majority of coverage errors .	187-215	187-215	Confidence intervals estimated from the asymptotic sampling variance tend to exhibit coverage below the nominal level , with overestimates of k comprising the great majority of coverage errors .	Confidence intervals estimated from the asymptotic sampling variance tend to exhibit coverage below the nominal level , with overestimates of k comprising the great majority of coverage errors .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	151-174	216-228	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	Estimation from outbreak datasets does not increase the bias of k estimates ,	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	Estimation from outbreak datasets does not increase the bias of k estimates ,	149-186	216-240	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	Estimation from outbreak datasets does not increase the bias of k estimates , but can add significant upward bias to estimates of the mean .	1<2	none	elaboration	elaboration
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	216-228	229-240	Estimation from outbreak datasets does not increase the bias of k estimates ,	but can add significant upward bias to estimates of the mean .	Estimation from outbreak datasets does not increase the bias of k estimates ,	but can add significant upward bias to estimates of the mean .	216-240	216-240	Estimation from outbreak datasets does not increase the bias of k estimates , but can add significant upward bias to estimates of the mean .	Estimation from outbreak datasets does not increase the bias of k estimates , but can add significant upward bias to estimates of the mean .	1<2	none	comparison	comparison
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	241-250	254-267	Because k varies inversely with the degree of overdispersion ,	that overestimation of the degree of overdispersion is very rare for these datasets .	Because k varies inversely with the degree of overdispersion ,	that overestimation of the degree of overdispersion is very rare for these datasets .	241-267	241-267	Because k varies inversely with the degree of overdispersion , these findings show that overestimation of the degree of overdispersion is very rare for these datasets .	Because k varies inversely with the degree of overdispersion , these findings show that overestimation of the degree of overdispersion is very rare for these datasets .	1>2	none	cause-result	cause-result
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	251-253	254-267	these findings show	that overestimation of the degree of overdispersion is very rare for these datasets .	these findings show	that overestimation of the degree of overdispersion is very rare for these datasets .	241-267	241-267	Because k varies inversely with the degree of overdispersion , these findings show that overestimation of the degree of overdispersion is very rare for these datasets .	Because k varies inversely with the degree of overdispersion , these findings show that overestimation of the degree of overdispersion is very rare for these datasets .	1>2	none	attribution	attribution
247d3262ad1b15f331a89f70eec56b34dbe6b8b5	151-174	254-267	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	that overestimation of the degree of overdispersion is very rare for these datasets .	that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events ,	that overestimation of the degree of overdispersion is very rare for these datasets .	149-186	241-267	Results show that maximum likelihood estimates of k can be biased upward by small sample size or under - reporting of zero - class events , but are not biased downward by any of the factors considered .	Because k varies inversely with the degree of overdispersion , these findings show that overestimation of the degree of overdispersion is very rare for these datasets .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	1-17	41-75	RNA dependent DNA - polymerases , reverse transcriptases , are key enzymes for retroviruses and retroelements .	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	RNA dependent DNA - polymerases , reverse transcriptases , are key enzymes for retroviruses and retroelements .	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	1-17	37-75	RNA dependent DNA - polymerases , reverse transcriptases , are key enzymes for retroviruses and retroelements .	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	1>2	none	background	background
25aad84c22269cf7221d0c22737e2e01a36ec51b	1-17	18-20,25-31	RNA dependent DNA - polymerases , reverse transcriptases , are key enzymes for retroviruses and retroelements .	Their fidelity , <*> is significant for their use as reagents	RNA dependent DNA - polymerases , reverse transcriptases , are key enzymes for retroviruses and retroelements .	Their fidelity , <*> is significant for their use as reagents	1-17	18-36	RNA dependent DNA - polymerases , reverse transcriptases , are key enzymes for retroviruses and retroelements .	Their fidelity , including indel generation , is significant for their use as reagents including for deep sequencing .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	18-20,25-31	21-24	Their fidelity , <*> is significant for their use as reagents	including indel generation ,	Their fidelity , <*> is significant for their use as reagents	including indel generation ,	18-36	18-36	Their fidelity , including indel generation , is significant for their use as reagents including for deep sequencing .	Their fidelity , including indel generation , is significant for their use as reagents including for deep sequencing .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	25-31	32-36	is significant for their use as reagents	including for deep sequencing .	is significant for their use as reagents	including for deep sequencing .	18-36	18-36	Their fidelity , including indel generation , is significant for their use as reagents including for deep sequencing .	Their fidelity , including indel generation , is significant for their use as reagents including for deep sequencing .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	37-40	41-75	Here , we report	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Here , we report	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	37-75	37-75	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	1>2	none	attribution	attribution
25aad84c22269cf7221d0c22737e2e01a36ec51b	76-80	81-90	Where slippage is stimulated ,	the resulting products have one or more additional base(s )	Where slippage is stimulated ,	the resulting products have one or more additional base(s )	76-97	76-97	Where slippage is stimulated , the resulting products have one or more additional base(s ) compared to the corresponding template motif .	Where slippage is stimulated , the resulting products have one or more additional base(s ) compared to the corresponding template motif .	1>2	none	condition	condition
25aad84c22269cf7221d0c22737e2e01a36ec51b	41-75	81-90	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	the resulting products have one or more additional base(s )	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	the resulting products have one or more additional base(s )	37-75	76-97	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Where slippage is stimulated , the resulting products have one or more additional base(s ) compared to the corresponding template motif .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	81-90	91-97	the resulting products have one or more additional base(s )	compared to the corresponding template motif .	the resulting products have one or more additional base(s )	compared to the corresponding template motif .	76-97	76-97	Where slippage is stimulated , the resulting products have one or more additional base(s ) compared to the corresponding template motif .	Where slippage is stimulated , the resulting products have one or more additional base(s ) compared to the corresponding template motif .	1<2	none	comparison	comparison
25aad84c22269cf7221d0c22737e2e01a36ec51b	41-75	98-104	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Such structures also inhibit slippagemediated base omission	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Such structures also inhibit slippagemediated base omission	37-75	98-119	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Such structures also inhibit slippagemediated base omission which can be more frequent in the absence of a relevant stem - loop .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	98-104	105-119	Such structures also inhibit slippagemediated base omission	which can be more frequent in the absence of a relevant stem - loop .	Such structures also inhibit slippagemediated base omission	which can be more frequent in the absence of a relevant stem - loop .	98-119	98-119	Such structures also inhibit slippagemediated base omission which can be more frequent in the absence of a relevant stem - loop .	Such structures also inhibit slippagemediated base omission which can be more frequent in the absence of a relevant stem - loop .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	98-104	120-136	Such structures also inhibit slippagemediated base omission	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs	Such structures also inhibit slippagemediated base omission	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs	98-119	120-151	Such structures also inhibit slippagemediated base omission which can be more frequent in the absence of a relevant stem - loop .	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs specified by the RNA template slippage - prone sequence and its 5 adjacent base .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	120-136	137-151	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs	specified by the RNA template slippage - prone sequence and its 5 adjacent base .	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs	specified by the RNA template slippage - prone sequence and its 5 adjacent base .	120-151	120-151	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs specified by the RNA template slippage - prone sequence and its 5 adjacent base .	Slippage directionality , base insertion and omission , is sensitive to the relative concentration ratio of dNTPs specified by the RNA template slippage - prone sequence and its 5 adjacent base .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	41-75	152-166	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	37-75	152-172	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes tested including that from HIV .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	152-166	167	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	tested	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	tested	152-172	152-172	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes tested including that from HIV .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes tested including that from HIV .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	152-166	168-172	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	including that from HIV .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	including that from HIV .	152-172	152-172	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes tested including that from HIV .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes tested including that from HIV .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	152-166	173-187	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	Structure - mediated slippage may be exhibited by other polymerases and enrich gene expression .	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes	Structure - mediated slippage may be exhibited by other polymerases and enrich gene expression .	152-172	173-187	The retrotransposon - derived enzyme TGIRT exhibits more slippage in vitro than the retroviral enzymes tested including that from HIV .	Structure - mediated slippage may be exhibited by other polymerases and enrich gene expression .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	41-75	188-198,207-212	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate <*> exhibits strong slippage in vitro .	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate <*> exhibits strong slippage in vitro .	37-75	188-212	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate for utilizing slippage for its GagPol synthesis , exhibits strong slippage in vitro .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	188-198,207-212	199-206	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate <*> exhibits strong slippage in vitro .	for utilizing slippage for its GagPol synthesis ,	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate <*> exhibits strong slippage in vitro .	for utilizing slippage for its GagPol synthesis ,	188-212	188-212	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate for utilizing slippage for its GagPol synthesis , exhibits strong slippage in vitro .	A cassette from Drosophila retrotransposon Dme1 chrX 2630566 , a candidate for utilizing slippage for its GagPol synthesis , exhibits strong slippage in vitro .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	213-221	222-223,235-237	Given the widespread occurrence and importance of retrotransposons ,	systematic studies <*> are merited .	Given the widespread occurrence and importance of retrotransposons ,	systematic studies <*> are merited .	213-237	213-237	Given the widespread occurrence and importance of retrotransposons , systematic studies to reveal the extent of their functional utilization of RT slippage are merited .	Given the widespread occurrence and importance of retrotransposons , systematic studies to reveal the extent of their functional utilization of RT slippage are merited .	1>2	none	cause-result	cause-result
25aad84c22269cf7221d0c22737e2e01a36ec51b	41-75	222-223,235-237	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	systematic studies <*> are merited .	that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	systematic studies <*> are merited .	37-75	213-237	Here , we report that certain RNA template structures and G - rich sequences , ahead of diverse reverse transcriptases can be strong stimulators for slippage at slippageprone template motif sequence 3 of such ' slippagestimulatory ' structures .	Given the widespread occurrence and importance of retrotransposons , systematic studies to reveal the extent of their functional utilization of RT slippage are merited .	1<2	none	elaboration	elaboration
25aad84c22269cf7221d0c22737e2e01a36ec51b	222-223,235-237	224-234	systematic studies <*> are merited .	to reveal the extent of their functional utilization of RT slippage	systematic studies <*> are merited .	to reveal the extent of their functional utilization of RT slippage	213-237	213-237	Given the widespread occurrence and importance of retrotransposons , systematic studies to reveal the extent of their functional utilization of RT slippage are merited .	Given the widespread occurrence and importance of retrotransposons , systematic studies to reveal the extent of their functional utilization of RT slippage are merited .	1<2	none	enablement	enablement
2a32218f7d0b647b6bebeb1526245a0dc8856546	1-16	62-67,75-98	The cell intrinsic innate immune responses provide a first line of defense against viral infection ,	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	The cell intrinsic innate immune responses provide a first line of defense against viral infection ,	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	1-30	60-108	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	1>2	none	background	background
2a32218f7d0b647b6bebeb1526245a0dc8856546	1-16	17-19	The cell intrinsic innate immune responses provide a first line of defense against viral infection ,	and often function	The cell intrinsic innate immune responses provide a first line of defense against viral infection ,	and often function	1-30	1-30	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	1<2	none	joint	joint
2a32218f7d0b647b6bebeb1526245a0dc8856546	17-19	20-23	and often function	by targeting cellular pathways	and often function	by targeting cellular pathways	1-30	1-30	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	1<2	none	manner-means	manner-means
2a32218f7d0b647b6bebeb1526245a0dc8856546	20-23	24-30	by targeting cellular pathways	usurped by the virus during infection .	by targeting cellular pathways	usurped by the virus during infection .	1-30	1-30	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	1-16	31-38	The cell intrinsic innate immune responses provide a first line of defense against viral infection ,	In particular , many viruses manipulate cellular lipids	The cell intrinsic innate immune responses provide a first line of defense against viral infection ,	In particular , many viruses manipulate cellular lipids	1-30	31-59	The cell intrinsic innate immune responses provide a first line of defense against viral infection , and often function by targeting cellular pathways usurped by the virus during infection .	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	31-38	39-42	In particular , many viruses manipulate cellular lipids	to form complex structures	In particular , many viruses manipulate cellular lipids	to form complex structures	31-59	31-59	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	1<2	none	enablement	enablement
2a32218f7d0b647b6bebeb1526245a0dc8856546	39-42	43-47	to form complex structures	required for viral replication ,	to form complex structures	required for viral replication ,	31-59	31-59	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	1<2	none	enablement	enablement
2a32218f7d0b647b6bebeb1526245a0dc8856546	31-38	48-59	In particular , many viruses manipulate cellular lipids	many of which are dependent on de novo fatty acid synthesis .	In particular , many viruses manipulate cellular lipids	many of which are dependent on de novo fatty acid synthesis .	31-59	31-59	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	In particular , many viruses manipulate cellular lipids to form complex structures required for viral replication , many of which are dependent on de novo fatty acid synthesis .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	60-61	62-67,75-98	We found	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	We found	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	60-108	60-108	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	1>2	none	attribution	attribution
2a32218f7d0b647b6bebeb1526245a0dc8856546	62-67,75-98	68-74	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	which potently inhibits fatty acid synthesis ,	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	which potently inhibits fatty acid synthesis ,	60-108	60-108	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	75-98	99-108	restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	for which there are no effective vaccines or therapeutics .	restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	for which there are no effective vaccines or therapeutics .	60-108	60-108	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	62-67,75-98	109-122	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	We show restriction of RVFV both by AMPK and its upstream activator LKB1 ,	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	We show restriction of RVFV both by AMPK and its upstream activator LKB1 ,	60-108	109-131	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	We show restriction of RVFV both by AMPK and its upstream activator LKB1 , indicating an antiviral role for this signaling pathway .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	109-122	123-131	We show restriction of RVFV both by AMPK and its upstream activator LKB1 ,	indicating an antiviral role for this signaling pathway .	We show restriction of RVFV both by AMPK and its upstream activator LKB1 ,	indicating an antiviral role for this signaling pathway .	109-131	109-131	We show restriction of RVFV both by AMPK and its upstream activator LKB1 , indicating an antiviral role for this signaling pathway .	We show restriction of RVFV both by AMPK and its upstream activator LKB1 , indicating an antiviral role for this signaling pathway .	1<2	none	cause-result	cause-result
2a32218f7d0b647b6bebeb1526245a0dc8856546	132-135	136-143	Furthermore , we found	that AMPK is activated during RVFV infection ,	Furthermore , we found	that AMPK is activated during RVFV infection ,	132-166	132-166	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	1>2	none	attribution	attribution
2a32218f7d0b647b6bebeb1526245a0dc8856546	62-67,75-98	136-143	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	that AMPK is activated during RVFV infection ,	that the energy regulator AMPK , <*> restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen	that AMPK is activated during RVFV infection ,	60-108	132-166	We found that the energy regulator AMPK , which potently inhibits fatty acid synthesis , restricts infection of the Bunyavirus , Rift Valley Fever Virus ( RVFV ) , an important re - emerging arthropod - borne human pathogen for which there are no effective vaccines or therapeutics .	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	136-143	144-166	that AMPK is activated during RVFV infection ,	leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	that AMPK is activated during RVFV infection ,	leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	132-166	132-166	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	1<2	none	cause-result	cause-result
2a32218f7d0b647b6bebeb1526245a0dc8856546	136-143	167-172	that AMPK is activated during RVFV infection ,	Activating AMPK pharmacologically both restricted infection	that AMPK is activated during RVFV infection ,	Activating AMPK pharmacologically both restricted infection	132-166	167-177	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	Activating AMPK pharmacologically both restricted infection and reduced lipid levels .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	167-172	173-177	Activating AMPK pharmacologically both restricted infection	and reduced lipid levels .	Activating AMPK pharmacologically both restricted infection	and reduced lipid levels .	167-177	167-177	Activating AMPK pharmacologically both restricted infection and reduced lipid levels .	Activating AMPK pharmacologically both restricted infection and reduced lipid levels .	1<2	none	joint	joint
2a32218f7d0b647b6bebeb1526245a0dc8856546	167-172	178-190	Activating AMPK pharmacologically both restricted infection	This restriction could be bypassed by treatment with the fatty acid palmitate ,	Activating AMPK pharmacologically both restricted infection	This restriction could be bypassed by treatment with the fatty acid palmitate ,	167-177	178-204	Activating AMPK pharmacologically both restricted infection and reduced lipid levels .	This restriction could be bypassed by treatment with the fatty acid palmitate , demonstrating that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	191	192-204	demonstrating	that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	demonstrating	that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	178-204	178-204	This restriction could be bypassed by treatment with the fatty acid palmitate , demonstrating that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	This restriction could be bypassed by treatment with the fatty acid palmitate , demonstrating that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	1>2	none	attribution	attribution
2a32218f7d0b647b6bebeb1526245a0dc8856546	178-190	192-204	This restriction could be bypassed by treatment with the fatty acid palmitate ,	that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	This restriction could be bypassed by treatment with the fatty acid palmitate ,	that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	178-204	178-204	This restriction could be bypassed by treatment with the fatty acid palmitate , demonstrating that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	This restriction could be bypassed by treatment with the fatty acid palmitate , demonstrating that AMPK restricts RVFV infection through its inhibition of fatty acid biosynthesis .	1<2	none	cause-result	cause-result
2a32218f7d0b647b6bebeb1526245a0dc8856546	205-208	209-218	Lastly , we found	that this pathway plays a broad role in antiviral defense	Lastly , we found	that this pathway plays a broad role in antiviral defense	205-232	205-232	Lastly , we found that this pathway plays a broad role in antiviral defense since additional viruses from disparate families were also restricted by AMPK and LKB1 .	Lastly , we found that this pathway plays a broad role in antiviral defense since additional viruses from disparate families were also restricted by AMPK and LKB1 .	1>2	none	attribution	attribution
2a32218f7d0b647b6bebeb1526245a0dc8856546	136-143	209-218	that AMPK is activated during RVFV infection ,	that this pathway plays a broad role in antiviral defense	that AMPK is activated during RVFV infection ,	that this pathway plays a broad role in antiviral defense	132-166	205-232	Furthermore , we found that AMPK is activated during RVFV infection , leading to the phosphorylation and inhibition of acetyl - CoA carboxylase , the first rate - limiting enzyme in fatty acid synthesis .	Lastly , we found that this pathway plays a broad role in antiviral defense since additional viruses from disparate families were also restricted by AMPK and LKB1 .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	209-218	219-232	that this pathway plays a broad role in antiviral defense	since additional viruses from disparate families were also restricted by AMPK and LKB1 .	that this pathway plays a broad role in antiviral defense	since additional viruses from disparate families were also restricted by AMPK and LKB1 .	205-232	205-232	Lastly , we found that this pathway plays a broad role in antiviral defense since additional viruses from disparate families were also restricted by AMPK and LKB1 .	Lastly , we found that this pathway plays a broad role in antiviral defense since additional viruses from disparate families were also restricted by AMPK and LKB1 .	1<2	none	cause-result	cause-result
2a32218f7d0b647b6bebeb1526245a0dc8856546	209-218	233-245	that this pathway plays a broad role in antiviral defense	Therefore , AMPK is an important component of the cell intrinsic immune response	that this pathway plays a broad role in antiviral defense	Therefore , AMPK is an important component of the cell intrinsic immune response	205-232	233-260	Lastly , we found that this pathway plays a broad role in antiviral defense since additional viruses from disparate families were also restricted by AMPK and LKB1 .	Therefore , AMPK is an important component of the cell intrinsic immune response that restricts infection through a novel mechanism involving the inhibition of fatty acid metabolism .	1<2	none	cause-result	cause-result
2a32218f7d0b647b6bebeb1526245a0dc8856546	233-245	246-252	Therefore , AMPK is an important component of the cell intrinsic immune response	that restricts infection through a novel mechanism	Therefore , AMPK is an important component of the cell intrinsic immune response	that restricts infection through a novel mechanism	233-260	233-260	Therefore , AMPK is an important component of the cell intrinsic immune response that restricts infection through a novel mechanism involving the inhibition of fatty acid metabolism .	Therefore , AMPK is an important component of the cell intrinsic immune response that restricts infection through a novel mechanism involving the inhibition of fatty acid metabolism .	1<2	none	elaboration	elaboration
2a32218f7d0b647b6bebeb1526245a0dc8856546	246-252	253-260	that restricts infection through a novel mechanism	involving the inhibition of fatty acid metabolism .	that restricts infection through a novel mechanism	involving the inhibition of fatty acid metabolism .	233-260	233-260	Therefore , AMPK is an important component of the cell intrinsic immune response that restricts infection through a novel mechanism involving the inhibition of fatty acid metabolism .	Therefore , AMPK is an important component of the cell intrinsic immune response that restricts infection through a novel mechanism involving the inhibition of fatty acid metabolism .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	1-9	32-43	Antimicrobial stewardship program aims to reduce antibiotic use .	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antimicrobial stewardship program aims to reduce antibiotic use .	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	1-9	32-43	Antimicrobial stewardship program aims to reduce antibiotic use .	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	1>2	none	background	background
2a6d03c2466a88098a79eb95b0bccd23d91168ff	1-9	10-31	Antimicrobial stewardship program aims to reduce antibiotic use .	Periodic measurement and monitoring of antibiotic use and comparison within the institution as well as with other organizations are important indicators .	Antimicrobial stewardship program aims to reduce antibiotic use .	Periodic measurement and monitoring of antibiotic use and comparison within the institution as well as with other organizations are important indicators .	1-9	10-31	Antimicrobial stewardship program aims to reduce antibiotic use .	Periodic measurement and monitoring of antibiotic use and comparison within the institution as well as with other organizations are important indicators .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	32-43	44-56	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 ,	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 ,	32-43	44-73	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 , and only adult patients ( > 15 year of age ) were included in the study .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	44-56	57-60,68-73	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 ,	and only adult patients <*> were included in the study .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 ,	and only adult patients <*> were included in the study .	44-73	44-73	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 , and only adult patients ( > 15 year of age ) were included in the study .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 , and only adult patients ( > 15 year of age ) were included in the study .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	57-60,68-73	61-67	and only adult patients <*> were included in the study .	( > 15 year of age )	and only adult patients <*> were included in the study .	( > 15 year of age )	44-73	44-73	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 , and only adult patients ( > 15 year of age ) were included in the study .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 , and only adult patients ( > 15 year of age ) were included in the study .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	44-56	74-91	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 ,	Data were presented as days of therapy ( DOT ) and defined daily dose ( DDD ) .	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 ,	Data were presented as days of therapy ( DOT ) and defined daily dose ( DDD ) .	44-73	74-91	Antibiotic data were collected retrospectively for 2011 and from 2013 to 2015 , and only adult patients ( > 15 year of age ) were included in the study .	Data were presented as days of therapy ( DOT ) and defined daily dose ( DDD ) .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	74-91	92-110	Data were presented as days of therapy ( DOT ) and defined daily dose ( DDD ) .	DDD was adjusted per 100 bed - days and according to the case mix index ( CMI ) .	Data were presented as days of therapy ( DOT ) and defined daily dose ( DDD ) .	DDD was adjusted per 100 bed - days and according to the case mix index ( CMI ) .	74-91	92-110	Data were presented as days of therapy ( DOT ) and defined daily dose ( DDD ) .	DDD was adjusted per 100 bed - days and according to the case mix index ( CMI ) .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	92-110	111-126	DDD was adjusted per 100 bed - days and according to the case mix index ( CMI ) .	The total DDD was 37,557 in 2013 , 36,550 in 2014 and 38,738 in 2015 .	DDD was adjusted per 100 bed - days and according to the case mix index ( CMI ) .	The total DDD was 37,557 in 2013 , 36,550 in 2014 and 38,738 in 2015 .	92-110	111-126	DDD was adjusted per 100 bed - days and according to the case mix index ( CMI ) .	The total DDD was 37,557 in 2013 , 36,550 in 2014 and 38,738 in 2015 .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	111-126	127-138	The total DDD was 37,557 in 2013 , 36,550 in 2014 and 38,738 in 2015 .	The DDD per 100 patient - days was 90.7 - 94.5 .	The total DDD was 37,557 in 2013 , 36,550 in 2014 and 38,738 in 2015 .	The DDD per 100 patient - days was 90.7 - 94.5 .	111-126	127-138	The total DDD was 37,557 in 2013 , 36,550 in 2014 and 38,738 in 2015 .	The DDD per 100 patient - days was 90.7 - 94.5 .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	32-43	139-146	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	There was a discordant findings of antibiotic measurements	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	There was a discordant findings of antibiotic measurements	32-43	139-164	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	1<2	none	findings	findings
2a6d03c2466a88098a79eb95b0bccd23d91168ff	139-146	147-150,155-157	There was a discordant findings of antibiotic measurements	based on the DDD <*> and DDD/100 beddays	There was a discordant findings of antibiotic measurements	based on the DDD <*> and DDD/100 beddays	139-164	139-164	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	1<2	none	cause-result	cause-result
2a6d03c2466a88098a79eb95b0bccd23d91168ff	147-150,155-157	151-154	based on the DDD <*> and DDD/100 beddays	compared to DOT ,	based on the DDD <*> and DDD/100 beddays	compared to DOT ,	139-164	139-164	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	1<2	none	comparison	comparison
2a6d03c2466a88098a79eb95b0bccd23d91168ff	155-157	158-164	and DDD/100 beddays	compared to DOT/100 bed - days .	and DDD/100 beddays	compared to DOT/100 bed - days .	139-164	139-164	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	1<2	none	comparison	comparison
2a6d03c2466a88098a79eb95b0bccd23d91168ff	139-146	165-177,183-190	There was a discordant findings of antibiotic measurements	There was a negative correlation between CMI and DDD per 100 bed days <*> but a positive correlation of CMI with DOT	There was a discordant findings of antibiotic measurements	There was a negative correlation between CMI and DDD per 100 bed days <*> but a positive correlation of CMI with DOT	139-164	165-195	There was a discordant findings of antibiotic measurements based on the DDD compared to DOT , and DDD/100 beddays compared to DOT/100 bed - days .	There was a negative correlation between CMI and DDD per 100 bed days ( r −0.696 ) , but a positive correlation of CMI with DOT ( r +0.93 ) .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	165-177,183-190	178-182	There was a negative correlation between CMI and DDD per 100 bed days <*> but a positive correlation of CMI with DOT	( r −0.696 ) ,	There was a negative correlation between CMI and DDD per 100 bed days <*> but a positive correlation of CMI with DOT	( r −0.696 ) ,	165-195	165-195	There was a negative correlation between CMI and DDD per 100 bed days ( r −0.696 ) , but a positive correlation of CMI with DOT ( r +0.93 ) .	There was a negative correlation between CMI and DDD per 100 bed days ( r −0.696 ) , but a positive correlation of CMI with DOT ( r +0.93 ) .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	183-190	191-195	but a positive correlation of CMI with DOT	( r +0.93 ) .	but a positive correlation of CMI with DOT	( r +0.93 ) .	165-195	165-195	There was a negative correlation between CMI and DDD per 100 bed days ( r −0.696 ) , but a positive correlation of CMI with DOT ( r +0.93 ) .	There was a negative correlation between CMI and DDD per 100 bed days ( r −0.696 ) , but a positive correlation of CMI with DOT ( r +0.93 ) .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	165-177,183-190	196-208	There was a negative correlation between CMI and DDD per 100 bed days <*> but a positive correlation of CMI with DOT	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics ,	There was a negative correlation between CMI and DDD per 100 bed days <*> but a positive correlation of CMI with DOT	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics ,	165-195	196-216	There was a negative correlation between CMI and DDD per 100 bed days ( r −0.696 ) , but a positive correlation of CMI with DOT ( r +0.93 ) .	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics , reflecting activities of the antibiotic stewardship program .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	196-208	209-216	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics ,	reflecting activities of the antibiotic stewardship program .	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics ,	reflecting activities of the antibiotic stewardship program .	196-216	196-216	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics , reflecting activities of the antibiotic stewardship program .	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics , reflecting activities of the antibiotic stewardship program .	1<2	none	elaboration	elaboration
2a6d03c2466a88098a79eb95b0bccd23d91168ff	196-208	217-232	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics ,	The increase in DOT/100 bed - days may indicate the favorable utilization of combination therapy .	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics ,	The increase in DOT/100 bed - days may indicate the favorable utilization of combination therapy .	196-216	217-232	Adjusted DDD/100 bed - days showed decrease in the usage of antibiotics , reflecting activities of the antibiotic stewardship program .	The increase in DOT/100 bed - days may indicate the favorable utilization of combination therapy .	1<2	none	comparison	comparison
2a6d03c2466a88098a79eb95b0bccd23d91168ff	32-43	233-267	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antibiotic usage needs to be adjusted per 100 bed - days and correlated with CMI for better reflection of optimal antibiotic utilization , activities of the antibiotic stewardship program , and to allow benchmarking .	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antibiotic usage needs to be adjusted per 100 bed - days and correlated with CMI for better reflection of optimal antibiotic utilization , activities of the antibiotic stewardship program , and to allow benchmarking .	32-43	233-267	We analyzed antibiotic usage in a general hospital in Saudi Arabia .	Antibiotic usage needs to be adjusted per 100 bed - days and correlated with CMI for better reflection of optimal antibiotic utilization , activities of the antibiotic stewardship program , and to allow benchmarking .	1<2	none	findings	findings
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	1-14	71-81	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments	we examine three categories of everyday practice during the COVID-19 pandemic	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments	we examine three categories of everyday practice during the COVID-19 pandemic	1-23	54-129	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments when social and political institutions are in flux .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1>2	none	background	background
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	1-14	15-23	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments	when social and political institutions are in flux .	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments	when social and political institutions are in flux .	1-23	1-23	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments when social and political institutions are in flux .	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments when social and political institutions are in flux .	1<2	none	temporal	temporal
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	1-14	24-32,37-41	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments	During such crises , the ordinary and unnoticed routines <*> are thrust into the spotlight	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments	During such crises , the ordinary and unnoticed routines <*> are thrust into the spotlight	1-23	24-53	Pandemics and other crisis situations result in unsettled times , or ontologically insecure moments when social and political institutions are in flux .	During such crises , the ordinary and unnoticed routines that structure everyday life are thrust into the spotlight as people struggle to maintain or recreate a sense of normalcy .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	24-32,37-41	33-36	During such crises , the ordinary and unnoticed routines <*> are thrust into the spotlight	that structure everyday life	During such crises , the ordinary and unnoticed routines <*> are thrust into the spotlight	that structure everyday life	24-53	24-53	During such crises , the ordinary and unnoticed routines that structure everyday life are thrust into the spotlight as people struggle to maintain or recreate a sense of normalcy .	During such crises , the ordinary and unnoticed routines that structure everyday life are thrust into the spotlight as people struggle to maintain or recreate a sense of normalcy .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	37-41	42-53	are thrust into the spotlight	as people struggle to maintain or recreate a sense of normalcy .	are thrust into the spotlight	as people struggle to maintain or recreate a sense of normalcy .	24-53	24-53	During such crises , the ordinary and unnoticed routines that structure everyday life are thrust into the spotlight as people struggle to maintain or recreate a sense of normalcy .	During such crises , the ordinary and unnoticed routines that structure everyday life are thrust into the spotlight as people struggle to maintain or recreate a sense of normalcy .	1<2	none	cause-result	cause-result
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	54-59	71-81	Drawing on a range of cases	we examine three categories of everyday practice during the COVID-19 pandemic	Drawing on a range of cases	we examine three categories of everyday practice during the COVID-19 pandemic	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1>2	none	manner-means	manner-means
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	54-59	60-70	Drawing on a range of cases	including China , Russia , the UK , and USA ,	Drawing on a range of cases	including China , Russia , the UK , and USA ,	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	71-81	82-88	we examine three categories of everyday practice during the COVID-19 pandemic	that respond to disruptions in daily routines	we examine three categories of everyday practice during the COVID-19 pandemic	that respond to disruptions in daily routines	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	82-88	89-96	that respond to disruptions in daily routines	and seek a return to national normality :	that respond to disruptions in daily routines	and seek a return to national normality :	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	joint	joint
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	71-81	97-101	we examine three categories of everyday practice during the COVID-19 pandemic	performing national solidarities and exclusions	we examine three categories of everyday practice during the COVID-19 pandemic	performing national solidarities and exclusions	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	97-101	102-106	performing national solidarities and exclusions	by wearing face masks ;	performing national solidarities and exclusions	by wearing face masks ;	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	manner-means	manner-means
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	97-101	107-119	performing national solidarities and exclusions	consuming the nation in the form of panic buying and conspiracy theories ;	performing national solidarities and exclusions	consuming the nation in the form of panic buying and conspiracy theories ;	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	joint	joint
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	97-101	120-129	performing national solidarities and exclusions	and enforcing foreign policies through social media and embodiment .	performing national solidarities and exclusions	and enforcing foreign policies through social media and embodiment .	54-129	54-129	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	1<2	none	joint	joint
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	71-81	130-142	we examine three categories of everyday practice during the COVID-19 pandemic	This analysis thus breaks with existing works on everyday nationalism and banal nationalism	we examine three categories of everyday practice during the COVID-19 pandemic	This analysis thus breaks with existing works on everyday nationalism and banal nationalism	54-129	130-177	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	130-142	143-155	This analysis thus breaks with existing works on everyday nationalism and banal nationalism	that typically focus on pervasively unnoticed forms of nationalism during settled times ,	This analysis thus breaks with existing works on everyday nationalism and banal nationalism	that typically focus on pervasively unnoticed forms of nationalism during settled times ,	130-177	130-177	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	130-142	156-162	This analysis thus breaks with existing works on everyday nationalism and banal nationalism	and it challenges approaches to contentious politics	This analysis thus breaks with existing works on everyday nationalism and banal nationalism	and it challenges approaches to contentious politics	130-177	130-177	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	156-162	163-177	and it challenges approaches to contentious politics	that predict protest mobilization for change rather than restoration of the status quo ante .	and it challenges approaches to contentious politics	that predict protest mobilization for change rather than restoration of the status quo ante .	130-177	130-177	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	This analysis thus breaks with existing works on everyday nationalism and banal nationalism that typically focus on pervasively unnoticed forms of nationalism during settled times , and it challenges approaches to contentious politics that predict protest mobilization for change rather than restoration of the status quo ante .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	178-181	191-197	In highlighting the ways	this work also presents a first attempt	In highlighting the ways	this work also presents a first attempt	178-208	178-208	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	1>2	none	manner-means	manner-means
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	178-181	182-190	In highlighting the ways	that unsettled times disrupt domestic and international structures ,	In highlighting the ways	that unsettled times disrupt domestic and international structures ,	178-208	178-208	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	71-81	191-197	we examine three categories of everyday practice during the COVID-19 pandemic	this work also presents a first attempt	we examine three categories of everyday practice during the COVID-19 pandemic	this work also presents a first attempt	54-129	178-208	Drawing on a range of cases including China , Russia , the UK , and USA , we examine three categories of everyday practice during the COVID-19 pandemic that respond to disruptions in daily routines and seek a return to national normality : performing national solidarities and exclusions by wearing face masks ; consuming the nation in the form of panic buying and conspiracy theories ; and enforcing foreign policies through social media and embodiment .	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	1<2	none	elaboration	elaboration
2bc85cf8715cbd57eb454b5a0d8966c787aca1e5	191-197	198-208	this work also presents a first attempt	to link everyday nationalism with growing work on international practices .	this work also presents a first attempt	to link everyday nationalism with growing work on international practices .	178-208	178-208	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	In highlighting the ways that unsettled times disrupt domestic and international structures , this work also presents a first attempt to link everyday nationalism with growing work on international practices .	1<2	none	enablement	enablement
2c798963aaa2245c095624af78d5638bebf60c2f	1-15	57-64,80-85	Air sampling as an aid to infection control is still in an experimental stage ,	This case report used a button sampler , <*> for environmental sampling around a child	Air sampling as an aid to infection control is still in an experimental stage ,	This case report used a button sampler , <*> for environmental sampling around a child	1-56	57-112	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	1>2	none	background	background
2c798963aaa2245c095624af78d5638bebf60c2f	1-15	16-20	Air sampling as an aid to infection control is still in an experimental stage ,	as there is no consensus	Air sampling as an aid to infection control is still in an experimental stage ,	as there is no consensus	1-56	1-56	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	1<2	none	cause-result	cause-result
2c798963aaa2245c095624af78d5638bebf60c2f	16-20	21-42,51-56	as there is no consensus	about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations <*> constitutes a true clinical risk .	as there is no consensus	about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations <*> constitutes a true clinical risk .	1-56	1-56	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	21-42,51-56	43-50	about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations <*> constitutes a true clinical risk .	( staff , patients , or visitors )	about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations <*> constitutes a true clinical risk .	( staff , patients , or visitors )	1-56	1-56	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	Air sampling as an aid to infection control is still in an experimental stage , as there is no consensus about which air samplers and pathogen detection methods should be used , and what thresholds of specific pathogens in specific exposed populations ( staff , patients , or visitors ) constitutes a true clinical risk .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	57-64,80-85	65-69	This case report used a button sampler , <*> for environmental sampling around a child	worn or held by staff	This case report used a button sampler , <*> for environmental sampling around a child	worn or held by staff	57-112	57-112	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	65-69	70-79	worn or held by staff	or left free - standing in a fixed location ,	worn or held by staff	or left free - standing in a fixed location ,	57-112	57-112	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	1<2	none	joint	joint
2c798963aaa2245c095624af78d5638bebf60c2f	80-85	86-94	for environmental sampling around a child	who was chronically infected by a respiratory adenovirus ,	for environmental sampling around a child	who was chronically infected by a respiratory adenovirus ,	57-112	57-112	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	57-64,80-85	95-112	This case report used a button sampler , <*> for environmental sampling around a child	to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	This case report used a button sampler , <*> for environmental sampling around a child	to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	57-112	57-112	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	1<2	none	enablement	enablement
2c798963aaa2245c095624af78d5638bebf60c2f	113-116	139-148	Despite multiple air samples	none of the air samples contained any detectable adenovirus DNA	Despite multiple air samples	none of the air samples contained any detectable adenovirus DNA	113-161	113-161	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	1>2	none	comparison	comparison
2c798963aaa2245c095624af78d5638bebf60c2f	113-116	117-121	Despite multiple air samples	taken on difference days ,	Despite multiple air samples	taken on difference days ,	113-161	113-161	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	122-138	139-148	coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) ,	none of the air samples contained any detectable adenovirus DNA	coinciding with high levels of adenovirus detectable in the child's nasopharyngeal aspirates ( NPAs ) ,	none of the air samples contained any detectable adenovirus DNA	113-161	113-161	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	1>2	none	comparison	comparison
2c798963aaa2245c095624af78d5638bebf60c2f	57-64,80-85	139-148	This case report used a button sampler , <*> for environmental sampling around a child	none of the air samples contained any detectable adenovirus DNA	This case report used a button sampler , <*> for environmental sampling around a child	none of the air samples contained any detectable adenovirus DNA	57-112	113-161	This case report used a button sampler , worn or held by staff or left free - standing in a fixed location , for environmental sampling around a child who was chronically infected by a respiratory adenovirus , to determine whether there was any risk of secondary adenovirus infection to the staff managing the patient .	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	1<2	none	findings	findings
2c798963aaa2245c095624af78d5638bebf60c2f	139-148	149-161	none of the air samples contained any detectable adenovirus DNA	using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	none of the air samples contained any detectable adenovirus DNA	using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	113-161	113-161	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	1<2	none	manner-means	manner-means
2c798963aaa2245c095624af78d5638bebf60c2f	162-173	182-199	Although highly sensitive , in - house PCR assays have been developed	it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	Although highly sensitive , in - house PCR assays have been developed	it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	162-199	162-199	Although highly sensitive , in - house PCR assays have been developed to detect airborne pathogen RNA / DNA , it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	Although highly sensitive , in - house PCR assays have been developed to detect airborne pathogen RNA / DNA , it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	1>2	none	comparison	comparison
2c798963aaa2245c095624af78d5638bebf60c2f	162-173	174-181	Although highly sensitive , in - house PCR assays have been developed	to detect airborne pathogen RNA / DNA ,	Although highly sensitive , in - house PCR assays have been developed	to detect airborne pathogen RNA / DNA ,	162-199	162-199	Although highly sensitive , in - house PCR assays have been developed to detect airborne pathogen RNA / DNA , it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	Although highly sensitive , in - house PCR assays have been developed to detect airborne pathogen RNA / DNA , it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	1<2	none	enablement	enablement
2c798963aaa2245c095624af78d5638bebf60c2f	139-148	182-199	none of the air samples contained any detectable adenovirus DNA	it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	none of the air samples contained any detectable adenovirus DNA	it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	113-161	162-199	Despite multiple air samples taken on difference days , coinciding with high levels of adenovirus detectable in the child 's nasopharyngeal aspirates ( NPAs ) , none of the air samples contained any detectable adenovirus DNA using a clinically validated diagnostic polymerase chain reaction ( PCR ) assay .	Although highly sensitive , in - house PCR assays have been developed to detect airborne pathogen RNA / DNA , it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	182-199	200-210,216-227	it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	In this case , the absence of detectable airborne adenovirus DNA <*> removed the requirement for staff to wear surgical masks and face visors	it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	In this case , the absence of detectable airborne adenovirus DNA <*> removed the requirement for staff to wear surgical masks and face visors	162-199	200-235	Although highly sensitive , in - house PCR assays have been developed to detect airborne pathogen RNA / DNA , it is still unclear what level of specific pathogen RNA / DNA constitutes a true clinical risk .	In this case , the absence of detectable airborne adenovirus DNA using a conventional diagnostic assay removed the requirement for staff to wear surgical masks and face visors when they entered the child 's room .	1<2	none	elaboration	elaboration
2c798963aaa2245c095624af78d5638bebf60c2f	200-210,216-227	211-215	In this case , the absence of detectable airborne adenovirus DNA <*> removed the requirement for staff to wear surgical masks and face visors	using a conventional diagnostic assay	In this case , the absence of detectable airborne adenovirus DNA <*> removed the requirement for staff to wear surgical masks and face visors	using a conventional diagnostic assay	200-235	200-235	In this case , the absence of detectable airborne adenovirus DNA using a conventional diagnostic assay removed the requirement for staff to wear surgical masks and face visors when they entered the child 's room .	In this case , the absence of detectable airborne adenovirus DNA using a conventional diagnostic assay removed the requirement for staff to wear surgical masks and face visors when they entered the child 's room .	1<2	none	manner-means	manner-means
2c798963aaa2245c095624af78d5638bebf60c2f	216-227	228-235	removed the requirement for staff to wear surgical masks and face visors	when they entered the child 's room .	removed the requirement for staff to wear surgical masks and face visors	when they entered the child's room .	200-235	200-235	In this case , the absence of detectable airborne adenovirus DNA using a conventional diagnostic assay removed the requirement for staff to wear surgical masks and face visors when they entered the child 's room .	In this case , the absence of detectable airborne adenovirus DNA using a conventional diagnostic assay removed the requirement for staff to wear surgical masks and face visors when they entered the child 's room .	1<2	none	temporal	temporal
2c798963aaa2245c095624af78d5638bebf60c2f	200-210,216-227	236-249	In this case , the absence of detectable airborne adenovirus DNA <*> removed the requirement for staff to wear surgical masks and face visors	No subsequent staff infections or outbreaks of adenovirus have so far been identified .	In this case , the absence of detectable airborne adenovirus DNA <*> removed the requirement for staff to wear surgical masks and face visors	No subsequent staff infections or outbreaks of adenovirus have so far been identified .	200-235	236-249	In this case , the absence of detectable airborne adenovirus DNA using a conventional diagnostic assay removed the requirement for staff to wear surgical masks and face visors when they entered the child 's room .	No subsequent staff infections or outbreaks of adenovirus have so far been identified .	1<2	none	elaboration	elaboration
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	1-12	39-65	Transshipment hub selection becomes increasingly important to the global logistics community .	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Transshipment hub selection becomes increasingly important to the global logistics community .	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	1-12	39-65	Transshipment hub selection becomes increasingly important to the global logistics community .	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	1>2	none	background	background
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	1-12	13-29	Transshipment hub selection becomes increasingly important to the global logistics community .	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy	Transshipment hub selection becomes increasingly important to the global logistics community .	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy	1-12	13-38	Transshipment hub selection becomes increasingly important to the global logistics community .	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy and sustain service reliability across cooperative service providers .	1<2	none	elaboration	elaboration
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	13-29	30-38	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy	and sustain service reliability across cooperative service providers .	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy	and sustain service reliability across cooperative service providers .	13-38	13-38	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy and sustain service reliability across cooperative service providers .	From the perspectives of shippers and freight forwarders , a selection must align with cost control strategy and sustain service reliability across cooperative service providers .	1<2	none	joint	joint
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	39-65	66-84	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Critical factors of transshipment hub selection , both qualitative and quantitative , are identified through focus group discussions .	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Critical factors of transshipment hub selection , both qualitative and quantitative , are identified through focus group discussions .	39-65	66-84	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Critical factors of transshipment hub selection , both qualitative and quantitative , are identified through focus group discussions .	1<2	none	elaboration	elaboration
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	66-84	85-91	Critical factors of transshipment hub selection , both qualitative and quantitative , are identified through focus group discussions .	Relative importance of these factors is determined	Critical factors of transshipment hub selection , both qualitative and quantitative , are identified through focus group discussions .	Relative importance of these factors is determined	66-84	85-99	Critical factors of transshipment hub selection , both qualitative and quantitative , are identified through focus group discussions .	Relative importance of these factors is determined based on collective views of logistics stakeholders .	1<2	none	elaboration	elaboration
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	85-91	92-99	Relative importance of these factors is determined	based on collective views of logistics stakeholders .	Relative importance of these factors is determined	based on collective views of logistics stakeholders .	85-99	85-99	Relative importance of these factors is determined based on collective views of logistics stakeholders .	Relative importance of these factors is determined based on collective views of logistics stakeholders .	1<2	none	manner-means	manner-means
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	39-65	100-107	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	The competitiveness of transshipment hubs is then assessed	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	The competitiveness of transshipment hubs is then assessed	39-65	100-112	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	The competitiveness of transshipment hubs is then assessed using an AHP approach .	1<2	none	elaboration	elaboration
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	100-107	108-112	The competitiveness of transshipment hubs is then assessed	using an AHP approach .	The competitiveness of transshipment hubs is then assessed	using an AHP approach .	100-112	100-112	The competitiveness of transshipment hubs is then assessed using an AHP approach .	The competitiveness of transshipment hubs is then assessed using an AHP approach .	1<2	none	manner-means	manner-means
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	39-65	113-131	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Our analysis is based on the historical implementation of direct transportation link policy between Mainland China and Taiwan .	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Our analysis is based on the historical implementation of direct transportation link policy between Mainland China and Taiwan .	39-65	113-131	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	Our analysis is based on the historical implementation of direct transportation link policy between Mainland China and Taiwan .	1<2	none	manner-means	manner-means
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	132-139	140-162	With this empirical work , the finding suggests	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	With this empirical work , the finding suggests	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	132-178	132-178	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	1>2	none	attribution	attribution
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	39-65	140-162	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	39-65	132-178	This paper assesses the selection with the options of both sea and air transports , and from the influence of country of origin of the company .	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	1<2	none	findings	findings
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	140-162	163-171	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	such as customs regulations & government policies and connectivity	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	such as customs regulations & government policies and connectivity	132-178	132-178	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	1<2	none	elaboration	elaboration
2cd74646ef69d8ea8f04a046a88eb22dc7187dab	140-162	172-178	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	that a transshipment hub is preferred .	that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors	that a transshipment hub is preferred .	132-178	132-178	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	With this empirical work , the finding suggests that even the spawn of other nearby ports with shorter transport distance and closer proximity to cargo sources , there remain overriding factors such as customs regulations & government policies and connectivity that a transshipment hub is preferred .	1<2	none	elaboration	elaboration
2cfc9d870895fa21b90e90ab86d1343b0da35457	1-10	11-23	This study explores the divergence pattern of SARS - CoV-2	using whole genome sequences of the isolates from various COVID-19 affected countries .	This study explores the divergence pattern of SARS - CoV-2	using whole genome sequences of the isolates from various COVID-19 affected countries .	1-23	1-23	This study explores the divergence pattern of SARS - CoV-2 using whole genome sequences of the isolates from various COVID-19 affected countries .	This study explores the divergence pattern of SARS - CoV-2 using whole genome sequences of the isolates from various COVID-19 affected countries .	1<2	none	manner-means	manner-means
2cfc9d870895fa21b90e90ab86d1343b0da35457	1-10	24-42	This study explores the divergence pattern of SARS - CoV-2	The phylogenomic analysis indicates the presence of at least four distinct groups of the SARS - CoV-2 genomes .	This study explores the divergence pattern of SARS - CoV-2	The phylogenomic analysis indicates the presence of at least four distinct groups of the SARS - CoV-2 genomes .	1-23	24-42	This study explores the divergence pattern of SARS - CoV-2 using whole genome sequences of the isolates from various COVID-19 affected countries .	The phylogenomic analysis indicates the presence of at least four distinct groups of the SARS - CoV-2 genomes .	1<2	none	findings	findings
2cfc9d870895fa21b90e90ab86d1343b0da35457	24-42	43-59	The phylogenomic analysis indicates the presence of at least four distinct groups of the SARS - CoV-2 genomes .	The emergent groups have been found to be associated with signature structural changes in specific proteins .	The phylogenomic analysis indicates the presence of at least four distinct groups of the SARS - CoV-2 genomes .	The emergent groups have been found to be associated with signature structural changes in specific proteins .	24-42	43-59	The phylogenomic analysis indicates the presence of at least four distinct groups of the SARS - CoV-2 genomes .	The emergent groups have been found to be associated with signature structural changes in specific proteins .	1<2	none	elaboration	elaboration
2cfc9d870895fa21b90e90ab86d1343b0da35457	1-10	60-76	This study explores the divergence pattern of SARS - CoV-2	Also , this study reveals the differential levels of divergence patterns for the protein coding regions .	This study explores the divergence pattern of SARS - CoV-2	Also , this study reveals the differential levels of divergence patterns for the protein coding regions .	1-23	60-76	This study explores the divergence pattern of SARS - CoV-2 using whole genome sequences of the isolates from various COVID-19 affected countries .	Also , this study reveals the differential levels of divergence patterns for the protein coding regions .	1<2	none	elaboration	elaboration
2cfc9d870895fa21b90e90ab86d1343b0da35457	60-76	77-98	Also , this study reveals the differential levels of divergence patterns for the protein coding regions .	Moreover , we have predicted the impact of structural changes on a couple of important viral proteins via structural modelling techniques .	Also , this study reveals the differential levels of divergence patterns for the protein coding regions .	Moreover , we have predicted the impact of structural changes on a couple of important viral proteins via structural modelling techniques .	60-76	77-98	Also , this study reveals the differential levels of divergence patterns for the protein coding regions .	Moreover , we have predicted the impact of structural changes on a couple of important viral proteins via structural modelling techniques .	1<2	none	elaboration	elaboration
2cfc9d870895fa21b90e90ab86d1343b0da35457	77-98	99-123	Moreover , we have predicted the impact of structural changes on a couple of important viral proteins via structural modelling techniques .	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts ' response for better understanding of SARS - CoV-2 pathogenesis	Moreover , we have predicted the impact of structural changes on a couple of important viral proteins via structural modelling techniques .	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts' response for better understanding of SARS - CoV-2 pathogenesis	77-98	99-131	Moreover , we have predicted the impact of structural changes on a couple of important viral proteins via structural modelling techniques .	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts ' response for better understanding of SARS - CoV-2 pathogenesis enabling better mitigation of this pandemic situation .	1<2	none	elaboration	elaboration
2cfc9d870895fa21b90e90ab86d1343b0da35457	99-123	124-131	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts ' response for better understanding of SARS - CoV-2 pathogenesis	enabling better mitigation of this pandemic situation .	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts' response for better understanding of SARS - CoV-2 pathogenesis	enabling better mitigation of this pandemic situation .	99-131	99-131	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts ' response for better understanding of SARS - CoV-2 pathogenesis enabling better mitigation of this pandemic situation .	This study further advocates for more viral genetic studies with associated clinical outcomes and hosts ' response for better understanding of SARS - CoV-2 pathogenesis enabling better mitigation of this pandemic situation .	1<2	none	enablement	enablement
2e6263111a76ff0d43e7e3cde2692df04533e4f7	1-17	84-88	It is well established that increasing age is associated with a decreased capacity of the immune system	This review describes key findings	It is well established that increasing age is associated with a decreased capacity of the immune system	This review describes key findings	1-28	84-111	It is well established that increasing age is associated with a decreased capacity of the immune system to mediate effective immune responses to vaccination and invading pathogens .	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	1>2	none	background	background
2e6263111a76ff0d43e7e3cde2692df04533e4f7	1-17	18-28	It is well established that increasing age is associated with a decreased capacity of the immune system	to mediate effective immune responses to vaccination and invading pathogens .	It is well established that increasing age is associated with a decreased capacity of the immune system	to mediate effective immune responses to vaccination and invading pathogens .	1-28	1-28	It is well established that increasing age is associated with a decreased capacity of the immune system to mediate effective immune responses to vaccination and invading pathogens .	It is well established that increasing age is associated with a decreased capacity of the immune system to mediate effective immune responses to vaccination and invading pathogens .	1<2	none	enablement	enablement
2e6263111a76ff0d43e7e3cde2692df04533e4f7	29-33	40-57	Because of the inherent limitations	much of what we have learned is owed to the utility of experimental mouse models of aging .	Because of the inherent limitations	much of what we have learned is owed to the utility of experimental mouse models of aging .	29-57	29-57	Because of the inherent limitations of conducting experiments in humans , much of what we have learned is owed to the utility of experimental mouse models of aging .	Because of the inherent limitations of conducting experiments in humans , much of what we have learned is owed to the utility of experimental mouse models of aging .	1>2	none	cause-result	cause-result
2e6263111a76ff0d43e7e3cde2692df04533e4f7	29-33	34-39	Because of the inherent limitations	of conducting experiments in humans ,	Because of the inherent limitations	of conducting experiments in humans ,	29-57	29-57	Because of the inherent limitations of conducting experiments in humans , much of what we have learned is owed to the utility of experimental mouse models of aging .	Because of the inherent limitations of conducting experiments in humans , much of what we have learned is owed to the utility of experimental mouse models of aging .	1<2	none	elaboration	elaboration
2e6263111a76ff0d43e7e3cde2692df04533e4f7	1-17	40-57	It is well established that increasing age is associated with a decreased capacity of the immune system	much of what we have learned is owed to the utility of experimental mouse models of aging .	It is well established that increasing age is associated with a decreased capacity of the immune system	much of what we have learned is owed to the utility of experimental mouse models of aging .	1-28	29-57	It is well established that increasing age is associated with a decreased capacity of the immune system to mediate effective immune responses to vaccination and invading pathogens .	Because of the inherent limitations of conducting experiments in humans , much of what we have learned is owed to the utility of experimental mouse models of aging .	1<2	none	elaboration	elaboration
2e6263111a76ff0d43e7e3cde2692df04533e4f7	40-57	58-59,64-83	much of what we have learned is owed to the utility of experimental mouse models of aging .	Recent studies <*> have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	much of what we have learned is owed to the utility of experimental mouse models of aging .	Recent studies <*> have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	29-57	58-83	Because of the inherent limitations of conducting experiments in humans , much of what we have learned is owed to the utility of experimental mouse models of aging .	Recent studies performed in the mouse have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	1<2	none	elaboration	elaboration
2e6263111a76ff0d43e7e3cde2692df04533e4f7	58-59,64-83	60-63	Recent studies <*> have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	performed in the mouse	Recent studies <*> have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	performed in the mouse	58-83	58-83	Recent studies performed in the mouse have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	Recent studies performed in the mouse have demonstrated mechanisms responsible for age - related declines in the function of CD4 + and CD8 + cells .	1<2	none	elaboration	elaboration
2e6263111a76ff0d43e7e3cde2692df04533e4f7	84-88	89-98	This review describes key findings	regarding age - related defects in T - cell function	This review describes key findings	regarding age - related defects in T - cell function	84-111	84-111	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	1<2	none	elaboration	elaboration
2e6263111a76ff0d43e7e3cde2692df04533e4f7	84-88	99-102	This review describes key findings	and discusses the impact	This review describes key findings	and discusses the impact	84-111	84-111	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	1<2	none	elaboration	elaboration
2e6263111a76ff0d43e7e3cde2692df04533e4f7	99-102	103-111	and discusses the impact	these defects have on vaccine efficacy and immunity .	and discusses the impact	these defects have on vaccine efficacy and immunity .	84-111	84-111	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	This review describes key findings regarding age - related defects in T - cell function and discusses the impact these defects have on vaccine efficacy and immunity .	1<2	none	elaboration	elaboration
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	1-14	38-43	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality ,	we elucidate cellular and signaling mechanisms	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality ,	we elucidate cellular and signaling mechanisms	1-21	22-51	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality , yet the cellular sources remain undefined .	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	1>2	none	background	background
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	1-14	15-21	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality ,	yet the cellular sources remain undefined .	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality ,	yet the cellular sources remain undefined .	1-21	1-21	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality , yet the cellular sources remain undefined .	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality , yet the cellular sources remain undefined .	1<2	none	comparison	comparison
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	22-28	38-43	Here , using genetic and chemical tools	we elucidate cellular and signaling mechanisms	Here , using genetic and chemical tools	we elucidate cellular and signaling mechanisms	22-51	22-51	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	1>2	none	manner-means	manner-means
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	22-28	29-37	Here , using genetic and chemical tools	to probe functions of the S1P 1 receptor ,	Here , using genetic and chemical tools	to probe functions of the S1P 1 receptor ,	22-51	22-51	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	1<2	none	enablement	enablement
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	38-43	44-51	we elucidate cellular and signaling mechanisms	that are important in initiating cytokine storm .	we elucidate cellular and signaling mechanisms	that are important in initiating cytokine storm .	22-51	22-51	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	1<2	none	elaboration	elaboration
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	52-66	67-86	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue ,	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue ,	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	52-96	52-96	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue , S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice , identifying endothelial cells as central regulators of cytokine storm .	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue , S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice , identifying endothelial cells as central regulators of cytokine storm .	1>2	none	comparison	comparison
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	38-43	67-86	we elucidate cellular and signaling mechanisms	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	we elucidate cellular and signaling mechanisms	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	22-51	52-96	Here , using genetic and chemical tools to probe functions of the S1P 1 receptor , we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm .	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue , S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice , identifying endothelial cells as central regulators of cytokine storm .	1<2	none	findings	findings
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	67-86	87-96	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	identifying endothelial cells as central regulators of cytokine storm .	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	identifying endothelial cells as central regulators of cytokine storm .	52-96	52-96	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue , S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice , identifying endothelial cells as central regulators of cytokine storm .	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue , S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice , identifying endothelial cells as central regulators of cytokine storm .	1<2	none	cause-result	cause-result
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	67-86	97-110	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events	S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice ,	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events	52-96	97-118	Whereas S1P 1 receptor is expressed on endothelial cells and lymphocytes within lung tissue , S1P 1 agonism suppresses cytokines and innate immune cell recruitment in wild - type and lymphocyte - deficient mice , identifying endothelial cells as central regulators of cytokine storm .	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events that are both orchestrated by endothelial cells .	1<2	none	elaboration	elaboration
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	97-110	111-118	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events	that are both orchestrated by endothelial cells .	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events	that are both orchestrated by endothelial cells .	97-118	97-118	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events that are both orchestrated by endothelial cells .	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events that are both orchestrated by endothelial cells .	1<2	none	elaboration	elaboration
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	119-122	123-148	Moreover , we demonstrate	that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	Moreover , we demonstrate	that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	119-148	119-148	Moreover , we demonstrate that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	Moreover , we demonstrate that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	1>2	none	attribution	attribution
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	97-110	123-148	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events	that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events	that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	97-118	119-148	Furthermore , our data reveal immune cell infiltration and cytokine production as distinct events that are both orchestrated by endothelial cells .	Moreover , we demonstrate that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	1<2	none	elaboration	elaboration
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	149-156	157-158,170-174	Modulation of endothelium with a specific agonist suggests	that diseases <*> could be chemically tractable .	Modulation of endothelium with a specific agonist suggests	that diseases <*> could be chemically tractable .	149-174	149-174	Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable .	Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable .	1>2	none	attribution	attribution
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	123-148	157-158,170-174	that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	that diseases <*> could be chemically tractable .	that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	that diseases <*> could be chemically tractable .	119-148	149-174	Moreover , we demonstrate that suppression of early innate immune responses through S1P 1 signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus .	Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable .	1<2	none	elaboration	elaboration
2ebd4ba5ce0c32a5c7ef6396e35262bd667f1dcc	157-158,170-174	159-169	that diseases <*> could be chemically tractable .	in which amplification of cytokine storm is a significant pathological component	that diseases <*> could be chemically tractable .	in which amplification of cytokine storm is a significant pathological component	149-174	149-174	Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable .	Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	1-13	73-78	It is normal for hosts to be co - infected by parasites .	Here , we demonstrate a method	It is normal for hosts to be co - infected by parasites .	Here , we demonstrate a method	1-13	73-98	It is normal for hosts to be co - infected by parasites .	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	1>2	none	background	background
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	1-13	14-24	It is normal for hosts to be co - infected by parasites .	Interactions among co - infecting species can have profound consequences ,	It is normal for hosts to be co - infected by parasites .	Interactions among co - infecting species can have profound consequences ,	1-13	14-40	It is normal for hosts to be co - infected by parasites .	Interactions among co - infecting species can have profound consequences , including changing parasite transmission dynamics , altering disease severity and confounding attempts at parasite control .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	14-24	25-40	Interactions among co - infecting species can have profound consequences ,	including changing parasite transmission dynamics , altering disease severity and confounding attempts at parasite control .	Interactions among co - infecting species can have profound consequences ,	including changing parasite transmission dynamics , altering disease severity and confounding attempts at parasite control .	14-40	14-40	Interactions among co - infecting species can have profound consequences , including changing parasite transmission dynamics , altering disease severity and confounding attempts at parasite control .	Interactions among co - infecting species can have profound consequences , including changing parasite transmission dynamics , altering disease severity and confounding attempts at parasite control .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	41-48	49-53	Despite the importance of co - infection ,	there is currently no way	Despite the importance of co - infection ,	there is currently no way	41-72	41-72	Despite the importance of co - infection , there is currently no way to predict how different parasite species may interact with one another , nor the consequences of those interactions .	Despite the importance of co - infection , there is currently no way to predict how different parasite species may interact with one another , nor the consequences of those interactions .	1>2	none	comparison	comparison
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	1-13	49-53	It is normal for hosts to be co - infected by parasites .	there is currently no way	It is normal for hosts to be co - infected by parasites .	there is currently no way	1-13	41-72	It is normal for hosts to be co - infected by parasites .	Despite the importance of co - infection , there is currently no way to predict how different parasite species may interact with one another , nor the consequences of those interactions .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	49-53	54-72	there is currently no way	to predict how different parasite species may interact with one another , nor the consequences of those interactions .	there is currently no way	to predict how different parasite species may interact with one another , nor the consequences of those interactions .	41-72	41-72	Despite the importance of co - infection , there is currently no way to predict how different parasite species may interact with one another , nor the consequences of those interactions .	Despite the importance of co - infection , there is currently no way to predict how different parasite species may interact with one another , nor the consequences of those interactions .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	73-78	79-82	Here , we demonstrate a method	that enables such prediction	Here , we demonstrate a method	that enables such prediction	73-98	73-98	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	1<2	none	enablement	enablement
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	79-82	83-88	that enables such prediction	by identifying two nematode parasite groups	that enables such prediction	by identifying two nematode parasite groups	73-98	73-98	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	1<2	none	manner-means	manner-means
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	83-88	89-98	by identifying two nematode parasite groups	based on taxonomy and characteristics of the parasitological niche .	by identifying two nematode parasite groups	based on taxonomy and characteristics of the parasitological niche .	73-98	73-98	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	1<2	none	manner-means	manner-means
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	73-78	99-113,119-143	Here , we demonstrate a method	From an understanding of the interactions between the two defined groups in one host system <*> we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	Here , we demonstrate a method	From an understanding of the interactions between the two defined groups in one host system <*> we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	73-98	99-154	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	99-113,119-143	114-118	From an understanding of the interactions between the two defined groups in one host system <*> we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	( wild rabbits ) ,	From an understanding of the interactions between the two defined groups in one host system <*> we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	( wild rabbits ) ,	99-154	99-154	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	119-143	144-147	we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	( sheep ) ,	we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	( sheep ) ,	99-154	99-154	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	119-143	148-154	we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	and then we test this experimentally .	we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system	and then we test this experimentally .	99-154	99-154	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	From an understanding of the interactions between the two defined groups in one host system ( wild rabbits ) , we predict how two different nematode species , from the same defined groups , will interact in co - infections in a different host system ( sheep ) , and then we test this experimentally .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	155-156	157-158,162-181	We show	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	We show	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	155-207	155-207	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	1>2	none	attribution	attribution
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	73-78	157-158,162-181	Here , we demonstrate a method	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	Here , we demonstrate a method	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	73-98	155-207	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	1<2	none	findings	findings
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	157-158,162-181	159-161	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	as predicted ,	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	as predicted ,	155-207	155-207	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	162-181	182-193	in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ;	in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ;	155-207	155-207	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	1<2	none	cause-result	cause-result
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	157-158,162-181	194-207	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	and that the T. colubriformis - induced immune response negatively affects H. contortus .	that , <*> in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response ,	and that the T. colubriformis - induced immune response negatively affects H. contortus .	155-207	155-207	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	We show that , as predicted , in co - infections , the blood - feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response , thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis ; and that the T. colubriformis - induced immune response negatively affects H. contortus .	1<2	none	joint	joint
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	73-78	208-217	Here , we demonstrate a method	This work is , to our knowledge , the first	Here , we demonstrate a method	This work is , to our knowledge , the first	73-98	208-243	Here , we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche .	This work is , to our knowledge , the first to use empirical data from one host system to successfully predict the specific outcome of a different co - infection in a second host species .	1<2	none	findings	findings
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	208-217	218-225	This work is , to our knowledge , the first	to use empirical data from one host system	This work is , to our knowledge , the first	to use empirical data from one host system	208-243	208-243	This work is , to our knowledge , the first to use empirical data from one host system to successfully predict the specific outcome of a different co - infection in a second host species .	This work is , to our knowledge , the first to use empirical data from one host system to successfully predict the specific outcome of a different co - infection in a second host species .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	218-225	226-243	to use empirical data from one host system	to successfully predict the specific outcome of a different co - infection in a second host species .	to use empirical data from one host system	to successfully predict the specific outcome of a different co - infection in a second host species .	208-243	208-243	This work is , to our knowledge , the first to use empirical data from one host system to successfully predict the specific outcome of a different co - infection in a second host species .	This work is , to our knowledge , the first to use empirical data from one host system to successfully predict the specific outcome of a different co - infection in a second host species .	1<2	none	enablement	enablement
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	208-217	244-250	This work is , to our knowledge , the first	The study therefore takes the first step	This work is , to our knowledge , the first	The study therefore takes the first step	208-243	244-265	This work is , to our knowledge , the first to use empirical data from one host system to successfully predict the specific outcome of a different co - infection in a second host species .	The study therefore takes the first step in defining a practical framework for predicting interspecific parasite interactions in other animal systems .	1<2	none	cause-result	cause-result
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	244-250	251-255	The study therefore takes the first step	in defining a practical framework	The study therefore takes the first step	in defining a practical framework	244-265	244-265	The study therefore takes the first step in defining a practical framework for predicting interspecific parasite interactions in other animal systems .	The study therefore takes the first step in defining a practical framework for predicting interspecific parasite interactions in other animal systems .	1<2	none	elaboration	elaboration
2f071bf96a0a2a1c4fc270a41ca7f4535f474ec5	251-255	256-265	in defining a practical framework	for predicting interspecific parasite interactions in other animal systems .	in defining a practical framework	for predicting interspecific parasite interactions in other animal systems .	244-265	244-265	The study therefore takes the first step in defining a practical framework for predicting interspecific parasite interactions in other animal systems .	The study therefore takes the first step in defining a practical framework for predicting interspecific parasite interactions in other animal systems .	1<2	none	enablement	enablement
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	1-17	100-142	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health ,	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health ,	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	1-28	100-142	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health , and its diffusion around the world is causing dramatic consequences .	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	1>2	none	background	background
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	1-17	18-28	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health ,	and its diffusion around the world is causing dramatic consequences .	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health ,	and its diffusion around the world is causing dramatic consequences .	1-28	1-28	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health , and its diffusion around the world is causing dramatic consequences .	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health , and its diffusion around the world is causing dramatic consequences .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	1-17	29-49	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health ,	The knowledge of the 3D structures of SARS - CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules .	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health ,	The knowledge of the 3D structures of SARS - CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules .	1-28	29-49	The appearance of the novel betacoronavirus SARS - CoV-2 represents a major threat to human health , and its diffusion around the world is causing dramatic consequences .	The knowledge of the 3D structures of SARS - CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	29-49	50-69,76-82	The knowledge of the 3D structures of SARS - CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules .	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , <*> can reveal the common and/or distinctive traits	The knowledge of the 3D structures of SARS - CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules .	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , <*> can reveal the common and/or distinctive traits	29-49	50-99	The knowledge of the 3D structures of SARS - CoV-2 proteins can facilitate the development of therapeutic and diagnostic molecules .	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , such as SARS - CoV , can reveal the common and/or distinctive traits that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	50-69,76-82	70-75	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , <*> can reveal the common and/or distinctive traits	such as SARS - CoV ,	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , <*> can reveal the common and/or distinctive traits	such as SARS - CoV ,	50-99	50-99	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , such as SARS - CoV , can reveal the common and/or distinctive traits that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , such as SARS - CoV , can reveal the common and/or distinctive traits that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	76-82	83-99	can reveal the common and/or distinctive traits	that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	can reveal the common and/or distinctive traits	that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	50-99	50-99	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , such as SARS - CoV , can reveal the common and/or distinctive traits that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	Specifically , comparative analyses of the structures of SARS - CoV-2 proteins and homologous proteins from previously characterized viruses , such as SARS - CoV , can reveal the common and/or distinctive traits that underlie the mechanisms of recognition of cell receptors and of molecules of the immune system .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	100-142	143-157	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	Our analysis focusses only on the study of the structure of RBDs in isolation ,	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	Our analysis focusses only on the study of the structure of RBDs in isolation ,	100-142	143-168	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	Our analysis focusses only on the study of the structure of RBDs in isolation , without making use of any previous knowledge of binding properties .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	143-157	158-168	Our analysis focusses only on the study of the structure of RBDs in isolation ,	without making use of any previous knowledge of binding properties .	Our analysis focusses only on the study of the structure of RBDs in isolation ,	without making use of any previous knowledge of binding properties .	143-168	143-168	Our analysis focusses only on the study of the structure of RBDs in isolation , without making use of any previous knowledge of binding properties .	Our analysis focusses only on the study of the structure of RBDs in isolation , without making use of any previous knowledge of binding properties .	1<2	none	manner-means	manner-means
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	100-142	169-180	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	Importantly , our results highlight structural and sequence differences among the regions	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	Importantly , our results highlight structural and sequence differences among the regions	100-142	169-192	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	Importantly , our results highlight structural and sequence differences among the regions that are predicted to be immunoreactive and bind / elicit antibodies .	1<2	none	findings	findings
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	169-180	181-192	Importantly , our results highlight structural and sequence differences among the regions	that are predicted to be immunoreactive and bind / elicit antibodies .	Importantly , our results highlight structural and sequence differences among the regions	that are predicted to be immunoreactive and bind / elicit antibodies .	169-192	169-192	Importantly , our results highlight structural and sequence differences among the regions that are predicted to be immunoreactive and bind / elicit antibodies .	Importantly , our results highlight structural and sequence differences among the regions that are predicted to be immunoreactive and bind / elicit antibodies .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	169-180	193-201	Importantly , our results highlight structural and sequence differences among the regions	These results provide a rational basis to the observation	Importantly , our results highlight structural and sequence differences among the regions	These results provide a rational basis to the observation	169-192	193-221	Importantly , our results highlight structural and sequence differences among the regions that are predicted to be immunoreactive and bind / elicit antibodies .	These results provide a rational basis to the observation that several SARS - CoV RDB - specific monoclonal antibodies fail to appreciably bind the SARS - CoV-2 counterpart .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	193-201	202-221	These results provide a rational basis to the observation	that several SARS - CoV RDB - specific monoclonal antibodies fail to appreciably bind the SARS - CoV-2 counterpart .	These results provide a rational basis to the observation	that several SARS - CoV RDB - specific monoclonal antibodies fail to appreciably bind the SARS - CoV-2 counterpart .	193-221	193-221	These results provide a rational basis to the observation that several SARS - CoV RDB - specific monoclonal antibodies fail to appreciably bind the SARS - CoV-2 counterpart .	These results provide a rational basis to the observation that several SARS - CoV RDB - specific monoclonal antibodies fail to appreciably bind the SARS - CoV-2 counterpart .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	193-201	222-233	These results provide a rational basis to the observation	Furthermore , we correctly identify the region of SARS - CoV-2 RBD	These results provide a rational basis to the observation	Furthermore , we correctly identify the region of SARS - CoV-2 RBD	193-221	222-248	These results provide a rational basis to the observation that several SARS - CoV RDB - specific monoclonal antibodies fail to appreciably bind the SARS - CoV-2 counterpart .	Furthermore , we correctly identify the region of SARS - CoV-2 RBD that is engaged by the cell receptor ACE2 during viral entry into host cells .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	222-233	234-248	Furthermore , we correctly identify the region of SARS - CoV-2 RBD	that is engaged by the cell receptor ACE2 during viral entry into host cells .	Furthermore , we correctly identify the region of SARS - CoV-2 RBD	that is engaged by the cell receptor ACE2 during viral entry into host cells .	222-248	222-248	Furthermore , we correctly identify the region of SARS - CoV-2 RBD that is engaged by the cell receptor ACE2 during viral entry into host cells .	Furthermore , we correctly identify the region of SARS - CoV-2 RBD that is engaged by the cell receptor ACE2 during viral entry into host cells .	1<2	none	elaboration	elaboration
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	100-142	249-254,258-270	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	The data , sequences and structures <*> can be useful for the development of novel therapeutic and diagnostic interventions .	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	The data , sequences and structures <*> can be useful for the development of novel therapeutic and diagnostic interventions .	100-142	249-270	Herein , we apply our recently developed energy - based methods for the prediction of antibodybinding epitopes and protein - protein interaction regions to the Receptor Binding Domain ( RBD ) of the Spike proteins from SARS - CoV-2 and SARS - CoV.	The data , sequences and structures we present here can be useful for the development of novel therapeutic and diagnostic interventions .	1<2	none	findings	findings
2f6efc4edc0c9fffd3acc810efd8616e7772b28a	249-254,258-270	255-257	The data , sequences and structures <*> can be useful for the development of novel therapeutic and diagnostic interventions .	we present here	The data , sequences and structures <*> can be useful for the development of novel therapeutic and diagnostic interventions .	we present here	249-270	249-270	The data , sequences and structures we present here can be useful for the development of novel therapeutic and diagnostic interventions .	The data , sequences and structures we present here can be useful for the development of novel therapeutic and diagnostic interventions .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	1-5	30-56	Viruses have evolved elaborate mechanisms	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	Viruses have evolved elaborate mechanisms	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	1-26	27-75	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response .	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	1>2	none	background	background
2f8012db8f2100bb1876e19722d6c131849e2315	1-5	6-17	Viruses have evolved elaborate mechanisms	to evade or inactivate the complex system of sensors and signaling molecules	Viruses have evolved elaborate mechanisms	to evade or inactivate the complex system of sensors and signaling molecules	1-26	1-26	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response .	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response .	1<2	none	enablement	enablement
2f8012db8f2100bb1876e19722d6c131849e2315	6-17	18-26	to evade or inactivate the complex system of sensors and signaling molecules	that make up the host innate immune response .	to evade or inactivate the complex system of sensors and signaling molecules	that make up the host innate immune response .	1-26	1-26	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response .	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	27-29	30-56	Here we show	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	Here we show	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	27-75	27-75	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	1>2	none	attribution	attribution
2f8012db8f2100bb1876e19722d6c131849e2315	30-56	57-59	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	mediated by STING	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	mediated by STING	27-75	27-75	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	57-59	60-75	mediated by STING	( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	mediated by STING	( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	27-75	27-75	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	30-56	76-81	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	STING resides in the endoplasmic reticulum	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	STING resides in the endoplasmic reticulum	27-75	76-109	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	76-81	82-87	STING resides in the endoplasmic reticulum	and upon activation , forms dimers	STING resides in the endoplasmic reticulum	and upon activation , forms dimers	76-109	76-109	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	1<2	none	joint	joint
2f8012db8f2100bb1876e19722d6c131849e2315	82-87	88-96	and upon activation , forms dimers	which assemble with MAVS , TBK-1 and IKKe ,	and upon activation , forms dimers	which assemble with MAVS , TBK-1 and IKKe ,	76-109	76-109	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	82-87	97-109	and upon activation , forms dimers	leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	and upon activation , forms dimers	leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	76-109	76-109	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	STING resides in the endoplasmic reticulum and upon activation , forms dimers which assemble with MAVS , TBK-1 and IKKe , leading to IRF-3 activation and subsequent induction of interferon ( IFN ) .	1<2	none	cause-result	cause-result
2f8012db8f2100bb1876e19722d6c131849e2315	110-111	112-152	We found	that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	We found	that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	110-152	110-152	We found that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	We found that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	1>2	none	attribution	attribution
2f8012db8f2100bb1876e19722d6c131849e2315	30-56	112-152	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	27-75	110-152	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	We found that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	1<2	none	findings	findings
2f8012db8f2100bb1876e19722d6c131849e2315	112-152	153-167	that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING ,	that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING ,	110-152	153-182	We found that expression of the membrane anchored PLP domain from human HCoV - NL63 ( PLP2-TM ) or SARS - CoV ( PLpro - TM ) inhibits STING - mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters .	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING , and viral replicase proteins co - localize with STING in HCoV - NL63-infected cells .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	153-167	168-182	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING ,	and viral replicase proteins co - localize with STING in HCoV - NL63-infected cells .	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING ,	and viral replicase proteins co - localize with STING in HCoV - NL63-infected cells .	153-182	153-182	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING , and viral replicase proteins co - localize with STING in HCoV - NL63-infected cells .	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING , and viral replicase proteins co - localize with STING in HCoV - NL63-infected cells .	1<2	none	joint	joint
2f8012db8f2100bb1876e19722d6c131849e2315	153-167	183-192	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING ,	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING ,	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation	153-182	183-211	Both catalytically active and inactive forms of CoV PLPs co - immunoprecipitated with STING , and viral replicase proteins co - localize with STING in HCoV - NL63-infected cells .	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes required for activation of IRF-3 .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	183-192	193-205	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation	and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation	and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes	183-211	183-211	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes required for activation of IRF-3 .	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes required for activation of IRF-3 .	1<2	none	joint	joint
2f8012db8f2100bb1876e19722d6c131849e2315	193-205	206-211	and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes	required for activation of IRF-3 .	and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes	required for activation of IRF-3 .	183-211	183-211	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes required for activation of IRF-3 .	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes required for activation of IRF-3 .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	183-192	212-219	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation	STING dimerization was also substantially reduced in cells	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation	STING dimerization was also substantially reduced in cells	183-211	212-224	Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING - MAVS - TBK1 / IKKe complexes required for activation of IRF-3 .	STING dimerization was also substantially reduced in cells infected with SARS - CoV.	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	212-219	220-224	STING dimerization was also substantially reduced in cells	infected with SARS - CoV.	STING dimerization was also substantially reduced in cells	infected with SARS - CoV.	212-224	212-224	STING dimerization was also substantially reduced in cells infected with SARS - CoV.	STING dimerization was also substantially reduced in cells infected with SARS - CoV.	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	212-219	225-245	STING dimerization was also substantially reduced in cells	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells	STING dimerization was also substantially reduced in cells	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells	212-224	225-265	STING dimerization was also substantially reduced in cells infected with SARS - CoV.	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	225-245	246-254	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells	expressing wild type or catalytic mutants of PLP2-TM ,	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells	expressing wild type or catalytic mutants of PLP2-TM ,	225-265	225-265	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	225-245	255-260	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells	likely contributing to disruption of signaling	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells	likely contributing to disruption of signaling	225-265	225-265	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	255-260	261-265	likely contributing to disruption of signaling	required for IFN induction .	likely contributing to disruption of signaling	required for IFN induction .	225-265	225-265	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	Furthermore , the level of ubiquitinated forms of STING , RIG - I , TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM , likely contributing to disruption of signaling required for IFN induction .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	30-56	266-271	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	These results describe a new mechanism	that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling	These results describe a new mechanism	27-75	266-291	Here we show that human coronavirus ( HCoV ) NL63 and severe acute respiratory syndrome ( SARS ) CoV papain - like proteases ( PLP ) antagonize innate immune signaling mediated by STING ( stimulator of interferon genes , also known as MITA / ERIS / MYPS ) .	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	1<2	none	findings	findings
2f8012db8f2100bb1876e19722d6c131849e2315	266-271	272-274	These results describe a new mechanism	used by CoVs	These results describe a new mechanism	used by CoVs	266-291	266-291	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	266-271	275-282	These results describe a new mechanism	in which CoV PLPs negatively regulate antiviral defenses	These results describe a new mechanism	in which CoV PLPs negatively regulate antiviral defenses	266-291	266-291	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	1<2	none	elaboration	elaboration
2f8012db8f2100bb1876e19722d6c131849e2315	275-282	283-291	in which CoV PLPs negatively regulate antiviral defenses	by disrupting the STING - mediated IFN induction .	in which CoV PLPs negatively regulate antiviral defenses	by disrupting the STING - mediated IFN induction .	266-291	266-291	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING - mediated IFN induction .	1<2	none	manner-means	manner-means
31fae2807695521804442fedcd3f7b9f17d0f9ea	1-2	3-14	BACKGROUND :	Evaluation of interindividual variability is a challenging step in risk assessment .	BACKGROUND :	Evaluation of interindividual variability is a challenging step in risk assessment .	1-2	3-14	BACKGROUND :	Evaluation of interindividual variability is a challenging step in risk assessment .	1>2	none	textual-organization	textual-organization
31fae2807695521804442fedcd3f7b9f17d0f9ea	3-14	48-61	Evaluation of interindividual variability is a challenging step in risk assessment .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	Evaluation of interindividual variability is a challenging step in risk assessment .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	3-14	48-79	Evaluation of interindividual variability is a challenging step in risk assessment .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	1>2	none	background	background
31fae2807695521804442fedcd3f7b9f17d0f9ea	3-14	15-19,26-30	Evaluation of interindividual variability is a challenging step in risk assessment .	For most environmental pollutants , <*> experimental data are lacking ,	Evaluation of interindividual variability is a challenging step in risk assessment .	For most environmental pollutants , <*> experimental data are lacking ,	3-14	15-45	Evaluation of interindividual variability is a challenging step in risk assessment .	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	15-19,26-30	20-25	For most environmental pollutants , <*> experimental data are lacking ,	including perchloroethylene ( PERC ) ,	For most environmental pollutants , <*> experimental data are lacking ,	including perchloroethylene ( PERC ) ,	15-45	15-45	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	26-30	31-34	experimental data are lacking ,	resulting in default assumptions	experimental data are lacking ,	resulting in default assumptions	15-45	15-45	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	1<2	none	cause-result	cause-result
31fae2807695521804442fedcd3f7b9f17d0f9ea	31-34	35-36	resulting in default assumptions	being used	resulting in default assumptions	being used	15-45	15-45	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	35-36	37-45	being used	to account for variability in toxicokinetics and toxicodynamics .	being used	to account for variability in toxicokinetics and toxicodynamics .	15-45	15-45	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	For most environmental pollutants , including perchloroethylene ( PERC ) , experimental data are lacking , resulting in default assumptions being used to account for variability in toxicokinetics and toxicodynamics .	1<2	none	enablement	enablement
31fae2807695521804442fedcd3f7b9f17d0f9ea	46-47	48-61	OBJECTIVE :	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	OBJECTIVE :	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	46-47	48-79	OBJECTIVE :	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	1>2	none	textual-organization	textual-organization
31fae2807695521804442fedcd3f7b9f17d0f9ea	48-61	62-75	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity	48-79	48-79	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	1<2	none	enablement	enablement
31fae2807695521804442fedcd3f7b9f17d0f9ea	62-75	76-79	to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity	following PERC exposure .	to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity	following PERC exposure .	48-79	48-79	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	1<2	none	temporal	temporal
31fae2807695521804442fedcd3f7b9f17d0f9ea	80-81	82-101,108-109	METHODS :	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	METHODS :	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	80-81	82-130	METHODS :	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	1>2	none	textual-organization	textual-organization
31fae2807695521804442fedcd3f7b9f17d0f9ea	48-61	82-101,108-109	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	48-79	82-130	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	1<2	none	manner-means	manner-means
31fae2807695521804442fedcd3f7b9f17d0f9ea	82-101,108-109	102-107	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	( 1,000 mg / kg )	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	( 1,000 mg / kg )	82-130	82-130	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	108-109	110-114	or vehicle	( Alkamuls - EL620 )	or vehicle	( Alkamuls - EL620 )	82-130	82-130	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	108-109	115-120	or vehicle	and euthanized at various time points	or vehicle	and euthanized at various time points	82-130	82-130	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	115-120	121-130	and euthanized at various time points	( n = 1 = strain = time ) .	and euthanized at various time points	( n = 1 = strain = time ) .	82-130	82-130	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	82-101,108-109	131-151	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	Concentration - time profiles were generated for PERC and its primary oxidative metabolite trichloroacetate ( TCA ) in multiple tissues .	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC <*> or vehicle	Concentration - time profiles were generated for PERC and its primary oxidative metabolite trichloroacetate ( TCA ) in multiple tissues .	82-130	131-151	Male mice from 45 strains of the Collaborative Cross ( CC ) were orally administered a single dose of PERC ( 1,000 mg / kg ) or vehicle ( Alkamuls - EL620 ) and euthanized at various time points ( n = 1 = strain = time ) .	Concentration - time profiles were generated for PERC and its primary oxidative metabolite trichloroacetate ( TCA ) in multiple tissues .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	131-151	152-157	Concentration - time profiles were generated for PERC and its primary oxidative metabolite trichloroacetate ( TCA ) in multiple tissues .	Toxicodynamic phenotyping was also performed .	Concentration - time profiles were generated for PERC and its primary oxidative metabolite trichloroacetate ( TCA ) in multiple tissues .	Toxicodynamic phenotyping was also performed .	131-151	152-157	Concentration - time profiles were generated for PERC and its primary oxidative metabolite trichloroacetate ( TCA ) in multiple tissues .	Toxicodynamic phenotyping was also performed .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	158-159	160-176	RESULTS :	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	RESULTS :	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	158-159	160-176	RESULTS :	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	1>2	none	textual-organization	textual-organization
31fae2807695521804442fedcd3f7b9f17d0f9ea	48-61	160-176	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	48-79	160-176	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	1<2	none	findings	findings
31fae2807695521804442fedcd3f7b9f17d0f9ea	177-186	187-198	Based on area under the curve ( AUC ) ,	the range of liver TCA levels spanned nearly an order of magnitude	Based on area under the curve ( AUC ) ,	the range of liver TCA levels spanned nearly an order of magnitude	177-203	177-203	Based on area under the curve ( AUC ) , the range of liver TCA levels spanned nearly an order of magnitude ( ∼ 8-fold ) .	Based on area under the curve ( AUC ) , the range of liver TCA levels spanned nearly an order of magnitude ( ∼ 8-fold ) .	1>2	none	cause-result	cause-result
31fae2807695521804442fedcd3f7b9f17d0f9ea	160-176	187-198	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	the range of liver TCA levels spanned nearly an order of magnitude	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	the range of liver TCA levels spanned nearly an order of magnitude	160-176	177-203	Significant variability among strains was observed in toxicokinetics of PERC and TCA in every tissue examined .	Based on area under the curve ( AUC ) , the range of liver TCA levels spanned nearly an order of magnitude ( ∼ 8-fold ) .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	187-198	199-203	the range of liver TCA levels spanned nearly an order of magnitude	( ∼ 8-fold ) .	the range of liver TCA levels spanned nearly an order of magnitude	( ∼ 8-fold ) .	177-203	177-203	Based on area under the curve ( AUC ) , the range of liver TCA levels spanned nearly an order of magnitude ( ∼ 8-fold ) .	Based on area under the curve ( AUC ) , the range of liver TCA levels spanned nearly an order of magnitude ( ∼ 8-fold ) .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	187-198	204-215	the range of liver TCA levels spanned nearly an order of magnitude	Expression of liver cytochrome P4502E1 did not correlate with TCA levels .	the range of liver TCA levels spanned nearly an order of magnitude	Expression of liver cytochrome P4502E1 did not correlate with TCA levels .	177-203	204-215	Based on area under the curve ( AUC ) , the range of liver TCA levels spanned nearly an order of magnitude ( ∼ 8-fold ) .	Expression of liver cytochrome P4502E1 did not correlate with TCA levels .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	204-215	216-245	Expression of liver cytochrome P4502E1 did not correlate with TCA levels .	Toxicodynamic phenotyping revealed an effect of PERC on bodyweight loss , induction of peroxisome proliferator activated receptor - alpha ( PPARa)-regulated genes , and dysregulation of hepatic lipid homeostasis .	Expression of liver cytochrome P4502E1 did not correlate with TCA levels .	Toxicodynamic phenotyping revealed an effect of PERC on bodyweight loss , induction of peroxisome proliferator activated receptor - alpha ( PPARa)-regulated genes , and dysregulation of hepatic lipid homeostasis .	204-215	216-245	Expression of liver cytochrome P4502E1 did not correlate with TCA levels .	Toxicodynamic phenotyping revealed an effect of PERC on bodyweight loss , induction of peroxisome proliferator activated receptor - alpha ( PPARa)-regulated genes , and dysregulation of hepatic lipid homeostasis .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	216-245	246-285	Toxicodynamic phenotyping revealed an effect of PERC on bodyweight loss , induction of peroxisome proliferator activated receptor - alpha ( PPARa)-regulated genes , and dysregulation of hepatic lipid homeostasis .	Clustering was observed among a ) liver levels of PERC , TCA , and triglycerides ; b ) TCA levels in liver and kidney ; and c ) TCA levels in serum , brain , fat , and lung .	Toxicodynamic phenotyping revealed an effect of PERC on bodyweight loss , induction of peroxisome proliferator activated receptor - alpha ( PPARa)-regulated genes , and dysregulation of hepatic lipid homeostasis .	Clustering was observed among a ) liver levels of PERC , TCA , and triglycerides ; b ) TCA levels in liver and kidney ; and c ) TCA levels in serum , brain , fat , and lung .	216-245	246-285	Toxicodynamic phenotyping revealed an effect of PERC on bodyweight loss , induction of peroxisome proliferator activated receptor - alpha ( PPARa)-regulated genes , and dysregulation of hepatic lipid homeostasis .	Clustering was observed among a ) liver levels of PERC , TCA , and triglycerides ; b ) TCA levels in liver and kidney ; and c ) TCA levels in serum , brain , fat , and lung .	1<2	none	elaboration	elaboration
31fae2807695521804442fedcd3f7b9f17d0f9ea	286-287	295-315	CONCLUSIONS :	we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	CONCLUSIONS :	we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	286-287	288-315	CONCLUSIONS :	Using the CC mouse population model , we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	1>2	none	textual-organization	textual-organization
31fae2807695521804442fedcd3f7b9f17d0f9ea	288-294	295-315	Using the CC mouse population model ,	we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	Using the CC mouse population model ,	we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	288-315	288-315	Using the CC mouse population model , we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	Using the CC mouse population model , we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	1>2	none	manner-means	manner-means
31fae2807695521804442fedcd3f7b9f17d0f9ea	48-61	295-315	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	48-79	288-315	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	Using the CC mouse population model , we have demonstrated a complex and highly variable relationship between PERC and TCA toxicokinetics and toxicodynamics at the population level .	1<2	none	findings	findings
31fae2807695521804442fedcd3f7b9f17d0f9ea	48-61	316-317	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	https://doi .	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level	https://doi .	48-79	316-317	We quantitatively examined the relationship between PERC toxicokinetics and toxicodynamics at the population level to test whether individuals with increased oxidative metabolism are be more sensitive to hepatotoxicity following PERC exposure .	https://doi .	1<2	none	textual-organization	textual-organization
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	1-14	37-48,72-75	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	1-36	37-95	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	1>2	none	background	background
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	1-14	15-21	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay	for detecting and differentiating similarly related pathogens	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay	for detecting and differentiating similarly related pathogens	1-36	1-36	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	1<2	none	enablement	enablement
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	15-21	22-27	for detecting and differentiating similarly related pathogens	by using closely overlapping probe sets	for detecting and differentiating similarly related pathogens	by using closely overlapping probe sets	1-36	1-36	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	1<2	none	manner-means	manner-means
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	22-27	28-36	by using closely overlapping probe sets	to determine a target organism 's nucleotide sequence .	by using closely overlapping probe sets	to determine a target organism's nucleotide sequence .	1-36	1-36	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	A Resequencing Pathogen Microarray ( RPM ) is a single , highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism 's nucleotide sequence .	1<2	none	enablement	enablement
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	37-48,72-75	49-54	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	that consisted of 224-bp detector tiles	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	that consisted of 224-bp detector tiles	37-95	37-95	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	49-54	55-71	that consisted of 224-bp detector tiles	corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses	that consisted of 224-bp detector tiles	corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses	37-95	37-95	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	72-75	76-82	was developed and optimized	to provide individual and simultaneous detection sensitivities	was developed and optimized	to provide individual and simultaneous detection sensitivities	37-95	37-95	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	1<2	none	enablement	enablement
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	76-82	83-95	to provide individual and simultaneous detection sensitivities	ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	to provide individual and simultaneous detection sensitivities	ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	37-95	37-95	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	37-48,72-75	96-109,122-128	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) <*> were assessed using the new assay .	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) <*> were assessed using the new assay .	37-95	96-128	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) admitted to 5 district general hospitals in Beijing during a 1-year period were assessed using the new assay .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	96-109,122-128	110-121	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) <*> were assessed using the new assay .	admitted to 5 district general hospitals in Beijing during a 1-year period	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) <*> were assessed using the new assay .	admitted to 5 district general hospitals in Beijing during a 1-year period	96-128	96-128	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) admitted to 5 district general hospitals in Beijing during a 1-year period were assessed using the new assay .	A total of 110 consecutive patients with community - acquired pneumonia ( CAP ) admitted to 5 district general hospitals in Beijing during a 1-year period were assessed using the new assay .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	37-48,72-75	129-165	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively ,	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively ,	37-95	129-172	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively , which is consistent with reference assays .	1<2	none	findings	findings
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	129-165	166-172	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively ,	which is consistent with reference assays .	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively ,	which is consistent with reference assays .	129-172	129-172	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively , which is consistent with reference assays .	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively , which is consistent with reference assays .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	129-165	173-174,200-203	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively ,	Atypical pathogens <*> were also detected .	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively ,	Atypical pathogens <*> were also detected .	129-172	173-203	Among the children ( under age 5 ) and adult patients ( above age 18 ) , respiratory syncytial virus ( RSV ) and rhinovirus ( RV ) were the most common etiological agents , respectively , which is consistent with reference assays .	Atypical pathogens that may cause CAP - like illness , including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV ) were also detected .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	173-174,200-203	175-182	Atypical pathogens <*> were also detected .	that may cause CAP - like illness ,	Atypical pathogens <*> were also detected .	that may cause CAP - like illness ,	173-203	173-203	Atypical pathogens that may cause CAP - like illness , including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV ) were also detected .	Atypical pathogens that may cause CAP - like illness , including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV ) were also detected .	1<2	none	cause-result	cause-result
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	175-182	183-199	that may cause CAP - like illness ,	including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV )	that may cause CAP - like illness ,	including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV )	173-203	173-203	Atypical pathogens that may cause CAP - like illness , including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV ) were also detected .	Atypical pathogens that may cause CAP - like illness , including rubella virus , measles virus , influenza type C virus , human herpesvirus ( HHV ) were also detected .	1<2	none	elaboration	elaboration
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	37-48,72-75	204-223	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types ,	In this study , a new RPM ( RPM - IVDC1 ) <*> was developed and optimized	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types ,	37-95	204-239	In this study , a new RPM ( RPM - IVDC1 ) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes , 11 rhinoviruses , 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens .	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types , which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens .	1<2	none	findings	findings
338d45deb88de8cc7f4cf5158c4752fb3533a0b7	204-223	224-239	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types ,	which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens .	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types ,	which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens .	204-239	204-239	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types , which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens .	The results show the capability of RPM - IVDC1 for the accurate detection and identification of multiple virus types , which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	1-30	202-210	Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries ' policies with respect to BCG vaccination on the other .	that population age is a very significant confounding factor	Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries' policies with respect to BCG vaccination on the other .	that population age is a very significant confounding factor	1-30	199-229	Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries ' policies with respect to BCG vaccination on the other .	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	1>2	none	background	background
34694791cd158e785ad16404d5d34ad8559792c0	1-30	31-42	Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries ' policies with respect to BCG vaccination on the other .	This connection arises from differences in the rates of infection in countries	Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries' policies with respect to BCG vaccination on the other .	This connection arises from differences in the rates of infection in countries	1-30	31-65	Recently a number of publications looked at the association between COVID-19 morbidity and mortality on one hand and countries ' policies with respect to BCG vaccination on the other .	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	31-42	43-47	This connection arises from differences in the rates of infection in countries	where BCG vaccination is mandatory	This connection arises from differences in the rates of infection in countries	where BCG vaccination is mandatory	31-65	31-65	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	31-42	48-50	This connection arises from differences in the rates of infection in countries	compared to countries	This connection arises from differences in the rates of infection in countries	compared to countries	31-65	31-65	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	1<2	none	comparison	comparison
34694791cd158e785ad16404d5d34ad8559792c0	48-50	51-56	compared to countries	where mandatory vaccination no longer exists	compared to countries	where mandatory vaccination no longer exists	31-65	31-65	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	51-56	57-65	where mandatory vaccination no longer exists	or was never implemented in the first place .	where mandatory vaccination no longer exists	or was never implemented in the first place .	31-65	31-65	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	1<2	none	joint	joint
34694791cd158e785ad16404d5d34ad8559792c0	31-42	66-76	This connection arises from differences in the rates of infection in countries	In at least 2 preprint publications the authors expressed the view	This connection arises from differences in the rates of infection in countries	In at least 2 preprint publications the authors expressed the view	31-65	66-96	This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place .	In at least 2 preprint publications the authors expressed the view that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	66-76	77-96	In at least 2 preprint publications the authors expressed the view	that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	In at least 2 preprint publications the authors expressed the view	that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	66-96	66-96	In at least 2 preprint publications the authors expressed the view that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	In at least 2 preprint publications the authors expressed the view that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	66-76	97-107	In at least 2 preprint publications the authors expressed the view	One study accounted for different income levels in different groups .	In at least 2 preprint publications the authors expressed the view	One study accounted for different income levels in different groups .	66-96	97-107	In at least 2 preprint publications the authors expressed the view that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	One study accounted for different income levels in different groups .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	97-107	108-116	One study accounted for different income levels in different groups .	Another study did not attempted to do so ,	One study accounted for different income levels in different groups .	Another study did not attempted to do so ,	97-107	108-141	One study accounted for different income levels in different groups .	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	108-116	117-122,129-130	Another study did not attempted to do so ,	instead exploring the differences between countries <*> vs others	Another study did not attempted to do so ,	instead exploring the differences between countries <*> vs others	108-141	108-141	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	1<2	none	comparison	comparison
34694791cd158e785ad16404d5d34ad8559792c0	117-122,129-130	123-128	instead exploring the differences between countries <*> vs others	where a booster shot is given	instead exploring the differences between countries <*> vs others	where a booster shot is given	108-141	108-141	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	129-130	131-141	vs others	where no such practice exists ( finding no connection ) .	vs others	where no such practice exists ( finding no connection ) .	108-141	108-141	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	Another study did not attempted to do so , instead exploring the differences between countries where a booster shot is given vs others where no such practice exists ( finding no connection ) .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	66-76	142-153	In at least 2 preprint publications the authors expressed the view	Both of these studies did not explore other potential confounding factors .	In at least 2 preprint publications the authors expressed the view	Both of these studies did not explore other potential confounding factors .	66-96	142-153	In at least 2 preprint publications the authors expressed the view that the " known immunological benefits " of BCG vaccination may be behind the biological mechanism of such observation .	Both of these studies did not explore other potential confounding factors .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	142-153	154-161	Both of these studies did not explore other potential confounding factors .	Meanwhile the press has focused on these headlines	Both of these studies did not explore other potential confounding factors .	Meanwhile the press has focused on these headlines	142-153	154-177	Both of these studies did not explore other potential confounding factors .	Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates .	1<2	none	comparison	comparison
34694791cd158e785ad16404d5d34ad8559792c0	154-161	162-165	Meanwhile the press has focused on these headlines	and pushed the narrative	Meanwhile the press has focused on these headlines	and pushed the narrative	154-177	154-177	Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates .	Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	162-165	166-177	and pushed the narrative	that BCG vaccination is causally linked to infection and mortality rates .	and pushed the narrative	that BCG vaccination is causally linked to infection and mortality rates .	154-177	154-177	Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates .	Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	154-161	178-183	Meanwhile the press has focused on these headlines	This poses a serious challenge ,	Meanwhile the press has focused on these headlines	This poses a serious challenge ,	154-177	178-198	Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates .	This poses a serious challenge , demonstrated by the recently initiated clinical trials on BCG vaccination within the COVID19 context .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	178-183	184-198	This poses a serious challenge ,	demonstrated by the recently initiated clinical trials on BCG vaccination within the COVID19 context .	This poses a serious challenge ,	demonstrated by the recently initiated clinical trials on BCG vaccination within the COVID19 context .	178-198	178-198	This poses a serious challenge , demonstrated by the recently initiated clinical trials on BCG vaccination within the COVID19 context .	This poses a serious challenge , demonstrated by the recently initiated clinical trials on BCG vaccination within the COVID19 context .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	199-201	202-210	This study shows	that population age is a very significant confounding factor	This study shows	that population age is a very significant confounding factor	199-229	199-229	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	1>2	none	attribution	attribution
34694791cd158e785ad16404d5d34ad8559792c0	202-210	211-218	that population age is a very significant confounding factor	that explains the rates of infections much better	that population age is a very significant confounding factor	that explains the rates of infections much better	199-229	199-229	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	211-218	219-224	that explains the rates of infections much better	and has a solid biology mechanism	that explains the rates of infections much better	and has a solid biology mechanism	199-229	199-229	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	1<2	none	joint	joint
34694791cd158e785ad16404d5d34ad8559792c0	219-224	225-229	and has a solid biology mechanism	which explains this correlation .	and has a solid biology mechanism	which explains this correlation .	199-229	199-229	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	1<2	none	elaboration	elaboration
34694791cd158e785ad16404d5d34ad8559792c0	230-231	232-244	It suggests	that BCG vaccination may have little or no causal link to infection rates	It suggests	that BCG vaccination may have little or no causal link to infection rates	230-286	230-286	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	1>2	none	attribution	attribution
34694791cd158e785ad16404d5d34ad8559792c0	202-210	232-244	that population age is a very significant confounding factor	that BCG vaccination may have little or no causal link to infection rates	that population age is a very significant confounding factor	that BCG vaccination may have little or no causal link to infection rates	199-229	230-286	This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation .	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	1<2	none	cause-result	cause-result
34694791cd158e785ad16404d5d34ad8559792c0	245-246	247-258	and advises	that any follow up studies should control for several confounding factors ,	and advises	that any follow up studies should control for several confounding factors ,	230-286	230-286	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	1>2	none	attribution	attribution
34694791cd158e785ad16404d5d34ad8559792c0	232-244	247-258	that BCG vaccination may have little or no causal link to infection rates	that any follow up studies should control for several confounding factors ,	that BCG vaccination may have little or no causal link to infection rates	that any follow up studies should control for several confounding factors ,	230-286	230-286	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	1<2	none	joint	joint
34694791cd158e785ad16404d5d34ad8559792c0	247-258	259-286	that any follow up studies should control for several confounding factors ,	such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	that any follow up studies should control for several confounding factors ,	such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	230-286	230-286	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors , such as population age , ethnicity , rates of certain chronic diseases , time from community spread start date , major public policy decisions and income levels .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	1-31	59-65	The integration of proteomic methods to virology has facilitated a significant breadth of biological insight into mechanisms of virus replication , antiviral host responses and viral subversion of host defenses .	Reviewed here are proteomic - based approaches	The integration of proteomic methods to virology has facilitated a significant breadth of biological insight into mechanisms of virus replication , antiviral host responses and viral subversion of host defenses .	Reviewed here are proteomic - based approaches	1-31	59-78	The integration of proteomic methods to virology has facilitated a significant breadth of biological insight into mechanisms of virus replication , antiviral host responses and viral subversion of host defenses .	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	1>2	none	background	background
352657225f9b69e4693a466de17c2a4d55ccc1d3	1-31	32-58	The integration of proteomic methods to virology has facilitated a significant breadth of biological insight into mechanisms of virus replication , antiviral host responses and viral subversion of host defenses .	Throughout the course of infection , these cellular mechanisms rely heavily on the formation of temporally and spatially regulated virus - host protein - protein interactions .	The integration of proteomic methods to virology has facilitated a significant breadth of biological insight into mechanisms of virus replication , antiviral host responses and viral subversion of host defenses .	Throughout the course of infection , these cellular mechanisms rely heavily on the formation of temporally and spatially regulated virus - host protein - protein interactions .	1-31	32-58	The integration of proteomic methods to virology has facilitated a significant breadth of biological insight into mechanisms of virus replication , antiviral host responses and viral subversion of host defenses .	Throughout the course of infection , these cellular mechanisms rely heavily on the formation of temporally and spatially regulated virus - host protein - protein interactions .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	59-65	66-69	Reviewed here are proteomic - based approaches	that have been used	Reviewed here are proteomic - based approaches	that have been used	59-78	59-78	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	66-69	70-78	that have been used	to characterize this dynamic virus - host interplay .	that have been used	to characterize this dynamic virus - host interplay .	59-78	59-78	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	1<2	none	enablement	enablement
352657225f9b69e4693a466de17c2a4d55ccc1d3	59-65	79-102	Reviewed here are proteomic - based approaches	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques	Reviewed here are proteomic - based approaches	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques	59-78	79-124	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques for elucidating complex networks of virus - host protein associations during infection with a diverse range of RNA and DNA viruses .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	79-102	103-124	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques	for elucidating complex networks of virus - host protein associations during infection with a diverse range of RNA and DNA viruses .	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques	for elucidating complex networks of virus - host protein associations during infection with a diverse range of RNA and DNA viruses .	79-124	79-124	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques for elucidating complex networks of virus - host protein associations during infection with a diverse range of RNA and DNA viruses .	Specifically discussed are the contribution of integrative mass spectrometry , antibodybased affinity purification of protein complexes , cross - linking and protein array techniques for elucidating complex networks of virus - host protein associations during infection with a diverse range of RNA and DNA viruses .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	59-65	125-128,135-137	Reviewed here are proteomic - based approaches	The benefits and limitations <*> are explored ,	Reviewed here are proteomic - based approaches	The benefits and limitations <*> are explored ,	59-78	125-162	Reviewed here are proteomic - based approaches that have been used to characterize this dynamic virus - host interplay .	The benefits and limitations of applying proteomic methods to virology are explored , and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	125-128,135-137	129-134	The benefits and limitations <*> are explored ,	of applying proteomic methods to virology	The benefits and limitations <*> are explored ,	of applying proteomic methods to virology	125-162	125-162	The benefits and limitations of applying proteomic methods to virology are explored , and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	The benefits and limitations of applying proteomic methods to virology are explored , and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	1<2	none	elaboration	elaboration
352657225f9b69e4693a466de17c2a4d55ccc1d3	125-128,135-137	138-162	The benefits and limitations <*> are explored ,	and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	The benefits and limitations <*> are explored ,	and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	125-162	125-162	The benefits and limitations of applying proteomic methods to virology are explored , and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	The benefits and limitations of applying proteomic methods to virology are explored , and the contribution of these approaches to important biological discoveries and to inspiring new tractable avenues for the design of antiviral therapeutics is highlighted .	1<2	none	elaboration	elaboration
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	1-6	88-107	Coronaviruses are positive stranded RNA viruses	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential	Coronaviruses are positive stranded RNA viruses	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential	1-23	88-114	Coronaviruses are positive stranded RNA viruses that cause respiratory , enteric and central nervous system diseases in many species , including humans .	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential to inhibit the novel MERS - CoV.	1>2	none	background	background
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	1-6	7-20	Coronaviruses are positive stranded RNA viruses	that cause respiratory , enteric and central nervous system diseases in many species ,	Coronaviruses are positive stranded RNA viruses	that cause respiratory , enteric and central nervous system diseases in many species ,	1-23	1-23	Coronaviruses are positive stranded RNA viruses that cause respiratory , enteric and central nervous system diseases in many species , including humans .	Coronaviruses are positive stranded RNA viruses that cause respiratory , enteric and central nervous system diseases in many species , including humans .	1<2	none	cause-result	cause-result
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	7-20	21-23	that cause respiratory , enteric and central nervous system diseases in many species ,	including humans .	that cause respiratory , enteric and central nervous system diseases in many species ,	including humans .	1-23	1-23	Coronaviruses are positive stranded RNA viruses that cause respiratory , enteric and central nervous system diseases in many species , including humans .	Coronaviruses are positive stranded RNA viruses that cause respiratory , enteric and central nervous system diseases in many species , including humans .	1<2	none	elaboration	elaboration
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	1-6	24-34,41-48	Coronaviruses are positive stranded RNA viruses	Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .	Coronaviruses are positive stranded RNA viruses	Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .	1-23	24-48	Coronaviruses are positive stranded RNA viruses that cause respiratory , enteric and central nervous system diseases in many species , including humans .	Until recently , the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics .	1<2	none	elaboration	elaboration
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	24-34,41-48	35-40	Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .	caused by few of these viruses	Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .	caused by few of these viruses	24-48	24-48	Until recently , the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics .	Until recently , the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics .	1<2	none	cause-result	cause-result
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	24-34,41-48	49-87	Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .	However , the emergence of severe acute respiratory syndrome coronavirus ( SARS - CoV ) , and more recently , Middle East respiratory syndrome coronavirus ( MERS - CoV ) , has impelled the development of such drugs .	Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .	However , the emergence of severe acute respiratory syndrome coronavirus ( SARS - CoV ) , and more recently , Middle East respiratory syndrome coronavirus ( MERS - CoV ) , has impelled the development of such drugs .	24-48	49-87	Until recently , the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics .	However , the emergence of severe acute respiratory syndrome coronavirus ( SARS - CoV ) , and more recently , Middle East respiratory syndrome coronavirus ( MERS - CoV ) , has impelled the development of such drugs .	1<2	none	comparison	comparison
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	88-107	108-114	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential	to inhibit the novel MERS - CoV.	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential	to inhibit the novel MERS - CoV.	88-114	88-114	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential to inhibit the novel MERS - CoV.	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential to inhibit the novel MERS - CoV.	1<2	none	enablement	enablement
36f9ee4d21bf47a3f9f504f7fca3a1db625899d2	88-107	115-149	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential	The clinical development of optimized versions of such compounds could be beneficial for the treatment and control of SARS - CoV , the current MERS - CoV and other future SARS - like epidemics .	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential	The clinical development of optimized versions of such compounds could be beneficial for the treatment and control of SARS - CoV , the current MERS - CoV and other future SARS - like epidemics .	88-114	115-149	This review focuses on some newly identified SARS - CoV inhibitors , with known mechanisms of action and their potential to inhibit the novel MERS - CoV.	The clinical development of optimized versions of such compounds could be beneficial for the treatment and control of SARS - CoV , the current MERS - CoV and other future SARS - like epidemics .	1<2	none	findings	findings
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	1-9	198-206	Pandemics have a profound impact on our world ,	In this paper we provide relatively efficient pooling methods	Pandemics have a profound impact on our world ,	In this paper we provide relatively efficient pooling methods	1-23	198-222	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	1>2	none	background	background
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	1-9	10-14	Pandemics have a profound impact on our world ,	causing loss of life ,	Pandemics have a profound impact on our world ,	causing loss of life ,	1-23	1-23	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	1<2	none	cause-result	cause-result
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	10-14	15-17	causing loss of life ,	affecting our culture	causing loss of life ,	affecting our culture	1-23	1-23	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	1<2	none	joint	joint
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	10-14	18-23	causing loss of life ,	and historically shaping our genetics .	causing loss of life ,	and historically shaping our genetics .	1-23	1-23	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	1<2	none	joint	joint
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	1-9	24-34	Pandemics have a profound impact on our world ,	The response to a pandemic requires both resilience and imagination .	Pandemics have a profound impact on our world ,	The response to a pandemic requires both resilience and imagination .	1-23	24-34	Pandemics have a profound impact on our world , causing loss of life , affecting our culture and historically shaping our genetics .	The response to a pandemic requires both resilience and imagination .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	24-34	35-64	The response to a pandemic requires both resilience and imagination .	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	The response to a pandemic requires both resilience and imagination .	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	24-34	35-64	The response to a pandemic requires both resilience and imagination .	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	35-64	65-70	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	One can not estimate mortality rates	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	One can not estimate mortality rates	35-64	65-84	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	One can not estimate mortality rates without an accurate assessment of the number of infected individuals in the population .	1<2	none	comparison	comparison
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	65-70	71-84	One can not estimate mortality rates	without an accurate assessment of the number of infected individuals in the population .	One can not estimate mortality rates	without an accurate assessment of the number of infected individuals in the population .	65-84	65-84	One can not estimate mortality rates without an accurate assessment of the number of infected individuals in the population .	One can not estimate mortality rates without an accurate assessment of the number of infected individuals in the population .	1<2	none	condition	condition
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	65-70	85-94	One can not estimate mortality rates	This need is also aligned with identifying the infected individuals	One can not estimate mortality rates	This need is also aligned with identifying the infected individuals	65-84	85-105	One can not estimate mortality rates without an accurate assessment of the number of infected individuals in the population .	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	85-94	95-101	This need is also aligned with identifying the infected individuals	so they can be properly treated ,	This need is also aligned with identifying the infected individuals	so they can be properly treated ,	85-105	85-105	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	1<2	none	enablement	enablement
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	95-101	102	so they can be properly treated ,	monitored	so they can be properly treated ,	monitored	85-105	85-105	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	1<2	none	joint	joint
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	95-101	103-105	so they can be properly treated ,	and tracked .	so they can be properly treated ,	and tracked .	85-105	85-105	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	This need is also aligned with identifying the infected individuals so they can be properly treated , monitored and tracked .	1<2	none	joint	joint
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	35-64	106-123	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	However , accurate estimation of the infection rate , locally , geographically and nationally is important independently .	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	However , accurate estimation of the infection rate , locally , geographically and nationally is important independently .	35-64	106-123	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	However , accurate estimation of the infection rate , locally , geographically and nationally is important independently .	1<2	none	comparison	comparison
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	35-64	124-149	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	These infection rate estimates can guide policy makers at both state , national or world level to achieve a better management of risk to society .	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	These infection rate estimates can guide policy makers at both state , national or world level to achieve a better management of risk to society .	35-64	124-149	It has been clearly documented that obtaining an accurate estimate and trends of the actual infection rate and mortality risk are very important for policy makers and medical professionals .	These infection rate estimates can guide policy makers at both state , national or world level to achieve a better management of risk to society .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	124-149	150-151,155-164	These infection rate estimates can guide policy makers at both state , national or world level to achieve a better management of risk to society .	The decisions <*> are very different during early stages of an emerging epidemic	These infection rate estimates can guide policy makers at both state , national or world level to achieve a better management of risk to society .	The decisions <*> are very different during early stages of an emerging epidemic	124-149	150-197	These infection rate estimates can guide policy makers at both state , national or world level to achieve a better management of risk to society .	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	150-151,155-164	152-154	The decisions <*> are very different during early stages of an emerging epidemic	facing policy makers	The decisions <*> are very different during early stages of an emerging epidemic	facing policy makers	150-197	150-197	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	155-164,172-173	165-171	are very different during early stages of an emerging epidemic <*> middle stages	where the infection rate is low ,	are very different during early stages of an emerging epidemic <*> middle stages	where the infection rate is low ,	150-197	150-197	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	172-173,181-183	174-180	middle stages <*> and later stages	where the rate is rapidly climbing ,	middle stages <*> and later stages	where the rate is rapidly climbing ,	150-197	150-197	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	181-183	184-197	and later stages	where the epidemic curve has flattened to a low and relatively sustainable rate .	and later stages	where the epidemic curve has flattened to a low and relatively sustainable rate .	150-197	150-197	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	The decisions facing policy makers are very different during early stages of an emerging epidemic where the infection rate is low , middle stages where the rate is rapidly climbing , and later stages where the epidemic curve has flattened to a low and relatively sustainable rate .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	198-206	207-211	In this paper we provide relatively efficient pooling methods	to both estimate infection rates	In this paper we provide relatively efficient pooling methods	to both estimate infection rates	198-222	198-222	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	1<2	none	enablement	enablement
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	207-211	212-222	to both estimate infection rates	and identify infected individuals for populations with low infection rates .	to both estimate infection rates	and identify infected individuals for populations with low infection rates .	198-222	198-222	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	1<2	none	joint	joint
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	207-211	223-229	to both estimate infection rates	These estimates may provide significant cost reductions	to both estimate infection rates	These estimates may provide significant cost reductions	198-222	223-255	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	1<2	none	findings	findings
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	223-229	230-241	These estimates may provide significant cost reductions	for testing in rural communities , third world countries and other situations	These estimates may provide significant cost reductions	for testing in rural communities , third world countries and other situations	223-255	223-255	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	230-241	242-248	for testing in rural communities , third world countries and other situations	where the cost of testing is expensive	for testing in rural communities , third world countries and other situations	where the cost of testing is expensive	223-255	223-255	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	1<2	none	elaboration	elaboration
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	242-248	249-255	where the cost of testing is expensive	or testing is not widely available .	where the cost of testing is expensive	or testing is not widely available .	223-255	223-255	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	These estimates may provide significant cost reductions for testing in rural communities , third world countries and other situations where the cost of testing is expensive or testing is not widely available .	1<2	none	joint	joint
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	256-265	266-285	As we prepare for the second wave of the pandemic	this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	As we prepare for the second wave of the pandemic	this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	256-285	256-285	As we prepare for the second wave of the pandemic this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	As we prepare for the second wave of the pandemic this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	1>2	none	temporal	temporal
393df9f3bd2b9ab0e100ab48688cebc9e86c5a60	198-206	266-285	In this paper we provide relatively efficient pooling methods	this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	In this paper we provide relatively efficient pooling methods	this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	198-222	256-285	In this paper we provide relatively efficient pooling methods to both estimate infection rates and identify infected individuals for populations with low infection rates .	As we prepare for the second wave of the pandemic this line of work may provide new solutions for both the biomedical community and policy makers at all levels .	1<2	none	findings	findings
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	1-3,12-17	106-108	Coronavirus disease 2019 <*> has spread rapidly around the world	we developed recommendations	Coronavirus disease 2019 <*> has spread rapidly around the world	we developed recommendations	1-26	88-139	Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread rapidly around the world and is a significant threat to global health .	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	1>2	none	background	background
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	1-3,12-17	4-11	Coronavirus disease 2019 <*> has spread rapidly around the world	caused by severe acute respiratory syndrome coronavirus 2	Coronavirus disease 2019 <*> has spread rapidly around the world	caused by severe acute respiratory syndrome coronavirus 2	1-26	1-26	Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread rapidly around the world and is a significant threat to global health .	Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread rapidly around the world and is a significant threat to global health .	1<2	none	cause-result	cause-result
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	12-17	18-26	has spread rapidly around the world	and is a significant threat to global health .	has spread rapidly around the world	and is a significant threat to global health .	1-26	1-26	Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread rapidly around the world and is a significant threat to global health .	Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread rapidly around the world and is a significant threat to global health .	1<2	none	joint	joint
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	1-3,12-17	27-40	Coronavirus disease 2019 <*> has spread rapidly around the world	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity ,	Coronavirus disease 2019 <*> has spread rapidly around the world	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity ,	1-26	27-53	Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread rapidly around the world and is a significant threat to global health .	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity , which makes them vulnerable to pulmonary infection and a relatively higher mortality .	1<2	none	elaboration	elaboration
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	27-40	41-53	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity ,	which makes them vulnerable to pulmonary infection and a relatively higher mortality .	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity ,	which makes them vulnerable to pulmonary infection and a relatively higher mortality .	27-53	27-53	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity , which makes them vulnerable to pulmonary infection and a relatively higher mortality .	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity , which makes them vulnerable to pulmonary infection and a relatively higher mortality .	1<2	none	cause-result	cause-result
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	54-55	56-61	This means	that these patients require multidisciplinary treatment	This means	that these patients require multidisciplinary treatment	54-75	54-75	This means that these patients require multidisciplinary treatment including early diagnosis , timely transport , emergency surgery and intensive critical care .	This means that these patients require multidisciplinary treatment including early diagnosis , timely transport , emergency surgery and intensive critical care .	1>2	none	attribution	attribution
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	27-40	56-61	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity ,	that these patients require multidisciplinary treatment	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity ,	that these patients require multidisciplinary treatment	27-53	54-75	Patients in the Neonatal Surgery Department have rapidly progressing diseases and immature immunity , which makes them vulnerable to pulmonary infection and a relatively higher mortality .	This means that these patients require multidisciplinary treatment including early diagnosis , timely transport , emergency surgery and intensive critical care .	1<2	none	cause-result	cause-result
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	56-61	62-75	that these patients require multidisciplinary treatment	including early diagnosis , timely transport , emergency surgery and intensive critical care .	that these patients require multidisciplinary treatment	including early diagnosis , timely transport , emergency surgery and intensive critical care .	54-75	54-75	This means that these patients require multidisciplinary treatment including early diagnosis , timely transport , emergency surgery and intensive critical care .	This means that these patients require multidisciplinary treatment including early diagnosis , timely transport , emergency surgery and intensive critical care .	1<2	none	elaboration	elaboration
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	56-61	76-87	that these patients require multidisciplinary treatment	The COVID-19 pandemic poses a threat to carrying out these treatments .	that these patients require multidisciplinary treatment	The COVID-19 pandemic poses a threat to carrying out these treatments .	54-75	76-87	This means that these patients require multidisciplinary treatment including early diagnosis , timely transport , emergency surgery and intensive critical care .	The COVID-19 pandemic poses a threat to carrying out these treatments .	1<2	none	comparison	comparison
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	88-105	106-108	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department ,	we developed recommendations	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department ,	we developed recommendations	88-139	88-139	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	1>2	none	enablement	enablement
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	106-108	109-118	we developed recommendations	focusing on patient transport , surgery selection and protection requirements	we developed recommendations	focusing on patient transport , surgery selection and protection requirements	88-139	88-139	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	1<2	none	elaboration	elaboration
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	106-108	119-121	we developed recommendations	with the aim	we developed recommendations	with the aim	88-139	88-139	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	1<2	none	enablement	enablement
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	119-121	122-127	with the aim	of improving treatment strategies for patients	with the aim	of improving treatment strategies for patients	88-139	88-139	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	1<2	none	elaboration	elaboration
3b2db322b3470bdbc2145b4b348b1dc2c8e054ec	122-127	128-139	of improving treatment strategies for patients	and preventing infection in medical staff during the current COVID-19 pandemic .	of improving treatment strategies for patients	and preventing infection in medical staff during the current COVID-19 pandemic .	88-139	88-139	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	To provide support for the health protection requirements of the medical services in the Neonatal Surgery Department , we developed recommendations focusing on patient transport , surgery selection and protection requirements with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current COVID-19 pandemic .	1<2	none	joint	joint
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	1-6	122-130	Identification of regulatory elements is essential	In this paper , we present an algorithmic solution	Identification of regulatory elements is essential	In this paper , we present an algorithmic solution	1-15	122-149	Identification of regulatory elements is essential for understanding the mechanism behind regulating gene expression .	In this paper , we present an algorithmic solution to produce coding sequences that follow exactly a primary amino acid sequence and a desired GC - content .	1>2	none	background	background
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	1-6	7-15	Identification of regulatory elements is essential	for understanding the mechanism behind regulating gene expression .	Identification of regulatory elements is essential	for understanding the mechanism behind regulating gene expression .	1-15	1-15	Identification of regulatory elements is essential for understanding the mechanism behind regulating gene expression .	Identification of regulatory elements is essential for understanding the mechanism behind regulating gene expression .	1<2	none	enablement	enablement
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	1-6	16-18,26-28	Identification of regulatory elements is essential	These regulatory elements <*> bind to proteins	Identification of regulatory elements is essential	These regulatory elements <*> bind to proteins	1-15	16-37	Identification of regulatory elements is essential for understanding the mechanism behind regulating gene expression .	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	16-18,26-28	19-25	These regulatory elements <*> bind to proteins	- located in or near gene -	These regulatory elements <*> bind to proteins	- located in or near gene -	16-37	16-37	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	26-28	29-31	bind to proteins	called transcription factors	bind to proteins	called transcription factors	16-37	16-37	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	26-28	32-37	bind to proteins	to initiate the transcription process .	bind to proteins	to initiate the transcription process .	16-37	16-37	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	1<2	none	enablement	enablement
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	16-18,26-28	38-50	These regulatory elements <*> bind to proteins	Their occurrences are influenced by the GC - content or nucleotide composition .	These regulatory elements <*> bind to proteins	Their occurrences are influenced by the GC - content or nucleotide composition .	16-37	38-50	These regulatory elements - located in or near gene - bind to proteins called transcription factors to initiate the transcription process .	Their occurrences are influenced by the GC - content or nucleotide composition .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	51-68	69-79	For generating synthetic coding sequences with pre - specified amino acid sequence and desired GC - content ,	there exist two stochastic methods , multinomial and maximum entropy .	For generating synthetic coding sequences with pre - specified amino acid sequence and desired GC - content ,	there exist two stochastic methods , multinomial and maximum entropy .	51-79	51-79	For generating synthetic coding sequences with pre - specified amino acid sequence and desired GC - content , there exist two stochastic methods , multinomial and maximum entropy .	For generating synthetic coding sequences with pre - specified amino acid sequence and desired GC - content , there exist two stochastic methods , multinomial and maximum entropy .	1>2	none	enablement	enablement
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	38-50	69-79	Their occurrences are influenced by the GC - content or nucleotide composition .	there exist two stochastic methods , multinomial and maximum entropy .	Their occurrences are influenced by the GC - content or nucleotide composition .	there exist two stochastic methods , multinomial and maximum entropy .	38-50	51-79	Their occurrences are influenced by the GC - content or nucleotide composition .	For generating synthetic coding sequences with pre - specified amino acid sequence and desired GC - content , there exist two stochastic methods , multinomial and maximum entropy .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	69-79	80-85	there exist two stochastic methods , multinomial and maximum entropy .	Both methods rely on the probability	there exist two stochastic methods , multinomial and maximum entropy .	Both methods rely on the probability	51-79	80-100	For generating synthetic coding sequences with pre - specified amino acid sequence and desired GC - content , there exist two stochastic methods , multinomial and maximum entropy .	Both methods rely on the probability of choosing the codon synonymous for usage in regard to a specific amino acid .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	80-85	86-100	Both methods rely on the probability	of choosing the codon synonymous for usage in regard to a specific amino acid .	Both methods rely on the probability	of choosing the codon synonymous for usage in regard to a specific amino acid .	80-100	80-100	Both methods rely on the probability of choosing the codon synonymous for usage in regard to a specific amino acid .	Both methods rely on the probability of choosing the codon synonymous for usage in regard to a specific amino acid .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	101-108	109-121	In spite the latter exhibited unbiased manner ,	the produced sequences are not exactly obeying the GC - content constraint .	In spite the latter exhibited unbiased manner ,	the produced sequences are not exactly obeying the GC - content constraint .	101-121	101-121	In spite the latter exhibited unbiased manner , the produced sequences are not exactly obeying the GC - content constraint .	In spite the latter exhibited unbiased manner , the produced sequences are not exactly obeying the GC - content constraint .	1>2	none	comparison	comparison
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	80-85	109-121	Both methods rely on the probability	the produced sequences are not exactly obeying the GC - content constraint .	Both methods rely on the probability	the produced sequences are not exactly obeying the GC - content constraint .	80-100	101-121	Both methods rely on the probability of choosing the codon synonymous for usage in regard to a specific amino acid .	In spite the latter exhibited unbiased manner , the produced sequences are not exactly obeying the GC - content constraint .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	122-130	131-134	In this paper , we present an algorithmic solution	to produce coding sequences	In this paper , we present an algorithmic solution	to produce coding sequences	122-149	122-149	In this paper , we present an algorithmic solution to produce coding sequences that follow exactly a primary amino acid sequence and a desired GC - content .	In this paper , we present an algorithmic solution to produce coding sequences that follow exactly a primary amino acid sequence and a desired GC - content .	1<2	none	enablement	enablement
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	131-134	135-149	to produce coding sequences	that follow exactly a primary amino acid sequence and a desired GC - content .	to produce coding sequences	that follow exactly a primary amino acid sequence and a desired GC - content .	122-149	122-149	In this paper , we present an algorithmic solution to produce coding sequences that follow exactly a primary amino acid sequence and a desired GC - content .	In this paper , we present an algorithmic solution to produce coding sequences that follow exactly a primary amino acid sequence and a desired GC - content .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	122-130	150-163	In this paper , we present an algorithmic solution	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets	In this paper , we present an algorithmic solution	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets	122-149	150-171	In this paper , we present an algorithmic solution to produce coding sequences that follow exactly a primary amino acid sequence and a desired GC - content .	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets to be traversed using the backtracking approach .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	150-163	164-166	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets	to be traversed	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets	to be traversed	150-171	150-171	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets to be traversed using the backtracking approach .	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets to be traversed using the backtracking approach .	1<2	none	elaboration	elaboration
3d026627a1f1f6af6f6fbb07bbcb84d917c7c946	164-166	167-171	to be traversed	using the backtracking approach .	to be traversed	using the backtracking approach .	150-171	150-171	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets to be traversed using the backtracking approach .	The proposed tool , namely CodSeqGen , depends on random selection for smaller subsets to be traversed using the backtracking approach .	1<2	none	manner-means	manner-means
3db88b442b2c693d0783756c733c55bcec669df0	1-24	25-54	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic	based on official data and on the use of a function of the type of a Gauss error function , with four parameters , as a cumulative distribution function .	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic	based on official data and on the use of a function of the type of a Gauss error function , with four parameters , as a cumulative distribution function .	1-54	1-54	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic based on official data and on the use of a function of the type of a Gauss error function , with four parameters , as a cumulative distribution function .	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic based on official data and on the use of a function of the type of a Gauss error function , with four parameters , as a cumulative distribution function .	1<2	none	manner-means	manner-means
3db88b442b2c693d0783756c733c55bcec669df0	1-24	55-65	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic	We have analyzed the available data for China and Italy .	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic	We have analyzed the available data for China and Italy .	1-54	55-65	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic based on official data and on the use of a function of the type of a Gauss error function , with four parameters , as a cumulative distribution function .	We have analyzed the available data for China and Italy .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	55-65	66-94	We have analyzed the available data for China and Italy .	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function ,	We have analyzed the available data for China and Italy .	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function ,	55-65	66-106	We have analyzed the available data for China and Italy .	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function , that is , the integral of a normal , Gaussian distribution .	1<2	none	findings	findings
3db88b442b2c693d0783756c733c55bcec669df0	66-94	95-106	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function ,	that is , the integral of a normal , Gaussian distribution .	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function ,	that is , the integral of a normal , Gaussian distribution .	66-106	66-106	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function , that is , the integral of a normal , Gaussian distribution .	The evolution in time of the number of cumulative diagnosed positive cases of COVID-19 in China very well approximates a distribution of the type of the error function , that is , the integral of a normal , Gaussian distribution .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	55-65	107-113	We have analyzed the available data for China and Italy .	We have then used such a function	We have analyzed the available data for China and Italy .	We have then used such a function	55-65	107-142	We have analyzed the available data for China and Italy .	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	107-113	114-128	We have then used such a function	to study the potential evolution in time of the number of positive cases in Italy	We have then used such a function	to study the potential evolution in time of the number of positive cases in Italy	107-142	107-142	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	1<2	none	enablement	enablement
3db88b442b2c693d0783756c733c55bcec669df0	114-128	129-142	to study the potential evolution in time of the number of positive cases in Italy	by performing a number of fits of the official data so far available .	to study the potential evolution in time of the number of positive cases in Italy	by performing a number of fits of the official data so far available .	107-142	107-142	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	1<2	none	manner-means	manner-means
3db88b442b2c693d0783756c733c55bcec669df0	107-113	143-151	We have then used such a function	We then found a statistical prediction for the day	We have then used such a function	We then found a statistical prediction for the day	107-142	143-217	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	1<2	none	findings	findings
3db88b442b2c693d0783756c733c55bcec669df0	143-151	152-166	We then found a statistical prediction for the day	in which the peak of the number of daily positive cases in Italy occurs ,	We then found a statistical prediction for the day	in which the peak of the number of daily positive cases in Italy occurs ,	143-217	143-217	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	143-151	167-174	We then found a statistical prediction for the day	corresponding to the flex of the fit ,	We then found a statistical prediction for the day	corresponding to the flex of the fit ,	143-217	143-217	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	167-174	175-186,198-203	corresponding to the flex of the fit ,	that is , to the change in sign of its second derivative <*> as well as of the day	corresponding to the flex of the fit ,	that is , to the change in sign of its second derivative <*> as well as of the day	143-217	143-217	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	175-186,198-203	187-197	that is , to the change in sign of its second derivative <*> as well as of the day	( i.e. , the change from acceleration to deceleration ) ,	that is , to the change in sign of its second derivative <*> as well as of the day	( i.e. , the change from acceleration to deceleration ) ,	143-217	143-217	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	198-203	204-217	as well as of the day	in which a substantial attenuation of such number of daily cases is reached .	as well as of the day	in which a substantial attenuation of such number of daily cases is reached .	143-217	143-217	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	We then found a statistical prediction for the day in which the peak of the number of daily positive cases in Italy occurs , corresponding to the flex of the fit , that is , to the change in sign of its second derivative ( i.e. , the change from acceleration to deceleration ) , as well as of the day in which a substantial attenuation of such number of daily cases is reached .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	107-113	218-235	We have then used such a function	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy ,	We have then used such a function	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy ,	107-142	218-239	We have then used such a function to study the potential evolution in time of the number of positive cases in Italy by performing a number of fits of the official data so far available .	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy , obtaining consistent results .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	218-235	236-239	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy ,	obtaining consistent results .	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy ,	obtaining consistent results .	218-239	218-239	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy , obtaining consistent results .	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy , obtaining consistent results .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	218-235	240-247	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy ,	We have then performed 150 Monte Carlo simulations	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy ,	We have then performed 150 Monte Carlo simulations	218-239	240-280	We have also analyzed the predictions of the cumulative number of fatalities in both China and Italy , obtaining consistent results .	We have then performed 150 Monte Carlo simulations to have a more robust prediction of the day of the above - mentioned peak and of the day of the substantial decrease in the number of daily positive cases and fatalities .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	240-247	248-280	We have then performed 150 Monte Carlo simulations	to have a more robust prediction of the day of the above - mentioned peak and of the day of the substantial decrease in the number of daily positive cases and fatalities .	We have then performed 150 Monte Carlo simulations	to have a more robust prediction of the day of the above - mentioned peak and of the day of the substantial decrease in the number of daily positive cases and fatalities .	240-280	240-280	We have then performed 150 Monte Carlo simulations to have a more robust prediction of the day of the above - mentioned peak and of the day of the substantial decrease in the number of daily positive cases and fatalities .	We have then performed 150 Monte Carlo simulations to have a more robust prediction of the day of the above - mentioned peak and of the day of the substantial decrease in the number of daily positive cases and fatalities .	1<2	none	enablement	enablement
3db88b442b2c693d0783756c733c55bcec669df0	281-287	288-295	Although official data have been used ,	those predictions are obtained with a heuristic approach	Although official data have been used ,	those predictions are obtained with a heuristic approach	281-339	281-339	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	1>2	none	comparison	comparison
3db88b442b2c693d0783756c733c55bcec669df0	1-24	288-295	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic	those predictions are obtained with a heuristic approach	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic	those predictions are obtained with a heuristic approach	1-54	281-339	In this paper are presented mathematical predictions on the evolution in time of the number of positive cases in Italy of the COVID-19 pandemic based on official data and on the use of a function of the type of a Gauss error function , with four parameters , as a cumulative distribution function .	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	1<2	none	elaboration	elaboration
3db88b442b2c693d0783756c733c55bcec669df0	288-295	296-303	those predictions are obtained with a heuristic approach	since they are based on a statistical approach	those predictions are obtained with a heuristic approach	since they are based on a statistical approach	281-339	281-339	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	1<2	none	cause-result	cause-result
3db88b442b2c693d0783756c733c55bcec669df0	288-295	304-315,334-339	those predictions are obtained with a heuristic approach	and do not take into account either a number of relevant issues <*> or models of contamination diffusion .	those predictions are obtained with a heuristic approach	and do not take into account either a number of relevant issues <*> or models of contamination diffusion .	281-339	281-339	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	1<2	none	joint	joint
3db88b442b2c693d0783756c733c55bcec669df0	304-315,334-339	316-333	and do not take into account either a number of relevant issues <*> or models of contamination diffusion .	( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological )	and do not take into account either a number of relevant issues <*> or models of contamination diffusion .	( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological )	281-339	281-339	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	Although official data have been used , those predictions are obtained with a heuristic approach since they are based on a statistical approach and do not take into account either a number of relevant issues ( such as number of daily nasopharyngeal swabs , medical , social distancing , virological and epidemiological ) or models of contamination diffusion .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	1-2,10-13	76-90	Shotgun metagenomics <*> is a promising technique	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	Shotgun metagenomics <*> is a promising technique	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	1-25	76-115	Shotgun metagenomics using next generation sequencing ( NGS ) is a promising technique to analyze both DNA and RNA microbial material from patient samples .	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	1>2	none	background	background
3e8d0363f49f83917e0ddddf7b4322186da47dbc	1-2,10-13	3-9	Shotgun metagenomics <*> is a promising technique	using next generation sequencing ( NGS )	Shotgun metagenomics <*> is a promising technique	using next generation sequencing ( NGS )	1-25	1-25	Shotgun metagenomics using next generation sequencing ( NGS ) is a promising technique to analyze both DNA and RNA microbial material from patient samples .	Shotgun metagenomics using next generation sequencing ( NGS ) is a promising technique to analyze both DNA and RNA microbial material from patient samples .	1<2	none	manner-means	manner-means
3e8d0363f49f83917e0ddddf7b4322186da47dbc	10-13	14-25	is a promising technique	to analyze both DNA and RNA microbial material from patient samples .	is a promising technique	to analyze both DNA and RNA microbial material from patient samples .	1-25	1-25	Shotgun metagenomics using next generation sequencing ( NGS ) is a promising technique to analyze both DNA and RNA microbial material from patient samples .	Shotgun metagenomics using next generation sequencing ( NGS ) is a promising technique to analyze both DNA and RNA microbial material from patient samples .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	26-32	33-45	Mostly used in a research setting ,	it is now increasingly being used in the clinical realm as well ,	Mostly used in a research setting ,	it is now increasingly being used in the clinical realm as well ,	26-75	26-75	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	1>2	none	comparison	comparison
3e8d0363f49f83917e0ddddf7b4322186da47dbc	1-2,10-13	33-45	Shotgun metagenomics <*> is a promising technique	it is now increasingly being used in the clinical realm as well ,	Shotgun metagenomics <*> is a promising technique	it is now increasingly being used in the clinical realm as well ,	1-25	26-75	Shotgun metagenomics using next generation sequencing ( NGS ) is a promising technique to analyze both DNA and RNA microbial material from patient samples .	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	33-45	46-53	it is now increasingly being used in the clinical realm as well ,	notably to support diagnosis of viral infections ,	it is now increasingly being used in the clinical realm as well ,	notably to support diagnosis of viral infections ,	26-75	26-75	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	33-45	54-67	it is now increasingly being used in the clinical realm as well ,	thereby calling for quality control and the implementation of ring trials ( RT )	it is now increasingly being used in the clinical realm as well ,	thereby calling for quality control and the implementation of ring trials ( RT )	26-75	26-75	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	1<2	none	cause-result	cause-result
3e8d0363f49f83917e0ddddf7b4322186da47dbc	54-67	68-70	thereby calling for quality control and the implementation of ring trials ( RT )	to benchmark pipelines	thereby calling for quality control and the implementation of ring trials ( RT )	to benchmark pipelines	26-75	26-75	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	68-70	71-75	to benchmark pipelines	and ensure comparable results .	to benchmark pipelines	and ensure comparable results .	26-75	26-75	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	Mostly used in a research setting , it is now increasingly being used in the clinical realm as well , notably to support diagnosis of viral infections , thereby calling for quality control and the implementation of ring trials ( RT ) to benchmark pipelines and ensure comparable results .	1<2	none	joint	joint
3e8d0363f49f83917e0ddddf7b4322186da47dbc	76-90	91-97	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	in order to benchmark current metagenomic workflows	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	in order to benchmark current metagenomic workflows	76-115	76-115	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	91-97	98-104	in order to benchmark current metagenomic workflows	used at Swiss clinical virology laboratories ,	in order to benchmark current metagenomic workflows	used at Swiss clinical virology laboratories ,	76-115	76-115	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	91-97	105-115	in order to benchmark current metagenomic workflows	and thereby contribute to the definition of common best practices .	in order to benchmark current metagenomic workflows	and thereby contribute to the definition of common best practices .	76-115	76-115	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	1<2	none	cause-result	cause-result
3e8d0363f49f83917e0ddddf7b4322186da47dbc	76-90	116-121	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	The RT consisted of two parts	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	The RT consisted of two parts	76-115	116-145	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	116-121	122-125	The RT consisted of two parts	( increments ) ,	The RT consisted of two parts	( increments ) ,	116-145	116-145	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	116-121	126-131	The RT consisted of two parts	in order to disentangle the variability	The RT consisted of two parts	in order to disentangle the variability	116-145	116-145	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	126-131	132-135	in order to disentangle the variability	arising from the experimental	in order to disentangle the variability	arising from the experimental	116-145	116-145	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	126-131	136-145	in order to disentangle the variability	compared to the bioinformatics parts of the laboratory pipeline .	in order to disentangle the variability	compared to the bioinformatics parts of the laboratory pipeline .	116-145	116-145	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	1<2	none	comparison	comparison
3e8d0363f49f83917e0ddddf7b4322186da47dbc	116-121	146-153	The RT consisted of two parts	In addition , the RT was also designed	The RT consisted of two parts	In addition , the RT was also designed	116-145	146-192	The RT consisted of two parts ( increments ) , in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline .	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	146-153	154-159	In addition , the RT was also designed	to assess the impact of databases	In addition , the RT was also designed	to assess the impact of databases	146-192	146-192	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	154-159	160-168	to assess the impact of databases	compared to bioinformatics algorithms on the final results ,	to assess the impact of databases	compared to bioinformatics algorithms on the final results ,	146-192	146-192	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	154-159	169-181	to assess the impact of databases	by asking participants to perform the bioinformatics analysis with a common database ,	to assess the impact of databases	by asking participants to perform the bioinformatics analysis with a common database ,	146-192	146-192	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	1<2	none	manner-means	manner-means
3e8d0363f49f83917e0ddddf7b4322186da47dbc	169-181	182-192	by asking participants to perform the bioinformatics analysis with a common database ,	in addition to using their own in - house database .	by asking participants to perform the bioinformatics analysis with a common database ,	in addition to using their own in - house database .	146-192	146-192	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	In addition , the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results , by asking participants to perform the bioinformatics analysis with a common database , in addition to using their own in - house database .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	76-90	193-198	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	Five laboratories participated in the RT	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	Five laboratories participated in the RT	76-115	193-198	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	Five laboratories participated in the RT	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	193-198	199-205	Five laboratories participated in the RT	( seven pipelines were tested ) .	Five laboratories participated in the RT	( seven pipelines were tested ) .	193-198	199-205	Five laboratories participated in the RT	( seven pipelines were tested ) .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	206-207	208-226	We observed	that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	We observed	that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	206-226	206-226	We observed that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	We observed that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	1>2	none	attribution	attribution
3e8d0363f49f83917e0ddddf7b4322186da47dbc	76-90	208-226	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	76-115	206-226	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	We observed that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	1<2	none	findings	findings
3e8d0363f49f83917e0ddddf7b4322186da47dbc	227-230	231-244	Our results also suggest	that differences in sample preparation can lead to significant differences in the performance ,	Our results also suggest	that differences in sample preparation can lead to significant differences in the performance ,	227-277	227-277	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	1>2	none	attribution	attribution
3e8d0363f49f83917e0ddddf7b4322186da47dbc	208-226	231-244	that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	that differences in sample preparation can lead to significant differences in the performance ,	that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	that differences in sample preparation can lead to significant differences in the performance ,	206-226	227-277	We observed that the algorithms had a stronger impact on the overall performance than the choice of the reference database .	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	231-244	245-259	that differences in sample preparation can lead to significant differences in the performance ,	and that laboratories should aim for at least 5 - 10 Mio reads per sample	that differences in sample preparation can lead to significant differences in the performance ,	and that laboratories should aim for at least 5 - 10 Mio reads per sample	227-277	227-277	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	1<2	none	joint	joint
3e8d0363f49f83917e0ddddf7b4322186da47dbc	245-259	260-270	and that laboratories should aim for at least 5 - 10 Mio reads per sample	and use depth of coverage in addition to other interpretation metrics	and that laboratories should aim for at least 5 - 10 Mio reads per sample	and use depth of coverage in addition to other interpretation metrics	227-277	227-277	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	1<2	none	joint	joint
3e8d0363f49f83917e0ddddf7b4322186da47dbc	260-270	271-277	and use depth of coverage in addition to other interpretation metrics	such as the percent of coverage .	and use depth of coverage in addition to other interpretation metrics	such as the percent of coverage .	227-277	227-277	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	231-244	278-281	that differences in sample preparation can lead to significant differences in the performance ,	Performance was generally lower	that differences in sample preparation can lead to significant differences in the performance ,	Performance was generally lower	227-277	278-290	Our results also suggest that differences in sample preparation can lead to significant differences in the performance , and that laboratories should aim for at least 5 - 10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage .	Performance was generally lower when increasing the number of viruses per sample .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	278-281	282-290	Performance was generally lower	when increasing the number of viruses per sample .	Performance was generally lower	when increasing the number of viruses per sample .	278-290	278-290	Performance was generally lower when increasing the number of viruses per sample .	Performance was generally lower when increasing the number of viruses per sample .	1<2	none	temporal	temporal
3e8d0363f49f83917e0ddddf7b4322186da47dbc	76-90	291-292,298-308	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	The lessons <*> will be useful for the development of larger - scale RTs	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 ,	The lessons <*> will be useful for the development of larger - scale RTs	76-115	291-327	The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018 , in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories , and thereby contribute to the definition of common best practices .	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	1<2	none	findings	findings
3e8d0363f49f83917e0ddddf7b4322186da47dbc	291-292,298-308	293-297	The lessons <*> will be useful for the development of larger - scale RTs	learned from this pilot study	The lessons <*> will be useful for the development of larger - scale RTs	learned from this pilot study	291-327	291-327	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	1<2	none	elaboration	elaboration
3e8d0363f49f83917e0ddddf7b4322186da47dbc	298-308	309-317	will be useful for the development of larger - scale RTs	to serve as regular quality control tests for laboratories	will be useful for the development of larger - scale RTs	to serve as regular quality control tests for laboratories	291-327	291-327	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	1<2	none	enablement	enablement
3e8d0363f49f83917e0ddddf7b4322186da47dbc	309-317	318-327	to serve as regular quality control tests for laboratories	performing NGS analyses of viruses in a clinical setting .	to serve as regular quality control tests for laboratories	performing NGS analyses of viruses in a clinical setting .	291-327	291-327	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	The lessons learned from this pilot study will be useful for the development of larger - scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	1-9,17-31	72-87	Porcine β - defensin 2 ( PBD-2 ) , <*> is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	Porcine β - defensin 2 ( PBD-2 ) , <*> is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	1-31	72-98	Porcine β - defensin 2 ( PBD-2 ) , expressed by different tissues of pigs , is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs using the CRISPR / Cas9 and Cre / loxP systems .	1>2	none	background	background
3f8d61cff42f5714412479237e85de075e817fae	1-9,17-31	10-16	Porcine β - defensin 2 ( PBD-2 ) , <*> is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	expressed by different tissues of pigs ,	Porcine β - defensin 2 ( PBD-2 ) , <*> is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	expressed by different tissues of pigs ,	1-31	1-31	Porcine β - defensin 2 ( PBD-2 ) , expressed by different tissues of pigs , is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	Porcine β - defensin 2 ( PBD-2 ) , expressed by different tissues of pigs , is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	1-9,17-31	32-71	Porcine β - defensin 2 ( PBD-2 ) , <*> is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	As the latest generation of genome - editing tool , CRISPR / Cas9 system makes it possible to enhance the expression of PBD-2 in pigs by site - specific knock - in of pbd-2 gene into the pig genome .	Porcine β - defensin 2 ( PBD-2 ) , <*> is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	As the latest generation of genome - editing tool , CRISPR / Cas9 system makes it possible to enhance the expression of PBD-2 in pigs by site - specific knock - in of pbd-2 gene into the pig genome .	1-31	32-71	Porcine β - defensin 2 ( PBD-2 ) , expressed by different tissues of pigs , is a multifunctional cationic peptide with antimicrobial , immunomodulatory and growth - promoting abilities .	As the latest generation of genome - editing tool , CRISPR / Cas9 system makes it possible to enhance the expression of PBD-2 in pigs by site - specific knock - in of pbd-2 gene into the pig genome .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	72-87	88-98	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	using the CRISPR / Cas9 and Cre / loxP systems .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	using the CRISPR / Cas9 and Cre / loxP systems .	72-98	72-98	In this study , we aimed to generate marker - free pbd-2 knock - in pigs using the CRISPR / Cas9 and Cre / loxP systems .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs using the CRISPR / Cas9 and Cre / loxP systems .	1<2	none	manner-means	manner-means
3f8d61cff42f5714412479237e85de075e817fae	72-87	99-103,109-124	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	Two copies of pbd-2 gene <*> were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	Two copies of pbd-2 gene <*> were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	72-98	99-124	In this study , we aimed to generate marker - free pbd-2 knock - in pigs using the CRISPR / Cas9 and Cre / loxP systems .	Two copies of pbd-2 gene linked by a T2A sequence were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	99-103,109-124	104-108	Two copies of pbd-2 gene <*> were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	linked by a T2A sequence	Two copies of pbd-2 gene <*> were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	linked by a T2A sequence	99-124	99-124	Two copies of pbd-2 gene linked by a T2A sequence were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	Two copies of pbd-2 gene linked by a T2A sequence were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	99-103,109-124	125-131,141-156	Two copies of pbd-2 gene <*> were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	The floxed selectable marker gene neoR , <*> was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	Two copies of pbd-2 gene <*> were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	The floxed selectable marker gene neoR , <*> was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	99-124	125-156	Two copies of pbd-2 gene linked by a T2A sequence were inserted into the porcine Rosa26 locus through CRISPR / Cas9-mediated homology - directed repair .	The floxed selectable marker gene neoR , used for G418 screening of positive cell clones , was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	125-131,141-156	132-140	The floxed selectable marker gene neoR , <*> was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	used for G418 screening of positive cell clones ,	The floxed selectable marker gene neoR , <*> was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	used for G418 screening of positive cell clones ,	125-156	125-156	The floxed selectable marker gene neoR , used for G418 screening of positive cell clones , was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	The floxed selectable marker gene neoR , used for G418 screening of positive cell clones , was removed by cell - penetrating Cre recombinase with a recombination efficiency of 48.3 % .	1<2	none	enablement	enablement
3f8d61cff42f5714412479237e85de075e817fae	72-87	157-165	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	Cloned piglets were produced via somatic cell nuclear transfer	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	Cloned piglets were produced via somatic cell nuclear transfer	72-98	157-179	In this study , we aimed to generate marker - free pbd-2 knock - in pigs using the CRISPR / Cas9 and Cre / loxP systems .	Cloned piglets were produced via somatic cell nuclear transfer and correct insertion of pbd-2 genes was confirmed by PCR and Southern blot .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	157-165	166-179	Cloned piglets were produced via somatic cell nuclear transfer	and correct insertion of pbd-2 genes was confirmed by PCR and Southern blot .	Cloned piglets were produced via somatic cell nuclear transfer	and correct insertion of pbd-2 genes was confirmed by PCR and Southern blot .	157-179	157-179	Cloned piglets were produced via somatic cell nuclear transfer and correct insertion of pbd-2 genes was confirmed by PCR and Southern blot .	Cloned piglets were produced via somatic cell nuclear transfer and correct insertion of pbd-2 genes was confirmed by PCR and Southern blot .	1<2	none	joint	joint
3f8d61cff42f5714412479237e85de075e817fae	180-184	185-213	Immunohistochemistry and immunofluorescence analyses indicated	that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	Immunohistochemistry and immunofluorescence analyses indicated	that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	180-213	180-213	Immunohistochemistry and immunofluorescence analyses indicated that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	Immunohistochemistry and immunofluorescence analyses indicated that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	1>2	none	attribution	attribution
3f8d61cff42f5714412479237e85de075e817fae	72-87	185-213	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	In this study , we aimed to generate marker - free pbd-2 knock - in pigs	that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	72-98	180-213	In this study , we aimed to generate marker - free pbd-2 knock - in pigs using the CRISPR / Cas9 and Cre / loxP systems .	Immunohistochemistry and immunofluorescence analyses indicated that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	1<2	none	findings	findings
3f8d61cff42f5714412479237e85de075e817fae	214-216	217-239	Bactericidal assays demonstrated	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	Bactericidal assays demonstrated	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	214-248	214-248	Bactericidal assays demonstrated that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs in comparison to those from the WT pigs .	Bactericidal assays demonstrated that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs in comparison to those from the WT pigs .	1>2	none	attribution	attribution
3f8d61cff42f5714412479237e85de075e817fae	185-213	217-239	that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	180-213	214-248	Immunohistochemistry and immunofluorescence analyses indicated that expression levels of PBD-2 in different tissues of transgenic ( TG ) piglets were significantly higher than those of their wild - type ( WT ) littermates .	Bactericidal assays demonstrated that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs in comparison to those from the WT pigs .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	217-239	240-248	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	in comparison to those from the WT pigs .	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	in comparison to those from the WT pigs .	214-248	214-248	Bactericidal assays demonstrated that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs in comparison to those from the WT pigs .	Bactericidal assays demonstrated that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs in comparison to those from the WT pigs .	1<2	none	comparison	comparison
3f8d61cff42f5714412479237e85de075e817fae	217-239	249-273	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome ,	that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome ,	214-248	249-305	Bactericidal assays demonstrated that there was a significant increase in the antimicrobial properties of the cell culture supernatants of porcine ear fibroblasts from the TG pigs in comparison to those from the WT pigs .	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	249-273	274-281	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome ,	which not only provided an effective pig model	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome ,	which not only provided an effective pig model	249-305	249-305	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	1<2	none	elaboration	elaboration
3f8d61cff42f5714412479237e85de075e817fae	274-281	282-290	which not only provided an effective pig model	to study the anti - infection mechanisms of PBD-2	which not only provided an effective pig model	to study the anti - infection mechanisms of PBD-2	249-305	249-305	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	1<2	none	enablement	enablement
3f8d61cff42f5714412479237e85de075e817fae	274-281	291-305	which not only provided an effective pig model	but also a promising genetic material for the breeding of disease - resistant pigs .	which not only provided an effective pig model	but also a promising genetic material for the breeding of disease - resistant pigs .	249-305	249-305	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	Altogether , our study improved the protein expression level of PBD-2 in pigs by site - specific integration of pbd-2 into the pig genome , which not only provided an effective pig model to study the anti - infection mechanisms of PBD-2 but also a promising genetic material for the breeding of disease - resistant pigs .	1<2	none	joint	joint
40276a234b15f83ca6f70b4956659025fd7b2ae5	1-2	3-13	Background :	HRV infections are generally self - limiting in healthy subjects ,	Background :	HRV infections are generally self - limiting in healthy subjects ,	1-2	3-28	Background :	HRV infections are generally self - limiting in healthy subjects , whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	1>2	none	textual-organization	textual-organization
40276a234b15f83ca6f70b4956659025fd7b2ae5	3-13	50-68	HRV infections are generally self - limiting in healthy subjects ,	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	HRV infections are generally self - limiting in healthy subjects ,	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	3-28	50-68	HRV infections are generally self - limiting in healthy subjects , whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	1>2	none	background	background
40276a234b15f83ca6f70b4956659025fd7b2ae5	3-13	14-28	HRV infections are generally self - limiting in healthy subjects ,	whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	HRV infections are generally self - limiting in healthy subjects ,	whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	3-28	3-28	HRV infections are generally self - limiting in healthy subjects , whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	HRV infections are generally self - limiting in healthy subjects , whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	1<2	none	comparison	comparison
40276a234b15f83ca6f70b4956659025fd7b2ae5	14-28	29-47	whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	The persistence of HRV shedding could be due to the inefficient immunological control of a single infectious episode .	whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	The persistence of HRV shedding could be due to the inefficient immunological control of a single infectious episode .	3-28	29-47	HRV infections are generally self - limiting in healthy subjects , whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections .	The persistence of HRV shedding could be due to the inefficient immunological control of a single infectious episode .	1<2	none	cause-result	cause-result
40276a234b15f83ca6f70b4956659025fd7b2ae5	48-49	50-68	Objectives :	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	Objectives :	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	48-49	50-68	Objectives :	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	1>2	none	textual-organization	textual-organization
40276a234b15f83ca6f70b4956659025fd7b2ae5	69-71	72-92	Study design :	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	Study design :	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	69-71	72-101	Study design :	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection ( HRV - PI , ≥30 days ) .	1>2	none	textual-organization	textual-organization
40276a234b15f83ca6f70b4956659025fd7b2ae5	50-68	72-92	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	50-68	72-101	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection ( HRV - PI , ≥30 days ) .	1<2	none	manner-means	manner-means
40276a234b15f83ca6f70b4956659025fd7b2ae5	72-92	93-101	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	( HRV - PI , ≥30 days ) .	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	( HRV - PI , ≥30 days ) .	72-101	72-101	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection ( HRV - PI , ≥30 days ) .	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection ( HRV - PI , ≥30 days ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	72-92	102-136	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection	72-101	102-145	During the period 2006 - 2012 , eight hematopoietic stem cell transplant ( HSCT ) recipients presented with persistent rhinovirus infection ( HRV - PI , ≥30 days ) .	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection ( HRV - AI , ≤15 days ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	102-136	137-145	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection	( HRV - AI , ≤15 days ) .	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection	( HRV - AI , ≤15 days ) .	102-145	102-145	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection ( HRV - AI , ≤15 days ) .	Viral load and T - CD4 + , T - CD8 + , B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection ( HRV - AI , ≤15 days ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	146-147	148-162	Results :	The median duration of HRV positivity in patients with HRV - PI was 61 days	Results :	The median duration of HRV positivity in patients with HRV - PI was 61 days	146-147	148-188	Results :	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	1>2	none	textual-organization	textual-organization
40276a234b15f83ca6f70b4956659025fd7b2ae5	50-68	148-162	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	The median duration of HRV positivity in patients with HRV - PI was 61 days	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	The median duration of HRV positivity in patients with HRV - PI was 61 days	50-68	148-188	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	1<2	none	findings	findings
40276a234b15f83ca6f70b4956659025fd7b2ae5	148-162	163-169	The median duration of HRV positivity in patients with HRV - PI was 61 days	( range 30 - 174 days )	The median duration of HRV positivity in patients with HRV - PI was 61 days	( range 30 - 174 days )	148-188	148-188	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	148-162	170-183	The median duration of HRV positivity in patients with HRV - PI was 61 days	and phylogenetic analysis showed the persistence of a single HRV type in all patients	The median duration of HRV positivity in patients with HRV - PI was 61 days	and phylogenetic analysis showed the persistence of a single HRV type in all patients	148-188	148-188	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	170-183	184-188	and phylogenetic analysis showed the persistence of a single HRV type in all patients	( 100 % ) .	and phylogenetic analysis showed the persistence of a single HRV type in all patients	( 100 % ) .	148-188	148-188	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	148-162	189-219	The median duration of HRV positivity in patients with HRV - PI was 61 days	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	The median duration of HRV positivity in patients with HRV - PI was 61 days	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	148-188	189-248	The median duration of HRV positivity in patients with HRV - PI was 61 days ( range 30 - 174 days ) and phylogenetic analysis showed the persistence of a single HRV type in all patients ( 100 % ) .	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	189-219	220-226	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	observed in recipients with HRV - AI	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	observed in recipients with HRV - AI	189-248	189-248	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	189-219	227-232	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	( p < 0.01 ) ,	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	( p < 0.01 ) ,	189-248	189-248	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	189-219	233-242	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	while B cell counts were similar in the two groups	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	while B cell counts were similar in the two groups	189-248	189-248	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	1<2	none	comparison	comparison
40276a234b15f83ca6f70b4956659025fd7b2ae5	233-242	243-248	while B cell counts were similar in the two groups	( p = 0.25 ) .	while B cell counts were similar in the two groups	( p = 0.25 ) .	189-248	189-248	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	189-219	249-278	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients	189-248	249-284	In HSCT recipients with HRV - PI , T - CD4 + , T - CD8 + and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV - AI ( p < 0.01 ) , while B cell counts were similar in the two groups ( p = 0.25 ) .	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients ( p < 0.01 ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	249-278	279-284	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients	( p < 0.01 ) .	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients	( p < 0.01 ) .	249-284	249-284	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients ( p < 0.01 ) .	A decrease in HRV load was associated with a significant increase in T - CD4 + , T - CD8 + and NK lymphocyte counts in HRV - PI patients ( p < 0.01 ) .	1<2	none	elaboration	elaboration
40276a234b15f83ca6f70b4956659025fd7b2ae5	285-286	287-297	Conclusions :	This study suggests a role for cellular immunity in HRV clearance	Conclusions :	This study suggests a role for cellular immunity in HRV clearance	285-286	287-314	Conclusions :	This study suggests a role for cellular immunity in HRV clearance and highlights the importance of its recovery for the control of HRV infection in HSCT recipients .	1>2	none	textual-organization	textual-organization
40276a234b15f83ca6f70b4956659025fd7b2ae5	50-68	287-297	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	This study suggests a role for cellular immunity in HRV clearance	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	This study suggests a role for cellular immunity in HRV clearance	50-68	287-314	To investigate the clinical , virologic and immunologic characteristics of pediatric HSCT recipients with HRV - PI infection .	This study suggests a role for cellular immunity in HRV clearance and highlights the importance of its recovery for the control of HRV infection in HSCT recipients .	1<2	none	findings	findings
40276a234b15f83ca6f70b4956659025fd7b2ae5	287-297	298-314	This study suggests a role for cellular immunity in HRV clearance	and highlights the importance of its recovery for the control of HRV infection in HSCT recipients .	This study suggests a role for cellular immunity in HRV clearance	and highlights the importance of its recovery for the control of HRV infection in HSCT recipients .	287-314	287-314	This study suggests a role for cellular immunity in HRV clearance and highlights the importance of its recovery for the control of HRV infection in HSCT recipients .	This study suggests a role for cellular immunity in HRV clearance and highlights the importance of its recovery for the control of HRV infection in HSCT recipients .	1<2	none	joint	joint
414d4a7cbe08a1904b9b3c2716562f40983f1087	1-4,16-18	57-61	The COVID-19 epidemic , <*> has spread rapidly	Here we summarize the lessons	The COVID-19 epidemic , <*> has spread rapidly	Here we summarize the lessons	1-26	57-82	The COVID-19 epidemic , which is caused by the novel coronavirus SARS - CoV-2 , has spread rapidly to become a world - wide pandemic .	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	1>2	none	background	background
414d4a7cbe08a1904b9b3c2716562f40983f1087	1-4,16-18	5-15	The COVID-19 epidemic , <*> has spread rapidly	which is caused by the novel coronavirus SARS - CoV-2 ,	The COVID-19 epidemic , <*> has spread rapidly	which is caused by the novel coronavirus SARS - CoV-2 ,	1-26	1-26	The COVID-19 epidemic , which is caused by the novel coronavirus SARS - CoV-2 , has spread rapidly to become a world - wide pandemic .	The COVID-19 epidemic , which is caused by the novel coronavirus SARS - CoV-2 , has spread rapidly to become a world - wide pandemic .	1<2	none	cause-result	cause-result
414d4a7cbe08a1904b9b3c2716562f40983f1087	16-18	19-26	has spread rapidly	to become a world - wide pandemic .	has spread rapidly	to become a world - wide pandemic .	1-26	1-26	The COVID-19 epidemic , which is caused by the novel coronavirus SARS - CoV-2 , has spread rapidly to become a world - wide pandemic .	The COVID-19 epidemic , which is caused by the novel coronavirus SARS - CoV-2 , has spread rapidly to become a world - wide pandemic .	1<2	none	cause-result	cause-result
414d4a7cbe08a1904b9b3c2716562f40983f1087	1-4,16-18	27-34	The COVID-19 epidemic , <*> has spread rapidly	Chest radiography and chest CT are frequently used	The COVID-19 epidemic , <*> has spread rapidly	Chest radiography and chest CT are frequently used	1-26	27-42	The COVID-19 epidemic , which is caused by the novel coronavirus SARS - CoV-2 , has spread rapidly to become a world - wide pandemic .	Chest radiography and chest CT are frequently used to support the diagnosis of COVID-19 infection .	1<2	none	elaboration	elaboration
414d4a7cbe08a1904b9b3c2716562f40983f1087	27-34	35-42	Chest radiography and chest CT are frequently used	to support the diagnosis of COVID-19 infection .	Chest radiography and chest CT are frequently used	to support the diagnosis of COVID-19 infection .	27-42	27-42	Chest radiography and chest CT are frequently used to support the diagnosis of COVID-19 infection .	Chest radiography and chest CT are frequently used to support the diagnosis of COVID-19 infection .	1<2	none	enablement	enablement
414d4a7cbe08a1904b9b3c2716562f40983f1087	27-34	43-56	Chest radiography and chest CT are frequently used	However , multiple cases of COVID-19 transmission in radiology department have been reported .	Chest radiography and chest CT are frequently used	However , multiple cases of COVID-19 transmission in radiology department have been reported .	27-42	43-56	Chest radiography and chest CT are frequently used to support the diagnosis of COVID-19 infection .	However , multiple cases of COVID-19 transmission in radiology department have been reported .	1<2	none	comparison	comparison
414d4a7cbe08a1904b9b3c2716562f40983f1087	57-61	62-63	Here we summarize the lessons	we learned	Here we summarize the lessons	we learned	57-82	57-82	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	1<2	none	elaboration	elaboration
414d4a7cbe08a1904b9b3c2716562f40983f1087	57-61	64-66	Here we summarize the lessons	and provide suggestions	Here we summarize the lessons	and provide suggestions	57-82	57-82	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	1<2	none	elaboration	elaboration
414d4a7cbe08a1904b9b3c2716562f40983f1087	64-66	67-82	and provide suggestions	to improve the infection control and prevention practices of healthcare workers in departments of radiology .	and provide suggestions	to improve the infection control and prevention practices of healthcare workers in departments of radiology .	57-82	57-82	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	Here we summarize the lessons we learned and provide suggestions to improve the infection control and prevention practices of healthcare workers in departments of radiology .	1<2	none	enablement	enablement
422787d1a8391db8a23e809e861e477df0753c99	1-2	3-14	Background .	Brazil detected community transmission of COVID-19 on March 13 , 2020 .	Background .	Brazil detected community transmission of COVID-19 on March 13 , 2020 .	1-2	3-14	Background .	Brazil detected community transmission of COVID-19 on March 13 , 2020 .	1>2	none	textual-organization	textual-organization
422787d1a8391db8a23e809e861e477df0753c99	3-14	15-48	Brazil detected community transmission of COVID-19 on March 13 , 2020 .	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	Brazil detected community transmission of COVID-19 on March 13 , 2020 .	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	3-14	15-48	Brazil detected community transmission of COVID-19 on March 13 , 2020 .	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	1>2	none	background	background
422787d1a8391db8a23e809e861e477df0753c99	15-48	49-60	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	The micro - regions with higher social vulnerability are also identified .	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	The micro - regions with higher social vulnerability are also identified .	15-48	49-60	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	The micro - regions with higher social vulnerability are also identified .	1<2	none	elaboration	elaboration
422787d1a8391db8a23e809e861e477df0753c99	61-62	63-66	Methods .	Probabilistic models were used	Methods .	Probabilistic models were used	61-62	63-92	Methods .	Probabilistic models were used to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	1>2	none	textual-organization	textual-organization
422787d1a8391db8a23e809e861e477df0753c99	15-48	63-66	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	Probabilistic models were used	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	Probabilistic models were used	15-48	63-92	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	Probabilistic models were used to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	1<2	none	manner-means	manner-means
422787d1a8391db8a23e809e861e477df0753c99	63-66	67-92	Probabilistic models were used	to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	Probabilistic models were used	to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	63-92	63-92	Probabilistic models were used to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	Probabilistic models were used to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	1<2	none	enablement	enablement
422787d1a8391db8a23e809e861e477df0753c99	63-66	93-104	Probabilistic models were used	We also perform a multivariate cluster analysis of socio - economic indices	Probabilistic models were used	We also perform a multivariate cluster analysis of socio - economic indices	63-92	93-112	Probabilistic models were used to calculate the probability of COVID-19 spread from São Paulo and Rio de Janeiro , according to previous data available on human mobility in Brazil .	We also perform a multivariate cluster analysis of socio - economic indices to identify areas with similar social vulnerability .	1<2	none	elaboration	elaboration
422787d1a8391db8a23e809e861e477df0753c99	93-104	105-112	We also perform a multivariate cluster analysis of socio - economic indices	to identify areas with similar social vulnerability .	We also perform a multivariate cluster analysis of socio - economic indices	to identify areas with similar social vulnerability .	93-112	93-112	We also perform a multivariate cluster analysis of socio - economic indices to identify areas with similar social vulnerability .	We also perform a multivariate cluster analysis of socio - economic indices to identify areas with similar social vulnerability .	1<2	none	enablement	enablement
422787d1a8391db8a23e809e861e477df0753c99	113-114	115-135	Results .	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	Results .	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	113-114	115-135	Results .	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	1>2	none	textual-organization	textual-organization
422787d1a8391db8a23e809e861e477df0753c99	15-48	115-135	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	15-48	115-135	In this study we identify which areas in the country are most vulnerable for COVID-19 , both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission .	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	1<2	none	findings	findings
422787d1a8391db8a23e809e861e477df0753c99	115-135	136-149	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	They show areas in the North and Northeast with high risk of COVID-19 outbreak	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	They show areas in the North and Northeast with high risk of COVID-19 outbreak	115-135	136-155	The results consist of a series of maps of effective distance , outbreak probability , hospital capacity and social vulnerability .	They show areas in the North and Northeast with high risk of COVID-19 outbreak that are also highly vulnerable .	1<2	none	elaboration	elaboration
422787d1a8391db8a23e809e861e477df0753c99	136-149	150-155	They show areas in the North and Northeast with high risk of COVID-19 outbreak	that are also highly vulnerable .	They show areas in the North and Northeast with high risk of COVID-19 outbreak	that are also highly vulnerable .	136-155	136-155	They show areas in the North and Northeast with high risk of COVID-19 outbreak that are also highly vulnerable .	They show areas in the North and Northeast with high risk of COVID-19 outbreak that are also highly vulnerable .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	1-31	32-51	Objectives of this study were to determine prevalence of infection in feral cats in Northern Florida with a select group of infectious organisms and to determine risk factors for infection .	Blood samples or sera from 553 cats were tested with a panel of antibody , antigen or PCR assays .	Objectives of this study were to determine prevalence of infection in feral cats in Northern Florida with a select group of infectious organisms and to determine risk factors for infection .	Blood samples or sera from 553 cats were tested with a panel of antibody , antigen or PCR assays .	1-31	32-51	Objectives of this study were to determine prevalence of infection in feral cats in Northern Florida with a select group of infectious organisms and to determine risk factors for infection .	Blood samples or sera from 553 cats were tested with a panel of antibody , antigen or PCR assays .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	1-31	52-67	Objectives of this study were to determine prevalence of infection in feral cats in Northern Florida with a select group of infectious organisms and to determine risk factors for infection .	Male cats were at higher risk for FIV , Mycoplasma haemofelis , and M. haemominutum .	Objectives of this study were to determine prevalence of infection in feral cats in Northern Florida with a select group of infectious organisms and to determine risk factors for infection .	Male cats were at higher risk for FIV , Mycoplasma haemofelis , and M. haemominutum .	1-31	52-67	Objectives of this study were to determine prevalence of infection in feral cats in Northern Florida with a select group of infectious organisms and to determine risk factors for infection .	Male cats were at higher risk for FIV , Mycoplasma haemofelis , and M. haemominutum .	1<2	none	findings	findings
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	52-67	68-92	Male cats were at higher risk for FIV , Mycoplasma haemofelis , and M. haemominutum .	Infection with either FeLV or FIV was associated with increased risk for coinfection with the other retrovirus , M. haemofelis , or M. haemominutum .	Male cats were at higher risk for FIV , Mycoplasma haemofelis , and M. haemominutum .	Infection with either FeLV or FIV was associated with increased risk for coinfection with the other retrovirus , M. haemofelis , or M. haemominutum .	52-67	68-92	Male cats were at higher risk for FIV , Mycoplasma haemofelis , and M. haemominutum .	Infection with either FeLV or FIV was associated with increased risk for coinfection with the other retrovirus , M. haemofelis , or M. haemominutum .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	68-92	93-98	Infection with either FeLV or FIV was associated with increased risk for coinfection with the other retrovirus , M. haemofelis , or M. haemominutum .	Bartonella henselae had the highest prevalence	Infection with either FeLV or FIV was associated with increased risk for coinfection with the other retrovirus , M. haemofelis , or M. haemominutum .	Bartonella henselae had the highest prevalence	68-92	93-116	Infection with either FeLV or FIV was associated with increased risk for coinfection with the other retrovirus , M. haemofelis , or M. haemominutum .	Bartonella henselae had the highest prevalence and was the only organism that did not have any associated risk for coinfection with other organisms .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	93-98	99-103	Bartonella henselae had the highest prevalence	and was the only organism	Bartonella henselae had the highest prevalence	and was the only organism	93-116	93-116	Bartonella henselae had the highest prevalence and was the only organism that did not have any associated risk for coinfection with other organisms .	Bartonella henselae had the highest prevalence and was the only organism that did not have any associated risk for coinfection with other organisms .	1<2	none	joint	joint
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	99-103	104-116	and was the only organism	that did not have any associated risk for coinfection with other organisms .	and was the only organism	that did not have any associated risk for coinfection with other organisms .	93-116	93-116	Bartonella henselae had the highest prevalence and was the only organism that did not have any associated risk for coinfection with other organisms .	Bartonella henselae had the highest prevalence and was the only organism that did not have any associated risk for coinfection with other organisms .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	93-98	117-131	Bartonella henselae had the highest prevalence	Feral cats in this study had similar or lower prevalence rates of infections than those	Bartonella henselae had the highest prevalence	Feral cats in this study had similar or lower prevalence rates of infections than those	93-116	117-140	Bartonella henselae had the highest prevalence and was the only organism that did not have any associated risk for coinfection with other organisms .	Feral cats in this study had similar or lower prevalence rates of infections than those published for pet cats in the United States .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	117-131	132-140	Feral cats in this study had similar or lower prevalence rates of infections than those	published for pet cats in the United States .	Feral cats in this study had similar or lower prevalence rates of infections than those	published for pet cats in the United States .	117-140	117-140	Feral cats in this study had similar or lower prevalence rates of infections than those published for pet cats in the United States .	Feral cats in this study had similar or lower prevalence rates of infections than those published for pet cats in the United States .	1<2	none	elaboration	elaboration
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	117-131	141-144,149-165	Feral cats in this study had similar or lower prevalence rates of infections than those	Thus , feral cats <*> appear to be of no greater risk to human beings or other cats than pet cats .	Feral cats in this study had similar or lower prevalence rates of infections than those	Thus , feral cats <*> appear to be of no greater risk to human beings or other cats than pet cats .	117-140	141-165	Feral cats in this study had similar or lower prevalence rates of infections than those published for pet cats in the United States .	Thus , feral cats assessed in this study appear to be of no greater risk to human beings or other cats than pet cats .	1<2	none	cause-result	cause-result
43568a4ba8221af0f87a1c7d1ddbd2a48eb27e79	141-144,149-165	145-148	Thus , feral cats <*> appear to be of no greater risk to human beings or other cats than pet cats .	assessed in this study	Thus , feral cats <*> appear to be of no greater risk to human beings or other cats than pet cats .	assessed in this study	141-165	141-165	Thus , feral cats assessed in this study appear to be of no greater risk to human beings or other cats than pet cats .	Thus , feral cats assessed in this study appear to be of no greater risk to human beings or other cats than pet cats .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	1-15	66-76	The ultimate goal of proteomics is to identify biologically active proteins and to produce them	In this paper , the new method , PFLC is introduced	The ultimate goal of proteomics is to identify biologically active proteins and to produce them	In this paper , the new method , PFLC is introduced	1-23	66-83	The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts .	In this paper , the new method , PFLC is introduced and its recent development is reviewed .	1>2	none	background	background
4467298e39f2e2c43a48135ce26a887ea78b5706	1-15	16-18	The ultimate goal of proteomics is to identify biologically active proteins and to produce them	using biotechnology tools	The ultimate goal of proteomics is to identify biologically active proteins and to produce them	using biotechnology tools	1-23	1-23	The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts .	The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts .	1<2	none	manner-means	manner-means
4467298e39f2e2c43a48135ce26a887ea78b5706	16-18	19-23	using biotechnology tools	such as bacterial hosts .	using biotechnology tools	such as bacterial hosts .	1-23	1-23	The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts .	The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	1-15	24-26,31-38	The ultimate goal of proteomics is to identify biologically active proteins and to produce them	However , proteins <*> must be refolded to their native state .	The ultimate goal of proteomics is to identify biologically active proteins and to produce them	However , proteins <*> must be refolded to their native state .	1-23	24-38	The ultimate goal of proteomics is to identify biologically active proteins and to produce them using biotechnology tools such as bacterial hosts .	However , proteins produced by Escherichia coli must be refolded to their native state .	1<2	none	comparison	comparison
4467298e39f2e2c43a48135ce26a887ea78b5706	24-26,31-38	27-30	However , proteins <*> must be refolded to their native state .	produced by Escherichia coli	However , proteins <*> must be refolded to their native state .	produced by Escherichia coli	24-38	24-38	However , proteins produced by Escherichia coli must be refolded to their native state .	However , proteins produced by Escherichia coli must be refolded to their native state .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	24-26,31-38	39-49	However , proteins <*> must be refolded to their native state .	Protein folding liquid chromatography ( PFLC ) is a new method	However , proteins <*> must be refolded to their native state .	Protein folding liquid chromatography ( PFLC ) is a new method	24-38	39-65	However , proteins produced by Escherichia coli must be refolded to their native state .	Protein folding liquid chromatography ( PFLC ) is a new method developed in recent years , and it is widely used in molecular biology and biotechnology .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	39-49	50-54	Protein folding liquid chromatography ( PFLC ) is a new method	developed in recent years ,	Protein folding liquid chromatography ( PFLC ) is a new method	developed in recent years ,	39-65	39-65	Protein folding liquid chromatography ( PFLC ) is a new method developed in recent years , and it is widely used in molecular biology and biotechnology .	Protein folding liquid chromatography ( PFLC ) is a new method developed in recent years , and it is widely used in molecular biology and biotechnology .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	39-49	55-65	Protein folding liquid chromatography ( PFLC ) is a new method	and it is widely used in molecular biology and biotechnology .	Protein folding liquid chromatography ( PFLC ) is a new method	and it is widely used in molecular biology and biotechnology .	39-65	39-65	Protein folding liquid chromatography ( PFLC ) is a new method developed in recent years , and it is widely used in molecular biology and biotechnology .	Protein folding liquid chromatography ( PFLC ) is a new method developed in recent years , and it is widely used in molecular biology and biotechnology .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	66-76	77-83	In this paper , the new method , PFLC is introduced	and its recent development is reviewed .	In this paper , the new method , PFLC is introduced	and its recent development is reviewed .	66-83	66-83	In this paper , the new method , PFLC is introduced and its recent development is reviewed .	In this paper , the new method , PFLC is introduced and its recent development is reviewed .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	66-76	84-110	In this paper , the new method , PFLC is introduced	In addition the paper includes definitions , advantages , principles , applications for both laboratory and large scales , apparatus , and effecting factors of PFLC .	In this paper , the new method , PFLC is introduced	In addition the paper includes definitions , advantages , principles , applications for both laboratory and large scales , apparatus , and effecting factors of PFLC .	66-83	84-110	In this paper , the new method , PFLC is introduced and its recent development is reviewed .	In addition the paper includes definitions , advantages , principles , applications for both laboratory and large scales , apparatus , and effecting factors of PFLC .	1<2	none	elaboration	elaboration
4467298e39f2e2c43a48135ce26a887ea78b5706	84-110	111-124	In addition the paper includes definitions , advantages , principles , applications for both laboratory and large scales , apparatus , and effecting factors of PFLC .	In addition , the role of this method in the future is examined .	In addition the paper includes definitions , advantages , principles , applications for both laboratory and large scales , apparatus , and effecting factors of PFLC .	In addition , the role of this method in the future is examined .	84-110	111-124	In addition the paper includes definitions , advantages , principles , applications for both laboratory and large scales , apparatus , and effecting factors of PFLC .	In addition , the role of this method in the future is examined .	1<2	none	elaboration	elaboration
48356622cf00b854864f09f21cacca3c5f444225	1-5,14-19	36-47	The novel coronavirus disease-2019 , <*> has spread worldwide from China .	We herein report a case of COVID-19 pneumonia in a Japanese woman	The novel coronavirus disease-2019 , <*> has spread worldwide from China .	We herein report a case of COVID-19 pneumonia in a Japanese woman	1-19	36-56	The novel coronavirus disease-2019 , caused by severe acute respiratory syndrome coronavirus-2 , has spread worldwide from China .	We herein report a case of COVID-19 pneumonia in a Japanese woman who showed facial nerve palsy and olfactory disturbance .	1>2	none	background	background
48356622cf00b854864f09f21cacca3c5f444225	1-5,14-19	6-13	The novel coronavirus disease-2019 , <*> has spread worldwide from China .	caused by severe acute respiratory syndrome coronavirus-2 ,	The novel coronavirus disease-2019 , <*> has spread worldwide from China .	caused by severe acute respiratory syndrome coronavirus-2 ,	1-19	1-19	The novel coronavirus disease-2019 , caused by severe acute respiratory syndrome coronavirus-2 , has spread worldwide from China .	The novel coronavirus disease-2019 , caused by severe acute respiratory syndrome coronavirus-2 , has spread worldwide from China .	1<2	none	cause-result	cause-result
48356622cf00b854864f09f21cacca3c5f444225	1-5,14-19	20-35	The novel coronavirus disease-2019 , <*> has spread worldwide from China .	There are no case reports from Asia of COVID-19 with facial paralysis and olfactory disturbance .	The novel coronavirus disease-2019 , <*> has spread worldwide from China .	There are no case reports from Asia of COVID-19 with facial paralysis and olfactory disturbance .	1-19	20-35	The novel coronavirus disease-2019 , caused by severe acute respiratory syndrome coronavirus-2 , has spread worldwide from China .	There are no case reports from Asia of COVID-19 with facial paralysis and olfactory disturbance .	1<2	none	elaboration	elaboration
48356622cf00b854864f09f21cacca3c5f444225	36-47	48-56	We herein report a case of COVID-19 pneumonia in a Japanese woman	who showed facial nerve palsy and olfactory disturbance .	We herein report a case of COVID-19 pneumonia in a Japanese woman	who showed facial nerve palsy and olfactory disturbance .	36-56	36-56	We herein report a case of COVID-19 pneumonia in a Japanese woman who showed facial nerve palsy and olfactory disturbance .	We herein report a case of COVID-19 pneumonia in a Japanese woman who showed facial nerve palsy and olfactory disturbance .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	1-39	40-52	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M ,	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M ,	1-39	40-66	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M , at which the enzymatic activity loss showed close correlation with the subunit dissociation .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	40-52	53-66	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M ,	at which the enzymatic activity loss showed close correlation with the subunit dissociation .	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M ,	at which the enzymatic activity loss showed close correlation with the subunit dissociation .	40-66	40-66	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M , at which the enzymatic activity loss showed close correlation with the subunit dissociation .	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M , at which the enzymatic activity loss showed close correlation with the subunit dissociation .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	40-52	67-80	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M ,	Further increase in guanidinium chloride induced a reversible biphasic unfolding of the enzyme .	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M ,	Further increase in guanidinium chloride induced a reversible biphasic unfolding of the enzyme .	40-66	67-80	The dimeric enzyme dissociated at guanidinium chloride concentration of , 0.4 M , at which the enzymatic activity loss showed close correlation with the subunit dissociation .	Further increase in guanidinium chloride induced a reversible biphasic unfolding of the enzyme .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	67-80	81-103	Further increase in guanidinium chloride induced a reversible biphasic unfolding of the enzyme .	The unfolding of the C - terminal domain - truncated enzyme , on the other hand , followed a monophasic unfolding curve .	Further increase in guanidinium chloride induced a reversible biphasic unfolding of the enzyme .	The unfolding of the C - terminal domain - truncated enzyme , on the other hand , followed a monophasic unfolding curve .	67-80	81-103	Further increase in guanidinium chloride induced a reversible biphasic unfolding of the enzyme .	The unfolding of the C - terminal domain - truncated enzyme , on the other hand , followed a monophasic unfolding curve .	1<2	none	comparison	comparison
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	1-39	104-111,120-123	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	Different mutants of the full - length protease <*> with tryptophanyl residue(s )	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	Different mutants of the full - length protease <*> with tryptophanyl residue(s )	1-39	104-142	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	Different mutants of the full - length protease ( W31 and W207 / W218 ) , with tryptophanyl residue(s ) mutated to phenylalanine at the C - terminal or N - terminal domain , respectively , were constructed .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	104-111,120-123	112-119	Different mutants of the full - length protease <*> with tryptophanyl residue(s )	( W31 and W207 / W218 ) ,	Different mutants of the full - length protease <*> with tryptophanyl residue(s )	( W31 and W207 / W218 ) ,	104-142	104-142	Different mutants of the full - length protease ( W31 and W207 / W218 ) , with tryptophanyl residue(s ) mutated to phenylalanine at the C - terminal or N - terminal domain , respectively , were constructed .	Different mutants of the full - length protease ( W31 and W207 / W218 ) , with tryptophanyl residue(s ) mutated to phenylalanine at the C - terminal or N - terminal domain , respectively , were constructed .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	120-123,140-142	124-139	with tryptophanyl residue(s ) <*> were constructed .	mutated to phenylalanine at the C - terminal or N - terminal domain , respectively ,	with tryptophanyl residue(s ) <*> were constructed .	mutated to phenylalanine at the C - terminal or N - terminal domain , respectively ,	104-142	104-142	Different mutants of the full - length protease ( W31 and W207 / W218 ) , with tryptophanyl residue(s ) mutated to phenylalanine at the C - terminal or N - terminal domain , respectively , were constructed .	Different mutants of the full - length protease ( W31 and W207 / W218 ) , with tryptophanyl residue(s ) mutated to phenylalanine at the C - terminal or N - terminal domain , respectively , were constructed .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	104-111,120-123	143-149	Different mutants of the full - length protease <*> with tryptophanyl residue(s )	Unfolding curves of these mutants were monophasic	Different mutants of the full - length protease <*> with tryptophanyl residue(s )	Unfolding curves of these mutants were monophasic	104-142	143-163	Different mutants of the full - length protease ( W31 and W207 / W218 ) , with tryptophanyl residue(s ) mutated to phenylalanine at the C - terminal or N - terminal domain , respectively , were constructed .	Unfolding curves of these mutants were monophasic but corresponded to the first and second phases of the protease , respectively .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	143-149	150-163	Unfolding curves of these mutants were monophasic	but corresponded to the first and second phases of the protease , respectively .	Unfolding curves of these mutants were monophasic	but corresponded to the first and second phases of the protease , respectively .	143-163	143-163	Unfolding curves of these mutants were monophasic but corresponded to the first and second phases of the protease , respectively .	Unfolding curves of these mutants were monophasic but corresponded to the first and second phases of the protease , respectively .	1<2	none	comparison	comparison
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	143-149	164-185	Unfolding curves of these mutants were monophasic	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain ,	Unfolding curves of these mutants were monophasic	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain ,	143-163	164-196	Unfolding curves of these mutants were monophasic but corresponded to the first and second phases of the protease , respectively .	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain , which is enzymatically inactive due to loss of regulatory properties .	1<2	none	cause-result	cause-result
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	164-185	186-189	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain ,	which is enzymatically inactive	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain ,	which is enzymatically inactive	164-196	164-196	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain , which is enzymatically inactive due to loss of regulatory properties .	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain , which is enzymatically inactive due to loss of regulatory properties .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	186-189	190-196	which is enzymatically inactive	due to loss of regulatory properties .	which is enzymatically inactive	due to loss of regulatory properties .	164-196	164-196	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain , which is enzymatically inactive due to loss of regulatory properties .	The unfolding intermediate of the protease thus represented a folded C - terminal domain but an unfolded N - terminal domain , which is enzymatically inactive due to loss of regulatory properties .	1<2	none	cause-result	cause-result
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	1-39	197-214	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	The various enzyme forms were characterized in terms of hydrophobicity and size - and - shape distributions .	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	The various enzyme forms were characterized in terms of hydrophobicity and size - and - shape distributions .	1-39	197-214	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	The various enzyme forms were characterized in terms of hydrophobicity and size - and - shape distributions .	1<2	none	elaboration	elaboration
4894e8b3062d3304ef9cc17f72efcea7e66bbe4d	1-39	215-242	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	We provide direct evidence for the functional role of C - terminal domain in stabilization of the catalytic N - terminal domain of SARS coronavirus main protease .	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	We provide direct evidence for the functional role of C - terminal domain in stabilization of the catalytic N - terminal domain of SARS coronavirus main protease .	1-39	215-242	Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome ( SARS ) coronavirus to guanidinium chloride was examined in terms of fluorescence spectroscopy , circular dichroism , analytical ultracentrifuge , and enzyme activity change .	We provide direct evidence for the functional role of C - terminal domain in stabilization of the catalytic N - terminal domain of SARS coronavirus main protease .	1<2	none	findings	findings
492a1c000e859332a6e5d333aef1d74c4147b4e1	1-5,13-17	48-53	The coronavirus disease 2019 , <*> is now a pandemic ,	We proposed a SEIR epidemic model	The coronavirus disease 2019 , <*> is now a pandemic ,	We proposed a SEIR epidemic model	1-22	48-97	The coronavirus disease 2019 , which emerged from Wuhan , China , is now a pandemic , affecting across the globe .	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	1>2	none	background	background
492a1c000e859332a6e5d333aef1d74c4147b4e1	1-5,13-17	6-12	The coronavirus disease 2019 , <*> is now a pandemic ,	which emerged from Wuhan , China ,	The coronavirus disease 2019 , <*> is now a pandemic ,	which emerged from Wuhan , China ,	1-22	1-22	The coronavirus disease 2019 , which emerged from Wuhan , China , is now a pandemic , affecting across the globe .	The coronavirus disease 2019 , which emerged from Wuhan , China , is now a pandemic , affecting across the globe .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	13-17	18-22	is now a pandemic ,	affecting across the globe .	is now a pandemic ,	affecting across the globe .	1-22	1-22	The coronavirus disease 2019 , which emerged from Wuhan , China , is now a pandemic , affecting across the globe .	The coronavirus disease 2019 , which emerged from Wuhan , China , is now a pandemic , affecting across the globe .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	1-5,13-17	23-32	The coronavirus disease 2019 , <*> is now a pandemic ,	Government of different countries have developed and adopted various policies	The coronavirus disease 2019 , <*> is now a pandemic ,	Government of different countries have developed and adopted various policies	1-22	23-47	The coronavirus disease 2019 , which emerged from Wuhan , China , is now a pandemic , affecting across the globe .	Government of different countries have developed and adopted various policies to contain this epidemic and the most common were the social distancing and lockdown .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	23-32	33-36	Government of different countries have developed and adopted various policies	to contain this epidemic	Government of different countries have developed and adopted various policies	to contain this epidemic	23-47	23-47	Government of different countries have developed and adopted various policies to contain this epidemic and the most common were the social distancing and lockdown .	Government of different countries have developed and adopted various policies to contain this epidemic and the most common were the social distancing and lockdown .	1<2	none	enablement	enablement
492a1c000e859332a6e5d333aef1d74c4147b4e1	23-32	37-47	Government of different countries have developed and adopted various policies	and the most common were the social distancing and lockdown .	Government of different countries have developed and adopted various policies	and the most common were the social distancing and lockdown .	23-47	23-47	Government of different countries have developed and adopted various policies to contain this epidemic and the most common were the social distancing and lockdown .	Government of different countries have developed and adopted various policies to contain this epidemic and the most common were the social distancing and lockdown .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	48-53	54-64	We proposed a SEIR epidemic model	that accommodates the effects of lockdown and individual based precautionary measures	We proposed a SEIR epidemic model	that accommodates the effects of lockdown and individual based precautionary measures	48-97	48-97	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	48-53	65-67	We proposed a SEIR epidemic model	and used it	We proposed a SEIR epidemic model	and used it	48-97	48-97	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	65-67	68-82	and used it	to estimate model parameters from the epidemic data up to 2nd April , 2020 ,	and used it	to estimate model parameters from the epidemic data up to 2nd April , 2020 ,	48-97	48-97	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	1<2	none	enablement	enablement
492a1c000e859332a6e5d333aef1d74c4147b4e1	68-82	83-97	to estimate model parameters from the epidemic data up to 2nd April , 2020 ,	freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	to estimate model parameters from the epidemic data up to 2nd April , 2020 ,	freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	48-97	48-97	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	68-82	98-102	to estimate model parameters from the epidemic data up to 2nd April , 2020 ,	We used the estimated parameters	to estimate model parameters from the epidemic data up to 2nd April , 2020 ,	We used the estimated parameters	48-97	98-120	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	We used the estimated parameters to predict the disease burden in these countries with special emphasis on India , Bangladesh and Pakistan .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	98-102	103-120	We used the estimated parameters	to predict the disease burden in these countries with special emphasis on India , Bangladesh and Pakistan .	We used the estimated parameters	to predict the disease burden in these countries with special emphasis on India , Bangladesh and Pakistan .	98-120	98-120	We used the estimated parameters to predict the disease burden in these countries with special emphasis on India , Bangladesh and Pakistan .	We used the estimated parameters to predict the disease burden in these countries with special emphasis on India , Bangladesh and Pakistan .	1<2	none	enablement	enablement
492a1c000e859332a6e5d333aef1d74c4147b4e1	121-123	124-135	Our analysis revealed	that the lockdown and recommended individual hygiene can slow down the outbreak	Our analysis revealed	that the lockdown and recommended individual hygiene can slow down the outbreak	121-145	121-145	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	1>2	none	attribution	attribution
492a1c000e859332a6e5d333aef1d74c4147b4e1	48-53	124-135	We proposed a SEIR epidemic model	that the lockdown and recommended individual hygiene can slow down the outbreak	We proposed a SEIR epidemic model	that the lockdown and recommended individual hygiene can slow down the outbreak	48-97	121-145	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	1<2	none	findings	findings
492a1c000e859332a6e5d333aef1d74c4147b4e1	124-135	136-145	that the lockdown and recommended individual hygiene can slow down the outbreak	but unable to eradicate the disease from the society .	that the lockdown and recommended individual hygiene can slow down the outbreak	but unable to eradicate the disease from the society .	121-145	121-145	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	1<2	none	comparison	comparison
492a1c000e859332a6e5d333aef1d74c4147b4e1	146-162	163-179	With the current human - to - human transmission rate and existing level of personal precautionary ,	the number of infected individuals in India will be increasing at least for the next 3 months	With the current human - to - human transmission rate and existing level of personal precautionary ,	the number of infected individuals in India will be increasing at least for the next 3 months	146-188	146-188	With the current human - to - human transmission rate and existing level of personal precautionary , the number of infected individuals in India will be increasing at least for the next 3 months and the peak will come in 5 months .	With the current human - to - human transmission rate and existing level of personal precautionary , the number of infected individuals in India will be increasing at least for the next 3 months and the peak will come in 5 months .	1>2	none	condition	condition
492a1c000e859332a6e5d333aef1d74c4147b4e1	136-145	163-179	but unable to eradicate the disease from the society .	the number of infected individuals in India will be increasing at least for the next 3 months	but unable to eradicate the disease from the society .	the number of infected individuals in India will be increasing at least for the next 3 months	121-145	146-188	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	With the current human - to - human transmission rate and existing level of personal precautionary , the number of infected individuals in India will be increasing at least for the next 3 months and the peak will come in 5 months .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	163-179	180-188	the number of infected individuals in India will be increasing at least for the next 3 months	and the peak will come in 5 months .	the number of infected individuals in India will be increasing at least for the next 3 months	and the peak will come in 5 months .	146-188	146-188	With the current human - to - human transmission rate and existing level of personal precautionary , the number of infected individuals in India will be increasing at least for the next 3 months and the peak will come in 5 months .	With the current human - to - human transmission rate and existing level of personal precautionary , the number of infected individuals in India will be increasing at least for the next 3 months and the peak will come in 5 months .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	136-145	189-197	but unable to eradicate the disease from the society .	We can , however , reduce the epidemic size	but unable to eradicate the disease from the society .	We can , however , reduce the epidemic size	121-145	189-215	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	1<2	none	comparison	comparison
492a1c000e859332a6e5d333aef1d74c4147b4e1	189-197	198-201	We can , however , reduce the epidemic size	and prolong the time	We can , however , reduce the epidemic size	and prolong the time	189-215	189-215	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	1<2	none	joint	joint
492a1c000e859332a6e5d333aef1d74c4147b4e1	198-201	202-205	and prolong the time	to arrive epidemic peak	and prolong the time	to arrive epidemic peak	189-215	189-215	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	189-197	206-210	We can , however , reduce the epidemic size	by seriously following the measures	We can , however , reduce the epidemic size	by seriously following the measures	189-215	189-215	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	1<2	none	manner-means	manner-means
492a1c000e859332a6e5d333aef1d74c4147b4e1	206-210	211-215	by seriously following the measures	suggested by the authorities .	by seriously following the measures	suggested by the authorities .	189-215	189-215	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	We can , however , reduce the epidemic size and prolong the time to arrive epidemic peak by seriously following the measures suggested by the authorities .	1<2	none	attribution	attribution
492a1c000e859332a6e5d333aef1d74c4147b4e1	124-135	216-223	that the lockdown and recommended individual hygiene can slow down the outbreak	We need to wait for another one month	that the lockdown and recommended individual hygiene can slow down the outbreak	We need to wait for another one month	121-145	216-239	Our analysis revealed that the lockdown and recommended individual hygiene can slow down the outbreak but unable to eradicate the disease from the society .	We need to wait for another one month to obtain more data and epidemiological parameters for giving a better prediction about the pandemic .	1<2	none	elaboration	elaboration
492a1c000e859332a6e5d333aef1d74c4147b4e1	216-223	224-230	We need to wait for another one month	to obtain more data and epidemiological parameters	We need to wait for another one month	to obtain more data and epidemiological parameters	216-239	216-239	We need to wait for another one month to obtain more data and epidemiological parameters for giving a better prediction about the pandemic .	We need to wait for another one month to obtain more data and epidemiological parameters for giving a better prediction about the pandemic .	1<2	none	enablement	enablement
492a1c000e859332a6e5d333aef1d74c4147b4e1	224-230	231-239	to obtain more data and epidemiological parameters	for giving a better prediction about the pandemic .	to obtain more data and epidemiological parameters	for giving a better prediction about the pandemic .	216-239	216-239	We need to wait for another one month to obtain more data and epidemiological parameters for giving a better prediction about the pandemic .	We need to wait for another one month to obtain more data and epidemiological parameters for giving a better prediction about the pandemic .	1<2	none	enablement	enablement
492a1c000e859332a6e5d333aef1d74c4147b4e1	48-53	240-256	We proposed a SEIR epidemic model	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19	We proposed a SEIR epidemic model	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19	48-97	240-269	We proposed a SEIR epidemic model that accommodates the effects of lockdown and individual based precautionary measures and used it to estimate model parameters from the epidemic data up to 2nd April , 2020 , freely available in GitHub repository for COVID-19 , for nine developed and developing countries .	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19 and the presence of such pharmaceutical interventions will significantly alter the results .	1<2	none	findings	findings
492a1c000e859332a6e5d333aef1d74c4147b4e1	240-256	257-269	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19	and the presence of such pharmaceutical interventions will significantly alter the results .	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19	and the presence of such pharmaceutical interventions will significantly alter the results .	240-269	240-269	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19 and the presence of such pharmaceutical interventions will significantly alter the results .	It is to be mentioned that research community is working for drugs and/ or vaccines against COVID19 and the presence of such pharmaceutical interventions will significantly alter the results .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	1-9	136-140,150-161	The current Ebola virus outbreak has highlighted the uncertainties	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	The current Ebola virus outbreak has highlighted the uncertainties	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	1-22	136-179	The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology , including routes of transmission .	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	1>2	none	background	background
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	1-9	10-17	The current Ebola virus outbreak has highlighted the uncertainties	surrounding many aspects of Ebola virus virology ,	The current Ebola virus outbreak has highlighted the uncertainties	surrounding many aspects of Ebola virus virology ,	1-22	1-22	The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology , including routes of transmission .	The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology , including routes of transmission .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	10-17	18-22	surrounding many aspects of Ebola virus virology ,	including routes of transmission .	surrounding many aspects of Ebola virus virology ,	including routes of transmission .	1-22	1-22	The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology , including routes of transmission .	The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology , including routes of transmission .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	1-9	23-32	The current Ebola virus outbreak has highlighted the uncertainties	The scientific community played a leading role during the outbreak	The current Ebola virus outbreak has highlighted the uncertainties	The scientific community played a leading role during the outbreak	1-22	23-56	The current Ebola virus outbreak has highlighted the uncertainties surrounding many aspects of Ebola virus virology , including routes of transmission .	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	23-32	33-41	The scientific community played a leading role during the outbreak	- potentially , the largest of its kind -	The scientific community played a leading role during the outbreak	- potentially , the largest of its kind -	23-56	23-56	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	23-32	42-46,49-56	The scientific community played a leading role during the outbreak	as many of the questions <*> have only been interrogated in the laboratory .	The scientific community played a leading role during the outbreak	as many of the questions <*> have only been interrogated in the laboratory .	23-56	23-56	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	42-46,49-56	47-48	as many of the questions <*> have only been interrogated in the laboratory .	surrounding ebolaviruses	as many of the questions <*> have only been interrogated in the laboratory .	surrounding ebolaviruses	23-56	23-56	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	23-32	57-75	The scientific community played a leading role during the outbreak	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public	The scientific community played a leading role during the outbreak	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public	23-56	57-88	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public in understanding the progress of Ebola virus disease and the continuing outbreak .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	57-75	76-88	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public	in understanding the progress of Ebola virus disease and the continuing outbreak .	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public	in understanding the progress of Ebola virus disease and the continuing outbreak .	57-88	57-88	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public in understanding the progress of Ebola virus disease and the continuing outbreak .	Scientists provided an invaluable resource for clinicians , public health officials , policy makers , and the lay public in understanding the progress of Ebola virus disease and the continuing outbreak .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	23-32	89-102	The scientific community played a leading role during the outbreak	Not all of the scientific communication , however , was accurate or effective .	The scientific community played a leading role during the outbreak	Not all of the scientific communication , however , was accurate or effective .	23-56	89-102	The scientific community played a leading role during the outbreak - potentially , the largest of its kind - as many of the questions surrounding ebolaviruses have only been interrogated in the laboratory .	Not all of the scientific communication , however , was accurate or effective .	1<2	none	comparison	comparison
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	89-102	103-115	Not all of the scientific communication , however , was accurate or effective .	There were multiple instances of published articles during the height of the outbreak	Not all of the scientific communication , however , was accurate or effective .	There were multiple instances of published articles during the height of the outbreak	89-102	103-135	Not all of the scientific communication , however , was accurate or effective .	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	1<2	none	cause-result	cause-result
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	103-115	116-120	There were multiple instances of published articles during the height of the outbreak	containing potentially misleading scientific language	There were multiple instances of published articles during the height of the outbreak	containing potentially misleading scientific language	103-135	103-135	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	116-120	121-124	containing potentially misleading scientific language	that spurred media overreaction	containing potentially misleading scientific language	that spurred media overreaction	103-135	103-135	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	121-124	125-135	that spurred media overreaction	and potentially jeopardized preparedness and policy decisions at critical points .	that spurred media overreaction	and potentially jeopardized preparedness and policy decisions at critical points .	103-135	103-135	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	There were multiple instances of published articles during the height of the outbreak containing potentially misleading scientific language that spurred media overreaction and potentially jeopardized preparedness and policy decisions at critical points .	1<2	none	joint	joint
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	136-140,150-161	141-149	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	declaring the potential for airborne transmission of Ebola virus	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	declaring the potential for airborne transmission of Ebola virus	136-179	136-179	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	136-140,150-161	162-165	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	and we provide recommendations	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	and we provide recommendations	136-179	136-179	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	1<2	none	joint	joint
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	162-165	166-179	and we provide recommendations	for improving the communication about unknown aspects of disease during public health crises .	and we provide recommendations	for improving the communication about unknown aspects of disease during public health crises .	136-179	136-179	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	1<2	none	enablement	enablement
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	136-140,150-161	180-199	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	Basic scientific research is now considered an integral component of the fight against emerging infectious diseases like Ebola virus .	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	Basic scientific research is now considered an integral component of the fight against emerging infectious diseases like Ebola virus .	136-179	180-199	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	Basic scientific research is now considered an integral component of the fight against emerging infectious diseases like Ebola virus .	1<2	none	background	background
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	200-207	208-219	The recent Ebola outbreak , however , demonstrates	how the ineffective communication of basic science can stoke public panic more	The recent Ebola outbreak , however , demonstrates	how the ineffective communication of basic science can stoke public panic more	200-227	200-227	The recent Ebola outbreak , however , demonstrates how the ineffective communication of basic science can stoke public panic more than it provides helpful tools to responders ;	The recent Ebola outbreak , however , demonstrates how the ineffective communication of basic science can stoke public panic more than it provides helpful tools to responders ;	1>2	none	attribution	attribution
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	180-199	208-219	Basic scientific research is now considered an integral component of the fight against emerging infectious diseases like Ebola virus .	how the ineffective communication of basic science can stoke public panic more	Basic scientific research is now considered an integral component of the fight against emerging infectious diseases like Ebola virus .	how the ineffective communication of basic science can stoke public panic more	180-199	200-227	Basic scientific research is now considered an integral component of the fight against emerging infectious diseases like Ebola virus .	The recent Ebola outbreak , however , demonstrates how the ineffective communication of basic science can stoke public panic more than it provides helpful tools to responders ;	1<2	none	comparison	comparison
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	208-219	220-227	how the ineffective communication of basic science can stoke public panic more	than it provides helpful tools to responders ;	how the ineffective communication of basic science can stoke public panic more	than it provides helpful tools to responders ;	200-227	200-227	The recent Ebola outbreak , however , demonstrates how the ineffective communication of basic science can stoke public panic more than it provides helpful tools to responders ;	The recent Ebola outbreak , however , demonstrates how the ineffective communication of basic science can stoke public panic more than it provides helpful tools to responders ;	1<2	none	comparison	comparison
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	208-219	228-235	how the ineffective communication of basic science can stoke public panic more	basic science trades in probabilities and uncertainty ,	how the ineffective communication of basic science can stoke public panic more	basic science trades in probabilities and uncertainty ,	200-227	228-245	The recent Ebola outbreak , however , demonstrates how the ineffective communication of basic science can stoke public panic more than it provides helpful tools to responders ;	basic science trades in probabilities and uncertainty , while public communication tends to favor more categorical claims .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	228-235	236-245	basic science trades in probabilities and uncertainty ,	while public communication tends to favor more categorical claims .	basic science trades in probabilities and uncertainty ,	while public communication tends to favor more categorical claims .	228-245	228-245	basic science trades in probabilities and uncertainty , while public communication tends to favor more categorical claims .	basic science trades in probabilities and uncertainty , while public communication tends to favor more categorical claims .	1<2	none	comparison	comparison
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	136-140,150-161	246-251	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	Here , we discuss the ethics	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	Here , we discuss the ethics	136-179	246-294	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	246-251	252-256	Here , we discuss the ethics	of communicating scientific results ,	Here , we discuss the ethics	of communicating scientific results ,	246-294	246-294	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	246-251	257-266	Here , we discuss the ethics	using , as a case study , the recent controversy	Here , we discuss the ethics	using , as a case study , the recent controversy	246-294	246-294	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1<2	none	manner-means	manner-means
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	267-273	274-283	over whether basic life sciences research demonstrates	that Ebola could become transmissible via airborne respiratory droplet nuclei	over whether basic life sciences research demonstrates	that Ebola could become transmissible via airborne respiratory droplet nuclei	246-294	246-294	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1>2	none	attribution	attribution
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	257-266	274-283	using , as a case study , the recent controversy	that Ebola could become transmissible via airborne respiratory droplet nuclei	using , as a case study , the recent controversy	that Ebola could become transmissible via airborne respiratory droplet nuclei	246-294	246-294	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	274-283	284-289	that Ebola could become transmissible via airborne respiratory droplet nuclei	- popularly known as a virus	that Ebola could become transmissible via airborne respiratory droplet nuclei	- popularly known as a virus	246-294	246-294	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	284-289	290-294	- popularly known as a virus	becoming " airborne . "	- popularly known as a virus	becoming " airborne . "	246-294	246-294	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	Here , we discuss the ethics of communicating scientific results , using , as a case study , the recent controversy over whether basic life sciences research demonstrates that Ebola could become transmissible via airborne respiratory droplet nuclei - popularly known as a virus becoming " airborne . "	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	295-296	297-305	We show	how the science does not demonstrate this possibility ,	We show	how the science does not demonstrate this possibility ,	295-315	295-315	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	1>2	none	attribution	attribution
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	136-140,150-161	297-305	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	how the science does not demonstrate this possibility ,	Here , we use articles <*> as a case study in the inaccurate reporting of basic science ,	how the science does not demonstrate this possibility ,	136-179	295-315	Here , we use articles declaring the potential for airborne transmission of Ebola virus as a case study in the inaccurate reporting of basic science , and we provide recommendations for improving the communication about unknown aspects of disease during public health crises .	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	1<2	none	findings	findings
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	297-305	306-307	how the science does not demonstrate this possibility ,	despite claims	how the science does not demonstrate this possibility ,	despite claims	295-315	295-315	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	1<2	none	comparison	comparison
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	306-307	308-315	despite claims	made in the popular and scientific press .	despite claims	made in the popular and scientific press .	295-315	295-315	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	316-318	319-352	We then recommend	that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence	We then recommend	that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence	316-360	316-360	We then recommend that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence that would give proof to controversial claims .	We then recommend that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence that would give proof to controversial claims .	1>2	none	attribution	attribution
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	297-305	319-352	how the science does not demonstrate this possibility ,	that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence	how the science does not demonstrate this possibility ,	that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence	295-315	316-360	We show how the science does not demonstrate this possibility , despite claims made in the popular and scientific press .	We then recommend that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence that would give proof to controversial claims .	1<2	none	elaboration	elaboration
4c76e1e9a4f5afc01accd2dbbd43f0463744e8d2	319-352	353-360	that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence	that would give proof to controversial claims .	that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence	that would give proof to controversial claims .	316-360	316-360	We then recommend that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence that would give proof to controversial claims .	We then recommend that uncertain scientific results in the context of public health crises ought to be communicated with humility , an emphasis on what is unknown , and a clear outline of the kinds of evidence that would give proof to controversial claims .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	1-18	19-30	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds	that display potent inhibitory activity against SARS - CoV 3CL pro .	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds	that display potent inhibitory activity against SARS - CoV 3CL pro .	1-30	1-30	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds that display potent inhibitory activity against SARS - CoV 3CL pro .	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds that display potent inhibitory activity against SARS - CoV 3CL pro .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	1-18	31-33,45-61	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	1-30	31-61	We report the design and synthesis of a series of dipeptide - type inhibitors with novel P3 scaffolds that display potent inhibitory activity against SARS - CoV 3CL pro .	A docking study involving binding between the dipeptidic lead compound 4 and 3CL pro suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	1<2	none	findings	findings
4cace95b9b4e1f4af324d1fa278274c53c2b00af	31-33,45-61	34-44	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	involving binding between the dipeptidic lead compound 4 and 3CL pro	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	involving binding between the dipeptidic lead compound 4 and 3CL pro	31-61	31-61	A docking study involving binding between the dipeptidic lead compound 4 and 3CL pro suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	A docking study involving binding between the dipeptidic lead compound 4 and 3CL pro suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	31-33,45-61	62-72	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	The modifications led to the identification of several potent derivatives ,	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	The modifications led to the identification of several potent derivatives ,	31-61	62-94	A docking study involving binding between the dipeptidic lead compound 4 and 3CL pro suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	The modifications led to the identification of several potent derivatives , including 5cek and 5n with the inhibitory activities ( K i or IC 50 ) in the submicromolar to nanomolar range .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	62-72	73-94	The modifications led to the identification of several potent derivatives ,	including 5cek and 5n with the inhibitory activities ( K i or IC 50 ) in the submicromolar to nanomolar range .	The modifications led to the identification of several potent derivatives ,	including 5cek and 5n with the inhibitory activities ( K i or IC 50 ) in the submicromolar to nanomolar range .	62-94	62-94	The modifications led to the identification of several potent derivatives , including 5cek and 5n with the inhibitory activities ( K i or IC 50 ) in the submicromolar to nanomolar range .	The modifications led to the identification of several potent derivatives , including 5cek and 5n with the inhibitory activities ( K i or IC 50 ) in the submicromolar to nanomolar range .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	62-72	95-115	The modifications led to the identification of several potent derivatives ,	Compound 5h , in particular , displayed the most potent inhibitory activity , with a K i value of 0.006 mM.	The modifications led to the identification of several potent derivatives ,	Compound 5h , in particular , displayed the most potent inhibitory activity , with a K i value of 0.006 mM.	62-94	95-115	The modifications led to the identification of several potent derivatives , including 5cek and 5n with the inhibitory activities ( K i or IC 50 ) in the submicromolar to nanomolar range .	Compound 5h , in particular , displayed the most potent inhibitory activity , with a K i value of 0.006 mM.	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	95-115	116-136	Compound 5h , in particular , displayed the most potent inhibitory activity , with a K i value of 0.006 mM.	This potency was 65-fold higher than the potency of the lead compound 4 ( K i ¼ 0.39 mM ) .	Compound 5h , in particular , displayed the most potent inhibitory activity , with a K i value of 0.006 mM.	This potency was 65-fold higher than the potency of the lead compound 4 ( K i ¼ 0.39 mM ) .	95-115	116-136	Compound 5h , in particular , displayed the most potent inhibitory activity , with a K i value of 0.006 mM.	This potency was 65-fold higher than the potency of the lead compound 4 ( K i ¼ 0.39 mM ) .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	116-136	137-158	This potency was 65-fold higher than the potency of the lead compound 4 ( K i ¼ 0.39 mM ) .	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM )	This potency was 65-fold higher than the potency of the lead compound 4 ( K i ¼ 0.39 mM ) .	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM )	116-136	137-167	This potency was 65-fold higher than the potency of the lead compound 4 ( K i ¼ 0.39 mM ) .	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM ) observed in isothermal titration calorimetry ( ITC ) .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	137-158	159-167	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM )	observed in isothermal titration calorimetry ( ITC ) .	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM )	observed in isothermal titration calorimetry ( ITC ) .	137-167	137-167	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM ) observed in isothermal titration calorimetry ( ITC ) .	In addition , the K i value of 5h was in very good agreement with the binding affinity ( 16 nM ) observed in isothermal titration calorimetry ( ITC ) .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	31-33,45-61	168-198	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	A SAR study around the P3 group in the lead 4 led to the identification of a rigid indole-2-carbonyl unit as one of the best P3 moieties ( 5c ) .	A docking study <*> suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	A SAR study around the P3 group in the lead 4 led to the identification of a rigid indole-2-carbonyl unit as one of the best P3 moieties ( 5c ) .	31-61	168-198	A docking study involving binding between the dipeptidic lead compound 4 and 3CL pro suggested the modification of a structurally flexible P3 N-(3methoxyphenyl)glycine with various rigid P3 moieties in 4 .	A SAR study around the P3 group in the lead 4 led to the identification of a rigid indole-2-carbonyl unit as one of the best P3 moieties ( 5c ) .	1<2	none	elaboration	elaboration
4cace95b9b4e1f4af324d1fa278274c53c2b00af	199-201	202-221	Further optimization showed	that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	Further optimization showed	that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	199-221	199-221	Further optimization showed that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	Further optimization showed that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	1>2	none	attribution	attribution
4cace95b9b4e1f4af324d1fa278274c53c2b00af	168-198	202-221	A SAR study around the P3 group in the lead 4 led to the identification of a rigid indole-2-carbonyl unit as one of the best P3 moieties ( 5c ) .	that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	A SAR study around the P3 group in the lead 4 led to the identification of a rigid indole-2-carbonyl unit as one of the best P3 moieties ( 5c ) .	that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	168-198	199-221	A SAR study around the P3 group in the lead 4 led to the identification of a rigid indole-2-carbonyl unit as one of the best P3 moieties ( 5c ) .	Further optimization showed that a methoxy substitution at the 4-position on the indole unit was highly favorable for enhancing the inhibitory potency .	1<2	none	elaboration	elaboration
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	1-21	36-74	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses ,	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses ,	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	1-35	36-74	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses , even though results are mostly available too late or lacked specificity and sensitivity .	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	1>2	none	background	background
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	1-21	22-29	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses ,	even though results are mostly available too late	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses ,	even though results are mostly available too late	1-35	1-35	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses , even though results are mostly available too late or lacked specificity and sensitivity .	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses , even though results are mostly available too late or lacked specificity and sensitivity .	1<2	none	comparison	comparison
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	22-29	30-35	even though results are mostly available too late	or lacked specificity and sensitivity .	even though results are mostly available too late	or lacked specificity and sensitivity .	1-35	1-35	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses , even though results are mostly available too late or lacked specificity and sensitivity .	Until recently , conventional culture techniques and immunofluorecence assays were considered the gold standard for the detection of respiratory viruses , even though results are mostly available too late or lacked specificity and sensitivity .	1<2	none	joint	joint
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	36-74	75-94	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results	36-74	75-98	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results due to contamination .	1<2	none	elaboration	elaboration
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	75-94	95-98	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results	due to contamination .	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results	due to contamination .	75-98	75-98	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results due to contamination .	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results due to contamination .	1<2	none	cause-result	cause-result
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	75-94	99-114	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible	75-98	99-122	Real - time PCR offers rapid results , efficiencies in work flow and a reduced risk of false positive results due to contamination .	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible leading to enhanced efficiencies in health care .	1<2	none	cause-result	cause-result
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	99-114	115-122	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible	leading to enhanced efficiencies in health care .	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible	leading to enhanced efficiencies in health care .	99-122	99-122	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible leading to enhanced efficiencies in health care .	As a result , better patient management or reduction of unnecessary antibiotic administration will be possible leading to enhanced efficiencies in health care .	1<2	none	cause-result	cause-result
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	123-130	131-137	In applying molecular methods to diagnostic use ,	the laboratory can optimise its diagnostic strategy	In applying molecular methods to diagnostic use ,	the laboratory can optimise its diagnostic strategy	123-159	123-159	In applying molecular methods to diagnostic use , the laboratory can optimise its diagnostic strategy by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	In applying molecular methods to diagnostic use , the laboratory can optimise its diagnostic strategy by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	1>2	none	elaboration	elaboration
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	36-74	131-137	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	the laboratory can optimise its diagnostic strategy	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	the laboratory can optimise its diagnostic strategy	36-74	123-159	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	In applying molecular methods to diagnostic use , the laboratory can optimise its diagnostic strategy by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	1<2	none	elaboration	elaboration
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	131-137	138-159	the laboratory can optimise its diagnostic strategy	by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	the laboratory can optimise its diagnostic strategy	by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	123-159	123-159	In applying molecular methods to diagnostic use , the laboratory can optimise its diagnostic strategy by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	In applying molecular methods to diagnostic use , the laboratory can optimise its diagnostic strategy by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	1<2	none	manner-means	manner-means
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	131-137	160-178	the laboratory can optimise its diagnostic strategy	However this must be done within a context of resource availability , technical expertise available and clinical utility .	the laboratory can optimise its diagnostic strategy	However this must be done within a context of resource availability , technical expertise available and clinical utility .	123-159	160-178	In applying molecular methods to diagnostic use , the laboratory can optimise its diagnostic strategy by applying a combination of real - time amplification tests for respiratory viruses and the non - viral respiratory bacterial pathogens .	However this must be done within a context of resource availability , technical expertise available and clinical utility .	1<2	none	comparison	comparison
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	36-74	179-189	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	It seems certain that molecular microbiology will continue to develop ,	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	It seems certain that molecular microbiology will continue to develop ,	36-74	179-213	These methods are now widely replaced with appropriate DNA - and RNA - based amplification techniques , in particular real time PCR amplification , for the detection of an extended number of agents responsible for acute respiratory infections .	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	1<2	none	elaboration	elaboration
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	179-189	190-197	It seems certain that molecular microbiology will continue to develop ,	leading to further applications in diagnostic technology ,	It seems certain that molecular microbiology will continue to develop ,	leading to further applications in diagnostic technology ,	179-213	179-213	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	1<2	none	cause-result	cause-result
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	190-197	198-204	leading to further applications in diagnostic technology ,	thereby improving our understanding of disease processes	leading to further applications in diagnostic technology ,	thereby improving our understanding of disease processes	179-213	179-213	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	1<2	none	cause-result	cause-result
4d2366b0ee4d6b5ec8c8b7376e7b343fa15e0ff8	198-204	205-213	thereby improving our understanding of disease processes	and enhancing our knowledge of the pathogens responsible .	thereby improving our understanding of disease processes	and enhancing our knowledge of the pathogens responsible .	179-213	179-213	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	It seems certain that molecular microbiology will continue to develop , leading to further applications in diagnostic technology , thereby improving our understanding of disease processes and enhancing our knowledge of the pathogens responsible .	1<2	none	joint	joint
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	1-18	19-22,33-34	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population ,	a virus neutralization test <*> was established	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population ,	a virus neutralization test <*> was established	1-49	1-49	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	1>2	none	enablement	enablement
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	19-22,33-34	23-32	a virus neutralization test <*> was established	detecting specific antibodies against CCV in giant panda 's sera	a virus neutralization test <*> was established	detecting specific antibodies against CCV in giant panda's sera	1-49	1-49	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	1<2	none	elaboration	elaboration
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	33-34	35-49	was established	by using two - fold dilutions of serum and 100 TCIDso of the virus .	was established	by using two - fold dilutions of serum and 100 TCIDso of the virus .	1-49	1-49	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	1<2	none	manner-means	manner-means
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	19-22,33-34	50-57,71-73	a virus neutralization test <*> was established	The 62 sera samples of giant pandas , <*> were detected .	a virus neutralization test <*> was established	The 62 sera samples of giant pandas , <*> were detected .	1-49	50-73	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	The 62 sera samples of giant pandas , which were gathered from zoos and reserve region of Sichuan Province , China were detected .	1<2	none	elaboration	elaboration
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	50-57,71-73	58-70	The 62 sera samples of giant pandas , <*> were detected .	which were gathered from zoos and reserve region of Sichuan Province , China	The 62 sera samples of giant pandas , <*> were detected .	which were gathered from zoos and reserve region of Sichuan Province , China	50-73	50-73	The 62 sera samples of giant pandas , which were gathered from zoos and reserve region of Sichuan Province , China were detected .	The 62 sera samples of giant pandas , which were gathered from zoos and reserve region of Sichuan Province , China were detected .	1<2	none	elaboration	elaboration
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	19-22,33-34	74-86	a virus neutralization test <*> was established	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	a virus neutralization test <*> was established	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	1-49	74-103	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	1<2	none	findings	findings
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	74-86	87-95	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	8 sera samples were detected to be positive ,	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	8 sera samples were detected to be positive ,	74-103	74-103	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	1<2	none	joint	joint
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	74-86	96-103	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	and the positive rate was 12.9 % .	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	and the positive rate was 12.9 % .	74-103	74-103	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	1<2	none	joint	joint
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	74-86	104-114	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	The titers of neutralizing antibody ranged from 1:8 to 1:32 .	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	The titers of neutralizing antibody ranged from 1:8 to 1:32 .	74-103	104-114	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	The titers of neutralizing antibody ranged from 1:8 to 1:32 .	1<2	none	elaboration	elaboration
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	74-86	115-132	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	It was the first comprehensive investigation on neutralization antibodies against CCV in giant panda population in China .	The neutralization antibody titer of 1:4 was recognized as the positive criterion ,	It was the first comprehensive investigation on neutralization antibodies against CCV in giant panda population in China .	74-103	115-132	The neutralization antibody titer of 1:4 was recognized as the positive criterion , 8 sera samples were detected to be positive , and the positive rate was 12.9 % .	It was the first comprehensive investigation on neutralization antibodies against CCV in giant panda population in China .	1<2	none	elaboration	elaboration
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	133-137	138-149	The results of study showed	that the infection of CCV in giant panda population was universal ,	The results of study showed	that the infection of CCV in giant panda population was universal ,	133-161	133-161	The results of study showed that the infection of CCV in giant panda population was universal , which has posed a threat to the health of giant panda .	The results of study showed that the infection of CCV in giant panda population was universal , which has posed a threat to the health of giant panda .	1>2	none	attribution	attribution
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	19-22,33-34	138-149	a virus neutralization test <*> was established	that the infection of CCV in giant panda population was universal ,	a virus neutralization test <*> was established	that the infection of CCV in giant panda population was universal ,	1-49	133-161	In order to survey the infectious situation of canine coronavirus ( CCV ) in giant panda population , a virus neutralization test detecting specific antibodies against CCV in giant panda 's sera was established by using two - fold dilutions of serum and 100 TCIDso of the virus .	The results of study showed that the infection of CCV in giant panda population was universal , which has posed a threat to the health of giant panda .	1<2	none	findings	findings
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	138-149	150-161	that the infection of CCV in giant panda population was universal ,	which has posed a threat to the health of giant panda .	that the infection of CCV in giant panda population was universal ,	which has posed a threat to the health of giant panda .	133-161	133-161	The results of study showed that the infection of CCV in giant panda population was universal , which has posed a threat to the health of giant panda .	The results of study showed that the infection of CCV in giant panda population was universal , which has posed a threat to the health of giant panda .	1<2	none	elaboration	elaboration
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	138-149	162-174	that the infection of CCV in giant panda population was universal ,	Therefore , it is incumbent on us to study safe and effective vaccines	that the infection of CCV in giant panda population was universal ,	Therefore , it is incumbent on us to study safe and effective vaccines	133-161	162-182	The results of study showed that the infection of CCV in giant panda population was universal , which has posed a threat to the health of giant panda .	Therefore , it is incumbent on us to study safe and effective vaccines to protect giant panda against CCV infection .	1<2	none	cause-result	cause-result
50cde1e9f6887bf2ef3e41f30b17011e4e58aba8	162-174	175-182	Therefore , it is incumbent on us to study safe and effective vaccines	to protect giant panda against CCV infection .	Therefore , it is incumbent on us to study safe and effective vaccines	to protect giant panda against CCV infection .	162-182	162-182	Therefore , it is incumbent on us to study safe and effective vaccines to protect giant panda against CCV infection .	Therefore , it is incumbent on us to study safe and effective vaccines to protect giant panda against CCV infection .	1<2	none	enablement	enablement
5405330f85660bb35ec960a144e904c54c4c67a7	1-10	11-16	In this demo , we introduce an interactive system ,	which effectively applies multiple criteria analysis	In this demo , we introduce an interactive system ,	which effectively applies multiple criteria analysis	1-21	1-21	In this demo , we introduce an interactive system , which effectively applies multiple criteria analysis to rank association rules .	In this demo , we introduce an interactive system , which effectively applies multiple criteria analysis to rank association rules .	1<2	none	elaboration	elaboration
5405330f85660bb35ec960a144e904c54c4c67a7	11-16	17-21	which effectively applies multiple criteria analysis	to rank association rules .	which effectively applies multiple criteria analysis	to rank association rules .	1-21	1-21	In this demo , we introduce an interactive system , which effectively applies multiple criteria analysis to rank association rules .	In this demo , we introduce an interactive system , which effectively applies multiple criteria analysis to rank association rules .	1<2	none	enablement	enablement
5405330f85660bb35ec960a144e904c54c4c67a7	1-10	22-27	In this demo , we introduce an interactive system ,	We first use association rules techniques	In this demo , we introduce an interactive system ,	We first use association rules techniques	1-21	22-68	In this demo , we introduce an interactive system , which effectively applies multiple criteria analysis to rank association rules .	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	1<2	none	elaboration	elaboration
5405330f85660bb35ec960a144e904c54c4c67a7	22-27	28-36	We first use association rules techniques	to explore the correlations between variables in given data	We first use association rules techniques	to explore the correlations between variables in given data	22-68	22-68	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	1<2	none	enablement	enablement
5405330f85660bb35ec960a144e904c54c4c67a7	28-36	37-48	to explore the correlations between variables in given data	( i.e. , database and linked data ( LD ) ) ,	to explore the correlations between variables in given data	( i.e. , database and linked data ( LD ) ) ,	22-68	22-68	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	1<2	none	elaboration	elaboration
5405330f85660bb35ec960a144e904c54c4c67a7	22-27	49-57	We first use association rules techniques	and secondly apply multiple criteria analysis ( MCA )	We first use association rules techniques	and secondly apply multiple criteria analysis ( MCA )	22-68	22-68	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	1<2	none	elaboration	elaboration
5405330f85660bb35ec960a144e904c54c4c67a7	49-57	58-68	and secondly apply multiple criteria analysis ( MCA )	to select the most relevant rules according to user preferences .	and secondly apply multiple criteria analysis ( MCA )	to select the most relevant rules according to user preferences .	22-68	22-68	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	We first use association rules techniques to explore the correlations between variables in given data ( i.e. , database and linked data ( LD ) ) , and secondly apply multiple criteria analysis ( MCA ) to select the most relevant rules according to user preferences .	1<2	none	enablement	enablement
5405330f85660bb35ec960a144e904c54c4c67a7	1-10	69-73	In this demo , we introduce an interactive system ,	The developed system is flexible	In this demo , we introduce an interactive system ,	The developed system is flexible	1-21	69-92	In this demo , we introduce an interactive system , which effectively applies multiple criteria analysis to rank association rules .	The developed system is flexible and allows intuitive creation and execution of different algorithms for an extensive range of advanced data analysis topics .	1<2	none	findings	findings
5405330f85660bb35ec960a144e904c54c4c67a7	69-73	74-92	The developed system is flexible	and allows intuitive creation and execution of different algorithms for an extensive range of advanced data analysis topics .	The developed system is flexible	and allows intuitive creation and execution of different algorithms for an extensive range of advanced data analysis topics .	69-92	69-92	The developed system is flexible and allows intuitive creation and execution of different algorithms for an extensive range of advanced data analysis topics .	The developed system is flexible and allows intuitive creation and execution of different algorithms for an extensive range of advanced data analysis topics .	1<2	none	elaboration	elaboration
5405330f85660bb35ec960a144e904c54c4c67a7	69-73	93-110	The developed system is flexible	Furthermore , we demonstrate a case study of association rule mining and ranking on road accident data .	The developed system is flexible	Furthermore , we demonstrate a case study of association rule mining and ranking on road accident data .	69-92	93-110	The developed system is flexible and allows intuitive creation and execution of different algorithms for an extensive range of advanced data analysis topics .	Furthermore , we demonstrate a case study of association rule mining and ranking on road accident data .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	1-9	116-122	Tuberculosis is the deadliest infection of our time .	We describe our twelve - year experience	Tuberculosis is the deadliest infection of our time .	We describe our twelve - year experience	1-9	116-139	Tuberculosis is the deadliest infection of our time .	We describe our twelve - year experience building a TB vaccine trial site in contrast to the process in the recent Ebola outbreak .	1>2	none	background	background
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	1-9	10-23	Tuberculosis is the deadliest infection of our time .	In contrast , about 11,000 people died of Ebola between 2014 and 2016 .	Tuberculosis is the deadliest infection of our time .	In contrast , about 11,000 people died of Ebola between 2014 and 2016 .	1-9	10-23	Tuberculosis is the deadliest infection of our time .	In contrast , about 11,000 people died of Ebola between 2014 and 2016 .	1<2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	24-30	31-35,48-56	Despite this manifest difference in mortality ,	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	Despite this manifest difference in mortality ,	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	24-56	24-56	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	1>2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	1-9	31-35,48-56	Tuberculosis is the deadliest infection of our time .	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	Tuberculosis is the deadliest infection of our time .	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	1-9	24-56	Tuberculosis is the deadliest infection of our time .	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	31-35,48-56	36-47	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	licensed in the United States and by the European Medicines Agency ,	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	licensed in the United States and by the European Medicines Agency ,	24-56	24-56	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	31-35,48-56	57-58,68-72	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	The developments <*> were historic and unprecedented .	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	The developments <*> were historic and unprecedented .	24-56	57-72	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	The developments that led to the trialing of the Ebola vaccine were historic and unprecedented .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	57-58,68-72	59-67	The developments <*> were historic and unprecedented .	that led to the trialing of the Ebola vaccine	The developments <*> were historic and unprecedented .	that led to the trialing of the Ebola vaccine	57-72	57-72	The developments that led to the trialing of the Ebola vaccine were historic and unprecedented .	The developments that led to the trialing of the Ebola vaccine were historic and unprecedented .	1<2	none	cause-result	cause-result
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	31-35,48-56	73-84	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	The single licensed TB vaccine ( BCG ) has limited efficacy .	there is now a vaccine <*> with up to 100 % efficacy against Ebola .	The single licensed TB vaccine ( BCG ) has limited efficacy .	24-56	73-84	Despite this manifest difference in mortality , there is now a vaccine licensed in the United States and by the European Medicines Agency , with up to 100 % efficacy against Ebola .	The single licensed TB vaccine ( BCG ) has limited efficacy .	1<2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	73-84	85-96	The single licensed TB vaccine ( BCG ) has limited efficacy .	There is a dire need for a more efficacious TB vaccine .	The single licensed TB vaccine ( BCG ) has limited efficacy .	There is a dire need for a more efficacious TB vaccine .	73-84	85-96	The single licensed TB vaccine ( BCG ) has limited efficacy .	There is a dire need for a more efficacious TB vaccine .	1<2	none	cause-result	cause-result
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	97-101	102-106	To deploy such vaccines ,	trials are needed in sites	To deploy such vaccines ,	trials are needed in sites	97-115	97-115	To deploy such vaccines , trials are needed in sites that combine high disease incidence and research infrastructure .	To deploy such vaccines , trials are needed in sites that combine high disease incidence and research infrastructure .	1>2	none	enablement	enablement
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	85-96	102-106	There is a dire need for a more efficacious TB vaccine .	trials are needed in sites	There is a dire need for a more efficacious TB vaccine .	trials are needed in sites	85-96	97-115	There is a dire need for a more efficacious TB vaccine .	To deploy such vaccines , trials are needed in sites that combine high disease incidence and research infrastructure .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	102-106	107-115	trials are needed in sites	that combine high disease incidence and research infrastructure .	trials are needed in sites	that combine high disease incidence and research infrastructure .	97-115	97-115	To deploy such vaccines , trials are needed in sites that combine high disease incidence and research infrastructure .	To deploy such vaccines , trials are needed in sites that combine high disease incidence and research infrastructure .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	116-122	123-128	We describe our twelve - year experience	building a TB vaccine trial site	We describe our twelve - year experience	building a TB vaccine trial site	116-139	116-139	We describe our twelve - year experience building a TB vaccine trial site in contrast to the process in the recent Ebola outbreak .	We describe our twelve - year experience building a TB vaccine trial site in contrast to the process in the recent Ebola outbreak .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	123-128	129-139	building a TB vaccine trial site	in contrast to the process in the recent Ebola outbreak .	building a TB vaccine trial site	in contrast to the process in the recent Ebola outbreak .	116-139	116-139	We describe our twelve - year experience building a TB vaccine trial site in contrast to the process in the recent Ebola outbreak .	We describe our twelve - year experience building a TB vaccine trial site in contrast to the process in the recent Ebola outbreak .	1<2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	116-122	140-144	We describe our twelve - year experience	There are additional differences .	We describe our twelve - year experience	There are additional differences .	116-139	140-144	We describe our twelve - year experience building a TB vaccine trial site in contrast to the process in the recent Ebola outbreak .	There are additional differences .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	145-150	151-165	Relative to the Ebola pipeline ,	TB vaccines have fewer trials and a paucity of government and industry led trials .	Relative to the Ebola pipeline ,	TB vaccines have fewer trials and a paucity of government and industry led trials .	145-165	145-165	Relative to the Ebola pipeline , TB vaccines have fewer trials and a paucity of government and industry led trials .	Relative to the Ebola pipeline , TB vaccines have fewer trials and a paucity of government and industry led trials .	1>2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	140-144	151-165	There are additional differences .	TB vaccines have fewer trials and a paucity of government and industry led trials .	There are additional differences .	TB vaccines have fewer trials and a paucity of government and industry led trials .	140-144	145-165	There are additional differences .	Relative to the Ebola pipeline , TB vaccines have fewer trials and a paucity of government and industry led trials .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	166-180	181-194	While pathogens have varying levels of difficulty in the development of new vaccine candidates ,	there yet appears to be greater interest in funding and coordinating Ebola interventions .	While pathogens have varying levels of difficulty in the development of new vaccine candidates ,	there yet appears to be greater interest in funding and coordinating Ebola interventions .	166-194	166-194	While pathogens have varying levels of difficulty in the development of new vaccine candidates , there yet appears to be greater interest in funding and coordinating Ebola interventions .	While pathogens have varying levels of difficulty in the development of new vaccine candidates , there yet appears to be greater interest in funding and coordinating Ebola interventions .	1>2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	151-165	181-194	TB vaccines have fewer trials and a paucity of government and industry led trials .	there yet appears to be greater interest in funding and coordinating Ebola interventions .	TB vaccines have fewer trials and a paucity of government and industry led trials .	there yet appears to be greater interest in funding and coordinating Ebola interventions .	145-165	166-194	Relative to the Ebola pipeline , TB vaccines have fewer trials and a paucity of government and industry led trials .	While pathogens have varying levels of difficulty in the development of new vaccine candidates , there yet appears to be greater interest in funding and coordinating Ebola interventions .	1<2	none	elaboration	elaboration
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	151-165	195-199	TB vaccines have fewer trials and a paucity of government and industry led trials .	TB is a global threat	TB vaccines have fewer trials and a paucity of government and industry led trials .	TB is a global threat	145-165	195-207	Relative to the Ebola pipeline , TB vaccines have fewer trials and a paucity of government and industry led trials .	TB is a global threat that requires similar concerted effort for elimination .	1<2	none	comparison	comparison
55cb2d0edd96f893cd0f5e11ef9b7052841eec3a	195-199	200-207	TB is a global threat	that requires similar concerted effort for elimination .	TB is a global threat	that requires similar concerted effort for elimination .	195-207	195-207	TB is a global threat that requires similar concerted effort for elimination .	TB is a global threat that requires similar concerted effort for elimination .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	1-5,14-24	144-150	The current coronavirus disease pandemic <*> has led to immense strain on healthcare systems and workers .	Here , we describe important prognostic factors	The current coronavirus disease pandemic <*> has led to immense strain on healthcare systems and workers .	Here , we describe important prognostic factors	1-24	144-179	The current coronavirus disease pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to immense strain on healthcare systems and workers .	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	1>2	none	background	background
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	1-5,14-24	6-13	The current coronavirus disease pandemic <*> has led to immense strain on healthcare systems and workers .	caused by severe acute respiratory syndrome coronavirus 2	The current coronavirus disease pandemic <*> has led to immense strain on healthcare systems and workers .	caused by severe acute respiratory syndrome coronavirus 2	1-24	1-24	The current coronavirus disease pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to immense strain on healthcare systems and workers .	The current coronavirus disease pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to immense strain on healthcare systems and workers .	1<2	none	cause-result	cause-result
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	1-5,14-24	25-37	The current coronavirus disease pandemic <*> has led to immense strain on healthcare systems and workers .	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies	The current coronavirus disease pandemic <*> has led to immense strain on healthcare systems and workers .	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies	1-24	25-42	The current coronavirus disease pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to immense strain on healthcare systems and workers .	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies such as ischemic stroke .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	25-37	38-42	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies	such as ischemic stroke .	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies	such as ischemic stroke .	25-42	25-42	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies such as ischemic stroke .	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies such as ischemic stroke .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	38-42	43-76	such as ischemic stroke .	Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19 .	such as ischemic stroke .	Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19 .	25-42	43-76	Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies such as ischemic stroke .	Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19 .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	43-76	77-95	Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19 .	Acute ischemic stroke patients with large vessel occlusions require emergent triage , intensive care , and mechanical thrombectomy .	Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19 .	Acute ischemic stroke patients with large vessel occlusions require emergent triage , intensive care , and mechanical thrombectomy .	43-76	77-95	Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19 .	Acute ischemic stroke patients with large vessel occlusions require emergent triage , intensive care , and mechanical thrombectomy .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	77-95	96-113	Acute ischemic stroke patients with large vessel occlusions require emergent triage , intensive care , and mechanical thrombectomy .	Management of patients with large vessel occlusions ( LVO ) requires special considerations in the current pandemic .	Acute ischemic stroke patients with large vessel occlusions require emergent triage , intensive care , and mechanical thrombectomy .	Management of patients with large vessel occlusions ( LVO ) requires special considerations in the current pandemic .	77-95	96-113	Acute ischemic stroke patients with large vessel occlusions require emergent triage , intensive care , and mechanical thrombectomy .	Management of patients with large vessel occlusions ( LVO ) requires special considerations in the current pandemic .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	96-113	114-133	Management of patients with large vessel occlusions ( LVO ) requires special considerations in the current pandemic .	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers	Management of patients with large vessel occlusions ( LVO ) requires special considerations in the current pandemic .	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers	96-113	114-143	Management of patients with large vessel occlusions ( LVO ) requires special considerations in the current pandemic .	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers when determining eligibility for mechanical thrombectomy ( MT ) .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	114-133	134-143	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers	when determining eligibility for mechanical thrombectomy ( MT ) .	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers	when determining eligibility for mechanical thrombectomy ( MT ) .	114-143	114-143	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers when determining eligibility for mechanical thrombectomy ( MT ) .	Physicians must now account for prognosis of severe COVID-19 , resource utilization , and risk of infection to healthcare workers when determining eligibility for mechanical thrombectomy ( MT ) .	1<2	none	temporal	temporal
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	144-150	151-158	Here , we describe important prognostic factors	including age , laboratory , and imaging findings	Here , we describe important prognostic factors	including age , laboratory , and imaging findings	144-179	144-179	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	144-150	159-163	Here , we describe important prognostic factors	to consider for MT selection	Here , we describe important prognostic factors	to consider for MT selection	144-179	144-179	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	1<2	none	enablement	enablement
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	144-150	164-166	Here , we describe important prognostic factors	and provide suggestions	Here , we describe important prognostic factors	and provide suggestions	144-179	144-179	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	164-166	167-179	and provide suggestions	for taking care of patients with LVO and possible or confirmed COVID-19 .	and provide suggestions	for taking care of patients with LVO and possible or confirmed COVID-19 .	144-179	144-179	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	144-150	180-199	Here , we describe important prognostic factors	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases	Here , we describe important prognostic factors	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases	144-179	180-209	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases where there is clinical equipoise to minimize futile reperfusion .	1<2	none	findings	findings
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	180-199	200-204	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases	where there is clinical equipoise	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases	where there is clinical equipoise	180-209	180-209	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases where there is clinical equipoise to minimize futile reperfusion .	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases where there is clinical equipoise to minimize futile reperfusion .	1<2	none	elaboration	elaboration
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	200-204	205-209	where there is clinical equipoise	to minimize futile reperfusion .	where there is clinical equipoise	to minimize futile reperfusion .	180-209	180-209	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases where there is clinical equipoise to minimize futile reperfusion .	It is recommended to perform MT in patients within the established guidelines , and consider a conservative approach in cases where there is clinical equipoise to minimize futile reperfusion .	1<2	none	enablement	enablement
59f5a1087f771959fc4d01b18ea5bf91bf95bb94	144-150	210-225	Here , we describe important prognostic factors	Lastly , we describe an illustrative case of a patient with ischemic stroke and COVID-19 .	Here , we describe important prognostic factors	Lastly , we describe an illustrative case of a patient with ischemic stroke and COVID-19 .	144-179	210-225	Here , we describe important prognostic factors including age , laboratory , and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19 .	Lastly , we describe an illustrative case of a patient with ischemic stroke and COVID-19 .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	1-20	32-36	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses	We have created a surface	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses	We have created a surface	1-31	32-73	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact .	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	1>2	none	background	background
5c2bd95f80ed7229802a7fd01731a2586702f8b3	1-20	21	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses	triggered	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses	triggered	1-31	1-31	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact .	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	21	22-31	triggered	when biomaterials or therapeutic cells come into blood contact .	triggered	when biomaterials or therapeutic cells come into blood contact .	1-31	1-31	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact .	Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact .	1<2	none	condition	condition
5c2bd95f80ed7229802a7fd01731a2586702f8b3	32-36	37-45	We have created a surface	which is auto - protective to human innate immunity	We have created a surface	which is auto - protective to human innate immunity	32-73	32-73	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	32-36	46-52	We have created a surface	by combining three fundamentally different strategies ,	We have created a surface	by combining three fundamentally different strategies ,	32-73	32-73	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	1<2	none	manner-means	manner-means
5c2bd95f80ed7229802a7fd01731a2586702f8b3	46-52	53-58	by combining three fundamentally different strategies ,	all developed by us previously ,	by combining three fundamentally different strategies ,	all developed by us previously ,	32-73	32-73	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	46-52	59-69	by combining three fundamentally different strategies ,	which have been shown to induce substantial , but incomplete hemocompatibility	by combining three fundamentally different strategies ,	which have been shown to induce substantial , but incomplete hemocompatibility	32-73	32-73	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	59-69	70-73	which have been shown to induce substantial , but incomplete hemocompatibility	when used separately .	which have been shown to induce substantial , but incomplete hemocompatibility	when used separately .	32-73	32-73	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	1<2	none	condition	condition
5c2bd95f80ed7229802a7fd01731a2586702f8b3	32-36	74-91	We have created a surface	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	We have created a surface	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	32-73	74-102	We have created a surface which is auto - protective to human innate immunity by combining three fundamentally different strategies , all developed by us previously , which have been shown to induce substantial , but incomplete hemocompatibility when used separately .	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ; using a PEG linker on both material and cellular surfaces .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	74-91	92-102	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	using a PEG linker on both material and cellular surfaces .	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	using a PEG linker on both material and cellular surfaces .	74-102	74-102	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ; using a PEG linker on both material and cellular surfaces .	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ; using a PEG linker on both material and cellular surfaces .	1<2	none	manner-means	manner-means
5c2bd95f80ed7229802a7fd01731a2586702f8b3	103-109	110-118	When exposed to human whole blood ,	factor H was specifically recruited to the modified surfaces	When exposed to human whole blood ,	factor H was specifically recruited to the modified surfaces	103-123	103-123	When exposed to human whole blood , factor H was specifically recruited to the modified surfaces and inhibited complement attack .	When exposed to human whole blood , factor H was specifically recruited to the modified surfaces and inhibited complement attack .	1>2	none	temporal	temporal
5c2bd95f80ed7229802a7fd01731a2586702f8b3	74-91	110-118	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	factor H was specifically recruited to the modified surfaces	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	factor H was specifically recruited to the modified surfaces	74-102	103-123	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ; using a PEG linker on both material and cellular surfaces .	When exposed to human whole blood , factor H was specifically recruited to the modified surfaces and inhibited complement attack .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	110-118	119-123	factor H was specifically recruited to the modified surfaces	and inhibited complement attack .	factor H was specifically recruited to the modified surfaces	and inhibited complement attack .	103-123	103-123	When exposed to human whole blood , factor H was specifically recruited to the modified surfaces and inhibited complement attack .	When exposed to human whole blood , factor H was specifically recruited to the modified surfaces and inhibited complement attack .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	110-118	124-135	factor H was specifically recruited to the modified surfaces	In addition , activation of platelets and coagulation was efficiently attenuated ,	factor H was specifically recruited to the modified surfaces	In addition , activation of platelets and coagulation was efficiently attenuated ,	103-123	124-139	When exposed to human whole blood , factor H was specifically recruited to the modified surfaces and inhibited complement attack .	In addition , activation of platelets and coagulation was efficiently attenuated , by degrading ADP .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	124-135	136-139	In addition , activation of platelets and coagulation was efficiently attenuated ,	by degrading ADP .	In addition , activation of platelets and coagulation was efficiently attenuated ,	by degrading ADP .	124-139	124-139	In addition , activation of platelets and coagulation was efficiently attenuated , by degrading ADP .	In addition , activation of platelets and coagulation was efficiently attenuated , by degrading ADP .	1<2	none	manner-means	manner-means
5c2bd95f80ed7229802a7fd01731a2586702f8b3	74-91	140-141,150-158	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	Thus , <*> we have created a hybrid surface with the potential	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;	Thus , <*> we have created a hybrid surface with the potential	74-102	140-168	In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ; using a PEG linker on both material and cellular surfaces .	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	1<2	none	elaboration	elaboration
5c2bd95f80ed7229802a7fd01731a2586702f8b3	142-144	150-158	by inhibiting thromboinflammation	we have created a hybrid surface with the potential	by inhibiting thromboinflammation	we have created a hybrid surface with the potential	140-168	140-168	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	1>2	none	manner-means	manner-means
5c2bd95f80ed7229802a7fd01731a2586702f8b3	142-144	145-149	by inhibiting thromboinflammation	using a multicomponent approach ,	by inhibiting thromboinflammation	using a multicomponent approach ,	140-168	140-168	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	1<2	none	manner-means	manner-means
5c2bd95f80ed7229802a7fd01731a2586702f8b3	150-158	159-163	we have created a hybrid surface with the potential	to greatly reduce incompatibility reactions	we have created a hybrid surface with the potential	to greatly reduce incompatibility reactions	140-168	140-168	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	1<2	none	enablement	enablement
5c2bd95f80ed7229802a7fd01731a2586702f8b3	159-163	164-168	to greatly reduce incompatibility reactions	involving biomaterials and transplantation .	to greatly reduce incompatibility reactions	involving biomaterials and transplantation .	140-168	140-168	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	1-10	39-44	The 2019-nCoV outbreak has raised concern of global spread .	Here we present a simple approach	The 2019-nCoV outbreak has raised concern of global spread .	Here we present a simple approach	1-10	39-73	The 2019-nCoV outbreak has raised concern of global spread .	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	1>2	none	background	background
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	11-28	29-38	While person - to - person transmission within the Wuhan district has led to a large outbreak ,	the transmission potential outside of the region remains unclear .	While person - to - person transmission within the Wuhan district has led to a large outbreak ,	the transmission potential outside of the region remains unclear .	11-38	11-38	While person - to - person transmission within the Wuhan district has led to a large outbreak , the transmission potential outside of the region remains unclear .	While person - to - person transmission within the Wuhan district has led to a large outbreak , the transmission potential outside of the region remains unclear .	1>2	none	comparison	comparison
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	1-10	29-38	The 2019-nCoV outbreak has raised concern of global spread .	the transmission potential outside of the region remains unclear .	The 2019-nCoV outbreak has raised concern of global spread .	the transmission potential outside of the region remains unclear .	1-10	11-38	The 2019-nCoV outbreak has raised concern of global spread .	While person - to - person transmission within the Wuhan district has led to a large outbreak , the transmission potential outside of the region remains unclear .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	39-44	45-67	Here we present a simple approach	for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States ,	Here we present a simple approach	for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States ,	39-73	39-73	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	45-67	68-73	for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States ,	which would allow endemic transmission .	for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States ,	which would allow endemic transmission .	39-73	39-73	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	39-44	74-97	Here we present a simple approach	As of February 7 , 2020 , the number of cases in the United states support subcritical transmission , rather than ongoing transmission .	Here we present a simple approach	As of February 7 , 2020 , the number of cases in the United states support subcritical transmission , rather than ongoing transmission .	39-73	74-97	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	As of February 7 , 2020 , the number of cases in the United states support subcritical transmission , rather than ongoing transmission .	1<2	none	background	background
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	74-97	98-103	As of February 7 , 2020 , the number of cases in the United states support subcritical transmission , rather than ongoing transmission .	However , this conclusion can change	As of February 7 , 2020 , the number of cases in the United states support subcritical transmission , rather than ongoing transmission .	However , this conclusion can change	74-97	98-122	As of February 7 , 2020 , the number of cases in the United states support subcritical transmission , rather than ongoing transmission .	However , this conclusion can change if pre - symptomatic cases resulting from human - to - human transmission have not yet been identified .	1<2	none	comparison	comparison
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	98-103	104-108,117-122	However , this conclusion can change	if pre - symptomatic cases <*> have not yet been identified .	However , this conclusion can change	if pre - symptomatic cases <*> have not yet been identified .	98-122	98-122	However , this conclusion can change if pre - symptomatic cases resulting from human - to - human transmission have not yet been identified .	However , this conclusion can change if pre - symptomatic cases resulting from human - to - human transmission have not yet been identified .	1<2	none	condition	condition
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	104-108,117-122	109-116	if pre - symptomatic cases <*> have not yet been identified .	resulting from human - to - human transmission	if pre - symptomatic cases <*> have not yet been identified .	resulting from human - to - human transmission	98-122	98-122	However , this conclusion can change if pre - symptomatic cases resulting from human - to - human transmission have not yet been identified .	However , this conclusion can change if pre - symptomatic cases resulting from human - to - human transmission have not yet been identified .	1<2	none	cause-result	cause-result
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	39-44	123-131	Here we present a simple approach	The 2019-nCoV outbreak is a global health risk ,	Here we present a simple approach	The 2019-nCoV outbreak is a global health risk ,	39-73	123-149	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	1<2	none	background	background
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	123-131	132-137	The 2019-nCoV outbreak is a global health risk ,	especially considering the number of patients	The 2019-nCoV outbreak is a global health risk ,	especially considering the number of patients	123-149	123-149	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	1<2	none	condition	condition
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	132-137	138-141	especially considering the number of patients	who have already died	especially considering the number of patients	who have already died	123-149	123-149	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	138-141	142-149	who have already died	after becoming infected in Wuhan , China .	who have already died	after becoming infected in Wuhan , China .	123-149	123-149	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	The 2019-nCoV outbreak is a global health risk , especially considering the number of patients who have already died after becoming infected in Wuhan , China .	1<2	none	temporal	temporal
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	39-44	150-165	Here we present a simple approach	Many initial characterizations of the virus have focused on the basic reproduction number , R ,	Here we present a simple approach	Many initial characterizations of the virus have focused on the basic reproduction number , R ,	39-73	150-182	Here we present a simple approach for determining whether the upper limit of the confidence interval for the reproduction number exceeds one for transmission in the United States , which would allow endemic transmission .	Many initial characterizations of the virus have focused on the basic reproduction number , R , which reflects the average number of infections that each new infection causes in a susceptible population .	1<2	none	background	background
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	150-165	166-172	Many initial characterizations of the virus have focused on the basic reproduction number , R ,	which reflects the average number of infections	Many initial characterizations of the virus have focused on the basic reproduction number , R ,	which reflects the average number of infections	150-182	150-182	Many initial characterizations of the virus have focused on the basic reproduction number , R , which reflects the average number of infections that each new infection causes in a susceptible population .	Many initial characterizations of the virus have focused on the basic reproduction number , R , which reflects the average number of infections that each new infection causes in a susceptible population .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	166-172	173-182	which reflects the average number of infections	that each new infection causes in a susceptible population .	which reflects the average number of infections	that each new infection causes in a susceptible population .	150-182	150-182	Many initial characterizations of the virus have focused on the basic reproduction number , R , which reflects the average number of infections that each new infection causes in a susceptible population .	Many initial characterizations of the virus have focused on the basic reproduction number , R , which reflects the average number of infections that each new infection causes in a susceptible population .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	183-189	190-193	Whenever R is greater than one ,	epidemic transition becomes possible	Whenever R is greater than one ,	epidemic transition becomes possible	183-211	183-211	Whenever R is greater than one , epidemic transition becomes possible and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	Whenever R is greater than one , epidemic transition becomes possible and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	1>2	none	condition	condition
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	150-165	190-193	Many initial characterizations of the virus have focused on the basic reproduction number , R ,	epidemic transition becomes possible	Many initial characterizations of the virus have focused on the basic reproduction number , R ,	epidemic transition becomes possible	150-182	183-211	Many initial characterizations of the virus have focused on the basic reproduction number , R , which reflects the average number of infections that each new infection causes in a susceptible population .	Whenever R is greater than one , epidemic transition becomes possible and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	1<2	none	elaboration	elaboration
5cfb44ecdfb61b2898b6cf7315b1e810874a9560	190-193	194-211	epidemic transition becomes possible	and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	epidemic transition becomes possible	and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	183-211	183-211	Whenever R is greater than one , epidemic transition becomes possible and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	Whenever R is greater than one , epidemic transition becomes possible and within the Wuhan province , R has been estimated as high as 4.1 1 - 3 .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	1-12	118-130	Feline calicivirus ( FCV ) is a small non - enveloped virus	In this study , we identified fexaramine as a potent inhibitor of FCV	Feline calicivirus ( FCV ) is a small non - enveloped virus	In this study , we identified fexaramine as a potent inhibitor of FCV	1-28	118-173	Feline calicivirus ( FCV ) is a small non - enveloped virus containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	1>2	none	background	background
5e2c1be088e0e4406e9446e7efc610a6a53d2315	1-12	13-28	Feline calicivirus ( FCV ) is a small non - enveloped virus	containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	Feline calicivirus ( FCV ) is a small non - enveloped virus	containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	1-28	1-28	Feline calicivirus ( FCV ) is a small non - enveloped virus containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	Feline calicivirus ( FCV ) is a small non - enveloped virus containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	1-12	29-36	Feline calicivirus ( FCV ) is a small non - enveloped virus	FCV is a highly infectious pathogen of cats	Feline calicivirus ( FCV ) is a small non - enveloped virus	FCV is a highly infectious pathogen of cats	1-28	29-56	Feline calicivirus ( FCV ) is a small non - enveloped virus containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	FCV is a highly infectious pathogen of cats and typically causes moderate , self - limiting acute oral and upper respiratory tract diseases or chronic oral diseases .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	29-36	37-56	FCV is a highly infectious pathogen of cats	and typically causes moderate , self - limiting acute oral and upper respiratory tract diseases or chronic oral diseases .	FCV is a highly infectious pathogen of cats	and typically causes moderate , self - limiting acute oral and upper respiratory tract diseases or chronic oral diseases .	29-56	29-56	FCV is a highly infectious pathogen of cats and typically causes moderate , self - limiting acute oral and upper respiratory tract diseases or chronic oral diseases .	FCV is a highly infectious pathogen of cats and typically causes moderate , self - limiting acute oral and upper respiratory tract diseases or chronic oral diseases .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	29-36	57-73,88-93	FCV is a highly infectious pathogen of cats	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains <*> have been reported in cats .	FCV is a highly infectious pathogen of cats	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains <*> have been reported in cats .	29-56	57-93	FCV is a highly infectious pathogen of cats and typically causes moderate , self - limiting acute oral and upper respiratory tract diseases or chronic oral diseases .	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains causing severe systemic diseases with a high mortality rate of up to 67 % have been reported in cats .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	57-73,88-93	74-87	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains <*> have been reported in cats .	causing severe systemic diseases with a high mortality rate of up to 67 %	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains <*> have been reported in cats .	causing severe systemic diseases with a high mortality rate of up to 67 %	57-93	57-93	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains causing severe systemic diseases with a high mortality rate of up to 67 % have been reported in cats .	In addition , in recent years , virulent , systemic FCV ( vs - FCV ) strains causing severe systemic diseases with a high mortality rate of up to 67 % have been reported in cats .	1<2	none	cause-result	cause-result
5e2c1be088e0e4406e9446e7efc610a6a53d2315	94-100	101-104	Although FCV vaccines are commercially available ,	their efficacy is limited	Although FCV vaccines are commercially available ,	their efficacy is limited	94-117	94-117	Although FCV vaccines are commercially available , their efficacy is limited due to antigenic diversity of FCV strains and short duration of immunity .	Although FCV vaccines are commercially available , their efficacy is limited due to antigenic diversity of FCV strains and short duration of immunity .	1>2	none	comparison	comparison
5e2c1be088e0e4406e9446e7efc610a6a53d2315	1-12	101-104	Feline calicivirus ( FCV ) is a small non - enveloped virus	their efficacy is limited	Feline calicivirus ( FCV ) is a small non - enveloped virus	their efficacy is limited	1-28	94-117	Feline calicivirus ( FCV ) is a small non - enveloped virus containing a single - stranded , positive - sense RNA genome of approximately 7.7 kb .	Although FCV vaccines are commercially available , their efficacy is limited due to antigenic diversity of FCV strains and short duration of immunity .	1<2	none	comparison	comparison
5e2c1be088e0e4406e9446e7efc610a6a53d2315	101-104	105-117	their efficacy is limited	due to antigenic diversity of FCV strains and short duration of immunity .	their efficacy is limited	due to antigenic diversity of FCV strains and short duration of immunity .	94-117	94-117	Although FCV vaccines are commercially available , their efficacy is limited due to antigenic diversity of FCV strains and short duration of immunity .	Although FCV vaccines are commercially available , their efficacy is limited due to antigenic diversity of FCV strains and short duration of immunity .	1<2	none	cause-result	cause-result
5e2c1be088e0e4406e9446e7efc610a6a53d2315	118-130	131-138	In this study , we identified fexaramine as a potent inhibitor of FCV	including vs - FCV strains in cell culture	In this study , we identified fexaramine as a potent inhibitor of FCV	including vs - FCV strains in cell culture	118-173	118-173	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	139-140	141-148	and demonstrated	that fexaramine is a entry blocker for FCV	and demonstrated	that fexaramine is a entry blocker for FCV	118-173	118-173	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	1>2	none	attribution	attribution
5e2c1be088e0e4406e9446e7efc610a6a53d2315	118-130	141-148	In this study , we identified fexaramine as a potent inhibitor of FCV	that fexaramine is a entry blocker for FCV	In this study , we identified fexaramine as a potent inhibitor of FCV	that fexaramine is a entry blocker for FCV	118-173	118-173	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	139-140	149-152	and demonstrated	by using various experiments	and demonstrated	by using various experiments	118-173	118-173	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	1<2	none	manner-means	manner-means
5e2c1be088e0e4406e9446e7efc610a6a53d2315	149-152	153-173	by using various experiments	including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	by using various experiments	including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	118-173	118-173	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	118-130	174-196	In this study , we identified fexaramine as a potent inhibitor of FCV	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) ,	In this study , we identified fexaramine as a potent inhibitor of FCV	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) ,	118-173	174-213	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) , and the importance of this mutation for conferring resistance was confirmed using the reverse genetics system .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	174-196	197-207	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) ,	and the importance of this mutation for conferring resistance was confirmed	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) ,	and the importance of this mutation for conferring resistance was confirmed	174-213	174-213	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) , and the importance of this mutation for conferring resistance was confirmed using the reverse genetics system .	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) , and the importance of this mutation for conferring resistance was confirmed using the reverse genetics system .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	197-207	208-213	and the importance of this mutation for conferring resistance was confirmed	using the reverse genetics system .	and the importance of this mutation for conferring resistance was confirmed	using the reverse genetics system .	174-213	174-213	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) , and the importance of this mutation for conferring resistance was confirmed using the reverse genetics system .	A fexaramine resistant FCV mutant has a single amino acid change in the P2 domain of VP1 ( the major capsid ) , and the importance of this mutation for conferring resistance was confirmed using the reverse genetics system .	1<2	none	manner-means	manner-means
5e2c1be088e0e4406e9446e7efc610a6a53d2315	118-130	214-222	In this study , we identified fexaramine as a potent inhibitor of FCV	A comparative analysis of viral resistance was also performed	In this study , we identified fexaramine as a potent inhibitor of FCV	A comparative analysis of viral resistance was also performed	118-173	214-236	In this study , we identified fexaramine as a potent inhibitor of FCV including vs - FCV strains in cell culture and demonstrated that fexaramine is a entry blocker for FCV by using various experiments including time - of - addition studies , generation of resistant viruses in cell culture and the reverse genetics system .	A comparative analysis of viral resistance was also performed using a peptidyl inhibitor ( NPI52 ) targeting FCV 3C - like protease .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	214-222	223-229	A comparative analysis of viral resistance was also performed	using a peptidyl inhibitor ( NPI52 )	A comparative analysis of viral resistance was also performed	using a peptidyl inhibitor ( NPI52 )	214-236	214-236	A comparative analysis of viral resistance was also performed using a peptidyl inhibitor ( NPI52 ) targeting FCV 3C - like protease .	A comparative analysis of viral resistance was also performed using a peptidyl inhibitor ( NPI52 ) targeting FCV 3C - like protease .	1<2	none	manner-means	manner-means
5e2c1be088e0e4406e9446e7efc610a6a53d2315	223-229	230-236	using a peptidyl inhibitor ( NPI52 )	targeting FCV 3C - like protease .	using a peptidyl inhibitor ( NPI52 )	targeting FCV 3C - like protease .	214-236	214-236	A comparative analysis of viral resistance was also performed using a peptidyl inhibitor ( NPI52 ) targeting FCV 3C - like protease .	A comparative analysis of viral resistance was also performed using a peptidyl inhibitor ( NPI52 ) targeting FCV 3C - like protease .	1<2	none	elaboration	elaboration
5e2c1be088e0e4406e9446e7efc610a6a53d2315	214-222	237-261	A comparative analysis of viral resistance was also performed	Finally , the effects of combination treatment of fexaramine and NPI52 against FCV replication and emergence of resistant viruses were investigated in cell culture .	A comparative analysis of viral resistance was also performed	Finally , the effects of combination treatment of fexaramine and NPI52 against FCV replication and emergence of resistant viruses were investigated in cell culture .	214-236	237-261	A comparative analysis of viral resistance was also performed using a peptidyl inhibitor ( NPI52 ) targeting FCV 3C - like protease .	Finally , the effects of combination treatment of fexaramine and NPI52 against FCV replication and emergence of resistant viruses were investigated in cell culture .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	1-25	84-103	The early detection of SARS - CoV-2 , the causative agent of ( COVID-19 ) is now a critical task for the clinical practitioners .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	The early detection of SARS - CoV-2 , the causative agent of ( COVID-19 ) is now a critical task for the clinical practitioners .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	1-25	84-109	The early detection of SARS - CoV-2 , the causative agent of ( COVID-19 ) is now a critical task for the clinical practitioners .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients using X - ray images .	1>2	none	background	background
6197b0f53a6a883f99c2602a89309b8b2f27da92	1-25	26-43	The early detection of SARS - CoV-2 , the causative agent of ( COVID-19 ) is now a critical task for the clinical practitioners .	The COVID-19 spread is announced as pandemic outbreak between people worldwide by WHO since 11/ March/ 2020 .	The early detection of SARS - CoV-2 , the causative agent of ( COVID-19 ) is now a critical task for the clinical practitioners .	The COVID-19 spread is announced as pandemic outbreak between people worldwide by WHO since 11/ March/ 2020 .	1-25	26-43	The early detection of SARS - CoV-2 , the causative agent of ( COVID-19 ) is now a critical task for the clinical practitioners .	The COVID-19 spread is announced as pandemic outbreak between people worldwide by WHO since 11/ March/ 2020 .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	26-43	44-59	The COVID-19 spread is announced as pandemic outbreak between people worldwide by WHO since 11/ March/ 2020 .	In this consequence , it is top critical priority to become aware of the infected people	The COVID-19 spread is announced as pandemic outbreak between people worldwide by WHO since 11/ March/ 2020 .	In this consequence , it is top critical priority to become aware of the infected people	26-43	44-83	The COVID-19 spread is announced as pandemic outbreak between people worldwide by WHO since 11/ March/ 2020 .	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	44-59	60-66	In this consequence , it is top critical priority to become aware of the infected people	so that prevention procedures can be processed	In this consequence , it is top critical priority to become aware of the infected people	so that prevention procedures can be processed	44-83	44-83	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	1<2	none	enablement	enablement
6197b0f53a6a883f99c2602a89309b8b2f27da92	60-66	67-71	so that prevention procedures can be processed	to minimize the COVID-19 spread	so that prevention procedures can be processed	to minimize the COVID-19 spread	44-83	44-83	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	1<2	none	enablement	enablement
6197b0f53a6a883f99c2602a89309b8b2f27da92	67-71	72-83	to minimize the COVID-19 spread	and to begin early medical health care of those infected persons .	to minimize the COVID-19 spread	and to begin early medical health care of those infected persons .	44-83	44-83	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	In this consequence , it is top critical priority to become aware of the infected people so that prevention procedures can be processed to minimize the COVID-19 spread and to begin early medical health care of those infected persons .	1<2	none	joint	joint
6197b0f53a6a883f99c2602a89309b8b2f27da92	84-103	104-109	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	using X - ray images .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	using X - ray images .	84-109	84-109	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients using X - ray images .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients using X - ray images .	1<2	none	manner-means	manner-means
6197b0f53a6a883f99c2602a89309b8b2f27da92	84-103	110-130	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	The help vector gadget classifies the corona affected X - ray images from others through usage of the deep features .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	The help vector gadget classifies the corona affected X - ray images from others through usage of the deep features .	84-109	110-130	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients using X - ray images .	The help vector gadget classifies the corona affected X - ray images from others through usage of the deep features .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	110-130	131-146	The help vector gadget classifies the corona affected X - ray images from others through usage of the deep features .	The technique is useful for the clinical practitioners for early detection of COVID-19 infected patients .	The help vector gadget classifies the corona affected X - ray images from others through usage of the deep features .	The technique is useful for the clinical practitioners for early detection of COVID-19 infected patients .	110-130	131-146	The help vector gadget classifies the corona affected X - ray images from others through usage of the deep features .	The technique is useful for the clinical practitioners for early detection of COVID-19 infected patients .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	84-103	147-168	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	The suggested system of multi - level thresholding plus SVM presented high accuracy in classification of the infected lung with Covid-19 .	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	The suggested system of multi - level thresholding plus SVM presented high accuracy in classification of the infected lung with Covid-19 .	84-109	147-168	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients using X - ray images .	The suggested system of multi - level thresholding plus SVM presented high accuracy in classification of the infected lung with Covid-19 .	1<2	none	findings	findings
6197b0f53a6a883f99c2602a89309b8b2f27da92	84-103	169-175	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	All images were of the same size	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients	All images were of the same size	84-109	169-186	In this paper , the deep studying based totally methodology is usually recommended for the detection of COVID-19 infected patients using X - ray images .	All images were of the same size and stored in JPEG format with 512 * 512 pixels .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	169-175	176-186	All images were of the same size	and stored in JPEG format with 512 * 512 pixels .	All images were of the same size	and stored in JPEG format with 512 * 512 pixels .	169-186	169-186	All images were of the same size and stored in JPEG format with 512 * 512 pixels .	All images were of the same size and stored in JPEG format with 512 * 512 pixels .	1<2	none	joint	joint
6197b0f53a6a883f99c2602a89309b8b2f27da92	147-168	187-198,204-216	The suggested system of multi - level thresholding plus SVM presented high accuracy in classification of the infected lung with Covid-19 .	The average sensitivity , specificity , and accuracy of the lung classification <*> were 95.76 % , 99.7 % , and 97.48 % , respectively .	The suggested system of multi - level thresholding plus SVM presented high accuracy in classification of the infected lung with Covid-19 .	The average sensitivity , specificity , and accuracy of the lung classification <*> were 95.76 % , 99.7 % , and 97.48 % , respectively .	147-168	187-216	The suggested system of multi - level thresholding plus SVM presented high accuracy in classification of the infected lung with Covid-19 .	The average sensitivity , specificity , and accuracy of the lung classification using the proposed model results were 95.76 % , 99.7 % , and 97.48 % , respectively .	1<2	none	elaboration	elaboration
6197b0f53a6a883f99c2602a89309b8b2f27da92	187-198,204-216	199-203	The average sensitivity , specificity , and accuracy of the lung classification <*> were 95.76 % , 99.7 % , and 97.48 % , respectively .	using the proposed model results	The average sensitivity , specificity , and accuracy of the lung classification <*> were 95.76 % , 99.7 % , and 97.48 % , respectively .	using the proposed model results	187-216	187-216	The average sensitivity , specificity , and accuracy of the lung classification using the proposed model results were 95.76 % , 99.7 % , and 97.48 % , respectively .	The average sensitivity , specificity , and accuracy of the lung classification using the proposed model results were 95.76 % , 99.7 % , and 97.48 % , respectively .	1<2	none	manner-means	manner-means
628c524b306aaaa50ae9b6a7017423445fd97c44	1-2	3-7,17-25	Background :	Anecdotal reports of mood disorder <*> have been in existence since the last century .	Background :	Anecdotal reports of mood disorder <*> have been in existence since the last century .	1-2	3-25	Background :	Anecdotal reports of mood disorder following infection with common respiratory viruses with neurotropic potential have been in existence since the last century .	1>2	none	textual-organization	textual-organization
628c524b306aaaa50ae9b6a7017423445fd97c44	3-7,17-25	44-69	Anecdotal reports of mood disorder <*> have been in existence since the last century .	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Anecdotal reports of mood disorder <*> have been in existence since the last century .	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	3-25	44-69	Anecdotal reports of mood disorder following infection with common respiratory viruses with neurotropic potential have been in existence since the last century .	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	1>2	none	background	background
628c524b306aaaa50ae9b6a7017423445fd97c44	3-7,17-25	8-16	Anecdotal reports of mood disorder <*> have been in existence since the last century .	following infection with common respiratory viruses with neurotropic potential	Anecdotal reports of mood disorder <*> have been in existence since the last century .	following infection with common respiratory viruses with neurotropic potential	3-25	3-25	Anecdotal reports of mood disorder following infection with common respiratory viruses with neurotropic potential have been in existence since the last century .	Anecdotal reports of mood disorder following infection with common respiratory viruses with neurotropic potential have been in existence since the last century .	1<2	none	temporal	temporal
628c524b306aaaa50ae9b6a7017423445fd97c44	3-7,17-25	26-41	Anecdotal reports of mood disorder <*> have been in existence since the last century .	Nevertheless , systematic studies on the association between these viruses and mood disorders are lacking .	Anecdotal reports of mood disorder <*> have been in existence since the last century .	Nevertheless , systematic studies on the association between these viruses and mood disorders are lacking .	3-25	26-41	Anecdotal reports of mood disorder following infection with common respiratory viruses with neurotropic potential have been in existence since the last century .	Nevertheless , systematic studies on the association between these viruses and mood disorders are lacking .	1<2	none	comparison	comparison
628c524b306aaaa50ae9b6a7017423445fd97c44	42-43	44-69	Methods :	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Methods :	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	42-43	44-69	Methods :	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	1>2	none	textual-organization	textual-organization
628c524b306aaaa50ae9b6a7017423445fd97c44	44-69	70-79	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Pearson 's χ² tests and logistic regression models were used	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Pearson's χ² tests and logistic regression models were used	44-69	70-131	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Pearson 's χ² tests and logistic regression models were used to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following : a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	70-79	80-96	Pearson 's χ² tests and logistic regression models were used	to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following :	Pearson's χ² tests and logistic regression models were used	to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following :	70-131	70-131	Pearson 's χ² tests and logistic regression models were used to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following : a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	Pearson 's χ² tests and logistic regression models were used to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following : a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	1<2	none	enablement	enablement
628c524b306aaaa50ae9b6a7017423445fd97c44	80-96	97-131	to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following :	a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following :	a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	70-131	70-131	Pearson 's χ² tests and logistic regression models were used to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following : a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	Pearson 's χ² tests and logistic regression models were used to analyze associations between seropositivity for coronaviruses , influenza A and B viruses and the following : a ) history of recurrent mood disorders b ) having attempted suicide in the past c ) uni - vs . bi - polarity and d ) presence of psychotic symptoms during mood episodes .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	132-133	134-137,144	Results :	Seropositivity for influenza A <*> B	Results :	Seropositivity for influenza A <*> B	132-133	134-175	Results :	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	1>2	none	textual-organization	textual-organization
628c524b306aaaa50ae9b6a7017423445fd97c44	44-69	134-137,144	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Seropositivity for influenza A <*> B	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Seropositivity for influenza A <*> B	44-69	134-175	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	1<2	none	findings	findings
628c524b306aaaa50ae9b6a7017423445fd97c44	134-137,144	138-143	Seropositivity for influenza A <*> B	( p = 0.004 ) ,	Seropositivity for influenza A <*> B	( p = 0.004 ) ,	134-175	134-175	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	144,150-151	145-149	B <*> and coronaviruses	( p b 0.0001 )	B <*> and coronaviruses	( p b 0.0001 )	134-175	134-175	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	150-151,157-175	152-156	and coronaviruses <*> were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	( p b 0.0001 )	and coronaviruses <*> were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	( p b 0.0001 )	134-175	134-175	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	134-137,144	176-188,194-198	Seropositivity for influenza A <*> B	Seropositivity for influenza B was significantly associated with a history of suicide attempt <*> and history of psychotic symptoms	Seropositivity for influenza A <*> B	Seropositivity for influenza B was significantly associated with a history of suicide attempt <*> and history of psychotic symptoms	134-175	176-204	Seropositivity for influenza A ( p = 0.004 ) , B ( p b 0.0001 ) and coronaviruses ( p b 0.0001 ) were associated with history of mood disorders but not with the specific diagnosis of unipolar or bipolar depression .	Seropositivity for influenza B was significantly associated with a history of suicide attempt ( p = 0.001 ) and history of psychotic symptoms ( p = 0.005 ) .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	176-188,194-198	189-193	Seropositivity for influenza B was significantly associated with a history of suicide attempt <*> and history of psychotic symptoms	( p = 0.001 )	Seropositivity for influenza B was significantly associated with a history of suicide attempt <*> and history of psychotic symptoms	( p = 0.001 )	176-204	176-204	Seropositivity for influenza B was significantly associated with a history of suicide attempt ( p = 0.001 ) and history of psychotic symptoms ( p = 0.005 ) .	Seropositivity for influenza B was significantly associated with a history of suicide attempt ( p = 0.001 ) and history of psychotic symptoms ( p = 0.005 ) .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	194-198	199-204	and history of psychotic symptoms	( p = 0.005 ) .	and history of psychotic symptoms	( p = 0.005 ) .	176-204	176-204	Seropositivity for influenza B was significantly associated with a history of suicide attempt ( p = 0.001 ) and history of psychotic symptoms ( p = 0.005 ) .	Seropositivity for influenza B was significantly associated with a history of suicide attempt ( p = 0.001 ) and history of psychotic symptoms ( p = 0.005 ) .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	205-206	207-213	Limitations :	The design was cross - sectional .	Limitations :	The design was cross - sectional .	205-206	207-213	Limitations :	The design was cross - sectional .	1>2	none	textual-organization	textual-organization
628c524b306aaaa50ae9b6a7017423445fd97c44	44-69	207-213	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	The design was cross - sectional .	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	The design was cross - sectional .	44-69	207-213	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	The design was cross - sectional .	1<2	none	findings	findings
628c524b306aaaa50ae9b6a7017423445fd97c44	207-213	214-227	The design was cross - sectional .	Socioeconomic factors , inflammatory markers , and axis II psychopathology were not assessed .	The design was cross - sectional .	Socioeconomic factors , inflammatory markers , and axis II psychopathology were not assessed .	207-213	214-227	The design was cross - sectional .	Socioeconomic factors , inflammatory markers , and axis II psychopathology were not assessed .	1<2	none	elaboration	elaboration
628c524b306aaaa50ae9b6a7017423445fd97c44	228-229	230-257	Conclusions :	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	Conclusions :	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	228-229	230-257	Conclusions :	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	1>2	none	textual-organization	textual-organization
628c524b306aaaa50ae9b6a7017423445fd97c44	44-69	230-257	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	44-69	230-257	Influenza A , B and coronavirus antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls , by SCID .	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	1<2	none	findings	findings
628c524b306aaaa50ae9b6a7017423445fd97c44	230-257	258-287	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	The need for these studies is additionally supported by the high incidence of these viral infections , the high prevalence of mood disorders , and resilience of suicide epidemics .	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	The need for these studies is additionally supported by the high incidence of these viral infections , the high prevalence of mood disorders , and resilience of suicide epidemics .	230-257	258-287	The association of seropositivity for influenza and coronaviruses with a history of mood disorders , and influenza B with suicidal behavior require replication in larger longitudinal samples .	The need for these studies is additionally supported by the high incidence of these viral infections , the high prevalence of mood disorders , and resilience of suicide epidemics .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	1-9,17-21	29-38	The novel coronavirus ' high rate of asymptomatic transmission <*> call for a different approach	We proposed the use of hospitalizations and hospital utilization data	The novel coronavirus' high rate of asymptomatic transmission <*> call for a different approach	We proposed the use of hospitalizations and hospital utilization data	1-28	29-45	The novel coronavirus ' high rate of asymptomatic transmission combined with a lack of testing kits call for a different approach to monitor its spread and severity .	We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity .	1>2	none	background	background
64a850b409d63712791c985be7166bfc378315a3	1-9,17-21	10-16	The novel coronavirus ' high rate of asymptomatic transmission <*> call for a different approach	combined with a lack of testing kits	The novel coronavirus' high rate of asymptomatic transmission <*> call for a different approach	combined with a lack of testing kits	1-28	1-28	The novel coronavirus ' high rate of asymptomatic transmission combined with a lack of testing kits call for a different approach to monitor its spread and severity .	The novel coronavirus ' high rate of asymptomatic transmission combined with a lack of testing kits call for a different approach to monitor its spread and severity .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	17-21	22-28	call for a different approach	to monitor its spread and severity .	call for a different approach	to monitor its spread and severity .	1-28	1-28	The novel coronavirus ' high rate of asymptomatic transmission combined with a lack of testing kits call for a different approach to monitor its spread and severity .	The novel coronavirus ' high rate of asymptomatic transmission combined with a lack of testing kits call for a different approach to monitor its spread and severity .	1<2	none	enablement	enablement
64a850b409d63712791c985be7166bfc378315a3	29-38	39-45	We proposed the use of hospitalizations and hospital utilization data	to monitor the spread and severity .	We proposed the use of hospitalizations and hospital utilization data	to monitor the spread and severity .	29-45	29-45	We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity .	We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity .	1<2	none	enablement	enablement
64a850b409d63712791c985be7166bfc378315a3	29-38	46-64	We proposed the use of hospitalizations and hospital utilization data	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set	We proposed the use of hospitalizations and hospital utilization data	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set	29-45	46-77	We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity .	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set to communicate when a wave of the novel coronavirus may have passed .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	46-64	65-77	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set	to communicate when a wave of the novel coronavirus may have passed .	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set	to communicate when a wave of the novel coronavirus may have passed .	46-77	46-77	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set to communicate when a wave of the novel coronavirus may have passed .	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set to communicate when a wave of the novel coronavirus may have passed .	1<2	none	enablement	enablement
64a850b409d63712791c985be7166bfc378315a3	46-64	78-83	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set	The state of Ohio was chosen	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set	The state of Ohio was chosen	46-77	78-88	A proposed threshold of a declining 7-day moving average over a 14-day period , " 7&14 " was set to communicate when a wave of the novel coronavirus may have passed .	The state of Ohio was chosen to illustrate this threshold .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	78-83	84-88	The state of Ohio was chosen	to illustrate this threshold .	The state of Ohio was chosen	to illustrate this threshold .	78-88	78-88	The state of Ohio was chosen to illustrate this threshold .	The state of Ohio was chosen to illustrate this threshold .	1<2	none	enablement	enablement
64a850b409d63712791c985be7166bfc378315a3	89-93	102-110	While not the ideal solution	the proposed approach is an easy to implement framework	While not the ideal solution	the proposed approach is an easy to implement framework	89-122	89-122	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	1>2	none	comparison	comparison
64a850b409d63712791c985be7166bfc378315a3	89-93	94-101	While not the ideal solution	for monitoring the spread of the epidemic ,	While not the ideal solution	for monitoring the spread of the epidemic ,	89-122	89-122	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	29-38	102-110	We proposed the use of hospitalizations and hospital utilization data	the proposed approach is an easy to implement framework	We proposed the use of hospitalizations and hospital utilization data	the proposed approach is an easy to implement framework	29-45	89-122	We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity .	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	102-110	111-116	the proposed approach is an easy to implement framework	accounting for limitations of the data	the proposed approach is an easy to implement framework	accounting for limitations of the data	89-122	89-122	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	111-116	117-122	accounting for limitations of the data	inherent in the current epidemic .	accounting for limitations of the data	inherent in the current epidemic .	89-122	89-122	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	While not the ideal solution for monitoring the spread of the epidemic , the proposed approach is an easy to implement framework accounting for limitations of the data inherent in the current epidemic .	1<2	none	elaboration	elaboration
64a850b409d63712791c985be7166bfc378315a3	29-38	123-138	We proposed the use of hospitalizations and hospital utilization data	Hospital administrators and policy makers may benefit from incorporating this approach into their decision making .	We proposed the use of hospitalizations and hospital utilization data	Hospital administrators and policy makers may benefit from incorporating this approach into their decision making .	29-45	123-138	We proposed the use of hospitalizations and hospital utilization data to monitor the spread and severity .	Hospital administrators and policy makers may benefit from incorporating this approach into their decision making .	1<2	none	findings	findings
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	1-15	165-170	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	this manuscript critically reviews recent literature	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	this manuscript critically reviews recent literature	1-26	155-181	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic that has been spreading around the world since December 2019 .	Given the immense need for science led innovative solutions , this manuscript critically reviews recent literature to specifically illustrate nano - engineered effective and rapid solutions .	1>2	none	background	background
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	1-15	16-26	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	that has been spreading around the world since December 2019 .	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	that has been spreading around the world since December 2019 .	1-26	1-26	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic that has been spreading around the world since December 2019 .	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic that has been spreading around the world since December 2019 .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	1-15	27-45	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	More than 10 million affected cases and more than half a million deaths have been reported so far ,	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	More than 10 million affected cases and more than half a million deaths have been reported so far ,	1-26	27-55	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic that has been spreading around the world since December 2019 .	More than 10 million affected cases and more than half a million deaths have been reported so far , while no vaccine is yet available as a treatment .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	27-45	46-55	More than 10 million affected cases and more than half a million deaths have been reported so far ,	while no vaccine is yet available as a treatment .	More than 10 million affected cases and more than half a million deaths have been reported so far ,	while no vaccine is yet available as a treatment .	27-55	27-55	More than 10 million affected cases and more than half a million deaths have been reported so far , while no vaccine is yet available as a treatment .	More than 10 million affected cases and more than half a million deaths have been reported so far , while no vaccine is yet available as a treatment .	1<2	none	comparison	comparison
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	56-61	62-64,73-75	Considering the global healthcare urgency ,	several techniques , <*> have been employed	Considering the global healthcare urgency ,	several techniques , <*> have been employed	56-80	56-80	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	1>2	none	cause-result	cause-result
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	1-15	62-64,73-75	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	several techniques , <*> have been employed	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic	several techniques , <*> have been employed	1-26	56-80	Severe acute respiratory syndrome coronavirus 2 ( SARS - CoV-2 ) caused the COVID-19 pandemic that has been spreading around the world since December 2019 .	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	62-64,73-75	65-72	several techniques , <*> have been employed	including whole genome sequencing and computed tomography imaging	several techniques , <*> have been employed	including whole genome sequencing and computed tomography imaging	56-80	56-80	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	73-75	76-80	have been employed	for diagnosing infected people .	have been employed	for diagnosing infected people .	56-80	56-80	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	1<2	none	enablement	enablement
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	62-64,73-75	81-95	several techniques , <*> have been employed	Considerable efforts are also directed at detecting and preventing different modes of community transmission .	several techniques , <*> have been employed	Considerable efforts are also directed at detecting and preventing different modes of community transmission .	56-80	81-95	Considering the global healthcare urgency , several techniques , including whole genome sequencing and computed tomography imaging have been employed for diagnosing infected people .	Considerable efforts are also directed at detecting and preventing different modes of community transmission .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	81-95	96-107	Considerable efforts are also directed at detecting and preventing different modes of community transmission .	Among them is the rapid detection of virus presence on different surfaces	Considerable efforts are also directed at detecting and preventing different modes of community transmission .	Among them is the rapid detection of virus presence on different surfaces	81-95	96-115	Considerable efforts are also directed at detecting and preventing different modes of community transmission .	Among them is the rapid detection of virus presence on different surfaces with which people may come in contact .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	96-107	108-115	Among them is the rapid detection of virus presence on different surfaces	with which people may come in contact .	Among them is the rapid detection of virus presence on different surfaces	with which people may come in contact .	96-115	96-115	Among them is the rapid detection of virus presence on different surfaces with which people may come in contact .	Among them is the rapid detection of virus presence on different surfaces with which people may come in contact .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	96-107	116,124-143	Among them is the rapid detection of virus presence on different surfaces	Detection <*> is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	Among them is the rapid detection of virus presence on different surfaces	Detection <*> is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	96-115	116-143	Among them is the rapid detection of virus presence on different surfaces with which people may come in contact .	Detection based on non - contact optical techniques is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	116,124-143	117-123	Detection <*> is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	based on non - contact optical techniques	Detection <*> is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	based on non - contact optical techniques	116-143	116-143	Detection based on non - contact optical techniques is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	Detection based on non - contact optical techniques is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	1<2	none	manner-means	manner-means
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	116,124-143	144-154	Detection <*> is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	Nanomaterial - based methods are proven suitable for rapid detection .	Detection <*> is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	Nanomaterial - based methods are proven suitable for rapid detection .	116-143	144-154	Detection based on non - contact optical techniques is very helpful in managing the spread of the virus , and to aid in the disinfection of surfaces .	Nanomaterial - based methods are proven suitable for rapid detection .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	155-164	165-170	Given the immense need for science led innovative solutions ,	this manuscript critically reviews recent literature	Given the immense need for science led innovative solutions ,	this manuscript critically reviews recent literature	155-181	155-181	Given the immense need for science led innovative solutions , this manuscript critically reviews recent literature to specifically illustrate nano - engineered effective and rapid solutions .	Given the immense need for science led innovative solutions , this manuscript critically reviews recent literature to specifically illustrate nano - engineered effective and rapid solutions .	1>2	none	condition	condition
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	165-170	171-181	this manuscript critically reviews recent literature	to specifically illustrate nano - engineered effective and rapid solutions .	this manuscript critically reviews recent literature	to specifically illustrate nano - engineered effective and rapid solutions .	155-181	155-181	Given the immense need for science led innovative solutions , this manuscript critically reviews recent literature to specifically illustrate nano - engineered effective and rapid solutions .	Given the immense need for science led innovative solutions , this manuscript critically reviews recent literature to specifically illustrate nano - engineered effective and rapid solutions .	1<2	none	enablement	enablement
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	165-170	182-192	this manuscript critically reviews recent literature	In addition , all the different techniques are critically analyzed ,	this manuscript critically reviews recent literature	In addition , all the different techniques are critically analyzed ,	155-181	182-203	Given the immense need for science led innovative solutions , this manuscript critically reviews recent literature to specifically illustrate nano - engineered effective and rapid solutions .	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	182-192	193-194	In addition , all the different techniques are critically analyzed ,	compared ,	In addition , all the different techniques are critically analyzed ,	compared ,	182-203	182-203	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	1<2	none	joint	joint
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	182-192	195-196	In addition , all the different techniques are critically analyzed ,	and contrasted	In addition , all the different techniques are critically analyzed ,	and contrasted	182-203	182-203	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	1<2	none	joint	joint
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	182-192	197-203	In addition , all the different techniques are critically analyzed ,	to identify the most promising methods .	In addition , all the different techniques are critically analyzed ,	to identify the most promising methods .	182-203	182-203	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	1<2	none	enablement	enablement
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	182-192	204-226,247-250	In addition , all the different techniques are critically analyzed ,	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , <*> are also presented .	In addition , all the different techniques are critically analyzed ,	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , <*> are also presented .	182-203	204-250	In addition , all the different techniques are critically analyzed , compared , and contrasted to identify the most promising methods .	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , to assist fingerprint techniques ( to identify the virus at the contact surface of the gas and solid phase ) are also presented .	1<2	none	elaboration	elaboration
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	204-226,247-250	227-230	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , <*> are also presented .	to assist fingerprint techniques	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , <*> are also presented .	to assist fingerprint techniques	204-250	204-250	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , to assist fingerprint techniques ( to identify the virus at the contact surface of the gas and solid phase ) are also presented .	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , to assist fingerprint techniques ( to identify the virus at the contact surface of the gas and solid phase ) are also presented .	1<2	none	enablement	enablement
6b72cc2cfb96b6ed68bbf031175f2ff18ac80d2c	227-230	231-246	to assist fingerprint techniques	( to identify the virus at the contact surface of the gas and solid phase )	to assist fingerprint techniques	( to identify the virus at the contact surface of the gas and solid phase )	204-250	204-250	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , to assist fingerprint techniques ( to identify the virus at the contact surface of the gas and solid phase ) are also presented .	Moreover , promising research ideas for high accuracy of detection in trace concentrations , via color change and light - sensitive nanostructures , to assist fingerprint techniques ( to identify the virus at the contact surface of the gas and solid phase ) are also presented .	1<2	none	enablement	enablement
6e704c9d3e78ca76678b668e56990e6a02c0e966	1-2	3-14,21-31	We argue	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	We argue	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	1-31	1-31	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	1>2	none	attribution	attribution
6e704c9d3e78ca76678b668e56990e6a02c0e966	3-14,21-31	15-20	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	to contain the corona - pandemic	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	to contain the corona - pandemic	1-31	1-31	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	1<2	none	enablement	enablement
6e704c9d3e78ca76678b668e56990e6a02c0e966	3-14,21-31	32-46	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	We discuss a selection of theoretical and experimental key results of weakest - link games	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	We discuss a selection of theoretical and experimental key results of weakest - link games	1-31	32-58	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	We discuss a selection of theoretical and experimental key results of weakest - link games and interpret them in the light of the corona - pandemic .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	32-46	47-58	We discuss a selection of theoretical and experimental key results of weakest - link games	and interpret them in the light of the corona - pandemic .	We discuss a selection of theoretical and experimental key results of weakest - link games	and interpret them in the light of the corona - pandemic .	32-58	32-58	We discuss a selection of theoretical and experimental key results of weakest - link games and interpret them in the light of the corona - pandemic .	We discuss a selection of theoretical and experimental key results of weakest - link games and interpret them in the light of the corona - pandemic .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	59-62	63-70	First , we highlight	that experimental evidence does not support the assumption	First , we highlight	that experimental evidence does not support the assumption	59-82	59-82	First , we highlight that experimental evidence does not support the assumption that coordination can be trivially solved , even among symmetric players .	First , we highlight that experimental evidence does not support the assumption that coordination can be trivially solved , even among symmetric players .	1>2	none	attribution	attribution
6e704c9d3e78ca76678b668e56990e6a02c0e966	3-14,21-31	63-70	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	that experimental evidence does not support the assumption	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	that experimental evidence does not support the assumption	1-31	59-82	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	First , we highlight that experimental evidence does not support the assumption that coordination can be trivially solved , even among symmetric players .	1<2	none	findings	findings
6e704c9d3e78ca76678b668e56990e6a02c0e966	63-70	71-82	that experimental evidence does not support the assumption	that coordination can be trivially solved , even among symmetric players .	that experimental evidence does not support the assumption	that coordination can be trivially solved , even among symmetric players .	59-82	59-82	First , we highlight that experimental evidence does not support the assumption that coordination can be trivially solved , even among symmetric players .	First , we highlight that experimental evidence does not support the assumption that coordination can be trivially solved , even among symmetric players .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	83-86	87-104	Second , we argue	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	Second , we argue	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	83-111	83-111	Second , we argue that for asymmetric countries the weakest - link game does not only pose a problem of coordination , but also a problem of cooperation .	Second , we argue that for asymmetric countries the weakest - link game does not only pose a problem of coordination , but also a problem of cooperation .	1>2	none	attribution	attribution
6e704c9d3e78ca76678b668e56990e6a02c0e966	63-70	87-104	that experimental evidence does not support the assumption	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	that experimental evidence does not support the assumption	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	59-82	83-111	First , we highlight that experimental evidence does not support the assumption that coordination can be trivially solved , even among symmetric players .	Second , we argue that for asymmetric countries the weakest - link game does not only pose a problem of coordination , but also a problem of cooperation .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	87-104	105-111	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	but also a problem of cooperation .	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	but also a problem of cooperation .	83-111	83-111	Second , we argue that for asymmetric countries the weakest - link game does not only pose a problem of coordination , but also a problem of cooperation .	Second , we argue that for asymmetric countries the weakest - link game does not only pose a problem of coordination , but also a problem of cooperation .	1<2	none	joint	joint
6e704c9d3e78ca76678b668e56990e6a02c0e966	112-115	116-130	Third , we show	how and under which conditions self - enforcing treaties can foster coordination and cooperation .	Third , we show	how and under which conditions self - enforcing treaties can foster coordination and cooperation .	112-130	112-130	Third , we show how and under which conditions self - enforcing treaties can foster coordination and cooperation .	Third , we show how and under which conditions self - enforcing treaties can foster coordination and cooperation .	1>2	none	attribution	attribution
6e704c9d3e78ca76678b668e56990e6a02c0e966	87-104	116-130	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	how and under which conditions self - enforcing treaties can foster coordination and cooperation .	that for asymmetric countries the weakest - link game does not only pose a problem of coordination ,	how and under which conditions self - enforcing treaties can foster coordination and cooperation .	83-111	112-130	Second , we argue that for asymmetric countries the weakest - link game does not only pose a problem of coordination , but also a problem of cooperation .	Third , we show how and under which conditions self - enforcing treaties can foster coordination and cooperation .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	116-130	131-135	how and under which conditions self - enforcing treaties can foster coordination and cooperation .	We account for the possibility	how and under which conditions self - enforcing treaties can foster coordination and cooperation .	We account for the possibility	112-130	131-144	Third , we show how and under which conditions self - enforcing treaties can foster coordination and cooperation .	We account for the possibility that countries make mistakes when choosing their actions .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	131-135	136-139	We account for the possibility	that countries make mistakes	We account for the possibility	that countries make mistakes	131-144	131-144	We account for the possibility that countries make mistakes when choosing their actions .	We account for the possibility that countries make mistakes when choosing their actions .	1<2	none	elaboration	elaboration
6e704c9d3e78ca76678b668e56990e6a02c0e966	136-139	140-144	that countries make mistakes	when choosing their actions .	that countries make mistakes	when choosing their actions .	131-144	131-144	We account for the possibility that countries make mistakes when choosing their actions .	We account for the possibility that countries make mistakes when choosing their actions .	1<2	none	temporal	temporal
6e704c9d3e78ca76678b668e56990e6a02c0e966	145-147	148-154	Our discussion shows	that North - South cooperation is relevant	Our discussion shows	that North - South cooperation is relevant	145-177	145-177	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	1>2	none	attribution	attribution
6e704c9d3e78ca76678b668e56990e6a02c0e966	3-14,21-31	148-154	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	that North - South cooperation is relevant	that the incentive structure of all individual and coordinated measures across countries <*> is that of a weakest - link public good game .	that North - South cooperation is relevant	1-31	145-177	We argue that the incentive structure of all individual and coordinated measures across countries to contain the corona - pandemic is that of a weakest - link public good game .	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	1<2	none	findings	findings
6e704c9d3e78ca76678b668e56990e6a02c0e966	148-154	155-161	that North - South cooperation is relevant	and likely to be self - enforcing	that North - South cooperation is relevant	and likely to be self - enforcing	145-177	145-177	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	1<2	none	joint	joint
6e704c9d3e78ca76678b668e56990e6a02c0e966	148-154	162-166,173-177	that North - South cooperation is relevant	and that regional cooperation , <*> will also be important .	that North - South cooperation is relevant	and that regional cooperation , <*> will also be important .	145-177	145-177	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	1<2	none	joint	joint
6e704c9d3e78ca76678b668e56990e6a02c0e966	162-166,173-177	167-172	and that regional cooperation , <*> will also be important .	e.g. , within the EU ,	and that regional cooperation , <*> will also be important .	e.g. , within the EU ,	145-177	145-177	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	Our discussion shows that North - South cooperation is relevant and likely to be self - enforcing and that regional cooperation , e.g. , within the EU , will also be important .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	1-15	110-117	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic	We report on six Italian patients with COVID-19	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic	We report on six Italian patients with COVID-19	1-32	110-145	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic that has involved Italy as the second worldwide nation in terms of infected patients and deaths .	We report on six Italian patients with COVID-19 who presented sudden hyposmia as the only or most prominent disease manifestation , without upper or lower respiratory tract involvement or other major features of the disease .	1>2	none	background	background
714d9af12264fb74a536d77b974cbd6ad65f44e2	1-15	16-32	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic	that has involved Italy as the second worldwide nation in terms of infected patients and deaths .	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic	that has involved Italy as the second worldwide nation in terms of infected patients and deaths .	1-32	1-32	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic that has involved Italy as the second worldwide nation in terms of infected patients and deaths .	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic that has involved Italy as the second worldwide nation in terms of infected patients and deaths .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	1-15	33-46	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic	The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia .	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic	The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia .	1-32	33-46	Severe Acute Respiratory Syndrome Coronavirus-2 ( SARS - CoV-2 ) has recently caused a pandemic that has involved Italy as the second worldwide nation in terms of infected patients and deaths .	The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	33-46	47-52	The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia .	Asymptomatic individuals in Covid-19 are those	The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia .	Asymptomatic individuals in Covid-19 are those	33-46	47-79	The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia .	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	47-52	53-58	Asymptomatic individuals in Covid-19 are those	who are carriers of the virus	Asymptomatic individuals in Covid-19 are those	who are carriers of the virus	47-79	47-79	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	53-58	59-64	who are carriers of the virus	but do not show clinical symptoms	who are carriers of the virus	but do not show clinical symptoms	47-79	47-79	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	1<2	none	comparison	comparison
714d9af12264fb74a536d77b974cbd6ad65f44e2	53-58	65-79	who are carriers of the virus	and are able to transmit the disease in the same degree as symptomatic carriers .	who are carriers of the virus	and are able to transmit the disease in the same degree as symptomatic carriers .	47-79	47-79	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	1<2	none	joint	joint
714d9af12264fb74a536d77b974cbd6ad65f44e2	80-84	85-92	In order to contain contagions	is of supreme importance to identify asymptomatic patients	In order to contain contagions	is of supreme importance to identify asymptomatic patients	80-109	80-109	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	1>2	none	enablement	enablement
714d9af12264fb74a536d77b974cbd6ad65f44e2	47-52	85-92	Asymptomatic individuals in Covid-19 are those	is of supreme importance to identify asymptomatic patients	Asymptomatic individuals in Covid-19 are those	is of supreme importance to identify asymptomatic patients	47-79	80-109	Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers .	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	85-92	93-101	is of supreme importance to identify asymptomatic patients	because this subpopulation is one of the main factors	is of supreme importance to identify asymptomatic patients	because this subpopulation is one of the main factors	80-109	80-109	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	1<2	none	cause-result	cause-result
714d9af12264fb74a536d77b974cbd6ad65f44e2	93-101	102-109	because this subpopulation is one of the main factors	contributing to the spread of this disease .	because this subpopulation is one of the main factors	contributing to the spread of this disease .	80-109	80-109	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	110-117	118-145	We report on six Italian patients with COVID-19	who presented sudden hyposmia as the only or most prominent disease manifestation , without upper or lower respiratory tract involvement or other major features of the disease .	We report on six Italian patients with COVID-19	who presented sudden hyposmia as the only or most prominent disease manifestation , without upper or lower respiratory tract involvement or other major features of the disease .	110-145	110-145	We report on six Italian patients with COVID-19 who presented sudden hyposmia as the only or most prominent disease manifestation , without upper or lower respiratory tract involvement or other major features of the disease .	We report on six Italian patients with COVID-19 who presented sudden hyposmia as the only or most prominent disease manifestation , without upper or lower respiratory tract involvement or other major features of the disease .	1<2	none	elaboration	elaboration
714d9af12264fb74a536d77b974cbd6ad65f44e2	110-117	146-158	We report on six Italian patients with COVID-19	A supra - threshold olfaction test confirmed the hyposmia in all patients .	We report on six Italian patients with COVID-19	A supra - threshold olfaction test confirmed the hyposmia in all patients .	110-145	146-158	We report on six Italian patients with COVID-19 who presented sudden hyposmia as the only or most prominent disease manifestation , without upper or lower respiratory tract involvement or other major features of the disease .	A supra - threshold olfaction test confirmed the hyposmia in all patients .	1<2	none	findings	findings
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	1-11	101-124	Plant artificial micro - RNAs ( amiRs ) have been engineered	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	Plant artificial micro - RNAs ( amiRs ) have been engineered	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	1-20	101-124	Plant artificial micro - RNAs ( amiRs ) have been engineered to target viral genomes and induce their degradation .	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	1>2	none	background	background
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	1-11	12-15	Plant artificial micro - RNAs ( amiRs ) have been engineered	to target viral genomes	Plant artificial micro - RNAs ( amiRs ) have been engineered	to target viral genomes	1-20	1-20	Plant artificial micro - RNAs ( amiRs ) have been engineered to target viral genomes and induce their degradation .	Plant artificial micro - RNAs ( amiRs ) have been engineered to target viral genomes and induce their degradation .	1<2	none	enablement	enablement
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	12-15	16-20	to target viral genomes	and induce their degradation .	to target viral genomes	and induce their degradation .	1-20	1-20	Plant artificial micro - RNAs ( amiRs ) have been engineered to target viral genomes and induce their degradation .	Plant artificial micro - RNAs ( amiRs ) have been engineered to target viral genomes and induce their degradation .	1<2	none	joint	joint
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	1-11	21-35	Plant artificial micro - RNAs ( amiRs ) have been engineered	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance	Plant artificial micro - RNAs ( amiRs ) have been engineered	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance	1-20	21-40	Plant artificial micro - RNAs ( amiRs ) have been engineered to target viral genomes and induce their degradation .	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance conferred by these amiRs .	1<2	none	comparison	comparison
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	21-35	36-40	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance	conferred by these amiRs .	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance	conferred by these amiRs .	21-40	21-40	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance conferred by these amiRs .	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance conferred by these amiRs .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	21-35	41-48,58-67	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance	It has recently been shown that viral populations <*> may already contain enough genetic variability in the target sequence	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance	It has recently been shown that viral populations <*> may already contain enough genetic variability in the target sequence	21-40	41-77	However , the exceptional evolutionary plasticity of RNA viruses threatens the durability of the resistance conferred by these amiRs .	It has recently been shown that viral populations not experiencing strong selective pressure from an antiviral amiR may already contain enough genetic variability in the target sequence to escape plant resistance in an almost deterministic manner .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	41-48,58-67	49-57	It has recently been shown that viral populations <*> may already contain enough genetic variability in the target sequence	not experiencing strong selective pressure from an antiviral amiR	It has recently been shown that viral populations <*> may already contain enough genetic variability in the target sequence	not experiencing strong selective pressure from an antiviral amiR	41-77	41-77	It has recently been shown that viral populations not experiencing strong selective pressure from an antiviral amiR may already contain enough genetic variability in the target sequence to escape plant resistance in an almost deterministic manner .	It has recently been shown that viral populations not experiencing strong selective pressure from an antiviral amiR may already contain enough genetic variability in the target sequence to escape plant resistance in an almost deterministic manner .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	58-67	68-77	may already contain enough genetic variability in the target sequence	to escape plant resistance in an almost deterministic manner .	may already contain enough genetic variability in the target sequence	to escape plant resistance in an almost deterministic manner .	41-77	41-77	It has recently been shown that viral populations not experiencing strong selective pressure from an antiviral amiR may already contain enough genetic variability in the target sequence to escape plant resistance in an almost deterministic manner .	It has recently been shown that viral populations not experiencing strong selective pressure from an antiviral amiR may already contain enough genetic variability in the target sequence to escape plant resistance in an almost deterministic manner .	1<2	none	enablement	enablement
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	41-48,58-67	78-87,96-100	It has recently been shown that viral populations <*> may already contain enough genetic variability in the target sequence	Furthermore , it has also been shown that viral populations <*> speed up this process .	It has recently been shown that viral populations <*> may already contain enough genetic variability in the target sequence	Furthermore , it has also been shown that viral populations <*> speed up this process .	41-77	78-100	It has recently been shown that viral populations not experiencing strong selective pressure from an antiviral amiR may already contain enough genetic variability in the target sequence to escape plant resistance in an almost deterministic manner .	Furthermore , it has also been shown that viral populations exposed to subinhibitory concentrations of the antiviral amiR speed up this process .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	78-87,96-100	88-95	Furthermore , it has also been shown that viral populations <*> speed up this process .	exposed to subinhibitory concentrations of the antiviral amiR	Furthermore , it has also been shown that viral populations <*> speed up this process .	exposed to subinhibitory concentrations of the antiviral amiR	78-100	78-100	Furthermore , it has also been shown that viral populations exposed to subinhibitory concentrations of the antiviral amiR speed up this process .	Furthermore , it has also been shown that viral populations exposed to subinhibitory concentrations of the antiviral amiR speed up this process .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	101-124	125-154	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time	101-124	125-173	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time before and after the viral population was able of successfully infecting plants fully resistant to the ancestral virus .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	125-154	155-173	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time	before and after the viral population was able of successfully infecting plants fully resistant to the ancestral virus .	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time	before and after the viral population was able of successfully infecting plants fully resistant to the ancestral virus .	125-173	125-173	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time before and after the viral population was able of successfully infecting plants fully resistant to the ancestral virus .	The use of Illumina ultradeep sequencing has allowed us to identify virus sequence variants at frequencies as low as 2 Â 10 À6 and to track their variation in time before and after the viral population was able of successfully infecting plants fully resistant to the ancestral virus .	1<2	none	temporal	temporal
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	174-175	176-190	We found	that every site in the amiR - target sequence of the viral genome presented variation	We found	that every site in the amiR - target sequence of the viral genome presented variation	174-206	174-206	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	1>2	none	attribution	attribution
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	101-124	176-190	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	that every site in the amiR - target sequence of the viral genome presented variation	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	that every site in the amiR - target sequence of the viral genome presented variation	101-124	174-206	In this article , we have characterized the molecular evolutionary dynamics of an amiR target sequence in a viral genome under both conditions .	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	1<2	none	findings	findings
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	176-190	191-194,199-206	that every site in the amiR - target sequence of the viral genome presented variation	and that the variant <*> was sampled among the many coexisting ones .	that every site in the amiR - target sequence of the viral genome presented variation	and that the variant <*> was sampled among the many coexisting ones .	174-206	174-206	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	1<2	none	joint	joint
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	191-194,199-206	195-198	and that the variant <*> was sampled among the many coexisting ones .	that eventually broke resistance	and that the variant <*> was sampled among the many coexisting ones .	that eventually broke resistance	174-206	174-206	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	176-190	207-226	that every site in the amiR - target sequence of the viral genome presented variation	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift ,	that every site in the amiR - target sequence of the viral genome presented variation	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift ,	174-206	207-245	We found that every site in the amiR - target sequence of the viral genome presented variation and that the variant that eventually broke resistance was sampled among the many coexisting ones .	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift , whereas evolution in partially resistant plants originates from more complex dynamics involving mutation , selection , and drift .	1<2	none	elaboration	elaboration
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	207-226	227-237	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift ,	whereas evolution in partially resistant plants originates from more complex dynamics	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift ,	whereas evolution in partially resistant plants originates from more complex dynamics	207-245	207-245	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift , whereas evolution in partially resistant plants originates from more complex dynamics involving mutation , selection , and drift .	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift , whereas evolution in partially resistant plants originates from more complex dynamics involving mutation , selection , and drift .	1<2	none	comparison	comparison
74c27dd895ee9f14d0b9584b8a3551a0600f05e2	227-237	238-245	whereas evolution in partially resistant plants originates from more complex dynamics	involving mutation , selection , and drift .	whereas evolution in partially resistant plants originates from more complex dynamics	involving mutation , selection , and drift .	207-245	207-245	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift , whereas evolution in partially resistant plants originates from more complex dynamics involving mutation , selection , and drift .	In this system , viral evolution in fully susceptible plants results from an equilibrium between mutation and genetic drift , whereas evolution in partially resistant plants originates from more complex dynamics involving mutation , selection , and drift .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	1-16	91-96	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses ,	the recombinant protein was cloned ,	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses ,	the recombinant protein was cloned ,	1-46	76-105	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	1>2	none	background	background
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	1-16	17-24	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses ,	which differ from the other groups of coronaviruses	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses ,	which differ from the other groups of coronaviruses	1-46	1-46	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	17-24	25-40	which differ from the other groups of coronaviruses	in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 )	which differ from the other groups of coronaviruses	in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 )	1-46	1-46	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	25-40	41-46	in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 )	and instead start with nsp2 .	in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 )	and instead start with nsp2 .	1-46	1-46	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	1<2	none	comparison	comparison
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	1-16	47-55	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses ,	IBV nsp2 is one of the first replicase proteins	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses ,	IBV nsp2 is one of the first replicase proteins	1-46	47-66	Avian infectious bronchitis virus ( IBV ) is a member of the group III coronaviruses , which differ from the other groups of coronaviruses in that they do not encode the essential pathogenic factor nonstructural protein 1 ( nsp1 ) and instead start with nsp2 .	IBV nsp2 is one of the first replicase proteins to be translated and processed in the viral life cycle ;	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	47-55	56-66	IBV nsp2 is one of the first replicase proteins	to be translated and processed in the viral life cycle ;	IBV nsp2 is one of the first replicase proteins	to be translated and processed in the viral life cycle ;	47-66	47-66	IBV nsp2 is one of the first replicase proteins to be translated and processed in the viral life cycle ;	IBV nsp2 is one of the first replicase proteins to be translated and processed in the viral life cycle ;	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	47-55	67-75	IBV nsp2 is one of the first replicase proteins	however , it has an entirely unknown function .	IBV nsp2 is one of the first replicase proteins	however , it has an entirely unknown function .	47-66	67-75	IBV nsp2 is one of the first replicase proteins to be translated and processed in the viral life cycle ;	however , it has an entirely unknown function .	1<2	none	comparison	comparison
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	76-90	91-96	In order to better understand the structural details and functional mechanism of IBV nsp2 ,	the recombinant protein was cloned ,	In order to better understand the structural details and functional mechanism of IBV nsp2 ,	the recombinant protein was cloned ,	76-105	76-105	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	1>2	none	enablement	enablement
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	91-96	97-101	the recombinant protein was cloned ,	overexpressed in Escherichia coli ,	the recombinant protein was cloned ,	overexpressed in Escherichia coli ,	76-105	76-105	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	97-101	102	overexpressed in Escherichia coli ,	purified	overexpressed in Escherichia coli ,	purified	76-105	76-105	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	102	103-105	purified	and crystallized .	purified	and crystallized .	76-105	76-105	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	91-96	106-112	the recombinant protein was cloned ,	The crystals diffracted to 2.8 Å resolution	the recombinant protein was cloned ,	The crystals diffracted to 2.8 Å resolution	76-105	106-141	In order to better understand the structural details and functional mechanism of IBV nsp2 , the recombinant protein was cloned , overexpressed in Escherichia coli , purified and crystallized .	The crystals diffracted to 2.8 Å resolution and belonged to space group P2 1 , with unit - cell parameters a = 57.0 , b = 192.3 , c = 105.7 Å , = 90.8 .	1<2	none	findings	findings
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	106-112	113-141	The crystals diffracted to 2.8 Å resolution	and belonged to space group P2 1 , with unit - cell parameters a = 57.0 , b = 192.3 , c = 105.7 Å , = 90.8 .	The crystals diffracted to 2.8 Å resolution	and belonged to space group P2 1 , with unit - cell parameters a = 57.0 , b = 192.3 , c = 105.7 Å , = 90.8 .	106-141	106-141	The crystals diffracted to 2.8 Å resolution and belonged to space group P2 1 , with unit - cell parameters a = 57.0 , b = 192.3 , c = 105.7 Å , = 90.8 .	The crystals diffracted to 2.8 Å resolution and belonged to space group P2 1 , with unit - cell parameters a = 57.0 , b = 192.3 , c = 105.7 Å , = 90.8 .	1<2	none	joint	joint
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	106-112	142-150	The crystals diffracted to 2.8 Å resolution	Two molecules were found in the asymmetric unit ;	The crystals diffracted to 2.8 Å resolution	Two molecules were found in the asymmetric unit ;	106-141	142-150	The crystals diffracted to 2.8 Å resolution and belonged to space group P2 1 , with unit - cell parameters a = 57.0 , b = 192.3 , c = 105.7 Å , = 90.8 .	Two molecules were found in the asymmetric unit ;	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	142-150	151-160	Two molecules were found in the asymmetric unit ;	the Matthews coefficient was 3.9 Å 3 Da À1 ,	Two molecules were found in the asymmetric unit ;	the Matthews coefficient was 3.9 Å 3 Da À1 ,	142-150	151-169	Two molecules were found in the asymmetric unit ;	the Matthews coefficient was 3.9 Å 3 Da À1 , corresponding to a solvent content of 68.2 % .	1<2	none	elaboration	elaboration
762f9b6467251b8e21ad0a838c12a2c6c5ab9a10	151-160	161-169	the Matthews coefficient was 3.9 Å 3 Da À1 ,	corresponding to a solvent content of 68.2 % .	the Matthews coefficient was 3.9 Å 3 Da À1 ,	corresponding to a solvent content of 68.2 % .	151-169	151-169	the Matthews coefficient was 3.9 Å 3 Da À1 , corresponding to a solvent content of 68.2 % .	the Matthews coefficient was 3.9 Å 3 Da À1 , corresponding to a solvent content of 68.2 % .	1<2	none	elaboration	elaboration
79fa8fdc827ebf13a568461671621f811d9af7f5	1-25	26-30	Canine parvovirus ( CPV ) is the number one viral cause of enteritis , morbidity , and mortality in 8-week - old young puppies .	We have developed twin assays	Canine parvovirus ( CPV ) is the number one viral cause of enteritis , morbidity , and mortality in 8-week - old young puppies .	We have developed twin assays	1-25	26-84	Canine parvovirus ( CPV ) is the number one viral cause of enteritis , morbidity , and mortality in 8-week - old young puppies .	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	1>2	none	background	background
79fa8fdc827ebf13a568461671621f811d9af7f5	26-30	31-51	We have developed twin assays	( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody )	We have developed twin assays	( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody )	26-84	26-84	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	1<2	none	elaboration	elaboration
79fa8fdc827ebf13a568461671621f811d9af7f5	26-30	52-68	We have developed twin assays	that are sensitive , specific , cost - effective , generic for all genotypes of CPV ,	We have developed twin assays	that are sensitive , specific , cost - effective , generic for all genotypes of CPV ,	26-84	26-84	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	1<2	none	elaboration	elaboration
79fa8fdc827ebf13a568461671621f811d9af7f5	52-68	69-84	that are sensitive , specific , cost - effective , generic for all genotypes of CPV ,	and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	that are sensitive , specific , cost - effective , generic for all genotypes of CPV ,	and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	26-84	26-84	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	1<2	none	joint	joint
79fa8fdc827ebf13a568461671621f811d9af7f5	26-30	85-104	We have developed twin assays	We found these assays to be useful for routine applications in kennels with large numbers of puppies at risk .	We have developed twin assays	We found these assays to be useful for routine applications in kennels with large numbers of puppies at risk .	26-84	85-104	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	We found these assays to be useful for routine applications in kennels with large numbers of puppies at risk .	1<2	none	findings	findings
79fa8fdc827ebf13a568461671621f811d9af7f5	26-30	105-114	We have developed twin assays	The results of these assays are available in 1 min	We have developed twin assays	The results of these assays are available in 1 min	26-84	105-122	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	The results of these assays are available in 1 min and do not require any special instrumentation .	1<2	none	elaboration	elaboration
79fa8fdc827ebf13a568461671621f811d9af7f5	105-114	115-122	The results of these assays are available in 1 min	and do not require any special instrumentation .	The results of these assays are available in 1 min	and do not require any special instrumentation .	105-122	105-122	The results of these assays are available in 1 min and do not require any special instrumentation .	The results of these assays are available in 1 min and do not require any special instrumentation .	1<2	none	joint	joint
79fa8fdc827ebf13a568461671621f811d9af7f5	26-30	123-143	We have developed twin assays	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans	We have developed twin assays	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans	26-84	123-154	We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans ( influenza virus and severe acute respiratory syndrome coronavirus ) .	1<2	none	findings	findings
79fa8fdc827ebf13a568461671621f811d9af7f5	123-143	144-154	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans	( influenza virus and severe acute respiratory syndrome coronavirus ) .	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans	( influenza virus and severe acute respiratory syndrome coronavirus ) .	123-154	123-154	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans ( influenza virus and severe acute respiratory syndrome coronavirus ) .	SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans ( influenza virus and severe acute respiratory syndrome coronavirus ) .	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	1-2	3-14	Introduction :	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza	Introduction :	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza	1-2	3-23	Introduction :	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza while pregnancy is a rare cause of cardiomyopathy .	1>2	none	textual-organization	textual-organization
7a2057b8b17dac8f41d6e811296470fbca62165e	3-14	81-89,97-101	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	3-23	81-118	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza while pregnancy is a rare cause of cardiomyopathy .	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	1>2	none	background	background
7a2057b8b17dac8f41d6e811296470fbca62165e	3-14	15-23	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza	while pregnancy is a rare cause of cardiomyopathy .	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza	while pregnancy is a rare cause of cardiomyopathy .	3-23	3-23	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza while pregnancy is a rare cause of cardiomyopathy .	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza while pregnancy is a rare cause of cardiomyopathy .	1<2	none	comparison	comparison
7a2057b8b17dac8f41d6e811296470fbca62165e	15-23	24-36	while pregnancy is a rare cause of cardiomyopathy .	Pregnancy was identified as a major risk factor for increased mortality and morbidity	while pregnancy is a rare cause of cardiomyopathy .	Pregnancy was identified as a major risk factor for increased mortality and morbidity	3-23	24-51	Myocarditis is rarely reported as an extra - pulmonary manifestation of influenza while pregnancy is a rare cause of cardiomyopathy .	Pregnancy was identified as a major risk factor for increased mortality and morbidity due to H 1 N 1 influenza in the pandemic of 2009 to 2010 .	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	24-36	37-51	Pregnancy was identified as a major risk factor for increased mortality and morbidity	due to H 1 N 1 influenza in the pandemic of 2009 to 2010 .	Pregnancy was identified as a major risk factor for increased mortality and morbidity	due to H 1 N 1 influenza in the pandemic of 2009 to 2010 .	24-51	24-51	Pregnancy was identified as a major risk factor for increased mortality and morbidity due to H 1 N 1 influenza in the pandemic of 2009 to 2010 .	Pregnancy was identified as a major risk factor for increased mortality and morbidity due to H 1 N 1 influenza in the pandemic of 2009 to 2010 .	1<2	none	cause-result	cause-result
7a2057b8b17dac8f41d6e811296470fbca62165e	24-36	52-67	Pregnancy was identified as a major risk factor for increased mortality and morbidity	However , to the best of our knowledge there are no previous reports in the literature	Pregnancy was identified as a major risk factor for increased mortality and morbidity	However , to the best of our knowledge there are no previous reports in the literature	24-51	52-77	Pregnancy was identified as a major risk factor for increased mortality and morbidity due to H 1 N 1 influenza in the pandemic of 2009 to 2010 .	However , to the best of our knowledge there are no previous reports in the literature linking H 1 N 1 with myocarditis in pregnancy .	1<2	none	comparison	comparison
7a2057b8b17dac8f41d6e811296470fbca62165e	52-67	68-77	However , to the best of our knowledge there are no previous reports in the literature	linking H 1 N 1 with myocarditis in pregnancy .	However , to the best of our knowledge there are no previous reports in the literature	linking H 1 N 1 with myocarditis in pregnancy .	52-77	52-77	However , to the best of our knowledge there are no previous reports in the literature linking H 1 N 1 with myocarditis in pregnancy .	However , to the best of our knowledge there are no previous reports in the literature linking H 1 N 1 with myocarditis in pregnancy .	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	78-80	81-89,97-101	Case presentation :	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	Case presentation :	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	78-80	81-118	Case presentation :	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	1>2	none	textual-organization	textual-organization
7a2057b8b17dac8f41d6e811296470fbca62165e	81-89,97-101	90-96	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	( aged 29 and 30 ) ,	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	( aged 29 and 30 ) ,	81-118	81-118	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	81-89,97-101	102-118	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	81-118	81-118	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	81-89,97-101	119-125	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	Both women developed evidence of myocarditis .	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	Both women developed evidence of myocarditis .	81-118	119-125	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	Both women developed evidence of myocarditis .	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	119-125	126-133	Both women developed evidence of myocarditis .	One woman developed acute respiratory distress syndrome ,	Both women developed evidence of myocarditis .	One woman developed acute respiratory distress syndrome ,	119-125	126-151	Both women developed evidence of myocarditis .	One woman developed acute respiratory distress syndrome , almost reaching the point of requiring extra - corporeal membrane oxygenation , and subsequently developed persistent cardiomyopathy ;	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	126-133	134-145	One woman developed acute respiratory distress syndrome ,	almost reaching the point of requiring extra - corporeal membrane oxygenation ,	One woman developed acute respiratory distress syndrome ,	almost reaching the point of requiring extra - corporeal membrane oxygenation ,	126-151	126-151	One woman developed acute respiratory distress syndrome , almost reaching the point of requiring extra - corporeal membrane oxygenation , and subsequently developed persistent cardiomyopathy ;	One woman developed acute respiratory distress syndrome , almost reaching the point of requiring extra - corporeal membrane oxygenation , and subsequently developed persistent cardiomyopathy ;	1<2	none	cause-result	cause-result
7a2057b8b17dac8f41d6e811296470fbca62165e	126-133	146-151	One woman developed acute respiratory distress syndrome ,	and subsequently developed persistent cardiomyopathy ;	One woman developed acute respiratory distress syndrome ,	and subsequently developed persistent cardiomyopathy ;	126-151	126-151	One woman developed acute respiratory distress syndrome , almost reaching the point of requiring extra - corporeal membrane oxygenation , and subsequently developed persistent cardiomyopathy ;	One woman developed acute respiratory distress syndrome , almost reaching the point of requiring extra - corporeal membrane oxygenation , and subsequently developed persistent cardiomyopathy ;	1<2	none	elaboration	elaboration
7a2057b8b17dac8f41d6e811296470fbca62165e	126-133	152-161	One woman developed acute respiratory distress syndrome ,	the other recovered without any long - term consequence .	One woman developed acute respiratory distress syndrome ,	the other recovered without any long - term consequence .	126-151	152-161	One woman developed acute respiratory distress syndrome , almost reaching the point of requiring extra - corporeal membrane oxygenation , and subsequently developed persistent cardiomyopathy ;	the other recovered without any long - term consequence .	1<2	none	comparison	comparison
7a2057b8b17dac8f41d6e811296470fbca62165e	162-163	200-225	Conclusions :	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	Conclusions :	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	162-163	164-225	Conclusions :	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) , the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	1>2	none	textual-organization	textual-organization
7a2057b8b17dac8f41d6e811296470fbca62165e	164-199	200-225	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) ,	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) ,	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	164-225	164-225	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) , the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) , the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	1>2	none	comparison	comparison
7a2057b8b17dac8f41d6e811296470fbca62165e	81-89,97-101	200-225	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	We report the cases of two pregnant Caucasian women <*> with no preexisting illness ,	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	81-118	164-225	We report the cases of two pregnant Caucasian women ( aged 29 and 30 ) , with no preexisting illness , presenting with respiratory manifestations of H 1 N 1 influenza virus infection in their third trimester .	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) , the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	1<2	none	findings	findings
7a2057b8b17dac8f41d6e811296470fbca62165e	200-225	226-238	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	This highlights the need for health care providers to increase awareness amongst caregivers	the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	This highlights the need for health care providers to increase awareness amongst caregivers	164-225	226-253	While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H 1 N 1 virus or as a result of pregnancy ( in the absence of endomyocardial biopsies ) , the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H 1 N 1 influenza virus in pregnant women .	This highlights the need for health care providers to increase awareness amongst caregivers to target this ' at risk ' group aggressively with vaccination and prompt treatment .	1<2	none	cause-result	cause-result
7a2057b8b17dac8f41d6e811296470fbca62165e	226-238	239-253	This highlights the need for health care providers to increase awareness amongst caregivers	to target this ' at risk ' group aggressively with vaccination and prompt treatment .	This highlights the need for health care providers to increase awareness amongst caregivers	to target this ' at risk ' group aggressively with vaccination and prompt treatment .	226-253	226-253	This highlights the need for health care providers to increase awareness amongst caregivers to target this ' at risk ' group aggressively with vaccination and prompt treatment .	This highlights the need for health care providers to increase awareness amongst caregivers to target this ' at risk ' group aggressively with vaccination and prompt treatment .	1<2	none	enablement	enablement
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	1-8	98-112	SARS - CoV-2 is a new RNA virus	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	SARS - CoV-2 is a new RNA virus	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	1-26	82-112	SARS - CoV-2 is a new RNA virus affecting humans and spreads extensively through world populations since its first outbreak in late December , 2019 .	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	1>2	none	background	background
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	1-8	9-10	SARS - CoV-2 is a new RNA virus	affecting humans	SARS - CoV-2 is a new RNA virus	affecting humans	1-26	1-26	SARS - CoV-2 is a new RNA virus affecting humans and spreads extensively through world populations since its first outbreak in late December , 2019 .	SARS - CoV-2 is a new RNA virus affecting humans and spreads extensively through world populations since its first outbreak in late December , 2019 .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	1-8	11-26	SARS - CoV-2 is a new RNA virus	and spreads extensively through world populations since its first outbreak in late December , 2019 .	SARS - CoV-2 is a new RNA virus	and spreads extensively through world populations since its first outbreak in late December , 2019 .	1-26	1-26	SARS - CoV-2 is a new RNA virus affecting humans and spreads extensively through world populations since its first outbreak in late December , 2019 .	SARS - CoV-2 is a new RNA virus affecting humans and spreads extensively through world populations since its first outbreak in late December , 2019 .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	1-8	27-53	SARS - CoV-2 is a new RNA virus	Whether the transmissibility and pathogenicity of SARS - CoV-2 is actively evolving , and driven by adaptation to the new host and environments is still unknown .	SARS - CoV-2 is a new RNA virus	Whether the transmissibility and pathogenicity of SARS - CoV-2 is actively evolving , and driven by adaptation to the new host and environments is still unknown .	1-26	27-53	SARS - CoV-2 is a new RNA virus affecting humans and spreads extensively through world populations since its first outbreak in late December , 2019 .	Whether the transmissibility and pathogenicity of SARS - CoV-2 is actively evolving , and driven by adaptation to the new host and environments is still unknown .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	27-53	54-57,65-72	Whether the transmissibility and pathogenicity of SARS - CoV-2 is actively evolving , and driven by adaptation to the new host and environments is still unknown .	Understanding the evolutionary mechanism <*> is essential for predicting the epidemic trend ,	Whether the transmissibility and pathogenicity of SARS - CoV-2 is actively evolving , and driven by adaptation to the new host and environments is still unknown .	Understanding the evolutionary mechanism <*> is essential for predicting the epidemic trend ,	27-53	54-81	Whether the transmissibility and pathogenicity of SARS - CoV-2 is actively evolving , and driven by adaptation to the new host and environments is still unknown .	Understanding the evolutionary mechanism underlying epidemiological and pathological characteristics of COVID-19 is essential for predicting the epidemic trend , and providing guidance for disease control and treatments .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	54-57,65-72	58-64	Understanding the evolutionary mechanism <*> is essential for predicting the epidemic trend ,	underlying epidemiological and pathological characteristics of COVID-19	Understanding the evolutionary mechanism <*> is essential for predicting the epidemic trend ,	underlying epidemiological and pathological characteristics of COVID-19	54-81	54-81	Understanding the evolutionary mechanism underlying epidemiological and pathological characteristics of COVID-19 is essential for predicting the epidemic trend , and providing guidance for disease control and treatments .	Understanding the evolutionary mechanism underlying epidemiological and pathological characteristics of COVID-19 is essential for predicting the epidemic trend , and providing guidance for disease control and treatments .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	65-72	73-81	is essential for predicting the epidemic trend ,	and providing guidance for disease control and treatments .	is essential for predicting the epidemic trend ,	and providing guidance for disease control and treatments .	54-81	54-81	Understanding the evolutionary mechanism underlying epidemiological and pathological characteristics of COVID-19 is essential for predicting the epidemic trend , and providing guidance for disease control and treatments .	Understanding the evolutionary mechanism underlying epidemiological and pathological characteristics of COVID-19 is essential for predicting the epidemic trend , and providing guidance for disease control and treatments .	1<2	none	joint	joint
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	82-92	93-97	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries ,	we demonstrate with convincing evidence	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries ,	we demonstrate with convincing evidence	82-112	82-112	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	1>2	none	manner-means	manner-means
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	93-97	98-112	we demonstrate with convincing evidence	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	we demonstrate with convincing evidence	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	82-112	82-112	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	1>2	none	attribution	attribution
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	98-112	113-127	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	( ii ) Ongoing positive selection is actively driving the evolution of specific genes .	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	( ii ) Ongoing positive selection is actively driving the evolution of specific genes .	82-112	113-127	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	( ii ) Ongoing positive selection is actively driving the evolution of specific genes .	1<2	none	joint	joint
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	98-112	128-130,140-143	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	Notably , genes <*> are under adaptive evolution	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	Notably , genes <*> are under adaptive evolution	82-112	128-159	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	128-130,140-143	131-139	Notably , genes <*> are under adaptive evolution	related to coronavirus infection and host immune system defense	Notably , genes <*> are under adaptive evolution	related to coronavirus infection and host immune system defense	128-159	128-159	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	128-130,140-143	144-145,155-159	Notably , genes <*> are under adaptive evolution	while genes <*> are under purifying selection .	Notably , genes <*> are under adaptive evolution	while genes <*> are under purifying selection .	128-159	128-159	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	1<2	none	comparison	comparison
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	144-145,155-159	146-154	while genes <*> are under purifying selection .	related to viral RNA replication , transcription and translation	while genes <*> are under purifying selection .	related to viral RNA replication , transcription and translation	128-159	128-159	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	Notably , genes related to coronavirus infection and host immune system defense are under adaptive evolution while genes related to viral RNA replication , transcription and translation are under purifying selection .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	98-112	160-170	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	A spatial and temporal landscape of 54 critical mutants is constructed	that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	A spatial and temporal landscape of 54 critical mutants is constructed	82-112	160-198	Interrogating 22,078 SARS - CoV-2 genome sequences of 84 countries , we demonstrate with convincing evidence that ( i ) SARS - CoV-2 genomes are overall conserved under purifying selection .	A spatial and temporal landscape of 54 critical mutants is constructed based on their divergence among viral haplotype clusters , of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	1<2	none	elaboration	elaboration
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	160-170	171-179	A spatial and temporal landscape of 54 critical mutants is constructed	based on their divergence among viral haplotype clusters ,	A spatial and temporal landscape of 54 critical mutants is constructed	based on their divergence among viral haplotype clusters ,	160-198	160-198	A spatial and temporal landscape of 54 critical mutants is constructed based on their divergence among viral haplotype clusters , of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	A spatial and temporal landscape of 54 critical mutants is constructed based on their divergence among viral haplotype clusters , of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	1<2	none	manner-means	manner-means
7f4558c4cb1d6fb9bbe9a522ca25924740e76b0a	160-170	180-198	A spatial and temporal landscape of 54 critical mutants is constructed	of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	A spatial and temporal landscape of 54 critical mutants is constructed	of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	160-198	160-198	A spatial and temporal landscape of 54 critical mutants is constructed based on their divergence among viral haplotype clusters , of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	A spatial and temporal landscape of 54 critical mutants is constructed based on their divergence among viral haplotype clusters , of which multiple mutants potentially conferring viral transmissibility , infectivity and virulence of SARS - CoV-2 are highlighted .	1<2	none	elaboration	elaboration
804c9ade797c3eae734ac34ddbaa256b02672668	1-9,13-42	43-47	The current health , political , and environmental crisis <*> and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	We performed spatial correlation analysis	The current health , political , and environmental crisis <*> and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	We performed spatial correlation analysis	1-42	43-72	The current health , political , and environmental crisis ongoing in Brazil and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	1>2	none	background	background
804c9ade797c3eae734ac34ddbaa256b02672668	1-9,13-42	10-12	The current health , political , and environmental crisis <*> and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	ongoing in Brazil	The current health , political , and environmental crisis <*> and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	ongoing in Brazil	1-42	1-42	The current health , political , and environmental crisis ongoing in Brazil and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	The current health , political , and environmental crisis ongoing in Brazil and the advances of the impacts of COVID-19 in traditional populations ( as indigenous and quilombolas ) are not yet prioritized in the scientific production about the novel coronavirus .	1<2	none	elaboration	elaboration
804c9ade797c3eae734ac34ddbaa256b02672668	43-47	48-59	We performed spatial correlation analysis	to map the clusters and outliers of COVID-19 in South of Brazil	We performed spatial correlation analysis	to map the clusters and outliers of COVID-19 in South of Brazil	43-72	43-72	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	1<2	none	enablement	enablement
804c9ade797c3eae734ac34ddbaa256b02672668	48-59	60-65	to map the clusters and outliers of COVID-19 in South of Brazil	to identify indigenous and quilombolas communities	to map the clusters and outliers of COVID-19 in South of Brazil	to identify indigenous and quilombolas communities	43-72	43-72	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	1<2	none	enablement	enablement
804c9ade797c3eae734ac34ddbaa256b02672668	60-65	66-72	to identify indigenous and quilombolas communities	impacted right now in the pandemic .	to identify indigenous and quilombolas communities	impacted right now in the pandemic .	43-72	43-72	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	1<2	none	elaboration	elaboration
804c9ade797c3eae734ac34ddbaa256b02672668	73-74	75-76,86-92	We show	that communities <*> are the most impacted by the COVID-19	We show	that communities <*> are the most impacted by the COVID-19	73-115	73-115	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	1>2	none	attribution	attribution
804c9ade797c3eae734ac34ddbaa256b02672668	43-47	75-76,86-92	We performed spatial correlation analysis	that communities <*> are the most impacted by the COVID-19	We performed spatial correlation analysis	that communities <*> are the most impacted by the COVID-19	43-72	73-115	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	1<2	none	findings	findings
804c9ade797c3eae734ac34ddbaa256b02672668	75-76,86-92	77-85	that communities <*> are the most impacted by the COVID-19	located nearby metropolitan areas and mid - sized cities	that communities <*> are the most impacted by the COVID-19	located nearby metropolitan areas and mid - sized cities	73-115	73-115	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	1<2	none	elaboration	elaboration
804c9ade797c3eae734ac34ddbaa256b02672668	75-76,86-92	93-115	that communities <*> are the most impacted by the COVID-19	and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	that communities <*> are the most impacted by the COVID-19	and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	73-115	73-115	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	We show that communities located nearby metropolitan areas and mid - sized cities are the most impacted by the COVID-19 and the advance of the transmission to inner states may intensify the ongoing historical process of elimination of indigenous and quilombolas people .	1<2	none	elaboration	elaboration
804c9ade797c3eae734ac34ddbaa256b02672668	43-47	116-130	We performed spatial correlation analysis	We call for a global response to the indigenous and quilombolas situation in Brazil ,	We performed spatial correlation analysis	We call for a global response to the indigenous and quilombolas situation in Brazil ,	43-72	116-141	We performed spatial correlation analysis to map the clusters and outliers of COVID-19 in South of Brazil to identify indigenous and quilombolas communities impacted right now in the pandemic .	We call for a global response to the indigenous and quilombolas situation in Brazil , pointing to the need of more analysis in the country ;	1<2	none	findings	findings
804c9ade797c3eae734ac34ddbaa256b02672668	116-130	131-141	We call for a global response to the indigenous and quilombolas situation in Brazil ,	pointing to the need of more analysis in the country ;	We call for a global response to the indigenous and quilombolas situation in Brazil ,	pointing to the need of more analysis in the country ;	116-141	116-141	We call for a global response to the indigenous and quilombolas situation in Brazil , pointing to the need of more analysis in the country ;	We call for a global response to the indigenous and quilombolas situation in Brazil , pointing to the need of more analysis in the country ;	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	1-9	66-72	The COVID-19 pandemic is the most devastating health emergency	Herein , we propose a novel hypothesis	The COVID-19 pandemic is the most devastating health emergency	Herein , we propose a novel hypothesis	1-18	66-95	The COVID-19 pandemic is the most devastating health emergency that humans have seen over the past century .	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	1>2	none	background	background
80bd28c8ba829f2173211a2fad8f98657676e0a6	1-9	10-18	The COVID-19 pandemic is the most devastating health emergency	that humans have seen over the past century .	The COVID-19 pandemic is the most devastating health emergency	that humans have seen over the past century .	1-18	1-18	The COVID-19 pandemic is the most devastating health emergency that humans have seen over the past century .	The COVID-19 pandemic is the most devastating health emergency that humans have seen over the past century .	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	1-9	19-33	The COVID-19 pandemic is the most devastating health emergency	The war against the disease has been handicapped by unavailability of effective therapeutic options .	The COVID-19 pandemic is the most devastating health emergency	The war against the disease has been handicapped by unavailability of effective therapeutic options .	1-18	19-33	The COVID-19 pandemic is the most devastating health emergency that humans have seen over the past century .	The war against the disease has been handicapped by unavailability of effective therapeutic options .	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	19-33	34-50	The war against the disease has been handicapped by unavailability of effective therapeutic options .	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 ,	The war against the disease has been handicapped by unavailability of effective therapeutic options .	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 ,	19-33	34-65	The war against the disease has been handicapped by unavailability of effective therapeutic options .	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 , and the ongoing search to find a novel therapy is progressing at pandemic pace .	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	34-50	51-54,60-65	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 ,	and the ongoing search <*> is progressing at pandemic pace .	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 ,	and the ongoing search <*> is progressing at pandemic pace .	34-65	34-65	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 , and the ongoing search to find a novel therapy is progressing at pandemic pace .	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 , and the ongoing search to find a novel therapy is progressing at pandemic pace .	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	51-54,60-65	55-59	and the ongoing search <*> is progressing at pandemic pace .	to find a novel therapy	and the ongoing search <*> is progressing at pandemic pace .	to find a novel therapy	34-65	34-65	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 , and the ongoing search to find a novel therapy is progressing at pandemic pace .	Till date , there is no clinically approved vaccine or drug for the treatment of COVID-19 , and the ongoing search to find a novel therapy is progressing at pandemic pace .	1<2	none	enablement	enablement
80bd28c8ba829f2173211a2fad8f98657676e0a6	66-72	73-77	Herein , we propose a novel hypothesis	based on sound research evidence	Herein , we propose a novel hypothesis	based on sound research evidence	66-95	66-95	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	1<2	none	cause-result	cause-result
80bd28c8ba829f2173211a2fad8f98657676e0a6	66-72	78-95	Herein , we propose a novel hypothesis	that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	Herein , we propose a novel hypothesis	that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	66-95	66-95	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	96-100	101-102	Based on preclinical evidence ,	we propose	Based on preclinical evidence ,	we propose	96-129	96-129	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1>2	none	cause-result	cause-result
80bd28c8ba829f2173211a2fad8f98657676e0a6	101-102	103-110	we propose	that electric stimulation can improve respiratory functions ,	we propose	that electric stimulation can improve respiratory functions ,	96-129	96-129	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1>2	none	attribution	attribution
80bd28c8ba829f2173211a2fad8f98657676e0a6	66-72	103-110	Herein , we propose a novel hypothesis	that electric stimulation can improve respiratory functions ,	Herein , we propose a novel hypothesis	that electric stimulation can improve respiratory functions ,	66-95	96-129	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1<2	none	elaboration	elaboration
80bd28c8ba829f2173211a2fad8f98657676e0a6	103-110	111-116	that electric stimulation can improve respiratory functions ,	inhibit SARS - CoV-2 growth ,	that electric stimulation can improve respiratory functions ,	inhibit SARS - CoV-2 growth ,	96-129	96-129	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1<2	none	joint	joint
80bd28c8ba829f2173211a2fad8f98657676e0a6	103-110	117-119	that electric stimulation can improve respiratory functions ,	reduce pain ,	that electric stimulation can improve respiratory functions ,	reduce pain ,	96-129	96-129	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1<2	none	joint	joint
80bd28c8ba829f2173211a2fad8f98657676e0a6	103-110	120-121	that electric stimulation can improve respiratory functions ,	boost immunity	that electric stimulation can improve respiratory functions ,	boost immunity	96-129	96-129	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1<2	none	joint	joint
80bd28c8ba829f2173211a2fad8f98657676e0a6	103-110	122-129	that electric stimulation can improve respiratory functions ,	and improve the penetration of antiviral drugs .	that electric stimulation can improve respiratory functions ,	and improve the penetration of antiviral drugs .	96-129	96-129	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	Based on preclinical evidence , we propose that electric stimulation can improve respiratory functions , inhibit SARS - CoV-2 growth , reduce pain , boost immunity and improve the penetration of antiviral drugs .	1<2	none	joint	joint
80bd28c8ba829f2173211a2fad8f98657676e0a6	130-131	132-135,143-153	We envisage	that our hypothesis , <*> may significantly improve the therapeutic outcomes of the current treatment regimen	We envisage	that our hypothesis , <*> may significantly improve the therapeutic outcomes of the current treatment regimen	130-164	130-164	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	1>2	none	attribution	attribution
80bd28c8ba829f2173211a2fad8f98657676e0a6	66-72	132-135,143-153	Herein , we propose a novel hypothesis	that our hypothesis , <*> may significantly improve the therapeutic outcomes of the current treatment regimen	Herein , we propose a novel hypothesis	that our hypothesis , <*> may significantly improve the therapeutic outcomes of the current treatment regimen	66-95	130-164	Herein , we propose a novel hypothesis based on sound research evidence that electric stimulation can be a potential adjuvant to the currently used symptomatic therapies and antiviral drugs .	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	1<2	none	findings	findings
80bd28c8ba829f2173211a2fad8f98657676e0a6	132-135,143-153	136-142	that our hypothesis , <*> may significantly improve the therapeutic outcomes of the current treatment regimen	if used clinically as an adjuvant ,	that our hypothesis , <*> may significantly improve the therapeutic outcomes of the current treatment regimen	if used clinically as an adjuvant ,	130-164	130-164	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	1<2	none	condition	condition
80bd28c8ba829f2173211a2fad8f98657676e0a6	143-153	154-164	may significantly improve the therapeutic outcomes of the current treatment regimen	being used around the globe for the management of COVID-19 .	may significantly improve the therapeutic outcomes of the current treatment regimen	being used around the globe for the management of COVID-19 .	130-164	130-164	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	We envisage that our hypothesis , if used clinically as an adjuvant , may significantly improve the therapeutic outcomes of the current treatment regimen being used around the globe for the management of COVID-19 .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	1-8,18-40	9-17	A central nervous system ( CNS ) disorder <*> was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	characterized by non - suppurative encephalomyelitis with neurological signs	A central nervous system ( CNS ) disorder <*> was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	characterized by non - suppurative encephalomyelitis with neurological signs	1-47	1-47	A central nervous system ( CNS ) disorder characterized by non - suppurative encephalomyelitis with neurological signs was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain isolated from breeding pigs in Japan .	A central nervous system ( CNS ) disorder characterized by non - suppurative encephalomyelitis with neurological signs was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain isolated from breeding pigs in Japan .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	18-40	41-47	was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	isolated from breeding pigs in Japan .	was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	isolated from breeding pigs in Japan .	1-47	1-47	A central nervous system ( CNS ) disorder characterized by non - suppurative encephalomyelitis with neurological signs was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain isolated from breeding pigs in Japan .	A central nervous system ( CNS ) disorder characterized by non - suppurative encephalomyelitis with neurological signs was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain isolated from breeding pigs in Japan .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	1-8,18-40	48,64-74	A central nervous system ( CNS ) disorder <*> was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	A central nervous system ( CNS ) disorder <*> was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	1-47	48-74	A central nervous system ( CNS ) disorder characterized by non - suppurative encephalomyelitis with neurological signs was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain isolated from breeding pigs in Japan .	Lesions consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia were observed in the brainstem , cerebellum and spinal cord .	1<2	none	findings	findings
8872c8e69ad8ba0f3df7454eb8121c712e60011b	48,64-74	49-63	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia	48-74	48-74	Lesions consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia were observed in the brainstem , cerebellum and spinal cord .	Lesions consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia were observed in the brainstem , cerebellum and spinal cord .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	48,64-74	75-92	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	Non - suppurative ganglionitis in the spinal ganglion and neuritis in the spinal root were also observed .	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	Non - suppurative ganglionitis in the spinal ganglion and neuritis in the spinal root were also observed .	48-74	75-92	Lesions consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia were observed in the brainstem , cerebellum and spinal cord .	Non - suppurative ganglionitis in the spinal ganglion and neuritis in the spinal root were also observed .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	93-99	100-101,106-113	Regardless of the route of inoculation ,	all pigs <*> showed a similar distribution of CNS lesions .	Regardless of the route of inoculation ,	all pigs <*> showed a similar distribution of CNS lesions .	93-113	93-113	Regardless of the route of inoculation , all pigs infected experimentally with PTV showed a similar distribution of CNS lesions .	Regardless of the route of inoculation , all pigs infected experimentally with PTV showed a similar distribution of CNS lesions .	1>2	none	comparison	comparison
8872c8e69ad8ba0f3df7454eb8121c712e60011b	48,64-74	100-101,106-113	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	all pigs <*> showed a similar distribution of CNS lesions .	Lesions <*> were observed in the brainstem , cerebellum and spinal cord .	all pigs <*> showed a similar distribution of CNS lesions .	48-74	93-113	Lesions consisting of perivascular cuffing of mononuclear cells , focal gliosis , neuronal necrosis and neuronophagia were observed in the brainstem , cerebellum and spinal cord .	Regardless of the route of inoculation , all pigs infected experimentally with PTV showed a similar distribution of CNS lesions .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	100-101,106-113	102-105	all pigs <*> showed a similar distribution of CNS lesions .	infected experimentally with PTV	all pigs <*> showed a similar distribution of CNS lesions .	infected experimentally with PTV	93-113	93-113	Regardless of the route of inoculation , all pigs infected experimentally with PTV showed a similar distribution of CNS lesions .	Regardless of the route of inoculation , all pigs infected experimentally with PTV showed a similar distribution of CNS lesions .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	100-101,106-113	114-118,128-129	all pigs <*> showed a similar distribution of CNS lesions .	Histological lesions in the CNS <*> were mild	all pigs <*> showed a similar distribution of CNS lesions .	Histological lesions in the CNS <*> were mild	93-113	114-137	Regardless of the route of inoculation , all pigs infected experimentally with PTV showed a similar distribution of CNS lesions .	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	114-118,128-129	119-127	Histological lesions in the CNS <*> were mild	caused by oral or intranasal inoculation of the virus	Histological lesions in the CNS <*> were mild	caused by oral or intranasal inoculation of the virus	114-137	114-137	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	1<2	none	cause-result	cause-result
8872c8e69ad8ba0f3df7454eb8121c712e60011b	128-129	130-132	were mild	compared with those	were mild	compared with those	114-137	114-137	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	1<2	none	comparison	comparison
8872c8e69ad8ba0f3df7454eb8121c712e60011b	130-132	133-137	compared with those	induced by intravenous infection .	compared with those	induced by intravenous infection .	114-137	114-137	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	114-118,128-129	138-153	Histological lesions in the CNS <*> were mild	Immunohistochemically , the distribution of PTV antigens corresponded closely with the distribution of brain lesions .	Histological lesions in the CNS <*> were mild	Immunohistochemically , the distribution of PTV antigens corresponded closely with the distribution of brain lesions .	114-137	138-153	Histological lesions in the CNS caused by oral or intranasal inoculation of the virus were mild compared with those induced by intravenous infection .	Immunohistochemically , the distribution of PTV antigens corresponded closely with the distribution of brain lesions .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	138-153	154-181	Immunohistochemically , the distribution of PTV antigens corresponded closely with the distribution of brain lesions .	PTV particles were detected via electron microscopy in the cytoplasm of nerve cells and the endothelial cells of blood vessels in the spinal cord of inoculated pigs .	Immunohistochemically , the distribution of PTV antigens corresponded closely with the distribution of brain lesions .	PTV particles were detected via electron microscopy in the cytoplasm of nerve cells and the endothelial cells of blood vessels in the spinal cord of inoculated pigs .	138-153	154-181	Immunohistochemically , the distribution of PTV antigens corresponded closely with the distribution of brain lesions .	PTV particles were detected via electron microscopy in the cytoplasm of nerve cells and the endothelial cells of blood vessels in the spinal cord of inoculated pigs .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	154-181	182-207	PTV particles were detected via electron microscopy in the cytoplasm of nerve cells and the endothelial cells of blood vessels in the spinal cord of inoculated pigs .	Polymerase chain reaction analysis demonstrated the presence of PTV RNA in the CNS , tonsils and large intestines of 21 of the 22 pigs inoculated .	PTV particles were detected via electron microscopy in the cytoplasm of nerve cells and the endothelial cells of blood vessels in the spinal cord of inoculated pigs .	Polymerase chain reaction analysis demonstrated the presence of PTV RNA in the CNS , tonsils and large intestines of 21 of the 22 pigs inoculated .	154-181	182-207	PTV particles were detected via electron microscopy in the cytoplasm of nerve cells and the endothelial cells of blood vessels in the spinal cord of inoculated pigs .	Polymerase chain reaction analysis demonstrated the presence of PTV RNA in the CNS , tonsils and large intestines of 21 of the 22 pigs inoculated .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	182-207	208-225	Polymerase chain reaction analysis demonstrated the presence of PTV RNA in the CNS , tonsils and large intestines of 21 of the 22 pigs inoculated .	Direct CNS invasion via the blood vessels appears to be a major route of infection for PTV .	Polymerase chain reaction analysis demonstrated the presence of PTV RNA in the CNS , tonsils and large intestines of 21 of the 22 pigs inoculated .	Direct CNS invasion via the blood vessels appears to be a major route of infection for PTV .	182-207	208-225	Polymerase chain reaction analysis demonstrated the presence of PTV RNA in the CNS , tonsils and large intestines of 21 of the 22 pigs inoculated .	Direct CNS invasion via the blood vessels appears to be a major route of infection for PTV .	1<2	none	elaboration	elaboration
8872c8e69ad8ba0f3df7454eb8121c712e60011b	1-8,18-40	226-239	A central nervous system ( CNS ) disorder <*> was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	The gnotobiotic pig provides a useful model for further study of PTV pathogenesis .	A central nervous system ( CNS ) disorder <*> was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain	The gnotobiotic pig provides a useful model for further study of PTV pathogenesis .	1-47	226-239	A central nervous system ( CNS ) disorder characterized by non - suppurative encephalomyelitis with neurological signs was induced experimentally in gnotobiotic pigs by intravenous and oral or intranasal inoculation of the porcine teschovirus ( PTV ) Toyama 2002 strain isolated from breeding pigs in Japan .	The gnotobiotic pig provides a useful model for further study of PTV pathogenesis .	1<2	none	findings	findings
8d0569b9fe93d0997ca38060117ffc6381122957	1-8	29-34	RNA interference ( RNAi ) is a process	The present study was carried out	RNA interference ( RNAi ) is a process	The present study was carried out	1-28	29-51	RNA interference ( RNAi ) is a process in which double - stranded RNA induces the post - transcriptional sequence - specific degradation of homologous messenger RNA .	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	1>2	none	background	background
8d0569b9fe93d0997ca38060117ffc6381122957	1-8	9-28	RNA interference ( RNAi ) is a process	in which double - stranded RNA induces the post - transcriptional sequence - specific degradation of homologous messenger RNA .	RNA interference ( RNAi ) is a process	in which double - stranded RNA induces the post - transcriptional sequence - specific degradation of homologous messenger RNA .	1-28	1-28	RNA interference ( RNAi ) is a process in which double - stranded RNA induces the post - transcriptional sequence - specific degradation of homologous messenger RNA .	RNA interference ( RNAi ) is a process in which double - stranded RNA induces the post - transcriptional sequence - specific degradation of homologous messenger RNA .	1<2	none	elaboration	elaboration
8d0569b9fe93d0997ca38060117ffc6381122957	29-34	35-39	The present study was carried out	to apply the RNAi technology	The present study was carried out	to apply the RNAi technology	29-51	29-51	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	1<2	none	enablement	enablement
8d0569b9fe93d0997ca38060117ffc6381122957	35-39	40-51	to apply the RNAi technology	to inhibit the replication of feline immunodeficiency virus ( FIV ) .	to apply the RNAi technology	to inhibit the replication of feline immunodeficiency virus ( FIV ) .	29-51	29-51	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	1<2	none	enablement	enablement
8d0569b9fe93d0997ca38060117ffc6381122957	29-34	52-66	The present study was carried out	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	The present study was carried out	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	29-51	52-84	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	1<2	none	elaboration	elaboration
8d0569b9fe93d0997ca38060117ffc6381122957	52-66	67-74	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	and transfected into a feline fibroblastic cell line	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	and transfected into a feline fibroblastic cell line	52-84	52-84	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	1<2	none	elaboration	elaboration
8d0569b9fe93d0997ca38060117ffc6381122957	67-74	75-84	and transfected into a feline fibroblastic cell line	chronically infected with FIV ( CRFK / FIV ) .	and transfected into a feline fibroblastic cell line	chronically infected with FIV ( CRFK / FIV ) .	52-84	52-84	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	1<2	none	elaboration	elaboration
8d0569b9fe93d0997ca38060117ffc6381122957	52-66	85-94	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	These synthetic siRNAs efficiently inhibited the replication of FIV .	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	These synthetic siRNAs efficiently inhibited the replication of FIV .	52-84	85-94	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	These synthetic siRNAs efficiently inhibited the replication of FIV .	1<2	none	findings	findings
8d0569b9fe93d0997ca38060117ffc6381122957	52-66	95-126	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line	52-84	95-134	Four small interfering RNAs ( siRNAs ) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV ( CRFK / FIV ) .	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line chronically infected with FIV ( FL4 ) .	1<2	none	elaboration	elaboration
8d0569b9fe93d0997ca38060117ffc6381122957	95-126	127-134	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line	chronically infected with FIV ( FL4 ) .	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line	chronically infected with FIV ( FL4 ) .	95-134	95-134	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line chronically infected with FIV ( FL4 ) .	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line chronically infected with FIV ( FL4 ) .	1<2	none	elaboration	elaboration
8d0569b9fe93d0997ca38060117ffc6381122957	95-126	135-159	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line	The retroviral vector - mediated transfer of FIV - specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells .	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line	The retroviral vector - mediated transfer of FIV - specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells .	95-134	135-159	Next , we examined the effect of retroviral vector - mediated transfer of FIVspecific short hairpin RNA ( shRNA ) on the replication of FIV in a feline T - cell line chronically infected with FIV ( FL4 ) .	The retroviral vector - mediated transfer of FIV - specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells .	1<2	none	findings	findings
8d0569b9fe93d0997ca38060117ffc6381122957	29-34	160-174	The present study was carried out	These results provide useful information for the development of RNAi - based gene therapy strategy	The present study was carried out	These results provide useful information for the development of RNAi - based gene therapy strategy	29-51	160-179	The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus ( FIV ) .	These results provide useful information for the development of RNAi - based gene therapy strategy to control FIV infection .	1<2	none	findings	findings
8d0569b9fe93d0997ca38060117ffc6381122957	160-174	175-179	These results provide useful information for the development of RNAi - based gene therapy strategy	to control FIV infection .	These results provide useful information for the development of RNAi - based gene therapy strategy	to control FIV infection .	160-179	160-179	These results provide useful information for the development of RNAi - based gene therapy strategy to control FIV infection .	These results provide useful information for the development of RNAi - based gene therapy strategy to control FIV infection .	1<2	none	enablement	enablement
8e0331893b4854ecd4c22be2f4661f1c6e444405	1-17	47-56	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	and in this paper , we propose a new methodology	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	and in this paper , we propose a new methodology	1-17	39-72	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	1>2	none	background	background
8e0331893b4854ecd4c22be2f4661f1c6e444405	1-17	18-24	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	The construction of these networks is difficult	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	The construction of these networks is difficult	1-17	18-38	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	The construction of these networks is difficult and is mostly done with a static approach , neglecting time delayed interdependences .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	18-24	25-33	The construction of these networks is difficult	and is mostly done with a static approach ,	The construction of these networks is difficult	and is mostly done with a static approach ,	18-38	18-38	The construction of these networks is difficult and is mostly done with a static approach , neglecting time delayed interdependences .	The construction of these networks is difficult and is mostly done with a static approach , neglecting time delayed interdependences .	1<2	none	joint	joint
8e0331893b4854ecd4c22be2f4661f1c6e444405	25-33	34-38	and is mostly done with a static approach ,	neglecting time delayed interdependences .	and is mostly done with a static approach ,	neglecting time delayed interdependences .	18-38	18-38	The construction of these networks is difficult and is mostly done with a static approach , neglecting time delayed interdependences .	The construction of these networks is difficult and is mostly done with a static approach , neglecting time delayed interdependences .	1<2	none	cause-result	cause-result
8e0331893b4854ecd4c22be2f4661f1c6e444405	1-17	39-41	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	Tensors are objects	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	Tensors are objects	1-17	39-72	Multilayer networks proved to be suitable in extracting and providing dependency information of different complex systems .	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	39-41	42-46	Tensors are objects	that naturally represent multilayer networks	Tensors are objects	that naturally represent multilayer networks	39-72	39-72	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	47-56	57-61	and in this paper , we propose a new methodology	based on Tucker tensor autoregression	and in this paper , we propose a new methodology	based on Tucker tensor autoregression	39-72	39-72	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	1<2	none	manner-means	manner-means
8e0331893b4854ecd4c22be2f4661f1c6e444405	47-56	62-72	and in this paper , we propose a new methodology	in order to build a multilayer network directly from data .	and in this paper , we propose a new methodology	in order to build a multilayer network directly from data .	39-72	39-72	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	1<2	none	enablement	enablement
8e0331893b4854ecd4c22be2f4661f1c6e444405	47-56	73-81	and in this paper , we propose a new methodology	This methodology captures within and between connections across layers	and in this paper , we propose a new methodology	This methodology captures within and between connections across layers	39-72	73-96	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	73-81	82-88	This methodology captures within and between connections across layers	and makes use of a filtering procedure	This methodology captures within and between connections across layers	and makes use of a filtering procedure	73-96	73-96	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	1<2	none	joint	joint
8e0331893b4854ecd4c22be2f4661f1c6e444405	82-88	89-92	and makes use of a filtering procedure	to extract relevant information	and makes use of a filtering procedure	to extract relevant information	73-96	73-96	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	1<2	none	enablement	enablement
8e0331893b4854ecd4c22be2f4661f1c6e444405	89-92	93-96	to extract relevant information	and improve visualization .	to extract relevant information	and improve visualization .	73-96	73-96	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	This methodology captures within and between connections across layers and makes use of a filtering procedure to extract relevant information and improve visualization .	1<2	none	joint	joint
8e0331893b4854ecd4c22be2f4661f1c6e444405	47-56	97-111	and in this paper , we propose a new methodology	We show the application of this methodology to different stationary fractionally differenced financial data .	and in this paper , we propose a new methodology	We show the application of this methodology to different stationary fractionally differenced financial data .	39-72	97-111	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	We show the application of this methodology to different stationary fractionally differenced financial data .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	112-113	114-130	We argue	that our result is useful to understand the dependencies across three different aspects of financial risk ,	We argue	that our result is useful to understand the dependencies across three different aspects of financial risk ,	112-141	112-141	We argue that our result is useful to understand the dependencies across three different aspects of financial risk , namely market risk , liquidity risk , and volatility risk .	We argue that our result is useful to understand the dependencies across three different aspects of financial risk , namely market risk , liquidity risk , and volatility risk .	1>2	none	attribution	attribution
8e0331893b4854ecd4c22be2f4661f1c6e444405	47-56	114-130	and in this paper , we propose a new methodology	that our result is useful to understand the dependencies across three different aspects of financial risk ,	and in this paper , we propose a new methodology	that our result is useful to understand the dependencies across three different aspects of financial risk ,	39-72	112-141	Tensors are objects that naturally represent multilayer networks and in this paper , we propose a new methodology based on Tucker tensor autoregression in order to build a multilayer network directly from data .	We argue that our result is useful to understand the dependencies across three different aspects of financial risk , namely market risk , liquidity risk , and volatility risk .	1<2	none	findings	findings
8e0331893b4854ecd4c22be2f4661f1c6e444405	114-130	131-141	that our result is useful to understand the dependencies across three different aspects of financial risk ,	namely market risk , liquidity risk , and volatility risk .	that our result is useful to understand the dependencies across three different aspects of financial risk ,	namely market risk , liquidity risk , and volatility risk .	112-141	112-141	We argue that our result is useful to understand the dependencies across three different aspects of financial risk , namely market risk , liquidity risk , and volatility risk .	We argue that our result is useful to understand the dependencies across three different aspects of financial risk , namely market risk , liquidity risk , and volatility risk .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	142-145	146-156	Indeed , we show	how the resulting visualization is a useful tool for risk managers	Indeed , we show	how the resulting visualization is a useful tool for risk managers	142-170	142-170	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	1>2	none	attribution	attribution
8e0331893b4854ecd4c22be2f4661f1c6e444405	114-130	146-156	that our result is useful to understand the dependencies across three different aspects of financial risk ,	how the resulting visualization is a useful tool for risk managers	that our result is useful to understand the dependencies across three different aspects of financial risk ,	how the resulting visualization is a useful tool for risk managers	112-141	142-170	We argue that our result is useful to understand the dependencies across three different aspects of financial risk , namely market risk , liquidity risk , and volatility risk .	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	146-156	157-163	how the resulting visualization is a useful tool for risk managers	depicting dependency asymmetries between different risk factors	how the resulting visualization is a useful tool for risk managers	depicting dependency asymmetries between different risk factors	142-170	142-170	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	157-163	164-170	depicting dependency asymmetries between different risk factors	and accounting for delayed cross dependencies .	depicting dependency asymmetries between different risk factors	and accounting for delayed cross dependencies .	142-170	142-170	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	1<2	none	joint	joint
8e0331893b4854ecd4c22be2f4661f1c6e444405	146-156	171-189	how the resulting visualization is a useful tool for risk managers	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered	how the resulting visualization is a useful tool for risk managers	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered	142-170	171-202	Indeed , we show how the resulting visualization is a useful tool for risk managers depicting dependency asymmetries between different risk factors and accounting for delayed cross dependencies .	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered while a lower number of interconnections between the uncertainty measures is identified .	1<2	none	elaboration	elaboration
8e0331893b4854ecd4c22be2f4661f1c6e444405	171-189	190-202	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered	while a lower number of interconnections between the uncertainty measures is identified .	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered	while a lower number of interconnections between the uncertainty measures is identified .	171-202	171-202	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered while a lower number of interconnections between the uncertainty measures is identified .	The constructed multilayer network shows a strong interconnection between the volumes and prices layers across all the stocks considered while a lower number of interconnections between the uncertainty measures is identified .	1<2	none	comparison	comparison
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	1-6,18-26	80-89	A novel coronavirus ( CoV ) <*> emerged in the Middle East region in 2012 .	that chains of transmission were not self - sustaining ,	A novel coronavirus ( CoV ) <*> emerged in the Middle East region in 2012 .	that chains of transmission were not self - sustaining ,	1-26	65-96	A novel coronavirus ( CoV ) that causes a severe lower respiratory tract infection in humans , emerged in the Middle East region in 2012 .	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	1>2	none	background	background
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	1-6,18-26	7-17	A novel coronavirus ( CoV ) <*> emerged in the Middle East region in 2012 .	that causes a severe lower respiratory tract infection in humans ,	A novel coronavirus ( CoV ) <*> emerged in the Middle East region in 2012 .	that causes a severe lower respiratory tract infection in humans ,	1-26	1-26	A novel coronavirus ( CoV ) that causes a severe lower respiratory tract infection in humans , emerged in the Middle East region in 2012 .	A novel coronavirus ( CoV ) that causes a severe lower respiratory tract infection in humans , emerged in the Middle East region in 2012 .	1<2	none	cause-result	cause-result
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	1-6,18-26	27-29,38-44	A novel coronavirus ( CoV ) <*> emerged in the Middle East region in 2012 .	This virus , <*> is phylogenetically related to bat CoVs ,	A novel coronavirus ( CoV ) <*> emerged in the Middle East region in 2012 .	This virus , <*> is phylogenetically related to bat CoVs ,	1-26	27-64	A novel coronavirus ( CoV ) that causes a severe lower respiratory tract infection in humans , emerged in the Middle East region in 2012 .	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	1<2	none	elaboration	elaboration
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	27-29,38-44	30-37	This virus , <*> is phylogenetically related to bat CoVs ,	named Middle East respiratory syndrome ( MERS)-CoV ,	This virus , <*> is phylogenetically related to bat CoVs ,	named Middle East respiratory syndrome ( MERS)-CoV ,	27-64	27-64	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	1<2	none	elaboration	elaboration
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	38-44	45-57	is phylogenetically related to bat CoVs ,	but other animal species like dromedary camels may potentially act as intermediate hosts	is phylogenetically related to bat CoVs ,	but other animal species like dromedary camels may potentially act as intermediate hosts	27-64	27-64	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	1<2	none	comparison	comparison
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	45-57	58-64	but other animal species like dromedary camels may potentially act as intermediate hosts	by spreading the virus to humans .	but other animal species like dromedary camels may potentially act as intermediate hosts	by spreading the virus to humans .	27-64	27-64	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	This virus , named Middle East respiratory syndrome ( MERS)-CoV , is phylogenetically related to bat CoVs , but other animal species like dromedary camels may potentially act as intermediate hosts by spreading the virus to humans .	1<2	none	manner-means	manner-means
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	65-73	80-89	Although human to human transmission has been demonstrated ,	that chains of transmission were not self - sustaining ,	Although human to human transmission has been demonstrated ,	that chains of transmission were not self - sustaining ,	65-96	65-96	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	1>2	none	comparison	comparison
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	74-79	80-89	analysis of human MERS clusters indicated	that chains of transmission were not self - sustaining ,	analysis of human MERS clusters indicated	that chains of transmission were not self - sustaining ,	65-96	65-96	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	1>2	none	attribution	attribution
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	80-89	90-96	that chains of transmission were not self - sustaining ,	especially when infection control was implemented .	that chains of transmission were not self - sustaining ,	especially when infection control was implemented .	65-96	65-96	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	1<2	none	condition	condition
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	80-89	97-104,128-138	that chains of transmission were not self - sustaining ,	Thus , timely identification of new MERS cases <*> may be crucial in controlling the outbreak of this emerging CoV.	that chains of transmission were not self - sustaining ,	Thus , timely identification of new MERS cases <*> may be crucial in controlling the outbreak of this emerging CoV.	65-96	97-138	Although human to human transmission has been demonstrated , analysis of human MERS clusters indicated that chains of transmission were not self - sustaining , especially when infection control was implemented .	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	1<2	none	cause-result	cause-result
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	97-104,128-138	105-109	Thus , timely identification of new MERS cases <*> may be crucial in controlling the outbreak of this emerging CoV.	followed by their quarantine ,	Thus , timely identification of new MERS cases <*> may be crucial in controlling the outbreak of this emerging CoV.	followed by their quarantine ,	97-138	97-138	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	1<2	none	temporal	temporal
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	97-104,128-138	110-112	Thus , timely identification of new MERS cases <*> may be crucial in controlling the outbreak of this emerging CoV.	combined with measures	Thus , timely identification of new MERS cases <*> may be crucial in controlling the outbreak of this emerging CoV.	combined with measures	97-138	97-138	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	1<2	none	elaboration	elaboration
8ed17fe60158dbfa61e3d0f39f2838d687bd6dd8	110-112	113-127	combined with measures	to limit spread of the virus from the ( intermediate ) host to humans ,	combined with measures	to limit spread of the virus from the ( intermediate ) host to humans ,	97-138	97-138	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	Thus , timely identification of new MERS cases followed by their quarantine , combined with measures to limit spread of the virus from the ( intermediate ) host to humans , may be crucial in controlling the outbreak of this emerging CoV.	1<2	none	enablement	enablement
90662d7dc7b09e018829ae2bc13e167b218931d8	1-2	3-8,17-33	Background :	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	Background :	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	1-2	3-41	Background :	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	1>2	none	textual-organization	textual-organization
90662d7dc7b09e018829ae2bc13e167b218931d8	3-8,17-33	115-134	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	3-41	115-134	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	1>2	none	background	background
90662d7dc7b09e018829ae2bc13e167b218931d8	3-8,17-33	9-16	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	generated as a result of the immune response	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	generated as a result of the immune response	3-41	3-41	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	1<2	none	cause-result	cause-result
90662d7dc7b09e018829ae2bc13e167b218931d8	17-33	34-41	are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	against which the immune response is protective .	are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	against which the immune response is protective .	3-41	3-41	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	3-8,17-33	42-51	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus	Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus	3-41	42-62	Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus that is the most serious pathogenic agent in transplant patients .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	42-51	52-62	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus	that is the most serious pathogenic agent in transplant patients .	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus	that is the most serious pathogenic agent in transplant patients .	42-62	42-62	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus that is the most serious pathogenic agent in transplant patients .	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus that is the most serious pathogenic agent in transplant patients .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	42-51	63-66,75-89	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus	The available therapeutic armamentarium <*> is associated with severe side effects and the emergence of drug - resistant strains ;	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus	The available therapeutic armamentarium <*> is associated with severe side effects and the emergence of drug - resistant strains ;	42-62	63-114	Human cytomegalovirus ( HCMV ) is an ubiquitous opportunistic virus that is the most serious pathogenic agent in transplant patients .	The available therapeutic armamentarium ( e.g. HCMV hyperimmune globulins or antivirals ) is associated with severe side effects and the emergence of drug - resistant strains ; therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	63-66,75-89	67-74	The available therapeutic armamentarium <*> is associated with severe side effects and the emergence of drug - resistant strains ;	( e.g. HCMV hyperimmune globulins or antivirals )	The available therapeutic armamentarium <*> is associated with severe side effects and the emergence of drug - resistant strains ;	( e.g. HCMV hyperimmune globulins or antivirals )	63-114	63-114	The available therapeutic armamentarium ( e.g. HCMV hyperimmune globulins or antivirals ) is associated with severe side effects and the emergence of drug - resistant strains ; therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	The available therapeutic armamentarium ( e.g. HCMV hyperimmune globulins or antivirals ) is associated with severe side effects and the emergence of drug - resistant strains ; therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	63-66,75-89	90-114	The available therapeutic armamentarium <*> is associated with severe side effects and the emergence of drug - resistant strains ;	therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	The available therapeutic armamentarium <*> is associated with severe side effects and the emergence of drug - resistant strains ;	therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	63-114	63-114	The available therapeutic armamentarium ( e.g. HCMV hyperimmune globulins or antivirals ) is associated with severe side effects and the emergence of drug - resistant strains ; therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	The available therapeutic armamentarium ( e.g. HCMV hyperimmune globulins or antivirals ) is associated with severe side effects and the emergence of drug - resistant strains ; therefore , neutralizing human mAb may be a decisive alternative in the prevention of primary and re - activated HCMV infections in these patients .	1<2	none	cause-result	cause-result
90662d7dc7b09e018829ae2bc13e167b218931d8	115-134	135-143	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	To this aim , we designed an efficient technology	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	To this aim , we designed an efficient technology	115-134	135-179	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	1<2	none	manner-means	manner-means
90662d7dc7b09e018829ae2bc13e167b218931d8	135-143	144-151	To this aim , we designed an efficient technology	relying on two discrete and sequential steps :	To this aim , we designed an efficient technology	relying on two discrete and sequential steps :	135-179	135-179	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	135-143	152-164	To this aim , we designed an efficient technology	first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ;	To this aim , we designed an efficient technology	first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ;	135-179	135-179	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	152-164	165-166,173-179	first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ;	second , <*> the cells are infected with EBV .	first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ;	second , <*> the cells are infected with EBV .	135-179	135-179	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	167-172	173-179	after both additives are removed ,	the cells are infected with EBV .	after both additives are removed ,	the cells are infected with EBV .	135-179	135-179	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	1>2	none	temporal	temporal
90662d7dc7b09e018829ae2bc13e167b218931d8	180-182	183-186	Using this strategy	we obtained 29 clones	Using this strategy	we obtained 29 clones	180-200	180-200	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	1>2	none	manner-means	manner-means
90662d7dc7b09e018829ae2bc13e167b218931d8	135-143	183-186	To this aim , we designed an efficient technology	we obtained 29 clones	To this aim , we designed an efficient technology	we obtained 29 clones	135-179	180-200	To this aim , we designed an efficient technology relying on two discrete and sequential steps : first , human B - lymphocytes are stimulated with TLR9-agonists and IL-2 ; second , after both additives are removed , the cells are infected with EBV .	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	1<2	none	cause-result	cause-result
90662d7dc7b09e018829ae2bc13e167b218931d8	183-186	187-188	we obtained 29 clones	secreting IgG	we obtained 29 clones	secreting IgG	180-200	180-200	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	187-188	189-193	secreting IgG	neutralizing the HCMV infectivity ;	secreting IgG	neutralizing the HCMV infectivity ;	180-200	180-200	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	183-186	194-200	we obtained 29 clones	four among these were further characterized .	we obtained 29 clones	four among these were further characterized .	180-200	180-200	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	Using this strategy we obtained 29 clones secreting IgG neutralizing the HCMV infectivity ; four among these were further characterized .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	115-134	201-231	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,	115-134	201-237	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins , currently used in transplant recipients .	1<2	none	findings	findings
90662d7dc7b09e018829ae2bc13e167b218931d8	201-231	232-237	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,	currently used in transplant recipients .	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,	currently used in transplant recipients .	201-237	201-237	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins , currently used in transplant recipients .	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins , currently used in transplant recipients .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	201-231	238-255	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,	Recombinant human monoclonal IgG1 suitable as a prophylactic or therapeutic tool in clinical applications has been generated .	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins ,	Recombinant human monoclonal IgG1 suitable as a prophylactic or therapeutic tool in clinical applications has been generated .	201-237	238-255	All of the mAbs neutralize the infection in different combinations of HCMV strains and target cells , with a potency ~20 fold higher than that of the HCMV hyperimmune globulins , currently used in transplant recipients .	Recombinant human monoclonal IgG1 suitable as a prophylactic or therapeutic tool in clinical applications has been generated .	1<2	none	elaboration	elaboration
90662d7dc7b09e018829ae2bc13e167b218931d8	115-134	256-273	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques ,	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques ,	115-134	256-297	The purpose of this study was to generate neutralizing mAb against HCMV from the immunological repertoire of immune donors .	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques , and can be adopted at low overall costs by any cell biology laboratory for the development of fully human mAbs for immunotherapeutic uses .	1<2	none	findings	findings
90662d7dc7b09e018829ae2bc13e167b218931d8	256-273	274-297	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques ,	and can be adopted at low overall costs by any cell biology laboratory for the development of fully human mAbs for immunotherapeutic uses .	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques ,	and can be adopted at low overall costs by any cell biology laboratory for the development of fully human mAbs for immunotherapeutic uses .	256-297	256-297	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques , and can be adopted at low overall costs by any cell biology laboratory for the development of fully human mAbs for immunotherapeutic uses .	The technology described has proven to be more reproducible , efficient and rapid than previously reported techniques , and can be adopted at low overall costs by any cell biology laboratory for the development of fully human mAbs for immunotherapeutic uses .	1<2	none	joint	joint
909b7a89053c834c12a9d4348e977e66c6116d42	1-13	222-236	Among coronaviruses , several members are able to interact with sialic acids .	that the BCoV group of viruses may have evolved from a TGEV - like ancestor	Among coronaviruses , several members are able to interact with sialic acids .	that the BCoV group of viruses may have evolved from a TGEV - like ancestor	1-13	220-245	Among coronaviruses , several members are able to interact with sialic acids .	We discuss that the BCoV group of viruses may have evolved from a TGEV - like ancestor by acquiring an acetylesterase gene through heterologous recombination .	1>2	none	background	background
909b7a89053c834c12a9d4348e977e66c6116d42	1-13	14-28,35-42	Among coronaviruses , several members are able to interact with sialic acids .	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	Among coronaviruses , several members are able to interact with sialic acids .	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	1-13	14-42	Among coronaviruses , several members are able to interact with sialic acids .	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components containing N -acetyl-9-O - acetylneuraminic acid is essential for initiation of an infection .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	14-28,35-42	29-34	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	containing N -acetyl-9-O - acetylneuraminic acid	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	containing N -acetyl-9-O - acetylneuraminic acid	14-42	14-42	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components containing N -acetyl-9-O - acetylneuraminic acid is essential for initiation of an infection .	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components containing N -acetyl-9-O - acetylneuraminic acid is essential for initiation of an infection .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	14-28,35-42	43-48	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	These viruses resemble influenza C viruses	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	These viruses resemble influenza C viruses	14-42	43-90	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components containing N -acetyl-9-O - acetylneuraminic acid is essential for initiation of an infection .	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	43-48	49-57	These viruses resemble influenza C viruses	because they share not only the receptor determinant ,	These viruses resemble influenza C viruses	because they share not only the receptor determinant ,	43-90	43-90	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	1<2	none	cause-result	cause-result
909b7a89053c834c12a9d4348e977e66c6116d42	49-57	58-64	because they share not only the receptor determinant ,	but also the presence of an acetylesterase	because they share not only the receptor determinant ,	but also the presence of an acetylesterase	43-90	43-90	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	1<2	none	joint	joint
909b7a89053c834c12a9d4348e977e66c6116d42	58-64	65-74	but also the presence of an acetylesterase	that releases the 9-O - acetyl group from sialic acid	but also the presence of an acetylesterase	that releases the 9-O - acetyl group from sialic acid	43-90	43-90	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	65-74	75-90	that releases the 9-O - acetyl group from sialic acid	and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	that releases the 9-O - acetyl group from sialic acid	and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	43-90	43-90	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	1<2	none	cause-result	cause-result
909b7a89053c834c12a9d4348e977e66c6116d42	75-90	91-114	and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection	and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection	43-90	91-133	These viruses resemble influenza C viruses because they share not only the receptor determinant , but also the presence of an acetylesterase that releases the 9-O - acetyl group from sialic acid and thus abolishes the ability of the respective sialoglycoconjugate to function as a receptor for BCoV.	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection by removing receptor determinants from the surface of infected cells and by preventing the formation of virus aggregates .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	91-114	115-124	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection	by removing receptor determinants from the surface of infected cells	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection	by removing receptor determinants from the surface of infected cells	91-133	91-133	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection by removing receptor determinants from the surface of infected cells and by preventing the formation of virus aggregates .	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection by removing receptor determinants from the surface of infected cells and by preventing the formation of virus aggregates .	1<2	none	manner-means	manner-means
909b7a89053c834c12a9d4348e977e66c6116d42	115-124	125-133	by removing receptor determinants from the surface of infected cells	and by preventing the formation of virus aggregates .	by removing receptor determinants from the surface of infected cells	and by preventing the formation of virus aggregates .	91-133	91-133	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection by removing receptor determinants from the surface of infected cells and by preventing the formation of virus aggregates .	As in the case of influenza viruses , the receptor - destroying enzyme of BCoV is believed to facilitate the spread of virus infection by removing receptor determinants from the surface of infected cells and by preventing the formation of virus aggregates .	1<2	none	joint	joint
909b7a89053c834c12a9d4348e977e66c6116d42	14-28,35-42	134-149	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	Another coronavirus , porcine transmissible gastroenteritis virus ( TGEV ) preferentially recognizes N -glycolylneuraminic acid .	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components <*> is essential for initiation of an infection .	Another coronavirus , porcine transmissible gastroenteritis virus ( TGEV ) preferentially recognizes N -glycolylneuraminic acid .	14-42	134-149	For bovine coronavirus ( BCoV ) and related viruses , binding to cell surface components containing N -acetyl-9-O - acetylneuraminic acid is essential for initiation of an infection .	Another coronavirus , porcine transmissible gastroenteritis virus ( TGEV ) preferentially recognizes N -glycolylneuraminic acid .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	134-149	150-158	Another coronavirus , porcine transmissible gastroenteritis virus ( TGEV ) preferentially recognizes N -glycolylneuraminic acid .	TGEV does not contain a receptor - destroying enzyme	Another coronavirus , porcine transmissible gastroenteritis virus ( TGEV ) preferentially recognizes N -glycolylneuraminic acid .	TGEV does not contain a receptor - destroying enzyme	134-149	150-174	Another coronavirus , porcine transmissible gastroenteritis virus ( TGEV ) preferentially recognizes N -glycolylneuraminic acid .	TGEV does not contain a receptor - destroying enzyme and does not depend on the sialic acid binding activity for infection of cultured cells .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	150-158	159-174	TGEV does not contain a receptor - destroying enzyme	and does not depend on the sialic acid binding activity for infection of cultured cells .	TGEV does not contain a receptor - destroying enzyme	and does not depend on the sialic acid binding activity for infection of cultured cells .	150-174	150-174	TGEV does not contain a receptor - destroying enzyme and does not depend on the sialic acid binding activity for infection of cultured cells .	TGEV does not contain a receptor - destroying enzyme and does not depend on the sialic acid binding activity for infection of cultured cells .	1<2	none	joint	joint
909b7a89053c834c12a9d4348e977e66c6116d42	150-158	175-188	TGEV does not contain a receptor - destroying enzyme	However , binding to sialic acids is required for the enteropathogenicity of TGEV .	TGEV does not contain a receptor - destroying enzyme	However , binding to sialic acids is required for the enteropathogenicity of TGEV .	150-174	175-188	TGEV does not contain a receptor - destroying enzyme and does not depend on the sialic acid binding activity for infection of cultured cells .	However , binding to sialic acids is required for the enteropathogenicity of TGEV .	1<2	none	comparison	comparison
909b7a89053c834c12a9d4348e977e66c6116d42	175-188	189-205	However , binding to sialic acids is required for the enteropathogenicity of TGEV .	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer	However , binding to sialic acids is required for the enteropathogenicity of TGEV .	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer	175-188	189-219	However , binding to sialic acids is required for the enteropathogenicity of TGEV .	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer that covers the viral target cells in the epithelium of the small intestine .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	189-205	206-219	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer	that covers the viral target cells in the epithelium of the small intestine .	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer	that covers the viral target cells in the epithelium of the small intestine .	189-219	189-219	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer that covers the viral target cells in the epithelium of the small intestine .	Interaction with sialoglycoconjugates may help the virus to pass through the sialic acid - rich mucus layer that covers the viral target cells in the epithelium of the small intestine .	1<2	none	elaboration	elaboration
909b7a89053c834c12a9d4348e977e66c6116d42	220-221	222-236	We discuss	that the BCoV group of viruses may have evolved from a TGEV - like ancestor	We discuss	that the BCoV group of viruses may have evolved from a TGEV - like ancestor	220-245	220-245	We discuss that the BCoV group of viruses may have evolved from a TGEV - like ancestor by acquiring an acetylesterase gene through heterologous recombination .	We discuss that the BCoV group of viruses may have evolved from a TGEV - like ancestor by acquiring an acetylesterase gene through heterologous recombination .	1>2	none	attribution	attribution
909b7a89053c834c12a9d4348e977e66c6116d42	222-236	237-245	that the BCoV group of viruses may have evolved from a TGEV - like ancestor	by acquiring an acetylesterase gene through heterologous recombination .	that the BCoV group of viruses may have evolved from a TGEV - like ancestor	by acquiring an acetylesterase gene through heterologous recombination .	220-245	220-245	We discuss that the BCoV group of viruses may have evolved from a TGEV - like ancestor by acquiring an acetylesterase gene through heterologous recombination .	We discuss that the BCoV group of viruses may have evolved from a TGEV - like ancestor by acquiring an acetylesterase gene through heterologous recombination .	1<2	none	manner-means	manner-means
91595c90cb3ae1139a1090369bab9b25abbf6f1d	1-33	34-48	Two recently detected viruses , human metapneumovirus ( hMPV ) and coronavirus NL63 ( HCoV - NL63 ) , have been associated with acute respiratory tract infections , particularly in young children .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	Two recently detected viruses , human metapneumovirus ( hMPV ) and coronavirus NL63 ( HCoV - NL63 ) , have been associated with acute respiratory tract infections , particularly in young children .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	1-33	34-82	Two recently detected viruses , human metapneumovirus ( hMPV ) and coronavirus NL63 ( HCoV - NL63 ) , have been associated with acute respiratory tract infections , particularly in young children .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	1>2	none	background	background
91595c90cb3ae1139a1090369bab9b25abbf6f1d	34-48	49-54,63-65	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	by screening 221 nasopharyngeal aspirates , <*> from 212 children	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	by screening 221 nasopharyngeal aspirates , <*> from 212 children	34-82	34-82	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	1<2	none	manner-means	manner-means
91595c90cb3ae1139a1090369bab9b25abbf6f1d	49-54,63-65	55-62	by screening 221 nasopharyngeal aspirates , <*> from 212 children	collected between November 2003 and May 2005 ,	by screening 221 nasopharyngeal aspirates , <*> from 212 children	collected between November 2003 and May 2005 ,	34-82	34-82	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	63-65	66-75	from 212 children	attending the paediatric department of a county hospital in Sweden	from 212 children	attending the paediatric department of a county hospital in Sweden	34-82	34-82	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	63-65	76-82	from 212 children	or submitted from local general practitioners .	from 212 children	or submitted from local general practitioners .	34-82	34-82	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	1<2	none	joint	joint
91595c90cb3ae1139a1090369bab9b25abbf6f1d	49-54,63-65	83-87	by screening 221 nasopharyngeal aspirates , <*> from 212 children	The samples were originally submitted	by screening 221 nasopharyngeal aspirates , <*> from 212 children	The samples were originally submitted	34-82	83-113	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	The samples were originally submitted to be tested for respiratory syncytial virus ( RSV ) , and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	83-87	88-98	The samples were originally submitted	to be tested for respiratory syncytial virus ( RSV ) ,	The samples were originally submitted	to be tested for respiratory syncytial virus ( RSV ) ,	83-113	83-113	The samples were originally submitted to be tested for respiratory syncytial virus ( RSV ) , and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	The samples were originally submitted to be tested for respiratory syncytial virus ( RSV ) , and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	1<2	none	enablement	enablement
91595c90cb3ae1139a1090369bab9b25abbf6f1d	83-87	99-113	The samples were originally submitted	and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	The samples were originally submitted	and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	83-113	83-113	The samples were originally submitted to be tested for respiratory syncytial virus ( RSV ) , and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	The samples were originally submitted to be tested for respiratory syncytial virus ( RSV ) , and were examined retrospectively for hMPV and HCoV - NL63 by RT - PCR .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	34-48	114-123	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	Of the 212 patients , 101 were positive for RSV	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	Of the 212 patients , 101 were positive for RSV	34-82	114-151	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	1<2	none	findings	findings
91595c90cb3ae1139a1090369bab9b25abbf6f1d	114-123	124-128	Of the 212 patients , 101 were positive for RSV	( 48 % ) ,	Of the 212 patients , 101 were positive for RSV	( 48 % ) ,	114-151	114-151	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	114-123	129,134-138	Of the 212 patients , 101 were positive for RSV	22 <*> were positive for hMPV ,	Of the 212 patients , 101 were positive for RSV	22 <*> were positive for hMPV ,	114-151	114-151	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	1<2	none	joint	joint
91595c90cb3ae1139a1090369bab9b25abbf6f1d	129,134-138	130-133	22 <*> were positive for hMPV ,	( 10 % )	22 <*> were positive for hMPV ,	( 10 % )	114-151	114-151	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	114-123	139-140,145-151	Of the 212 patients , 101 were positive for RSV	and 12 <*> were positive for HCoV - NL63 .	Of the 212 patients , 101 were positive for RSV	and 12 <*> were positive for HCoV - NL63 .	114-151	114-151	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	1<2	none	joint	joint
91595c90cb3ae1139a1090369bab9b25abbf6f1d	139-140,145-151	141-144	and 12 <*> were positive for HCoV - NL63 .	( 6 % )	and 12 <*> were positive for HCoV - NL63 .	( 6 % )	114-151	114-151	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	114-123	152-174	Of the 212 patients , 101 were positive for RSV	The frequency of HCoV - NL63 infection increased from 1 % in 2003 - 2004 to 10 % in 2004 - 2005 .	Of the 212 patients , 101 were positive for RSV	The frequency of HCoV - NL63 infection increased from 1 % in 2003 - 2004 to 10 % in 2004 - 2005 .	114-151	152-174	Of the 212 patients , 101 were positive for RSV ( 48 % ) , 22 ( 10 % ) were positive for hMPV , and 12 ( 6 % ) were positive for HCoV - NL63 .	The frequency of HCoV - NL63 infection increased from 1 % in 2003 - 2004 to 10 % in 2004 - 2005 .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	152-174	175-193	The frequency of HCoV - NL63 infection increased from 1 % in 2003 - 2004 to 10 % in 2004 - 2005 .	Sequence analysis of parts of the coronavirus genomes showed considerable similarity to the HCoV - NL63 prototype sequence .	The frequency of HCoV - NL63 infection increased from 1 % in 2003 - 2004 to 10 % in 2004 - 2005 .	Sequence analysis of parts of the coronavirus genomes showed considerable similarity to the HCoV - NL63 prototype sequence .	152-174	175-193	The frequency of HCoV - NL63 infection increased from 1 % in 2003 - 2004 to 10 % in 2004 - 2005 .	Sequence analysis of parts of the coronavirus genomes showed considerable similarity to the HCoV - NL63 prototype sequence .	1<2	none	elaboration	elaboration
91595c90cb3ae1139a1090369bab9b25abbf6f1d	194-196	197-219	The study demonstrated	that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics	The study demonstrated	that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics	194-227	194-227	The study demonstrated that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics as have been reported in other countries .	The study demonstrated that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics as have been reported in other countries .	1>2	none	attribution	attribution
91595c90cb3ae1139a1090369bab9b25abbf6f1d	34-48	197-219	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children	that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics	34-82	194-227	This study investigated the frequency of hMPV and HCoV - NL63 infections in Swedish children by screening 221 nasopharyngeal aspirates , collected between November 2003 and May 2005 , from 212 children attending the paediatric department of a county hospital in Sweden or submitted from local general practitioners .	The study demonstrated that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics as have been reported in other countries .	1<2	none	findings	findings
91595c90cb3ae1139a1090369bab9b25abbf6f1d	197-219	220-227	that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics	as have been reported in other countries .	that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics	as have been reported in other countries .	194-227	194-227	The study demonstrated that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics as have been reported in other countries .	The study demonstrated that HCoV - NL63 and hMPV occur in south - west Sweden with essentially the same frequency , seasonal distribution and clinical characteristics as have been reported in other countries .	1<2	none	comparison	comparison
94156e6941fe78191b5997cdeb10cb3fd06e1221	1-2	3-17	Background :	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease	Background :	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease	1-2	3-29	Background :	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease resulting in high mortality in cultured Chinese scallops , Chlamys farreri .	1>2	none	textual-organization	textual-organization
94156e6941fe78191b5997cdeb10cb3fd06e1221	3-17	30-40	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease	We have sequenced and analyzed the complete genome of AVNV .	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease	We have sequenced and analyzed the complete genome of AVNV .	3-29	30-40	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease resulting in high mortality in cultured Chinese scallops , Chlamys farreri .	We have sequenced and analyzed the complete genome of AVNV .	1>2	none	background	background
94156e6941fe78191b5997cdeb10cb3fd06e1221	3-17	18-29	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease	resulting in high mortality in cultured Chinese scallops , Chlamys farreri .	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease	resulting in high mortality in cultured Chinese scallops , Chlamys farreri .	3-29	3-29	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease resulting in high mortality in cultured Chinese scallops , Chlamys farreri .	Acute viral necrosis virus ( AVNV ) is the causative agent of a serious disease resulting in high mortality in cultured Chinese scallops , Chlamys farreri .	1<2	none	cause-result	cause-result
94156e6941fe78191b5997cdeb10cb3fd06e1221	41-42	43-67	Results :	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	Results :	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	41-42	43-67	Results :	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	1>2	none	textual-organization	textual-organization
94156e6941fe78191b5997cdeb10cb3fd06e1221	30-40	43-67	We have sequenced and analyzed the complete genome of AVNV .	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	We have sequenced and analyzed the complete genome of AVNV .	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	30-40	43-67	We have sequenced and analyzed the complete genome of AVNV .	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	1<2	none	findings	findings
94156e6941fe78191b5997cdeb10cb3fd06e1221	43-67	68-76	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	A total of 123 open reading frames were predicted	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	A total of 123 open reading frames were predicted	43-67	68-90	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	A total of 123 open reading frames were predicted to encode functional proteins , ranging from 41 to 1,878 amino acid residues .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	68-76	77-81	A total of 123 open reading frames were predicted	to encode functional proteins ,	A total of 123 open reading frames were predicted	to encode functional proteins ,	68-90	68-90	A total of 123 open reading frames were predicted to encode functional proteins , ranging from 41 to 1,878 amino acid residues .	A total of 123 open reading frames were predicted to encode functional proteins , ranging from 41 to 1,878 amino acid residues .	1<2	none	enablement	enablement
94156e6941fe78191b5997cdeb10cb3fd06e1221	77-81	82-90	to encode functional proteins ,	ranging from 41 to 1,878 amino acid residues .	to encode functional proteins ,	ranging from 41 to 1,878 amino acid residues .	68-90	68-90	A total of 123 open reading frames were predicted to encode functional proteins , ranging from 41 to 1,878 amino acid residues .	A total of 123 open reading frames were predicted to encode functional proteins , ranging from 41 to 1,878 amino acid residues .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	43-67	91-109	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) ,	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) ,	43-67	91-129	The AVNV genome is a linear , double - stranded DNA molecule of 210,993 bp with a nucleotide composition of 38.5 % G + C.	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) , and the amino acid sequences of the encoded proteins of these two viruses are 94 - 100 % identical .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	91-109	110-129	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) ,	and the amino acid sequences of the encoded proteins of these two viruses are 94 - 100 % identical .	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) ,	and the amino acid sequences of the encoded proteins of these two viruses are 94 - 100 % identical .	91-129	91-129	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) , and the amino acid sequences of the encoded proteins of these two viruses are 94 - 100 % identical .	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) , and the amino acid sequences of the encoded proteins of these two viruses are 94 - 100 % identical .	1<2	none	joint	joint
94156e6941fe78191b5997cdeb10cb3fd06e1221	91-109	130-141	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) ,	The genomic organization of AVNV is similar to that of OsHV-1 ,	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) ,	The genomic organization of AVNV is similar to that of OsHV-1 ,	91-129	130-189	The DNA sequence of AVNV is 97 % identical to that of ostreid herpesvirus 1 ( OsHV-1 ) , and the amino acid sequences of the encoded proteins of these two viruses are 94 - 100 % identical .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	130-141	142-147,174-178	The genomic organization of AVNV is similar to that of OsHV-1 ,	and consists of two unique regions <*> with a third unique region	The genomic organization of AVNV is similar to that of OsHV-1 ,	and consists of two unique regions <*> with a third unique region	130-189	130-189	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	joint	joint
94156e6941fe78191b5997cdeb10cb3fd06e1221	142-147,174-178	148-157	and consists of two unique regions <*> with a third unique region	( 170.4 kb and 3.4 kb , respectively ) ,	and consists of two unique regions <*> with a third unique region	( 170.4 kb and 3.4 kb , respectively ) ,	130-189	130-189	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	142-147,174-178	158-163	and consists of two unique regions <*> with a third unique region	each flanked by two inverted repeats	and consists of two unique regions <*> with a third unique region	each flanked by two inverted repeats	130-189	130-189	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	158-163	164-173	each flanked by two inverted repeats	( 7.6 kb and 10.2 kb , respectively ) ,	each flanked by two inverted repeats	( 7.6 kb and 10.2 kb , respectively ) ,	130-189	130-189	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	174-178	179-182	with a third unique region	( 1.5 kb )	with a third unique region	( 1.5 kb )	130-189	130-189	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	174-178	183-189	with a third unique region	situated between the two internal repeats .	with a third unique region	situated between the two internal repeats .	130-189	130-189	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	The genomic organization of AVNV is similar to that of OsHV-1 , and consists of two unique regions ( 170.4 kb and 3.4 kb , respectively ) , each flanked by two inverted repeats ( 7.6 kb and 10.2 kb , respectively ) , with a third unique region ( 1.5 kb ) situated between the two internal repeats .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	190-191	195-202	Conclusions :	that AVNV is a variant of OsHV-1 .	Conclusions :	that AVNV is a variant of OsHV-1 .	190-191	192-202	Conclusions :	Our results indicate that AVNV is a variant of OsHV-1 .	1>2	none	textual-organization	textual-organization
94156e6941fe78191b5997cdeb10cb3fd06e1221	192-194	195-202	Our results indicate	that AVNV is a variant of OsHV-1 .	Our results indicate	that AVNV is a variant of OsHV-1 .	192-202	192-202	Our results indicate that AVNV is a variant of OsHV-1 .	Our results indicate that AVNV is a variant of OsHV-1 .	1>2	none	attribution	attribution
94156e6941fe78191b5997cdeb10cb3fd06e1221	30-40	195-202	We have sequenced and analyzed the complete genome of AVNV .	that AVNV is a variant of OsHV-1 .	We have sequenced and analyzed the complete genome of AVNV .	that AVNV is a variant of OsHV-1 .	30-40	192-202	We have sequenced and analyzed the complete genome of AVNV .	Our results indicate that AVNV is a variant of OsHV-1 .	1<2	none	findings	findings
94156e6941fe78191b5997cdeb10cb3fd06e1221	195-202	203-208	that AVNV is a variant of OsHV-1 .	The AVNV genome sequence provides information	that AVNV is a variant of OsHV-1 .	The AVNV genome sequence provides information	192-202	203-221	Our results indicate that AVNV is a variant of OsHV-1 .	The AVNV genome sequence provides information useful for understanding the evolution and divergence of OsHV-1 in marine molluscs .	1<2	none	elaboration	elaboration
94156e6941fe78191b5997cdeb10cb3fd06e1221	203-208	209-221	The AVNV genome sequence provides information	useful for understanding the evolution and divergence of OsHV-1 in marine molluscs .	The AVNV genome sequence provides information	useful for understanding the evolution and divergence of OsHV-1 in marine molluscs .	203-221	203-221	The AVNV genome sequence provides information useful for understanding the evolution and divergence of OsHV-1 in marine molluscs .	The AVNV genome sequence provides information useful for understanding the evolution and divergence of OsHV-1 in marine molluscs .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	1-21	22-43	Rheum palmatum , Chinese traditional herb , exhibits a great variety of anti - cancer and anti - viruses properties .	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Rheum palmatum , Chinese traditional herb , exhibits a great variety of anti - cancer and anti - viruses properties .	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	1-21	22-43	Rheum palmatum , Chinese traditional herb , exhibits a great variety of anti - cancer and anti - viruses properties .	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	1>2	none	background	background
97adff711db916914190dd5fde9ec4923a13f46d	22-43	44-66	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Methanol extract of R. palmatum contained higher levels of aloe emodin , chrysophanol , rhein , emodin and physcion than water extract .	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Methanol extract of R. palmatum contained higher levels of aloe emodin , chrysophanol , rhein , emodin and physcion than water extract .	22-43	44-66	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Methanol extract of R. palmatum contained higher levels of aloe emodin , chrysophanol , rhein , emodin and physcion than water extract .	1<2	none	findings	findings
97adff711db916914190dd5fde9ec4923a13f46d	44-66	67-68,78-89	Methanol extract of R. palmatum contained higher levels of aloe emodin , chrysophanol , rhein , emodin and physcion than water extract .	Methanol extract <*> exhibited more potent inhibitory effects on JEV plaque reduction than water extract	Methanol extract of R. palmatum contained higher levels of aloe emodin , chrysophanol , rhein , emodin and physcion than water extract .	Methanol extract <*> exhibited more potent inhibitory effects on JEV plaque reduction than water extract	44-66	67-99	Methanol extract of R. palmatum contained higher levels of aloe emodin , chrysophanol , rhein , emodin and physcion than water extract .	Methanol extract ( IC 50 = 15.04 lg / ml ) exhibited more potent inhibitory effects on JEV plaque reduction than water extract ( IC 50 = 51.41 lg / ml ) .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	67-68,78-89	69-77	Methanol extract <*> exhibited more potent inhibitory effects on JEV plaque reduction than water extract	( IC 50 = 15.04 lg / ml )	Methanol extract <*> exhibited more potent inhibitory effects on JEV plaque reduction than water extract	( IC 50 = 15.04 lg / ml )	67-99	67-99	Methanol extract ( IC 50 = 15.04 lg / ml ) exhibited more potent inhibitory effects on JEV plaque reduction than water extract ( IC 50 = 51.41 lg / ml ) .	Methanol extract ( IC 50 = 15.04 lg / ml ) exhibited more potent inhibitory effects on JEV plaque reduction than water extract ( IC 50 = 51.41 lg / ml ) .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	78-89	90-99	exhibited more potent inhibitory effects on JEV plaque reduction than water extract	( IC 50 = 51.41 lg / ml ) .	exhibited more potent inhibitory effects on JEV plaque reduction than water extract	( IC 50 = 51.41 lg / ml ) .	67-99	67-99	Methanol extract ( IC 50 = 15.04 lg / ml ) exhibited more potent inhibitory effects on JEV plaque reduction than water extract ( IC 50 = 51.41 lg / ml ) .	Methanol extract ( IC 50 = 15.04 lg / ml ) exhibited more potent inhibitory effects on JEV plaque reduction than water extract ( IC 50 = 51.41 lg / ml ) .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	67-68,78-89	100-104,110-128	Methanol extract <*> exhibited more potent inhibitory effects on JEV plaque reduction than water extract	Meanwhile , IC 50 values <*> were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	Methanol extract <*> exhibited more potent inhibitory effects on JEV plaque reduction than water extract	Meanwhile , IC 50 values <*> were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	67-99	100-128	Methanol extract ( IC 50 = 15.04 lg / ml ) exhibited more potent inhibitory effects on JEV plaque reduction than water extract ( IC 50 = 51.41 lg / ml ) .	Meanwhile , IC 50 values determined by plaque reduction assay were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	100-104,110-128	105-109	Meanwhile , IC 50 values <*> were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	determined by plaque reduction assay	Meanwhile , IC 50 values <*> were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	determined by plaque reduction assay	100-128	100-128	Meanwhile , IC 50 values determined by plaque reduction assay were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	Meanwhile , IC 50 values determined by plaque reduction assay were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	100-104,110-128	129-139	Meanwhile , IC 50 values <*> were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	Virucidal activity of agents correlated with anti - JEV activity ,	Meanwhile , IC 50 values <*> were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	Virucidal activity of agents correlated with anti - JEV activity ,	100-128	129-179	Meanwhile , IC 50 values determined by plaque reduction assay were 15.82 lg / ml for chrysophanol and 17.39 lg / ml for aloe - emodin , respectively .	Virucidal activity of agents correlated with anti - JEV activity , while virucidal IC 50 values were 7.58 lg / ml for methanol extract , 17.36 lg / ml for water extract , 0.75 lg / ml for chrysophanol and 0.46 lg / ml for aloe - emodin , respectively .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	129-139	140-179	Virucidal activity of agents correlated with anti - JEV activity ,	while virucidal IC 50 values were 7.58 lg / ml for methanol extract , 17.36 lg / ml for water extract , 0.75 lg / ml for chrysophanol and 0.46 lg / ml for aloe - emodin , respectively .	Virucidal activity of agents correlated with anti - JEV activity ,	while virucidal IC 50 values were 7.58 lg / ml for methanol extract , 17.36 lg / ml for water extract , 0.75 lg / ml for chrysophanol and 0.46 lg / ml for aloe - emodin , respectively .	129-179	129-179	Virucidal activity of agents correlated with anti - JEV activity , while virucidal IC 50 values were 7.58 lg / ml for methanol extract , 17.36 lg / ml for water extract , 0.75 lg / ml for chrysophanol and 0.46 lg / ml for aloe - emodin , respectively .	Virucidal activity of agents correlated with anti - JEV activity , while virucidal IC 50 values were 7.58 lg / ml for methanol extract , 17.36 lg / ml for water extract , 0.75 lg / ml for chrysophanol and 0.46 lg / ml for aloe - emodin , respectively .	1<2	none	comparison	comparison
97adff711db916914190dd5fde9ec4923a13f46d	129-139	180-202	Virucidal activity of agents correlated with anti - JEV activity ,	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells	Virucidal activity of agents correlated with anti - JEV activity ,	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells	129-179	180-212	Virucidal activity of agents correlated with anti - JEV activity , while virucidal IC 50 values were 7.58 lg / ml for methanol extract , 17.36 lg / ml for water extract , 0.75 lg / ml for chrysophanol and 0.46 lg / ml for aloe - emodin , respectively .	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells and significantly activated gamma activated sequence - driven promoters .	1<2	none	elaboration	elaboration
97adff711db916914190dd5fde9ec4923a13f46d	180-202	203-212	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells	and significantly activated gamma activated sequence - driven promoters .	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells	and significantly activated gamma activated sequence - driven promoters .	180-212	180-212	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells and significantly activated gamma activated sequence - driven promoters .	In addition , 10 lg / ml of extract , chrysophanol or aloe emodin caused 90 % inhibition of JEV yields in cells and significantly activated gamma activated sequence - driven promoters .	1<2	none	joint	joint
97adff711db916914190dd5fde9ec4923a13f46d	22-43	213-236	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Hence , methanol extract of R. palmatum and chrysophanol with high therapeutic index might be useful for development of antiviral agents against JEV .	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Hence , methanol extract of R. palmatum and chrysophanol with high therapeutic index might be useful for development of antiviral agents against JEV .	22-43	213-236	This study rates antiviral activity of R. palmatum extracts and its components against Japanese encephalitis virus ( JEV ) in vitro .	Hence , methanol extract of R. palmatum and chrysophanol with high therapeutic index might be useful for development of antiviral agents against JEV .	1<2	none	findings	findings
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	1-15	29-39	Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management .	This review explains the principles of PCR and the methodological factors	Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management .	This review explains the principles of PCR and the methodological factors	1-15	29-46	Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management .	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	1>2	none	background	background
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	1-15	16-28	Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management .	The polymerase chain reaction ( PCR ) is foremost amongst these techniques .	Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management .	The polymerase chain reaction ( PCR ) is foremost amongst these techniques .	1-15	16-28	Pathology practice is increasingly augmented with molecular tests for improved diagnostics and patient management .	The polymerase chain reaction ( PCR ) is foremost amongst these techniques .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	29-39	40-46	This review explains the principles of PCR and the methodological factors	that contribute to a successful assay .	This review explains the principles of PCR and the methodological factors	that contribute to a successful assay .	29-46	29-46	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	29-39	47-51,68-69	This review explains the principles of PCR and the methodological factors	Key PCR technique variations , <*> are described	This review explains the principles of PCR and the methodological factors	Key PCR technique variations , <*> are described	29-46	47-81	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	47-51,68-69	52-67	Key PCR technique variations , <*> are described	such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR ,	Key PCR technique variations , <*> are described	such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR ,	47-81	47-81	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	68-69	70-74	are described	and an overview is provided	are described	and an overview is provided	47-81	47-81	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	1<2	none	joint	joint
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	70-74	75-81	and an overview is provided	of how PCR products are analysed .	and an overview is provided	of how PCR products are analysed .	47-81	47-81	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	Key PCR technique variations , such as reverse transcription ( RT)-PCR and quantitative real - time ( q ) PCR , are described and an overview is provided of how PCR products are analysed .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	29-39	82-108	This review explains the principles of PCR and the methodological factors	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications	This review explains the principles of PCR and the methodological factors	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications	29-46	82-114	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications such as specimen identity confirmation .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	82-108	109-114	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications	such as specimen identity confirmation .	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications	such as specimen identity confirmation .	82-114	82-114	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications such as specimen identity confirmation .	The review includes examples of PCR usage in clinical practice for the detection of infectious and genetic diseases , for tumour diagnostics and in molecular forensic applications such as specimen identity confirmation .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	29-39	115-132	This review explains the principles of PCR and the methodological factors	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences	This review explains the principles of PCR and the methodological factors	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences	29-46	115-148	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences and involves automated cycles of denaturation , annealing and extension or synthesis using a thermocycler .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	115-132	133-144	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences	and involves automated cycles of denaturation , annealing and extension or synthesis	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences	and involves automated cycles of denaturation , annealing and extension or synthesis	115-148	115-148	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences and involves automated cycles of denaturation , annealing and extension or synthesis using a thermocycler .	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences and involves automated cycles of denaturation , annealing and extension or synthesis using a thermocycler .	1<2	none	joint	joint
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	133-144	145-148	and involves automated cycles of denaturation , annealing and extension or synthesis	using a thermocycler .	and involves automated cycles of denaturation , annealing and extension or synthesis	using a thermocycler .	115-148	115-148	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences and involves automated cycles of denaturation , annealing and extension or synthesis using a thermocycler .	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences and involves automated cycles of denaturation , annealing and extension or synthesis using a thermocycler .	1<2	none	manner-means	manner-means
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	115-132	149-161	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences	PCR was conceived and developed in the early 1980s by Kary Mullis ,	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences	PCR was conceived and developed in the early 1980s by Kary Mullis ,	115-148	149-176	The polymerase chain reaction ( PCR ) is a method for the in vitro amplification of DNA sequences and involves automated cycles of denaturation , annealing and extension or synthesis using a thermocycler .	PCR was conceived and developed in the early 1980s by Kary Mullis , who was awarded the Nobel Prize for Chemistry for the invention in 1993 . 1	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	149-161	162-176	PCR was conceived and developed in the early 1980s by Kary Mullis ,	who was awarded the Nobel Prize for Chemistry for the invention in 1993 . 1	PCR was conceived and developed in the early 1980s by Kary Mullis ,	who was awarded the Nobel Prize for Chemistry for the invention in 1993 . 1	149-176	149-176	PCR was conceived and developed in the early 1980s by Kary Mullis , who was awarded the Nobel Prize for Chemistry for the invention in 1993 . 1	PCR was conceived and developed in the early 1980s by Kary Mullis , who was awarded the Nobel Prize for Chemistry for the invention in 1993 . 1	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	149-161	177-191	PCR was conceived and developed in the early 1980s by Kary Mullis ,	The technique allows the sensitive detection and analysis of miniscule quantities of nucleic acids .	PCR was conceived and developed in the early 1980s by Kary Mullis ,	The technique allows the sensitive detection and analysis of miniscule quantities of nucleic acids .	149-176	177-191	PCR was conceived and developed in the early 1980s by Kary Mullis , who was awarded the Nobel Prize for Chemistry for the invention in 1993 . 1	The technique allows the sensitive detection and analysis of miniscule quantities of nucleic acids .	1<2	none	enablement	enablement
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	177-191	192-202	The technique allows the sensitive detection and analysis of miniscule quantities of nucleic acids .	PCR has become established as a routine method in pathology diagnostics	The technique allows the sensitive detection and analysis of miniscule quantities of nucleic acids .	PCR has become established as a routine method in pathology diagnostics	177-191	192-229	The technique allows the sensitive detection and analysis of miniscule quantities of nucleic acids .	PCR has become established as a routine method in pathology diagnostics and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications including identity testing .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	192-202	203-225	PCR has become established as a routine method in pathology diagnostics	and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications	PCR has become established as a routine method in pathology diagnostics	and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications	192-229	192-229	PCR has become established as a routine method in pathology diagnostics and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications including identity testing .	PCR has become established as a routine method in pathology diagnostics and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications including identity testing .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	203-225	226-229	and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications	including identity testing .	and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications	including identity testing .	192-229	192-229	PCR has become established as a routine method in pathology diagnostics and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications including identity testing .	PCR has become established as a routine method in pathology diagnostics and has been adapted for the detection of infectious agents , mutations , translocations and gene amplifications , and for molecular forensic applications including identity testing .	1<2	none	elaboration	elaboration
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	29-39	230-239	This review explains the principles of PCR and the methodological factors	This review covers the basics of the PCR assay ,	This review explains the principles of PCR and the methodological factors	This review covers the basics of the PCR assay ,	29-46	230-249	This review explains the principles of PCR and the methodological factors that contribute to a successful assay .	This review covers the basics of the PCR assay , describes PCR method variations and details current pathology applications .	1<2	none	findings	findings
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	230-239	240-243	This review covers the basics of the PCR assay ,	describes PCR method variations	This review covers the basics of the PCR assay ,	describes PCR method variations	230-249	230-249	This review covers the basics of the PCR assay , describes PCR method variations and details current pathology applications .	This review covers the basics of the PCR assay , describes PCR method variations and details current pathology applications .	1<2	none	joint	joint
980c48327d3bfbfcb0373fdbef063cd1a3d1d339	230-239	244-249	This review covers the basics of the PCR assay ,	and details current pathology applications .	This review covers the basics of the PCR assay ,	and details current pathology applications .	230-249	230-249	This review covers the basics of the PCR assay , describes PCR method variations and details current pathology applications .	This review covers the basics of the PCR assay , describes PCR method variations and details current pathology applications .	1<2	none	joint	joint
998006100007fee546077ce3c05ded0d35d08ff8	1-11	12-13	The goal of this article is to analyze some compartmental models	specially designed	The goal of this article is to analyze some compartmental models	specially designed	1-29	1-29	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	1<2	none	elaboration	elaboration
998006100007fee546077ce3c05ded0d35d08ff8	12-13	14-20	specially designed	to model the spread of a disease	specially designed	to model the spread of a disease	1-29	1-29	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	1<2	none	enablement	enablement
998006100007fee546077ce3c05ded0d35d08ff8	14-20	21-29	to model the spread of a disease	whose transmission has the same features as COVID-19 .	to model the spread of a disease	whose transmission has the same features as COVID-19 .	1-29	1-29	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	1<2	none	elaboration	elaboration
998006100007fee546077ce3c05ded0d35d08ff8	1-11	30-37	The goal of this article is to analyze some compartmental models	The major contributions of this article are :	The goal of this article is to analyze some compartmental models	The major contributions of this article are :	1-29	30-97	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	findings	findings
998006100007fee546077ce3c05ded0d35d08ff8	30-37	38-53	The major contributions of this article are :	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	The major contributions of this article are :	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	elaboration	elaboration
998006100007fee546077ce3c05ded0d35d08ff8	38-53	54-63	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	i.e. for no second wave of infection to form ;	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	i.e. for no second wave of infection to form ;	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	elaboration	elaboration
998006100007fee546077ce3c05ded0d35d08ff8	38-53	64-74	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	( 2 ) Investigate the formation of other waves of infection	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	( 2 ) Investigate the formation of other waves of infection	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	joint	joint
998006100007fee546077ce3c05ded0d35d08ff8	64-74	75-81	( 2 ) Investigate the formation of other waves of infection	when such conditions are not met ;	( 2 ) Investigate the formation of other waves of infection	when such conditions are not met ;	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	temporal	temporal
998006100007fee546077ce3c05ded0d35d08ff8	38-53	82-87	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	( 3 ) Use numerical simulations	( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak ,	( 3 ) Use numerical simulations	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	joint	joint
998006100007fee546077ce3c05ded0d35d08ff8	82-87	88-92	( 3 ) Use numerical simulations	to analyze the different roles	( 3 ) Use numerical simulations	to analyze the different roles	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	enablement	enablement
998006100007fee546077ce3c05ded0d35d08ff8	88-92	93-97	to analyze the different roles	asymptomatic carriers can have .	to analyze the different roles	asymptomatic carriers can have .	30-97	30-97	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	1<2	none	elaboration	elaboration
998006100007fee546077ce3c05ded0d35d08ff8	98-100	101-119	We also argue	that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	We also argue	that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	98-119	98-119	We also argue that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	We also argue that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	1>2	none	attribution	attribution
998006100007fee546077ce3c05ded0d35d08ff8	30-37	101-119	The major contributions of this article are :	that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	The major contributions of this article are :	that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	30-97	98-119	The major contributions of this article are : ( 1 ) Rigorously find sufficient conditions for the outbreak to only have one peak , i.e. for no second wave of infection to form ; ( 2 ) Investigate the formation of other waves of infection when such conditions are not met ; ( 3 ) Use numerical simulations to analyze the different roles asymptomatic carriers can have .	We also argue that dividing the population into non - interacting groups leads to an effective reduction of the transmission rates .	1<2	none	elaboration	elaboration
998006100007fee546077ce3c05ded0d35d08ff8	1-11	120-141	The goal of this article is to analyze some compartmental models	As in any compartmental model , the goal of this article is to provide qualitative understanding rather than exact quantitative predictions .	The goal of this article is to analyze some compartmental models	As in any compartmental model , the goal of this article is to provide qualitative understanding rather than exact quantitative predictions .	1-29	120-141	The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19 .	As in any compartmental model , the goal of this article is to provide qualitative understanding rather than exact quantitative predictions .	1<2	none	findings	findings
9ddc68cec5cd84cb4e0ffebe2950149cca597811	1-23	54-59,74-78	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain	In this context , our laboratory <*> re - modulated its priorities	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain	In this context , our laboratory <*> re - modulated its priorities	1-35	54-97	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia .	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	1>2	none	background	background
9ddc68cec5cd84cb4e0ffebe2950149cca597811	1-23	24-35	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain	that represents one of the largest known COVID-19 outbreaks outside Asia .	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain	that represents one of the largest known COVID-19 outbreaks outside Asia .	1-35	1-35	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia .	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	1-23	36-45	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain	Hospitals have been forced to reorganized their units in response	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain	Hospitals have been forced to reorganized their units in response	1-35	36-53	The first person - to - person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia .	Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	36-45	46-53	Hospitals have been forced to reorganized their units in response	to prepare for an unforeseen healthcare emergency .	Hospitals have been forced to reorganized their units in response	to prepare for an unforeseen healthcare emergency .	36-53	36-53	Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency .	Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency .	1<2	none	enablement	enablement
9ddc68cec5cd84cb4e0ffebe2950149cca597811	54-59,74-78	60-73	In this context , our laboratory <*> re - modulated its priorities	( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS )	In this context , our laboratory <*> re - modulated its priorities	( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS )	54-97	54-97	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	74-78	79-86	re - modulated its priorities	by temporarily interrupting most of the molecular tests	re - modulated its priorities	by temporarily interrupting most of the molecular tests	54-97	54-97	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	1<2	none	manner-means	manner-means
9ddc68cec5cd84cb4e0ffebe2950149cca597811	74-78	87-89	re - modulated its priorities	guaranteeing only those	re - modulated its priorities	guaranteeing only those	54-97	54-97	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	1<2	none	enablement	enablement
9ddc68cec5cd84cb4e0ffebe2950149cca597811	87-89	90-97	guaranteeing only those	considered " urgent " and not postponable .	guaranteeing only those	considered " urgent " and not postponable .	54-97	54-97	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	54-59,74-78	98-104	In this context , our laboratory <*> re - modulated its priorities	In particular , this paper details changes	In this context , our laboratory <*> re - modulated its priorities	In particular , this paper details changes	54-97	98-118	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	In particular , this paper details changes regarding the execution of germline BRCA ( gBRCA ) testing in our laboratory .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	98-104	105-118	In particular , this paper details changes	regarding the execution of germline BRCA ( gBRCA ) testing in our laboratory .	In particular , this paper details changes	regarding the execution of germline BRCA ( gBRCA ) testing in our laboratory .	98-118	98-118	In particular , this paper details changes regarding the execution of germline BRCA ( gBRCA ) testing in our laboratory .	In particular , this paper details changes regarding the execution of germline BRCA ( gBRCA ) testing in our laboratory .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	54-59,74-78	119-124,140-142	In this context , our laboratory <*> re - modulated its priorities	A substantial reduction in gBRCA testing <*> was registered ,	In this context , our laboratory <*> re - modulated its priorities	A substantial reduction in gBRCA testing <*> was registered ,	54-97	119-150	In this context , our laboratory ( Molecular and Genomic Diagnostics Unit , Fondazione Policlinico Universitario Agostino Gemelli IRCCS ) re - modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered " urgent " and not postponable .	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	1<2	none	findings	findings
9ddc68cec5cd84cb4e0ffebe2950149cca597811	119-124,140-142	125-129	A substantial reduction in gBRCA testing <*> was registered ,	( about 60 % )	A substantial reduction in gBRCA testing <*> was registered ,	( about 60 % )	119-150	119-150	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	119-124,140-142	130-139	A substantial reduction in gBRCA testing <*> was registered ,	compared to the first 2 months of the current year	A substantial reduction in gBRCA testing <*> was registered ,	compared to the first 2 months of the current year	119-150	119-150	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	1<2	none	comparison	comparison
9ddc68cec5cd84cb4e0ffebe2950149cca597811	140-142	143-150	was registered ,	but the requests have not been reset .	was registered ,	but the requests have not been reset .	119-150	119-150	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	1<2	none	comparison	comparison
9ddc68cec5cd84cb4e0ffebe2950149cca597811	143-150	151-159	but the requests have not been reset .	The requesting physicians were mainly gynaecologists and oncologists .	but the requests have not been reset .	The requesting physicians were mainly gynaecologists and oncologists .	119-150	151-159	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	The requesting physicians were mainly gynaecologists and oncologists .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	119-124,140-142	160-175	A substantial reduction in gBRCA testing <*> was registered ,	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients	A substantial reduction in gBRCA testing <*> was registered ,	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients	119-150	160-194	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing / Next Generation Sequencing ( NGS ) into clinical oncology .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	160-175	176-194	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients	and confirms definitively the integration of gBRCA testing / Next Generation Sequencing ( NGS ) into clinical oncology .	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients	and confirms definitively the integration of gBRCA testing / Next Generation Sequencing ( NGS ) into clinical oncology .	160-194	160-194	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing / Next Generation Sequencing ( NGS ) into clinical oncology .	These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing / Next Generation Sequencing ( NGS ) into clinical oncology .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	119-124,140-142	195-207,217-219	A substantial reduction in gBRCA testing <*> was registered ,	Finally , a re - organization of gBRCA testing in our Unit , <*> was necessary ,	A substantial reduction in gBRCA testing <*> was registered ,	Finally , a re - organization of gBRCA testing in our Unit , <*> was necessary ,	119-150	195-240	A substantial reduction in gBRCA testing ( about 60 % ) compared to the first 2 months of the current year was registered , but the requests have not been reset .	Finally , a re - organization of gBRCA testing in our Unit , mainly related to delayed and reduced arrival of tests was necessary , ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	195-207,217-219	208-216	Finally , a re - organization of gBRCA testing in our Unit , <*> was necessary ,	mainly related to delayed and reduced arrival of tests	Finally , a re - organization of gBRCA testing in our Unit , <*> was necessary ,	mainly related to delayed and reduced arrival of tests	195-240	195-240	Finally , a re - organization of gBRCA testing in our Unit , mainly related to delayed and reduced arrival of tests was necessary , ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	Finally , a re - organization of gBRCA testing in our Unit , mainly related to delayed and reduced arrival of tests was necessary , ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	1<2	none	elaboration	elaboration
9ddc68cec5cd84cb4e0ffebe2950149cca597811	217-219	220-240	was necessary ,	ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	was necessary ,	ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	195-240	195-240	Finally , a re - organization of gBRCA testing in our Unit , mainly related to delayed and reduced arrival of tests was necessary , ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	Finally , a re - organization of gBRCA testing in our Unit , mainly related to delayed and reduced arrival of tests was necessary , ensuring , however , a high - quality standard and reliability , mandatory for gBRCA testing in a clinical setting .	1<2	none	comparison	comparison
9f75a36d8f57e382a717ee506b636cbdb355802a	1-10	26-48	Cases of COVID-19 are escalating rapidly across the globe ,	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	Cases of COVID-19 are escalating rapidly across the globe ,	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	1-25	26-55	Cases of COVID-19 are escalating rapidly across the globe , with the mortality risk being especially high among those with existing illness and multimorbidity .	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	1>2	none	background	background
9f75a36d8f57e382a717ee506b636cbdb355802a	1-10	11-25	Cases of COVID-19 are escalating rapidly across the globe ,	with the mortality risk being especially high among those with existing illness and multimorbidity .	Cases of COVID-19 are escalating rapidly across the globe ,	with the mortality risk being especially high among those with existing illness and multimorbidity .	1-25	1-25	Cases of COVID-19 are escalating rapidly across the globe , with the mortality risk being especially high among those with existing illness and multimorbidity .	Cases of COVID-19 are escalating rapidly across the globe , with the mortality risk being especially high among those with existing illness and multimorbidity .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	26-48	49-55	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	to inform the COVID-19 pandemic response .	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	to inform the COVID-19 pandemic response .	26-55	26-55	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	1<2	none	enablement	enablement
9f75a36d8f57e382a717ee506b636cbdb355802a	26-48	56-69	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	We conducted a rapid systematic review according to PRISMA guidelines in five databases .	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	We conducted a rapid systematic review according to PRISMA guidelines in five databases .	26-55	56-69	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	We conducted a rapid systematic review according to PRISMA guidelines in five databases .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	56-69	70-82	We conducted a rapid systematic review according to PRISMA guidelines in five databases .	Of 3094 papers identified , ten were included in this narrative synthesis .	We conducted a rapid systematic review according to PRISMA guidelines in five databases .	Of 3094 papers identified , ten were included in this narrative synthesis .	56-69	70-82	We conducted a rapid systematic review according to PRISMA guidelines in five databases .	Of 3094 papers identified , ten were included in this narrative synthesis .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	70-82	83-102	Of 3094 papers identified , ten were included in this narrative synthesis .	Included studies were from West Africa , Taiwan , Hong Kong , Singapore , the United States and Italy .	Of 3094 papers identified , ten were included in this narrative synthesis .	Included studies were from West Africa , Taiwan , Hong Kong , Singapore , the United States and Italy .	70-82	83-102	Of 3094 papers identified , ten were included in this narrative synthesis .	Included studies were from West Africa , Taiwan , Hong Kong , Singapore , the United States and Italy .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	70-82	103-108	Of 3094 papers identified , ten were included in this narrative synthesis .	All had an observational design .	Of 3094 papers identified , ten were included in this narrative synthesis .	All had an observational design .	70-82	103-108	Of 3094 papers identified , ten were included in this narrative synthesis .	All had an observational design .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	26-48	109-111,117-121	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	Findings were synthesised <*> according to ' systems '	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	Findings were synthesised <*> according to ' systems '	26-55	109-172	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	109-111,117-121	112-116	Findings were synthesised <*> according to ' systems '	using a previously proposed framework	Findings were synthesised <*> according to ' systems '	using a previously proposed framework	109-172	109-172	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	1<2	none	manner-means	manner-means
9f75a36d8f57e382a717ee506b636cbdb355802a	117-121,136-138	122-135	according to ' systems ' <*> ' staff '	( policies , training and protocols , communication and coordination , data ) ,	according to ' systems ' <*> ' staff '	( policies , training and protocols , communication and coordination , data ) ,	109-172	109-172	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	136-138,148-150	139-147	' staff ' <*> ' space '	( deployment , skill mix , resilience ) ,	' staff ' <*> ' space '	( deployment , skill mix , resilience ) ,	109-172	109-172	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	148-150,159-162	151-158	' space ' <*> and ' stuff '	( community provision , use of technology )	' space ' <*> and ' stuff '	( community provision , use of technology )	109-172	109-172	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	159-162	163-172	and ' stuff '	( medicines and equipment , personal protective equipment ) .	and ' stuff '	( medicines and equipment , personal protective equipment ) .	109-172	109-172	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	Findings were synthesised using a previously proposed framework according to ' systems ' ( policies , training and protocols , communication and coordination , data ) , ' staff ' ( deployment , skill mix , resilience ) , ' space ' ( community provision , use of technology ) and ' stuff ' ( medicines and equipment , personal protective equipment ) .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	173-174	175-190	We conclude	that hospice and palliative services have an essential role in the response to COVID-19 by :	We conclude	that hospice and palliative services have an essential role in the response to COVID-19 by :	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1>2	none	attribution	attribution
9f75a36d8f57e382a717ee506b636cbdb355802a	26-48	175-190	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	that hospice and palliative services have an essential role in the response to COVID-19 by :	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	that hospice and palliative services have an essential role in the response to COVID-19 by :	26-55	173-283	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	findings	findings
9f75a36d8f57e382a717ee506b636cbdb355802a	175-190	191-197	that hospice and palliative services have an essential role in the response to COVID-19 by :	1 ) responding rapidly and flexibly ;	that hospice and palliative services have an essential role in the response to COVID-19 by :	1 ) responding rapidly and flexibly ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	manner-means	manner-means
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	198-207	1 ) responding rapidly and flexibly ;	2 ) ensuring protocols for symptom management are available ,	1 ) responding rapidly and flexibly ;	2 ) ensuring protocols for symptom management are available ,	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	198-207	208-216	2 ) ensuring protocols for symptom management are available ,	and training non - specialists in their use ;	2 ) ensuring protocols for symptom management are available ,	and training non - specialists in their use ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	217-223	1 ) responding rapidly and flexibly ;	3 ) being involved in triage ;	1 ) responding rapidly and flexibly ;	3 ) being involved in triage ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	224-232	1 ) responding rapidly and flexibly ;	4 ) considering shifting resources into the community ;	1 ) responding rapidly and flexibly ;	4 ) considering shifting resources into the community ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	233-237	1 ) responding rapidly and flexibly ;	5 ) considering redeploying volunteers	1 ) responding rapidly and flexibly ;	5 ) considering redeploying volunteers	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	233-237	238-244	5 ) considering redeploying volunteers	to provide psychosocial and bereavement care ;	5 ) considering redeploying volunteers	to provide psychosocial and bereavement care ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	enablement	enablement
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	245-250	1 ) responding rapidly and flexibly ;	6 ) facilitating camaraderie among staff	1 ) responding rapidly and flexibly ;	6 ) facilitating camaraderie among staff	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	245-250	251-253	6 ) facilitating camaraderie among staff	and adopt measures	6 ) facilitating camaraderie among staff	and adopt measures	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	251-253	254-258	and adopt measures	to deal with stress ;	and adopt measures	to deal with stress ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	enablement	enablement
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	259-262	1 ) responding rapidly and flexibly ;	7 ) using technology	1 ) responding rapidly and flexibly ;	7 ) using technology	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	259-262	263-269	7 ) using technology	to communicate with patients and carers ;	7 ) using technology	to communicate with patients and carers ;	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	enablement	enablement
9f75a36d8f57e382a717ee506b636cbdb355802a	191-197	270-275	1 ) responding rapidly and flexibly ;	8) adopting standardised data collection systems	1 ) responding rapidly and flexibly ;	8) adopting standardised data collection systems	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	270-275	276-279	8) adopting standardised data collection systems	to inform operational changes	8) adopting standardised data collection systems	to inform operational changes	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	enablement	enablement
9f75a36d8f57e382a717ee506b636cbdb355802a	276-279	280-283	to inform operational changes	and improve care .	to inform operational changes	and improve care .	173-283	173-283	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	We conclude that hospice and palliative services have an essential role in the response to COVID-19 by : 1 ) responding rapidly and flexibly ; 2 ) ensuring protocols for symptom management are available , and training non - specialists in their use ; 3 ) being involved in triage ; 4 ) considering shifting resources into the community ; 5 ) considering redeploying volunteers to provide psychosocial and bereavement care ; 6 ) facilitating camaraderie among staff and adopt measures to deal with stress ; 7 ) using technology to communicate with patients and carers ; 8) adopting standardised data collection systems to inform operational changes and improve care .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	26-48	284-301	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics ,	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics ,	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics ,	26-55	284-307	This study aimed to synthesise evidence for the role and response of palliative care and hospice teams to viral epi / pandemics , to inform the COVID-19 pandemic response .	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics , to inform response to COVID-19 .	1<2	none	findings	findings
9f75a36d8f57e382a717ee506b636cbdb355802a	284-301	302-307	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics ,	to inform response to COVID-19 .	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics ,	to inform response to COVID-19 .	284-307	284-307	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics , to inform response to COVID-19 .	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics , to inform response to COVID-19 .	1<2	none	enablement	enablement
9f75a36d8f57e382a717ee506b636cbdb355802a	284-301	308-314	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics ,	Hospice and palliative care services should :	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics ,	Hospice and palliative care services should :	284-307	308-347	An evidence synthesis on the role and response of hospice and palliative care in epi / pandemics , to inform response to COVID-19 .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	308-314	315-319	Hospice and palliative care services should :	respond rapidly and flexibly ;	Hospice and palliative care services should :	respond rapidly and flexibly ;	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	elaboration	elaboration
9f75a36d8f57e382a717ee506b636cbdb355802a	315-319	320-322	respond rapidly and flexibly ;	produce protocols ;	respond rapidly and flexibly ;	produce protocols ;	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	315-319	323-328	respond rapidly and flexibly ;	shift resources to the community ;	respond rapidly and flexibly ;	shift resources to the community ;	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	315-319	329-331	respond rapidly and flexibly ;	redeploy volunteers ;	respond rapidly and flexibly ;	redeploy volunteers ;	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	315-319	332-335	respond rapidly and flexibly ;	facilitate staff camaraderie ;	respond rapidly and flexibly ;	facilitate staff camaraderie ;	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	315-319	336-343	respond rapidly and flexibly ;	communicate with patients / carers via technology ;	respond rapidly and flexibly ;	communicate with patients / carers via technology ;	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	joint	joint
9f75a36d8f57e382a717ee506b636cbdb355802a	315-319	344-347	respond rapidly and flexibly ;	standardise data collection .	respond rapidly and flexibly ;	standardise data collection .	308-347	308-347	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	Hospice and palliative care services should : respond rapidly and flexibly ; produce protocols ; shift resources to the community ; redeploy volunteers ; facilitate staff camaraderie ; communicate with patients / carers via technology ; standardise data collection .	1<2	none	joint	joint
a5ff05575328a71f49ebc06441902568fc955c72	1-5	124-137	RNA viruses show enormous capacity	This review summarises our knowledge of the functional RNA domains of human RNA viruses	RNA viruses show enormous capacity	This review summarises our knowledge of the functional RNA domains of human RNA viruses	1-34	124-158	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	1>2	none	background	background
a5ff05575328a71f49ebc06441902568fc955c72	1-5	6-7	RNA viruses show enormous capacity	to evolve	RNA viruses show enormous capacity	to evolve	1-34	1-34	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	6-7	8-16	to evolve	and adapt to new cellular and molecular contexts ,	to evolve	and adapt to new cellular and molecular contexts ,	1-34	1-34	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	1<2	none	joint	joint
a5ff05575328a71f49ebc06441902568fc955c72	1-5	17-20	RNA viruses show enormous capacity	a consequence of mutations	RNA viruses show enormous capacity	a consequence of mutations	1-34	1-34	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	1<2	none	cause-result	cause-result
a5ff05575328a71f49ebc06441902568fc955c72	17-20	21-23	a consequence of mutations	arising from errors	a consequence of mutations	arising from errors	1-34	1-34	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	1<2	none	cause-result	cause-result
a5ff05575328a71f49ebc06441902568fc955c72	21-23	24-34	arising from errors	made by viral RNA - dependent RNA polymerase during replication .	arising from errors	made by viral RNA - dependent RNA polymerase during replication .	1-34	1-34	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	17-20	35-41	a consequence of mutations	Sequence variation must occur , however ,	a consequence of mutations	Sequence variation must occur , however ,	1-34	35-53	RNA viruses show enormous capacity to evolve and adapt to new cellular and molecular contexts , a consequence of mutations arising from errors made by viral RNA - dependent RNA polymerase during replication .	Sequence variation must occur , however , without compromising functions essential for the completion of the viral cycle .	1<2	none	comparison	comparison
a5ff05575328a71f49ebc06441902568fc955c72	35-41	42-44	Sequence variation must occur , however ,	without compromising functions	Sequence variation must occur , however ,	without compromising functions	35-53	35-53	Sequence variation must occur , however , without compromising functions essential for the completion of the viral cycle .	Sequence variation must occur , however , without compromising functions essential for the completion of the viral cycle .	1<2	none	manner-means	manner-means
a5ff05575328a71f49ebc06441902568fc955c72	42-44	45-53	without compromising functions	essential for the completion of the viral cycle .	without compromising functions	essential for the completion of the viral cycle .	35-53	35-53	Sequence variation must occur , however , without compromising functions essential for the completion of the viral cycle .	Sequence variation must occur , however , without compromising functions essential for the completion of the viral cycle .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	35-41	54-63	Sequence variation must occur , however ,	RNA viruses are safeguarded in this respect by their genome	Sequence variation must occur , however ,	RNA viruses are safeguarded in this respect by their genome	35-53	54-90	Sequence variation must occur , however , without compromising functions essential for the completion of the viral cycle .	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	54-63	64-66	RNA viruses are safeguarded in this respect by their genome	carrying conserved information	RNA viruses are safeguarded in this respect by their genome	carrying conserved information	54-90	54-90	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	64-66	67-73	carrying conserved information	that does not code only for proteins	carrying conserved information	that does not code only for proteins	54-90	54-90	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	67-73	74-83	that does not code only for proteins	but also for the formation of structurally conserved RNA domains	that does not code only for proteins	but also for the formation of structurally conserved RNA domains	54-90	54-90	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	1<2	none	joint	joint
a5ff05575328a71f49ebc06441902568fc955c72	74-83	84-90	but also for the formation of structurally conserved RNA domains	that directly perform these critical functions .	but also for the formation of structurally conserved RNA domains	that directly perform these critical functions .	54-90	54-90	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	54-63	91-104	RNA viruses are safeguarded in this respect by their genome	Functional RNA domains can interact with other regions of the viral genome and/or proteins	RNA viruses are safeguarded in this respect by their genome	Functional RNA domains can interact with other regions of the viral genome and/or proteins	54-90	91-113	RNA viruses are safeguarded in this respect by their genome carrying conserved information that does not code only for proteins but also for the formation of structurally conserved RNA domains that directly perform these critical functions .	Functional RNA domains can interact with other regions of the viral genome and/or proteins to direct viral translation , replication and encapsidation .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	91-104	105-113	Functional RNA domains can interact with other regions of the viral genome and/or proteins	to direct viral translation , replication and encapsidation .	Functional RNA domains can interact with other regions of the viral genome and/or proteins	to direct viral translation , replication and encapsidation .	91-113	91-113	Functional RNA domains can interact with other regions of the viral genome and/or proteins to direct viral translation , replication and encapsidation .	Functional RNA domains can interact with other regions of the viral genome and/or proteins to direct viral translation , replication and encapsidation .	1<2	none	enablement	enablement
a5ff05575328a71f49ebc06441902568fc955c72	91-104	114-123	Functional RNA domains can interact with other regions of the viral genome and/or proteins	They are therefore potential targets for novel therapeutic strategies .	Functional RNA domains can interact with other regions of the viral genome and/or proteins	They are therefore potential targets for novel therapeutic strategies .	91-113	114-123	Functional RNA domains can interact with other regions of the viral genome and/or proteins to direct viral translation , replication and encapsidation .	They are therefore potential targets for novel therapeutic strategies .	1<2	none	cause-result	cause-result
a5ff05575328a71f49ebc06441902568fc955c72	124-137	138-141	This review summarises our knowledge of the functional RNA domains of human RNA viruses	and examines the achievements	This review summarises our knowledge of the functional RNA domains of human RNA viruses	and examines the achievements	124-158	124-158	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	138-141	142-148	and examines the achievements	made in the design of antiviral compounds	and examines the achievements	made in the design of antiviral compounds	124-158	124-158	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	1<2	none	elaboration	elaboration
a5ff05575328a71f49ebc06441902568fc955c72	142-148	149-158	made in the design of antiviral compounds	that interfere with their folding and therefore their function .	made in the design of antiviral compounds	that interfere with their folding and therefore their function .	124-158	124-158	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	This review summarises our knowledge of the functional RNA domains of human RNA viruses and examines the achievements made in the design of antiviral compounds that interfere with their folding and therefore their function .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	1-4	20-41	There is limited evidence	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	There is limited evidence	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	1-19	20-49	There is limited evidence as to how COVID-19 infection fatality rates ( IFR ) may vary by ethnicity .	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups to estimate inequities in IFR by ethnicity .	1>2	none	background	background
a64f73ac0e74f9eca66d9c4876006757c8399e49	1-4	5-19	There is limited evidence	as to how COVID-19 infection fatality rates ( IFR ) may vary by ethnicity .	There is limited evidence	as to how COVID-19 infection fatality rates ( IFR ) may vary by ethnicity .	1-19	1-19	There is limited evidence as to how COVID-19 infection fatality rates ( IFR ) may vary by ethnicity .	There is limited evidence as to how COVID-19 infection fatality rates ( IFR ) may vary by ethnicity .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	20-41	42-49	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	to estimate inequities in IFR by ethnicity .	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	to estimate inequities in IFR by ethnicity .	20-49	20-49	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups to estimate inequities in IFR by ethnicity .	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups to estimate inequities in IFR by ethnicity .	1<2	none	enablement	enablement
a64f73ac0e74f9eca66d9c4876006757c8399e49	50-51	52-53,63-76	We find	that , <*> estimated IFR for Māori is around 50 % higher than non - Māori .	We find	that , <*> estimated IFR for Māori is around 50 % higher than non - Māori .	50-76	50-76	We find that , if age is the dominant factor determining IFR , estimated IFR for Māori is around 50 % higher than non - Māori .	We find that , if age is the dominant factor determining IFR , estimated IFR for Māori is around 50 % higher than non - Māori .	1>2	none	attribution	attribution
a64f73ac0e74f9eca66d9c4876006757c8399e49	20-41	52-53,63-76	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	that , <*> estimated IFR for Māori is around 50 % higher than non - Māori .	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	that , <*> estimated IFR for Māori is around 50 % higher than non - Māori .	20-49	50-76	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups to estimate inequities in IFR by ethnicity .	We find that , if age is the dominant factor determining IFR , estimated IFR for Māori is around 50 % higher than non - Māori .	1<2	none	findings	findings
a64f73ac0e74f9eca66d9c4876006757c8399e49	54-62	63-76	if age is the dominant factor determining IFR ,	estimated IFR for Māori is around 50 % higher than non - Māori .	if age is the dominant factor determining IFR ,	estimated IFR for Māori is around 50 % higher than non - Māori .	50-76	50-76	We find that , if age is the dominant factor determining IFR , estimated IFR for Māori is around 50 % higher than non - Māori .	We find that , if age is the dominant factor determining IFR , estimated IFR for Māori is around 50 % higher than non - Māori .	1>2	none	condition	condition
a64f73ac0e74f9eca66d9c4876006757c8399e49	77-88	89-104	If underlying health conditions are more important than age per se ,	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	If underlying health conditions are more important than age per se ,	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	77-118	77-118	If underlying health conditions are more important than age per se , then estimated IFR for Māori is more than 2.5 times that of New Zealand European , and estimated IFR for Pasifika is almost double that of New Zealand European .	If underlying health conditions are more important than age per se , then estimated IFR for Māori is more than 2.5 times that of New Zealand European , and estimated IFR for Pasifika is almost double that of New Zealand European .	1>2	none	condition	condition
a64f73ac0e74f9eca66d9c4876006757c8399e49	52-53,63-76	89-104	that , <*> estimated IFR for Māori is around 50 % higher than non - Māori .	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	that , <*> estimated IFR for Māori is around 50 % higher than non - Māori .	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	50-76	77-118	We find that , if age is the dominant factor determining IFR , estimated IFR for Māori is around 50 % higher than non - Māori .	If underlying health conditions are more important than age per se , then estimated IFR for Māori is more than 2.5 times that of New Zealand European , and estimated IFR for Pasifika is almost double that of New Zealand European .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	89-104	105-118	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	and estimated IFR for Pasifika is almost double that of New Zealand European .	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	and estimated IFR for Pasifika is almost double that of New Zealand European .	77-118	77-118	If underlying health conditions are more important than age per se , then estimated IFR for Māori is more than 2.5 times that of New Zealand European , and estimated IFR for Pasifika is almost double that of New Zealand European .	If underlying health conditions are more important than age per se , then estimated IFR for Māori is more than 2.5 times that of New Zealand European , and estimated IFR for Pasifika is almost double that of New Zealand European .	1<2	none	joint	joint
a64f73ac0e74f9eca66d9c4876006757c8399e49	89-104	119-140	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities	then estimated IFR for Māori is more than 2.5 times that of New Zealand European ,	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities	77-118	119-146	If underlying health conditions are more important than age per se , then estimated IFR for Māori is more than 2.5 times that of New Zealand European , and estimated IFR for Pasifika is almost double that of New Zealand European .	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities not reflected in official data .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	119-140	141-146	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities	not reflected in official data .	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities	not reflected in official data .	119-146	119-146	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities not reflected in official data .	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities not reflected in official data .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	119-140	147-158	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities	IFR does not account for differences among ethnicities in COVID-19 incidence ,	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities	IFR does not account for differences among ethnicities in COVID-19 incidence ,	119-146	147-178	IFRs for Māori and Pasifika are likely to be increased above these estimates by racism within the healthcare system and other inequities not reflected in official data .	IFR does not account for differences among ethnicities in COVID-19 incidence , which could be higher in Māori and Pasifik as a result of crowded housing and higher intergenerational contact rates .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	147-158	159-166	IFR does not account for differences among ethnicities in COVID-19 incidence ,	which could be higher in Māori and Pasifik	IFR does not account for differences among ethnicities in COVID-19 incidence ,	which could be higher in Māori and Pasifik	147-178	147-178	IFR does not account for differences among ethnicities in COVID-19 incidence , which could be higher in Māori and Pasifik as a result of crowded housing and higher intergenerational contact rates .	IFR does not account for differences among ethnicities in COVID-19 incidence , which could be higher in Māori and Pasifik as a result of crowded housing and higher intergenerational contact rates .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	159-166	167-178	which could be higher in Māori and Pasifik	as a result of crowded housing and higher intergenerational contact rates .	which could be higher in Māori and Pasifik	as a result of crowded housing and higher intergenerational contact rates .	147-178	147-178	IFR does not account for differences among ethnicities in COVID-19 incidence , which could be higher in Māori and Pasifik as a result of crowded housing and higher intergenerational contact rates .	IFR does not account for differences among ethnicities in COVID-19 incidence , which could be higher in Māori and Pasifik as a result of crowded housing and higher intergenerational contact rates .	1<2	none	cause-result	cause-result
a64f73ac0e74f9eca66d9c4876006757c8399e49	20-41	179-189	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	These factors should be included in future disease incidence modelling .	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups	These factors should be included in future disease incidence modelling .	20-49	179-189	We combine demographic and health data for ethnic groupings in Aotearoa New Zealand with international data on IFR for different age groups to estimate inequities in IFR by ethnicity .	These factors should be included in future disease incidence modelling .	1<2	none	findings	findings
a64f73ac0e74f9eca66d9c4876006757c8399e49	179-189	190-208	These factors should be included in future disease incidence modelling .	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities ,	These factors should be included in future disease incidence modelling .	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities ,	179-189	190-237	These factors should be included in future disease incidence modelling .	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	190-208	209-227	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities ,	where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities ,	where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk	190-237	190-237	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	209-227	228-231	where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk	of contracting COVID-19 ,	where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk	of contracting COVID-19 ,	190-237	190-237	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	1<2	none	elaboration	elaboration
a64f73ac0e74f9eca66d9c4876006757c8399e49	228-231	232-237	of contracting COVID-19 ,	becoming unwell , and death .	of contracting COVID-19 ,	becoming unwell , and death .	190-237	190-237	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	The communities at the highest risk will be those with elderly populations , and Māori and Pasifika communities , where the compounded effects of underlying health conditions , socioeconomic disadvantage , and structural racism result in imbricated risk of contracting COVID-19 , becoming unwell , and death .	1<2	none	joint	joint
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	1-17	155-168	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	In this review , we discuss an in vivo virusinduced mouse model of MS	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	In this review , we discuss an in vivo virusinduced mouse model of MS	1-27	155-191	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS ) that affects about 0.1 % of the worldwide population .	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	1>2	none	background	background
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	1-17	18-27	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	that affects about 0.1 % of the worldwide population .	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	that affects about 0.1 % of the worldwide population .	1-27	1-27	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS ) that affects about 0.1 % of the worldwide population .	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS ) that affects about 0.1 % of the worldwide population .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	1-17	28-38	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	This deleterious disease is marked by infiltration of myelinspecific T cells	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	This deleterious disease is marked by infiltration of myelinspecific T cells	1-27	28-50	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS ) that affects about 0.1 % of the worldwide population .	This deleterious disease is marked by infiltration of myelinspecific T cells that attack the protective myelin sheath that surrounds CNS nerve axons .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	28-38	39-44	This deleterious disease is marked by infiltration of myelinspecific T cells	that attack the protective myelin sheath	This deleterious disease is marked by infiltration of myelinspecific T cells	that attack the protective myelin sheath	28-50	28-50	This deleterious disease is marked by infiltration of myelinspecific T cells that attack the protective myelin sheath that surrounds CNS nerve axons .	This deleterious disease is marked by infiltration of myelinspecific T cells that attack the protective myelin sheath that surrounds CNS nerve axons .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	39-44	45-50	that attack the protective myelin sheath	that surrounds CNS nerve axons .	that attack the protective myelin sheath	that surrounds CNS nerve axons .	28-50	28-50	This deleterious disease is marked by infiltration of myelinspecific T cells that attack the protective myelin sheath that surrounds CNS nerve axons .	This deleterious disease is marked by infiltration of myelinspecific T cells that attack the protective myelin sheath that surrounds CNS nerve axons .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	28-38	51-59	This deleterious disease is marked by infiltration of myelinspecific T cells	Upon demyelination , saltatory nerve conduction is disrupted ,	This deleterious disease is marked by infiltration of myelinspecific T cells	Upon demyelination , saltatory nerve conduction is disrupted ,	28-50	51-65	This deleterious disease is marked by infiltration of myelinspecific T cells that attack the protective myelin sheath that surrounds CNS nerve axons .	Upon demyelination , saltatory nerve conduction is disrupted , and patients experience neurologic deficiencies .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	51-59	60-65	Upon demyelination , saltatory nerve conduction is disrupted ,	and patients experience neurologic deficiencies .	Upon demyelination , saltatory nerve conduction is disrupted ,	and patients experience neurologic deficiencies .	51-65	51-65	Upon demyelination , saltatory nerve conduction is disrupted , and patients experience neurologic deficiencies .	Upon demyelination , saltatory nerve conduction is disrupted , and patients experience neurologic deficiencies .	1<2	none	joint	joint
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	1-17	66-73	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	The exact cause for MS remains unknown ,	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS )	The exact cause for MS remains unknown ,	1-27	66-90	Multiple sclerosis ( MS ) is an autoimmune disease of the central nervous system ( CNS ) that affects about 0.1 % of the worldwide population .	The exact cause for MS remains unknown , although most evidence supports the hypothesis that both genetic and environmental factors contribute to disease development .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	66-73	74-79	The exact cause for MS remains unknown ,	although most evidence supports the hypothesis	The exact cause for MS remains unknown ,	although most evidence supports the hypothesis	66-90	66-90	The exact cause for MS remains unknown , although most evidence supports the hypothesis that both genetic and environmental factors contribute to disease development .	The exact cause for MS remains unknown , although most evidence supports the hypothesis that both genetic and environmental factors contribute to disease development .	1<2	none	comparison	comparison
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	74-79	80-90	although most evidence supports the hypothesis	that both genetic and environmental factors contribute to disease development .	although most evidence supports the hypothesis	that both genetic and environmental factors contribute to disease development .	66-90	66-90	The exact cause for MS remains unknown , although most evidence supports the hypothesis that both genetic and environmental factors contribute to disease development .	The exact cause for MS remains unknown , although most evidence supports the hypothesis that both genetic and environmental factors contribute to disease development .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	74-79	91-99,104-111	although most evidence supports the hypothesis	Epidemiologic evidence supports a role for environmental pathogens , <*> as potentially key contributors to MS induction .	although most evidence supports the hypothesis	Epidemiologic evidence supports a role for environmental pathogens , <*> as potentially key contributors to MS induction .	66-90	91-111	The exact cause for MS remains unknown , although most evidence supports the hypothesis that both genetic and environmental factors contribute to disease development .	Epidemiologic evidence supports a role for environmental pathogens , such as viruses , as potentially key contributors to MS induction .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	91-99,104-111	100-103	Epidemiologic evidence supports a role for environmental pathogens , <*> as potentially key contributors to MS induction .	such as viruses ,	Epidemiologic evidence supports a role for environmental pathogens , <*> as potentially key contributors to MS induction .	such as viruses ,	91-111	91-111	Epidemiologic evidence supports a role for environmental pathogens , such as viruses , as potentially key contributors to MS induction .	Epidemiologic evidence supports a role for environmental pathogens , such as viruses , as potentially key contributors to MS induction .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	91-99,104-111	112-129	Epidemiologic evidence supports a role for environmental pathogens , <*> as potentially key contributors to MS induction .	Pathogens can induce autoimmunity via several well - studied mechanisms with the most postulated being molecular mimicry .	Epidemiologic evidence supports a role for environmental pathogens , <*> as potentially key contributors to MS induction .	Pathogens can induce autoimmunity via several well - studied mechanisms with the most postulated being molecular mimicry .	91-111	112-129	Epidemiologic evidence supports a role for environmental pathogens , such as viruses , as potentially key contributors to MS induction .	Pathogens can induce autoimmunity via several well - studied mechanisms with the most postulated being molecular mimicry .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	112-129	130-132	Pathogens can induce autoimmunity via several well - studied mechanisms with the most postulated being molecular mimicry .	Molecular mimicry occurs	Pathogens can induce autoimmunity via several well - studied mechanisms with the most postulated being molecular mimicry .	Molecular mimicry occurs	112-129	130-154	Pathogens can induce autoimmunity via several well - studied mechanisms with the most postulated being molecular mimicry .	Molecular mimicry occurs when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes , leading to autoimmune tissue destruction .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	130-132	133-148	Molecular mimicry occurs	when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes ,	Molecular mimicry occurs	when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes ,	130-154	130-154	Molecular mimicry occurs when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes , leading to autoimmune tissue destruction .	Molecular mimicry occurs when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes , leading to autoimmune tissue destruction .	1<2	none	temporal	temporal
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	130-132	149-154	Molecular mimicry occurs	leading to autoimmune tissue destruction .	Molecular mimicry occurs	leading to autoimmune tissue destruction .	130-154	130-154	Molecular mimicry occurs when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes , leading to autoimmune tissue destruction .	Molecular mimicry occurs when T cells specific for peptide epitopes derived from pathogens cross - react with selfepitopes , leading to autoimmune tissue destruction .	1<2	none	cause-result	cause-result
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	155-168	169-173	In this review , we discuss an in vivo virusinduced mouse model of MS	developed in our laboratory ,	In this review , we discuss an in vivo virusinduced mouse model of MS	developed in our laboratory ,	155-191	155-191	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	155-168	174-183	In this review , we discuss an in vivo virusinduced mouse model of MS	which has contributed greatly to our understanding of the mechanisms	In this review , we discuss an in vivo virusinduced mouse model of MS	which has contributed greatly to our understanding of the mechanisms	155-191	155-191	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	1<2	none	elaboration	elaboration
a6ae0b0a1b76a367c6a95d58052c65b2c5feb850	174-183	184-191	which has contributed greatly to our understanding of the mechanisms	underlying molecular mimicry - induced CNS autoimmunity .	which has contributed greatly to our understanding of the mechanisms	underlying molecular mimicry - induced CNS autoimmunity .	155-191	155-191	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	In this review , we discuss an in vivo virusinduced mouse model of MS developed in our laboratory , which has contributed greatly to our understanding of the mechanisms underlying molecular mimicry - induced CNS autoimmunity .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	1-11	112-125	In mammalian cells , the Golgi complex has an elaborate structure	This review summarizes our understanding of intra - Golgi transport of large cargo ,	In mammalian cells , the Golgi complex has an elaborate structure	This review summarizes our understanding of intra - Golgi transport of large cargo ,	1-29	112-133	In mammalian cells , the Golgi complex has an elaborate structure consisting of stacked , flattened cisternal membranes collected into a ribbon in the center of the cell .	This review summarizes our understanding of intra - Golgi transport of large cargo , and outlines current questions open for experimentation .	1>2	none	background	background
a6f51bc35967b5ec3948012d00a543a9f51b450f	1-11	12-18	In mammalian cells , the Golgi complex has an elaborate structure	consisting of stacked , flattened cisternal membranes	In mammalian cells , the Golgi complex has an elaborate structure	consisting of stacked , flattened cisternal membranes	1-29	1-29	In mammalian cells , the Golgi complex has an elaborate structure consisting of stacked , flattened cisternal membranes collected into a ribbon in the center of the cell .	In mammalian cells , the Golgi complex has an elaborate structure consisting of stacked , flattened cisternal membranes collected into a ribbon in the center of the cell .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	12-18	19-29	consisting of stacked , flattened cisternal membranes	collected into a ribbon in the center of the cell .	consisting of stacked , flattened cisternal membranes	collected into a ribbon in the center of the cell .	1-29	1-29	In mammalian cells , the Golgi complex has an elaborate structure consisting of stacked , flattened cisternal membranes collected into a ribbon in the center of the cell .	In mammalian cells , the Golgi complex has an elaborate structure consisting of stacked , flattened cisternal membranes collected into a ribbon in the center of the cell .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	1-11	30-37	In mammalian cells , the Golgi complex has an elaborate structure	Amazingly , the flattened cisternae can rapidly dilate	In mammalian cells , the Golgi complex has an elaborate structure	Amazingly , the flattened cisternae can rapidly dilate	1-29	30-48	In mammalian cells , the Golgi complex has an elaborate structure consisting of stacked , flattened cisternal membranes collected into a ribbon in the center of the cell .	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	30-37	38-41	Amazingly , the flattened cisternae can rapidly dilate	to accommodate large cargo	Amazingly , the flattened cisternae can rapidly dilate	to accommodate large cargo	30-48	30-48	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	1<2	none	enablement	enablement
a6f51bc35967b5ec3948012d00a543a9f51b450f	38-41	42-48	to accommodate large cargo	as it traffics through the organelle .	to accommodate large cargo	as it traffics through the organelle .	30-48	30-48	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	1<2	none	temporal	temporal
a6f51bc35967b5ec3948012d00a543a9f51b450f	30-37	49-50,55-57	Amazingly , the flattened cisternae can rapidly dilate	The mechanism <*> is unknown .	Amazingly , the flattened cisternae can rapidly dilate	The mechanism <*> is unknown .	30-48	49-57	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	The mechanism by which this occurs is unknown .	1<2	none	comparison	comparison
a6f51bc35967b5ec3948012d00a543a9f51b450f	49-50,55-57	51-54	The mechanism <*> is unknown .	by which this occurs	The mechanism <*> is unknown .	by which this occurs	49-57	49-57	The mechanism by which this occurs is unknown .	The mechanism by which this occurs is unknown .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	30-37	58-68	Amazingly , the flattened cisternae can rapidly dilate	Exocytosis of large cargo is essential for many physiological processes ,	Amazingly , the flattened cisternae can rapidly dilate	Exocytosis of large cargo is essential for many physiological processes ,	30-48	58-83	Amazingly , the flattened cisternae can rapidly dilate to accommodate large cargo as it traffics through the organelle .	Exocytosis of large cargo is essential for many physiological processes , including collagen and lipoprotein secretion , and defects in the process lead to disease .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	58-68	69-74	Exocytosis of large cargo is essential for many physiological processes ,	including collagen and lipoprotein secretion ,	Exocytosis of large cargo is essential for many physiological processes ,	including collagen and lipoprotein secretion ,	58-83	58-83	Exocytosis of large cargo is essential for many physiological processes , including collagen and lipoprotein secretion , and defects in the process lead to disease .	Exocytosis of large cargo is essential for many physiological processes , including collagen and lipoprotein secretion , and defects in the process lead to disease .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	58-68	75-83	Exocytosis of large cargo is essential for many physiological processes ,	and defects in the process lead to disease .	Exocytosis of large cargo is essential for many physiological processes ,	and defects in the process lead to disease .	58-83	58-83	Exocytosis of large cargo is essential for many physiological processes , including collagen and lipoprotein secretion , and defects in the process lead to disease .	Exocytosis of large cargo is essential for many physiological processes , including collagen and lipoprotein secretion , and defects in the process lead to disease .	1<2	none	cause-result	cause-result
a6f51bc35967b5ec3948012d00a543a9f51b450f	58-68	84-88,98-111	Exocytosis of large cargo is essential for many physiological processes ,	In addition , enveloped viruses <*> must also be transported through Golgi cisternae for secretion from the infected cell .	Exocytosis of large cargo is essential for many physiological processes ,	In addition , enveloped viruses <*> must also be transported through Golgi cisternae for secretion from the infected cell .	58-83	84-111	Exocytosis of large cargo is essential for many physiological processes , including collagen and lipoprotein secretion , and defects in the process lead to disease .	In addition , enveloped viruses that bud into the endoplasmic reticulum or Golgi complex must also be transported through Golgi cisternae for secretion from the infected cell .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	84-88,98-111	89-97	In addition , enveloped viruses <*> must also be transported through Golgi cisternae for secretion from the infected cell .	that bud into the endoplasmic reticulum or Golgi complex	In addition , enveloped viruses <*> must also be transported through Golgi cisternae for secretion from the infected cell .	that bud into the endoplasmic reticulum or Golgi complex	84-111	84-111	In addition , enveloped viruses that bud into the endoplasmic reticulum or Golgi complex must also be transported through Golgi cisternae for secretion from the infected cell .	In addition , enveloped viruses that bud into the endoplasmic reticulum or Golgi complex must also be transported through Golgi cisternae for secretion from the infected cell .	1<2	none	elaboration	elaboration
a6f51bc35967b5ec3948012d00a543a9f51b450f	112-125	126-129	This review summarizes our understanding of intra - Golgi transport of large cargo ,	and outlines current questions	This review summarizes our understanding of intra - Golgi transport of large cargo ,	and outlines current questions	112-133	112-133	This review summarizes our understanding of intra - Golgi transport of large cargo , and outlines current questions open for experimentation .	This review summarizes our understanding of intra - Golgi transport of large cargo , and outlines current questions open for experimentation .	1<2	none	joint	joint
a6f51bc35967b5ec3948012d00a543a9f51b450f	126-129	130-133	and outlines current questions	open for experimentation .	and outlines current questions	open for experimentation .	112-133	112-133	This review summarizes our understanding of intra - Golgi transport of large cargo , and outlines current questions open for experimentation .	This review summarizes our understanding of intra - Golgi transport of large cargo , and outlines current questions open for experimentation .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	1-11	112-121	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis	In the present study , clinical Norovirus specimens were used	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis	In the present study , clinical Norovirus specimens were used	1-24	112-169	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis associated with food as well as person - to - person transmission .	In the present study , clinical Norovirus specimens were used to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods which had a high detection rate .	1>2	none	background	background
a7ba852208db4acf89b85705dd9a04d667da521c	1-11	12-24	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis	associated with food as well as person - to - person transmission .	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis	associated with food as well as person - to - person transmission .	1-24	1-24	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis associated with food as well as person - to - person transmission .	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis associated with food as well as person - to - person transmission .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	1-11	25-41	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis	The ubiquitous nature of Norovirus necessitates simple and rapid detection methods with high accuracy and sensitivity .	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis	The ubiquitous nature of Norovirus necessitates simple and rapid detection methods with high accuracy and sensitivity .	1-24	25-41	Norovirus is a major etiologic agent in worldwide outbreaks of gastroenteritis associated with food as well as person - to - person transmission .	The ubiquitous nature of Norovirus necessitates simple and rapid detection methods with high accuracy and sensitivity .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	25-41	42-67	The ubiquitous nature of Norovirus necessitates simple and rapid detection methods with high accuracy and sensitivity .	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits	The ubiquitous nature of Norovirus necessitates simple and rapid detection methods with high accuracy and sensitivity .	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits	25-41	42-81	The ubiquitous nature of Norovirus necessitates simple and rapid detection methods with high accuracy and sensitivity .	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits for detecting Norovirus genogroups I ( GI ) and II ( GII ) .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	42-67	68-81	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits	for detecting Norovirus genogroups I ( GI ) and II ( GII ) .	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits	for detecting Norovirus genogroups I ( GI ) and II ( GII ) .	42-81	42-81	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits for detecting Norovirus genogroups I ( GI ) and II ( GII ) .	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits for detecting Norovirus genogroups I ( GI ) and II ( GII ) .	1<2	none	enablement	enablement
a7ba852208db4acf89b85705dd9a04d667da521c	42-67	82-99	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate ,	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate ,	42-81	82-111	To this end , several investigators have evaluated the usefulness of commercial reverse - transcription loop - mediated isothermal amplification ( RT - LAMP ) kits for detecting Norovirus genogroups I ( GI ) and II ( GII ) .	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate , while that for Norovirus GI showed a relatively low detection rate .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	82-99	100-111	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate ,	while that for Norovirus GI showed a relatively low detection rate .	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate ,	while that for Norovirus GI showed a relatively low detection rate .	82-111	82-111	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate , while that for Norovirus GI showed a relatively low detection rate .	In previous studies , the conventional Loopamp kit for Norovirus GII showed a relatively high detection rate , while that for Norovirus GI showed a relatively low detection rate .	1<2	none	comparison	comparison
a7ba852208db4acf89b85705dd9a04d667da521c	112-121	122-162	In the present study , clinical Norovirus specimens were used	to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods	In the present study , clinical Norovirus specimens were used	to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods	112-169	112-169	In the present study , clinical Norovirus specimens were used to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods which had a high detection rate .	In the present study , clinical Norovirus specimens were used to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods which had a high detection rate .	1<2	none	enablement	enablement
a7ba852208db4acf89b85705dd9a04d667da521c	122-162	163-169	to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods	which had a high detection rate .	to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods	which had a high detection rate .	112-169	112-169	In the present study , clinical Norovirus specimens were used to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods which had a high detection rate .	In the present study , clinical Norovirus specimens were used to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods which had a high detection rate .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	170-175	176-192	Results from the present study showed	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	Results from the present study showed	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	170-198	170-198	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	1>2	none	attribution	attribution
a7ba852208db4acf89b85705dd9a04d667da521c	112-121	176-192	In the present study , clinical Norovirus specimens were used	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	In the present study , clinical Norovirus specimens were used	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	112-169	170-198	In the present study , clinical Norovirus specimens were used to compare the detection rate of a modified Loopamp kit for Norovirus GI with the rates of the conventional Loopamp kit for Norovirus GI and an ' ' in - house ' ' RT - LAMP GI primer set , methods which had a high detection rate .	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	1<2	none	findings	findings
a7ba852208db4acf89b85705dd9a04d667da521c	176-192	193-198	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	( GI.3 , GI.11 ) .	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	( GI.3 , GI.11 ) .	170-198	170-198	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	199-212	220-242	On comparison with an ' ' in - house ' ' GII primer set	the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	On comparison with an ' ' in - house ' ' GII primer set	the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	199-242	199-242	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	1>2	none	comparison	comparison
a7ba852208db4acf89b85705dd9a04d667da521c	199-212	213-216	On comparison with an ' ' in - house ' ' GII primer set	using genotype GII.4 viruses	On comparison with an ' ' in - house ' ' GII primer set	using genotype GII.4 viruses	199-242	199-242	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	1<2	none	manner-means	manner-means
a7ba852208db4acf89b85705dd9a04d667da521c	213-216	217-219	using genotype GII.4 viruses	circulating recently ,	using genotype GII.4 viruses	circulating recently ,	199-242	199-242	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	176-192	220-242	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	170-198	199-242	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	On comparison with an ' ' in - house ' ' GII primer set using genotype GII.4 viruses circulating recently , the detection rate by the Loopamp kit for Norovirus GII was found to be higher , with a 98 % detection rate .	1<2	none	elaboration	elaboration
a7ba852208db4acf89b85705dd9a04d667da521c	176-192	243-269	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	These results indicate the applicability of the modified LAMP kit for GI and the conventional LAMP kit for GII for detection of Noroviruses in clinical samples .	that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes	These results indicate the applicability of the modified LAMP kit for GI and the conventional LAMP kit for GII for detection of Noroviruses in clinical samples .	170-198	243-269	Results from the present study showed that the modified Loopamp kit for Norovirus GI had a higher detection rate for two viral genotypes ( GI.3 , GI.11 ) .	These results indicate the applicability of the modified LAMP kit for GI and the conventional LAMP kit for GII for detection of Noroviruses in clinical samples .	1<2	none	elaboration	elaboration
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	1-12	13-31	Apoptosis plays an important role in the pathogenesis of viral infections .	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	Apoptosis plays an important role in the pathogenesis of viral infections .	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	1-12	13-31	Apoptosis plays an important role in the pathogenesis of viral infections .	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	1>2	none	background	background
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	32-40	41-49	Annexin V - PI staining and electron microscopy indicated	that HHV-6A is a strong inducer of apoptosis .	Annexin V - PI staining and electron microscopy indicated	that HHV-6A is a strong inducer of apoptosis .	32-49	32-49	Annexin V - PI staining and electron microscopy indicated that HHV-6A is a strong inducer of apoptosis .	Annexin V - PI staining and electron microscopy indicated that HHV-6A is a strong inducer of apoptosis .	1>2	none	attribution	attribution
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	13-31	41-49	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	that HHV-6A is a strong inducer of apoptosis .	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	that HHV-6A is a strong inducer of apoptosis .	13-31	32-49	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	Annexin V - PI staining and electron microscopy indicated that HHV-6A is a strong inducer of apoptosis .	1<2	none	findings	findings
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	41-49	50-55	that HHV-6A is a strong inducer of apoptosis .	HHV-6A infection decreased mitochondrial transmembrane potential	that HHV-6A is a strong inducer of apoptosis .	HHV-6A infection decreased mitochondrial transmembrane potential	32-49	50-63	Annexin V - PI staining and electron microscopy indicated that HHV-6A is a strong inducer of apoptosis .	HHV-6A infection decreased mitochondrial transmembrane potential and led to morphological changes of mitochondria .	1<2	none	elaboration	elaboration
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	50-55	56-63	HHV-6A infection decreased mitochondrial transmembrane potential	and led to morphological changes of mitochondria .	HHV-6A infection decreased mitochondrial transmembrane potential	and led to morphological changes of mitochondria .	50-63	50-63	HHV-6A infection decreased mitochondrial transmembrane potential and led to morphological changes of mitochondria .	HHV-6A infection decreased mitochondrial transmembrane potential and led to morphological changes of mitochondria .	1<2	none	joint	joint
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	41-49	64-86	that HHV-6A is a strong inducer of apoptosis .	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase ,	that HHV-6A is a strong inducer of apoptosis .	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase ,	32-49	64-98	Annexin V - PI staining and electron microscopy indicated that HHV-6A is a strong inducer of apoptosis .	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase , which is known to be an important substrate for activated caspase-3 .	1<2	none	elaboration	elaboration
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	64-86	87-98	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase ,	which is known to be an important substrate for activated caspase-3 .	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase ,	which is known to be an important substrate for activated caspase-3 .	64-98	64-98	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase , which is known to be an important substrate for activated caspase-3 .	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase , which is known to be an important substrate for activated caspase-3 .	1<2	none	elaboration	elaboration
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	64-86	99-106	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase ,	Caspase-9 was activated significantly in HHV-6Ainfected cells ,	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase ,	Caspase-9 was activated significantly in HHV-6Ainfected cells ,	64-98	99-113	The cell death was associated with activation of caspase-3 and cleavage of DNA repair enzyme poly ( ADP - ribose ) polymerase , which is known to be an important substrate for activated caspase-3 .	Caspase-9 was activated significantly in HHV-6Ainfected cells , whereas caspase-8 was not activated obviously .	1<2	none	elaboration	elaboration
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	99-106	107-113	Caspase-9 was activated significantly in HHV-6Ainfected cells ,	whereas caspase-8 was not activated obviously .	Caspase-9 was activated significantly in HHV-6Ainfected cells ,	whereas caspase-8 was not activated obviously .	99-113	99-113	Caspase-9 was activated significantly in HHV-6Ainfected cells , whereas caspase-8 was not activated obviously .	Caspase-9 was activated significantly in HHV-6Ainfected cells , whereas caspase-8 was not activated obviously .	1<2	none	comparison	comparison
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	99-106	114-123	Caspase-9 was activated significantly in HHV-6Ainfected cells ,	Moreover , HHV-6A infection upregulated Bax and downregulated Bcl-2 .	Caspase-9 was activated significantly in HHV-6Ainfected cells ,	Moreover , HHV-6A infection upregulated Bax and downregulated Bcl-2 .	99-113	114-123	Caspase-9 was activated significantly in HHV-6Ainfected cells , whereas caspase-8 was not activated obviously .	Moreover , HHV-6A infection upregulated Bax and downregulated Bcl-2 .	1<2	none	elaboration	elaboration
a924e53c9e50e932f6d0b3938b5bdf284e1736a7	13-31	124-143	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	This is the first demonstration of mitochondrion - mediated , caspase - dependent apoptosis in HHV-6A - infected cells .	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	This is the first demonstration of mitochondrion - mediated , caspase - dependent apoptosis in HHV-6A - infected cells .	13-31	124-143	In this study , we investigated the cell death processes during productive HHV-6A infection and the underlying mechanisms .	This is the first demonstration of mitochondrion - mediated , caspase - dependent apoptosis in HHV-6A - infected cells .	1<2	none	findings	findings
a987e584291a44e8bbab14f9909629b8bba57853	1-18	30-38,56-76	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay ,	Herein , we assessed the RNA extraction necessity , <*> in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay ,	Herein , we assessed the RNA extraction necessity , <*> in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	1-29	30-76	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay , however recent studies support the elimination of the extraction step .	Herein , we assessed the RNA extraction necessity , by comparing RT - qPCR efficacy in several direct approaches vs. the gold standard RNA extraction , in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	1>2	none	background	background
a987e584291a44e8bbab14f9909629b8bba57853	1-18	19-29	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay ,	however recent studies support the elimination of the extraction step .	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay ,	however recent studies support the elimination of the extraction step .	1-29	1-29	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay , however recent studies support the elimination of the extraction step .	SARS - CoV-2 genetic identification is based on viral RNA extraction prior to RT - qPCR assay , however recent studies support the elimination of the extraction step .	1<2	none	comparison	comparison
a987e584291a44e8bbab14f9909629b8bba57853	30-38,56-76	39-55	Herein , we assessed the RNA extraction necessity , <*> in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	by comparing RT - qPCR efficacy in several direct approaches vs. the gold standard RNA extraction ,	Herein , we assessed the RNA extraction necessity , <*> in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	by comparing RT - qPCR efficacy in several direct approaches vs. the gold standard RNA extraction ,	30-76	30-76	Herein , we assessed the RNA extraction necessity , by comparing RT - qPCR efficacy in several direct approaches vs. the gold standard RNA extraction , in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	Herein , we assessed the RNA extraction necessity , by comparing RT - qPCR efficacy in several direct approaches vs. the gold standard RNA extraction , in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	1<2	none	manner-means	manner-means
a987e584291a44e8bbab14f9909629b8bba57853	30-38,56-76	77-85	Herein , we assessed the RNA extraction necessity , <*> in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	Our findings show advantage for the extraction procedure ,	Herein , we assessed the RNA extraction necessity , <*> in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	Our findings show advantage for the extraction procedure ,	30-76	77-109	Herein , we assessed the RNA extraction necessity , by comparing RT - qPCR efficacy in several direct approaches vs. the gold standard RNA extraction , in detection of SARS - CoV-2 from laboratory samples as well as clinical Oro - nasopharyngeal SARS - CoV-2 swabs .	Our findings show advantage for the extraction procedure , however a direct no - buffer approach might be an alternative , since it identified up to 70 % of positive clinical specimens .	1<2	none	findings	findings
a987e584291a44e8bbab14f9909629b8bba57853	77-85	86-97	Our findings show advantage for the extraction procedure ,	however a direct no - buffer approach might be an alternative ,	Our findings show advantage for the extraction procedure ,	however a direct no - buffer approach might be an alternative ,	77-109	77-109	Our findings show advantage for the extraction procedure , however a direct no - buffer approach might be an alternative , since it identified up to 70 % of positive clinical specimens .	Our findings show advantage for the extraction procedure , however a direct no - buffer approach might be an alternative , since it identified up to 70 % of positive clinical specimens .	1<2	none	comparison	comparison
a987e584291a44e8bbab14f9909629b8bba57853	86-97	98-109	however a direct no - buffer approach might be an alternative ,	since it identified up to 70 % of positive clinical specimens .	however a direct no - buffer approach might be an alternative ,	since it identified up to 70 % of positive clinical specimens .	77-109	77-109	Our findings show advantage for the extraction procedure , however a direct no - buffer approach might be an alternative , since it identified up to 70 % of positive clinical specimens .	Our findings show advantage for the extraction procedure , however a direct no - buffer approach might be an alternative , since it identified up to 70 % of positive clinical specimens .	1<2	none	cause-result	cause-result
aa339dc08635486396623300d7ab64d1c8d632f6	1-19	35-40	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) ,	We propose FastGAT , a method	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) ,	We propose FastGAT , a method	1-34	35-60	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) , however , they result in a high computational burden during both training and inference .	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	1>2	none	background	background
aa339dc08635486396623300d7ab64d1c8d632f6	1-19	20-34	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) ,	however , they result in a high computational burden during both training and inference .	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) ,	however , they result in a high computational burden during both training and inference .	1-34	1-34	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) , however , they result in a high computational burden during both training and inference .	The attention mechanism has demonstrated superior performance for inference over nodes in graph neural networks ( GNNs ) , however , they result in a high computational burden during both training and inference .	1<2	none	comparison	comparison
aa339dc08635486396623300d7ab64d1c8d632f6	35-40	41-46	We propose FastGAT , a method	to make attention based GNNs lightweight	We propose FastGAT , a method	to make attention based GNNs lightweight	35-60	35-60	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	41-46	47-50	to make attention based GNNs lightweight	by using spectral sparsification	to make attention based GNNs lightweight	by using spectral sparsification	35-60	35-60	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	1<2	none	manner-means	manner-means
aa339dc08635486396623300d7ab64d1c8d632f6	47-50	51-60	by using spectral sparsification	to generate an optimal pruning of the input graph .	by using spectral sparsification	to generate an optimal pruning of the input graph .	35-60	35-60	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	1<2	none	enablement	enablement
aa339dc08635486396623300d7ab64d1c8d632f6	35-40	61-68	We propose FastGAT , a method	This results in a per - epoch time	We propose FastGAT , a method	This results in a per - epoch time	35-60	61-83	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	This results in a per - epoch time that is almost linear in the number of graph nodes as opposed to quadratic .	1<2	none	cause-result	cause-result
aa339dc08635486396623300d7ab64d1c8d632f6	61-68	69-78	This results in a per - epoch time	that is almost linear in the number of graph nodes	This results in a per - epoch time	that is almost linear in the number of graph nodes	61-83	61-83	This results in a per - epoch time that is almost linear in the number of graph nodes as opposed to quadratic .	This results in a per - epoch time that is almost linear in the number of graph nodes as opposed to quadratic .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	69-78	79-83	that is almost linear in the number of graph nodes	as opposed to quadratic .	that is almost linear in the number of graph nodes	as opposed to quadratic .	61-83	61-83	This results in a per - epoch time that is almost linear in the number of graph nodes as opposed to quadratic .	This results in a per - epoch time that is almost linear in the number of graph nodes as opposed to quadratic .	1<2	none	comparison	comparison
aa339dc08635486396623300d7ab64d1c8d632f6	35-40	84-104	We propose FastGAT , a method	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT )	We propose FastGAT , a method	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT )	35-60	84-120	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT ) that interprets it as a graph convolution method using the random walk normalized graph Laplacian .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	84-104	105-112	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT )	that interprets it as a graph convolution method	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT )	that interprets it as a graph convolution method	84-120	84-120	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT ) that interprets it as a graph convolution method using the random walk normalized graph Laplacian .	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT ) that interprets it as a graph convolution method using the random walk normalized graph Laplacian .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	105-112	113-120	that interprets it as a graph convolution method	using the random walk normalized graph Laplacian .	that interprets it as a graph convolution method	using the random walk normalized graph Laplacian .	84-120	84-120	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT ) that interprets it as a graph convolution method using the random walk normalized graph Laplacian .	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT ) that interprets it as a graph convolution method using the random walk normalized graph Laplacian .	1<2	none	manner-means	manner-means
aa339dc08635486396623300d7ab64d1c8d632f6	121-124	125-127	Using this framework ,	we theoretically prove	Using this framework ,	we theoretically prove	121-145	121-145	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	1>2	none	manner-means	manner-means
aa339dc08635486396623300d7ab64d1c8d632f6	125-127	128-133	we theoretically prove	that spectral sparsification preserves the features	we theoretically prove	that spectral sparsification preserves the features	121-145	121-145	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	1>2	none	attribution	attribution
aa339dc08635486396623300d7ab64d1c8d632f6	84-104	128-133	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT )	that spectral sparsification preserves the features	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT )	that spectral sparsification preserves the features	84-120	121-145	Further , we provide a re - formulation of a specific attention based GNN , Graph Attention Network ( GAT ) that interprets it as a graph convolution method using the random walk normalized graph Laplacian .	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	128-133	134-139	that spectral sparsification preserves the features	computed by the GAT model ,	that spectral sparsification preserves the features	computed by the GAT model ,	121-145	121-145	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	128-133	140-145	that spectral sparsification preserves the features	thereby justifying our FastGAT algorithm .	that spectral sparsification preserves the features	thereby justifying our FastGAT algorithm .	121-145	121-145	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	Using this framework , we theoretically prove that spectral sparsification preserves the features computed by the GAT model , thereby justifying our FastGAT algorithm .	1<2	none	cause-result	cause-result
aa339dc08635486396623300d7ab64d1c8d632f6	146-161	162-165,171-177	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks ,	FastGAT can dramatically reduce <*> the computational time and memory requirements ,	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks ,	FastGAT can dramatically reduce <*> the computational time and memory requirements ,	146-188	146-188	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	1>2	none	manner-means	manner-means
aa339dc08635486396623300d7ab64d1c8d632f6	35-40	162-165,171-177	We propose FastGAT , a method	FastGAT can dramatically reduce <*> the computational time and memory requirements ,	We propose FastGAT , a method	FastGAT can dramatically reduce <*> the computational time and memory requirements ,	35-60	146-188	We propose FastGAT , a method to make attention based GNNs lightweight by using spectral sparsification to generate an optimal pruning of the input graph .	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	1<2	none	findings	findings
aa339dc08635486396623300d7ab64d1c8d632f6	162-165,171-177	166-170	FastGAT can dramatically reduce <*> the computational time and memory requirements ,	( up to 10x )	FastGAT can dramatically reduce <*> the computational time and memory requirements ,	( up to 10x )	146-188	146-188	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	1<2	none	elaboration	elaboration
aa339dc08635486396623300d7ab64d1c8d632f6	171-177	178-188	the computational time and memory requirements ,	allowing the usage of attention based GNNs on large graphs .	the computational time and memory requirements ,	allowing the usage of attention based GNNs on large graphs .	146-188	146-188	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	We experimentally evaluate FastGAT on several large real world graph datasets for node classification tasks , FastGAT can dramatically reduce ( up to 10x ) the computational time and memory requirements , allowing the usage of attention based GNNs on large graphs .	1<2	none	cause-result	cause-result
ab47b7fee600cd540e17d363002a05a3bdfdd306	1-5	6-31	Current research is an attempt	to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting	Current research is an attempt	to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting	1-41	1-41	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	1<2	none	enablement	enablement
ab47b7fee600cd540e17d363002a05a3bdfdd306	6-31	32-41	to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting	to estimate infected population along with 30 days projection .	to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting	to estimate infected population along with 30 days projection .	1-41	1-41	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	1<2	none	enablement	enablement
ab47b7fee600cd540e17d363002a05a3bdfdd306	1-5	42-70	Current research is an attempt	The pandemic curve has been explored for above average affected countries , six regions and global scale during 64 days of 22nd January to 24th March , 2020 .	Current research is an attempt	The pandemic curve has been explored for above average affected countries , six regions and global scale during 64 days of 22nd January to 24th March , 2020 .	1-41	42-70	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	The pandemic curve has been explored for above average affected countries , six regions and global scale during 64 days of 22nd January to 24th March , 2020 .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	1-5	71-94	Current research is an attempt	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	Current research is an attempt	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	1-41	71-94	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	1<2	none	findings	findings
ab47b7fee600cd540e17d363002a05a3bdfdd306	71-94	95-115	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	The confirmed cases probability density curve is high positive skewed and leptokurtic with mean global infected daily population of 6620 .	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	The confirmed cases probability density curve is high positive skewed and leptokurtic with mean global infected daily population of 6620 .	71-94	95-115	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	The confirmed cases probability density curve is high positive skewed and leptokurtic with mean global infected daily population of 6620 .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	95-115	116-132	The confirmed cases probability density curve is high positive skewed and leptokurtic with mean global infected daily population of 6620 .	The recovered cases showed bimodal positive skewed curve of leptokurtic type with daily recovery of 1708 .	The confirmed cases probability density curve is high positive skewed and leptokurtic with mean global infected daily population of 6620 .	The recovered cases showed bimodal positive skewed curve of leptokurtic type with daily recovery of 1708 .	95-115	116-132	The confirmed cases probability density curve is high positive skewed and leptokurtic with mean global infected daily population of 6620 .	The recovered cases showed bimodal positive skewed curve of leptokurtic type with daily recovery of 1708 .	1<2	none	joint	joint
ab47b7fee600cd540e17d363002a05a3bdfdd306	71-94	133-156	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	The change point detection helped to understand the CoVID-19 curve in term of sudden change in term of mean or mean with variance .	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	The change point detection helped to understand the CoVID-19 curve in term of sudden change in term of mean or mean with variance .	71-94	133-156	The global cases infection as well as recovery rate curves remained in the ranged of 0 -9.89 and 0 -8.89 % , respectively .	The change point detection helped to understand the CoVID-19 curve in term of sudden change in term of mean or mean with variance .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	157-159	160-169	This pointed out	disease curve is consist of three phases and last segment	This pointed out	disease curve is consist of three phases and last segment	157-177	157-177	This pointed out disease curve is consist of three phases and last segment that varies in term of day lengths .	This pointed out disease curve is consist of three phases and last segment that varies in term of day lengths .	1>2	none	attribution	attribution
ab47b7fee600cd540e17d363002a05a3bdfdd306	133-156	160-169	The change point detection helped to understand the CoVID-19 curve in term of sudden change in term of mean or mean with variance .	disease curve is consist of three phases and last segment	The change point detection helped to understand the CoVID-19 curve in term of sudden change in term of mean or mean with variance .	disease curve is consist of three phases and last segment	133-156	157-177	The change point detection helped to understand the CoVID-19 curve in term of sudden change in term of mean or mean with variance .	This pointed out disease curve is consist of three phases and last segment that varies in term of day lengths .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	160-169	170-177	disease curve is consist of three phases and last segment	that varies in term of day lengths .	disease curve is consist of three phases and last segment	that varies in term of day lengths .	157-177	157-177	This pointed out disease curve is consist of three phases and last segment that varies in term of day lengths .	This pointed out disease curve is consist of three phases and last segment that varies in term of day lengths .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	160-169	178-193	disease curve is consist of three phases and last segment	The mean with variance based change detection is better in differentiating phases and associated segment length	disease curve is consist of three phases and last segment	The mean with variance based change detection is better in differentiating phases and associated segment length	157-177	178-198	This pointed out disease curve is consist of three phases and last segment that varies in term of day lengths .	The mean with variance based change detection is better in differentiating phases and associated segment length as compared to mean .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	178-193	194-198	The mean with variance based change detection is better in differentiating phases and associated segment length	as compared to mean .	The mean with variance based change detection is better in differentiating phases and associated segment length	as compared to mean .	178-198	178-198	The mean with variance based change detection is better in differentiating phases and associated segment length as compared to mean .	The mean with variance based change detection is better in differentiating phases and associated segment length as compared to mean .	1<2	none	comparison	comparison
ab47b7fee600cd540e17d363002a05a3bdfdd306	1-5	199-217	Current research is an attempt	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 ,	Current research is an attempt	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 ,	1-41	199-229	Current research is an attempt to understand the CoVID-19 pandemic curve through statistical approach of probability density function with associated skewness and kurtosis measures , change point detection and polynomial fitting to estimate infected population along with 30 days projection .	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 , depending upon the pandemic curve progress beyond 24th March , 2020 .	1<2	none	findings	findings
ab47b7fee600cd540e17d363002a05a3bdfdd306	199-217	218-229	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 ,	depending upon the pandemic curve progress beyond 24th March , 2020 .	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 ,	depending upon the pandemic curve progress beyond 24th March , 2020 .	199-229	199-229	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 , depending upon the pandemic curve progress beyond 24th March , 2020 .	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 , depending upon the pandemic curve progress beyond 24th March , 2020 .	1<2	none	condition	condition
ab47b7fee600cd540e17d363002a05a3bdfdd306	199-217	230-249	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 ,	Expected most affected countries will be USA , and UK with at least infected population of over 0.100 million .	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 ,	Expected most affected countries will be USA , and UK with at least infected population of over 0.100 million .	199-229	230-249	Global infected population might rise in the range of 0.750 to 4.680 million by 24 th April 2020 , depending upon the pandemic curve progress beyond 24th March , 2020 .	Expected most affected countries will be USA , and UK with at least infected population of over 0.100 million .	1<2	none	elaboration	elaboration
ab47b7fee600cd540e17d363002a05a3bdfdd306	230-249	250-264	Expected most affected countries will be USA , and UK with at least infected population of over 0.100 million .	Infected population polynomial projection errors remained in the range of -78.8 to 49.0 % .	Expected most affected countries will be USA , and UK with at least infected population of over 0.100 million .	Infected population polynomial projection errors remained in the range of -78.8 to 49.0 % .	230-249	250-264	Expected most affected countries will be USA , and UK with at least infected population of over 0.100 million .	Infected population polynomial projection errors remained in the range of -78.8 to 49.0 % .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	1-23	136-148	TREM2 variants have been identified as risk factors for Alzheimer 's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	We provide a comprehensive review of our current understanding of TREM2 biology ,	TREM2 variants have been identified as risk factors for Alzheimer's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	We provide a comprehensive review of our current understanding of TREM2 biology ,	1-23	136-166	TREM2 variants have been identified as risk factors for Alzheimer 's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	We provide a comprehensive review of our current understanding of TREM2 biology , including new insights into the regulation of TREM2 expression , and TREM2 signaling and function across NDDs .	1>2	none	background	background
ac51af9995edb441f0ce4fdc384908daa6e83675	24-28	41-55	Because TREM2 encodes a receptor	that the immune response can play an active role in the pathogenesis of NDDs .	Because TREM2 encodes a receptor	that the immune response can play an active role in the pathogenesis of NDDs .	24-55	24-55	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	1>2	none	cause-result	cause-result
ac51af9995edb441f0ce4fdc384908daa6e83675	24-28	29-34	Because TREM2 encodes a receptor	exclusively expressed on immune cells ,	Because TREM2 encodes a receptor	exclusively expressed on immune cells ,	24-55	24-55	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	35-40	41-55	identification of these variants conclusively demonstrates	that the immune response can play an active role in the pathogenesis of NDDs .	identification of these variants conclusively demonstrates	that the immune response can play an active role in the pathogenesis of NDDs .	24-55	24-55	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	1>2	none	attribution	attribution
ac51af9995edb441f0ce4fdc384908daa6e83675	1-23	41-55	TREM2 variants have been identified as risk factors for Alzheimer 's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	that the immune response can play an active role in the pathogenesis of NDDs .	TREM2 variants have been identified as risk factors for Alzheimer's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	that the immune response can play an active role in the pathogenesis of NDDs .	1-23	24-55	TREM2 variants have been identified as risk factors for Alzheimer 's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	Because TREM2 encodes a receptor exclusively expressed on immune cells , identification of these variants conclusively demonstrates that the immune response can play an active role in the pathogenesis of NDDs .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	1-23	56-63	TREM2 variants have been identified as risk factors for Alzheimer 's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	These TREM2 variants also confer the highest risk	TREM2 variants have been identified as risk factors for Alzheimer's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	These TREM2 variants also confer the highest risk	1-23	56-105	TREM2 variants have been identified as risk factors for Alzheimer 's disease ( AD ) and other neurodegenerative diseases ( NDDs ) .	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	56-63	64-72	These TREM2 variants also confer the highest risk	for developing Alzheimer 's disease of any risk factor	These TREM2 variants also confer the highest risk	for developing Alzheimer's disease of any risk factor	56-105	56-105	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	64-72	73-78	for developing Alzheimer 's disease of any risk factor	identified in nearly two decades ,	for developing Alzheimer's disease of any risk factor	identified in nearly two decades ,	56-105	56-105	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	79	80-92	suggesting	that understanding more about TREM2 function could provide key insights into NDD pathology	suggesting	that understanding more about TREM2 function could provide key insights into NDD pathology	56-105	56-105	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	1>2	none	attribution	attribution
ac51af9995edb441f0ce4fdc384908daa6e83675	56-63	80-92	These TREM2 variants also confer the highest risk	that understanding more about TREM2 function could provide key insights into NDD pathology	These TREM2 variants also confer the highest risk	that understanding more about TREM2 function could provide key insights into NDD pathology	56-105	56-105	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	1<2	none	cause-result	cause-result
ac51af9995edb441f0ce4fdc384908daa6e83675	80-92	93-105	that understanding more about TREM2 function could provide key insights into NDD pathology	and provide avenues for novel immune - related NDD biomarkers and therapeutics .	that understanding more about TREM2 function could provide key insights into NDD pathology	and provide avenues for novel immune - related NDD biomarkers and therapeutics .	56-105	56-105	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	1<2	none	joint	joint
ac51af9995edb441f0ce4fdc384908daa6e83675	80-92	106-122	that understanding more about TREM2 function could provide key insights into NDD pathology	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort	that understanding more about TREM2 function could provide key insights into NDD pathology	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort	56-105	106-135	These TREM2 variants also confer the highest risk for developing Alzheimer 's disease of any risk factor identified in nearly two decades , suggesting that understanding more about TREM2 function could provide key insights into NDD pathology and provide avenues for novel immune - related NDD biomarkers and therapeutics .	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort to understand the role of immune function in disease pathogenesis and progression .	1<2	none	cause-result	cause-result
ac51af9995edb441f0ce4fdc384908daa6e83675	106-122	123-135	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort	to understand the role of immune function in disease pathogenesis and progression .	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort	to understand the role of immune function in disease pathogenesis and progression .	106-135	106-135	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort to understand the role of immune function in disease pathogenesis and progression .	The expression , signaling and function of TREM2 in NDDs have been extensively investigated in an effort to understand the role of immune function in disease pathogenesis and progression .	1<2	none	enablement	enablement
ac51af9995edb441f0ce4fdc384908daa6e83675	136-148	149-166	We provide a comprehensive review of our current understanding of TREM2 biology ,	including new insights into the regulation of TREM2 expression , and TREM2 signaling and function across NDDs .	We provide a comprehensive review of our current understanding of TREM2 biology ,	including new insights into the regulation of TREM2 expression , and TREM2 signaling and function across NDDs .	136-166	136-166	We provide a comprehensive review of our current understanding of TREM2 biology , including new insights into the regulation of TREM2 expression , and TREM2 signaling and function across NDDs .	We provide a comprehensive review of our current understanding of TREM2 biology , including new insights into the regulation of TREM2 expression , and TREM2 signaling and function across NDDs .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	167-172	173-183	While many open questions remain ,	the current body of literature provides clarity on several issues .	While many open questions remain ,	the current body of literature provides clarity on several issues .	167-183	167-183	While many open questions remain , the current body of literature provides clarity on several issues .	While many open questions remain , the current body of literature provides clarity on several issues .	1>2	none	comparison	comparison
ac51af9995edb441f0ce4fdc384908daa6e83675	136-148	173-183	We provide a comprehensive review of our current understanding of TREM2 biology ,	the current body of literature provides clarity on several issues .	We provide a comprehensive review of our current understanding of TREM2 biology ,	the current body of literature provides clarity on several issues .	136-166	167-183	We provide a comprehensive review of our current understanding of TREM2 biology , including new insights into the regulation of TREM2 expression , and TREM2 signaling and function across NDDs .	While many open questions remain , the current body of literature provides clarity on several issues .	1<2	none	findings	findings
ac51af9995edb441f0ce4fdc384908daa6e83675	184-200	201-211	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli ,	it is now clear that this is true in vitro ,	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli ,	it is now clear that this is true in vitro ,	184-222	184-222	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli , it is now clear that this is true in vitro , but inflammatory stimuli in vivo almost universally increase TREM2 expression .	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli , it is now clear that this is true in vitro , but inflammatory stimuli in vivo almost universally increase TREM2 expression .	1>2	none	comparison	comparison
ac51af9995edb441f0ce4fdc384908daa6e83675	173-183	201-211	the current body of literature provides clarity on several issues .	it is now clear that this is true in vitro ,	the current body of literature provides clarity on several issues .	it is now clear that this is true in vitro ,	167-183	184-222	While many open questions remain , the current body of literature provides clarity on several issues .	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli , it is now clear that this is true in vitro , but inflammatory stimuli in vivo almost universally increase TREM2 expression .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	201-211	212-222	it is now clear that this is true in vitro ,	but inflammatory stimuli in vivo almost universally increase TREM2 expression .	it is now clear that this is true in vitro ,	but inflammatory stimuli in vivo almost universally increase TREM2 expression .	184-222	184-222	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli , it is now clear that this is true in vitro , but inflammatory stimuli in vivo almost universally increase TREM2 expression .	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli , it is now clear that this is true in vitro , but inflammatory stimuli in vivo almost universally increase TREM2 expression .	1<2	none	comparison	comparison
ac51af9995edb441f0ce4fdc384908daa6e83675	201-211	223-224,239-253	it is now clear that this is true in vitro ,	Likewise , <*> more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	it is now clear that this is true in vitro ,	Likewise , <*> more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	184-222	223-264	While it is still often cited that TREM2 expression is decreased by pro - inflammatory stimuli , it is now clear that this is true in vitro , but inflammatory stimuli in vivo almost universally increase TREM2 expression .	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	225-238	239-253	while TREM2 function is classically described as promoting an anti - inflammatory phenotype ,	more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	while TREM2 function is classically described as promoting an anti - inflammatory phenotype ,	more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	223-264	223-264	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	1>2	none	comparison	comparison
ac51af9995edb441f0ce4fdc384908daa6e83675	254	255-264	suggesting	that its role in inflammation is much more complex .	suggesting	that its role in inflammation is much more complex .	223-264	223-264	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	1>2	none	attribution	attribution
ac51af9995edb441f0ce4fdc384908daa6e83675	239-253	255-264	more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	that its role in inflammation is much more complex .	more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	that its role in inflammation is much more complex .	223-264	223-264	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	1<2	none	cause-result	cause-result
ac51af9995edb441f0ce4fdc384908daa6e83675	223-224,239-253	265-276,283-286	Likewise , <*> more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	Finally , these components of TREM2 biology are applied to a discussion <*> and the latest assessment	Likewise , <*> more than half of published studies demonstrate a pro - inflammatory role for TREM2 ,	Finally , these components of TREM2 biology are applied to a discussion <*> and the latest assessment	223-264	265-302	Likewise , while TREM2 function is classically described as promoting an anti - inflammatory phenotype , more than half of published studies demonstrate a pro - inflammatory role for TREM2 , suggesting that its role in inflammation is much more complex .	Finally , these components of TREM2 biology are applied to a discussion of how TREM2 impacts NDD pathologies and the latest assessment of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	265-276,283-286	277-282	Finally , these components of TREM2 biology are applied to a discussion <*> and the latest assessment	of how TREM2 impacts NDD pathologies	Finally , these components of TREM2 biology are applied to a discussion <*> and the latest assessment	of how TREM2 impacts NDD pathologies	265-302	265-302	Finally , these components of TREM2 biology are applied to a discussion of how TREM2 impacts NDD pathologies and the latest assessment of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	Finally , these components of TREM2 biology are applied to a discussion of how TREM2 impacts NDD pathologies and the latest assessment of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	1<2	none	elaboration	elaboration
ac51af9995edb441f0ce4fdc384908daa6e83675	283-286	287-302	and the latest assessment	of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	and the latest assessment	of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	265-302	265-302	Finally , these components of TREM2 biology are applied to a discussion of how TREM2 impacts NDD pathologies and the latest assessment of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	Finally , these components of TREM2 biology are applied to a discussion of how TREM2 impacts NDD pathologies and the latest assessment of how these findings might be applied to immune - directed clinical biomarkers and therapeutics .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	1-16	87-106	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	1-25	82-106	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters that permit epidemics from those that do not .	Here , we show analytically how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	1>2	none	background	background
ad147a4279222c5e480a5636fb879540eded760e	1-16	17-21	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters	that permit epidemics from those	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters	that permit epidemics from those	1-25	1-25	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters that permit epidemics from those that do not .	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters that permit epidemics from those that do not .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	17-21	22-25	that permit epidemics from those	that do not .	that permit epidemics from those	that do not .	1-25	1-25	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters that permit epidemics from those that do not .	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters that permit epidemics from those that do not .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	1-16	26-30	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters	This threshold corresponds to parameters	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters	This threshold corresponds to parameters	1-25	26-38	The epidemic threshold of the susceptible - infected - recovered model is a boundary separating parameters that permit epidemics from those that do not .	This threshold corresponds to parameters where the system 's equilibrium becomes unstable .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	26-30	31-38	This threshold corresponds to parameters	where the system 's equilibrium becomes unstable .	This threshold corresponds to parameters	where the system's equilibrium becomes unstable .	26-38	26-38	This threshold corresponds to parameters where the system 's equilibrium becomes unstable .	This threshold corresponds to parameters where the system 's equilibrium becomes unstable .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	26-30	39-45	This threshold corresponds to parameters	Consequently , we use the average rate	This threshold corresponds to parameters	Consequently , we use the average rate	26-38	39-60	This threshold corresponds to parameters where the system 's equilibrium becomes unstable .	Consequently , we use the average rate at which deviations from the equilibrium shrink to define a distance to this threshold .	1<2	none	cause-result	cause-result
ad147a4279222c5e480a5636fb879540eded760e	39-45	46-52	Consequently , we use the average rate	at which deviations from the equilibrium shrink	Consequently , we use the average rate	at which deviations from the equilibrium shrink	39-60	39-60	Consequently , we use the average rate at which deviations from the equilibrium shrink to define a distance to this threshold .	Consequently , we use the average rate at which deviations from the equilibrium shrink to define a distance to this threshold .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	39-45	53-60	Consequently , we use the average rate	to define a distance to this threshold .	Consequently , we use the average rate	to define a distance to this threshold .	39-60	39-60	Consequently , we use the average rate at which deviations from the equilibrium shrink to define a distance to this threshold .	Consequently , we use the average rate at which deviations from the equilibrium shrink to define a distance to this threshold .	1<2	none	enablement	enablement
ad147a4279222c5e480a5636fb879540eded760e	39-45	61-72	Consequently , we use the average rate	However , the vital dynamics of the host population may occur slowly	Consequently , we use the average rate	However , the vital dynamics of the host population may occur slowly	39-60	61-81	Consequently , we use the average rate at which deviations from the equilibrium shrink to define a distance to this threshold .	However , the vital dynamics of the host population may occur slowly even when transmission is far from threshold levels .	1<2	none	comparison	comparison
ad147a4279222c5e480a5636fb879540eded760e	61-72	73-81	However , the vital dynamics of the host population may occur slowly	even when transmission is far from threshold levels .	However , the vital dynamics of the host population may occur slowly	even when transmission is far from threshold levels .	61-81	61-81	However , the vital dynamics of the host population may occur slowly even when transmission is far from threshold levels .	However , the vital dynamics of the host population may occur slowly even when transmission is far from threshold levels .	1<2	none	comparison	comparison
ad147a4279222c5e480a5636fb879540eded760e	82-86	87-106	Here , we show analytically	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	Here , we show analytically	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	82-106	82-106	Here , we show analytically how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	Here , we show analytically how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	1>2	none	attribution	attribution
ad147a4279222c5e480a5636fb879540eded760e	107-125	128-148	Although these results are exact only in the limit of long - term observation of a large system ,	that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	Although these results are exact only in the limit of long - term observation of a large system ,	that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	107-148	107-148	Although these results are exact only in the limit of long - term observation of a large system , simulations show that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	Although these results are exact only in the limit of long - term observation of a large system , simulations show that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	1>2	none	comparison	comparison
ad147a4279222c5e480a5636fb879540eded760e	126-127	128-148	simulations show	that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	simulations show	that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	107-148	107-148	Although these results are exact only in the limit of long - term observation of a large system , simulations show that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	Although these results are exact only in the limit of long - term observation of a large system , simulations show that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	1>2	none	attribution	attribution
ad147a4279222c5e480a5636fb879540eded760e	87-106	128-148	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	82-106	107-148	Here , we show analytically how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	Although these results are exact only in the limit of long - term observation of a large system , simulations show that they still provide useful insight into systems with a range of population sizes , environmental noise and observation schemes .	1<2	none	findings	findings
ad147a4279222c5e480a5636fb879540eded760e	149-152	162-168	Having established some guidelines	how multiple distance estimates can be used	Having established some guidelines	how multiple distance estimates can be used	149-178	149-178	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	1>2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	149-152	153-158	Having established some guidelines	about when estimates are accurate ,	Having established some guidelines	about when estimates are accurate ,	149-178	149-178	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	159-161	162-168	we then illustrate	how multiple distance estimates can be used	we then illustrate	how multiple distance estimates can be used	149-178	149-178	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	1>2	none	attribution	attribution
ad147a4279222c5e480a5636fb879540eded760e	87-106	162-168	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	how multiple distance estimates can be used	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	how multiple distance estimates can be used	82-106	149-178	Here , we show analytically how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	1<2	none	elaboration	elaboration
ad147a4279222c5e480a5636fb879540eded760e	162-168	169-178	how multiple distance estimates can be used	to estimate the rate of approach to the threshold .	how multiple distance estimates can be used	to estimate the rate of approach to the threshold .	149-178	149-178	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	Having established some guidelines about when estimates are accurate , we then illustrate how multiple distance estimates can be used to estimate the rate of approach to the threshold .	1<2	none	enablement	enablement
ad147a4279222c5e480a5636fb879540eded760e	87-106	179-183	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	The estimation approach is general	how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	The estimation approach is general	82-106	179-214	Here , we show analytically how such slow dynamics can prevent estimation of the distance to the threshold from fluctuations in the susceptible population .	The estimation approach is general and may be applicable to zoonotic pathogens such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	1<2	none	findings	findings
ad147a4279222c5e480a5636fb879540eded760e	179-183	184-190	The estimation approach is general	and may be applicable to zoonotic pathogens	The estimation approach is general	and may be applicable to zoonotic pathogens	179-214	179-214	The estimation approach is general and may be applicable to zoonotic pathogens such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	The estimation approach is general and may be applicable to zoonotic pathogens such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	1<2	none	joint	joint
ad147a4279222c5e480a5636fb879540eded760e	184-190	191-214	and may be applicable to zoonotic pathogens	such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	and may be applicable to zoonotic pathogens	such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	179-214	179-214	The estimation approach is general and may be applicable to zoonotic pathogens such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	The estimation approach is general and may be applicable to zoonotic pathogens such as Middle East respiratory syndrome - related coronavirus ( MERS - CoV ) as well as vaccine - preventable diseases like measles .	1<2	none	elaboration	elaboration
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	1-15	16-25,31-36	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed	using biochemical inhibitors , dominant negative mutants of cellular proteins <*> fluorescence microscopy and infectivity determinations .	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed	using biochemical inhibitors , dominant negative mutants of cellular proteins <*> fluorescence microscopy and infectivity determinations .	1-36	1-36	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed using biochemical inhibitors , dominant negative mutants of cellular proteins involved in endocytic pathways , fluorescence microscopy and infectivity determinations .	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed using biochemical inhibitors , dominant negative mutants of cellular proteins involved in endocytic pathways , fluorescence microscopy and infectivity determinations .	1<2	none	manner-means	manner-means
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	16-25,31-36	26-30	using biochemical inhibitors , dominant negative mutants of cellular proteins <*> fluorescence microscopy and infectivity determinations .	involved in endocytic pathways ,	using biochemical inhibitors , dominant negative mutants of cellular proteins <*> fluorescence microscopy and infectivity determinations .	involved in endocytic pathways ,	1-36	1-36	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed using biochemical inhibitors , dominant negative mutants of cellular proteins involved in endocytic pathways , fluorescence microscopy and infectivity determinations .	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed using biochemical inhibitors , dominant negative mutants of cellular proteins involved in endocytic pathways , fluorescence microscopy and infectivity determinations .	1<2	none	elaboration	elaboration
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	1-15	37-68	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated	1-36	37-84	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed using biochemical inhibitors , dominant negative mutants of cellular proteins involved in endocytic pathways , fluorescence microscopy and infectivity determinations .	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	1<2	none	findings	findings
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	37-68	69-84	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated	whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated	whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	37-84	37-84	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	1<2	none	comparison	comparison
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	69-84	85-116	whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	Treatment with the inhibitors nystatin and methyl - b - cyclodextrin , as well as transfection of Vero cells with dominant negative caveolin-1 , had no effect on DENV-2 virus infection .	whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	Treatment with the inhibitors nystatin and methyl - b - cyclodextrin , as well as transfection of Vero cells with dominant negative caveolin-1 , had no effect on DENV-2 virus infection .	37-84	85-116	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	Treatment with the inhibitors nystatin and methyl - b - cyclodextrin , as well as transfection of Vero cells with dominant negative caveolin-1 , had no effect on DENV-2 virus infection .	1<2	none	elaboration	elaboration
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	85-116	117-121,132-139	Treatment with the inhibitors nystatin and methyl - b - cyclodextrin , as well as transfection of Vero cells with dominant negative caveolin-1 , had no effect on DENV-2 virus infection .	It was also shown , <*> that dynamin was required for DENV-2 entry .	Treatment with the inhibitors nystatin and methyl - b - cyclodextrin , as well as transfection of Vero cells with dominant negative caveolin-1 , had no effect on DENV-2 virus infection .	It was also shown , <*> that dynamin was required for DENV-2 entry .	85-116	117-139	Treatment with the inhibitors nystatin and methyl - b - cyclodextrin , as well as transfection of Vero cells with dominant negative caveolin-1 , had no effect on DENV-2 virus infection .	It was also shown , by using the K44A mutant and the inhibitor dynasore , that dynamin was required for DENV-2 entry .	1<2	none	elaboration	elaboration
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	117-121,132-139	122-131	It was also shown , <*> that dynamin was required for DENV-2 entry .	by using the K44A mutant and the inhibitor dynasore ,	It was also shown , <*> that dynamin was required for DENV-2 entry .	by using the K44A mutant and the inhibitor dynasore ,	117-139	117-139	It was also shown , by using the K44A mutant and the inhibitor dynasore , that dynamin was required for DENV-2 entry .	It was also shown , by using the K44A mutant and the inhibitor dynasore , that dynamin was required for DENV-2 entry .	1<2	none	manner-means	manner-means
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	69-84	140-171	whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	Consequently , the infectious entry of DENV-2 into Vero cells occurs by a non - classical endocytic pathway independent of clathrin , caveolae and lipid rafts , but dependent on dynamin .	whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	Consequently , the infectious entry of DENV-2 into Vero cells occurs by a non - classical endocytic pathway independent of clathrin , caveolae and lipid rafts , but dependent on dynamin .	37-84	140-171	By treatment with dansylcadaverine and chlorpromazine and overexpression of a dominant negative form of the Eps15 protein , a clathrin - mediated endocytosis for productive DENV-1 internalization into Vero cells was demonstrated whereas the infectious entry of DENV-2 in the same cell system was independent of clathrin .	Consequently , the infectious entry of DENV-2 into Vero cells occurs by a non - classical endocytic pathway independent of clathrin , caveolae and lipid rafts , but dependent on dynamin .	1<2	none	elaboration	elaboration
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	140-171	172-184	Consequently , the infectious entry of DENV-2 into Vero cells occurs by a non - classical endocytic pathway independent of clathrin , caveolae and lipid rafts , but dependent on dynamin .	By contrast , DENV-2 entry into A549 cells was clathrin - dependent ,	Consequently , the infectious entry of DENV-2 into Vero cells occurs by a non - classical endocytic pathway independent of clathrin , caveolae and lipid rafts , but dependent on dynamin .	By contrast , DENV-2 entry into A549 cells was clathrin - dependent ,	140-171	172-197	Consequently , the infectious entry of DENV-2 into Vero cells occurs by a non - classical endocytic pathway independent of clathrin , caveolae and lipid rafts , but dependent on dynamin .	By contrast , DENV-2 entry into A549 cells was clathrin - dependent , as previously reported in HeLa , C6/36 and BS - C-1 cells .	1<2	none	comparison	comparison
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	172-184	185-197	By contrast , DENV-2 entry into A549 cells was clathrin - dependent ,	as previously reported in HeLa , C6/36 and BS - C-1 cells .	By contrast , DENV-2 entry into A549 cells was clathrin - dependent ,	as previously reported in HeLa , C6/36 and BS - C-1 cells .	172-197	172-197	By contrast , DENV-2 entry into A549 cells was clathrin - dependent , as previously reported in HeLa , C6/36 and BS - C-1 cells .	By contrast , DENV-2 entry into A549 cells was clathrin - dependent , as previously reported in HeLa , C6/36 and BS - C-1 cells .	1<2	none	comparison	comparison
aedcbf29dcf8ecc0cf24cccd05124571f06fe258	1-15	198-245	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed	Our results conclusively show , for the first time , a differential mode of infective entry for DENV-1 and DENV-2 into a common host cell , Vero cells , as well as alternative entry pathways for a given serotype , DENV-2 , into different types of cells .	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed	Our results conclusively show , for the first time , a differential mode of infective entry for DENV-1 and DENV-2 into a common host cell , Vero cells , as well as alternative entry pathways for a given serotype , DENV-2 , into different types of cells .	1-36	198-245	The entry of two dengue virus ( DENV ) serotypes into Vero cells was analysed using biochemical inhibitors , dominant negative mutants of cellular proteins involved in endocytic pathways , fluorescence microscopy and infectivity determinations .	Our results conclusively show , for the first time , a differential mode of infective entry for DENV-1 and DENV-2 into a common host cell , Vero cells , as well as alternative entry pathways for a given serotype , DENV-2 , into different types of cells .	1<2	none	findings	findings
b25406fedda8c98e076135cef12df228ca6fd4f1	1-13	33-40,54-71	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	1-32	33-71	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission , including the aerosol box for use during tracheal intubation .	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	1>2	none	background	background
b25406fedda8c98e076135cef12df228ca6fd4f1	1-13	14-22	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices	to protect clinicians from the risk of transmission ,	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices	to protect clinicians from the risk of transmission ,	1-32	1-32	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission , including the aerosol box for use during tracheal intubation .	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission , including the aerosol box for use during tracheal intubation .	1<2	none	enablement	enablement
b25406fedda8c98e076135cef12df228ca6fd4f1	1-13	23-32	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices	including the aerosol box for use during tracheal intubation .	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices	including the aerosol box for use during tracheal intubation .	1-32	1-32	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission , including the aerosol box for use during tracheal intubation .	The coronavirus disease 2019 pandemic has led to the manufacturing of novel devices to protect clinicians from the risk of transmission , including the aerosol box for use during tracheal intubation .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	33-40,54-71	41-53	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	( an early - generation box and a latest - generation box )	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	( an early - generation box and a latest - generation box )	33-71	33-71	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	33-40,54-71	72-87	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The simulated process complied with the Safe Airway Society coronavirus disease 2019 airway management guidelines .	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The simulated process complied with the Safe Airway Society coronavirus disease 2019 airway management guidelines .	33-71	72-87	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The simulated process complied with the Safe Airway Society coronavirus disease 2019 airway management guidelines .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	33-40,54-71	88-94	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The primary outcome was intubation time ;	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The primary outcome was intubation time ;	33-71	88-108	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	The primary outcome was intubation time ; secondary outcomes included first - pass success and breaches to personal protective equipment .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	88-94	95-108	The primary outcome was intubation time ;	secondary outcomes included first - pass success and breaches to personal protective equipment .	The primary outcome was intubation time ;	secondary outcomes included first - pass success and breaches to personal protective equipment .	88-108	88-108	The primary outcome was intubation time ; secondary outcomes included first - pass success and breaches to personal protective equipment .	The primary outcome was intubation time ; secondary outcomes included first - pass success and breaches to personal protective equipment .	1<2	none	joint	joint
b25406fedda8c98e076135cef12df228ca6fd4f1	33-40,54-71	109-122	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	All intubations were performed by specialist ( consultant ) anaesthetists and video recorded .	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	All intubations were performed by specialist ( consultant ) anaesthetists and video recorded .	33-71	109-122	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	All intubations were performed by specialist ( consultant ) anaesthetists and video recorded .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	109-122	123-128	All intubations were performed by specialist ( consultant ) anaesthetists and video recorded .	Twelve anaesthetists performed 36 intubations .	All intubations were performed by specialist ( consultant ) anaesthetists and video recorded .	Twelve anaesthetists performed 36 intubations .	109-122	123-128	All intubations were performed by specialist ( consultant ) anaesthetists and video recorded .	Twelve anaesthetists performed 36 intubations .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	33-40,54-71	129-144,176-181	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	Intubation time with no aerosol box was significantly shorter than with the early - generation box <*> and the latest - generation box	We evaluated the impact of two aerosol boxes <*> on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	Intubation time with no aerosol box was significantly shorter than with the early - generation box <*> and the latest - generation box	33-71	129-197	We evaluated the impact of two aerosol boxes ( an early - generation box and a latest - generation box ) on intubations in patients with severe coronavirus disease 2019 with an in - situ simulation crossover study .	Intubation time with no aerosol box was significantly shorter than with the early - generation box ( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 ) and the latest - generation box ( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	1<2	none	findings	findings
b25406fedda8c98e076135cef12df228ca6fd4f1	129-144,176-181	145-175	Intubation time with no aerosol box was significantly shorter than with the early - generation box <*> and the latest - generation box	( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 )	Intubation time with no aerosol box was significantly shorter than with the early - generation box <*> and the latest - generation box	( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 )	129-197	129-197	Intubation time with no aerosol box was significantly shorter than with the early - generation box ( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 ) and the latest - generation box ( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	Intubation time with no aerosol box was significantly shorter than with the early - generation box ( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 ) and the latest - generation box ( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	176-181	182-197	and the latest - generation box	( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	and the latest - generation box	( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	129-197	129-197	Intubation time with no aerosol box was significantly shorter than with the early - generation box ( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 ) and the latest - generation box ( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	Intubation time with no aerosol box was significantly shorter than with the early - generation box ( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 ) and the latest - generation box ( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	129-144,176-181	198-208	Intubation time with no aerosol box was significantly shorter than with the early - generation box <*> and the latest - generation box	No intubations without a box took more than 1 min ,	Intubation time with no aerosol box was significantly shorter than with the early - generation box <*> and the latest - generation box	No intubations without a box took more than 1 min ,	129-197	198-238	Intubation time with no aerosol box was significantly shorter than with the early - generation box ( median ( IQR [ range ] ) 42.9 ( 32.9 - 46.9 [ 30.9 - 57.6])s vs. 82.1 ( 45.1 - 98.3 [ 30.8 - 180.0])s p = 0.002 ) and the latest - generation box ( 52.4 ( 43.1 - 70.3 [ 35.7 - 169.2])s , p = 0.008 ) .	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	198-208	209-210,215-222	No intubations without a box took more than 1 min ,	whereas 14 <*> intubations with a box took over 1 min	No intubations without a box took more than 1 min ,	whereas 14 <*> intubations with a box took over 1 min	198-238	198-238	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	1<2	none	comparison	comparison
b25406fedda8c98e076135cef12df228ca6fd4f1	209-210,215-222	211-214	whereas 14 <*> intubations with a box took over 1 min	( 58 % )	whereas 14 <*> intubations with a box took over 1 min	( 58 % )	198-238	198-238	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	215-222	223-224,229-232	intubations with a box took over 1 min	and 4 <*> took over 2 min	intubations with a box took over 1 min	and 4 <*> took over 2 min	198-238	198-238	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	1<2	none	joint	joint
b25406fedda8c98e076135cef12df228ca6fd4f1	223-224,229-232	225-228	and 4 <*> took over 2 min	( 17 % )	and 4 <*> took over 2 min	( 17 % )	198-238	198-238	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	229-232	233-238	took over 2 min	( including one failure ) .	took over 2 min	( including one failure ) .	198-238	198-238	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	198-208	239-251	No intubations without a box took more than 1 min ,	Without an aerosol box , all anaesthetists obtained first - pass success .	No intubations without a box took more than 1 min ,	Without an aerosol box , all anaesthetists obtained first - pass success .	198-238	239-251	No intubations without a box took more than 1 min , whereas 14 ( 58 % ) intubations with a box took over 1 min and 4 ( 17 % ) took over 2 min ( including one failure ) .	Without an aerosol box , all anaesthetists obtained first - pass success .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	239-251	252-263,268-269	Without an aerosol box , all anaesthetists obtained first - pass success .	With the early - generation and latest - generation boxes , 9 <*> and 10	Without an aerosol box , all anaesthetists obtained first - pass success .	With the early - generation and latest - generation boxes , 9 <*> and 10	239-251	252-282	Without an aerosol box , all anaesthetists obtained first - pass success .	With the early - generation and latest - generation boxes , 9 ( 75 % ) and 10 ( 83 % ) participants obtained first - pass success , respectively .	1<2	none	comparison	comparison
b25406fedda8c98e076135cef12df228ca6fd4f1	252-263,268-269	264-267	With the early - generation and latest - generation boxes , 9 <*> and 10	( 75 % )	With the early - generation and latest - generation boxes , 9 <*> and 10	( 75 % )	252-282	252-282	With the early - generation and latest - generation boxes , 9 ( 75 % ) and 10 ( 83 % ) participants obtained first - pass success , respectively .	With the early - generation and latest - generation boxes , 9 ( 75 % ) and 10 ( 83 % ) participants obtained first - pass success , respectively .	1<2	none	elaboration	elaboration
b25406fedda8c98e076135cef12df228ca6fd4f1	268-269,274-282	270-273	and 10 <*> participants obtained first - pass success , respectively .	( 83 % )	and 10 <*> participants obtained first - pass success , respectively .	( 83 % )	252-282	252-282	With the early - generation and latest - generation boxes , 9 ( 75 % ) and 10 ( 83 % ) participants obtained first - pass success , respectively .	With the early - generation and latest - generation boxes , 9 ( 75 % ) and 10 ( 83 % ) participants obtained first - pass success , respectively .	1<2	none	elaboration	elaboration
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	1-9	101-111	As intracellular parasites , viruses require a host cell	how viruses have evolved different control strategies at the SG level	As intracellular parasites , viruses require a host cell	how viruses have evolved different control strategies at the SG level	1-14	98-128	As intracellular parasites , viruses require a host cell in order to replicate .	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	1>2	none	background	background
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	1-9	10-14	As intracellular parasites , viruses require a host cell	in order to replicate .	As intracellular parasites , viruses require a host cell	in order to replicate .	1-14	1-14	As intracellular parasites , viruses require a host cell in order to replicate .	As intracellular parasites , viruses require a host cell in order to replicate .	1<2	none	enablement	enablement
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	1-9	15-26	As intracellular parasites , viruses require a host cell	However , they face a series of cellular responses against infection .	As intracellular parasites , viruses require a host cell	However , they face a series of cellular responses against infection .	1-14	15-26	As intracellular parasites , viruses require a host cell in order to replicate .	However , they face a series of cellular responses against infection .	1<2	none	comparison	comparison
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	15-26	27-48	However , they face a series of cellular responses against infection .	One of these responses is the activation of the double - stranded RNA ( dsRNA)-activated protein kinase R ( PKR ) .	However , they face a series of cellular responses against infection .	One of these responses is the activation of the double - stranded RNA ( dsRNA)-activated protein kinase R ( PKR ) .	15-26	27-48	However , they face a series of cellular responses against infection .	One of these responses is the activation of the double - stranded RNA ( dsRNA)-activated protein kinase R ( PKR ) .	1<2	none	elaboration	elaboration
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	27-48	49-63	One of these responses is the activation of the double - stranded RNA ( dsRNA)-activated protein kinase R ( PKR ) .	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) ,	One of these responses is the activation of the double - stranded RNA ( dsRNA)-activated protein kinase R ( PKR ) .	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) ,	27-48	49-81	One of these responses is the activation of the double - stranded RNA ( dsRNA)-activated protein kinase R ( PKR ) .	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) , which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	1<2	none	elaboration	elaboration
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	49-63	64-81	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) ,	which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) ,	which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	49-81	49-81	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) , which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) , which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	1<2	none	cause-result	cause-result
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	82-85	86-97	Recent studies have shown	that SGs can interfere with the replicative cycle of certain viruses .	Recent studies have shown	that SGs can interfere with the replicative cycle of certain viruses .	82-97	82-97	Recent studies have shown that SGs can interfere with the replicative cycle of certain viruses .	Recent studies have shown that SGs can interfere with the replicative cycle of certain viruses .	1>2	none	attribution	attribution
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	64-81	86-97	which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	that SGs can interfere with the replicative cycle of certain viruses .	which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	that SGs can interfere with the replicative cycle of certain viruses .	49-81	82-97	PKR phosphorylates the α subunit of eukaryotic translation initiation factor 2 ( eIF2α ) , which in turn results in global protein synthesis inhibition and formation of stress granules ( SGs ) .	Recent studies have shown that SGs can interfere with the replicative cycle of certain viruses .	1<2	none	elaboration	elaboration
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	98-100	101-111	This review addresses	how viruses have evolved different control strategies at the SG level	This review addresses	how viruses have evolved different control strategies at the SG level	98-128	98-128	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	1>2	none	attribution	attribution
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	101-111	112-122	how viruses have evolved different control strategies at the SG level	to ensure an efficient replication cycle during the cellular stress response	how viruses have evolved different control strategies at the SG level	to ensure an efficient replication cycle during the cellular stress response	98-128	98-128	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	1<2	none	enablement	enablement
b61d4d87ea3b4fa2ff058ee867bdac4f15c0cf11	112-122	123-128	to ensure an efficient replication cycle during the cellular stress response	triggered by the viral infection .	to ensure an efficient replication cycle during the cellular stress response	triggered by the viral infection .	98-128	98-128	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	This review addresses how viruses have evolved different control strategies at the SG level to ensure an efficient replication cycle during the cellular stress response triggered by the viral infection .	1<2	none	cause-result	cause-result
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	1-9	112-129	Monadic decomposability is a notion of variable independence ,	In this paper , we study monadic decomposability of integer linear arithmetic in the setting of SMT .	Monadic decomposability is a notion of variable independence ,	In this paper , we study monadic decomposability of integer linear arithmetic in the setting of SMT .	1-34	112-129	Monadic decomposability is a notion of variable independence , which asks whether a given formula in a first - order theory is expressible as a Boolean combination of monadic predicates in the theory .	In this paper , we study monadic decomposability of integer linear arithmetic in the setting of SMT .	1>2	none	background	background
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	1-9	10-34	Monadic decomposability is a notion of variable independence ,	which asks whether a given formula in a first - order theory is expressible as a Boolean combination of monadic predicates in the theory .	Monadic decomposability is a notion of variable independence ,	which asks whether a given formula in a first - order theory is expressible as a Boolean combination of monadic predicates in the theory .	1-34	1-34	Monadic decomposability is a notion of variable independence , which asks whether a given formula in a first - order theory is expressible as a Boolean combination of monadic predicates in the theory .	Monadic decomposability is a notion of variable independence , which asks whether a given formula in a first - order theory is expressible as a Boolean combination of monadic predicates in the theory .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	1-9	35-51	Monadic decomposability is a notion of variable independence ,	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	Monadic decomposability is a notion of variable independence ,	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	1-34	35-71	Monadic decomposability is a notion of variable independence , which asks whether a given formula in a first - order theory is expressible as a Boolean combination of monadic predicates in the theory .	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	35-51	52-62	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	( i.e. the input formula is quantifier - free ) ,	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	( i.e. the input formula is quantifier - free ) ,	35-71	35-71	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	35-51	63-67	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	and found various interesting applications	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	and found various interesting applications	35-71	35-71	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	63-67	68-71	and found various interesting applications	including string analysis .	and found various interesting applications	including string analysis .	35-71	35-71	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	35-51	72-81	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	However , checking monadic decomposability is undecidable in general .	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT	However , checking monadic decomposability is undecidable in general .	35-71	72-81	Recently , Veanes et al . showed the usefulness of monadic decomposability in the context of SMT ( i.e. the input formula is quantifier - free ) , and found various interesting applications including string analysis .	However , checking monadic decomposability is undecidable in general .	1<2	none	comparison	comparison
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	72-81	82-87	However , checking monadic decomposability is undecidable in general .	Decidability for certain theories is known	However , checking monadic decomposability is undecidable in general .	Decidability for certain theories is known	72-81	82-111	However , checking monadic decomposability is undecidable in general .	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	82-87	88-100	Decidability for certain theories is known	( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) ,	Decidability for certain theories is known	( e.g. Presburger Arithmetic , Tarski's Real - Closed Field ) ,	82-111	82-111	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	82-87	101-106	Decidability for certain theories is known	but there are very few results	Decidability for certain theories is known	but there are very few results	82-111	82-111	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	1<2	none	comparison	comparison
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	101-106	107-111	but there are very few results	regarding their computational complexity .	but there are very few results	regarding their computational complexity .	82-111	82-111	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	Decidability for certain theories is known ( e.g. Presburger Arithmetic , Tarski 's Real - Closed Field ) , but there are very few results regarding their computational complexity .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	112-129	130-139	In this paper , we study monadic decomposability of integer linear arithmetic in the setting of SMT .	We show that this decision problem is coNP - complete	In this paper , we study monadic decomposability of integer linear arithmetic in the setting of SMT .	We show that this decision problem is coNP - complete	112-129	130-158	In this paper , we study monadic decomposability of integer linear arithmetic in the setting of SMT .	We show that this decision problem is coNP - complete and , when monadically decomposable , a formula admits a decomposition of exponential size in the worst case .	1<2	none	findings	findings
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	130-139	140-141,146-158	We show that this decision problem is coNP - complete	and , <*> a formula admits a decomposition of exponential size in the worst case .	We show that this decision problem is coNP - complete	and , <*> a formula admits a decomposition of exponential size in the worst case .	130-158	130-158	We show that this decision problem is coNP - complete and , when monadically decomposable , a formula admits a decomposition of exponential size in the worst case .	We show that this decision problem is coNP - complete and , when monadically decomposable , a formula admits a decomposition of exponential size in the worst case .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	142-145	146-158	when monadically decomposable ,	a formula admits a decomposition of exponential size in the worst case .	when monadically decomposable ,	a formula admits a decomposition of exponential size in the worst case .	130-158	130-158	We show that this decision problem is coNP - complete and , when monadically decomposable , a formula admits a decomposition of exponential size in the worst case .	We show that this decision problem is coNP - complete and , when monadically decomposable , a formula admits a decomposition of exponential size in the worst case .	1>2	none	condition	condition
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	130-139	159-174	We show that this decision problem is coNP - complete	We provide a new application of our results to string constraint solving with length constraints .	We show that this decision problem is coNP - complete	We provide a new application of our results to string constraint solving with length constraints .	130-158	159-174	We show that this decision problem is coNP - complete and , when monadically decomposable , a formula admits a decomposition of exponential size in the worst case .	We provide a new application of our results to string constraint solving with length constraints .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	159-174	175-183	We provide a new application of our results to string constraint solving with length constraints .	We then extend our results to variadic decomposability ,	We provide a new application of our results to string constraint solving with length constraints .	We then extend our results to variadic decomposability ,	159-174	175-198	We provide a new application of our results to string constraint solving with length constraints .	We then extend our results to variadic decomposability , where predicates could admit multiple free variables ( in contrast to monadic decomposability ) .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	175-183	184-190	We then extend our results to variadic decomposability ,	where predicates could admit multiple free variables	We then extend our results to variadic decomposability ,	where predicates could admit multiple free variables	175-198	175-198	We then extend our results to variadic decomposability , where predicates could admit multiple free variables ( in contrast to monadic decomposability ) .	We then extend our results to variadic decomposability , where predicates could admit multiple free variables ( in contrast to monadic decomposability ) .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	184-190	191-198	where predicates could admit multiple free variables	( in contrast to monadic decomposability ) .	where predicates could admit multiple free variables	( in contrast to monadic decomposability ) .	175-198	175-198	We then extend our results to variadic decomposability , where predicates could admit multiple free variables ( in contrast to monadic decomposability ) .	We then extend our results to variadic decomposability , where predicates could admit multiple free variables ( in contrast to monadic decomposability ) .	1<2	none	comparison	comparison
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	175-183	199-211	We then extend our results to variadic decomposability ,	Finally , we give an application to quantifier elimination in integer linear arithmetic	We then extend our results to variadic decomposability ,	Finally , we give an application to quantifier elimination in integer linear arithmetic	175-198	199-241	We then extend our results to variadic decomposability , where predicates could admit multiple free variables ( in contrast to monadic decomposability ) .	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	199-211	212-220,224-229	Finally , we give an application to quantifier elimination in integer linear arithmetic	where the variables in a block of quantifiers , <*> could be eliminated with an exponential	Finally , we give an application to quantifier elimination in integer linear arithmetic	where the variables in a block of quantifiers , <*> could be eliminated with an exponential	199-241	199-241	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	1<2	none	elaboration	elaboration
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	212-220,224-229	221-223	where the variables in a block of quantifiers , <*> could be eliminated with an exponential	if independent ,	where the variables in a block of quantifiers , <*> could be eliminated with an exponential	if independent ,	199-241	199-241	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	1<2	none	condition	condition
b663a1cc707cf69d2f90bda78f077b45b4f4daa5	224-229,238-241	230-237	could be eliminated with an exponential <*> blow - up .	( instead of the standard doubly exponential )	could be eliminated with an exponential <*> blow - up .	( instead of the standard doubly exponential )	199-241	199-241	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	Finally , we give an application to quantifier elimination in integer linear arithmetic where the variables in a block of quantifiers , if independent , could be eliminated with an exponential ( instead of the standard doubly exponential ) blow - up .	1<2	none	comparison	comparison
ba3522d00ecebd159c5b5dc90119df8642993c49	1-23	67-93	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	1-39	63-93	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture and may play an important role in viral spread and pathogenesis in the infected host .	Here , we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	1>2	none	background	background
ba3522d00ecebd159c5b5dc90119df8642993c49	1-23	24-39	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture	and may play an important role in viral spread and pathogenesis in the infected host .	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture	and may play an important role in viral spread and pathogenesis in the infected host .	1-39	1-39	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture and may play an important role in viral spread and pathogenesis in the infected host .	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture and may play an important role in viral spread and pathogenesis in the infected host .	1<2	none	elaboration	elaboration
ba3522d00ecebd159c5b5dc90119df8642993c49	1-23	40-62	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture	However , it is at present largely unclear to what extent these proteases are expressed in viral target cells in human tissues .	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture	However , it is at present largely unclear to what extent these proteases are expressed in viral target cells in human tissues .	1-39	40-62	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS - coronavirus ( TMPRSS2 ) in cell culture and may play an important role in viral spread and pathogenesis in the infected host .	However , it is at present largely unclear to what extent these proteases are expressed in viral target cells in human tissues .	1<2	none	comparison	comparison
ba3522d00ecebd159c5b5dc90119df8642993c49	63-66	67-93	Here , we show	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	Here , we show	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	63-93	63-93	Here , we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	Here , we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	1>2	none	attribution	attribution
ba3522d00ecebd159c5b5dc90119df8642993c49	67-93	94-130	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	Similarly , coexpression of ACE2 , the SARS - coronavirus receptor , and TMPRSS2 was frequently found in the upper and lower aerodigestive tract , with the exception of the vocal folds , epiglottis and trachea .	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	Similarly , coexpression of ACE2 , the SARS - coronavirus receptor , and TMPRSS2 was frequently found in the upper and lower aerodigestive tract , with the exception of the vocal folds , epiglottis and trachea .	63-93	94-130	Here , we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	Similarly , coexpression of ACE2 , the SARS - coronavirus receptor , and TMPRSS2 was frequently found in the upper and lower aerodigestive tract , with the exception of the vocal folds , epiglottis and trachea .	1<2	none	elaboration	elaboration
ba3522d00ecebd159c5b5dc90119df8642993c49	94-130	131-146	Similarly , coexpression of ACE2 , the SARS - coronavirus receptor , and TMPRSS2 was frequently found in the upper and lower aerodigestive tract , with the exception of the vocal folds , epiglottis and trachea .	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 ,	Similarly , coexpression of ACE2 , the SARS - coronavirus receptor , and TMPRSS2 was frequently found in the upper and lower aerodigestive tract , with the exception of the vocal folds , epiglottis and trachea .	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 ,	94-130	131-163	Similarly , coexpression of ACE2 , the SARS - coronavirus receptor , and TMPRSS2 was frequently found in the upper and lower aerodigestive tract , with the exception of the vocal folds , epiglottis and trachea .	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 , suggesting that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	1<2	none	elaboration	elaboration
ba3522d00ecebd159c5b5dc90119df8642993c49	147	148-163	suggesting	that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	suggesting	that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	131-163	131-163	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 , suggesting that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 , suggesting that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	1>2	none	attribution	attribution
ba3522d00ecebd159c5b5dc90119df8642993c49	131-146	148-163	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 ,	that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 ,	that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	131-163	131-163	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 , suggesting that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	Finally , activation of influenza virus was conserved between human , avian and porcine TMPRSS2 , suggesting that this protease might activate influenza virus in reservoir- , intermediate - and human hosts .	1<2	none	cause-result	cause-result
ba3522d00ecebd159c5b5dc90119df8642993c49	164-169	170-184	In sum , our results show	that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells	In sum , our results show	that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells	164-195	164-195	In sum , our results show that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells and could thus support viral spread in the human host .	In sum , our results show that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells and could thus support viral spread in the human host .	1>2	none	attribution	attribution
ba3522d00ecebd159c5b5dc90119df8642993c49	67-93	170-184	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells	that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells	63-93	164-195	Here , we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids , the major receptor determinant of human influenza viruses , throughout the human respiratory tract .	In sum , our results show that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells and could thus support viral spread in the human host .	1<2	none	findings	findings
ba3522d00ecebd159c5b5dc90119df8642993c49	170-184	185-195	that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells	and could thus support viral spread in the human host .	that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells	and could thus support viral spread in the human host .	164-195	164-195	In sum , our results show that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells and could thus support viral spread in the human host .	In sum , our results show that TMPRSS2 and HAT are expressed by important influenza and SARS - coronavirus target cells and could thus support viral spread in the human host .	1<2	none	cause-result	cause-result
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	1-2	3-12,16-23	Background :	In China , large - scale outbreaks of severe diarrhea <*> have occurred in pigs since late 2010 .	Background :	In China , large - scale outbreaks of severe diarrhea <*> have occurred in pigs since late 2010 .	1-2	3-23	Background :	In China , large - scale outbreaks of severe diarrhea caused by viruses have occurred in pigs since late 2010 .	1>2	none	textual-organization	textual-organization
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	3-12,16-23	41-47,63-65	In China , large - scale outbreaks of severe diarrhea <*> have occurred in pigs since late 2010 .	a total of 2987 field diarrheal samples <*> were tested .	In China , large - scale outbreaks of severe diarrhea <*> have occurred in pigs since late 2010 .	a total of 2987 field diarrheal samples <*> were tested .	3-23	24-65	In China , large - scale outbreaks of severe diarrhea caused by viruses have occurred in pigs since late 2010 .	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	1>2	none	background	background
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	3-12,16-23	13-15	In China , large - scale outbreaks of severe diarrhea <*> have occurred in pigs since late 2010 .	caused by viruses	In China , large - scale outbreaks of severe diarrhea <*> have occurred in pigs since late 2010 .	caused by viruses	3-23	3-23	In China , large - scale outbreaks of severe diarrhea caused by viruses have occurred in pigs since late 2010 .	In China , large - scale outbreaks of severe diarrhea caused by viruses have occurred in pigs since late 2010 .	1<2	none	cause-result	cause-result
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	24-35	41-47,63-65	To investigate the prevalence and genetic evolution of diarrhea - associated viruses	a total of 2987 field diarrheal samples <*> were tested .	To investigate the prevalence and genetic evolution of diarrhea - associated viruses	a total of 2987 field diarrheal samples <*> were tested .	24-65	24-65	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	1>2	none	enablement	enablement
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	24-35	36-40	To investigate the prevalence and genetic evolution of diarrhea - associated viruses	responsible for the outbreaks ,	To investigate the prevalence and genetic evolution of diarrhea - associated viruses	responsible for the outbreaks ,	24-65	24-65	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	41-47,63-65	48-62	a total of 2987 field diarrheal samples <*> were tested .	collected from 168 pig farms in five provinces in Southern China during 2012 - 2018	a total of 2987 field diarrheal samples <*> were tested .	collected from 168 pig farms in five provinces in Southern China during 2012 - 2018	24-65	24-65	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	66-67	68-101	Results :	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Results :	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	66-67	68-101	Results :	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	1>2	none	textual-organization	textual-organization
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	41-47,63-65	68-101	a total of 2987 field diarrheal samples <*> were tested .	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	a total of 2987 field diarrheal samples <*> were tested .	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	24-65	68-101	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	1<2	none	findings	findings
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	68-101	102-114	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates	68-101	102-134	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates ranging from 19.62 to 29.19 % in samples , and 70.24 % ( 118/168 ) in premises , respectively .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	102-114	115-126,130-134	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates	ranging from 19.62 to 29.19 % in samples , and 70.24 % <*> in premises , respectively .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates	ranging from 19.62 to 29.19 % in samples , and 70.24 % <*> in premises , respectively .	102-134	102-134	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates ranging from 19.62 to 29.19 % in samples , and 70.24 % ( 118/168 ) in premises , respectively .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates ranging from 19.62 to 29.19 % in samples , and 70.24 % ( 118/168 ) in premises , respectively .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	115-126,130-134	127-129	ranging from 19.62 to 29.19 % in samples , and 70.24 % <*> in premises , respectively .	( 118/168 )	ranging from 19.62 to 29.19 % in samples , and 70.24 % <*> in premises , respectively .	( 118/168 )	102-134	102-134	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates ranging from 19.62 to 29.19 % in samples , and 70.24 % ( 118/168 ) in premises , respectively .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates ranging from 19.62 to 29.19 % in samples , and 70.24 % ( 118/168 ) in premises , respectively .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	102-114	135-165	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates	Both transmissible gastroenteritis virus ( TGEV ) and porcine rotavirus ( PoRV ) were detected at low prevalence rates of < 3 % in samples and 10.12 % in premises .	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates	Both transmissible gastroenteritis virus ( TGEV ) and porcine rotavirus ( PoRV ) were detected at low prevalence rates of < 3 % in samples and 10.12 % in premises .	102-134	135-165	Porcine deltacoronavirus ( PDCoV ) was the second prevalent virus with prevalence rates ranging from 19.62 to 29.19 % in samples , and 70.24 % ( 118/168 ) in premises , respectively .	Both transmissible gastroenteritis virus ( TGEV ) and porcine rotavirus ( PoRV ) were detected at low prevalence rates of < 3 % in samples and 10.12 % in premises .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	135-165	166-196	Both transmissible gastroenteritis virus ( TGEV ) and porcine rotavirus ( PoRV ) were detected at low prevalence rates of < 3 % in samples and 10.12 % in premises .	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China ,	Both transmissible gastroenteritis virus ( TGEV ) and porcine rotavirus ( PoRV ) were detected at low prevalence rates of < 3 % in samples and 10.12 % in premises .	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China ,	135-165	166-211	Both transmissible gastroenteritis virus ( TGEV ) and porcine rotavirus ( PoRV ) were detected at low prevalence rates of < 3 % in samples and 10.12 % in premises .	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China , and the prevalence rate of SADS - CoV was 10.29 % ( 7/68 ) .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	166-196	197-207	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China ,	and the prevalence rate of SADS - CoV was 10.29 %	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China ,	and the prevalence rate of SADS - CoV was 10.29 %	166-211	166-211	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China , and the prevalence rate of SADS - CoV was 10.29 % ( 7/68 ) .	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China , and the prevalence rate of SADS - CoV was 10.29 % ( 7/68 ) .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	197-207	208-211	and the prevalence rate of SADS - CoV was 10.29 %	( 7/68 ) .	and the prevalence rate of SADS - CoV was 10.29 %	( 7/68 ) .	166-211	166-211	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China , and the prevalence rate of SADS - CoV was 10.29 % ( 7/68 ) .	In this study , we identified a newly emerged swine acute diarrhea syndrome coronavirus ( SADS - CoV ) in diarrheal samples of piglets from Fujian province in Southern China , and the prevalence rate of SADS - CoV was 10.29 % ( 7/68 ) .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	68-101	212-223	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Co - infections of these diarrhea - associated viruses were common .	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Co - infections of these diarrhea - associated viruses were common .	68-101	212-223	Porcine epidemic diarrhea virus ( PEDV ) was most frequently detected virus with prevalence rates between 50.21 and 62.10 % in samples , and 96.43 % ( 162/168 ) in premises , respectively .	Co - infections of these diarrhea - associated viruses were common .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	212-223	224-242	Co - infections of these diarrhea - associated viruses were common .	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 %	Co - infections of these diarrhea - associated viruses were common .	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 %	212-223	224-253	Co - infections of these diarrhea - associated viruses were common .	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 % ( 380/2987 , ranging from 8.26 - 17.33 % ) .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	224-242	243-253	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 %	( 380/2987 , ranging from 8.26 - 17.33 % ) .	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 %	( 380/2987 , ranging from 8.26 - 17.33 % ) .	224-253	224-253	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 % ( 380/2987 , ranging from 8.26 - 17.33 % ) .	The most frequent co - infection was PEDV with PDCoV , with an average detection rate of 12.72 % ( 380/2987 , ranging from 8.26 - 17.33 % ) .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	254-256	257-258,268-279	Phylogenetic analysis revealed	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	Phylogenetic analysis revealed	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	254-279	254-279	Phylogenetic analysis revealed that PEDVs circulating in Southern China during the last 7 years were clustered with the variant strains of PEDV in genotype IIa .	Phylogenetic analysis revealed that PEDVs circulating in Southern China during the last 7 years were clustered with the variant strains of PEDV in genotype IIa .	1>2	none	attribution	attribution
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	212-223	257-258,268-279	Co - infections of these diarrhea - associated viruses were common .	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	Co - infections of these diarrhea - associated viruses were common .	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	212-223	254-279	Co - infections of these diarrhea - associated viruses were common .	Phylogenetic analysis revealed that PEDVs circulating in Southern China during the last 7 years were clustered with the variant strains of PEDV in genotype IIa .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	257-258,268-279	259-267	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	circulating in Southern China during the last 7 years	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	circulating in Southern China during the last 7 years	254-279	254-279	Phylogenetic analysis revealed that PEDVs circulating in Southern China during the last 7 years were clustered with the variant strains of PEDV in genotype IIa .	Phylogenetic analysis revealed that PEDVs circulating in Southern China during the last 7 years were clustered with the variant strains of PEDV in genotype IIa .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	257-258,268-279	280-302	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs	that PEDVs <*> were clustered with the variant strains of PEDV in genotype IIa .	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs	254-279	280-308	Phylogenetic analysis revealed that PEDVs circulating in Southern China during the last 7 years were clustered with the variant strains of PEDV in genotype IIa .	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs currently circulating in the field .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	280-302	303-308	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs	currently circulating in the field .	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs	currently circulating in the field .	280-308	280-308	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs currently circulating in the field .	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs currently circulating in the field .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	280-302	309-336	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs	Genetic relationships of PDCoVs were closely related with Chinese strains , other than those present in the USA , South Korea , Thailand and Lao 's public .	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs	Genetic relationships of PDCoVs were closely related with Chinese strains , other than those present in the USA , South Korea , Thailand and Lao's public .	280-308	309-336	The most frequent mutations were present in the collagenase equivalent ( COE ) and epitope regions of the spike gene of the PEDVs currently circulating in the field .	Genetic relationships of PDCoVs were closely related with Chinese strains , other than those present in the USA , South Korea , Thailand and Lao 's public .	1<2	none	elaboration	elaboration
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	337-338	339-344	Conclusions :	The findings of this study indicated	Conclusions :	The findings of this study indicated	337-338	339-387	Conclusions :	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	1>2	none	textual-organization	textual-organization
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	339-344	345-362	The findings of this study indicated	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	The findings of this study indicated	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	339-387	339-387	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	1>2	none	attribution	attribution
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	41-47,63-65	345-362	a total of 2987 field diarrheal samples <*> were tested .	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	a total of 2987 field diarrheal samples <*> were tested .	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	24-65	339-387	To investigate the prevalence and genetic evolution of diarrhea - associated viruses responsible for the outbreaks , a total of 2987 field diarrheal samples collected from 168 pig farms in five provinces in Southern China during 2012 - 2018 were tested .	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	1<2	none	findings	findings
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	345-362	363-387	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	339-387	339-387	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	1<2	none	joint	joint
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	345-362	388-394	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	Thus , significant attention should be paid	that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea ,	Thus , significant attention should be paid	339-387	388-405	The findings of this study indicated that variant PEDV , PDCoV , and SADS - CoV were leading etiologic agents of porcine diarrhea , and either mono - infections or co - infections of pathogenic enteric CoVs were common in pigs in Southern China during 2012 - 2018 .	Thus , significant attention should be paid in order to effectively prevent and control porcine viral diarrhea .	1<2	none	cause-result	cause-result
ba755009e5f7330a8344f1b2dd8e65d54b8488e8	388-394	395-405	Thus , significant attention should be paid	in order to effectively prevent and control porcine viral diarrhea .	Thus , significant attention should be paid	in order to effectively prevent and control porcine viral diarrhea .	388-405	388-405	Thus , significant attention should be paid in order to effectively prevent and control porcine viral diarrhea .	Thus , significant attention should be paid in order to effectively prevent and control porcine viral diarrhea .	1<2	none	enablement	enablement
bab3d2a212eaf7740a45ee8efeec3db99bf94589	1-16	17-43	The classical symptoms of porcine epidemic diarrhea ( PED ) are acute diarrhea and dehydration .	The isolated porcine epidemic diarrhea virus ( PEDV ) CH / GDGZ/2012 strain was obtained from the feces of diseased pigs in 2012 in southern China .	The classical symptoms of porcine epidemic diarrhea ( PED ) are acute diarrhea and dehydration .	The isolated porcine epidemic diarrhea virus ( PEDV ) CH / GDGZ/2012 strain was obtained from the feces of diseased pigs in 2012 in southern China .	1-16	17-43	The classical symptoms of porcine epidemic diarrhea ( PED ) are acute diarrhea and dehydration .	The isolated porcine epidemic diarrhea virus ( PEDV ) CH / GDGZ/2012 strain was obtained from the feces of diseased pigs in 2012 in southern China .	1>2	none	background	background
bab3d2a212eaf7740a45ee8efeec3db99bf94589	17-43	44-55	The isolated porcine epidemic diarrhea virus ( PEDV ) CH / GDGZ/2012 strain was obtained from the feces of diseased pigs in 2012 in southern China .	We report the complete genome sequence of strain CH / GDGZ/2012 ,	The isolated porcine epidemic diarrhea virus ( PEDV ) CH / GDGZ/2012 strain was obtained from the feces of diseased pigs in 2012 in southern China .	We report the complete genome sequence of strain CH / GDGZ/2012 ,	17-43	44-69	The isolated porcine epidemic diarrhea virus ( PEDV ) CH / GDGZ/2012 strain was obtained from the feces of diseased pigs in 2012 in southern China .	We report the complete genome sequence of strain CH / GDGZ/2012 , which might be useful for better understanding the molecular characteristics of this virus .	1<2	none	findings	findings
bab3d2a212eaf7740a45ee8efeec3db99bf94589	44-55	56-69	We report the complete genome sequence of strain CH / GDGZ/2012 ,	which might be useful for better understanding the molecular characteristics of this virus .	We report the complete genome sequence of strain CH / GDGZ/2012 ,	which might be useful for better understanding the molecular characteristics of this virus .	44-69	44-69	We report the complete genome sequence of strain CH / GDGZ/2012 , which might be useful for better understanding the molecular characteristics of this virus .	We report the complete genome sequence of strain CH / GDGZ/2012 , which might be useful for better understanding the molecular characteristics of this virus .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	1-8	41-61	In Tanzania , Unprecedented measures have been adopted	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	In Tanzania , Unprecedented measures have been adopted	In this study , we investigated Tanzanian residents' KAP towards COVID-19 during the rapid rise period of the outbreak .	1-19	41-61	In Tanzania , Unprecedented measures have been adopted to control the rapid spread of the ongoing COVID-19 epidemic .	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	1>2	none	background	background
bcbee2c092b43738b2504034db8246acb059d4c5	1-8	9-19	In Tanzania , Unprecedented measures have been adopted	to control the rapid spread of the ongoing COVID-19 epidemic .	In Tanzania , Unprecedented measures have been adopted	to control the rapid spread of the ongoing COVID-19 epidemic .	1-19	1-19	In Tanzania , Unprecedented measures have been adopted to control the rapid spread of the ongoing COVID-19 epidemic .	In Tanzania , Unprecedented measures have been adopted to control the rapid spread of the ongoing COVID-19 epidemic .	1<2	none	enablement	enablement
bcbee2c092b43738b2504034db8246acb059d4c5	1-8	20-40	In Tanzania , Unprecedented measures have been adopted	Residents adherence to control measures is affected by their knowledge , attitudes , and practices ( KAP ) towards COVID-19 .	In Tanzania , Unprecedented measures have been adopted	Residents adherence to control measures is affected by their knowledge , attitudes , and practices ( KAP ) towards COVID-19 .	1-19	20-40	In Tanzania , Unprecedented measures have been adopted to control the rapid spread of the ongoing COVID-19 epidemic .	Residents adherence to control measures is affected by their knowledge , attitudes , and practices ( KAP ) towards COVID-19 .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	41-61	62-67	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	This was a cross sectional study	In this study , we investigated Tanzanian residents' KAP towards COVID-19 during the rapid rise period of the outbreak .	This was a cross sectional study	41-61	62-86	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	62-67	68-74	This was a cross sectional study	that involved sample of online Tanzanian residents	This was a cross sectional study	that involved sample of online Tanzanian residents	62-86	62-86	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	68-74	75-86	that involved sample of online Tanzanian residents	who was recruited via authors networks with residents and social media .	that involved sample of online Tanzanian residents	who was recruited via authors networks with residents and social media .	62-86	62-86	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	62-67	87-93,98-99	This was a cross sectional study	A self - developed online KAP questionnaire <*> was used	This was a cross sectional study	A self - developed online KAP questionnaire <*> was used	62-86	87-105	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	A self - developed online KAP questionnaire using Survey Monkey tool was used to collect data from participants .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	87-93,98-99	94-97	A self - developed online KAP questionnaire <*> was used	using Survey Monkey tool	A self - developed online KAP questionnaire <*> was used	using Survey Monkey tool	87-105	87-105	A self - developed online KAP questionnaire using Survey Monkey tool was used to collect data from participants .	A self - developed online KAP questionnaire using Survey Monkey tool was used to collect data from participants .	1<2	none	manner-means	manner-means
bcbee2c092b43738b2504034db8246acb059d4c5	98-99	100-105	was used	to collect data from participants .	was used	to collect data from participants .	87-105	87-105	A self - developed online KAP questionnaire using Survey Monkey tool was used to collect data from participants .	A self - developed online KAP questionnaire using Survey Monkey tool was used to collect data from participants .	1<2	none	enablement	enablement
bcbee2c092b43738b2504034db8246acb059d4c5	87-93,98-99	106-109	A self - developed online KAP questionnaire <*> was used	The questionnaire assessed demographic	A self - developed online KAP questionnaire <*> was used	The questionnaire assessed demographic	87-105	106-124	A self - developed online KAP questionnaire using Survey Monkey tool was used to collect data from participants .	The questionnaire assessed demographic and had 12 questions on COVID Knowledge and 5 questions on attitude and practice .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	106-109	110-124	The questionnaire assessed demographic	and had 12 questions on COVID Knowledge and 5 questions on attitude and practice .	The questionnaire assessed demographic	and had 12 questions on COVID Knowledge and 5 questions on attitude and practice .	106-124	106-124	The questionnaire assessed demographic and had 12 questions on COVID Knowledge and 5 questions on attitude and practice .	The questionnaire assessed demographic and had 12 questions on COVID Knowledge and 5 questions on attitude and practice .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	106-109	125-131	The questionnaire assessed demographic	Descriptive and inferential analysis was carried out	The questionnaire assessed demographic	Descriptive and inferential analysis was carried out	106-124	125-135	The questionnaire assessed demographic and had 12 questions on COVID Knowledge and 5 questions on attitude and practice .	Descriptive and inferential analysis was carried out using SPSS 17 .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	125-131	132-135	Descriptive and inferential analysis was carried out	using SPSS 17 .	Descriptive and inferential analysis was carried out	using SPSS 17 .	125-135	125-135	Descriptive and inferential analysis was carried out using SPSS 17 .	Descriptive and inferential analysis was carried out using SPSS 17 .	1<2	none	manner-means	manner-means
bcbee2c092b43738b2504034db8246acb059d4c5	62-67	136-142	This was a cross sectional study	Four hundred residents completed a survey .	This was a cross sectional study	Four hundred residents completed a survey .	62-86	136-142	This was a cross sectional study that involved sample of online Tanzanian residents who was recruited via authors networks with residents and social media .	Four hundred residents completed a survey .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	136-142	143-152	Four hundred residents completed a survey .	The mean age of study participants was 28 years ,	Four hundred residents completed a survey .	The mean age of study participants was 28 years ,	136-142	143-162	Four hundred residents completed a survey .	The mean age of study participants was 28 years , and majorities were females 216 ( 54.0 % ) .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	143-152	153-157	The mean age of study participants was 28 years ,	and majorities were females 216	The mean age of study participants was 28 years ,	and majorities were females 216	143-162	143-162	The mean age of study participants was 28 years , and majorities were females 216 ( 54.0 % ) .	The mean age of study participants was 28 years , and majorities were females 216 ( 54.0 % ) .	1<2	none	joint	joint
bcbee2c092b43738b2504034db8246acb059d4c5	153-157	158-162	and majorities were females 216	( 54.0 % ) .	and majorities were females 216	( 54.0 % ) .	143-162	143-162	The mean age of study participants was 28 years , and majorities were females 216 ( 54.0 % ) .	The mean age of study participants was 28 years , and majorities were females 216 ( 54.0 % ) .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	41-61	163-172	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	There were no significant different in relation to demographic variables	In this study , we investigated Tanzanian residents' KAP towards COVID-19 during the rapid rise period of the outbreak .	There were no significant different in relation to demographic variables	41-61	163-176	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	There were no significant different in relation to demographic variables ( p>0.3 ) .	1<2	none	findings	findings
bcbee2c092b43738b2504034db8246acb059d4c5	163-172	173-176	There were no significant different in relation to demographic variables	( p>0.3 ) .	There were no significant different in relation to demographic variables	( p>0.3 ) .	163-176	163-176	There were no significant different in relation to demographic variables ( p>0.3 ) .	There were no significant different in relation to demographic variables ( p>0.3 ) .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	163-172	177-184,189-193	There were no significant different in relation to demographic variables	Those who held a bachelor degree or above <*> had more correct score .	There were no significant different in relation to demographic variables	Those who held a bachelor degree or above <*> had more correct score .	163-176	177-193	There were no significant different in relation to demographic variables ( p>0.3 ) .	Those who held a bachelor degree or above ( 60.3 % ) had more correct score .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	177-184,189-193	185-188	Those who held a bachelor degree or above <*> had more correct score .	( 60.3 % )	Those who held a bachelor degree or above <*> had more correct score .	( 60.3 % )	177-193	177-193	Those who held a bachelor degree or above ( 60.3 % ) had more correct score .	Those who held a bachelor degree or above ( 60.3 % ) had more correct score .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	177-184,189-193	194-206	Those who held a bachelor degree or above <*> had more correct score .	The overall , ( 84.4 % ) of participants had good knowledge level	Those who held a bachelor degree or above <*> had more correct score .	The overall , ( 84.4 % ) of participants had good knowledge level	177-193	194-219	Those who held a bachelor degree or above ( 60.3 % ) had more correct score .	The overall , ( 84.4 % ) of participants had good knowledge level and the good knowledge was associated with education level ( p=0.001 ) .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	194-206	207-215	The overall , ( 84.4 % ) of participants had good knowledge level	and the good knowledge was associated with education level	The overall , ( 84.4 % ) of participants had good knowledge level	and the good knowledge was associated with education level	194-219	194-219	The overall , ( 84.4 % ) of participants had good knowledge level and the good knowledge was associated with education level ( p=0.001 ) .	The overall , ( 84.4 % ) of participants had good knowledge level and the good knowledge was associated with education level ( p=0.001 ) .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	207-215	216-219	and the good knowledge was associated with education level	( p=0.001 ) .	and the good knowledge was associated with education level	( p=0.001 ) .	194-219	194-219	The overall , ( 84.4 % ) of participants had good knowledge level and the good knowledge was associated with education level ( p=0.001 ) .	The overall , ( 84.4 % ) of participants had good knowledge level and the good knowledge was associated with education level ( p=0.001 ) .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	194-206	220-224,229-230	The overall , ( 84.4 % ) of participants had good knowledge level	Nearly all of the participants <*> had confidence	The overall , ( 84.4 % ) of participants had good knowledge level	Nearly all of the participants <*> had confidence	194-219	220-239	The overall , ( 84.4 % ) of participants had good knowledge level and the good knowledge was associated with education level ( p=0.001 ) .	Nearly all of the participants ( 96.0 % ) had confidence that Tanzania can win the battle against COVID-19 .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	220-224,229-230	225-228	Nearly all of the participants <*> had confidence	( 96.0 % )	Nearly all of the participants <*> had confidence	( 96.0 % )	220-239	220-239	Nearly all of the participants ( 96.0 % ) had confidence that Tanzania can win the battle against COVID-19 .	Nearly all of the participants ( 96.0 % ) had confidence that Tanzania can win the battle against COVID-19 .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	229-230	231-239	had confidence	that Tanzania can win the battle against COVID-19 .	had confidence	that Tanzania can win the battle against COVID-19 .	220-239	220-239	Nearly all of the participants ( 96.0 % ) had confidence that Tanzania can win the battle against COVID-19 .	Nearly all of the participants ( 96.0 % ) had confidence that Tanzania can win the battle against COVID-19 .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	41-61	240-243	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	: medRxiv preprint 2	In this study , we investigated Tanzanian residents' KAP towards COVID-19 during the rapid rise period of the outbreak .	: medRxiv preprint 2	41-61	240-243	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	: medRxiv preprint 2	1<2	none	textual-organization	textual-organization
bcbee2c092b43738b2504034db8246acb059d4c5	220-224,229-230	244-248,253-263	Nearly all of the participants <*> had confidence	The majority of the respondents <*> did not do to the crowded place in recent says .	Nearly all of the participants <*> had confidence	The majority of the respondents <*> did not do to the crowded place in recent says .	220-239	244-263	Nearly all of the participants ( 96.0 % ) had confidence that Tanzania can win the battle against COVID-19 .	The majority of the respondents ( 77 % ) did not do to the crowded place in recent says .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	244-248,253-263	249-252	The majority of the respondents <*> did not do to the crowded place in recent says .	( 77 % )	The majority of the respondents <*> did not do to the crowded place in recent says .	( 77 % )	244-263	244-263	The majority of the respondents ( 77 % ) did not do to the crowded place in recent says .	The majority of the respondents ( 77 % ) did not do to the crowded place in recent says .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	244-248,253-263	264-268	The majority of the respondents <*> did not do to the crowded place in recent says .	Multiple linear regression analysis showed	The majority of the respondents <*> did not do to the crowded place in recent says .	Multiple linear regression analysis showed	244-263	264-294	The majority of the respondents ( 77 % ) did not do to the crowded place in recent says .	Multiple linear regression analysis showed that male gender , age - group of 16 - 29 years and education of secondary or lower were significantly associated with lower knowledge score .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	244-248,253-263	269-294	The majority of the respondents <*> did not do to the crowded place in recent says .	that male gender , age - group of 16 - 29 years and education of secondary or lower were significantly associated with lower knowledge score .	The majority of the respondents <*> did not do to the crowded place in recent says .	that male gender , age - group of 16 - 29 years and education of secondary or lower were significantly associated with lower knowledge score .	244-263	264-294	The majority of the respondents ( 77 % ) did not do to the crowded place in recent says .	Multiple linear regression analysis showed that male gender , age - group of 16 - 29 years and education of secondary or lower were significantly associated with lower knowledge score .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	295-297	298-331	Our findings suggest	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	Our findings suggest	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	295-331	295-331	Our findings suggest that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	Our findings suggest that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	1>2	none	attribution	attribution
bcbee2c092b43738b2504034db8246acb059d4c5	41-61	298-331	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	In this study , we investigated Tanzanian residents' KAP towards COVID-19 during the rapid rise period of the outbreak .	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	41-61	295-331	In this study , we investigated Tanzanian residents ' KAP towards COVID-19 during the rapid rise period of the outbreak .	Our findings suggest that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	1<2	none	findings	findings
bcbee2c092b43738b2504034db8246acb059d4c5	332	333-336,342-353	Suggesting	that health education programs <*> are helpful for encouraging an optimistic attitudes and maintaining safe practices .	Suggesting	that health education programs <*> are helpful for encouraging an optimistic attitudes and maintaining safe practices .	332-353	332-353	Suggesting that health education programs aimed at improving COVID-19 knowledge are helpful for encouraging an optimistic attitudes and maintaining safe practices .	Suggesting that health education programs aimed at improving COVID-19 knowledge are helpful for encouraging an optimistic attitudes and maintaining safe practices .	1>2	none	attribution	attribution
bcbee2c092b43738b2504034db8246acb059d4c5	298-331	333-336,342-353	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	that health education programs <*> are helpful for encouraging an optimistic attitudes and maintaining safe practices .	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	that health education programs <*> are helpful for encouraging an optimistic attitudes and maintaining safe practices .	295-331	332-353	Our findings suggest that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	Suggesting that health education programs aimed at improving COVID-19 knowledge are helpful for encouraging an optimistic attitudes and maintaining safe practices .	1<2	none	cause-result	cause-result
bcbee2c092b43738b2504034db8246acb059d4c5	333-336,342-353	337-341	that health education programs <*> are helpful for encouraging an optimistic attitudes and maintaining safe practices .	aimed at improving COVID-19 knowledge	that health education programs <*> are helpful for encouraging an optimistic attitudes and maintaining safe practices .	aimed at improving COVID-19 knowledge	332-353	332-353	Suggesting that health education programs aimed at improving COVID-19 knowledge are helpful for encouraging an optimistic attitudes and maintaining safe practices .	Suggesting that health education programs aimed at improving COVID-19 knowledge are helpful for encouraging an optimistic attitudes and maintaining safe practices .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	354-363	364-367	Due to the limitation in representativeness of the sample ,	more studies are warranted	Due to the limitation in representativeness of the sample ,	more studies are warranted	354-382	354-382	Due to the limitation in representativeness of the sample , more studies are warranted to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	Due to the limitation in representativeness of the sample , more studies are warranted to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	1>2	none	cause-result	cause-result
bcbee2c092b43738b2504034db8246acb059d4c5	298-331	364-367	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	more studies are warranted	that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	more studies are warranted	295-331	354-382	Our findings suggest that residents of a relatively high level of socioeconomic status , have had good knowledge , optimistic attitudes , and appropriate practices towards COVID-19 during the rapid rise period of the COVID-19 outbreak .	Due to the limitation in representativeness of the sample , more studies are warranted to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	1<2	none	elaboration	elaboration
bcbee2c092b43738b2504034db8246acb059d4c5	364-367	368-382	more studies are warranted	to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	more studies are warranted	to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	354-382	354-382	Due to the limitation in representativeness of the sample , more studies are warranted to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	Due to the limitation in representativeness of the sample , more studies are warranted to investigate the KAP towards COVID-19 among Tanzania residents of a low socioeconomic status .	1<2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	1-12	107-121	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 ,	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 ,	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	1-22	102-131	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 , causing the world to face an existential health crisis .	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	1>2	none	background	background
be7c8e5eb861bc4ef5334a348c6741638ffef108	1-12	13-22	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 ,	causing the world to face an existential health crisis .	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 ,	causing the world to face an existential health crisis .	1-22	1-22	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 , causing the world to face an existential health crisis .	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 , causing the world to face an existential health crisis .	1<2	none	cause-result	cause-result
be7c8e5eb861bc4ef5334a348c6741638ffef108	1-12	23-38	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 ,	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 ,	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential	1-22	23-48	Coronavirus Disease 2019 ( COVID-19 ) spread globally in early 2020 , causing the world to face an existential health crisis .	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential to augment the traditional healthcare strategy for tackling COVID-19 .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	23-38	39-44	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential	to augment the traditional healthcare strategy	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential	to augment the traditional healthcare strategy	23-48	23-48	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential to augment the traditional healthcare strategy for tackling COVID-19 .	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential to augment the traditional healthcare strategy for tackling COVID-19 .	1<2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	39-44	45-48	to augment the traditional healthcare strategy	for tackling COVID-19 .	to augment the traditional healthcare strategy	for tackling COVID-19 .	23-48	23-48	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential to augment the traditional healthcare strategy for tackling COVID-19 .	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential to augment the traditional healthcare strategy for tackling COVID-19 .	1<2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	23-38	49-60	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential	However , segmenting infected regions from CT scans faces several challenges ,	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential	However , segmenting infected regions from CT scans faces several challenges ,	23-48	49-77	Automated detection of lung infections from computed tomography ( CT ) images offers a great potential to augment the traditional healthcare strategy for tackling COVID-19 .	However , segmenting infected regions from CT scans faces several challenges , including high variation in infection characteristics , and low intensity contrast between infections and normal tissues .	1<2	none	comparison	comparison
be7c8e5eb861bc4ef5334a348c6741638ffef108	49-60	61-77	However , segmenting infected regions from CT scans faces several challenges ,	including high variation in infection characteristics , and low intensity contrast between infections and normal tissues .	However , segmenting infected regions from CT scans faces several challenges ,	including high variation in infection characteristics , and low intensity contrast between infections and normal tissues .	49-77	49-77	However , segmenting infected regions from CT scans faces several challenges , including high variation in infection characteristics , and low intensity contrast between infections and normal tissues .	However , segmenting infected regions from CT scans faces several challenges , including high variation in infection characteristics , and low intensity contrast between infections and normal tissues .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	49-60	78-93	However , segmenting infected regions from CT scans faces several challenges ,	Further , collecting a large amount of data is impractical within a short time period ,	However , segmenting infected regions from CT scans faces several challenges ,	Further , collecting a large amount of data is impractical within a short time period ,	49-77	78-101	However , segmenting infected regions from CT scans faces several challenges , including high variation in infection characteristics , and low intensity contrast between infections and normal tissues .	Further , collecting a large amount of data is impractical within a short time period , inhibiting the training of a deep model .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	78-93	94-101	Further , collecting a large amount of data is impractical within a short time period ,	inhibiting the training of a deep model .	Further , collecting a large amount of data is impractical within a short time period ,	inhibiting the training of a deep model .	78-101	78-101	Further , collecting a large amount of data is impractical within a short time period , inhibiting the training of a deep model .	Further , collecting a large amount of data is impractical within a short time period , inhibiting the training of a deep model .	1<2	none	cause-result	cause-result
be7c8e5eb861bc4ef5334a348c6741638ffef108	102-106	107-121	To address these challenges ,	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	To address these challenges ,	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	102-131	102-131	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	1>2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	107-121	122-131	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	to automatically identify infected regions from chest CT scans .	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	to automatically identify infected regions from chest CT scans .	102-131	102-131	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	1<2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	107-121	132-143	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	In our Inf - Net , a parallel partial decoder is used	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	In our Inf - Net , a parallel partial decoder is used	102-131	132-156	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	In our Inf - Net , a parallel partial decoder is used to aggregate the high - level features and generate a global map .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	132-143	144-150	In our Inf - Net , a parallel partial decoder is used	to aggregate the high - level features	In our Inf - Net , a parallel partial decoder is used	to aggregate the high - level features	132-156	132-156	In our Inf - Net , a parallel partial decoder is used to aggregate the high - level features and generate a global map .	In our Inf - Net , a parallel partial decoder is used to aggregate the high - level features and generate a global map .	1<2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	144-150	151-156	to aggregate the high - level features	and generate a global map .	to aggregate the high - level features	and generate a global map .	132-156	132-156	In our Inf - Net , a parallel partial decoder is used to aggregate the high - level features and generate a global map .	In our Inf - Net , a parallel partial decoder is used to aggregate the high - level features and generate a global map .	1<2	none	joint	joint
be7c8e5eb861bc4ef5334a348c6741638ffef108	132-143	157-169	In our Inf - Net , a parallel partial decoder is used	Then , the implicit reverse attention and explicit edge - attention are utilized	In our Inf - Net , a parallel partial decoder is used	Then , the implicit reverse attention and explicit edge - attention are utilized	132-156	157-178	In our Inf - Net , a parallel partial decoder is used to aggregate the high - level features and generate a global map .	Then , the implicit reverse attention and explicit edge - attention are utilized to model the boundaries and enhance the representations .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	157-169	170-173	Then , the implicit reverse attention and explicit edge - attention are utilized	to model the boundaries	Then , the implicit reverse attention and explicit edge - attention are utilized	to model the boundaries	157-178	157-178	Then , the implicit reverse attention and explicit edge - attention are utilized to model the boundaries and enhance the representations .	Then , the implicit reverse attention and explicit edge - attention are utilized to model the boundaries and enhance the representations .	1<2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	170-173	174-178	to model the boundaries	and enhance the representations .	to model the boundaries	and enhance the representations .	157-178	157-178	Then , the implicit reverse attention and explicit edge - attention are utilized to model the boundaries and enhance the representations .	Then , the implicit reverse attention and explicit edge - attention are utilized to model the boundaries and enhance the representations .	1<2	none	joint	joint
be7c8e5eb861bc4ef5334a348c6741638ffef108	107-121	179-180,189-196	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	Moreover , <*> we present a semi - supervised segmentation framework	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	Moreover , <*> we present a semi - supervised segmentation framework	102-131	179-217	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	181-188	189-196	to alleviate the shortage of labeled data ,	we present a semi - supervised segmentation framework	to alleviate the shortage of labeled data ,	we present a semi - supervised segmentation framework	179-217	179-217	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	1>2	none	enablement	enablement
be7c8e5eb861bc4ef5334a348c6741638ffef108	189-196	197-204	we present a semi - supervised segmentation framework	based on a randomly selected propagation strategy ,	we present a semi - supervised segmentation framework	based on a randomly selected propagation strategy ,	179-217	179-217	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	1<2	none	manner-means	manner-means
be7c8e5eb861bc4ef5334a348c6741638ffef108	197-204	205-211	based on a randomly selected propagation strategy ,	which only requires a few labeled images	based on a randomly selected propagation strategy ,	which only requires a few labeled images	179-217	179-217	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	205-211	212-217	which only requires a few labeled images	and leverages primarily unlabeled data .	which only requires a few labeled images	and leverages primarily unlabeled data .	179-217	179-217	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	1<2	none	joint	joint
be7c8e5eb861bc4ef5334a348c6741638ffef108	179-180,189-196	218-227	Moreover , <*> we present a semi - supervised segmentation framework	Our semi - supervised framework can improve the learning ability	Moreover , <*> we present a semi - supervised segmentation framework	Our semi - supervised framework can improve the learning ability	179-217	218-233	Moreover , to alleviate the shortage of labeled data , we present a semi - supervised segmentation framework based on a randomly selected propagation strategy , which only requires a few labeled images and leverages primarily unlabeled data .	Our semi - supervised framework can improve the learning ability and achieve a higher performance .	1<2	none	findings	findings
be7c8e5eb861bc4ef5334a348c6741638ffef108	218-227	228-233	Our semi - supervised framework can improve the learning ability	and achieve a higher performance .	Our semi - supervised framework can improve the learning ability	and achieve a higher performance .	218-233	218-233	Our semi - supervised framework can improve the learning ability and achieve a higher performance .	Our semi - supervised framework can improve the learning ability and achieve a higher performance .	1<2	none	elaboration	elaboration
be7c8e5eb861bc4ef5334a348c6741638ffef108	234-246	247-259	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate	that the proposed Inf - Net outperforms most cutting - edge segmentation models	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate	that the proposed Inf - Net outperforms most cutting - edge segmentation models	234-269	234-269	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate that the proposed Inf - Net outperforms most cutting - edge segmentation models and advances the state - of - theart performance .	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate that the proposed Inf - Net outperforms most cutting - edge segmentation models and advances the state - of - theart performance .	1>2	none	attribution	attribution
be7c8e5eb861bc4ef5334a348c6741638ffef108	107-121	247-259	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	that the proposed Inf - Net outperforms most cutting - edge segmentation models	a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed	that the proposed Inf - Net outperforms most cutting - edge segmentation models	102-131	234-269	To address these challenges , a novel COVID-19 Lung Infection Segmentation Deep Network ( Inf - Net ) is proposed to automatically identify infected regions from chest CT scans .	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate that the proposed Inf - Net outperforms most cutting - edge segmentation models and advances the state - of - theart performance .	1<2	none	findings	findings
be7c8e5eb861bc4ef5334a348c6741638ffef108	247-259	260-269	that the proposed Inf - Net outperforms most cutting - edge segmentation models	and advances the state - of - theart performance .	that the proposed Inf - Net outperforms most cutting - edge segmentation models	and advances the state - of - theart performance .	234-269	234-269	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate that the proposed Inf - Net outperforms most cutting - edge segmentation models and advances the state - of - theart performance .	Extensive experiments on our COVID - SemiSeg and and real CT volumes demonstrate that the proposed Inf - Net outperforms most cutting - edge segmentation models and advances the state - of - theart performance .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	1-3,15-17	4-14	A simulation tool <*> is proposed .	that supports developers to build scenarios automatically in multiple simulation platforms	A simulation tool <*> is proposed .	that supports developers to build scenarios automatically in multiple simulation platforms	1-17	1-17	A simulation tool that supports developers to build scenarios automatically in multiple simulation platforms is proposed .	A simulation tool that supports developers to build scenarios automatically in multiple simulation platforms is proposed .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	1-3,15-17	18-32	A simulation tool <*> is proposed .	As an essential part of this simulator , this study proposed an activity schedule generator	A simulation tool <*> is proposed .	As an essential part of this simulator , this study proposed an activity schedule generator	1-17	18-43	A simulation tool that supports developers to build scenarios automatically in multiple simulation platforms is proposed .	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	18-32	33-40	As an essential part of this simulator , this study proposed an activity schedule generator	to mimic the daily life of elderly people	As an essential part of this simulator , this study proposed an activity schedule generator	to mimic the daily life of elderly people	18-43	18-43	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	33-40	41-43	to mimic the daily life of elderly people	living alone .	to mimic the daily life of elderly people	living alone .	18-43	18-43	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	18-32	44-56	As an essential part of this simulator , this study proposed an activity schedule generator	This generator outperforms existing methods of activity schedule planning in three aspects :	As an essential part of this simulator , this study proposed an activity schedule generator	This generator outperforms existing methods of activity schedule planning in three aspects :	18-43	44-56	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	This generator outperforms existing methods of activity schedule planning in three aspects :	1<2	none	findings	findings
bfab901132bb4f31381dd086e6c45472fa9b4e44	44-56	57-70	This generator outperforms existing methods of activity schedule planning in three aspects :	1 ) it is adaptive to the layout of a simulated smart house ;	This generator outperforms existing methods of activity schedule planning in three aspects :	1 ) it is adaptive to the layout of a simulated smart house ;	44-56	57-70	This generator outperforms existing methods of activity schedule planning in three aspects :	1 ) it is adaptive to the layout of a simulated smart house ;	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	57-70	71-84	1 ) it is adaptive to the layout of a simulated smart house ;	2 ) there is no unspecified time in the timeline of generated schedules ;	1 ) it is adaptive to the layout of a simulated smart house ;	2 ) there is no unspecified time in the timeline of generated schedules ;	57-70	71-84	1 ) it is adaptive to the layout of a simulated smart house ;	2 ) there is no unspecified time in the timeline of generated schedules ;	1<2	none	joint	joint
bfab901132bb4f31381dd086e6c45472fa9b4e44	57-70	85-101	1 ) it is adaptive to the layout of a simulated smart house ;	and 3 ) it generates stable , but not tedious schedules for a number of days .	1 ) it is adaptive to the layout of a simulated smart house ;	and 3 ) it generates stable , but not tedious schedules for a number of days .	57-70	85-101	1 ) it is adaptive to the layout of a simulated smart house ;	and 3 ) it generates stable , but not tedious schedules for a number of days .	1<2	none	joint	joint
bfab901132bb4f31381dd086e6c45472fa9b4e44	18-32	102-110	As an essential part of this simulator , this study proposed an activity schedule generator	A real - time location data generator is proposed	As an essential part of this simulator , this study proposed an activity schedule generator	A real - time location data generator is proposed	18-43	102-161	As an essential part of this simulator , this study proposed an activity schedule generator to mimic the daily life of elderly people living alone .	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	102-110	111-125	A real - time location data generator is proposed	to convert generated schedules to simulated real - time location data of the resident ,	A real - time location data generator is proposed	to convert generated schedules to simulated real - time location data of the resident ,	102-161	102-161	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	1<2	none	enablement	enablement
bfab901132bb4f31381dd086e6c45472fa9b4e44	102-110	126-146	A real - time location data generator is proposed	and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors ,	A real - time location data generator is proposed	and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors ,	102-161	102-161	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	1<2	none	elaboration	elaboration
bfab901132bb4f31381dd086e6c45472fa9b4e44	126-146	147-150	and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors ,	which can be used	and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors ,	which can be used	102-161	102-161	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	1<2	none	manner-means	manner-means
bfab901132bb4f31381dd086e6c45472fa9b4e44	147-150	151-161	which can be used	to optimize placement of PIR sensors in a smart house .	which can be used	to optimize placement of PIR sensors in a smart house .	102-161	102-161	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	A real - time location data generator is proposed to convert generated schedules to simulated real - time location data of the resident , and a proposed interface converts these simulated location data to simulated records of virtual passive infrared ( PIR ) sensors , which can be used to optimize placement of PIR sensors in a smart house .	1<2	none	enablement	enablement
c0e6a4d852babb843d63198cc1e16146efc108b1	1-22	40-53	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein ,	we established a transgenic fly model for the SARS - CoV 3a gene .	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein ,	we established a transgenic fly model for the SARS - CoV 3a gene .	1-32	33-53	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein , and its expression has been confirmed in SARS patients .	To study functional roles of 3a , we established a transgenic fly model for the SARS - CoV 3a gene .	1>2	none	background	background
c0e6a4d852babb843d63198cc1e16146efc108b1	1-22	23-32	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein ,	and its expression has been confirmed in SARS patients .	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein ,	and its expression has been confirmed in SARS patients .	1-32	1-32	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein , and its expression has been confirmed in SARS patients .	The Severe Acute Respiratory Syndrome - Coronavirus ( SARS - CoV ) 3a locus encodes a 274 a.a . novel protein , and its expression has been confirmed in SARS patients .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	33-39	40-53	To study functional roles of 3a ,	we established a transgenic fly model for the SARS - CoV 3a gene .	To study functional roles of 3a ,	we established a transgenic fly model for the SARS - CoV 3a gene .	33-53	33-53	To study functional roles of 3a , we established a transgenic fly model for the SARS - CoV 3a gene .	To study functional roles of 3a , we established a transgenic fly model for the SARS - CoV 3a gene .	1>2	none	enablement	enablement
c0e6a4d852babb843d63198cc1e16146efc108b1	40-53	54-65	we established a transgenic fly model for the SARS - CoV 3a gene .	Misexpression of 3a in Drosophila caused a dominant rough eye phenotype .	we established a transgenic fly model for the SARS - CoV 3a gene .	Misexpression of 3a in Drosophila caused a dominant rough eye phenotype .	33-53	54-65	To study functional roles of 3a , we established a transgenic fly model for the SARS - CoV 3a gene .	Misexpression of 3a in Drosophila caused a dominant rough eye phenotype .	1<2	none	findings	findings
c0e6a4d852babb843d63198cc1e16146efc108b1	66-71	72-73	Using a specific monoclonal antibody ,	we demonstrated	Using a specific monoclonal antibody ,	we demonstrated	66-93	66-93	Using a specific monoclonal antibody , we demonstrated that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	Using a specific monoclonal antibody , we demonstrated that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	1>2	none	manner-means	manner-means
c0e6a4d852babb843d63198cc1e16146efc108b1	72-73	74-93	we demonstrated	that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	we demonstrated	that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	66-93	66-93	Using a specific monoclonal antibody , we demonstrated that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	Using a specific monoclonal antibody , we demonstrated that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	1>2	none	attribution	attribution
c0e6a4d852babb843d63198cc1e16146efc108b1	54-65	74-93	Misexpression of 3a in Drosophila caused a dominant rough eye phenotype .	that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	Misexpression of 3a in Drosophila caused a dominant rough eye phenotype .	that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	54-65	66-93	Misexpression of 3a in Drosophila caused a dominant rough eye phenotype .	Using a specific monoclonal antibody , we demonstrated that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	74-93	94-97	that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	We provide genetic evidence	that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	We provide genetic evidence	66-93	94-110	Using a specific monoclonal antibody , we demonstrated that the 3a protein displayed a punctate cytoplasmic localization in Drosophila as in SARS - CoV - infected cells .	We provide genetic evidence to support that 3a is functionally related to clathrin - mediated endocytosis .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	98-99	100-110	to support	that 3a is functionally related to clathrin - mediated endocytosis .	to support	that 3a is functionally related to clathrin - mediated endocytosis .	94-110	94-110	We provide genetic evidence to support that 3a is functionally related to clathrin - mediated endocytosis .	We provide genetic evidence to support that 3a is functionally related to clathrin - mediated endocytosis .	1>2	none	attribution	attribution
c0e6a4d852babb843d63198cc1e16146efc108b1	94-97	100-110	We provide genetic evidence	that 3a is functionally related to clathrin - mediated endocytosis .	We provide genetic evidence	that 3a is functionally related to clathrin - mediated endocytosis .	94-110	94-110	We provide genetic evidence to support that 3a is functionally related to clathrin - mediated endocytosis .	We provide genetic evidence to support that 3a is functionally related to clathrin - mediated endocytosis .	1<2	none	enablement	enablement
c0e6a4d852babb843d63198cc1e16146efc108b1	111-113	114-119	We further found	that 3a misexpression induces apoptosis ,	We further found	that 3a misexpression induces apoptosis ,	111-132	111-132	We further found that 3a misexpression induces apoptosis , which could be modulated by cellular cytochrome c levels and caspase activity .	We further found that 3a misexpression induces apoptosis , which could be modulated by cellular cytochrome c levels and caspase activity .	1>2	none	attribution	attribution
c0e6a4d852babb843d63198cc1e16146efc108b1	94-97	114-119	We provide genetic evidence	that 3a misexpression induces apoptosis ,	We provide genetic evidence	that 3a misexpression induces apoptosis ,	94-110	111-132	We provide genetic evidence to support that 3a is functionally related to clathrin - mediated endocytosis .	We further found that 3a misexpression induces apoptosis , which could be modulated by cellular cytochrome c levels and caspase activity .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	114-119	120-132	that 3a misexpression induces apoptosis ,	which could be modulated by cellular cytochrome c levels and caspase activity .	that 3a misexpression induces apoptosis ,	which could be modulated by cellular cytochrome c levels and caspase activity .	111-132	111-132	We further found that 3a misexpression induces apoptosis , which could be modulated by cellular cytochrome c levels and caspase activity .	We further found that 3a misexpression induces apoptosis , which could be modulated by cellular cytochrome c levels and caspase activity .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	114-119	133-145	that 3a misexpression induces apoptosis ,	From a forward genetic screen , 78 dominant 3a modifying loci were recovered	that 3a misexpression induces apoptosis ,	From a forward genetic screen , 78 dominant 3a modifying loci were recovered	111-132	133-173	We further found that 3a misexpression induces apoptosis , which could be modulated by cellular cytochrome c levels and caspase activity .	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	146-152	153-168	and the identity of these modifiers revealed	that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes	and the identity of these modifiers revealed	that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes	133-173	133-173	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	1>2	none	attribution	attribution
c0e6a4d852babb843d63198cc1e16146efc108b1	133-145	153-168	From a forward genetic screen , 78 dominant 3a modifying loci were recovered	that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes	From a forward genetic screen , 78 dominant 3a modifying loci were recovered	that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes	133-173	133-173	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	1<2	none	elaboration	elaboration
c0e6a4d852babb843d63198cc1e16146efc108b1	153-168	169-173	that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes	including gene transcriptional regulation .	that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes	including gene transcriptional regulation .	133-173	133-173	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	From a forward genetic screen , 78 dominant 3a modifying loci were recovered and the identity of these modifiers revealed that the severity of the 3a - induced rough eye phenotype depends on multiple cellular processes including gene transcriptional regulation .	1<2	none	elaboration	elaboration
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	1-6	29-44	Mucosal vaccination is an effective strategy	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	Mucosal vaccination is an effective strategy	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	1-28	29-60	Mucosal vaccination is an effective strategy for generating antigen - specific immune responses against mucosal infections of foot - and - mouth disease virus ( FMDV ) .	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	1>2	none	background	background
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	1-6	7-28	Mucosal vaccination is an effective strategy	for generating antigen - specific immune responses against mucosal infections of foot - and - mouth disease virus ( FMDV ) .	Mucosal vaccination is an effective strategy	for generating antigen - specific immune responses against mucosal infections of foot - and - mouth disease virus ( FMDV ) .	1-28	1-28	Mucosal vaccination is an effective strategy for generating antigen - specific immune responses against mucosal infections of foot - and - mouth disease virus ( FMDV ) .	Mucosal vaccination is an effective strategy for generating antigen - specific immune responses against mucosal infections of foot - and - mouth disease virus ( FMDV ) .	1<2	none	enablement	enablement
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	29-44	45-49	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	containing a pSIP411-VP1 recombinant plasmid	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	containing a pSIP411-VP1 recombinant plasmid	29-60	29-60	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	1<2	none	elaboration	elaboration
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	29-44	50-60	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	to initiate mucosal and systemic immune responses in guinea pigs .	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	to initiate mucosal and systemic immune responses in guinea pigs .	29-60	29-60	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	1<2	none	enablement	enablement
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	29-44	61-65,70-80	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	Guinea pigs were orally vaccinated <*> with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	Guinea pigs were orally vaccinated <*> with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	29-60	61-80	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	Guinea pigs were orally vaccinated ( three doses ) with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	1<2	none	elaboration	elaboration
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	61-65,70-80	66-69	Guinea pigs were orally vaccinated <*> with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	( three doses )	Guinea pigs were orally vaccinated <*> with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	( three doses )	61-80	61-80	Guinea pigs were orally vaccinated ( three doses ) with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	Guinea pigs were orally vaccinated ( three doses ) with NC8-pSIP411 , NC8-pSIP411-VP1 , WCFS1-pSIP411 , WCFS1-pSIP411-VP1 or milk .	1<2	none	elaboration	elaboration
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	29-44	81,87-110	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	Animals <*> developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles	Animals <*> developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	29-60	81-129	In this study , Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs .	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	1<2	none	findings	findings
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	81,87-110	82-86	Animals <*> developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1	Animals <*> developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1	81-129	81-129	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	1<2	none	elaboration	elaboration
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	87-110	111-118	developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	and revealed stronger cell - mediated immune responses	developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	and revealed stronger cell - mediated immune responses	81-129	81-129	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	1<2	none	joint	joint
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	87-110	119-124	developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	and enhanced protection against FMDV challenge	developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	and enhanced protection against FMDV challenge	81-129	81-129	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	1<2	none	joint	joint
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	87-110	125-129	developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	compared with control groups .	developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	compared with control groups .	81-129	81-129	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	1<2	none	comparison	comparison
c280d46d6fa7e2c2938a5c09bd6b092e1058a9b0	81,87-110	130-141	Animals <*> developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	The recombinant pSIP411-VP1 effectively improved immunoprotection against FMDV in guinea pigs .	Animals <*> developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies ,	The recombinant pSIP411-VP1 effectively improved immunoprotection against FMDV in guinea pigs .	81-129	130-141	Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen - specific serum IgG , IgA , IgM , mucosal secretory IgA ( sIgA ) and neutralizing antibodies , and revealed stronger cell - mediated immune responses and enhanced protection against FMDV challenge compared with control groups .	The recombinant pSIP411-VP1 effectively improved immunoprotection against FMDV in guinea pigs .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	1-2	3-6,10-11	Background .	Influenza A(H7N9 ) viruses <*> show features	Background .	Influenza A(H7N9 ) viruses <*> show features	1-2	3-17	Background .	Influenza A(H7N9 ) viruses isolated from humans show features suggesting partial adaptation to mammals .	1>2	none	textual-organization	textual-organization
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	3-6,10-11	29-40	Influenza A(H7N9 ) viruses <*> show features	we compared risk factors , clinical presentation , and progression of patients	Influenza A(H7N9 ) viruses <*> show features	we compared risk factors , clinical presentation , and progression of patients	3-17	18-56	Influenza A(H7N9 ) viruses isolated from humans show features suggesting partial adaptation to mammals .	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	1>2	none	background	background
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	3-6,10-11	7-9	Influenza A(H7N9 ) viruses <*> show features	isolated from humans	Influenza A(H7N9 ) viruses <*> show features	isolated from humans	3-17	3-17	Influenza A(H7N9 ) viruses isolated from humans show features suggesting partial adaptation to mammals .	Influenza A(H7N9 ) viruses isolated from humans show features suggesting partial adaptation to mammals .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	10-11	12-17	show features	suggesting partial adaptation to mammals .	show features	suggesting partial adaptation to mammals .	3-17	3-17	Influenza A(H7N9 ) viruses isolated from humans show features suggesting partial adaptation to mammals .	Influenza A(H7N9 ) viruses isolated from humans show features suggesting partial adaptation to mammals .	1<2	none	cause-result	cause-result
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	18-28	29-40	To provide insights into the pathogenesis of H7N9 virus infection ,	we compared risk factors , clinical presentation , and progression of patients	To provide insights into the pathogenesis of H7N9 virus infection ,	we compared risk factors , clinical presentation , and progression of patients	18-56	18-56	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	1>2	none	enablement	enablement
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	29-40	41-56	we compared risk factors , clinical presentation , and progression of patients	hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	we compared risk factors , clinical presentation , and progression of patients	hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	18-56	18-56	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	57-58	59-66	Methods .	We compared individual - level data from patients	Methods .	We compared individual - level data from patients	57-58	59-99	Methods .	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	1>2	none	textual-organization	textual-organization
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	29-40	59-66	we compared risk factors , clinical presentation , and progression of patients	We compared individual - level data from patients	we compared risk factors , clinical presentation , and progression of patients	We compared individual - level data from patients	18-56	59-99	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	1<2	none	manner-means	manner-means
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	59-66	67-71,78	We compared individual - level data from patients	hospitalized with infection by H7N9 <*> H5N1	We compared individual - level data from patients	hospitalized with infection by H7N9 <*> H5N1	59-99	59-99	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	67-71,78	72-77	hospitalized with infection by H7N9 <*> H5N1	( n = 123 ) ,	hospitalized with infection by H7N9 <*> H5N1	( n = 123 ) ,	59-99	59-99	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	78,90-92	79-89	H5N1 <*> , and pH1N1	( n = 119 ; 43 China , 76 Vietnam )	H5N1 <*> , and pH1N1	( n = 119 ; 43 China , 76 Vietnam )	59-99	59-99	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	90-92,98-99	93-97	, and pH1N1 <*> viruses .	( n = 3486 )	, and pH1N1 <*> viruses .	( n = 3486 )	59-99	59-99	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	59-66	100-124	We compared individual - level data from patients	We assessed risk factors for hospitalization after adjustment for age - and sex - specific prevalence of risk factors in the general Chinese population .	We compared individual - level data from patients	We assessed risk factors for hospitalization after adjustment for age - and sex - specific prevalence of risk factors in the general Chinese population .	59-99	100-124	We compared individual - level data from patients hospitalized with infection by H7N9 ( n = 123 ) , H5N1 ( n = 119 ; 43 China , 76 Vietnam ) , and pH1N1 ( n = 3486 ) viruses .	We assessed risk factors for hospitalization after adjustment for age - and sex - specific prevalence of risk factors in the general Chinese population .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	125-126	127-141	Results .	The median age of patients with H7N9 virus infection was older than other patient groups	Results .	The median age of patients with H7N9 virus infection was older than other patient groups	125-126	127-164	Results .	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	1>2	none	textual-organization	textual-organization
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	29-40	127-141	we compared risk factors , clinical presentation , and progression of patients	The median age of patients with H7N9 virus infection was older than other patient groups	we compared risk factors , clinical presentation , and progression of patients	The median age of patients with H7N9 virus infection was older than other patient groups	18-56	127-164	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	1<2	none	findings	findings
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	127-141	142-149	The median age of patients with H7N9 virus infection was older than other patient groups	( 63 years ; P < .001 )	The median age of patients with H7N9 virus infection was older than other patient groups	( 63 years ; P < .001 )	127-164	127-164	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	127-141	150-155	The median age of patients with H7N9 virus infection was older than other patient groups	and a higher proportion was male	The median age of patients with H7N9 virus infection was older than other patient groups	and a higher proportion was male	127-164	127-164	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	1<2	none	joint	joint
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	150-155	156-164	and a higher proportion was male	( 71 % ; P < .02 ) .	and a higher proportion was male	( 71 % ; P < .02 ) .	127-164	127-164	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	127-141	165-184	The median age of patients with H7N9 virus infection was older than other patient groups	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9	The median age of patients with H7N9 virus infection was older than other patient groups	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9	127-164	165-200	The median age of patients with H7N9 virus infection was older than other patient groups ( 63 years ; P < .001 ) and a higher proportion was male ( 71 % ; P < .02 ) .	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9 ( relative risk , 9.68 ; 95 % confidence interval , 5.24 - 17.9 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	165-184	185-200	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9	( relative risk , 9.68 ; 95 % confidence interval , 5.24 - 17.9 ) .	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9	( relative risk , 9.68 ; 95 % confidence interval , 5.24 - 17.9 ) .	165-200	165-200	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9 ( relative risk , 9.68 ; 95 % confidence interval , 5.24 - 17.9 ) .	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9 ( relative risk , 9.68 ; 95 % confidence interval , 5.24 - 17.9 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	165-184	201-228	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those	165-200	201-247	After adjustment for age and sex , chronic heart disease was associated with an increased risk of hospitalization with H7N9 ( relative risk , 9.68 ; 95 % confidence interval , 5.24 - 17.9 ) .	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	201-228	229-233	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those	seen in H5N1 patients ,	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those	seen in H5N1 patients ,	201-247	201-247	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	229-233	234-241	seen in H5N1 patients ,	which were all significantly different from pH1N1 patients	seen in H5N1 patients ,	which were all significantly different from pH1N1 patients	201-247	201-247	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	234-241	242-247	which were all significantly different from pH1N1 patients	( P < .005 ) .	which were all significantly different from pH1N1 patients	( P < .005 ) .	201-247	201-247	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	201-228	248-261	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients	201-247	248-301	H7N9 patients had similar patterns of leukopenia , thrombocytopenia , and elevated alanine aminotransferase , creatinine kinase , C - reactive protein , and lactate dehydrogenase to those seen in H5N1 patients , which were all significantly different from pH1N1 patients ( P < .005 ) .	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	248-261	262-267	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients	( P < .001 ) ,	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients	( P < .001 ) ,	248-301	248-301	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	248-261	268-280,286-295	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients	and the median time from onset to death was 18 days for H7N9 <*> vs 11 days for H5N1 and 15 days for pH1N1	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients	and the median time from onset to death was 18 days for H7N9 <*> vs 11 days for H5N1 and 15 days for pH1N1	248-301	248-301	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	1<2	none	joint	joint
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	268-280,286-295	281-285	and the median time from onset to death was 18 days for H7N9 <*> vs 11 days for H5N1 and 15 days for pH1N1	( P = .002 )	and the median time from onset to death was 18 days for H7N9 <*> vs 11 days for H5N1 and 15 days for pH1N1	( P = .002 )	248-301	248-301	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	286-295	296-301	vs 11 days for H5N1 and 15 days for pH1N1	( P = .154 ) .	vs 11 days for H5N1 and 15 days for pH1N1	( P = .154 ) .	248-301	248-301	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	H7N9 patients had a longer duration of hospitalization than either H5N1 or pH1N1 patients ( P < .001 ) , and the median time from onset to death was 18 days for H7N9 ( P = .002 ) vs 11 days for H5N1 and 15 days for pH1N1 ( P = .154 ) .	1<2	none	elaboration	elaboration
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	302-303	326-336	Conclusions .	that host factors are an important contributor to H7N9 severity .	Conclusions .	that host factors are an important contributor to H7N9 severity .	302-303	304-336	Conclusions .	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course compared with that of H5N1 suggests that host factors are an important contributor to H7N9 severity .	1>2	none	textual-organization	textual-organization
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	304-319,325	326-336	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course <*> suggests	that host factors are an important contributor to H7N9 severity .	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course <*> suggests	that host factors are an important contributor to H7N9 severity .	304-336	304-336	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course compared with that of H5N1 suggests that host factors are an important contributor to H7N9 severity .	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course compared with that of H5N1 suggests that host factors are an important contributor to H7N9 severity .	1>2	none	attribution	attribution
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	304-319,325	320-324	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course <*> suggests	compared with that of H5N1	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course <*> suggests	compared with that of H5N1	304-336	304-336	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course compared with that of H5N1 suggests that host factors are an important contributor to H7N9 severity .	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course compared with that of H5N1 suggests that host factors are an important contributor to H7N9 severity .	1<2	none	comparison	comparison
c4aa9bb066a64db00b8bdd44d5c021c5603a09a2	29-40	326-336	we compared risk factors , clinical presentation , and progression of patients	that host factors are an important contributor to H7N9 severity .	we compared risk factors , clinical presentation , and progression of patients	that host factors are an important contributor to H7N9 severity .	18-56	304-336	To provide insights into the pathogenesis of H7N9 virus infection , we compared risk factors , clinical presentation , and progression of patients hospitalized with H7N9 , H5N1 , and 2009 pandemic H1N1 ( pH1N1 ) virus infections .	The identification of known risk factors for severe seasonal influenza and the more protracted clinical course compared with that of H5N1 suggests that host factors are an important contributor to H7N9 severity .	1<2	none	findings	findings
c526fbee33eed355a7c7437950603c4835418b0e	1-26	77-98	In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	1-26	66-98	In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	In order to develop an effective vaccine and diagnostic tools , we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	1>2	none	background	background
c526fbee33eed355a7c7437950603c4835418b0e	1-26	27-28,36-47	In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	However , <*> it is necessary to take precautions against laboratory - acquired infection .	In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	However , <*> it is necessary to take precautions against laboratory - acquired infection .	1-26	27-47	In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	However , to work with highly contagious pathogens , it is necessary to take precautions against laboratory - acquired infection .	1<2	none	comparison	comparison
c526fbee33eed355a7c7437950603c4835418b0e	29-35	36-47	to work with highly contagious pathogens ,	it is necessary to take precautions against laboratory - acquired infection .	to work with highly contagious pathogens ,	it is necessary to take precautions against laboratory - acquired infection .	27-47	27-47	However , to work with highly contagious pathogens , it is necessary to take precautions against laboratory - acquired infection .	However , to work with highly contagious pathogens , it is necessary to take precautions against laboratory - acquired infection .	1>2	none	enablement	enablement
c526fbee33eed355a7c7437950603c4835418b0e	27-28,36-47	48-65	However , <*> it is necessary to take precautions against laboratory - acquired infection .	We have learned many lessons from the recent outbreak of severe acute respiratory syndrome ( SARS ) .	However , <*> it is necessary to take precautions against laboratory - acquired infection .	We have learned many lessons from the recent outbreak of severe acute respiratory syndrome ( SARS ) .	27-47	48-65	However , to work with highly contagious pathogens , it is necessary to take precautions against laboratory - acquired infection .	We have learned many lessons from the recent outbreak of severe acute respiratory syndrome ( SARS ) .	1<2	none	elaboration	elaboration
c526fbee33eed355a7c7437950603c4835418b0e	66-76	77-98	In order to develop an effective vaccine and diagnostic tools ,	we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	In order to develop an effective vaccine and diagnostic tools ,	we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	66-98	66-98	In order to develop an effective vaccine and diagnostic tools , we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	In order to develop an effective vaccine and diagnostic tools , we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	1>2	none	enablement	enablement
c526fbee33eed355a7c7437950603c4835418b0e	77-98	99-112,123-129	we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	Our protocol for large - scale preparation of UV - inactivated SARS - CoV <*> is applicable to any newly emerging virus	we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	Our protocol for large - scale preparation of UV - inactivated SARS - CoV <*> is applicable to any newly emerging virus	66-98	99-136	In order to develop an effective vaccine and diagnostic tools , we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	Our protocol for large - scale preparation of UV - inactivated SARS - CoV including virus expansion , titration , inactivation , and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future .	1<2	none	findings	findings
c526fbee33eed355a7c7437950603c4835418b0e	99-112,123-129	113-122	Our protocol for large - scale preparation of UV - inactivated SARS - CoV <*> is applicable to any newly emerging virus	including virus expansion , titration , inactivation , and ultracentrifugation	Our protocol for large - scale preparation of UV - inactivated SARS - CoV <*> is applicable to any newly emerging virus	including virus expansion , titration , inactivation , and ultracentrifugation	99-136	99-136	Our protocol for large - scale preparation of UV - inactivated SARS - CoV including virus expansion , titration , inactivation , and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future .	Our protocol for large - scale preparation of UV - inactivated SARS - CoV including virus expansion , titration , inactivation , and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future .	1<2	none	elaboration	elaboration
c526fbee33eed355a7c7437950603c4835418b0e	123-129	130-136	is applicable to any newly emerging virus	we might encounter in the future .	is applicable to any newly emerging virus	we might encounter in the future .	99-136	99-136	Our protocol for large - scale preparation of UV - inactivated SARS - CoV including virus expansion , titration , inactivation , and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future .	Our protocol for large - scale preparation of UV - inactivated SARS - CoV including virus expansion , titration , inactivation , and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	1-21	22-33	To assess the economic impact of bovine coronavirus ( BCV ) and bovine respiratory syncytial virus ( BRSV ) infections ,	accurate estimates of their associated effects on animal performance are needed .	To assess the economic impact of bovine coronavirus ( BCV ) and bovine respiratory syncytial virus ( BRSV ) infections ,	accurate estimates of their associated effects on animal performance are needed .	1-33	1-33	To assess the economic impact of bovine coronavirus ( BCV ) and bovine respiratory syncytial virus ( BRSV ) infections , accurate estimates of their associated effects on animal performance are needed .	To assess the economic impact of bovine coronavirus ( BCV ) and bovine respiratory syncytial virus ( BRSV ) infections , accurate estimates of their associated effects on animal performance are needed .	1>2	none	enablement	enablement
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	22-33	34-82	accurate estimates of their associated effects on animal performance are needed .	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	accurate estimates of their associated effects on animal performance are needed .	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	1-33	34-82	To assess the economic impact of bovine coronavirus ( BCV ) and bovine respiratory syncytial virus ( BRSV ) infections , accurate estimates of their associated effects on animal performance are needed .	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	1>2	none	background	background
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	34-82	83-94	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	Three types of status were defined for BCV and BRSV infections ,	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	Three types of status were defined for BCV and BRSV infections ,	34-82	83-147	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	83-94	95-120	Three types of status were defined for BCV and BRSV infections ,	based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ;	Three types of status were defined for BCV and BRSV infections ,	based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ;	83-147	83-147	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	1<2	none	manner-means	manner-means
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	95-120	121-136	based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ;	2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ;	based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ;	2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ;	83-147	83-147	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	1<2	none	joint	joint
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	95-120	137-147	based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ;	and 3 ) the combination of both pieces of information .	based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ;	and 3 ) the combination of both pieces of information .	83-147	83-147	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	Three types of status were defined for BCV and BRSV infections , based on 1 ) the dynamics over a 7-mo period of BCV - and BRSV - specific antibody levels in pooled milk of primiparous cows ; 2 ) the possible occurrence of presumably BCV - and BRSV - related clinical outbreaks ; and 3 ) the combination of both pieces of information .	1<2	none	joint	joint
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	34-82	148-176	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	A total of 36,184 test days , 2,716 cows with a first service , and 4,104 calves and heifers in 65 Swedish herds were included in the analyses .	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	A total of 36,184 test days , 2,716 cows with a first service , and 4,104 calves and heifers in 65 Swedish herds were included in the analyses .	34-82	148-176	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	A total of 36,184 test days , 2,716 cows with a first service , and 4,104 calves and heifers in 65 Swedish herds were included in the analyses .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	34-82	177-186	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	Animal performance associated with BCV and BRSV infections was quantified	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	Animal performance associated with BCV and BRSV infections was quantified	34-82	177-206	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	Animal performance associated with BCV and BRSV infections was quantified using hierarchical mixed generalized and survival models , after adjustment for covariates known to influence the performance under study .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	177-186	187-198	Animal performance associated with BCV and BRSV infections was quantified	using hierarchical mixed generalized and survival models , after adjustment for covariates	Animal performance associated with BCV and BRSV infections was quantified	using hierarchical mixed generalized and survival models , after adjustment for covariates	177-206	177-206	Animal performance associated with BCV and BRSV infections was quantified using hierarchical mixed generalized and survival models , after adjustment for covariates known to influence the performance under study .	Animal performance associated with BCV and BRSV infections was quantified using hierarchical mixed generalized and survival models , after adjustment for covariates known to influence the performance under study .	1<2	none	manner-means	manner-means
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	187-198	199-206	using hierarchical mixed generalized and survival models , after adjustment for covariates	known to influence the performance under study .	using hierarchical mixed generalized and survival models , after adjustment for covariates	known to influence the performance under study .	177-206	177-206	Animal performance associated with BCV and BRSV infections was quantified using hierarchical mixed generalized and survival models , after adjustment for covariates known to influence the performance under study .	Animal performance associated with BCV and BRSV infections was quantified using hierarchical mixed generalized and survival models , after adjustment for covariates known to influence the performance under study .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	34-82	207-236	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	34-82	207-258	This study aimed to quantify the variation in individual test - day milk yield and somatic cell count , risk of reproductive failure after first service of dairy cows , and risk of death of calves and heifers according to the BCV and BRSV status of the herd .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	1<2	none	findings	findings
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	207-236	237-248	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	( of 0.57 and 0.91 kg / d , respectively ) ,	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	( of 0.57 and 0.91 kg / d , respectively ) ,	207-258	207-258	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	207-236	249-258	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	compared with cows in presumably infection - free herds .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	compared with cows in presumably infection - free herds .	207-258	207-258	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	1<2	none	comparison	comparison
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	207-236	259-268,276-285	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	There was also a significant increase in somatic cell count <*> for cows located in herds with a BRSV outbreak .	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	There was also a significant increase in somatic cell count <*> for cows located in herds with a BRSV outbreak .	207-258	259-285	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	There was also a significant increase in somatic cell count ( of 12,000 cells / mL ) for cows located in herds with a BRSV outbreak .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	259-268,276-285	269-275	There was also a significant increase in somatic cell count <*> for cows located in herds with a BRSV outbreak .	( of 12,000 cells / mL )	There was also a significant increase in somatic cell count <*> for cows located in herds with a BRSV outbreak .	( of 12,000 cells / mL )	259-285	259-285	There was also a significant increase in somatic cell count ( of 12,000 cells / mL ) for cows located in herds with a BRSV outbreak .	There was also a significant increase in somatic cell count ( of 12,000 cells / mL ) for cows located in herds with a BRSV outbreak .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	207-236	286-314	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds ,	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds ,	207-258	286-321	A significant reduction in milk yield was observed for cows in presumably BRSV recently infected herds , as well as in herds having a presumably BRSV - related clinical outbreak ( of 0.57 and 0.91 kg / d , respectively ) , compared with cows in presumably infection - free herds .	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds , although this was not statistically significant .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	286-314	315-321	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds ,	although this was not statistically significant .	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds ,	although this was not statistically significant .	286-321	286-321	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds , although this was not statistically significant .	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds , although this was not statistically significant .	1<2	none	comparison	comparison
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	286-314	322-329,337-349	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds ,	In contrast , BCV infection herd status , <*> was not significantly associated with any production losses in animals from infected herds	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds ,	In contrast , BCV infection herd status , <*> was not significantly associated with any production losses in animals from infected herds	286-321	322-358	The risk of failure after first service , as well as the risk of death in calf and heifer , was numerically higher in BRSV - infected herds , although this was not statistically significant .	In contrast , BCV infection herd status , as defined in the present study , was not significantly associated with any production losses in animals from infected herds compared with those in infection - free herds .	1<2	none	comparison	comparison
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	322-329,337-349	330-336	In contrast , BCV infection herd status , <*> was not significantly associated with any production losses in animals from infected herds	as defined in the present study ,	In contrast , BCV infection herd status , <*> was not significantly associated with any production losses in animals from infected herds	as defined in the present study ,	322-358	322-358	In contrast , BCV infection herd status , as defined in the present study , was not significantly associated with any production losses in animals from infected herds compared with those in infection - free herds .	In contrast , BCV infection herd status , as defined in the present study , was not significantly associated with any production losses in animals from infected herds compared with those in infection - free herds .	1<2	none	elaboration	elaboration
c635d21a8dd780ebae0bfe87fd7ef1d7d717c4ec	337-349	350-358	was not significantly associated with any production losses in animals from infected herds	compared with those in infection - free herds .	was not significantly associated with any production losses in animals from infected herds	compared with those in infection - free herds .	322-358	322-358	In contrast , BCV infection herd status , as defined in the present study , was not significantly associated with any production losses in animals from infected herds compared with those in infection - free herds .	In contrast , BCV infection herd status , as defined in the present study , was not significantly associated with any production losses in animals from infected herds compared with those in infection - free herds .	1<2	none	comparison	comparison
c74427793f554edd3e181603dfdf53f4c89ad129	1-5,18-24	130-136	The treatment of surgical patients <*> is a challenge for all anesthesiologists .	Thus , careful consideration should be given	The treatment of surgical patients <*> is a challenge for all anesthesiologists .	Thus , careful consideration should be given	1-24	130-148	The treatment of surgical patients who are confirmed or suspected of coronavirus disease 2019 ( COVID-19 ) is a challenge for all anesthesiologists .	Thus , careful consideration should be given to ensure that the surgery is performed entirely under regional anesthesia .	1>2	none	background	background
c74427793f554edd3e181603dfdf53f4c89ad129	1-5,18-24	6-17	The treatment of surgical patients <*> is a challenge for all anesthesiologists .	who are confirmed or suspected of coronavirus disease 2019 ( COVID-19 )	The treatment of surgical patients <*> is a challenge for all anesthesiologists .	who are confirmed or suspected of coronavirus disease 2019 ( COVID-19 )	1-24	1-24	The treatment of surgical patients who are confirmed or suspected of coronavirus disease 2019 ( COVID-19 ) is a challenge for all anesthesiologists .	The treatment of surgical patients who are confirmed or suspected of coronavirus disease 2019 ( COVID-19 ) is a challenge for all anesthesiologists .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	1-5,18-24	25-37	The treatment of surgical patients <*> is a challenge for all anesthesiologists .	The safety of both patients and healthcare workers should be taken into consideration	The treatment of surgical patients <*> is a challenge for all anesthesiologists .	The safety of both patients and healthcare workers should be taken into consideration	1-24	25-46	The treatment of surgical patients who are confirmed or suspected of coronavirus disease 2019 ( COVID-19 ) is a challenge for all anesthesiologists .	The safety of both patients and healthcare workers should be taken into consideration when performing anesthesia management for patients with COVID-19 .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	25-37	38-46	The safety of both patients and healthcare workers should be taken into consideration	when performing anesthesia management for patients with COVID-19 .	The safety of both patients and healthcare workers should be taken into consideration	when performing anesthesia management for patients with COVID-19 .	25-46	25-46	The safety of both patients and healthcare workers should be taken into consideration when performing anesthesia management for patients with COVID-19 .	The safety of both patients and healthcare workers should be taken into consideration when performing anesthesia management for patients with COVID-19 .	1<2	none	temporal	temporal
c74427793f554edd3e181603dfdf53f4c89ad129	25-37	47-48,52-56	The safety of both patients and healthcare workers should be taken into consideration	General anesthesia <*> may exacerbate COVID-19 pneumonia ,	The safety of both patients and healthcare workers should be taken into consideration	General anesthesia <*> may exacerbate COVID-19 pneumonia ,	25-46	47-69	The safety of both patients and healthcare workers should be taken into consideration when performing anesthesia management for patients with COVID-19 .	General anesthesia requiring airway intervention may exacerbate COVID-19 pneumonia , and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	47-48,52-56	49-51	General anesthesia <*> may exacerbate COVID-19 pneumonia ,	requiring airway intervention	General anesthesia <*> may exacerbate COVID-19 pneumonia ,	requiring airway intervention	47-69	47-69	General anesthesia requiring airway intervention may exacerbate COVID-19 pneumonia , and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	General anesthesia requiring airway intervention may exacerbate COVID-19 pneumonia , and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	52-56	57-69	may exacerbate COVID-19 pneumonia ,	and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	may exacerbate COVID-19 pneumonia ,	and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	47-69	47-69	General anesthesia requiring airway intervention may exacerbate COVID-19 pneumonia , and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	General anesthesia requiring airway intervention may exacerbate COVID-19 pneumonia , and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	1<2	none	joint	joint
c74427793f554edd3e181603dfdf53f4c89ad129	47-48,52-56	70-81	General anesthesia <*> may exacerbate COVID-19 pneumonia ,	However , regional anesthesia is not an aerosol - generating procedure .	General anesthesia <*> may exacerbate COVID-19 pneumonia ,	However , regional anesthesia is not an aerosol - generating procedure .	47-69	70-81	General anesthesia requiring airway intervention may exacerbate COVID-19 pneumonia , and aerosol generation during airway intervention risks COVID-19 transmission to medical staff .	However , regional anesthesia is not an aerosol - generating procedure .	1<2	none	comparison	comparison
c74427793f554edd3e181603dfdf53f4c89ad129	70-81	82-96	However , regional anesthesia is not an aerosol - generating procedure .	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19	However , regional anesthesia is not an aerosol - generating procedure .	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19	70-81	82-102	However , regional anesthesia is not an aerosol - generating procedure .	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19 after reviewing previous case reports .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	82-96	97-102	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19	after reviewing previous case reports .	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19	after reviewing previous case reports .	82-102	82-102	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19 after reviewing previous case reports .	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19 after reviewing previous case reports .	1<2	none	cause-result	cause-result
c74427793f554edd3e181603dfdf53f4c89ad129	82-96	103-117	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19	Regional anesthesia may have some advantages over general anesthesia for this group of patients ,	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19	Regional anesthesia may have some advantages over general anesthesia for this group of patients ,	82-102	103-129	The neuraxial anesthesia may have little adverse influence on clinical outcomes in patients with COVID-19 after reviewing previous case reports .	Regional anesthesia may have some advantages over general anesthesia for this group of patients , but unplanned conversion to general anesthesia during surgery is not preferred .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	103-117	118-129	Regional anesthesia may have some advantages over general anesthesia for this group of patients ,	but unplanned conversion to general anesthesia during surgery is not preferred .	Regional anesthesia may have some advantages over general anesthesia for this group of patients ,	but unplanned conversion to general anesthesia during surgery is not preferred .	103-129	103-129	Regional anesthesia may have some advantages over general anesthesia for this group of patients , but unplanned conversion to general anesthesia during surgery is not preferred .	Regional anesthesia may have some advantages over general anesthesia for this group of patients , but unplanned conversion to general anesthesia during surgery is not preferred .	1<2	none	comparison	comparison
c74427793f554edd3e181603dfdf53f4c89ad129	137-138	139-148	to ensure	that the surgery is performed entirely under regional anesthesia .	to ensure	that the surgery is performed entirely under regional anesthesia .	130-148	130-148	Thus , careful consideration should be given to ensure that the surgery is performed entirely under regional anesthesia .	Thus , careful consideration should be given to ensure that the surgery is performed entirely under regional anesthesia .	1>2	none	attribution	attribution
c74427793f554edd3e181603dfdf53f4c89ad129	130-136	139-148	Thus , careful consideration should be given	that the surgery is performed entirely under regional anesthesia .	Thus , careful consideration should be given	that the surgery is performed entirely under regional anesthesia .	130-148	130-148	Thus , careful consideration should be given to ensure that the surgery is performed entirely under regional anesthesia .	Thus , careful consideration should be given to ensure that the surgery is performed entirely under regional anesthesia .	1<2	none	enablement	enablement
c74427793f554edd3e181603dfdf53f4c89ad129	130-136	149-170	Thus , careful consideration should be given	The use of ultrasound guidance and the performance by an experienced physician may reduce the incidence of failed block and complications .	Thus , careful consideration should be given	The use of ultrasound guidance and the performance by an experienced physician may reduce the incidence of failed block and complications .	130-148	149-170	Thus , careful consideration should be given to ensure that the surgery is performed entirely under regional anesthesia .	The use of ultrasound guidance and the performance by an experienced physician may reduce the incidence of failed block and complications .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	149-170	171-186	The use of ultrasound guidance and the performance by an experienced physician may reduce the incidence of failed block and complications .	The use of long - acting local anesthetic prolongs the anesthetic effect of regional anesthesia .	The use of ultrasound guidance and the performance by an experienced physician may reduce the incidence of failed block and complications .	The use of long - acting local anesthetic prolongs the anesthetic effect of regional anesthesia .	149-170	171-186	The use of ultrasound guidance and the performance by an experienced physician may reduce the incidence of failed block and complications .	The use of long - acting local anesthetic prolongs the anesthetic effect of regional anesthesia .	1<2	none	elaboration	elaboration
c74427793f554edd3e181603dfdf53f4c89ad129	171-186	187-200	The use of long - acting local anesthetic prolongs the anesthetic effect of regional anesthesia .	Besides , a safe and sufficient dose of local anesthetic should be used .	The use of long - acting local anesthetic prolongs the anesthetic effect of regional anesthesia .	Besides , a safe and sufficient dose of local anesthetic should be used .	171-186	187-200	The use of long - acting local anesthetic prolongs the anesthetic effect of regional anesthesia .	Besides , a safe and sufficient dose of local anesthetic should be used .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	1-17	103-116	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk	The aim of the present study was to improve the effectiveness of pulmonary vaccination	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk	The aim of the present study was to improve the effectiveness of pulmonary vaccination	1-27	103-133	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk of triggering a flu pandemic in the human population .	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	1>2	none	background	background
c90121a3f539b59d4b528f3a1dd172b75533c0cc	1-17	18-27	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk	of triggering a flu pandemic in the human population .	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk	of triggering a flu pandemic in the human population .	1-27	1-27	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk of triggering a flu pandemic in the human population .	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk of triggering a flu pandemic in the human population .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	1-17	28-42	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy	1-27	28-47	Bird to human transmission of high pathogenicity avian influenza virus ( HPAIV ) poses a significant risk of triggering a flu pandemic in the human population .	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy to prevent such transmissions .	1<2	none	cause-result	cause-result
c90121a3f539b59d4b528f3a1dd172b75533c0cc	28-42	43-47	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy	to prevent such transmissions .	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy	to prevent such transmissions .	28-47	28-47	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy to prevent such transmissions .	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy to prevent such transmissions .	1<2	none	enablement	enablement
c90121a3f539b59d4b528f3a1dd172b75533c0cc	28-42	48-59,67-71	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy	To this end , suitable formulations and an effective mass vaccination method <*> needs to be developed .	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy	To this end , suitable formulations and an effective mass vaccination method <*> needs to be developed .	28-47	48-71	Therefore , vaccination of susceptible poultry during an HPAIV outbreak might be the best remedy to prevent such transmissions .	To this end , suitable formulations and an effective mass vaccination method that can be translated to field settings needs to be developed .	1<2	none	enablement	enablement
c90121a3f539b59d4b528f3a1dd172b75533c0cc	48-59,67-71	60-66	To this end , suitable formulations and an effective mass vaccination method <*> needs to be developed .	that can be translated to field settings	To this end , suitable formulations and an effective mass vaccination method <*> needs to be developed .	that can be translated to field settings	48-71	48-71	To this end , suitable formulations and an effective mass vaccination method that can be translated to field settings needs to be developed .	To this end , suitable formulations and an effective mass vaccination method that can be translated to field settings needs to be developed .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	72-78	79-102	Our previous study in chickens has shown	that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	Our previous study in chickens has shown	that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	72-102	72-102	Our previous study in chickens has shown that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	Our previous study in chickens has shown that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	1>2	none	attribution	attribution
c90121a3f539b59d4b528f3a1dd172b75533c0cc	48-59,67-71	79-102	To this end , suitable formulations and an effective mass vaccination method <*> needs to be developed .	that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	To this end , suitable formulations and an effective mass vaccination method <*> needs to be developed .	that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	48-71	72-102	To this end , suitable formulations and an effective mass vaccination method that can be translated to field settings needs to be developed .	Our previous study in chickens has shown that inhalation of a non - adjuvanted dry powder influenza vaccine formulation during normal breathing results in partial protection against lethal influenza challenge .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	103-116	117-121,126-133	The aim of the present study was to improve the effectiveness of pulmonary vaccination	by increasing the vaccine dose <*> and by the use of suitable adjuvants .	The aim of the present study was to improve the effectiveness of pulmonary vaccination	by increasing the vaccine dose <*> and by the use of suitable adjuvants .	103-133	103-133	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	1<2	none	manner-means	manner-means
c90121a3f539b59d4b528f3a1dd172b75533c0cc	117-121,126-133	122-125	by increasing the vaccine dose <*> and by the use of suitable adjuvants .	deposited in the lungs	by increasing the vaccine dose <*> and by the use of suitable adjuvants .	deposited in the lungs	103-133	103-133	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	103-116	134-160	The aim of the present study was to improve the effectiveness of pulmonary vaccination	Two adjuvants , namely , Bacterium - like Particles ( BLP ) and Advax , were spray freeze dried with influenza vaccine into dry powder formulations .	The aim of the present study was to improve the effectiveness of pulmonary vaccination	Two adjuvants , namely , Bacterium - like Particles ( BLP ) and Advax , were spray freeze dried with influenza vaccine into dry powder formulations .	103-133	134-160	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	Two adjuvants , namely , Bacterium - like Particles ( BLP ) and Advax , were spray freeze dried with influenza vaccine into dry powder formulations .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	161-169	170-176	Delivery of dry formulations directly at the syrinx revealed	that BLP and Advax had the potential	Delivery of dry formulations directly at the syrinx revealed	that BLP and Advax had the potential	161-187	161-187	Delivery of dry formulations directly at the syrinx revealed that BLP and Advax had the potential to boost either systemic or mucosal immune responses or both .	Delivery of dry formulations directly at the syrinx revealed that BLP and Advax had the potential to boost either systemic or mucosal immune responses or both .	1>2	none	attribution	attribution
c90121a3f539b59d4b528f3a1dd172b75533c0cc	103-116	170-176	The aim of the present study was to improve the effectiveness of pulmonary vaccination	that BLP and Advax had the potential	The aim of the present study was to improve the effectiveness of pulmonary vaccination	that BLP and Advax had the potential	103-133	161-187	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	Delivery of dry formulations directly at the syrinx revealed that BLP and Advax had the potential to boost either systemic or mucosal immune responses or both .	1<2	none	findings	findings
c90121a3f539b59d4b528f3a1dd172b75533c0cc	170-176	177-187	that BLP and Advax had the potential	to boost either systemic or mucosal immune responses or both .	that BLP and Advax had the potential	to boost either systemic or mucosal immune responses or both .	161-187	161-187	Delivery of dry formulations directly at the syrinx revealed that BLP and Advax had the potential to boost either systemic or mucosal immune responses or both .	Delivery of dry formulations directly at the syrinx revealed that BLP and Advax had the potential to boost either systemic or mucosal immune responses or both .	1<2	none	enablement	enablement
c90121a3f539b59d4b528f3a1dd172b75533c0cc	170-176	188-220	that BLP and Advax had the potential	Upon passive inhalation of dry influenza vaccine formulations in an optimized set - up , BLP and Advax / BLP adjuvanted formulations induced significantly higher systemic immune responses than the nonadjuvanted formulation .	that BLP and Advax had the potential	Upon passive inhalation of dry influenza vaccine formulations in an optimized set - up , BLP and Advax / BLP adjuvanted formulations induced significantly higher systemic immune responses than the nonadjuvanted formulation .	161-187	188-220	Delivery of dry formulations directly at the syrinx revealed that BLP and Advax had the potential to boost either systemic or mucosal immune responses or both .	Upon passive inhalation of dry influenza vaccine formulations in an optimized set - up , BLP and Advax / BLP adjuvanted formulations induced significantly higher systemic immune responses than the nonadjuvanted formulation .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	188-220	221-233	Upon passive inhalation of dry influenza vaccine formulations in an optimized set - up , BLP and Advax / BLP adjuvanted formulations induced significantly higher systemic immune responses than the nonadjuvanted formulation .	Remarkably , all vaccinated animals not only survived a lethal influenza challenge ,	Upon passive inhalation of dry influenza vaccine formulations in an optimized set - up , BLP and Advax / BLP adjuvanted formulations induced significantly higher systemic immune responses than the nonadjuvanted formulation .	Remarkably , all vaccinated animals not only survived a lethal influenza challenge ,	188-220	221-255	Upon passive inhalation of dry influenza vaccine formulations in an optimized set - up , BLP and Advax / BLP adjuvanted formulations induced significantly higher systemic immune responses than the nonadjuvanted formulation .	Remarkably , all vaccinated animals not only survived a lethal influenza challenge , but also did not show any shedding of challenge virus except for two out of six animals in the Advax group .	1<2	none	elaboration	elaboration
c90121a3f539b59d4b528f3a1dd172b75533c0cc	221-233	234-255	Remarkably , all vaccinated animals not only survived a lethal influenza challenge ,	but also did not show any shedding of challenge virus except for two out of six animals in the Advax group .	Remarkably , all vaccinated animals not only survived a lethal influenza challenge ,	but also did not show any shedding of challenge virus except for two out of six animals in the Advax group .	221-255	221-255	Remarkably , all vaccinated animals not only survived a lethal influenza challenge , but also did not show any shedding of challenge virus except for two out of six animals in the Advax group .	Remarkably , all vaccinated animals not only survived a lethal influenza challenge , but also did not show any shedding of challenge virus except for two out of six animals in the Advax group .	1<2	none	joint	joint
c90121a3f539b59d4b528f3a1dd172b75533c0cc	256-260	261-274	Overall , our results indicate	that passive inhalation is feasible , effective and suitable for mass vaccination of chickens	Overall , our results indicate	that passive inhalation is feasible , effective and suitable for mass vaccination of chickens	256-283	256-283	Overall , our results indicate that passive inhalation is feasible , effective and suitable for mass vaccination of chickens if it can be adapted to field settings .	Overall , our results indicate that passive inhalation is feasible , effective and suitable for mass vaccination of chickens if it can be adapted to field settings .	1>2	none	attribution	attribution
c90121a3f539b59d4b528f3a1dd172b75533c0cc	103-116	261-274	The aim of the present study was to improve the effectiveness of pulmonary vaccination	that passive inhalation is feasible , effective and suitable for mass vaccination of chickens	The aim of the present study was to improve the effectiveness of pulmonary vaccination	that passive inhalation is feasible , effective and suitable for mass vaccination of chickens	103-133	256-283	The aim of the present study was to improve the effectiveness of pulmonary vaccination by increasing the vaccine dose deposited in the lungs and by the use of suitable adjuvants .	Overall , our results indicate that passive inhalation is feasible , effective and suitable for mass vaccination of chickens if it can be adapted to field settings .	1<2	none	findings	findings
c90121a3f539b59d4b528f3a1dd172b75533c0cc	261-274	275-283	that passive inhalation is feasible , effective and suitable for mass vaccination of chickens	if it can be adapted to field settings .	that passive inhalation is feasible , effective and suitable for mass vaccination of chickens	if it can be adapted to field settings .	256-283	256-283	Overall , our results indicate that passive inhalation is feasible , effective and suitable for mass vaccination of chickens if it can be adapted to field settings .	Overall , our results indicate that passive inhalation is feasible , effective and suitable for mass vaccination of chickens if it can be adapted to field settings .	1<2	none	condition	condition
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	1-24	125-141	The pandemic spread of the COVID-19 virus has , as of 20 th of April 2020 , reached most countries of the world .	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	The pandemic spread of the COVID-19 virus has , as of 20 th of April 2020 , reached most countries of the world .	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	1-24	119-141	The pandemic spread of the COVID-19 virus has , as of 20 th of April 2020 , reached most countries of the world .	In this work , we show that peak phase and data paucity have a substantial impact on the reliability of model predictions .	1>2	none	background	background
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	1-24	25-27,35-40	The pandemic spread of the COVID-19 virus has , as of 20 th of April 2020 , reached most countries of the world .	In an effort <*> many modelling studies have been performed	The pandemic spread of the COVID-19 virus has , as of 20 th of April 2020 , reached most countries of the world .	In an effort <*> many modelling studies have been performed	1-24	25-57	The pandemic spread of the COVID-19 virus has , as of 20 th of April 2020 , reached most countries of the world .	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	25-27,35-40	28-34	In an effort <*> many modelling studies have been performed	to design informed public health policies ,	In an effort <*> many modelling studies have been performed	to design informed public health policies ,	25-57	25-57	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	1<2	none	enablement	enablement
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	35-40	41-47	many modelling studies have been performed	to predict crucial outcomes of interest ,	many modelling studies have been performed	to predict crucial outcomes of interest ,	25-57	25-57	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	1<2	none	enablement	enablement
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	41-47	48-57	to predict crucial outcomes of interest ,	including ICU solicitation , cumulated death counts , etc …	to predict crucial outcomes of interest ,	including ICU solicitation , cumulated death counts , etc …	25-57	25-57	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	25-27,35-40	58-74	In an effort <*> many modelling studies have been performed	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources ,	In an effort <*> many modelling studies have been performed	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources ,	25-57	58-87	In an effort to design informed public health policies , many modelling studies have been performed to predict crucial outcomes of interest , including ICU solicitation , cumulated death counts , etc …	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources , which typically include daily death rates and confirmed COVID cases time series .	1<2	none	comparison	comparison
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	58-74	75-87	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources ,	which typically include daily death rates and confirmed COVID cases time series .	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources ,	which typically include daily death rates and confirmed COVID cases time series .	58-87	58-87	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources , which typically include daily death rates and confirmed COVID cases time series .	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources , which typically include daily death rates and confirmed COVID cases time series .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	58-74	88-96	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources ,	In addition , many of these predictions are derived	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources ,	In addition , many of these predictions are derived	58-87	88-118	The corresponding data analyses however , mostly rely on restricted ( openly available ) data sources , which typically include daily death rates and confirmed COVID cases time series .	In addition , many of these predictions are derived before the peak of the outbreak has been observed yet ( as is still currently the case for many countries ) .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	88-96	97-106	In addition , many of these predictions are derived	before the peak of the outbreak has been observed yet	In addition , many of these predictions are derived	before the peak of the outbreak has been observed yet	88-118	88-118	In addition , many of these predictions are derived before the peak of the outbreak has been observed yet ( as is still currently the case for many countries ) .	In addition , many of these predictions are derived before the peak of the outbreak has been observed yet ( as is still currently the case for many countries ) .	1<2	none	temporal	temporal
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	88-96	107-118	In addition , many of these predictions are derived	( as is still currently the case for many countries ) .	In addition , many of these predictions are derived	( as is still currently the case for many countries ) .	88-118	88-118	In addition , many of these predictions are derived before the peak of the outbreak has been observed yet ( as is still currently the case for many countries ) .	In addition , many of these predictions are derived before the peak of the outbreak has been observed yet ( as is still currently the case for many countries ) .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	119-124	125-141	In this work , we show	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	In this work , we show	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	119-141	119-141	In this work , we show that peak phase and data paucity have a substantial impact on the reliability of model predictions .	In this work , we show that peak phase and data paucity have a substantial impact on the reliability of model predictions .	1>2	none	attribution	attribution
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	142-153	154-163	Although we focus on a recent model of the COVID pandemics ,	our conclusions most likely apply to most existing models ,	Although we focus on a recent model of the COVID pandemics ,	our conclusions most likely apply to most existing models ,	142-180	142-180	Although we focus on a recent model of the COVID pandemics , our conclusions most likely apply to most existing models , which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	Although we focus on a recent model of the COVID pandemics , our conclusions most likely apply to most existing models , which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	1>2	none	comparison	comparison
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	125-141	154-163	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	our conclusions most likely apply to most existing models ,	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	our conclusions most likely apply to most existing models ,	119-141	142-180	In this work , we show that peak phase and data paucity have a substantial impact on the reliability of model predictions .	Although we focus on a recent model of the COVID pandemics , our conclusions most likely apply to most existing models , which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	154-163	164-180	our conclusions most likely apply to most existing models ,	which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	our conclusions most likely apply to most existing models ,	which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	142-180	142-180	Although we focus on a recent model of the COVID pandemics , our conclusions most likely apply to most existing models , which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	Although we focus on a recent model of the COVID pandemics , our conclusions most likely apply to most existing models , which are variants of the socalled " Susceptible - Infected - Removed " or SIR framework .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	125-141	181-185	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	Our results highlight the need	that peak phase and data paucity have a substantial impact on the reliability of model predictions .	Our results highlight the need	119-141	181-200	In this work , we show that peak phase and data paucity have a substantial impact on the reliability of model predictions .	Our results highlight the need for performing systematic reliability evaluations for all models that currently inform public health policies .	1<2	none	findings	findings
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	181-185	186-193	Our results highlight the need	for performing systematic reliability evaluations for all models	Our results highlight the need	for performing systematic reliability evaluations for all models	181-200	181-200	Our results highlight the need for performing systematic reliability evaluations for all models that currently inform public health policies .	Our results highlight the need for performing systematic reliability evaluations for all models that currently inform public health policies .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	186-193	194-200	for performing systematic reliability evaluations for all models	that currently inform public health policies .	for performing systematic reliability evaluations for all models	that currently inform public health policies .	181-200	181-200	Our results highlight the need for performing systematic reliability evaluations for all models that currently inform public health policies .	Our results highlight the need for performing systematic reliability evaluations for all models that currently inform public health policies .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	181-185	201-205	Our results highlight the need	They also motivate a plea	Our results highlight the need	They also motivate a plea	181-200	201-234	Our results highlight the need for performing systematic reliability evaluations for all models that currently inform public health policies .	They also motivate a plea for gathering and opening richer and more reliable data time series ( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	201-205	206-216	They also motivate a plea	for gathering and opening richer and more reliable data time series	They also motivate a plea	for gathering and opening richer and more reliable data time series	201-234	201-234	They also motivate a plea for gathering and opening richer and more reliable data time series ( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	They also motivate a plea for gathering and opening richer and more reliable data time series ( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	1<2	none	elaboration	elaboration
ca2a4dbdc3d133ac018b4427e143e1a5ca45d1eb	206-216	217-234	for gathering and opening richer and more reliable data time series	( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	for gathering and opening richer and more reliable data time series	( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	201-234	201-234	They also motivate a plea for gathering and opening richer and more reliable data time series ( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	They also motivate a plea for gathering and opening richer and more reliable data time series ( e.g. , ICU occupancy , negative test rates , social distancing commitment reports , etc ) .	1<2	none	elaboration	elaboration
cb6074cfc9898c507ee6f98f9888fb652b409069	1-23	41-48	On 30 January 2020 , the WHO declared the coronavirus disease 2019 ( COVID-19 ) a public health emergency of international concern .	In this short article we provide some information	On 30 January 2020 , the WHO declared the coronavirus disease 2019 ( COVID-19 ) a public health emergency of international concern .	In this short article we provide some information	1-23	41-64	On 30 January 2020 , the WHO declared the coronavirus disease 2019 ( COVID-19 ) a public health emergency of international concern .	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	1>2	none	background	background
cb6074cfc9898c507ee6f98f9888fb652b409069	1-23	24-33	On 30 January 2020 , the WHO declared the coronavirus disease 2019 ( COVID-19 ) a public health emergency of international concern .	By 11 March 2020 , it was designated a pandemic	On 30 January 2020 , the WHO declared the coronavirus disease 2019 ( COVID-19 ) a public health emergency of international concern .	By 11 March 2020 , it was designated a pandemic	1-23	24-40	On 30 January 2020 , the WHO declared the coronavirus disease 2019 ( COVID-19 ) a public health emergency of international concern .	By 11 March 2020 , it was designated a pandemic owing to its rapid worldwide spread .	1<2	none	elaboration	elaboration
cb6074cfc9898c507ee6f98f9888fb652b409069	24-33	34-40	By 11 March 2020 , it was designated a pandemic	owing to its rapid worldwide spread .	By 11 March 2020 , it was designated a pandemic	owing to its rapid worldwide spread .	24-40	24-40	By 11 March 2020 , it was designated a pandemic owing to its rapid worldwide spread .	By 11 March 2020 , it was designated a pandemic owing to its rapid worldwide spread .	1<2	none	cause-result	cause-result
cb6074cfc9898c507ee6f98f9888fb652b409069	41-48	49-52	In this short article we provide some information	that might be useful	In this short article we provide some information	that might be useful	41-64	41-64	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	1<2	none	elaboration	elaboration
cb6074cfc9898c507ee6f98f9888fb652b409069	49-52	53-56	that might be useful	and help equip colleagues	that might be useful	and help equip colleagues	41-64	41-64	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	1<2	none	joint	joint
cb6074cfc9898c507ee6f98f9888fb652b409069	49-52	57-64	that might be useful	to reduce medical error during a pandemic .	that might be useful	to reduce medical error during a pandemic .	41-64	41-64	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	1<2	none	enablement	enablement
cb6074cfc9898c507ee6f98f9888fb652b409069	41-48	65-80	In this short article we provide some information	We advocate a systems - based approach , rather than an individual 's sole responsibility ,	In this short article we provide some information	We advocate a systems - based approach , rather than an individual's sole responsibility ,	41-64	65-90	In this short article we provide some information that might be useful and help equip colleagues to reduce medical error during a pandemic .	We advocate a systems - based approach , rather than an individual 's sole responsibility , and , look at ways to provide safer healthcare .	1<2	none	elaboration	elaboration
cb6074cfc9898c507ee6f98f9888fb652b409069	65-80	81-85	We advocate a systems - based approach , rather than an individual 's sole responsibility ,	and , look at ways	We advocate a systems - based approach , rather than an individual's sole responsibility ,	and , look at ways	65-90	65-90	We advocate a systems - based approach , rather than an individual 's sole responsibility , and , look at ways to provide safer healthcare .	We advocate a systems - based approach , rather than an individual 's sole responsibility , and , look at ways to provide safer healthcare .	1<2	none	elaboration	elaboration
cb6074cfc9898c507ee6f98f9888fb652b409069	81-85	86-90	and , look at ways	to provide safer healthcare .	and , look at ways	to provide safer healthcare .	65-90	65-90	We advocate a systems - based approach , rather than an individual 's sole responsibility , and , look at ways to provide safer healthcare .	We advocate a systems - based approach , rather than an individual 's sole responsibility , and , look at ways to provide safer healthcare .	1<2	none	elaboration	elaboration
ceda3aacfcc249a8bdff8eb316c13638860e560b	1-12	13-29	I use the COVID-19 death rate in South Korea and a method	relating the ratio of death rates in a U.S. state to its share of cumulative positive tests	I use the COVID-19 death rate in South Korea and a method	relating the ratio of death rates in a U.S. state to its share of cumulative positive tests	1-72	1-72	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	1<2	none	elaboration	elaboration
ceda3aacfcc249a8bdff8eb316c13638860e560b	1-12	30-39	I use the COVID-19 death rate in South Korea and a method	to estimate the total cases of COVID-19 in the U.S.	I use the COVID-19 death rate in South Korea and a method	to estimate the total cases of COVID-19 in the U.S.	1-72	1-72	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	1<2	none	enablement	enablement
ceda3aacfcc249a8bdff8eb316c13638860e560b	30-39	40-72	to estimate the total cases of COVID-19 in the U.S.	and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	to estimate the total cases of COVID-19 in the U.S.	and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	1-72	1-72	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	1<2	none	joint	joint
ceda3aacfcc249a8bdff8eb316c13638860e560b	1-12	73-93	I use the COVID-19 death rate in South Korea and a method	I identify a logarithmic relationship between the cumulative death rate in a state and its cumulative positive share of tests .	I use the COVID-19 death rate in South Korea and a method	I identify a logarithmic relationship between the cumulative death rate in a state and its cumulative positive share of tests .	1-72	73-93	I use the COVID-19 death rate in South Korea and a method relating the ratio of death rates in a U.S. state to its share of cumulative positive tests to estimate the total cases of COVID-19 in the U.S. and to estimate the extent of infection and the unidentified share of the infected population in each of the lower-48 states and in New York City in mid - April , 2020 .	I identify a logarithmic relationship between the cumulative death rate in a state and its cumulative positive share of tests .	1<2	none	findings	findings
ceda3aacfcc249a8bdff8eb316c13638860e560b	94-97	98-99	Using this relationship ,	I find	Using this relationship ,	I find	94-150	94-150	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	1>2	none	manner-means	manner-means
ceda3aacfcc249a8bdff8eb316c13638860e560b	98-99	100-122	I find	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	I find	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	94-150	94-150	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	1>2	none	attribution	attribution
ceda3aacfcc249a8bdff8eb316c13638860e560b	73-93	100-122	I identify a logarithmic relationship between the cumulative death rate in a state and its cumulative positive share of tests .	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	I identify a logarithmic relationship between the cumulative death rate in a state and its cumulative positive share of tests .	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	73-93	94-150	I identify a logarithmic relationship between the cumulative death rate in a state and its cumulative positive share of tests .	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	1<2	none	elaboration	elaboration
ceda3aacfcc249a8bdff8eb316c13638860e560b	100-122	123-150	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	94-150	94-150	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	1<2	none	elaboration	elaboration
ceda3aacfcc249a8bdff8eb316c13638860e560b	100-122	151-165	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	Only 16 - 20 % of these infected individuals were identified later through testing .	that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection	Only 16 - 20 % of these infected individuals were identified later through testing .	94-150	151-165	Using this relationship , I find that 4.3 - 5.4 million people , 1.4 - 1.7 % of the U.S. population , were infected , with rates of infection that ranged from 0.1 % in more rural states to 8 - 10 % in New York state and 11 - 13 % in New York City .	Only 16 - 20 % of these infected individuals were identified later through testing .	1<2	none	elaboration	elaboration
d125abb6f1e1cb460e9dd29bf71df2895151761d	1-2	3-21	Background :	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	Background :	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	1-2	3-21	Background :	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	1>2	none	textual-organization	textual-organization
d125abb6f1e1cb460e9dd29bf71df2895151761d	3-21	59-61,69-79	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	3-21	59-79	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	Very recent studies focusing on abusive situations during COVID emergence were identified in PubMed / Medline , Scopus , Embase .	1>2	none	background	background
d125abb6f1e1cb460e9dd29bf71df2895151761d	3-21	22-27	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	It is typically experienced by women	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	It is typically experienced by women	3-21	22-35	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	It is typically experienced by women but can also be experienced by men .	1<2	none	elaboration	elaboration
d125abb6f1e1cb460e9dd29bf71df2895151761d	22-27	28-35	It is typically experienced by women	but can also be experienced by men .	It is typically experienced by women	but can also be experienced by men .	22-35	22-35	It is typically experienced by women but can also be experienced by men .	It is typically experienced by women but can also be experienced by men .	1<2	none	joint	joint
d125abb6f1e1cb460e9dd29bf71df2895151761d	3-21	36-56	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	During quarantine due to the COVID-19 , home risks to become a very dangerous place for victims of domestic violence .	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	During quarantine due to the COVID-19 , home risks to become a very dangerous place for victims of domestic violence .	3-21	36-56	Intimate partner violence ( IPV ) is defined as physical or sexual violence , emotional abuse and stalking .	During quarantine due to the COVID-19 , home risks to become a very dangerous place for victims of domestic violence .	1<2	none	elaboration	elaboration
d125abb6f1e1cb460e9dd29bf71df2895151761d	57-58	59-61,69-79	Method :	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	Method :	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	57-58	59-79	Method :	Very recent studies focusing on abusive situations during COVID emergence were identified in PubMed / Medline , Scopus , Embase .	1>2	none	textual-organization	textual-organization
d125abb6f1e1cb460e9dd29bf71df2895151761d	59-61,69-79	62-68	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	focusing on abusive situations during COVID emergence	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	focusing on abusive situations during COVID emergence	59-79	59-79	Very recent studies focusing on abusive situations during COVID emergence were identified in PubMed / Medline , Scopus , Embase .	Very recent studies focusing on abusive situations during COVID emergence were identified in PubMed / Medline , Scopus , Embase .	1<2	none	elaboration	elaboration
d125abb6f1e1cb460e9dd29bf71df2895151761d	80-81	82-96	Conclusions :	Especially during quarantine and COVID emergence around the world there is a need of programs	Conclusions :	Especially during quarantine and COVID emergence around the world there is a need of programs	80-81	82-137	Conclusions :	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	1>2	none	textual-organization	textual-organization
d125abb6f1e1cb460e9dd29bf71df2895151761d	59-61,69-79	82-96	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	Especially during quarantine and COVID emergence around the world there is a need of programs	Very recent studies <*> were identified in PubMed / Medline , Scopus , Embase .	Especially during quarantine and COVID emergence around the world there is a need of programs	59-79	82-137	Very recent studies focusing on abusive situations during COVID emergence were identified in PubMed / Medline , Scopus , Embase .	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	1<2	none	findings	findings
d125abb6f1e1cb460e9dd29bf71df2895151761d	82-96	97-113	Especially during quarantine and COVID emergence around the world there is a need of programs	aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse	Especially during quarantine and COVID emergence around the world there is a need of programs	aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse	82-137	82-137	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	1<2	none	enablement	enablement
d125abb6f1e1cb460e9dd29bf71df2895151761d	97-113	114-120	aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse	( psychological , physical , sexual )	aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse	( psychological , physical , sexual )	82-137	82-137	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	1<2	none	elaboration	elaboration
d125abb6f1e1cb460e9dd29bf71df2895151761d	82-96	121-125	Especially during quarantine and COVID emergence around the world there is a need of programs	provided by trained multidisciplinary staffs	Especially during quarantine and COVID emergence around the world there is a need of programs	provided by trained multidisciplinary staffs	82-137	82-137	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	1<2	none	elaboration	elaboration
d125abb6f1e1cb460e9dd29bf71df2895151761d	121-125	126-137	provided by trained multidisciplinary staffs	( including psychiatrists , psychologists , social and legal services ) .	provided by trained multidisciplinary staffs	( including psychiatrists , psychologists , social and legal services ) .	82-137	82-137	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	Especially during quarantine and COVID emergence around the world there is a need of programs aimed to prevent acts of domestic violence and to achieve accurate assessment of multiple domains of abuse ( psychological , physical , sexual ) provided by trained multidisciplinary staffs ( including psychiatrists , psychologists , social and legal services ) .	1<2	none	elaboration	elaboration
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	1-5	6-31	This paper employs syndemics theory	to explain high rates of sexually transmitted disease among inner city African American and Puerto Rican heterosexual young adults in Hartford , CT , USA .	This paper employs syndemics theory	to explain high rates of sexually transmitted disease among inner city African American and Puerto Rican heterosexual young adults in Hartford , CT , USA .	1-31	1-31	This paper employs syndemics theory to explain high rates of sexually transmitted disease among inner city African American and Puerto Rican heterosexual young adults in Hartford , CT , USA .	This paper employs syndemics theory to explain high rates of sexually transmitted disease among inner city African American and Puerto Rican heterosexual young adults in Hartford , CT , USA .	1<2	none	enablement	enablement
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	1-5	32-46	This paper employs syndemics theory	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics	This paper employs syndemics theory	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics	1-31	32-56	This paper employs syndemics theory to explain high rates of sexually transmitted disease among inner city African American and Puerto Rican heterosexual young adults in Hartford , CT , USA .	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics to develop under conditions of health and social disparity .	1<2	none	elaboration	elaboration
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	32-46	47-56	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics	to develop under conditions of health and social disparity .	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics	to develop under conditions of health and social disparity .	32-56	32-56	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics to develop under conditions of health and social disparity .	Syndemic theory helps to elucidate the tendency for multiple co - terminus and interacting epidemics to develop under conditions of health and social disparity .	1<2	none	enablement	enablement
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	57-68	69-71	Based on enhanced focus group and in - depth interview data ,	the paper argues	Based on enhanced focus group and in - depth interview data ,	the paper argues	57-90	57-90	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	1>2	none	manner-means	manner-means
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	69-71	72-80	the paper argues	that respondents employed a cultural logic of risk assessment	the paper argues	that respondents employed a cultural logic of risk assessment	57-90	57-90	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	1>2	none	attribution	attribution
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	1-5	72-80	This paper employs syndemics theory	that respondents employed a cultural logic of risk assessment	This paper employs syndemics theory	that respondents employed a cultural logic of risk assessment	1-31	57-90	This paper employs syndemics theory to explain high rates of sexually transmitted disease among inner city African American and Puerto Rican heterosexual young adults in Hartford , CT , USA .	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	1<2	none	findings	findings
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	72-80	81-90	that respondents employed a cultural logic of risk assessment	which put them at high risk for STD infection .	that respondents employed a cultural logic of risk assessment	which put them at high risk for STD infection .	57-90	57-90	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	1<2	none	cause-result	cause-result
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	72-80	91-98	that respondents employed a cultural logic of risk assessment	This cultural logic was shaped by their experiences	that respondents employed a cultural logic of risk assessment	This cultural logic was shaped by their experiences	57-90	91-153	Based on enhanced focus group and in - depth interview data , the paper argues that respondents employed a cultural logic of risk assessment which put them at high risk for STD infection .	This cultural logic was shaped by their experiences of growing up in the inner city which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	1<2	none	elaboration	elaboration
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	91-98	99-105	This cultural logic was shaped by their experiences	of growing up in the inner city	This cultural logic was shaped by their experiences	of growing up in the inner city	91-153	91-153	This cultural logic was shaped by their experiences of growing up in the inner city which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	This cultural logic was shaped by their experiences of growing up in the inner city which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	1<2	none	elaboration	elaboration
d1bc51c207da125a38e3ab23f94966c37bf6bf8f	91-98	106-153	This cultural logic was shaped by their experiences	which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	This cultural logic was shaped by their experiences	which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	91-153	91-153	This cultural logic was shaped by their experiences of growing up in the inner city which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	This cultural logic was shaped by their experiences of growing up in the inner city which included : coming of age in an impoverished family , living in a broken home , experiencing domestic violence , limited expectations of the future , limited exposure to positive role models , lack of expectation of the dependency of others , and fear of intimacy .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	1-17	116-134,140-151	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	1-35	116-151	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea and atypical EPEC ( aEPEC ) was recently identified as significantly associated with diarrheal mortality in kittens .	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens following experimentally - induced carriage and the influence of a disrupted intestinal microbiota on disease susceptibility .	1>2	none	background	background
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	1-17	18-35	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea	and atypical EPEC ( aEPEC ) was recently identified as significantly associated with diarrheal mortality in kittens .	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea	and atypical EPEC ( aEPEC ) was recently identified as significantly associated with diarrheal mortality in kittens .	1-35	1-35	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea and atypical EPEC ( aEPEC ) was recently identified as significantly associated with diarrheal mortality in kittens .	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea and atypical EPEC ( aEPEC ) was recently identified as significantly associated with diarrheal mortality in kittens .	1<2	none	joint	joint
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	1-17	36-52	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease ,	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease ,	1-35	36-65	Typical enteropathogenic E. coli ( tEPEC ) carries the highest hazard of death in children with diarrhea and atypical EPEC ( aEPEC ) was recently identified as significantly associated with diarrheal mortality in kittens .	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease , however the infection can be found in individuals with and without diarrhea .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	36-52	53-65	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease ,	however the infection can be found in individuals with and without diarrhea .	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease ,	however the infection can be found in individuals with and without diarrhea .	36-65	36-65	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease , however the infection can be found in individuals with and without diarrhea .	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease , however the infection can be found in individuals with and without diarrhea .	1<2	none	comparison	comparison
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	53-65	66-91	however the infection can be found in individuals with and without diarrhea .	It remains unclear to what extent , under what conditions , or by what mechanisms aEPEC serves as a primary pathogen in individuals with diarrhea .	however the infection can be found in individuals with and without diarrhea .	It remains unclear to what extent , under what conditions , or by what mechanisms aEPEC serves as a primary pathogen in individuals with diarrhea .	36-65	66-91	In both children and kittens there is a significant association between aEPEC burden and diarrheal disease , however the infection can be found in individuals with and without diarrhea .	It remains unclear to what extent , under what conditions , or by what mechanisms aEPEC serves as a primary pathogen in individuals with diarrhea .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	66-91	92-115	It remains unclear to what extent , under what conditions , or by what mechanisms aEPEC serves as a primary pathogen in individuals with diarrhea .	It seems likely that a combination of host and bacterial factors enable aEPEC to cause disease in some individuals and not in others .	It remains unclear to what extent , under what conditions , or by what mechanisms aEPEC serves as a primary pathogen in individuals with diarrhea .	It seems likely that a combination of host and bacterial factors enable aEPEC to cause disease in some individuals and not in others .	66-91	92-115	It remains unclear to what extent , under what conditions , or by what mechanisms aEPEC serves as a primary pathogen in individuals with diarrhea .	It seems likely that a combination of host and bacterial factors enable aEPEC to cause disease in some individuals and not in others .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	116-134,140-151	135-139	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	following experimentally - induced carriage	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	following experimentally - induced carriage	116-151	116-151	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens following experimentally - induced carriage and the influence of a disrupted intestinal microbiota on disease susceptibility .	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens following experimentally - induced carriage and the influence of a disrupted intestinal microbiota on disease susceptibility .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	116-134,140-151	152-164	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	Results of this study identify aEPEC as a potential pathogen in kittens .	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	Results of this study identify aEPEC as a potential pathogen in kittens .	116-151	152-164	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens following experimentally - induced carriage and the influence of a disrupted intestinal microbiota on disease susceptibility .	Results of this study identify aEPEC as a potential pathogen in kittens .	1<2	none	findings	findings
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	165-174	175-183	In the absence of disruption to the intestinal microbiota ,	kittens are resistant to clinical signs of aEPEC carriage	In the absence of disruption to the intestinal microbiota ,	kittens are resistant to clinical signs of aEPEC carriage	165-194	165-194	In the absence of disruption to the intestinal microbiota , kittens are resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal absorption and permeability .	In the absence of disruption to the intestinal microbiota , kittens are resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal absorption and permeability .	1>2	none	condition	condition
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	152-164	175-183	Results of this study identify aEPEC as a potential pathogen in kittens .	kittens are resistant to clinical signs of aEPEC carriage	Results of this study identify aEPEC as a potential pathogen in kittens .	kittens are resistant to clinical signs of aEPEC carriage	152-164	165-194	Results of this study identify aEPEC as a potential pathogen in kittens .	In the absence of disruption to the intestinal microbiota , kittens are resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal absorption and permeability .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	175-183	184-194	kittens are resistant to clinical signs of aEPEC carriage	but demonstrate significant occult changes in intestinal absorption and permeability .	kittens are resistant to clinical signs of aEPEC carriage	but demonstrate significant occult changes in intestinal absorption and permeability .	165-194	165-194	In the absence of disruption to the intestinal microbiota , kittens are resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal absorption and permeability .	In the absence of disruption to the intestinal microbiota , kittens are resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal absorption and permeability .	1<2	none	comparison	comparison
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	175-183	195-210	kittens are resistant to clinical signs of aEPEC carriage	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss	kittens are resistant to clinical signs of aEPEC carriage	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss	165-194	195-218	In the absence of disruption to the intestinal microbiota , kittens are resistant to clinical signs of aEPEC carriage but demonstrate significant occult changes in intestinal absorption and permeability .	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss as determined by % fecal wet weight .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	195-210	211-218	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss	as determined by % fecal wet weight .	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss	as determined by % fecal wet weight .	195-218	195-218	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss as determined by % fecal wet weight .	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss as determined by % fecal wet weight .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	195-210	219-252	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss	Enrichment of the intestinal microbiota with a commensal member of the feline mucosa - associated microbiota , Enterococcus hirae , ameliorated the effects of aEPEC experimental infection on intestinal function and water loss .	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss	Enrichment of the intestinal microbiota with a commensal member of the feline mucosa - associated microbiota , Enterococcus hirae , ameliorated the effects of aEPEC experimental infection on intestinal function and water loss .	195-218	219-252	Antibiotic - induced disruption of the intestinal microbiota prior to infection increases subsequent intestinal water loss as determined by % fecal wet weight .	Enrichment of the intestinal microbiota with a commensal member of the feline mucosa - associated microbiota , Enterococcus hirae , ameliorated the effects of aEPEC experimental infection on intestinal function and water loss .	1<2	none	elaboration	elaboration
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	116-134,140-151	253-259	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	These observations begin to unravel the mechanisms	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens <*> and the influence of a disrupted intestinal microbiota on disease susceptibility .	These observations begin to unravel the mechanisms	116-151	253-271	The purpose of this study was to determine the impact of aEPEC on intestinal function and diarrhea in kittens following experimentally - induced carriage and the influence of a disrupted intestinal microbiota on disease susceptibility .	These observations begin to unravel the mechanisms by which aEPEC infection may be able to exploit susceptible hosts .	1<2	none	findings	findings
d1ce2321a8a67ec9c9823cb9c15543fce565ed85	253-259	260-271	These observations begin to unravel the mechanisms	by which aEPEC infection may be able to exploit susceptible hosts .	These observations begin to unravel the mechanisms	by which aEPEC infection may be able to exploit susceptible hosts .	253-271	253-271	These observations begin to unravel the mechanisms by which aEPEC infection may be able to exploit susceptible hosts .	These observations begin to unravel the mechanisms by which aEPEC infection may be able to exploit susceptible hosts .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	1-8,21-35	51-65	Studies of SARS coronavirus ( SARS - CoV) <*> have been hampered by its high transmission rate and the pathogenicity of this virus .	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	Studies of SARS coronavirus ( SARS - CoV) <*> have been hampered by its high transmission rate and the pathogenicity of this virus .	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	1-35	36-76	Studies of SARS coronavirus ( SARS - CoV) - the causative agent of severe acute respiratory syndrome ( SARS) - have been hampered by its high transmission rate and the pathogenicity of this virus .	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	1>2	none	background	background
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	1-8,21-35	9-20	Studies of SARS coronavirus ( SARS - CoV) <*> have been hampered by its high transmission rate and the pathogenicity of this virus .	- the causative agent of severe acute respiratory syndrome ( SARS) -	Studies of SARS coronavirus ( SARS - CoV) <*> have been hampered by its high transmission rate and the pathogenicity of this virus .	- the causative agent of severe acute respiratory syndrome ( SARS) -	1-35	1-35	Studies of SARS coronavirus ( SARS - CoV) - the causative agent of severe acute respiratory syndrome ( SARS) - have been hampered by its high transmission rate and the pathogenicity of this virus .	Studies of SARS coronavirus ( SARS - CoV) - the causative agent of severe acute respiratory syndrome ( SARS) - have been hampered by its high transmission rate and the pathogenicity of this virus .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	36-50	51-65	To permit analysis of the host range and entry mechanism of SARS - CoV ,	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	To permit analysis of the host range and entry mechanism of SARS - CoV ,	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	36-76	36-76	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	1>2	none	enablement	enablement
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	51-65	66-76	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	to generate a highly infectious SARS - CoV pseudotyped virus .	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	to generate a highly infectious SARS - CoV pseudotyped virus .	36-76	36-76	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	1<2	none	enablement	enablement
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	51-65	77-81,92-101	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	The infection on Vero E6 <*> could be neutralized by sera from convalescent SARS patients ,	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	The infection on Vero E6 <*> could be neutralized by sera from convalescent SARS patients ,	36-76	77-111	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	The infection on Vero E6 - a permissive cell line to SARS - CoV - could be neutralized by sera from convalescent SARS patients , and the entry was a pH - dependent process .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	77-81,92-101	82-91	The infection on Vero E6 <*> could be neutralized by sera from convalescent SARS patients ,	- a permissive cell line to SARS - CoV -	The infection on Vero E6 <*> could be neutralized by sera from convalescent SARS patients ,	- a permissive cell line to SARS - CoV -	77-111	77-111	The infection on Vero E6 - a permissive cell line to SARS - CoV - could be neutralized by sera from convalescent SARS patients , and the entry was a pH - dependent process .	The infection on Vero E6 - a permissive cell line to SARS - CoV - could be neutralized by sera from convalescent SARS patients , and the entry was a pH - dependent process .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	77-81,92-101	102-111	The infection on Vero E6 <*> could be neutralized by sera from convalescent SARS patients ,	and the entry was a pH - dependent process .	The infection on Vero E6 <*> could be neutralized by sera from convalescent SARS patients ,	and the entry was a pH - dependent process .	77-111	77-111	The infection on Vero E6 - a permissive cell line to SARS - CoV - could be neutralized by sera from convalescent SARS patients , and the entry was a pH - dependent process .	The infection on Vero E6 - a permissive cell line to SARS - CoV - could be neutralized by sera from convalescent SARS patients , and the entry was a pH - dependent process .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	51-65	112-123,128-136	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	With these highly infectious SARS - CoV pseudotypes , several cell lines <*> were revealed as susceptible to SARS - CoV ,	we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles	With these highly infectious SARS - CoV pseudotypes , several cell lines <*> were revealed as susceptible to SARS - CoV ,	36-76	112-156	To permit analysis of the host range and entry mechanism of SARS - CoV , we incorporated the humanized SARS - CoV spike ( S ) glycoprotein into HIV particles to generate a highly infectious SARS - CoV pseudotyped virus .	With these highly infectious SARS - CoV pseudotypes , several cell lines derived from various tissues were revealed as susceptible to SARS - CoV , which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	1<2	none	findings	findings
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	112-123,128-136	124-127	With these highly infectious SARS - CoV pseudotypes , several cell lines <*> were revealed as susceptible to SARS - CoV ,	derived from various tissues	With these highly infectious SARS - CoV pseudotypes , several cell lines <*> were revealed as susceptible to SARS - CoV ,	derived from various tissues	112-156	112-156	With these highly infectious SARS - CoV pseudotypes , several cell lines derived from various tissues were revealed as susceptible to SARS - CoV , which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	With these highly infectious SARS - CoV pseudotypes , several cell lines derived from various tissues were revealed as susceptible to SARS - CoV , which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	128-136	137-156	were revealed as susceptible to SARS - CoV ,	which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	were revealed as susceptible to SARS - CoV ,	which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	112-156	112-156	With these highly infectious SARS - CoV pseudotypes , several cell lines derived from various tissues were revealed as susceptible to SARS - CoV , which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	With these highly infectious SARS - CoV pseudotypes , several cell lines derived from various tissues were revealed as susceptible to SARS - CoV , which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	157-162	163-168,174-183	In addition , we also demonstrated	angiotensin 1 converting enzyme ( ACE) <*> could not function as a receptor for SARS - CoV.	In addition , we also demonstrated	angiotensin 1 converting enzyme ( ACE) <*> could not function as a receptor for SARS - CoV.	157-183	157-183	In addition , we also demonstrated angiotensin 1 converting enzyme ( ACE) - the homologue of ACE2 could not function as a receptor for SARS - CoV.	In addition , we also demonstrated angiotensin 1 converting enzyme ( ACE) - the homologue of ACE2 could not function as a receptor for SARS - CoV.	1>2	none	attribution	attribution
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	112-123,128-136	163-168,174-183	With these highly infectious SARS - CoV pseudotypes , several cell lines <*> were revealed as susceptible to SARS - CoV ,	angiotensin 1 converting enzyme ( ACE) <*> could not function as a receptor for SARS - CoV.	With these highly infectious SARS - CoV pseudotypes , several cell lines <*> were revealed as susceptible to SARS - CoV ,	angiotensin 1 converting enzyme ( ACE) <*> could not function as a receptor for SARS - CoV.	112-156	157-183	With these highly infectious SARS - CoV pseudotypes , several cell lines derived from various tissues were revealed as susceptible to SARS - CoV , which were highly corresponding to the expression pattern of virusÕs receptor angiotensin - converting enzyme 2 ( ACE2 ) .	In addition , we also demonstrated angiotensin 1 converting enzyme ( ACE) - the homologue of ACE2 could not function as a receptor for SARS - CoV.	1<2	none	elaboration	elaboration
d2bf31d4a63b71e7b5bb16f4375134d4ef881d25	163-168,174-183	169-173	angiotensin 1 converting enzyme ( ACE) <*> could not function as a receptor for SARS - CoV.	- the homologue of ACE2	angiotensin 1 converting enzyme ( ACE) <*> could not function as a receptor for SARS - CoV.	- the homologue of ACE2	157-183	157-183	In addition , we also demonstrated angiotensin 1 converting enzyme ( ACE) - the homologue of ACE2 could not function as a receptor for SARS - CoV.	In addition , we also demonstrated angiotensin 1 converting enzyme ( ACE) - the homologue of ACE2 could not function as a receptor for SARS - CoV.	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	1-10	64-70	Next - Generation Sequencing has been used in numerous investigations	Here , we combine these two approaches	Next - Generation Sequencing has been used in numerous investigations	Here , we combine these two approaches	1-30	64-88	Next - Generation Sequencing has been used in numerous investigations to characterize andquantifythe genetic diversity of a virus sample through the mapping of polymorphisms and measurement of mutation frequencies .	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	1>2	none	background	background
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	1-10	11-30	Next - Generation Sequencing has been used in numerous investigations	to characterize andquantifythe genetic diversity of a virus sample through the mapping of polymorphisms and measurement of mutation frequencies .	Next - Generation Sequencing has been used in numerous investigations	to characterize andquantifythe genetic diversity of a virus sample through the mapping of polymorphisms and measurement of mutation frequencies .	1-30	1-30	Next - Generation Sequencing has been used in numerous investigations to characterize andquantifythe genetic diversity of a virus sample through the mapping of polymorphisms and measurement of mutation frequencies .	Next - Generation Sequencing has been used in numerous investigations to characterize andquantifythe genetic diversity of a virus sample through the mapping of polymorphisms and measurement of mutation frequencies .	1<2	none	enablement	enablement
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	1-10	31-38	Next - Generation Sequencing has been used in numerous investigations	Next - Generation Sequencing has also been employed	Next - Generation Sequencing has been used in numerous investigations	Next - Generation Sequencing has also been employed	1-30	31-63	Next - Generation Sequencing has been used in numerous investigations to characterize andquantifythe genetic diversity of a virus sample through the mapping of polymorphisms and measurement of mutation frequencies .	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	31-38	39-42	Next - Generation Sequencing has also been employed	to identify recombination events	Next - Generation Sequencing has also been employed	to identify recombination events	31-63	31-63	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	1<2	none	enablement	enablement
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	39-42	43-50	to identify recombination events	occurring within the genomes of higher organisms ,	to identify recombination events	occurring within the genomes of higher organisms ,	31-63	31-63	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	43-50	51-63	occurring within the genomes of higher organisms ,	for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	occurring within the genomes of higher organisms ,	for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	31-63	31-63	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	Next - Generation Sequencing has also been employed to identify recombination events occurring within the genomes of higher organisms , for example , detecting alternative RNA splicing events and oncogenic chromosomal rearrangements .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	64-70	71-88	Here , we combine these two approaches	to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	Here , we combine these two approaches	to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	64-88	64-88	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	1<2	none	enablement	enablement
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	64-70	89-103	Here , we combine these two approaches	We detect hundreds of thousands of recombination events , with single - nucleotide resolution ,	Here , we combine these two approaches	We detect hundreds of thousands of recombination events , with single - nucleotide resolution ,	64-88	89-118	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	We detect hundreds of thousands of recombination events , with single - nucleotide resolution , which result in diversity in the encapsidated genome rivaling that due to mismatch mutation .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	89-103	104-111	We detect hundreds of thousands of recombination events , with single - nucleotide resolution ,	which result in diversity in the encapsidated genome	We detect hundreds of thousands of recombination events , with single - nucleotide resolution ,	which result in diversity in the encapsidated genome	89-118	89-118	We detect hundreds of thousands of recombination events , with single - nucleotide resolution , which result in diversity in the encapsidated genome rivaling that due to mismatch mutation .	We detect hundreds of thousands of recombination events , with single - nucleotide resolution , which result in diversity in the encapsidated genome rivaling that due to mismatch mutation .	1<2	none	cause-result	cause-result
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	104-111	112-118	which result in diversity in the encapsidated genome	rivaling that due to mismatch mutation .	which result in diversity in the encapsidated genome	rivaling that due to mismatch mutation .	89-118	89-118	We detect hundreds of thousands of recombination events , with single - nucleotide resolution , which result in diversity in the encapsidated genome rivaling that due to mismatch mutation .	We detect hundreds of thousands of recombination events , with single - nucleotide resolution , which result in diversity in the encapsidated genome rivaling that due to mismatch mutation .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	89-103	119-137	We detect hundreds of thousands of recombination events , with single - nucleotide resolution ,	We detect previously identified Defective - RNAs as well as many other abundant and novel Defective - RNAs .	We detect hundreds of thousands of recombination events , with single - nucleotide resolution ,	We detect previously identified Defective - RNAs as well as many other abundant and novel Defective - RNAs .	89-118	119-137	We detect hundreds of thousands of recombination events , with single - nucleotide resolution , which result in diversity in the encapsidated genome rivaling that due to mismatch mutation .	We detect previously identified Defective - RNAs as well as many other abundant and novel Defective - RNAs .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	64-70	138-145	Here , we combine these two approaches	Our approach is exceptionally sensitive , unbiased ,	Here , we combine these two approaches	Our approach is exceptionally sensitive , unbiased ,	64-88	138-156	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	Our approach is exceptionally sensitive , unbiased , and requires no prior knowledge beyond the virus genome sequence .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	138-145	146-156	Our approach is exceptionally sensitive , unbiased ,	and requires no prior knowledge beyond the virus genome sequence .	Our approach is exceptionally sensitive , unbiased ,	and requires no prior knowledge beyond the virus genome sequence .	138-156	138-156	Our approach is exceptionally sensitive , unbiased , and requires no prior knowledge beyond the virus genome sequence .	Our approach is exceptionally sensitive , unbiased , and requires no prior knowledge beyond the virus genome sequence .	1<2	none	joint	joint
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	64-70	157-172	Here , we combine these two approaches	RNA recombination is a powerful driving force behind the evolution and adaptation of RNA viruses .	Here , we combine these two approaches	RNA recombination is a powerful driving force behind the evolution and adaptation of RNA viruses .	64-88	157-172	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	RNA recombination is a powerful driving force behind the evolution and adaptation of RNA viruses .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	64-70	173-174,177-179	Here , we combine these two approaches	The strategy <*> is widely applicable	Here , we combine these two approaches	The strategy <*> is widely applicable	64-88	173-196	Here , we combine these two approaches to profile RNA recombination within the encapsidated genome of a eukaryotic RNA virus , Flock House Virus .	The strategy implemented here is widely applicable and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	1<2	none	findings	findings
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	173-174,177-179	175-176	The strategy <*> is widely applicable	implemented here	The strategy <*> is widely applicable	implemented here	173-196	173-196	The strategy implemented here is widely applicable and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	The strategy implemented here is widely applicable and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	1<2	none	elaboration	elaboration
d7e5ba009aed400fac0a223f7fe364b16ac84ae6	177-179	180-196	is widely applicable	and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	is widely applicable	and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	173-196	173-196	The strategy implemented here is widely applicable and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	The strategy implemented here is widely applicable and provides a highly detailed description of the complex mutational landscape of the transmissible viral genome .	1<2	none	joint	joint
d87f44c7d76e4c51ed8e72103669c275e2db3e71	1-22	44-55	The major physiological function of milk is the transport of amino acids , carbohydrates , lipids and minerals to mammalian offspring .	We have analysed the role of the milk protein a - casein	The major physiological function of milk is the transport of amino acids , carbohydrates , lipids and minerals to mammalian offspring .	We have analysed the role of the milk protein a - casein	1-22	44-63	The major physiological function of milk is the transport of amino acids , carbohydrates , lipids and minerals to mammalian offspring .	We have analysed the role of the milk protein a - casein by inactivating the corresponding gene in mice .	1>2	none	background	background
d87f44c7d76e4c51ed8e72103669c275e2db3e71	1-22	23-37	The major physiological function of milk is the transport of amino acids , carbohydrates , lipids and minerals to mammalian offspring .	Caseins , the major milk proteins , are secreted in the form of a micelle	The major physiological function of milk is the transport of amino acids , carbohydrates , lipids and minerals to mammalian offspring .	Caseins , the major milk proteins , are secreted in the form of a micelle	1-22	23-43	The major physiological function of milk is the transport of amino acids , carbohydrates , lipids and minerals to mammalian offspring .	Caseins , the major milk proteins , are secreted in the form of a micelle consisting of protein and calciumphosphate .	1<2	none	elaboration	elaboration
d87f44c7d76e4c51ed8e72103669c275e2db3e71	23-37	38-43	Caseins , the major milk proteins , are secreted in the form of a micelle	consisting of protein and calciumphosphate .	Caseins , the major milk proteins , are secreted in the form of a micelle	consisting of protein and calciumphosphate .	23-43	23-43	Caseins , the major milk proteins , are secreted in the form of a micelle consisting of protein and calciumphosphate .	Caseins , the major milk proteins , are secreted in the form of a micelle consisting of protein and calciumphosphate .	1<2	none	elaboration	elaboration
d87f44c7d76e4c51ed8e72103669c275e2db3e71	44-55	56-63	We have analysed the role of the milk protein a - casein	by inactivating the corresponding gene in mice .	We have analysed the role of the milk protein a - casein	by inactivating the corresponding gene in mice .	44-63	44-63	We have analysed the role of the milk protein a - casein by inactivating the corresponding gene in mice .	We have analysed the role of the milk protein a - casein by inactivating the corresponding gene in mice .	1<2	none	manner-means	manner-means
d87f44c7d76e4c51ed8e72103669c275e2db3e71	44-55	64-81	We have analysed the role of the milk protein a - casein	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	We have analysed the role of the milk protein a - casein	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	44-63	64-95	We have analysed the role of the milk protein a - casein by inactivating the corresponding gene in mice .	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate , suggesting a role for a - casein in the establishment of casein micelles .	1<2	none	findings	findings
d87f44c7d76e4c51ed8e72103669c275e2db3e71	64-81	82-95	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	suggesting a role for a - casein in the establishment of casein micelles .	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	suggesting a role for a - casein in the establishment of casein micelles .	64-95	64-95	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate , suggesting a role for a - casein in the establishment of casein micelles .	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate , suggesting a role for a - casein in the establishment of casein micelles .	1<2	none	cause-result	cause-result
d87f44c7d76e4c51ed8e72103669c275e2db3e71	64-81	96-102,112-117	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	In contrast , secretion of albumin , <*> into milk is not reduced .	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	In contrast , secretion of albumin , <*> into milk is not reduced .	64-95	96-117	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate , suggesting a role for a - casein in the establishment of casein micelles .	In contrast , secretion of albumin , which is not synthesized in the mammary epithelium , into milk is not reduced .	1<2	none	comparison	comparison
d87f44c7d76e4c51ed8e72103669c275e2db3e71	96-102,112-117	103-111	In contrast , secretion of albumin , <*> into milk is not reduced .	which is not synthesized in the mammary epithelium ,	In contrast , secretion of albumin , <*> into milk is not reduced .	which is not synthesized in the mammary epithelium ,	96-117	96-117	In contrast , secretion of albumin , which is not synthesized in the mammary epithelium , into milk is not reduced .	In contrast , secretion of albumin , which is not synthesized in the mammary epithelium , into milk is not reduced .	1<2	none	elaboration	elaboration
d87f44c7d76e4c51ed8e72103669c275e2db3e71	64-81	118-133	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	The absence of a - casein also significantly inhibits transcription of the other casein genes .	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate ,	The absence of a - casein also significantly inhibits transcription of the other casein genes .	64-95	118-133	Absence of a - casein protein significantly curtails secretion of other milk proteins and calcium - phosphate , suggesting a role for a - casein in the establishment of casein micelles .	The absence of a - casein also significantly inhibits transcription of the other casein genes .	1<2	none	elaboration	elaboration
d87f44c7d76e4c51ed8e72103669c275e2db3e71	118-133	134-143	The absence of a - casein also significantly inhibits transcription of the other casein genes .	a - Casein deficiency severely delays pup growth during lactation	The absence of a - casein also significantly inhibits transcription of the other casein genes .	a - Casein deficiency severely delays pup growth during lactation	118-133	134-172	The absence of a - casein also significantly inhibits transcription of the other casein genes .	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	1<2	none	elaboration	elaboration
d87f44c7d76e4c51ed8e72103669c275e2db3e71	134-143	144-153	a - Casein deficiency severely delays pup growth during lactation	and results in a life - long body size reduction	a - Casein deficiency severely delays pup growth during lactation	and results in a life - long body size reduction	134-172	134-172	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	1<2	none	joint	joint
d87f44c7d76e4c51ed8e72103669c275e2db3e71	144-153	154-158	and results in a life - long body size reduction	compared to control animals ,	and results in a life - long body size reduction	compared to control animals ,	134-172	134-172	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	1<2	none	comparison	comparison
d87f44c7d76e4c51ed8e72103669c275e2db3e71	134-143	159-172	a - Casein deficiency severely delays pup growth during lactation	but has only transient effects on physical and behavioural development of the pups .	a - Casein deficiency severely delays pup growth during lactation	but has only transient effects on physical and behavioural development of the pups .	134-172	134-172	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	a - Casein deficiency severely delays pup growth during lactation and results in a life - long body size reduction compared to control animals , but has only transient effects on physical and behavioural development of the pups .	1<2	none	comparison	comparison
d87f44c7d76e4c51ed8e72103669c275e2db3e71	44-55	173-187	We have analysed the role of the milk protein a - casein	The data support a critical role for a - casein in casein micelle assembly .	We have analysed the role of the milk protein a - casein	The data support a critical role for a - casein in casein micelle assembly .	44-63	173-187	We have analysed the role of the milk protein a - casein by inactivating the corresponding gene in mice .	The data support a critical role for a - casein in casein micelle assembly .	1<2	none	findings	findings
d87f44c7d76e4c51ed8e72103669c275e2db3e71	173-187	188-199	The data support a critical role for a - casein in casein micelle assembly .	The results also confirm lactation as a critical window of metabolic programming	The data support a critical role for a - casein in casein micelle assembly .	The results also confirm lactation as a critical window of metabolic programming	173-187	188-214	The data support a critical role for a - casein in casein micelle assembly .	The results also confirm lactation as a critical window of metabolic programming and suggest milk protein concentration as a decisive factor in determining adult body weight .	1<2	none	elaboration	elaboration
d87f44c7d76e4c51ed8e72103669c275e2db3e71	188-199	200-208	The results also confirm lactation as a critical window of metabolic programming	and suggest milk protein concentration as a decisive factor	The results also confirm lactation as a critical window of metabolic programming	and suggest milk protein concentration as a decisive factor	188-214	188-214	The results also confirm lactation as a critical window of metabolic programming and suggest milk protein concentration as a decisive factor in determining adult body weight .	The results also confirm lactation as a critical window of metabolic programming and suggest milk protein concentration as a decisive factor in determining adult body weight .	1<2	none	joint	joint
d87f44c7d76e4c51ed8e72103669c275e2db3e71	200-208	209-214	and suggest milk protein concentration as a decisive factor	in determining adult body weight .	and suggest milk protein concentration as a decisive factor	in determining adult body weight .	188-214	188-214	The results also confirm lactation as a critical window of metabolic programming and suggest milk protein concentration as a decisive factor in determining adult body weight .	The results also confirm lactation as a critical window of metabolic programming and suggest milk protein concentration as a decisive factor in determining adult body weight .	1<2	none	elaboration	elaboration
db9cea6a24f86d7bc1250050693fd459e3de6e2b	1-12	74-86	The detection of scintillation light from liquid argon is an experimental technique	Here we report on xenon doping in a 100 l crogenic vessel .	The detection of scintillation light from liquid argon is an experimental technique	Here we report on xenon doping in a 100 l crogenic vessel .	1-40	74-86	The detection of scintillation light from liquid argon is an experimental technique key to a number of current and future nuclear / particle physics experiments , such as neutrino physics , neutrinoless double beta decay and dark matter searches .	Here we report on xenon doping in a 100 l crogenic vessel .	1>2	none	background	background
db9cea6a24f86d7bc1250050693fd459e3de6e2b	1-12	13-26	The detection of scintillation light from liquid argon is an experimental technique	key to a number of current and future nuclear / particle physics experiments ,	The detection of scintillation light from liquid argon is an experimental technique	key to a number of current and future nuclear / particle physics experiments ,	1-40	1-40	The detection of scintillation light from liquid argon is an experimental technique key to a number of current and future nuclear / particle physics experiments , such as neutrino physics , neutrinoless double beta decay and dark matter searches .	The detection of scintillation light from liquid argon is an experimental technique key to a number of current and future nuclear / particle physics experiments , such as neutrino physics , neutrinoless double beta decay and dark matter searches .	1<2	none	elaboration	elaboration
db9cea6a24f86d7bc1250050693fd459e3de6e2b	13-26	27-40	key to a number of current and future nuclear / particle physics experiments ,	such as neutrino physics , neutrinoless double beta decay and dark matter searches .	key to a number of current and future nuclear / particle physics experiments ,	such as neutrino physics , neutrinoless double beta decay and dark matter searches .	1-40	1-40	The detection of scintillation light from liquid argon is an experimental technique key to a number of current and future nuclear / particle physics experiments , such as neutrino physics , neutrinoless double beta decay and dark matter searches .	The detection of scintillation light from liquid argon is an experimental technique key to a number of current and future nuclear / particle physics experiments , such as neutrino physics , neutrinoless double beta decay and dark matter searches .	1<2	none	elaboration	elaboration
db9cea6a24f86d7bc1250050693fd459e3de6e2b	41-43,58-62	63-73	Although the idea <*> has attracted considerable interest ,	this technique has never been demonstrated at the necessary scale .	Although the idea <*> has attracted considerable interest ,	this technique has never been demonstrated at the necessary scale .	41-73	41-73	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	1>2	none	comparison	comparison
db9cea6a24f86d7bc1250050693fd459e3de6e2b	41-43,58-62	44-52	Although the idea <*> has attracted considerable interest ,	of adding small quantities of xenon ( doping )	Although the idea <*> has attracted considerable interest ,	of adding small quantities of xenon ( doping )	41-73	41-73	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	1<2	none	elaboration	elaboration
db9cea6a24f86d7bc1250050693fd459e3de6e2b	44-52	53-57	of adding small quantities of xenon ( doping )	to enhance the light yield	of adding small quantities of xenon ( doping )	to enhance the light yield	41-73	41-73	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	1<2	none	enablement	enablement
db9cea6a24f86d7bc1250050693fd459e3de6e2b	1-12	63-73	The detection of scintillation light from liquid argon is an experimental technique	this technique has never been demonstrated at the necessary scale .	The detection of scintillation light from liquid argon is an experimental technique	this technique has never been demonstrated at the necessary scale .	1-40	41-73	The detection of scintillation light from liquid argon is an experimental technique key to a number of current and future nuclear / particle physics experiments , such as neutrino physics , neutrinoless double beta decay and dark matter searches .	Although the idea of adding small quantities of xenon ( doping ) to enhance the light yield has attracted considerable interest , this technique has never been demonstrated at the necessary scale .	1<2	none	elaboration	elaboration
db9cea6a24f86d7bc1250050693fd459e3de6e2b	74-86	87-106	Here we report on xenon doping in a 100 l crogenic vessel .	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm ,	Here we report on xenon doping in a 100 l crogenic vessel .	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm ,	74-86	87-114	Here we report on xenon doping in a 100 l crogenic vessel .	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm , consistent with a Geant4 prediction of 1.83±0.02 .	1<2	none	findings	findings
db9cea6a24f86d7bc1250050693fd459e3de6e2b	87-106	107-114	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm ,	consistent with a Geant4 prediction of 1.83±0.02 .	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm ,	consistent with a Geant4 prediction of 1.83±0.02 .	87-114	87-114	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm , consistent with a Geant4 prediction of 1.83±0.02 .	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm , consistent with a Geant4 prediction of 1.83±0.02 .	1<2	none	elaboration	elaboration
db9cea6a24f86d7bc1250050693fd459e3de6e2b	87-106	115-133	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm ,	We determine a lower limit on the attenuation length of 3 m at a concentration of 10 ppm .	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm ,	We determine a lower limit on the attenuation length of 3 m at a concentration of 10 ppm .	87-114	115-133	We observed an increase in light yield by a factor of 1.81±0.04 at a dopant concentration of 10 ppm , consistent with a Geant4 prediction of 1.83±0.02 .	We determine a lower limit on the attenuation length of 3 m at a concentration of 10 ppm .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	1-22	23-29	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	that are commonly encountered in health research	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	that are commonly encountered in health research	1-36	1-36	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	23-29	30-36	that are commonly encountered in health research	involving disaggregate geographic data about individuals .	that are commonly encountered in health research	involving disaggregate geographic data about individuals .	1-36	1-36	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	1-22	37-56	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents	1-36	37-69	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents that captured mainstream media and public interest in recent months and years .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	37-56	57-69	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents	that captured mainstream media and public interest in recent months and years .	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents	that captured mainstream media and public interest in recent months and years .	37-69	37-69	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents that captured mainstream media and public interest in recent months and years .	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents that captured mainstream media and public interest in recent months and years .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	37-56	70-102	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond ,	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond ,	37-69	70-119	Key definitions are provided , along with some examples of actual and potential security and confidentiality breaches and related incidents that captured mainstream media and public interest in recent months and years .	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond , touching on the emerging privacy issues associated with online consumer geoinformatics and location - based services .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	70-102	103-108	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond ,	touching on the emerging privacy issues	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond ,	touching on the emerging privacy issues	70-119	70-119	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond , touching on the emerging privacy issues associated with online consumer geoinformatics and location - based services .	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond , touching on the emerging privacy issues associated with online consumer geoinformatics and location - based services .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	103-108	109-119	touching on the emerging privacy issues	associated with online consumer geoinformatics and location - based services .	touching on the emerging privacy issues	associated with online consumer geoinformatics and location - based services .	70-119	70-119	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond , touching on the emerging privacy issues associated with online consumer geoinformatics and location - based services .	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond , touching on the emerging privacy issues associated with online consumer geoinformatics and location - based services .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	70-102	120-139	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond ,	The ' missing ring ' ( in many treatments of the topic ) of data security is also discussed .	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond ,	The ' missing ring ' ( in many treatments of the topic ) of data security is also discussed .	70-119	120-139	The paper then goes on to present a brief survey of the research literature on location privacy / confidentiality concerns and on privacy - preserving solutions in conventional health research and beyond , touching on the emerging privacy issues associated with online consumer geoinformatics and location - based services .	The ' missing ring ' ( in many treatments of the topic ) of data security is also discussed .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	1-22	140-171	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	Personal information and privacy legislations in two countries , Canada and the UK , are covered , as well as some examples of recent research projects and events about the subject .	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	Personal information and privacy legislations in two countries , Canada and the UK , are covered , as well as some examples of recent research projects and events about the subject .	1-36	140-171	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	Personal information and privacy legislations in two countries , Canada and the UK , are covered , as well as some examples of recent research projects and events about the subject .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	120-139	172-204	The ' missing ring ' ( in many treatments of the topic ) of data security is also discussed .	Select highlights from a June 2009 URISA ( Urban and Regional Information Systems Association ) workshop entitled ' Protecting Privacy and Confidentiality of Geographic Data in Health Research ' are then presented .	The ' missing ring ' ( in many treatments of the topic ) of data security is also discussed .	Select highlights from a June 2009 URISA ( Urban and Regional Information Systems Association ) workshop entitled ' Protecting Privacy and Confidentiality of Geographic Data in Health Research ' are then presented .	120-139	172-204	The ' missing ring ' ( in many treatments of the topic ) of data security is also discussed .	Select highlights from a June 2009 URISA ( Urban and Regional Information Systems Association ) workshop entitled ' Protecting Privacy and Confidentiality of Geographic Data in Health Research ' are then presented .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	1-22	205-207	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	The paper concludes	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues	The paper concludes	1-36	205-283	This paper offers a state - of - the - art overview of the intertwined privacy , confidentiality , and security issues that are commonly encountered in health research involving disaggregate geographic data about individuals .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	findings	findings
e296fa71274bad6cabcf683a2ba47e58b1326877	205-207	208-219	The paper concludes	by briefly charting the complexity of the domain and the many challenges	The paper concludes	by briefly charting the complexity of the domain and the many challenges	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	manner-means	manner-means
e296fa71274bad6cabcf683a2ba47e58b1326877	208-219	220-223	by briefly charting the complexity of the domain and the many challenges	associated with it ,	by briefly charting the complexity of the domain and the many challenges	associated with it ,	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	208-219	224-238	by briefly charting the complexity of the domain and the many challenges	and proposing a novel , ' one stop shop ' case - based reasoning framework	by briefly charting the complexity of the domain and the many challenges	and proposing a novel , ' one stop shop ' case - based reasoning framework	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	joint	joint
e296fa71274bad6cabcf683a2ba47e58b1326877	224-238	239-256	and proposing a novel , ' one stop shop ' case - based reasoning framework	to streamline the provision of clear and individualised guidance for the design and approval of new research projects	and proposing a novel , ' one stop shop ' case - based reasoning framework	to streamline the provision of clear and individualised guidance for the design and approval of new research projects	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	enablement	enablement
e296fa71274bad6cabcf683a2ba47e58b1326877	239-256	257-264	to streamline the provision of clear and individualised guidance for the design and approval of new research projects	( involving geographical identifiers about individuals ) ,	to streamline the provision of clear and individualised guidance for the design and approval of new research projects	( involving geographical identifiers about individuals ) ,	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	205-207	265-267	The paper concludes	including crisp recommendations	The paper concludes	including crisp recommendations	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	elaboration	elaboration
e296fa71274bad6cabcf683a2ba47e58b1326877	265-267	268-283	including crisp recommendations	on which specific privacy - preserving solutions and approaches would be suitable in each case .	including crisp recommendations	on which specific privacy - preserving solutions and approaches would be suitable in each case .	205-283	205-283	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	The paper concludes by briefly charting the complexity of the domain and the many challenges associated with it , and proposing a novel , ' one stop shop ' case - based reasoning framework to streamline the provision of clear and individualised guidance for the design and approval of new research projects ( involving geographical identifiers about individuals ) , including crisp recommendations on which specific privacy - preserving solutions and approaches would be suitable in each case .	1<2	none	elaboration	elaboration
e29e17f37924d1d14edf56276a5dcca87851e62f	1-37	38-48	The HIV-1 frameshift - stimulating ( FSS ) RNA , a regulatory RNA of critical importance in the virus ' life cycle , has been posited as a novel target for anti - HIV drug development .	We report the synthesis and evaluation of triazole - containing compounds	The HIV-1 frameshift - stimulating ( FSS ) RNA , a regulatory RNA of critical importance in the virus' life cycle , has been posited as a novel target for anti - HIV drug development .	We report the synthesis and evaluation of triazole - containing compounds	1-37	38-59	The HIV-1 frameshift - stimulating ( FSS ) RNA , a regulatory RNA of critical importance in the virus ' life cycle , has been posited as a novel target for anti - HIV drug development .	We report the synthesis and evaluation of triazole - containing compounds able to bind the FSS with high affinity and selectivity .	1>2	none	background	background
e29e17f37924d1d14edf56276a5dcca87851e62f	38-48	49-59	We report the synthesis and evaluation of triazole - containing compounds	able to bind the FSS with high affinity and selectivity .	We report the synthesis and evaluation of triazole - containing compounds	able to bind the FSS with high affinity and selectivity .	38-59	38-59	We report the synthesis and evaluation of triazole - containing compounds able to bind the FSS with high affinity and selectivity .	We report the synthesis and evaluation of triazole - containing compounds able to bind the FSS with high affinity and selectivity .	1<2	none	enablement	enablement
e29e17f37924d1d14edf56276a5dcca87851e62f	38-48	60-74	We report the synthesis and evaluation of triazole - containing compounds	Readily accessible synthetically , these compounds are less toxic than previously reported olefin congeners .	We report the synthesis and evaluation of triazole - containing compounds	Readily accessible synthetically , these compounds are less toxic than previously reported olefin congeners .	38-59	60-74	We report the synthesis and evaluation of triazole - containing compounds able to bind the FSS with high affinity and selectivity .	Readily accessible synthetically , these compounds are less toxic than previously reported olefin congeners .	1<2	none	elaboration	elaboration
e29e17f37924d1d14edf56276a5dcca87851e62f	75-80	81-97	We show for the first time	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	We show for the first time	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	75-107	75-107	We show for the first time that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells , including a highly cytopathic , multidrug - resistant strain .	We show for the first time that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells , including a highly cytopathic , multidrug - resistant strain .	1>2	none	attribution	attribution
e29e17f37924d1d14edf56276a5dcca87851e62f	38-48	81-97	We report the synthesis and evaluation of triazole - containing compounds	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	We report the synthesis and evaluation of triazole - containing compounds	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	38-59	75-107	We report the synthesis and evaluation of triazole - containing compounds able to bind the FSS with high affinity and selectivity .	We show for the first time that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells , including a highly cytopathic , multidrug - resistant strain .	1<2	none	findings	findings
e29e17f37924d1d14edf56276a5dcca87851e62f	81-97	98-107	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	including a highly cytopathic , multidrug - resistant strain .	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	including a highly cytopathic , multidrug - resistant strain .	75-107	75-107	We show for the first time that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells , including a highly cytopathic , multidrug - resistant strain .	We show for the first time that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells , including a highly cytopathic , multidrug - resistant strain .	1<2	none	elaboration	elaboration
e29e17f37924d1d14edf56276a5dcca87851e62f	81-97	108-121	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	These results support the viability of the HIV-1 FSS RNA as a therapeutic target	that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells ,	These results support the viability of the HIV-1 FSS RNA as a therapeutic target	75-107	108-142	We show for the first time that FSS - targeting compounds have antiviral activity against replication - competent HIV in human cells , including a highly cytopathic , multidrug - resistant strain .	These results support the viability of the HIV-1 FSS RNA as a therapeutic target and more generally highlight opportunities for synthetic molecule - mediated interference with protein recoding in a wide range of organisms .	1<2	none	elaboration	elaboration
e29e17f37924d1d14edf56276a5dcca87851e62f	108-121	122-142	These results support the viability of the HIV-1 FSS RNA as a therapeutic target	and more generally highlight opportunities for synthetic molecule - mediated interference with protein recoding in a wide range of organisms .	These results support the viability of the HIV-1 FSS RNA as a therapeutic target	and more generally highlight opportunities for synthetic molecule - mediated interference with protein recoding in a wide range of organisms .	108-142	108-142	These results support the viability of the HIV-1 FSS RNA as a therapeutic target and more generally highlight opportunities for synthetic molecule - mediated interference with protein recoding in a wide range of organisms .	These results support the viability of the HIV-1 FSS RNA as a therapeutic target and more generally highlight opportunities for synthetic molecule - mediated interference with protein recoding in a wide range of organisms .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	1-11	102-111,116-119	COVID-19 has massively changed the health landscape around the world .	There is doubt how courts , and the medical experts <*> will evaluate clinical care	COVID-19 has massively changed the health landscape around the world .	There is doubt how courts , and the medical experts <*> will evaluate clinical care	1-11	102-139	COVID-19 has massively changed the health landscape around the world .	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	1>2	none	background	background
e2c49130523a4232721c16791431632d09810a38	1-11	12-27	COVID-19 has massively changed the health landscape around the world .	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	COVID-19 has massively changed the health landscape around the world .	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	1-11	12-27	COVID-19 has massively changed the health landscape around the world .	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	12-27	28-40	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	Health services have made local decisions about care pathways , in some cases	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	Health services have made local decisions about care pathways , in some cases	12-27	28-55	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	Health services have made local decisions about care pathways , in some cases deviating from what would , until recently , have been considered widely accepted care .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	28-40	41-55	Health services have made local decisions about care pathways , in some cases	deviating from what would , until recently , have been considered widely accepted care .	Health services have made local decisions about care pathways , in some cases	deviating from what would , until recently , have been considered widely accepted care .	28-55	28-55	Health services have made local decisions about care pathways , in some cases deviating from what would , until recently , have been considered widely accepted care .	Health services have made local decisions about care pathways , in some cases deviating from what would , until recently , have been considered widely accepted care .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	12-27	56-66	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	These changes bring with them new medicolegal risk for clinicians .	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	These changes bring with them new medicolegal risk for clinicians .	12-27	56-66	Wide - ranging changes to healthcare delivery have occurred , especially in hospitals and EDs .	These changes bring with them new medicolegal risk for clinicians .	1<2	none	cause-result	cause-result
e2c49130523a4232721c16791431632d09810a38	56-66	67-76	These changes bring with them new medicolegal risk for clinicians .	In Australia , civil liability Acts provide protection for professionals	These changes bring with them new medicolegal risk for clinicians .	In Australia , civil liability Acts provide protection for professionals	56-66	67-101	These changes bring with them new medicolegal risk for clinicians .	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	67-76	77-79,99-101	In Australia , civil liability Acts provide protection for professionals	when the criterion <*> is met .	In Australia , civil liability Acts provide protection for professionals	when the criterion <*> is met .	67-101	67-101	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	1<2	none	condition	condition
e2c49130523a4232721c16791431632d09810a38	77-79,99-101	80-86	when the criterion <*> is met .	of having undertaken ' competent ' practice	when the criterion <*> is met .	of having undertaken ' competent ' practice	67-101	67-101	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	80-86	87-98	of having undertaken ' competent ' practice	that would be ' widely accepted ' ' in the circumstances '	of having undertaken ' competent ' practice	that would be ' widely accepted ' ' in the circumstances '	67-101	67-101	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	In Australia , civil liability Acts provide protection for professionals when the criterion of having undertaken ' competent ' practice that would be ' widely accepted ' ' in the circumstances ' is met .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	102-111,116-119	112-115	There is doubt how courts , and the medical experts <*> will evaluate clinical care	who advise them ,	There is doubt how courts , and the medical experts <*> will evaluate clinical care	who advise them ,	102-139	102-139	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	116-119	120-123	will evaluate clinical care	provided during the pandemic	will evaluate clinical care	provided during the pandemic	102-139	102-139	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	1<2	none	elaboration	elaboration
e2c49130523a4232721c16791431632d09810a38	116-119	124-131	will evaluate clinical care	when health services have developed local care pathways	will evaluate clinical care	when health services have developed local care pathways	102-139	102-139	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	1<2	none	temporal	temporal
e2c49130523a4232721c16791431632d09810a38	124-131	132-139	when health services have developed local care pathways	and there is no nationally accepted standard .	when health services have developed local care pathways	and there is no nationally accepted standard .	102-139	102-139	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	There is doubt how courts , and the medical experts who advise them , will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard .	1<2	none	joint	joint
e6aaada1af8e6361fefb6307231035a4da1c6141	1-16,24-31	206-222	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus <*> and the etiological agent of Coronavirus Disease-2019 .	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus <*> and the etiological agent of Coronavirus Disease-2019 .	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice	1-31	206-227	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus first identified in Wuhan , China , and the etiological agent of Coronavirus Disease-2019 .	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice to reduce infection risk .	1>2	none	background	background
e6aaada1af8e6361fefb6307231035a4da1c6141	1-16,24-31	17-23	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus <*> and the etiological agent of Coronavirus Disease-2019 .	first identified in Wuhan , China ,	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus <*> and the etiological agent of Coronavirus Disease-2019 .	first identified in Wuhan , China ,	1-31	1-31	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus first identified in Wuhan , China , and the etiological agent of Coronavirus Disease-2019 .	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus first identified in Wuhan , China , and the etiological agent of Coronavirus Disease-2019 .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	1-16,24-31	32-45	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus <*> and the etiological agent of Coronavirus Disease-2019 .	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus <*> and the etiological agent of Coronavirus Disease-2019 .	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	1-31	32-51	The Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS - CoV-2 ) is a novel coronavirus first identified in Wuhan , China , and the etiological agent of Coronavirus Disease-2019 .	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets that remain suspended as aerosol .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	32-45	46-51	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	that remain suspended as aerosol .	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	that remain suspended as aerosol .	32-51	32-51	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets that remain suspended as aerosol .	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets that remain suspended as aerosol .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	32-45	52-75	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	Moreover , it has been reported that infected subjects , both with and without clinical signs of COVID-19 , can transmit the virus .	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	Moreover , it has been reported that infected subjects , both with and without clinical signs of COVID-19 , can transmit the virus .	32-51	52-75	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets that remain suspended as aerosol .	Moreover , it has been reported that infected subjects , both with and without clinical signs of COVID-19 , can transmit the virus .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	76-88	89-100	Since the infection typically enters through mouth , nose , and eyes ,	dentistry is one of the medical practices at highest risk of infection	Since the infection typically enters through mouth , nose , and eyes ,	dentistry is one of the medical practices at highest risk of infection	76-114	76-114	Since the infection typically enters through mouth , nose , and eyes , dentistry is one of the medical practices at highest risk of infection due to the frequent production of aerosol and the constant presence of saliva .	Since the infection typically enters through mouth , nose , and eyes , dentistry is one of the medical practices at highest risk of infection due to the frequent production of aerosol and the constant presence of saliva .	1>2	none	cause-result	cause-result
e6aaada1af8e6361fefb6307231035a4da1c6141	32-45	89-100	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	dentistry is one of the medical practices at highest risk of infection	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets	dentistry is one of the medical practices at highest risk of infection	32-51	76-114	This infection spreads mainly through direct contact with Flügge micro droplets or core droplets that remain suspended as aerosol .	Since the infection typically enters through mouth , nose , and eyes , dentistry is one of the medical practices at highest risk of infection due to the frequent production of aerosol and the constant presence of saliva .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	89-100	101-114	dentistry is one of the medical practices at highest risk of infection	due to the frequent production of aerosol and the constant presence of saliva .	dentistry is one of the medical practices at highest risk of infection	due to the frequent production of aerosol and the constant presence of saliva .	76-114	76-114	Since the infection typically enters through mouth , nose , and eyes , dentistry is one of the medical practices at highest risk of infection due to the frequent production of aerosol and the constant presence of saliva .	Since the infection typically enters through mouth , nose , and eyes , dentistry is one of the medical practices at highest risk of infection due to the frequent production of aerosol and the constant presence of saliva .	1<2	none	cause-result	cause-result
e6aaada1af8e6361fefb6307231035a4da1c6141	115-123	124-137	The World Health Organization ( WHO ) has suggested	that only emergency / urgent procedures should be performed during the coronavirus outbreak .	The World Health Organization ( WHO ) has suggested	that only emergency / urgent procedures should be performed during the coronavirus outbreak .	115-137	115-137	The World Health Organization ( WHO ) has suggested that only emergency / urgent procedures should be performed during the coronavirus outbreak .	The World Health Organization ( WHO ) has suggested that only emergency / urgent procedures should be performed during the coronavirus outbreak .	1>2	none	attribution	attribution
e6aaada1af8e6361fefb6307231035a4da1c6141	89-100	124-137	dentistry is one of the medical practices at highest risk of infection	that only emergency / urgent procedures should be performed during the coronavirus outbreak .	dentistry is one of the medical practices at highest risk of infection	that only emergency / urgent procedures should be performed during the coronavirus outbreak .	76-114	115-137	Since the infection typically enters through mouth , nose , and eyes , dentistry is one of the medical practices at highest risk of infection due to the frequent production of aerosol and the constant presence of saliva .	The World Health Organization ( WHO ) has suggested that only emergency / urgent procedures should be performed during the coronavirus outbreak .	1<2	none	cause-result	cause-result
e6aaada1af8e6361fefb6307231035a4da1c6141	138-145	146-151,158-161	Considering the virus ' route of transmission ,	a specific protocol should be applied <*> in addition to measures	Considering the virus' route of transmission ,	a specific protocol should be applied <*> in addition to measures	138-184	138-184	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	1>2	none	cause-result	cause-result
e6aaada1af8e6361fefb6307231035a4da1c6141	124-137	146-151,158-161	that only emergency / urgent procedures should be performed during the coronavirus outbreak .	a specific protocol should be applied <*> in addition to measures	that only emergency / urgent procedures should be performed during the coronavirus outbreak .	a specific protocol should be applied <*> in addition to measures	115-137	138-184	The World Health Organization ( WHO ) has suggested that only emergency / urgent procedures should be performed during the coronavirus outbreak .	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	146-151,158-161	152-157	a specific protocol should be applied <*> in addition to measures	to reduce the risk of infection	a specific protocol should be applied <*> in addition to measures	to reduce the risk of infection	138-184	138-184	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	1<2	none	enablement	enablement
e6aaada1af8e6361fefb6307231035a4da1c6141	158-161	162-184	in addition to measures	that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	in addition to measures	that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	138-184	138-184	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	146-151,158-161	185-189	a specific protocol should be applied <*> in addition to measures	This protocol should be implemented	a specific protocol should be applied <*> in addition to measures	This protocol should be implemented	138-184	185-205	Considering the virus ' route of transmission , a specific protocol should be applied to reduce the risk of infection in addition to measures that prevent the spread of infection from a patient to another person or medical tools and equipment ( cross - infection ) .	This protocol should be implemented by modifying both patient management and clinical practice , introducing particular devices and organizational practices .	1<2	none	elaboration	elaboration
e6aaada1af8e6361fefb6307231035a4da1c6141	185-189	190-198	This protocol should be implemented	by modifying both patient management and clinical practice ,	This protocol should be implemented	by modifying both patient management and clinical practice ,	185-205	185-205	This protocol should be implemented by modifying both patient management and clinical practice , introducing particular devices and organizational practices .	This protocol should be implemented by modifying both patient management and clinical practice , introducing particular devices and organizational practices .	1<2	none	manner-means	manner-means
e6aaada1af8e6361fefb6307231035a4da1c6141	185-189	199-205	This protocol should be implemented	introducing particular devices and organizational practices .	This protocol should be implemented	introducing particular devices and organizational practices .	185-205	185-205	This protocol should be implemented by modifying both patient management and clinical practice , introducing particular devices and organizational practices .	This protocol should be implemented by modifying both patient management and clinical practice , introducing particular devices and organizational practices .	1<2	none	cause-result	cause-result
e6aaada1af8e6361fefb6307231035a4da1c6141	206-222	223-227	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice	to reduce infection risk .	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice	to reduce infection risk .	206-227	206-227	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice to reduce infection risk .	This paper aims to discuss and suggest the most appropriate procedures in every aspect of dental practice to reduce infection risk .	1<2	none	enablement	enablement
e767d7dc7a215fc7e1eed093425089a179eba77a	1-21	22-33	A combination of federal and state - level decision making has shaped the response to COVID-19 in the United States .	In this paper we analyze the Twitter narratives around this decision making	A combination of federal and state - level decision making has shaped the response to COVID-19 in the United States .	In this paper we analyze the Twitter narratives around this decision making	1-21	22-51	A combination of federal and state - level decision making has shaped the response to COVID-19 in the United States .	In this paper we analyze the Twitter narratives around this decision making by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	1>2	none	background	background
e767d7dc7a215fc7e1eed093425089a179eba77a	22-33	34-51	In this paper we analyze the Twitter narratives around this decision making	by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	In this paper we analyze the Twitter narratives around this decision making	by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	22-51	22-51	In this paper we analyze the Twitter narratives around this decision making by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	In this paper we analyze the Twitter narratives around this decision making by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	1<2	none	manner-means	manner-means
e767d7dc7a215fc7e1eed093425089a179eba77a	34-51	52-59	by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	We use a network Hawkes binomial topic model	by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	We use a network Hawkes binomial topic model	22-51	52-72	In this paper we analyze the Twitter narratives around this decision making by applying a dynamic topic model to COVID-19 related tweets by U.S. Governors and Presidential cabinet members .	We use a network Hawkes binomial topic model to track evolving sub - topics around risk , testing and treatment .	1<2	none	elaboration	elaboration
e767d7dc7a215fc7e1eed093425089a179eba77a	52-59	60-72	We use a network Hawkes binomial topic model	to track evolving sub - topics around risk , testing and treatment .	We use a network Hawkes binomial topic model	to track evolving sub - topics around risk , testing and treatment .	52-72	52-72	We use a network Hawkes binomial topic model to track evolving sub - topics around risk , testing and treatment .	We use a network Hawkes binomial topic model to track evolving sub - topics around risk , testing and treatment .	1<2	none	enablement	enablement
e767d7dc7a215fc7e1eed093425089a179eba77a	52-59	73-80	We use a network Hawkes binomial topic model	We also construct influence networks amongst government officials	We use a network Hawkes binomial topic model	We also construct influence networks amongst government officials	52-72	73-90	We use a network Hawkes binomial topic model to track evolving sub - topics around risk , testing and treatment .	We also construct influence networks amongst government officials using Granger causality inferred from the network Hawkes process .	1<2	none	elaboration	elaboration
e767d7dc7a215fc7e1eed093425089a179eba77a	73-80	81-83	We also construct influence networks amongst government officials	using Granger causality	We also construct influence networks amongst government officials	using Granger causality	73-90	73-90	We also construct influence networks amongst government officials using Granger causality inferred from the network Hawkes process .	We also construct influence networks amongst government officials using Granger causality inferred from the network Hawkes process .	1<2	none	manner-means	manner-means
e767d7dc7a215fc7e1eed093425089a179eba77a	81-83	84-90	using Granger causality	inferred from the network Hawkes process .	using Granger causality	inferred from the network Hawkes process .	73-90	73-90	We also construct influence networks amongst government officials using Granger causality inferred from the network Hawkes process .	We also construct influence networks amongst government officials using Granger causality inferred from the network Hawkes process .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	1-6	75-86	The hologram is an ideal method	In this work , we demonstrate a design of meta - holography	The hologram is an ideal method	In this work , we demonstrate a design of meta - holography	1-18	75-111	The hologram is an ideal method for displaying three - dimensional images visible to the naked eye .	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	1>2	none	background	background
e8a03d8f27e9d7b3716997e27ae897e802221339	1-6	7-18	The hologram is an ideal method	for displaying three - dimensional images visible to the naked eye .	The hologram is an ideal method	for displaying three - dimensional images visible to the naked eye .	1-18	1-18	The hologram is an ideal method for displaying three - dimensional images visible to the naked eye .	The hologram is an ideal method for displaying three - dimensional images visible to the naked eye .	1<2	none	enablement	enablement
e8a03d8f27e9d7b3716997e27ae897e802221339	1-6	19,24-31	The hologram is an ideal method	Metasurfaces <*> show great potential in light field manipulation ,	The hologram is an ideal method	Metasurfaces <*> show great potential in light field manipulation ,	1-18	19-45	The hologram is an ideal method for displaying three - dimensional images visible to the naked eye .	Metasurfaces consisting of subwavelength structures show great potential in light field manipulation , which is useful for overcoming the drawbacks of common computer - generated holography .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	19,24-31	20-23	Metasurfaces <*> show great potential in light field manipulation ,	consisting of subwavelength structures	Metasurfaces <*> show great potential in light field manipulation ,	consisting of subwavelength structures	19-45	19-45	Metasurfaces consisting of subwavelength structures show great potential in light field manipulation , which is useful for overcoming the drawbacks of common computer - generated holography .	Metasurfaces consisting of subwavelength structures show great potential in light field manipulation , which is useful for overcoming the drawbacks of common computer - generated holography .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	24-31	32-45	show great potential in light field manipulation ,	which is useful for overcoming the drawbacks of common computer - generated holography .	show great potential in light field manipulation ,	which is useful for overcoming the drawbacks of common computer - generated holography .	19-45	19-45	Metasurfaces consisting of subwavelength structures show great potential in light field manipulation , which is useful for overcoming the drawbacks of common computer - generated holography .	Metasurfaces consisting of subwavelength structures show great potential in light field manipulation , which is useful for overcoming the drawbacks of common computer - generated holography .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	19,24-31	46-64	Metasurfaces <*> show great potential in light field manipulation ,	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range ,	Metasurfaces <*> show great potential in light field manipulation ,	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range ,	19-45	46-74	Metasurfaces consisting of subwavelength structures show great potential in light field manipulation , which is useful for overcoming the drawbacks of common computer - generated holography .	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range , such as low frame rate and low frame number .	1<2	none	comparison	comparison
e8a03d8f27e9d7b3716997e27ae897e802221339	46-64	65-74	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range ,	such as low frame rate and low frame number .	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range ,	such as low frame rate and low frame number .	46-74	46-74	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range , such as low frame rate and low frame number .	However , there are long - existing challenges to achieving dynamic meta - holography in the visible range , such as low frame rate and low frame number .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	75-86	87-100,107-111	In this work , we demonstrate a design of meta - holography	that can achieve 2 28 different holographic frames and an extremely high frame rate <*> in the visible range .	In this work , we demonstrate a design of meta - holography	that can achieve 2 28 different holographic frames and an extremely high frame rate <*> in the visible range .	75-111	75-111	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	1<2	none	findings	findings
e8a03d8f27e9d7b3716997e27ae897e802221339	87-100,107-111	101-106	that can achieve 2 28 different holographic frames and an extremely high frame rate <*> in the visible range .	( 9523 frames per second )	that can achieve 2 28 different holographic frames and an extremely high frame rate <*> in the visible range .	( 9523 frames per second )	75-111	75-111	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	75-86	112-132	In this work , we demonstrate a design of meta - holography	The design is based on a space channel metasurface and a high - speed dynamic structured laser beam modulation module .	In this work , we demonstrate a design of meta - holography	The design is based on a space channel metasurface and a high - speed dynamic structured laser beam modulation module .	75-111	112-132	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	The design is based on a space channel metasurface and a high - speed dynamic structured laser beam modulation module .	1<2	none	manner-means	manner-means
e8a03d8f27e9d7b3716997e27ae897e802221339	112-132	133-146	The design is based on a space channel metasurface and a high - speed dynamic structured laser beam modulation module .	The space channel consists of silicon nitride nanopillars with a high modulation efficiency .	The design is based on a space channel metasurface and a high - speed dynamic structured laser beam modulation module .	The space channel consists of silicon nitride nanopillars with a high modulation efficiency .	112-132	133-146	The design is based on a space channel metasurface and a high - speed dynamic structured laser beam modulation module .	The space channel consists of silicon nitride nanopillars with a high modulation efficiency .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	75-86	147-156	In this work , we demonstrate a design of meta - holography	This method can satisfy the needs of a holographic display	In this work , we demonstrate a design of meta - holography	This method can satisfy the needs of a holographic display	75-111	147-178	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	This method can satisfy the needs of a holographic display and be useful in other applications , such as laser fabrication , optical storage , optics communications , and information processing .	1<2	none	findings	findings
e8a03d8f27e9d7b3716997e27ae897e802221339	147-156	157-163	This method can satisfy the needs of a holographic display	and be useful in other applications ,	This method can satisfy the needs of a holographic display	and be useful in other applications ,	147-178	147-178	This method can satisfy the needs of a holographic display and be useful in other applications , such as laser fabrication , optical storage , optics communications , and information processing .	This method can satisfy the needs of a holographic display and be useful in other applications , such as laser fabrication , optical storage , optics communications , and information processing .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	157-163	164-178	and be useful in other applications ,	such as laser fabrication , optical storage , optics communications , and information processing .	and be useful in other applications ,	such as laser fabrication , optical storage , optics communications , and information processing .	147-178	147-178	This method can satisfy the needs of a holographic display and be useful in other applications , such as laser fabrication , optical storage , optics communications , and information processing .	This method can satisfy the needs of a holographic display and be useful in other applications , such as laser fabrication , optical storage , optics communications , and information processing .	1<2	none	elaboration	elaboration
e8a03d8f27e9d7b3716997e27ae897e802221339	75-86	179-195	In this work , we demonstrate a design of meta - holography	Dynamic 3D meta - holography in visible range with large frame number and high frame rate .	In this work , we demonstrate a design of meta - holography	Dynamic 3D meta - holography in visible range with large frame number and high frame rate .	75-111	179-195	In this work , we demonstrate a design of meta - holography that can achieve 2 28 different holographic frames and an extremely high frame rate ( 9523 frames per second ) in the visible range .	Dynamic 3D meta - holography in visible range with large frame number and high frame rate .	1<2	none	textual-organization	textual-organization
e8a03d8f27e9d7b3716997e27ae897e802221339	179-195	196-206	Dynamic 3D meta - holography in visible range with large frame number and high frame rate .	Sci . Adv . 6 , eaba8595 ( 2020 ) .	Dynamic 3D meta - holography in visible range with large frame number and high frame rate .	Sci . Adv . 6 , eaba8595 ( 2020 ) .	179-195	196-206	Dynamic 3D meta - holography in visible range with large frame number and high frame rate .	Sci . Adv . 6 , eaba8595 ( 2020 ) .	1<2	none	textual-organization	textual-organization
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	1-12	70-85	An increasing body of evidence highlights the role of host genetic variation	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	An increasing body of evidence highlights the role of host genetic variation	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	1-22	70-120	An increasing body of evidence highlights the role of host genetic variation in driving susceptibility to severe disease following pathogen infection .	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	1>2	none	background	background
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	1-12	13-18	An increasing body of evidence highlights the role of host genetic variation	in driving susceptibility to severe disease	An increasing body of evidence highlights the role of host genetic variation	in driving susceptibility to severe disease	1-22	1-22	An increasing body of evidence highlights the role of host genetic variation in driving susceptibility to severe disease following pathogen infection .	An increasing body of evidence highlights the role of host genetic variation in driving susceptibility to severe disease following pathogen infection .	1<2	none	elaboration	elaboration
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	13-18	19-22	in driving susceptibility to severe disease	following pathogen infection .	in driving susceptibility to severe disease	following pathogen infection .	1-22	1-22	An increasing body of evidence highlights the role of host genetic variation in driving susceptibility to severe disease following pathogen infection .	An increasing body of evidence highlights the role of host genetic variation in driving susceptibility to severe disease following pathogen infection .	1<2	none	temporal	temporal
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	23-39	40-48	In order to fully appreciate the importance of host genetics on infection susceptibility and resulting disease ,	genetically variable experimental model systems should be employed .	In order to fully appreciate the importance of host genetics on infection susceptibility and resulting disease ,	genetically variable experimental model systems should be employed .	23-48	23-48	In order to fully appreciate the importance of host genetics on infection susceptibility and resulting disease , genetically variable experimental model systems should be employed .	In order to fully appreciate the importance of host genetics on infection susceptibility and resulting disease , genetically variable experimental model systems should be employed .	1>2	none	enablement	enablement
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	1-12	40-48	An increasing body of evidence highlights the role of host genetic variation	genetically variable experimental model systems should be employed .	An increasing body of evidence highlights the role of host genetic variation	genetically variable experimental model systems should be employed .	1-22	23-48	An increasing body of evidence highlights the role of host genetic variation in driving susceptibility to severe disease following pathogen infection .	In order to fully appreciate the importance of host genetics on infection susceptibility and resulting disease , genetically variable experimental model systems should be employed .	1<2	none	elaboration	elaboration
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	40-48	49-63	genetically variable experimental model systems should be employed .	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants	genetically variable experimental model systems should be employed .	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants	23-48	49-69	In order to fully appreciate the importance of host genetics on infection susceptibility and resulting disease , genetically variable experimental model systems should be employed .	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants that cause differential disease responses .	1<2	none	enablement	enablement
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	49-63	64-69	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants	that cause differential disease responses .	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants	that cause differential disease responses .	49-69	49-69	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants that cause differential disease responses .	These systems allow for the identification , characterization , and mechanistic dissection of genetic variants that cause differential disease responses .	1<2	none	cause-result	cause-result
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	70-85	86-90	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	to study viral pathogenesis ,	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	to study viral pathogenesis ,	70-120	70-120	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	1<2	none	enablement	enablement
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	70-85	91-115	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources	70-120	70-120	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	1<2	none	elaboration	elaboration
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	91-115	116-120	focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources	developed for the CC .	focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources	developed for the CC .	70-120	70-120	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	1<2	none	elaboration	elaboration
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	121-131	132-135,138-158	Although the focus of this chapter is on viral pathogenesis ,	many of the methods <*> are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	Although the focus of this chapter is on viral pathogenesis ,	many of the methods <*> are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	121-158	121-158	Although the focus of this chapter is on viral pathogenesis , many of the methods presented within are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	Although the focus of this chapter is on viral pathogenesis , many of the methods presented within are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	1>2	none	comparison	comparison
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	70-85	132-135,138-158	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	many of the methods <*> are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains	many of the methods <*> are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	70-120	121-158	Herein we discuss application of the Collaborative Cross ( CC ) panel of recombinant inbred strains to study viral pathogenesis , focusing on practical considerations for experimental design , assessment and analysis of disease responses within the CC , as well as some of the resources developed for the CC .	Although the focus of this chapter is on viral pathogenesis , many of the methods presented within are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	1<2	none	findings	findings
e8c619b901c3fd4c2e830df5c471e7b7d204be6b	132-135,138-158	136-137	many of the methods <*> are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	presented within	many of the methods <*> are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	presented within	121-158	121-158	Although the focus of this chapter is on viral pathogenesis , many of the methods presented within are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	Although the focus of this chapter is on viral pathogenesis , many of the methods presented within are applicable to studies of other pathogens , as well as to case - control designs in genetically diverse populations .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	1-11	73-88	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	1-32	70-88	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase that processes the N - terminals of biologically active peptides such as enkephalins , angiotensins , neurokinins , and cytokines .	We show here that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	1>2	none	background	background
e8fa052071eb975ce74b51e1927e26803deea863	1-11	12-21	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase	that processes the N - terminals of biologically active peptides	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase	that processes the N - terminals of biologically active peptides	1-32	1-32	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase that processes the N - terminals of biologically active peptides such as enkephalins , angiotensins , neurokinins , and cytokines .	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase that processes the N - terminals of biologically active peptides such as enkephalins , angiotensins , neurokinins , and cytokines .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	12-21	22-32	that processes the N - terminals of biologically active peptides	such as enkephalins , angiotensins , neurokinins , and cytokines .	that processes the N - terminals of biologically active peptides	such as enkephalins , angiotensins , neurokinins , and cytokines .	1-32	1-32	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase that processes the N - terminals of biologically active peptides such as enkephalins , angiotensins , neurokinins , and cytokines .	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase that processes the N - terminals of biologically active peptides such as enkephalins , angiotensins , neurokinins , and cytokines .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	1-11	33-39	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase	It exerts profound activity on vital processes	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase	It exerts profound activity on vital processes	1-32	33-52	Alanyl aminopeptidase ( APN ) is a surface - bound metallopeptidase that processes the N - terminals of biologically active peptides such as enkephalins , angiotensins , neurokinins , and cytokines .	It exerts profound activity on vital processes such as immune response , cellular growth , and blood pressure control .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	33-39	40-52	It exerts profound activity on vital processes	such as immune response , cellular growth , and blood pressure control .	It exerts profound activity on vital processes	such as immune response , cellular growth , and blood pressure control .	33-52	33-52	It exerts profound activity on vital processes such as immune response , cellular growth , and blood pressure control .	It exerts profound activity on vital processes such as immune response , cellular growth , and blood pressure control .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	33-39	53-69	It exerts profound activity on vital processes	Inhibition of either APN gene expression or its enzymatic activity severely affects leukocyte growth and function .	It exerts profound activity on vital processes	Inhibition of either APN gene expression or its enzymatic activity severely affects leukocyte growth and function .	33-52	53-69	It exerts profound activity on vital processes such as immune response , cellular growth , and blood pressure control .	Inhibition of either APN gene expression or its enzymatic activity severely affects leukocyte growth and function .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	70-72	73-88	We show here	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	We show here	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	70-88	70-88	We show here that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	We show here that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	1>2	none	attribution	attribution
e8fa052071eb975ce74b51e1927e26803deea863	73-88	89-103	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	70-88	89-121	We show here that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	89-103	104-121	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	89-121	89-121	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	1<2	none	temporal	temporal
e8fa052071eb975ce74b51e1927e26803deea863	89-103	122-134	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	In contrast , the transmembrane Cys24 appears to have no similar function .	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	In contrast , the transmembrane Cys24 appears to have no similar function .	89-121	122-134	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	In contrast , the transmembrane Cys24 appears to have no similar function .	1<2	none	comparison	comparison
e8fa052071eb975ce74b51e1927e26803deea863	89-103	135-144	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum	89-121	135-156	Additional evidence for the pivotal role of extracellular cysteines in the APN molecule was obtained when substitution of any of these six cysteines caused complete loss of surface expression and enzymatic activity .	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum as shown by high - resolution imaging and Endoglycosidase H digestion .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	135-144	145-156	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum	as shown by high - resolution imaging and Endoglycosidase H digestion .	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum	as shown by high - resolution imaging and Endoglycosidase H digestion .	135-156	135-156	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum as shown by high - resolution imaging and Endoglycosidase H digestion .	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum as shown by high - resolution imaging and Endoglycosidase H digestion .	1<2	none	attribution	attribution
e8fa052071eb975ce74b51e1927e26803deea863	135-144	157-168,179-185	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum	In the absence of any crystal - structure data , the demonstration <*> appears to be of particular importance .	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum	In the absence of any crystal - structure data , the demonstration <*> appears to be of particular importance .	135-156	157-185	Enzymatically inactive cysteine mutants were retained in the endoplasmic reticulum as shown by high - resolution imaging and Endoglycosidase H digestion .	In the absence of any crystal - structure data , the demonstration that individual extracellular cysteines contribute to APN expression and function appears to be of particular importance .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	157-168,179-185	169-178	In the absence of any crystal - structure data , the demonstration <*> appears to be of particular importance .	that individual extracellular cysteines contribute to APN expression and function	In the absence of any crystal - structure data , the demonstration <*> appears to be of particular importance .	that individual extracellular cysteines contribute to APN expression and function	157-185	157-185	In the absence of any crystal - structure data , the demonstration that individual extracellular cysteines contribute to APN expression and function appears to be of particular importance .	In the absence of any crystal - structure data , the demonstration that individual extracellular cysteines contribute to APN expression and function appears to be of particular importance .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	73-88	186-190	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	The data are the first	that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	The data are the first	70-88	186-216	We show here that oxidoreductasemediated modulations of the cell surface thiol status affect the enzymatic activity of APN .	The data are the first to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface , probably reflecting a general regulating mechanism .	1<2	none	findings	findings
e8fa052071eb975ce74b51e1927e26803deea863	186-190	191-209	The data are the first	to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface ,	The data are the first	to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface ,	186-216	186-216	The data are the first to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface , probably reflecting a general regulating mechanism .	The data are the first to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface , probably reflecting a general regulating mechanism .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	191-209	210-216	to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface ,	probably reflecting a general regulating mechanism .	to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface ,	probably reflecting a general regulating mechanism .	186-216	186-216	The data are the first to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface , probably reflecting a general regulating mechanism .	The data are the first to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface , probably reflecting a general regulating mechanism .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	186-190	217-223	The data are the first	This may relate to various disease processes	The data are the first	This may relate to various disease processes	186-216	217-230	The data are the first to show thiol - dependent modulation of the activity of a typical surfacebound peptidase at the cell surface , probably reflecting a general regulating mechanism .	This may relate to various disease processes such as inflammation or malignant transformation .	1<2	none	elaboration	elaboration
e8fa052071eb975ce74b51e1927e26803deea863	217-223	224-230	This may relate to various disease processes	such as inflammation or malignant transformation .	This may relate to various disease processes	such as inflammation or malignant transformation .	217-230	217-230	This may relate to various disease processes such as inflammation or malignant transformation .	This may relate to various disease processes such as inflammation or malignant transformation .	1<2	none	elaboration	elaboration
eafd17ebcaf051ac6cdf146a974e4cd0a8f528ea	1-11	12-28	Although information on efficacy and adverse drug reactions is lacking ,	ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	Although information on efficacy and adverse drug reactions is lacking ,	ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	1-28	1-28	Although information on efficacy and adverse drug reactions is lacking , ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	Although information on efficacy and adverse drug reactions is lacking , ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	1>2	none	comparison	comparison
eafd17ebcaf051ac6cdf146a974e4cd0a8f528ea	12-28	29-41	ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	We report common adverse events in 110 patients with suspected or probable SARS	ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	We report common adverse events in 110 patients with suspected or probable SARS	1-28	29-47	Although information on efficacy and adverse drug reactions is lacking , ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .	We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin .	1>2	none	background	background
eafd17ebcaf051ac6cdf146a974e4cd0a8f528ea	29-41	42-47	We report common adverse events in 110 patients with suspected or probable SARS	who were treated with ribavirin .	We report common adverse events in 110 patients with suspected or probable SARS	who were treated with ribavirin .	29-47	29-47	We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin .	We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin .	1<2	none	elaboration	elaboration
eafd17ebcaf051ac6cdf146a974e4cd0a8f528ea	29-41	48-60	We report common adverse events in 110 patients with suspected or probable SARS	Sixty - one percent of the patients had evidence of hemolytic anemia ,	We report common adverse events in 110 patients with suspected or probable SARS	Sixty - one percent of the patients had evidence of hemolytic anemia ,	29-47	48-77	We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin .	Sixty - one percent of the patients had evidence of hemolytic anemia , and hypocalcemia and hypomagnesmia were reported in 58 % and 46 % of patients , respectively .	1<2	none	findings	findings
eafd17ebcaf051ac6cdf146a974e4cd0a8f528ea	48-60	61-77	Sixty - one percent of the patients had evidence of hemolytic anemia ,	and hypocalcemia and hypomagnesmia were reported in 58 % and 46 % of patients , respectively .	Sixty - one percent of the patients had evidence of hemolytic anemia ,	and hypocalcemia and hypomagnesmia were reported in 58 % and 46 % of patients , respectively .	48-77	48-77	Sixty - one percent of the patients had evidence of hemolytic anemia , and hypocalcemia and hypomagnesmia were reported in 58 % and 46 % of patients , respectively .	Sixty - one percent of the patients had evidence of hemolytic anemia , and hypocalcemia and hypomagnesmia were reported in 58 % and 46 % of patients , respectively .	1<2	none	joint	joint
eb68173ed9ade0c27573673e9a45ef1be8191edc	1-16	17-32	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Besides a standard geometric Brownian motion , another two driving processes are taken into account :	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Besides a standard geometric Brownian motion , another two driving processes are taken into account :	1-16	17-48	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Besides a standard geometric Brownian motion , another two driving processes are taken into account : a stationary Poisson point process and a continuous - time finite - state Markov chain .	1<2	none	elaboration	elaboration
eb68173ed9ade0c27573673e9a45ef1be8191edc	17-32	33-48	Besides a standard geometric Brownian motion , another two driving processes are taken into account :	a stationary Poisson point process and a continuous - time finite - state Markov chain .	Besides a standard geometric Brownian motion , another two driving processes are taken into account :	a stationary Poisson point process and a continuous - time finite - state Markov chain .	17-48	17-48	Besides a standard geometric Brownian motion , another two driving processes are taken into account : a stationary Poisson point process and a continuous - time finite - state Markov chain .	Besides a standard geometric Brownian motion , another two driving processes are taken into account : a stationary Poisson point process and a continuous - time finite - state Markov chain .	1<2	none	elaboration	elaboration
eb68173ed9ade0c27573673e9a45ef1be8191edc	1-16	49-60	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	The classical harvesting problem for this model is a big difficult puzzle	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	The classical harvesting problem for this model is a big difficult puzzle	1-16	49-78	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	The classical harvesting problem for this model is a big difficult puzzle since the corresponding Fokker - Planck equations with three types of noise are very difficult to solve .	1<2	none	background	background
eb68173ed9ade0c27573673e9a45ef1be8191edc	49-60	61-78	The classical harvesting problem for this model is a big difficult puzzle	since the corresponding Fokker - Planck equations with three types of noise are very difficult to solve .	The classical harvesting problem for this model is a big difficult puzzle	since the corresponding Fokker - Planck equations with three types of noise are very difficult to solve .	49-78	49-78	The classical harvesting problem for this model is a big difficult puzzle since the corresponding Fokker - Planck equations with three types of noise are very difficult to solve .	The classical harvesting problem for this model is a big difficult puzzle since the corresponding Fokker - Planck equations with three types of noise are very difficult to solve .	1<2	none	cause-result	cause-result
eb68173ed9ade0c27573673e9a45ef1be8191edc	1-16	79-98	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Our main goal of this paper is to work out the optimization problem with respect to stationary probability density .	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Our main goal of this paper is to work out the optimization problem with respect to stationary probability density .	1-16	79-98	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Our main goal of this paper is to work out the optimization problem with respect to stationary probability density .	1<2	none	elaboration	elaboration
eb68173ed9ade0c27573673e9a45ef1be8191edc	79-98	99-110	Our main goal of this paper is to work out the optimization problem with respect to stationary probability density .	One of the main contributions is to provide a new equivalent approach	Our main goal of this paper is to work out the optimization problem with respect to stationary probability density .	One of the main contributions is to provide a new equivalent approach	79-98	99-115	Our main goal of this paper is to work out the optimization problem with respect to stationary probability density .	One of the main contributions is to provide a new equivalent approach to overcome this problem .	1<2	none	elaboration	elaboration
eb68173ed9ade0c27573673e9a45ef1be8191edc	99-110	111-115	One of the main contributions is to provide a new equivalent approach	to overcome this problem .	One of the main contributions is to provide a new equivalent approach	to overcome this problem .	99-115	99-115	One of the main contributions is to provide a new equivalent approach to overcome this problem .	One of the main contributions is to provide a new equivalent approach to overcome this problem .	1<2	none	enablement	enablement
eb68173ed9ade0c27573673e9a45ef1be8191edc	99-110	116-123	One of the main contributions is to provide a new equivalent approach	More precisely , an ergodic method is used	One of the main contributions is to provide a new equivalent approach	More precisely , an ergodic method is used	99-115	116-138	One of the main contributions is to provide a new equivalent approach to overcome this problem .	More precisely , an ergodic method is used to show the almost surely equivalency between the time averaging yield and sustainable yield .	1<2	none	manner-means	manner-means
eb68173ed9ade0c27573673e9a45ef1be8191edc	116-123	124-138	More precisely , an ergodic method is used	to show the almost surely equivalency between the time averaging yield and sustainable yield .	More precisely , an ergodic method is used	to show the almost surely equivalency between the time averaging yield and sustainable yield .	116-138	116-138	More precisely , an ergodic method is used to show the almost surely equivalency between the time averaging yield and sustainable yield .	More precisely , an ergodic method is used to show the almost surely equivalency between the time averaging yield and sustainable yield .	1<2	none	enablement	enablement
eb68173ed9ade0c27573673e9a45ef1be8191edc	139-140	141-148	Results show	that the optimal strategy changes with environment .	Results show	that the optimal strategy changes with environment .	139-148	139-148	Results show that the optimal strategy changes with environment .	Results show that the optimal strategy changes with environment .	1>2	none	attribution	attribution
eb68173ed9ade0c27573673e9a45ef1be8191edc	1-16	141-148	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	that the optimal strategy changes with environment .	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	that the optimal strategy changes with environment .	1-16	139-148	The optimization problem of fishing for a stochastic logistic model is studied in this paper .	Results show that the optimal strategy changes with environment .	1<2	none	findings	findings
eb68173ed9ade0c27573673e9a45ef1be8191edc	141-148	149-166	that the optimal strategy changes with environment .	An interesting thing is that the optimal strategy for each state is equivalent to the global optimality .	that the optimal strategy changes with environment .	An interesting thing is that the optimal strategy for each state is equivalent to the global optimality .	139-148	149-166	Results show that the optimal strategy changes with environment .	An interesting thing is that the optimal strategy for each state is equivalent to the global optimality .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	1-2	26-42	Background :	real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	Background :	real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	1-2	3-42	Background :	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic , and it is rapidly expanding in Iran , real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	1>2	none	textual-organization	textual-organization
ed43a39e585d77f1fecd662508f8042ed4ad3396	3-17	26-42	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic ,	real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic ,	real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	3-42	3-42	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic , and it is rapidly expanding in Iran , real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic , and it is rapidly expanding in Iran , real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	1>2	none	cause-result	cause-result
ed43a39e585d77f1fecd662508f8042ed4ad3396	3-17	18-25	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic ,	and it is rapidly expanding in Iran ,	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic ,	and it is rapidly expanding in Iran ,	3-42	3-42	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic , and it is rapidly expanding in Iran , real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic , and it is rapidly expanding in Iran , real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	26-42	43-51	real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	In this study , we built a predictive model	real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	In this study , we built a predictive model	3-42	43-67	As the outbreak of Coronavirus disease 2019 ( COVID-19 ) is a worldwide pandemic , and it is rapidly expanding in Iran , real - time analyses of epidemiological data are needed to increase situational awareness and inform interventions .	In this study , we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces .	1>2	none	background	background
ed43a39e585d77f1fecd662508f8042ed4ad3396	43-51	52-67	In this study , we built a predictive model	based on the cumulative trend of new cases and deaths for the top five provinces .	In this study , we built a predictive model	based on the cumulative trend of new cases and deaths for the top five provinces .	43-67	43-67	In this study , we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces .	In this study , we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces .	1<2	none	manner-means	manner-means
ed43a39e585d77f1fecd662508f8042ed4ad3396	43-51	68-87	In this study , we built a predictive model	We will also look at modeling the trends for confirmed cases , deaths and recovered for the whole country .	In this study , we built a predictive model	We will also look at modeling the trends for confirmed cases , deaths and recovered for the whole country .	43-67	68-87	In this study , we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces .	We will also look at modeling the trends for confirmed cases , deaths and recovered for the whole country .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	88-89	90-102	Method :	In this study , we have chosen to apply the exponential smoothing model	Method :	In this study , we have chosen to apply the exponential smoothing model	88-89	90-120	Method :	In this study , we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time series from weighted averages of past daily values .	1>2	none	textual-organization	textual-organization
ed43a39e585d77f1fecd662508f8042ed4ad3396	43-51	90-102	In this study , we built a predictive model	In this study , we have chosen to apply the exponential smoothing model	In this study , we built a predictive model	In this study , we have chosen to apply the exponential smoothing model	43-67	90-120	In this study , we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces .	In this study , we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time series from weighted averages of past daily values .	1<2	none	manner-means	manner-means
ed43a39e585d77f1fecd662508f8042ed4ad3396	90-102	103-120	In this study , we have chosen to apply the exponential smoothing model	to iteratively forecast future values of a regular time series from weighted averages of past daily values .	In this study , we have chosen to apply the exponential smoothing model	to iteratively forecast future values of a regular time series from weighted averages of past daily values .	90-120	90-120	In this study , we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time series from weighted averages of past daily values .	In this study , we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time series from weighted averages of past daily values .	1<2	none	enablement	enablement
ed43a39e585d77f1fecd662508f8042ed4ad3396	90-102	121-124	In this study , we have chosen to apply the exponential smoothing model	This method is exponential	In this study , we have chosen to apply the exponential smoothing model	This method is exponential	90-120	121-151	In this study , we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time series from weighted averages of past daily values .	This method is exponential because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree - more recent values are given greater weight .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	121-124	125-142	This method is exponential	because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree	This method is exponential	because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree	121-151	121-151	This method is exponential because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree - more recent values are given greater weight .	This method is exponential because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree - more recent values are given greater weight .	1<2	none	cause-result	cause-result
ed43a39e585d77f1fecd662508f8042ed4ad3396	125-142	143-151	because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree	- more recent values are given greater weight .	because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree	- more recent values are given greater weight .	121-151	121-151	This method is exponential because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree - more recent values are given greater weight .	This method is exponential because the value of each level is influenced by every preceding actual value to an exponentially decreasing degree - more recent values are given greater weight .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	90-102	152-157	In this study , we have chosen to apply the exponential smoothing model	The available data is too small	In this study , we have chosen to apply the exponential smoothing model	The available data is too small	90-120	152-180	In this study , we have chosen to apply the exponential smoothing model to iteratively forecast future values of a regular time series from weighted averages of past daily values .	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	152-157	158-161	The available data is too small	to identify seasonal patterns	The available data is too small	to identify seasonal patterns	152-180	152-180	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	158-161	162-169	to identify seasonal patterns	and make a predictable variation in value ,	to identify seasonal patterns	and make a predictable variation in value ,	152-180	152-180	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	1<2	none	joint	joint
ed43a39e585d77f1fecd662508f8042ed4ad3396	158-161	170-175	to identify seasonal patterns	such as annual fluctuation in temperature	to identify seasonal patterns	such as annual fluctuation in temperature	152-180	152-180	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	170-175	176-180	such as annual fluctuation in temperature	related to the season .	such as annual fluctuation in temperature	related to the season .	152-180	152-180	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	The available data is too small to identify seasonal patterns and make a predictable variation in value , such as annual fluctuation in temperature related to the season .	1<2	none	elaboration	elaboration
ed43a39e585d77f1fecd662508f8042ed4ad3396	43-51	181-188	In this study , we built a predictive model	The trend is a tendency of the data	In this study , we built a predictive model	The trend is a tendency of the data	43-67	181-195	In this study , we built a predictive model based on the cumulative trend of new cases and deaths for the top five provinces .	The trend is a tendency of the data to increase or decrease over time .	1<2	none	findings	findings
ed43a39e585d77f1fecd662508f8042ed4ad3396	181-188	189-195	The trend is a tendency of the data	to increase or decrease over time .	The trend is a tendency of the data	to increase or decrease over time .	181-195	181-195	The trend is a tendency of the data to increase or decrease over time .	The trend is a tendency of the data to increase or decrease over time .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	1-11,21-31	86-95,105-108	The recent outbreak of severe acute respiratory syndrome ( SARS ) <*> has necessitated an in - depth molecular understanding of the virus	In this paper , a novel analysis of SARS genome <*> has been presented .	The recent outbreak of severe acute respiratory syndrome ( SARS ) <*> has necessitated an in - depth molecular understanding of the virus	In this paper , a novel analysis of SARS genome <*> has been presented .	1-37	86-108	The recent outbreak of severe acute respiratory syndrome ( SARS ) caused by SARS coronavirus ( SARS - CoV ) has necessitated an in - depth molecular understanding of the virus to identify new drug targets .	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	1>2	none	background	background
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	1-11,21-31	12-20	The recent outbreak of severe acute respiratory syndrome ( SARS ) <*> has necessitated an in - depth molecular understanding of the virus	caused by SARS coronavirus ( SARS - CoV )	The recent outbreak of severe acute respiratory syndrome ( SARS ) <*> has necessitated an in - depth molecular understanding of the virus	caused by SARS coronavirus ( SARS - CoV )	1-37	1-37	The recent outbreak of severe acute respiratory syndrome ( SARS ) caused by SARS coronavirus ( SARS - CoV ) has necessitated an in - depth molecular understanding of the virus to identify new drug targets .	The recent outbreak of severe acute respiratory syndrome ( SARS ) caused by SARS coronavirus ( SARS - CoV ) has necessitated an in - depth molecular understanding of the virus to identify new drug targets .	1<2	none	cause-result	cause-result
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	21-31	32-37	has necessitated an in - depth molecular understanding of the virus	to identify new drug targets .	has necessitated an in - depth molecular understanding of the virus	to identify new drug targets .	1-37	1-37	The recent outbreak of severe acute respiratory syndrome ( SARS ) caused by SARS coronavirus ( SARS - CoV ) has necessitated an in - depth molecular understanding of the virus to identify new drug targets .	The recent outbreak of severe acute respiratory syndrome ( SARS ) caused by SARS coronavirus ( SARS - CoV ) has necessitated an in - depth molecular understanding of the virus to identify new drug targets .	1<2	none	enablement	enablement
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	1-11,21-31	38-64	The recent outbreak of severe acute respiratory syndrome ( SARS ) <*> has necessitated an in - depth molecular understanding of the virus	The availability of complete genome sequence of several strains of SARS virus provides the possibility of identification of protein - coding genes and defining their functions .	The recent outbreak of severe acute respiratory syndrome ( SARS ) <*> has necessitated an in - depth molecular understanding of the virus	The availability of complete genome sequence of several strains of SARS virus provides the possibility of identification of protein - coding genes and defining their functions .	1-37	38-64	The recent outbreak of severe acute respiratory syndrome ( SARS ) caused by SARS coronavirus ( SARS - CoV ) has necessitated an in - depth molecular understanding of the virus to identify new drug targets .	The availability of complete genome sequence of several strains of SARS virus provides the possibility of identification of protein - coding genes and defining their functions .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	38-64	65-66,77-83	The availability of complete genome sequence of several strains of SARS virus provides the possibility of identification of protein - coding genes and defining their functions .	Computational approach <*> will help in designing experimental protocols .	The availability of complete genome sequence of several strains of SARS virus provides the possibility of identification of protein - coding genes and defining their functions .	Computational approach <*> will help in designing experimental protocols .	38-64	65-83	The availability of complete genome sequence of several strains of SARS virus provides the possibility of identification of protein - coding genes and defining their functions .	Computational approach to identify protein - coding genes and their putative functions will help in designing experimental protocols .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	65-66,77-83	67-76	Computational approach <*> will help in designing experimental protocols .	to identify protein - coding genes and their putative functions	Computational approach <*> will help in designing experimental protocols .	to identify protein - coding genes and their putative functions	65-83	65-83	Computational approach to identify protein - coding genes and their putative functions will help in designing experimental protocols .	Computational approach to identify protein - coding genes and their putative functions will help in designing experimental protocols .	1<2	none	enablement	enablement
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	84-85	86-95,105-108	Results :	In this paper , a novel analysis of SARS genome <*> has been presented .	Results :	In this paper , a novel analysis of SARS genome <*> has been presented .	84-85	86-108	Results :	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	1>2	none	textual-organization	textual-organization
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	86-95,105-108	96-100	In this paper , a novel analysis of SARS genome <*> has been presented .	using gene prediction method GeneDecipher	In this paper , a novel analysis of SARS genome <*> has been presented .	using gene prediction method GeneDecipher	86-108	86-108	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	1<2	none	manner-means	manner-means
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	96-100	101-104	using gene prediction method GeneDecipher	developed in our laboratory	using gene prediction method GeneDecipher	developed in our laboratory	86-108	86-108	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	86-95,105-108	109-121	In this paper , a novel analysis of SARS genome <*> has been presented .	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed	In this paper , a novel analysis of SARS genome <*> has been presented .	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed	86-108	109-124	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed using GeneDecipher .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	109-121	122-124	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed	using GeneDecipher .	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed	using GeneDecipher .	109-124	109-124	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed using GeneDecipher .	Each of the 18 newly sequenced SARS - CoV genomes has been analyzed using GeneDecipher .	1<2	none	manner-means	manner-means
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	86-95,105-108	125-171	In this paper , a novel analysis of SARS genome <*> has been presented .	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	In this paper , a novel analysis of SARS genome <*> has been presented .	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	86-108	125-177	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	1<2	none	findings	findings
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	125-171	172-175	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	depending upon the strain	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	depending upon the strain	125-177	125-177	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	1<2	none	condition	condition
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	172-175	176-177	depending upon the strain	analyzed .	depending upon the strain	analyzed .	125-177	125-177	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	125-171	178-187	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	Their lengths range between 61 and 274 amino acids .	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	Their lengths range between 61 and 274 amino acids .	125-177	178-187	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	Their lengths range between 61 and 274 amino acids .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	188-191	192-208	Our method also suggests	that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin	Our method also suggests	that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin	188-214	188-214	Our method also suggests that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin and others are of prokaryotic .	Our method also suggests that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin and others are of prokaryotic .	1>2	none	attribution	attribution
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	125-171	192-208	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin	125-177	188-214	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	Our method also suggests that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin and others are of prokaryotic .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	192-208	209-214	that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin	and others are of prokaryotic .	that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin	and others are of prokaryotic .	188-214	188-214	Our method also suggests that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin and others are of prokaryotic .	Our method also suggests that polyprotein 1ab , polyprotein 1a , S , M and N are proteins of viral origin and others are of prokaryotic .	1<2	none	joint	joint
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	125-171	215-226	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	Putative functions of all predicted protein - coding genes have been suggested	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted	Putative functions of all predicted protein - coding genes have been suggested	125-177	215-236	In addition to polyprotein 1ab 1 , polyprotein 1a and the four genes coding for major structural proteins spike ( S ) , small envelope ( E ) , membrane ( M ) and nucleocapsid ( N ) , six to eight additional proteins have been predicted depending upon the strain analyzed .	Putative functions of all predicted protein - coding genes have been suggested using conserved peptides present in their open reading frames .	1<2	none	elaboration	elaboration
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	215-226	227-236	Putative functions of all predicted protein - coding genes have been suggested	using conserved peptides present in their open reading frames .	Putative functions of all predicted protein - coding genes have been suggested	using conserved peptides present in their open reading frames .	215-236	215-236	Putative functions of all predicted protein - coding genes have been suggested using conserved peptides present in their open reading frames .	Putative functions of all predicted protein - coding genes have been suggested using conserved peptides present in their open reading frames .	1<2	none	manner-means	manner-means
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	237-238	239-256	Availability :	Detailed results of GeneDecipher analysis of all the 18 strains of SARS - CoV genomes are available at	Availability :	Detailed results of GeneDecipher analysis of all the 18 strains of SARS - CoV genomes are available at	237-238	239-256	Availability :	Detailed results of GeneDecipher analysis of all the 18 strains of SARS - CoV genomes are available at	1>2	none	textual-organization	textual-organization
ee370aa6a34ccb5c96e1a213dbed64a2fe4af89f	86-95,105-108	239-256	In this paper , a novel analysis of SARS genome <*> has been presented .	Detailed results of GeneDecipher analysis of all the 18 strains of SARS - CoV genomes are available at	In this paper , a novel analysis of SARS genome <*> has been presented .	Detailed results of GeneDecipher analysis of all the 18 strains of SARS - CoV genomes are available at	86-108	239-256	In this paper , a novel analysis of SARS genome using gene prediction method GeneDecipher developed in our laboratory has been presented .	Detailed results of GeneDecipher analysis of all the 18 strains of SARS - CoV genomes are available at	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	1-4,10-16	149-167	A number of methods <*> have been applied to medical image segmentation	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	A number of methods <*> have been applied to medical image segmentation	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	1-28	149-190	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	1>2	none	background	background
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	1-4,10-16	5-9	A number of methods <*> have been applied to medical image segmentation	based on the deep learning	A number of methods <*> have been applied to medical image segmentation	based on the deep learning	1-28	1-28	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	1<2	none	manner-means	manner-means
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	10-16	17-28	have been applied to medical image segmentation	and have achieved state - of - the - art performance .	have been applied to medical image segmentation	and have achieved state - of - the - art performance .	1-28	1-28	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	29-38	43-61	Due to the importance of chest x - ray data	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	Due to the importance of chest x - ray data	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	29-71	29-71	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	1>2	none	cause-result	cause-result
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	29-38	39-42	Due to the importance of chest x - ray data	in studying COVID-19 ,	Due to the importance of chest x - ray data	in studying COVID-19 ,	29-71	29-71	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	1-4,10-16	43-61	A number of methods <*> have been applied to medical image segmentation	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	A number of methods <*> have been applied to medical image segmentation	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	1-28	29-71	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	43-61	62-71	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	before obtaining mask annotations about this sort of dataset .	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	before obtaining mask annotations about this sort of dataset .	29-71	29-71	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	1<2	none	temporal	temporal
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	43-61	72-73,81-86	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	The dataset <*> is from Montgomery and Shenzhen hospital	there is a demand for state - of - art models capable of precisely segmenting chest x - rays	The dataset <*> is from Montgomery and Shenzhen hospital	29-71	72-92	Due to the importance of chest x - ray data in studying COVID-19 , there is a demand for state - of - art models capable of precisely segmenting chest x - rays before obtaining mask annotations about this sort of dataset .	The dataset for exploring best pre - trained model is from Montgomery and Shenzhen hospital which had opened in 2014 .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	72-73,81-86	74-80	The dataset <*> is from Montgomery and Shenzhen hospital	for exploring best pre - trained model	The dataset <*> is from Montgomery and Shenzhen hospital	for exploring best pre - trained model	72-92	72-92	The dataset for exploring best pre - trained model is from Montgomery and Shenzhen hospital which had opened in 2014 .	The dataset for exploring best pre - trained model is from Montgomery and Shenzhen hospital which had opened in 2014 .	1<2	none	enablement	enablement
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	81-86	87-92	is from Montgomery and Shenzhen hospital	which had opened in 2014 .	is from Montgomery and Shenzhen hospital	which had opened in 2014 .	72-92	72-92	The dataset for exploring best pre - trained model is from Montgomery and Shenzhen hospital which had opened in 2014 .	The dataset for exploring best pre - trained model is from Montgomery and Shenzhen hospital which had opened in 2014 .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	1-4,10-16	93-100	A number of methods <*> have been applied to medical image segmentation	The most famous technique is U - Net	A number of methods <*> have been applied to medical image segmentation	The most famous technique is U - Net	1-28	93-115	A number of methods based on the deep learning have been applied to medical image segmentation and have achieved state - of - the - art performance .	The most famous technique is U - Net which has been used to many medical datasets including the Chest X - ray .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	93-100	101-108	The most famous technique is U - Net	which has been used to many medical datasets	The most famous technique is U - Net	which has been used to many medical datasets	93-115	93-115	The most famous technique is U - Net which has been used to many medical datasets including the Chest X - ray .	The most famous technique is U - Net which has been used to many medical datasets including the Chest X - ray .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	101-108	109-115	which has been used to many medical datasets	including the Chest X - ray .	which has been used to many medical datasets	including the Chest X - ray .	93-115	93-115	The most famous technique is U - Net which has been used to many medical datasets including the Chest X - ray .	The most famous technique is U - Net which has been used to many medical datasets including the Chest X - ray .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	93-100	116-135	The most famous technique is U - Net	However , most of variant U - Net mainly focus on extraction of contextual information and dense skip connection .	The most famous technique is U - Net	However , most of variant U - Net mainly focus on extraction of contextual information and dense skip connection .	93-115	116-135	The most famous technique is U - Net which has been used to many medical datasets including the Chest X - ray .	However , most of variant U - Net mainly focus on extraction of contextual information and dense skip connection .	1<2	none	comparison	comparison
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	116-135	136-141	However , most of variant U - Net mainly focus on extraction of contextual information and dense skip connection .	There is still a large space	However , most of variant U - Net mainly focus on extraction of contextual information and dense skip connection .	There is still a large space	116-135	136-148	However , most of variant U - Net mainly focus on extraction of contextual information and dense skip connection .	There is still a large space for improving extraction of spatial feature .	1<2	none	cause-result	cause-result
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	136-141	142-148	There is still a large space	for improving extraction of spatial feature .	There is still a large space	for improving extraction of spatial feature .	136-148	136-148	There is still a large space for improving extraction of spatial feature .	There is still a large space for improving extraction of spatial feature .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	149-167	168-183	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network ,	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network ,	149-190	149-190	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	1<2	none	manner-means	manner-means
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	149-167	184-190	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	which is named DEFU - Net .	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	which is named DEFU - Net .	149-190	149-190	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	149-167	191-199	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	The densely connected recurrent path extends the network deeper	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	The densely connected recurrent path extends the network deeper	149-190	191-205	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	The densely connected recurrent path extends the network deeper for facilitating context feature extraction .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	191-199	200-205	The densely connected recurrent path extends the network deeper	for facilitating context feature extraction .	The densely connected recurrent path extends the network deeper	for facilitating context feature extraction .	191-205	191-205	The densely connected recurrent path extends the network deeper for facilitating context feature extraction .	The densely connected recurrent path extends the network deeper for facilitating context feature extraction .	1<2	none	enablement	enablement
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	206-213	220-228	In order to increase the width of network	the inception blocks with dilation have been used .	In order to increase the width of network	the inception blocks with dilation have been used .	206-228	206-228	In order to increase the width of network and enrich representation of features , the inception blocks with dilation have been used .	In order to increase the width of network and enrich representation of features , the inception blocks with dilation have been used .	1>2	none	enablement	enablement
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	206-213	214-219	In order to increase the width of network	and enrich representation of features ,	In order to increase the width of network	and enrich representation of features ,	206-228	206-228	In order to increase the width of network and enrich representation of features , the inception blocks with dilation have been used .	In order to increase the width of network and enrich representation of features , the inception blocks with dilation have been used .	1<2	none	joint	joint
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	191-199	220-228	The densely connected recurrent path extends the network deeper	the inception blocks with dilation have been used .	The densely connected recurrent path extends the network deeper	the inception blocks with dilation have been used .	191-205	206-228	The densely connected recurrent path extends the network deeper for facilitating context feature extraction .	In order to increase the width of network and enrich representation of features , the inception blocks with dilation have been used .	1<2	none	joint	joint
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	220-228	229-243	the inception blocks with dilation have been used .	The inception blocks can capture globally and locally spatial information by various receptive fields .	the inception blocks with dilation have been used .	The inception blocks can capture globally and locally spatial information by various receptive fields .	206-228	229-243	In order to increase the width of network and enrich representation of features , the inception blocks with dilation have been used .	The inception blocks can capture globally and locally spatial information by various receptive fields .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	191-199	244-264	The densely connected recurrent path extends the network deeper	Meanwhile , the features fusion of two path by summation preserve the context and the spatial information for decoding part .	The densely connected recurrent path extends the network deeper	Meanwhile , the features fusion of two path by summation preserve the context and the spatial information for decoding part .	191-205	244-264	The densely connected recurrent path extends the network deeper for facilitating context feature extraction .	Meanwhile , the features fusion of two path by summation preserve the context and the spatial information for decoding part .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	244-264	265-283	Meanwhile , the features fusion of two path by summation preserve the context and the spatial information for decoding part .	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers	Meanwhile , the features fusion of two path by summation preserve the context and the spatial information for decoding part .	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers	244-264	265-290	Meanwhile , the features fusion of two path by summation preserve the context and the spatial information for decoding part .	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers ( Montgomery and Shenzhen hospital ) .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	265-283	284-290	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers	( Montgomery and Shenzhen hospital ) .	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers	( Montgomery and Shenzhen hospital ) .	265-290	265-290	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers ( Montgomery and Shenzhen hospital ) .	This multi - learning - scale model are benefiting in Chest X - ray dataset from two different manufacturers ( Montgomery and Shenzhen hospital ) .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	149-167	291-324	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	The DEFU - Net achieves the better performance than basic U - Net , residual U - Net , BCDU - Net , modified R2U - Net and modified attention R2U - Net .	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	The DEFU - Net achieves the better performance than basic U - Net , residual U - Net , BCDU - Net , modified R2U - Net and modified attention R2U - Net .	149-190	291-324	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	The DEFU - Net achieves the better performance than basic U - Net , residual U - Net , BCDU - Net , modified R2U - Net and modified attention R2U - Net .	1<2	none	findings	findings
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	291-324	325-334	The DEFU - Net achieves the better performance than basic U - Net , residual U - Net , BCDU - Net , modified R2U - Net and modified attention R2U - Net .	This model is proved the feasibility for mixed dataset .	The DEFU - Net achieves the better performance than basic U - Net , residual U - Net , BCDU - Net , modified R2U - Net and modified attention R2U - Net .	This model is proved the feasibility for mixed dataset .	291-324	325-334	The DEFU - Net achieves the better performance than basic U - Net , residual U - Net , BCDU - Net , modified R2U - Net and modified attention R2U - Net .	This model is proved the feasibility for mixed dataset .	1<2	none	elaboration	elaboration
eeb7b153d2cd9b4aa3ce620bb2f1e538596a9309	149-167	335-347	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	The open source code for this proposed framework will be public soon .	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays	The open source code for this proposed framework will be public soon .	149-190	335-347	In this paper , we propose a dual encoder fusion U - Net framework for Chest X - rays based on Inception Convolutional Neural Network with dilation , Densely Connected Recurrent Convolutional Neural Network , which is named DEFU - Net .	The open source code for this proposed framework will be public soon .	1<2	none	elaboration	elaboration
f26b4d2b79d661c896a22c4050ae0818effafe8f	1-16	146-179	Porcine reproductive and respiratory syndrome virus ( PRRSV ) is an economically important swine pathogen .	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development ,	Porcine reproductive and respiratory syndrome virus ( PRRSV ) is an economically important swine pathogen .	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development ,	1-16	146-204	Porcine reproductive and respiratory syndrome virus ( PRRSV ) is an economically important swine pathogen .	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development , and provided a perspective on potential novel strategies and approaches that may be applicable to the development of the next generation of PRRSV vaccines .	1>2	none	background	background
f26b4d2b79d661c896a22c4050ae0818effafe8f	1-16	17-39	Porcine reproductive and respiratory syndrome virus ( PRRSV ) is an economically important swine pathogen .	Since its discovery in the early 1990s , tremendous progresses have been made in understanding the molecular biology and pathogenesis of PRRSV .	Porcine reproductive and respiratory syndrome virus ( PRRSV ) is an economically important swine pathogen .	Since its discovery in the early 1990s , tremendous progresses have been made in understanding the molecular biology and pathogenesis of PRRSV .	1-16	17-39	Porcine reproductive and respiratory syndrome virus ( PRRSV ) is an economically important swine pathogen .	Since its discovery in the early 1990s , tremendous progresses have been made in understanding the molecular biology and pathogenesis of PRRSV .	1<2	none	elaboration	elaboration
f26b4d2b79d661c896a22c4050ae0818effafe8f	40-62	63-69	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade ,	the disease remains difficult to control .	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade ,	the disease remains difficult to control .	40-69	40-69	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade , the disease remains difficult to control .	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade , the disease remains difficult to control .	1>2	none	comparison	comparison
f26b4d2b79d661c896a22c4050ae0818effafe8f	17-39	63-69	Since its discovery in the early 1990s , tremendous progresses have been made in understanding the molecular biology and pathogenesis of PRRSV .	the disease remains difficult to control .	Since its discovery in the early 1990s , tremendous progresses have been made in understanding the molecular biology and pathogenesis of PRRSV .	the disease remains difficult to control .	17-39	40-69	Since its discovery in the early 1990s , tremendous progresses have been made in understanding the molecular biology and pathogenesis of PRRSV .	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade , the disease remains difficult to control .	1<2	none	comparison	comparison
f26b4d2b79d661c896a22c4050ae0818effafe8f	40-62	70-81	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade ,	The efficacies of these vaccines especially against heterologous strains remain questionable :	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade ,	The efficacies of these vaccines especially against heterologous strains remain questionable :	40-69	70-81	Although modified live - attenuated vaccines ( MLVs ) and inactivated vaccines against PRRSV have been available for more than a decade , the disease remains difficult to control .	The efficacies of these vaccines especially against heterologous strains remain questionable :	1<2	none	elaboration	elaboration
f26b4d2b79d661c896a22c4050ae0818effafe8f	70-81	82-97	The efficacies of these vaccines especially against heterologous strains remain questionable :	the MLVs were generally effective against homologous strains but variable in success against heterologous strains ,	The efficacies of these vaccines especially against heterologous strains remain questionable :	the MLVs were generally effective against homologous strains but variable in success against heterologous strains ,	70-81	82-111	The efficacies of these vaccines especially against heterologous strains remain questionable :	the MLVs were generally effective against homologous strains but variable in success against heterologous strains , and the outcomes of inactivated vaccines in the field are not very promising .	1<2	none	elaboration	elaboration
f26b4d2b79d661c896a22c4050ae0818effafe8f	82-97	98-111	the MLVs were generally effective against homologous strains but variable in success against heterologous strains ,	and the outcomes of inactivated vaccines in the field are not very promising .	the MLVs were generally effective against homologous strains but variable in success against heterologous strains ,	and the outcomes of inactivated vaccines in the field are not very promising .	82-111	82-111	the MLVs were generally effective against homologous strains but variable in success against heterologous strains , and the outcomes of inactivated vaccines in the field are not very promising .	the MLVs were generally effective against homologous strains but variable in success against heterologous strains , and the outcomes of inactivated vaccines in the field are not very promising .	1<2	none	joint	joint
f26b4d2b79d661c896a22c4050ae0818effafe8f	70-81	112-145	The efficacies of these vaccines especially against heterologous strains remain questionable :	With the development of PRRSV reverse genetics systems and the acquisition of new understanding on anti - PRRSV immunity , rational design of the next generation of PRRSV vaccines can now be explored .	The efficacies of these vaccines especially against heterologous strains remain questionable :	With the development of PRRSV reverse genetics systems and the acquisition of new understanding on anti - PRRSV immunity , rational design of the next generation of PRRSV vaccines can now be explored .	70-81	112-145	The efficacies of these vaccines especially against heterologous strains remain questionable :	With the development of PRRSV reverse genetics systems and the acquisition of new understanding on anti - PRRSV immunity , rational design of the next generation of PRRSV vaccines can now be explored .	1<2	none	comparison	comparison
f26b4d2b79d661c896a22c4050ae0818effafe8f	146-179	180-189	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development ,	and provided a perspective on potential novel strategies and approaches	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development ,	and provided a perspective on potential novel strategies and approaches	146-204	146-204	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development , and provided a perspective on potential novel strategies and approaches that may be applicable to the development of the next generation of PRRSV vaccines .	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development , and provided a perspective on potential novel strategies and approaches that may be applicable to the development of the next generation of PRRSV vaccines .	1<2	none	elaboration	elaboration
f26b4d2b79d661c896a22c4050ae0818effafe8f	180-189	190-204	and provided a perspective on potential novel strategies and approaches	that may be applicable to the development of the next generation of PRRSV vaccines .	and provided a perspective on potential novel strategies and approaches	that may be applicable to the development of the next generation of PRRSV vaccines .	146-204	146-204	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development , and provided a perspective on potential novel strategies and approaches that may be applicable to the development of the next generation of PRRSV vaccines .	In this review , we discussed the recent advances in anti - PRRSV immunity and vaccinology , the recent progresses in PRRSV vaccine development particularly the reverse genetics system - based vaccine development , and provided a perspective on potential novel strategies and approaches that may be applicable to the development of the next generation of PRRSV vaccines .	1<2	none	elaboration	elaboration
f7185938312bfa794681998fe0bff4e2697c053d	1-11	140-150,161-164	The development of synthetic peptide - based vaccines has many advantages	Here , we summarize micro - and nanoparticulated vaccine delivery systems <*> as well as strategies	The development of synthetic peptide - based vaccines has many advantages	Here , we summarize micro - and nanoparticulated vaccine delivery systems <*> as well as strategies	1-29	140-169	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	Here , we summarize micro - and nanoparticulated vaccine delivery systems used in the field of synthetic peptide - based vaccines as well as strategies to increase their immunogenicity .	1>2	none	background	background
f7185938312bfa794681998fe0bff4e2697c053d	1-11	12-15	The development of synthetic peptide - based vaccines has many advantages	in comparison with vaccines	The development of synthetic peptide - based vaccines has many advantages	in comparison with vaccines	1-29	1-29	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	1<2	none	comparison	comparison
f7185938312bfa794681998fe0bff4e2697c053d	12-15	16-29	in comparison with vaccines	based on live attenuated organisms , inactivated or killed organism , or toxins .	in comparison with vaccines	based on live attenuated organisms , inactivated or killed organism , or toxins .	1-29	1-29	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	1<2	none	manner-means	manner-means
f7185938312bfa794681998fe0bff4e2697c053d	1-11	30-41	The development of synthetic peptide - based vaccines has many advantages	Peptide - based vaccines can not revert to a virulent form ,	The development of synthetic peptide - based vaccines has many advantages	Peptide - based vaccines can not revert to a virulent form ,	1-29	30-54	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	Peptide - based vaccines can not revert to a virulent form , allow a better conservation , and are produced more easily and safely .	1<2	none	elaboration	elaboration
f7185938312bfa794681998fe0bff4e2697c053d	30-41	42-46	Peptide - based vaccines can not revert to a virulent form ,	allow a better conservation ,	Peptide - based vaccines can not revert to a virulent form ,	allow a better conservation ,	30-54	30-54	Peptide - based vaccines can not revert to a virulent form , allow a better conservation , and are produced more easily and safely .	Peptide - based vaccines can not revert to a virulent form , allow a better conservation , and are produced more easily and safely .	1<2	none	joint	joint
f7185938312bfa794681998fe0bff4e2697c053d	30-41	47-54	Peptide - based vaccines can not revert to a virulent form ,	and are produced more easily and safely .	Peptide - based vaccines can not revert to a virulent form ,	and are produced more easily and safely .	30-54	30-54	Peptide - based vaccines can not revert to a virulent form , allow a better conservation , and are produced more easily and safely .	Peptide - based vaccines can not revert to a virulent form , allow a better conservation , and are produced more easily and safely .	1<2	none	joint	joint
f7185938312bfa794681998fe0bff4e2697c053d	1-11	55-66	The development of synthetic peptide - based vaccines has many advantages	However , they generate a weaker immune response than other vaccines ,	The development of synthetic peptide - based vaccines has many advantages	However , they generate a weaker immune response than other vaccines ,	1-29	55-83	The development of synthetic peptide - based vaccines has many advantages in comparison with vaccines based on live attenuated organisms , inactivated or killed organism , or toxins .	However , they generate a weaker immune response than other vaccines , and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	1<2	none	comparison	comparison
f7185938312bfa794681998fe0bff4e2697c053d	55-66	67-83	However , they generate a weaker immune response than other vaccines ,	and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	However , they generate a weaker immune response than other vaccines ,	and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	55-83	55-83	However , they generate a weaker immune response than other vaccines , and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	However , they generate a weaker immune response than other vaccines , and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	1<2	none	joint	joint
f7185938312bfa794681998fe0bff4e2697c053d	67-83	84-96	and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive ,	and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive ,	55-83	84-109	However , they generate a weaker immune response than other vaccines , and the inclusion of adjuvants and/or the use of vaccine delivery systems is almost always needed .	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive , because their particulate nature can increase cross - presentation of the peptide .	1<2	none	elaboration	elaboration
f7185938312bfa794681998fe0bff4e2697c053d	84-96	97-109	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive ,	because their particulate nature can increase cross - presentation of the peptide .	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive ,	because their particulate nature can increase cross - presentation of the peptide .	84-109	84-109	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive , because their particulate nature can increase cross - presentation of the peptide .	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive , because their particulate nature can increase cross - presentation of the peptide .	1<2	none	cause-result	cause-result
f7185938312bfa794681998fe0bff4e2697c053d	84-96	110-124	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive ,	In addition , they can be passively or actively targeted to antigen presenting cells .	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive ,	In addition , they can be passively or actively targeted to antigen presenting cells .	84-109	110-124	Among vaccine delivery systems , micro - and nanoparticulated ones are attractive , because their particulate nature can increase cross - presentation of the peptide .	In addition , they can be passively or actively targeted to antigen presenting cells .	1<2	none	elaboration	elaboration
f7185938312bfa794681998fe0bff4e2697c053d	110-124	125-139	In addition , they can be passively or actively targeted to antigen presenting cells .	Furthermore , particulate adjuvants are able to directly activate innate immune system in vivo .	In addition , they can be passively or actively targeted to antigen presenting cells .	Furthermore , particulate adjuvants are able to directly activate innate immune system in vivo .	110-124	125-139	In addition , they can be passively or actively targeted to antigen presenting cells .	Furthermore , particulate adjuvants are able to directly activate innate immune system in vivo .	1<2	none	elaboration	elaboration
f7185938312bfa794681998fe0bff4e2697c053d	140-150,161-164	151-160	Here , we summarize micro - and nanoparticulated vaccine delivery systems <*> as well as strategies	used in the field of synthetic peptide - based vaccines	Here , we summarize micro - and nanoparticulated vaccine delivery systems <*> as well as strategies	used in the field of synthetic peptide - based vaccines	140-169	140-169	Here , we summarize micro - and nanoparticulated vaccine delivery systems used in the field of synthetic peptide - based vaccines as well as strategies to increase their immunogenicity .	Here , we summarize micro - and nanoparticulated vaccine delivery systems used in the field of synthetic peptide - based vaccines as well as strategies to increase their immunogenicity .	1<2	none	elaboration	elaboration
f7185938312bfa794681998fe0bff4e2697c053d	161-164	165-169	as well as strategies	to increase their immunogenicity .	as well as strategies	to increase their immunogenicity .	140-169	140-169	Here , we summarize micro - and nanoparticulated vaccine delivery systems used in the field of synthetic peptide - based vaccines as well as strategies to increase their immunogenicity .	Here , we summarize micro - and nanoparticulated vaccine delivery systems used in the field of synthetic peptide - based vaccines as well as strategies to increase their immunogenicity .	1<2	none	enablement	enablement
f729e0e5f3472840a5f1be47d12b29c83d1c4879	1-17	92-101	Infection with Mycobacterium tuberculosis remains a major cause of morbidity and mortality all over the world .	We generated several subtypes of attenuated recombinant influenza A viruses	Infection with Mycobacterium tuberculosis remains a major cause of morbidity and mortality all over the world .	We generated several subtypes of attenuated recombinant influenza A viruses	1-17	92-121	Infection with Mycobacterium tuberculosis remains a major cause of morbidity and mortality all over the world .	We generated several subtypes of attenuated recombinant influenza A viruses expressing the 6-kDa early secretory antigenic target protein ( ESAT-6 ) of M. tuberculosis from the NS1 reading frame .	1>2	none	background	background
f729e0e5f3472840a5f1be47d12b29c83d1c4879	18-40	41-45	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal ,	there is a strong demand	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal ,	there is a strong demand	18-51	18-51	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	1>2	none	cause-result	cause-result
f729e0e5f3472840a5f1be47d12b29c83d1c4879	1-17	41-45	Infection with Mycobacterium tuberculosis remains a major cause of morbidity and mortality all over the world .	there is a strong demand	Infection with Mycobacterium tuberculosis remains a major cause of morbidity and mortality all over the world .	there is a strong demand	1-17	18-51	Infection with Mycobacterium tuberculosis remains a major cause of morbidity and mortality all over the world .	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	41-45	46-51	there is a strong demand	to develop new tuberculosis vaccines .	there is a strong demand	to develop new tuberculosis vaccines .	18-51	18-51	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	52-58	59-67	As tuberculosis is an airborne disease ,	the intranasal route of vaccination might be preferable .	As tuberculosis is an airborne disease ,	the intranasal route of vaccination might be preferable .	52-67	52-67	As tuberculosis is an airborne disease , the intranasal route of vaccination might be preferable .	As tuberculosis is an airborne disease , the intranasal route of vaccination might be preferable .	1>2	none	cause-result	cause-result
f729e0e5f3472840a5f1be47d12b29c83d1c4879	41-45	59-67	there is a strong demand	the intranasal route of vaccination might be preferable .	there is a strong demand	the intranasal route of vaccination might be preferable .	18-51	52-67	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	As tuberculosis is an airborne disease , the intranasal route of vaccination might be preferable .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	41-45	68-87	there is a strong demand	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens ,	there is a strong demand	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens ,	18-51	68-91	Since the effectiveness of the only available tuberculosis vaccine , Mycobacterium bovis bacillus Calmette - Guérin ( BCG ) , is suboptimal , there is a strong demand to develop new tuberculosis vaccines .	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens , including M. tuberculosis .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	68-87	88-91	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens ,	including M. tuberculosis .	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens ,	including M. tuberculosis .	68-91	68-91	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens , including M. tuberculosis .	Live influenza virus vaccines might be considered as potential vectors for mucosal immunization against various viral or bacterial pathogens , including M. tuberculosis .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	92-101	102-121	We generated several subtypes of attenuated recombinant influenza A viruses	expressing the 6-kDa early secretory antigenic target protein ( ESAT-6 ) of M. tuberculosis from the NS1 reading frame .	We generated several subtypes of attenuated recombinant influenza A viruses	expressing the 6-kDa early secretory antigenic target protein ( ESAT-6 ) of M. tuberculosis from the NS1 reading frame .	92-121	92-121	We generated several subtypes of attenuated recombinant influenza A viruses expressing the 6-kDa early secretory antigenic target protein ( ESAT-6 ) of M. tuberculosis from the NS1 reading frame .	We generated several subtypes of attenuated recombinant influenza A viruses expressing the 6-kDa early secretory antigenic target protein ( ESAT-6 ) of M. tuberculosis from the NS1 reading frame .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	92-101	122-133	We generated several subtypes of attenuated recombinant influenza A viruses	We were able to demonstrate the potency of influenza virus NS vectors	We generated several subtypes of attenuated recombinant influenza A viruses	We were able to demonstrate the potency of influenza virus NS vectors	92-121	122-144	We generated several subtypes of attenuated recombinant influenza A viruses expressing the 6-kDa early secretory antigenic target protein ( ESAT-6 ) of M. tuberculosis from the NS1 reading frame .	We were able to demonstrate the potency of influenza virus NS vectors to induce an M. tuberculosisspecific Th1 immune response in mice .	1<2	none	findings	findings
f729e0e5f3472840a5f1be47d12b29c83d1c4879	122-133	134-144	We were able to demonstrate the potency of influenza virus NS vectors	to induce an M. tuberculosisspecific Th1 immune response in mice .	We were able to demonstrate the potency of influenza virus NS vectors	to induce an M. tuberculosisspecific Th1 immune response in mice .	122-144	122-144	We were able to demonstrate the potency of influenza virus NS vectors to induce an M. tuberculosisspecific Th1 immune response in mice .	We were able to demonstrate the potency of influenza virus NS vectors to induce an M. tuberculosisspecific Th1 immune response in mice .	1<2	none	enablement	enablement
f729e0e5f3472840a5f1be47d12b29c83d1c4879	122-133	145-165	We were able to demonstrate the potency of influenza virus NS vectors	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that	We were able to demonstrate the potency of influenza virus NS vectors	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that	122-144	145-170	We were able to demonstrate the potency of influenza virus NS vectors to induce an M. tuberculosisspecific Th1 immune response in mice .	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that induced by BCG vaccination .	1<2	none	elaboration	elaboration
f729e0e5f3472840a5f1be47d12b29c83d1c4879	145-165	166-170	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that	induced by BCG vaccination .	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that	induced by BCG vaccination .	145-170	145-170	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that induced by BCG vaccination .	Moreover , intranasal immunization of mice and guinea pigs with such vectors induced protection against mycobacterial challenge , similar to that induced by BCG vaccination .	1<2	none	elaboration	elaboration
f72abb1b0683ec97335167e3e3b8c2790531654e	1-20	30-40	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative ,	This article summarizes the interpretation of laboratory results from rabbits .	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative ,	This article summarizes the interpretation of laboratory results from rabbits .	1-29	30-40	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative , although interpretation of the results is sometimes challenging .	This article summarizes the interpretation of laboratory results from rabbits .	1>2	none	background	background
f72abb1b0683ec97335167e3e3b8c2790531654e	1-20	21-29	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative ,	although interpretation of the results is sometimes challenging .	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative ,	although interpretation of the results is sometimes challenging .	1-29	1-29	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative , although interpretation of the results is sometimes challenging .	With rabbit patients , as in other species , analyzing blood and urine samples can be useful and informative , although interpretation of the results is sometimes challenging .	1<2	none	comparison	comparison
f72abb1b0683ec97335167e3e3b8c2790531654e	30-40	41-59	This article summarizes the interpretation of laboratory results from rabbits .	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	This article summarizes the interpretation of laboratory results from rabbits .	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	30-40	41-59	This article summarizes the interpretation of laboratory results from rabbits .	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	1<2	none	elaboration	elaboration
f72abb1b0683ec97335167e3e3b8c2790531654e	41-59	60-64	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Biochemistry evaluation can be used	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Biochemistry evaluation can be used	41-59	60-89	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Biochemistry evaluation can be used to investigate liver , kidney , and other organ function , and urinalysis results may yield additional information about kidney function and electrolyte imbalances .	1<2	none	joint	joint
f72abb1b0683ec97335167e3e3b8c2790531654e	60-64	65-75	Biochemistry evaluation can be used	to investigate liver , kidney , and other organ function ,	Biochemistry evaluation can be used	to investigate liver , kidney , and other organ function ,	60-89	60-89	Biochemistry evaluation can be used to investigate liver , kidney , and other organ function , and urinalysis results may yield additional information about kidney function and electrolyte imbalances .	Biochemistry evaluation can be used to investigate liver , kidney , and other organ function , and urinalysis results may yield additional information about kidney function and electrolyte imbalances .	1<2	none	enablement	enablement
f72abb1b0683ec97335167e3e3b8c2790531654e	41-59	76-89	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	and urinalysis results may yield additional information about kidney function and electrolyte imbalances .	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	and urinalysis results may yield additional information about kidney function and electrolyte imbalances .	41-59	60-89	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Biochemistry evaluation can be used to investigate liver , kidney , and other organ function , and urinalysis results may yield additional information about kidney function and electrolyte imbalances .	1<2	none	joint	joint
f72abb1b0683ec97335167e3e3b8c2790531654e	41-59	90-99	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Serological tests are available for several pathogens of rabbits ,	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Serological tests are available for several pathogens of rabbits ,	41-59	90-116	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Serological tests are available for several pathogens of rabbits , including Encephalitozoon cuniculi , although the significance of positive results and antibody titers is not clear .	1<2	none	joint	joint
f72abb1b0683ec97335167e3e3b8c2790531654e	90-99	100-103	Serological tests are available for several pathogens of rabbits ,	including Encephalitozoon cuniculi ,	Serological tests are available for several pathogens of rabbits ,	including Encephalitozoon cuniculi ,	90-116	90-116	Serological tests are available for several pathogens of rabbits , including Encephalitozoon cuniculi , although the significance of positive results and antibody titers is not clear .	Serological tests are available for several pathogens of rabbits , including Encephalitozoon cuniculi , although the significance of positive results and antibody titers is not clear .	1<2	none	elaboration	elaboration
f72abb1b0683ec97335167e3e3b8c2790531654e	90-99	104-116	Serological tests are available for several pathogens of rabbits ,	although the significance of positive results and antibody titers is not clear .	Serological tests are available for several pathogens of rabbits ,	although the significance of positive results and antibody titers is not clear .	90-116	90-116	Serological tests are available for several pathogens of rabbits , including Encephalitozoon cuniculi , although the significance of positive results and antibody titers is not clear .	Serological tests are available for several pathogens of rabbits , including Encephalitozoon cuniculi , although the significance of positive results and antibody titers is not clear .	1<2	none	comparison	comparison
f72abb1b0683ec97335167e3e3b8c2790531654e	41-59	117-135	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Serum protein electrophoresis aids the understanding of protein disorders and the immune response to acute and chronic inflammation .	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Serum protein electrophoresis aids the understanding of protein disorders and the immune response to acute and chronic inflammation .	41-59	117-135	Hematological parameters can yield information about the red blood cell population and leukocyte response to stress and pathogens .	Serum protein electrophoresis aids the understanding of protein disorders and the immune response to acute and chronic inflammation .	1<2	none	joint	joint
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	1-2	3-16	Background :	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	Background :	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	1-2	3-16	Background :	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	1>2	none	textual-organization	textual-organization
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	3-16	41-65	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	3-16	41-65	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	1>2	none	background	background
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	3-16	17-33	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases	3-16	17-40	Viral respiratory infection ( VRI ) is a common contraindication to elective surgery .	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases and cause outbreaks of respiratory diseases .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	17-33	34-40	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases	and cause outbreaks of respiratory diseases .	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases	and cause outbreaks of respiratory diseases .	17-40	17-40	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases and cause outbreaks of respiratory diseases .	Asymptomatic shedding among pediatric surgery patients ( PSPs ) could potentially lead to progression of symptomatic diseases and cause outbreaks of respiratory diseases .	1<2	none	cause-result	cause-result
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	66-67	68-76,84-98	Methods :	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	Methods :	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	66-67	68-98	Methods :	We collected the induced sputum from enrolled 1629 children ( under 18 years of age ) with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	1>2	none	textual-organization	textual-organization
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	41-65	68-76,84-98	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	41-65	68-98	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	We collected the induced sputum from enrolled 1629 children ( under 18 years of age ) with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	1<2	none	manner-means	manner-means
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	68-76,84-98	77-83	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	( under 18 years of age )	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	( under 18 years of age )	68-98	68-98	We collected the induced sputum from enrolled 1629 children ( under 18 years of age ) with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	We collected the induced sputum from enrolled 1629 children ( under 18 years of age ) with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	68-76,84-98	99-117	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group	We collected the induced sputum from enrolled 1629 children <*> with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group	68-98	99-136	We collected the induced sputum from enrolled 1629 children ( under 18 years of age ) with no respiratory symptom prior to pediatric surgery between March 2017 and February 2019 .	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group using a quantitative real - time reverse transcriptase polymerase chain reaction ( qRT - PCR ) assay panel .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	99-117	118-136	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group	using a quantitative real - time reverse transcriptase polymerase chain reaction ( qRT - PCR ) assay panel .	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group	using a quantitative real - time reverse transcriptase polymerase chain reaction ( qRT - PCR ) assay panel .	99-136	99-136	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group using a quantitative real - time reverse transcriptase polymerase chain reaction ( qRT - PCR ) assay panel .	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group using a quantitative real - time reverse transcriptase polymerase chain reaction ( qRT - PCR ) assay panel .	1<2	none	manner-means	manner-means
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	99-117	137-144	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group	We analyzed symptom data and quantitative viral load	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group	We analyzed symptom data and quantitative viral load	99-136	137-163	We tested 16 different respiratory virus infections in post - surgery mild symptomatic PSP group and asymptomatic PSP group using a quantitative real - time reverse transcriptase polymerase chain reaction ( qRT - PCR ) assay panel .	We analyzed symptom data and quantitative viral load to investigate the association between viruses , symptoms and viral quantity in qRT - PCR - positive PSPs .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	137-144	145-163	We analyzed symptom data and quantitative viral load	to investigate the association between viruses , symptoms and viral quantity in qRT - PCR - positive PSPs .	We analyzed symptom data and quantitative viral load	to investigate the association between viruses , symptoms and viral quantity in qRT - PCR - positive PSPs .	137-163	137-163	We analyzed symptom data and quantitative viral load to investigate the association between viruses , symptoms and viral quantity in qRT - PCR - positive PSPs .	We analyzed symptom data and quantitative viral load to investigate the association between viruses , symptoms and viral quantity in qRT - PCR - positive PSPs .	1<2	none	enablement	enablement
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	164-165	166-181,186	Results :	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	Results :	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	164-165	166-200	Results :	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	1>2	none	textual-organization	textual-organization
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	41-65	166-181,186	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	41-65	166-200	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	1<2	none	findings	findings
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	166-181,186	182-185	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	( 10.50 % )	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	( 10.50 % )	166-200	166-200	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	186	187-200	PSPs	including 47 patients with mild symptoms and 124 with no symptoms after surgery .	PSPs	including 47 patients with mild symptoms and 124 with no symptoms after surgery .	166-200	166-200	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	166-181,186	201-208,218-220	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	Commonly detected viruses were human rhino / enterovirus <*> parainfluenza virus 3	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 <*> PSPs	Commonly detected viruses were human rhino / enterovirus <*> parainfluenza virus 3	166-200	201-251	Out of 1629 children enrolled , a total of 204 respiratory viruses were present in 171 ( 10.50 % ) PSPs including 47 patients with mild symptoms and 124 with no symptoms after surgery .	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	201-208,218-220	209-217	Commonly detected viruses were human rhino / enterovirus <*> parainfluenza virus 3	( HRV / EV , 42.19 % ) ,	Commonly detected viruses were human rhino / enterovirus <*> parainfluenza virus 3	( HRV / EV , 42.19 % ) ,	201-251	201-251	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	218-220,228	221-227	parainfluenza virus 3 <*> coronavirus	( PIV3 , 24.48 % ) ,	parainfluenza virus 3 <*> coronavirus	( PIV3 , 24.48 % ) ,	201-251	201-251	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	228,241-244	229-240	coronavirus <*> and respiratory syncytial virus	( CoV NL63 , OC43 , HKU1 , 11.46 % ) ,	coronavirus <*> and respiratory syncytial virus	( CoV NL63 , OC43 , HKU1 , 11.46 % ) ,	201-251	201-251	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	241-244	245-251	and respiratory syncytial virus	( RSV , 9.9 % ) .	and respiratory syncytial virus	( RSV , 9.9 % ) .	201-251	201-251	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	201-208,218-220	252-263	Commonly detected viruses were human rhino / enterovirus <*> parainfluenza virus 3	PIV3 infection with a higher viral load was frequently found in PSPs	Commonly detected viruses were human rhino / enterovirus <*> parainfluenza virus 3	PIV3 infection with a higher viral load was frequently found in PSPs	201-251	252-277	Commonly detected viruses were human rhino / enterovirus ( HRV / EV , 42.19 % ) , parainfluenza virus 3 ( PIV3 , 24.48 % ) , coronavirus ( CoV NL63 , OC43 , HKU1 , 11.46 % ) , and respiratory syncytial virus ( RSV , 9.9 % ) .	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	252-263	264-268	PIV3 infection with a higher viral load was frequently found in PSPs	presenting with mild symptoms ,	PIV3 infection with a higher viral load was frequently found in PSPs	presenting with mild symptoms ,	252-277	252-277	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	252-263	269-277	PIV3 infection with a higher viral load was frequently found in PSPs	progressing to pneumonia with radiographic evidence after surgery .	PIV3 infection with a higher viral load was frequently found in PSPs	progressing to pneumonia with radiographic evidence after surgery .	252-277	252-277	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	1<2	none	cause-result	cause-result
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	252-263	278-294	PIV3 infection with a higher viral load was frequently found in PSPs	HRV / EV were the most commonly detected pathogens in both asymptomatic and mild symptomatic PSPs .	PIV3 infection with a higher viral load was frequently found in PSPs	HRV / EV were the most commonly detected pathogens in both asymptomatic and mild symptomatic PSPs .	252-277	278-294	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	HRV / EV were the most commonly detected pathogens in both asymptomatic and mild symptomatic PSPs .	1<2	none	joint	joint
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	252-263	295-319	PIV3 infection with a higher viral load was frequently found in PSPs	CoV ( OC43 , HKU1 ) infections with a higher viral load were mostly observed in asymptomatic PSPs progressing to alveolar or interstitial infiltration .	PIV3 infection with a higher viral load was frequently found in PSPs	CoV ( OC43 , HKU1 ) infections with a higher viral load were mostly observed in asymptomatic PSPs progressing to alveolar or interstitial infiltration .	252-277	295-319	PIV3 infection with a higher viral load was frequently found in PSPs presenting with mild symptoms , progressing to pneumonia with radiographic evidence after surgery .	CoV ( OC43 , HKU1 ) infections with a higher viral load were mostly observed in asymptomatic PSPs progressing to alveolar or interstitial infiltration .	1<2	none	joint	joint
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	320-321	325-336	Conclusions :	that PIV3 is a new risk factor for VRI in PSPs .	Conclusions :	that PIV3 is a new risk factor for VRI in PSPs .	320-321	322-336	Conclusions :	Our study suggested that PIV3 is a new risk factor for VRI in PSPs .	1>2	none	textual-organization	textual-organization
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	322-324	325-336	Our study suggested	that PIV3 is a new risk factor for VRI in PSPs .	Our study suggested	that PIV3 is a new risk factor for VRI in PSPs .	322-336	322-336	Our study suggested that PIV3 is a new risk factor for VRI in PSPs .	Our study suggested that PIV3 is a new risk factor for VRI in PSPs .	1>2	none	attribution	attribution
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	41-65	325-336	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	that PIV3 is a new risk factor for VRI in PSPs .	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	that PIV3 is a new risk factor for VRI in PSPs .	41-65	322-336	The aim of this study is to investigate the incidence of infection among mild symptomatic PSP group and asymptomatic PSP group after surgical procedure .	Our study suggested that PIV3 is a new risk factor for VRI in PSPs .	1<2	none	findings	findings
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	325-336	337-354	that PIV3 is a new risk factor for VRI in PSPs .	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses	that PIV3 is a new risk factor for VRI in PSPs .	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses	322-336	337-362	Our study suggested that PIV3 is a new risk factor for VRI in PSPs .	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses in order to guide optimal surgical timing .	1<2	none	elaboration	elaboration
f849d3e71f4d2eae8a1e39802195bc9c06fc30ae	337-354	355-362	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses	in order to guide optimal surgical timing .	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses	in order to guide optimal surgical timing .	337-362	337-362	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses in order to guide optimal surgical timing .	Employing a more comprehensive , sensitive and quantitative method should be considered for preoperative testing of respiratory viruses in order to guide optimal surgical timing .	1<2	none	enablement	enablement
faffbac0e2a22d215556feec30516c1a6ccdb283	1-21	38-43	The computational search of chemical libraries has been used as a powerful tool for the rapid discovery of candidate compounds .	we utilized a virtual screening technique	The computational search of chemical libraries has been used as a powerful tool for the rapid discovery of candidate compounds .	we utilized a virtual screening technique	1-21	22-61	The computational search of chemical libraries has been used as a powerful tool for the rapid discovery of candidate compounds .	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	1>2	none	background	background
faffbac0e2a22d215556feec30516c1a6ccdb283	22-37	38-43	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties ,	we utilized a virtual screening technique	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties ,	we utilized a virtual screening technique	22-61	22-61	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	1>2	none	enablement	enablement
faffbac0e2a22d215556feec30516c1a6ccdb283	38-43	44-61	we utilized a virtual screening technique	to identify the active site on the viral protease for the binding of the available natural compounds .	we utilized a virtual screening technique	to identify the active site on the viral protease for the binding of the available natural compounds .	22-61	22-61	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	1<2	none	enablement	enablement
faffbac0e2a22d215556feec30516c1a6ccdb283	38-43	62-86	we utilized a virtual screening technique	The protease 3CL ( 3CL pro ) plays an important role in the replication cycle of FIPV and other viruses within the family Coronaviridae .	we utilized a virtual screening technique	The protease 3CL ( 3CL pro ) plays an important role in the replication cycle of FIPV and other viruses within the family Coronaviridae .	22-61	62-86	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	The protease 3CL ( 3CL pro ) plays an important role in the replication cycle of FIPV and other viruses within the family Coronaviridae .	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	62-86	87-95,102-107	The protease 3CL ( 3CL pro ) plays an important role in the replication cycle of FIPV and other viruses within the family Coronaviridae .	The 15 best - ranked candidate consensus compounds , <*> were evaluated for further assays .	The protease 3CL ( 3CL pro ) plays an important role in the replication cycle of FIPV and other viruses within the family Coronaviridae .	The 15 best - ranked candidate consensus compounds , <*> were evaluated for further assays .	62-86	87-107	The protease 3CL ( 3CL pro ) plays an important role in the replication cycle of FIPV and other viruses within the family Coronaviridae .	The 15 best - ranked candidate consensus compounds , based on three docking tools , were evaluated for further assays .	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	87-95,102-107	96-101	The 15 best - ranked candidate consensus compounds , <*> were evaluated for further assays .	based on three docking tools ,	The 15 best - ranked candidate consensus compounds , <*> were evaluated for further assays .	based on three docking tools ,	87-107	87-107	The 15 best - ranked candidate consensus compounds , based on three docking tools , were evaluated for further assays .	The 15 best - ranked candidate consensus compounds , based on three docking tools , were evaluated for further assays .	1<2	none	manner-means	manner-means
faffbac0e2a22d215556feec30516c1a6ccdb283	87-95,102-107	108-118	The 15 best - ranked candidate consensus compounds , <*> were evaluated for further assays .	The protease inhibitor assay on recombinant FIPV 3CL pro was performed	The 15 best - ranked candidate consensus compounds , <*> were evaluated for further assays .	The protease inhibitor assay on recombinant FIPV 3CL pro was performed	87-107	108-140	The 15 best - ranked candidate consensus compounds , based on three docking tools , were evaluated for further assays .	The protease inhibitor assay on recombinant FIPV 3CL pro was performed to screen the inhibitory effect of the candidate compounds with IC 50 ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	108-118	119-130	The protease inhibitor assay on recombinant FIPV 3CL pro was performed	to screen the inhibitory effect of the candidate compounds with IC 50	The protease inhibitor assay on recombinant FIPV 3CL pro was performed	to screen the inhibitory effect of the candidate compounds with IC 50	108-140	108-140	The protease inhibitor assay on recombinant FIPV 3CL pro was performed to screen the inhibitory effect of the candidate compounds with IC 50 ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	The protease inhibitor assay on recombinant FIPV 3CL pro was performed to screen the inhibitory effect of the candidate compounds with IC 50 ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	1<2	none	enablement	enablement
faffbac0e2a22d215556feec30516c1a6ccdb283	119-130	131-140	to screen the inhibitory effect of the candidate compounds with IC 50	ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	to screen the inhibitory effect of the candidate compounds with IC 50	ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	108-140	108-140	The protease inhibitor assay on recombinant FIPV 3CL pro was performed to screen the inhibitory effect of the candidate compounds with IC 50 ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	The protease inhibitor assay on recombinant FIPV 3CL pro was performed to screen the inhibitory effect of the candidate compounds with IC 50 ranging from 6.36 ± 2.15 to 78.40 ± 2.60 μM.	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	141-149	150-181	As determined by the cell - based assay ,	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	As determined by the cell - based assay ,	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	141-196	141-196	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	1>2	none	manner-means	manner-means
faffbac0e2a22d215556feec30516c1a6ccdb283	38-43	150-181	we utilized a virtual screening technique	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	we utilized a virtual screening technique	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	22-61	141-196	To find small molecules with anti - feline infectious peritonitis virus ( FIPV ) properties , we utilized a virtual screening technique to identify the active site on the viral protease for the binding of the available natural compounds .	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	1<2	none	findings	findings
faffbac0e2a22d215556feec30516c1a6ccdb283	150-181	182-196	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	including pre - viral entry , post - viral entry , and prophylactic activity .	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	including pre - viral entry , post - viral entry , and prophylactic activity .	141-196	141-196	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	150-181	197-204	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	The NSC87511 particularly yielded the best selective index	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	The NSC87511 particularly yielded the best selective index	141-196	197-217	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	The NSC87511 particularly yielded the best selective index ( > 4 ; range of SI = 13.80 - 22.90 ) .	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	197-204	205-217	The NSC87511 particularly yielded the best selective index	( > 4 ; range of SI = 13.80 - 22.90 ) .	The NSC87511 particularly yielded the best selective index	( > 4 ; range of SI = 13.80 - 22.90 ) .	197-217	197-217	The NSC87511 particularly yielded the best selective index ( > 4 ; range of SI = 13.80 - 22.90 ) .	The NSC87511 particularly yielded the best selective index ( > 4 ; range of SI = 13.80 - 22.90 ) .	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	218-220	221-234	These results indicated	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	These results indicated	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	218-239	218-239	These results indicated that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV and inhibited its replication .	These results indicated that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV and inhibited its replication .	1>2	none	attribution	attribution
faffbac0e2a22d215556feec30516c1a6ccdb283	150-181	221-234	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	141-196	218-239	As determined by the cell - based assay , the compounds NSC345647 , NSC87511 , and NSC343256 showed better EC 50 values than the broad - spectrum antiviral drug ribavirin and the protease inhibitor lopinavir , under all the test conditions including pre - viral entry , post - viral entry , and prophylactic activity .	These results indicated that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV and inhibited its replication .	1<2	none	cause-result	cause-result
faffbac0e2a22d215556feec30516c1a6ccdb283	221-234	235-239	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	and inhibited its replication .	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	and inhibited its replication .	218-239	218-239	These results indicated that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV and inhibited its replication .	These results indicated that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV and inhibited its replication .	1<2	none	elaboration	elaboration
faffbac0e2a22d215556feec30516c1a6ccdb283	221-234	240-263	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	Structural modification of these compounds may generate a higher anti - viral potency for the further development of a novel therapy against FIP .	that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV	Structural modification of these compounds may generate a higher anti - viral potency for the further development of a novel therapy against FIP .	218-239	240-263	These results indicated that the natural small - molecular compounds specifically targeted the 3CL pro of FIPV and inhibited its replication .	Structural modification of these compounds may generate a higher anti - viral potency for the further development of a novel therapy against FIP .	1<2	none	cause-result	cause-result
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	1-10	11-19	As Sun Tzu wrote in The Art of War ,	" All warfare is based on deception " .	As Sun Tzu wrote in The Art of War ,	" All warfare is based on deception " .	1-19	1-19	As Sun Tzu wrote in The Art of War , " All warfare is based on deception " .	As Sun Tzu wrote in The Art of War , " All warfare is based on deception " .	1>2	none	attribution	attribution
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	11-19	42-46	" All warfare is based on deception " .	A virus must infect ,	" All warfare is based on deception " .	A virus must infect ,	1-19	42-67	As Sun Tzu wrote in The Art of War , " All warfare is based on deception " .	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	1>2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	11-19	20-41	" All warfare is based on deception " .	He could have easily been describing the ancient battle between virus and host rather than on the lore of Chinese warfare .	" All warfare is based on deception " .	He could have easily been describing the ancient battle between virus and host rather than on the lore of Chinese warfare .	1-19	20-41	As Sun Tzu wrote in The Art of War , " All warfare is based on deception " .	He could have easily been describing the ancient battle between virus and host rather than on the lore of Chinese warfare .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	42-46	47	A virus must infect ,	replicate	A virus must infect ,	replicate	42-67	42-67	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	47	48-49	replicate	and spread	replicate	and spread	42-67	42-67	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	42-46	50-54	A virus must infect ,	for it to survive ;	A virus must infect ,	for it to survive ;	42-67	42-67	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	1<2	none	enablement	enablement
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	42-46	55-67	A virus must infect ,	the host attempting to thwart it at every step of the way .	A virus must infect ,	the host attempting to thwart it at every step of the way .	42-67	42-67	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	1<2	none	comparison	comparison
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	42-46	68-77	A virus must infect ,	This ancient battle has been waged for millions of years	A virus must infect ,	This ancient battle has been waged for millions of years	42-67	68-99	A virus must infect , replicate and spread for it to survive ; the host attempting to thwart it at every step of the way .	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	68-77	78-92	This ancient battle has been waged for millions of years	and has spawned an innumerable number of viruses , each with their own unique ways	This ancient battle has been waged for millions of years	and has spawned an innumerable number of viruses , each with their own unique ways	68-99	68-99	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	78-92	93-99	and has spawned an innumerable number of viruses , each with their own unique ways	of trying to outsmart the host .	and has spawned an innumerable number of viruses , each with their own unique ways	of trying to outsmart the host .	68-99	68-99	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	78-92	100-103	and has spawned an innumerable number of viruses , each with their own unique ways	Some viruses encode proteins	and has spawned an innumerable number of viruses , each with their own unique ways	Some viruses encode proteins	68-99	100-126	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	100-103	104-112	Some viruses encode proteins	that directly inhibit / degrade / alter host pathways	Some viruses encode proteins	that directly inhibit / degrade / alter host pathways	100-126	100-126	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	100-103	113-118	Some viruses encode proteins	and some simply have evolved ways	Some viruses encode proteins	and some simply have evolved ways	100-126	100-126	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	1<2	none	joint	joint
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	113-118	119-126	and some simply have evolved ways	to hide from the hosts detection system .	and some simply have evolved ways	to hide from the hosts detection system .	100-126	100-126	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	Some viruses encode proteins that directly inhibit / degrade / alter host pathways and some simply have evolved ways to hide from the hosts detection system .	1<2	none	enablement	enablement
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	78-92	127-135	and has spawned an innumerable number of viruses , each with their own unique ways	The host is not passive in this battle .	and has spawned an innumerable number of viruses , each with their own unique ways	The host is not passive in this battle .	68-99	127-135	This ancient battle has been waged for millions of years and has spawned an innumerable number of viruses , each with their own unique ways of trying to outsmart the host .	The host is not passive in this battle .	1<2	none	comparison	comparison
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	127-135	136-143	The host is not passive in this battle .	It has evolved complex pathways and redundant mechanisms	The host is not passive in this battle .	It has evolved complex pathways and redundant mechanisms	127-135	136-149	The host is not passive in this battle .	It has evolved complex pathways and redundant mechanisms to respond to viral interlopers .	1<2	none	elaboration	elaboration
fb824a8c9ca3c15f49dffa5e22fbfdc1b1fec4ac	136-143	144-149	It has evolved complex pathways and redundant mechanisms	to respond to viral interlopers .	It has evolved complex pathways and redundant mechanisms	to respond to viral interlopers .	136-149	136-149	It has evolved complex pathways and redundant mechanisms to respond to viral interlopers .	It has evolved complex pathways and redundant mechanisms to respond to viral interlopers .	1<2	none	enablement	enablement
fcc503a22ab18a67222842a84aa2ba08e0e4865e	1-18	98-103	It is a much desirable skill among physicians that clinical practice should be guided by ethical norms .	The present review is an attempt	It is a much desirable skill among physicians that clinical practice should be guided by ethical norms .	The present review is an attempt	1-18	98-121	It is a much desirable skill among physicians that clinical practice should be guided by ethical norms .	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	1>2	none	background	background
fcc503a22ab18a67222842a84aa2ba08e0e4865e	1-18	19-25	It is a much desirable skill among physicians that clinical practice should be guided by ethical norms .	The dissection room experience provides an opportunity	It is a much desirable skill among physicians that clinical practice should be guided by ethical norms .	The dissection room experience provides an opportunity	1-18	19-40	It is a much desirable skill among physicians that clinical practice should be guided by ethical norms .	The dissection room experience provides an opportunity for nurturing the principles of ethical practice among medical students early in the curriculum .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	19-25	26-40	The dissection room experience provides an opportunity	for nurturing the principles of ethical practice among medical students early in the curriculum .	The dissection room experience provides an opportunity	for nurturing the principles of ethical practice among medical students early in the curriculum .	19-40	19-40	The dissection room experience provides an opportunity for nurturing the principles of ethical practice among medical students early in the curriculum .	The dissection room experience provides an opportunity for nurturing the principles of ethical practice among medical students early in the curriculum .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	41-53	54-63	When the exercise of human dissection is followed within the boundaries of ethics	it effectively props an ideal example for the young minds	When the exercise of human dissection is followed within the boundaries of ethics	it effectively props an ideal example for the young minds	41-69	41-69	When the exercise of human dissection is followed within the boundaries of ethics it effectively props an ideal example for the young minds to emulate in the future .	When the exercise of human dissection is followed within the boundaries of ethics it effectively props an ideal example for the young minds to emulate in the future .	1>2	none	condition	condition
fcc503a22ab18a67222842a84aa2ba08e0e4865e	19-25	54-63	The dissection room experience provides an opportunity	it effectively props an ideal example for the young minds	The dissection room experience provides an opportunity	it effectively props an ideal example for the young minds	19-40	41-69	The dissection room experience provides an opportunity for nurturing the principles of ethical practice among medical students early in the curriculum .	When the exercise of human dissection is followed within the boundaries of ethics it effectively props an ideal example for the young minds to emulate in the future .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	54-63	64-69	it effectively props an ideal example for the young minds	to emulate in the future .	it effectively props an ideal example for the young minds	to emulate in the future .	41-69	41-69	When the exercise of human dissection is followed within the boundaries of ethics it effectively props an ideal example for the young minds to emulate in the future .	When the exercise of human dissection is followed within the boundaries of ethics it effectively props an ideal example for the young minds to emulate in the future .	1<2	none	enablement	enablement
fcc503a22ab18a67222842a84aa2ba08e0e4865e	19-25	70-88	The dissection room experience provides an opportunity	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner	The dissection room experience provides an opportunity	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner	19-40	70-97	The dissection room experience provides an opportunity for nurturing the principles of ethical practice among medical students early in the curriculum .	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner so as to set a standard for the students	1<2	none	cause-result	cause-result
fcc503a22ab18a67222842a84aa2ba08e0e4865e	70-88	89-97	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner	so as to set a standard for the students	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner	so as to set a standard for the students	70-97	70-97	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner so as to set a standard for the students	Hence in every stage of dissection room activity precious human body needs to be handled in an ethical manner so as to set a standard for the students	1<2	none	enablement	enablement
fcc503a22ab18a67222842a84aa2ba08e0e4865e	98-103	104-107	The present review is an attempt	to collate the recommendations	The present review is an attempt	to collate the recommendations	98-121	98-121	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	1<2	none	enablement	enablement
fcc503a22ab18a67222842a84aa2ba08e0e4865e	104-107	108-121	to collate the recommendations	documented by researchers as per ethical guidelines in the context of human dissection .	to collate the recommendations	documented by researchers as per ethical guidelines in the context of human dissection .	98-121	98-121	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	98-103	122-128	The present review is an attempt	The review highlights on the ethical norms	The present review is an attempt	The review highlights on the ethical norms	98-121	122-149	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	The review highlights on the ethical norms which needs to be adhered to while receiving the human body of a donor and during preservation of the same .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	122-128	129-134	The review highlights on the ethical norms	which needs to be adhered to	The review highlights on the ethical norms	which needs to be adhered to	122-149	122-149	The review highlights on the ethical norms which needs to be adhered to while receiving the human body of a donor and during preservation of the same .	The review highlights on the ethical norms which needs to be adhered to while receiving the human body of a donor and during preservation of the same .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	129-134	135-149	which needs to be adhered to	while receiving the human body of a donor and during preservation of the same .	which needs to be adhered to	while receiving the human body of a donor and during preservation of the same .	122-149	122-149	The review highlights on the ethical norms which needs to be adhered to while receiving the human body of a donor and during preservation of the same .	The review highlights on the ethical norms which needs to be adhered to while receiving the human body of a donor and during preservation of the same .	1<2	none	temporal	temporal
fcc503a22ab18a67222842a84aa2ba08e0e4865e	122-128	150-164	The review highlights on the ethical norms	It reflects on ideal ethical behaviour in the dissection room during the act of dissection	The review highlights on the ethical norms	It reflects on ideal ethical behaviour in the dissection room during the act of dissection	122-149	150-180	The review highlights on the ethical norms which needs to be adhered to while receiving the human body of a donor and during preservation of the same .	It reflects on ideal ethical behaviour in the dissection room during the act of dissection and finally emphasize on the respectful disposal of the human remains in an ethical manner .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	150-164	165-180	It reflects on ideal ethical behaviour in the dissection room during the act of dissection	and finally emphasize on the respectful disposal of the human remains in an ethical manner .	It reflects on ideal ethical behaviour in the dissection room during the act of dissection	and finally emphasize on the respectful disposal of the human remains in an ethical manner .	150-180	150-180	It reflects on ideal ethical behaviour in the dissection room during the act of dissection and finally emphasize on the respectful disposal of the human remains in an ethical manner .	It reflects on ideal ethical behaviour in the dissection room during the act of dissection and finally emphasize on the respectful disposal of the human remains in an ethical manner .	1<2	none	elaboration	elaboration
fcc503a22ab18a67222842a84aa2ba08e0e4865e	98-103	181-200	The present review is an attempt	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies	The present review is an attempt	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies	98-121	181-205	The present review is an attempt to collate the recommendations documented by researchers as per ethical guidelines in the context of human dissection .	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies used in anatomical dissection .	1<2	none	enablement	enablement
fcc503a22ab18a67222842a84aa2ba08e0e4865e	181-200	201-205	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies	used in anatomical dissection .	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies	used in anatomical dissection .	181-205	181-205	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies used in anatomical dissection .	The intended purpose of this article is to support uniform adoption of the recommendations for ethical handling of human bodies used in anatomical dissection .	1<2	none	elaboration	elaboration
